Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,regulation of immune response (GO:0050776),0.669007065588668,2.1357921226677927,0.0,0.0,0.0,40/135,9.75%,ITGB7;JAML;ITGA4;FGR;ITGAL;SLAMF7;CD300E;KLRD1;FOXP1;CD300C;CD226;LYN;TREML4;PTPN22;SAMHD1;LILRB1;CD40;SYK;BCL6;PLSCR1;CD300A;DHX58;PILRA;SELL;CD300LG;KLRK1;BIRC3;SPN;ITGB2;IRF4;CD276;DENND1B;TIRAP;AHR;TRAF3;SPPL2A;CLEC2D;ICAM1;CD300LD;IRF7
prerank,positive regulation of immune effector process (GO:0002699),0.7965985985061433,2.0559271902048275,0.0,0.005967180507210343,0.012,6/27,3.26%,CCR2;PTPRC;IL1B;LILRB1;DHX58;ANKRD17
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.8785928745121503,2.0461836800853677,0.0,0.00563567047903199,0.017,4/16,1.36%,PTPRC;KLRD1;CYRIB;LILRB1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.7136034990731118,2.0155724341341994,0.0,0.009696668324216808,0.037,17/45,10.86%,CIITA;CD44;SP100;HCK;IFNGR1;OAS2;JAK2;TRIM26;TRIM62;IRF2;STAT1;IRF4;OASL;TRIM25;ICAM1;IRF7;B2M
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.8254951189818878,1.9885465950648016,0.0,0.01790154152163103,0.078,8/21,2.87%,CARD11;PTPRC;FOXP1;TESPA1;CD226;STAP1;NFAM1;PRKCH
prerank,regulation of B cell proliferation (GO:0030888),0.7042518304993282,1.974273173328317,0.0,0.022211171887949608,0.114,12/44,8.29%,CD74;VAV3;PTPRC;LYN;TNFSF13B;CD40;CD300A;RC3H1;TIRAP;AHR;IKZF3;EPHB2
prerank,regulation of dendritic spine development (GO:0060998),-0.699480606677897,-1.972233667977386,0.0,0.33599749415672076,0.243,6/19,4.57%,TANC2;APOE;MEF2C;NLGN1;CAMK1;KIF1A
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7998212003606251,1.9670755084887925,0.0,0.021879661859771256,0.128,11/24,9.18%,ITGA4;ITGAL;PECAM1;SYK;MSN;CD177;OLR1;ITGB2;F11R;EZR;ICAM1
prerank,innate immune response (GO:0045087),0.5917333385511232,1.9663574856203803,0.0,0.019269020387866733,0.129,49/217,10.86%,CD74;CIITA;FGR;CD300E;KLRD1;IFNLR1;SP100;CYBB;ALPK1;HCK;LYN;KYNU;PLCG2;FYN;PPARG;CD40;SYK;PTX3;TRIM26;MSRB1;DHX58;REL;ANKRD17;SLA;CXCL10;CORO1A;MALT1;POLR3A;SLPI;IKBKB;ZAP70;TRIM62;STYK1;IFIH1;IRAK4;CXCL16;PTK2B;TRIM25;TLR3;CAPZA1;NRROS;IRF7;NCF2;MBL2;CYLD;RNASE6;SETD2;TRIM14;B2M
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.9294206956291814,1.9596381619894843,0.0,0.021216641803414555,0.156,5/10,1.74%,BTLA;FGR;LYN;LILRB1;CD40
prerank,T cell activation (GO:0042110),0.6608392814157182,1.9548819426394324,0.0,0.02068622575832919,0.17,13/69,5.73%,CD74;DPP4;JAML;CD44;PTPRC;LCP1;PTPN22;MSN;LFNG;ZAP70;PPP3CA;IRF4;CD276
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.6574579641200323,1.9521559896501348,0.0,0.020161837168301618,0.179,26/70,10.70%,FGR;MYO1G;VAV3;HCK;LYN;PRKCE;WIPF1;ACTR3;PLCG2;FYN;SYK;PAK1;WASF2;CRK;MYO1C;ABI1;CDC42;ELMO2;GRB2;ACTR2;WIPF3;RAC1;ARPC1B;ARPC2;ARPC4;PIK3CA
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.6517029506008204,1.945136281982177,0.0,0.021962539366815845,0.207,26/71,10.70%,FGR;MYO1G;VAV3;HCK;LYN;PRKCE;WIPF1;ACTR3;PLCG2;FYN;SYK;PAK1;WASF2;CRK;MYO1C;ABI1;CDC42;ELMO2;GRB2;ACTR2;WIPF3;RAC1;ARPC1B;ARPC2;ARPC4;PIK3CA
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.6493546959138049,1.9414679358899127,0.0,0.021726657231381247,0.218,26/73,10.70%,FGR;MYO1G;VAV3;HCK;LYN;PRKCE;WIPF1;ACTR3;PLCG2;FYN;SYK;PAK1;WASF2;CRK;MYO1C;ABI1;CDC42;ELMO2;GRB2;ACTR2;WIPF3;RAC1;ARPC1B;ARPC2;ARPC4;PIK3CA
prerank,cellular potassium ion homeostasis (GO:0030007),-0.748614167693319,-1.9399791076436905,0.0,0.27021485222844716,0.363,5/13,7.58%,KCNMA1;ATP1B3;KCNJ2;ATP1B1;ATP1A2
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.6231309403055545,1.9318689227148107,0.0,0.02406762804574838,0.255,32/104,13.62%,CARD11;KLRD1;CLEC10A;LYN;MUC3B;MUC3A;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;MALT1;IKBKB;PSMB7;PSME2;FBXW11;RPS6KA5;PDPK1;PAK2;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;TAB3;PSMD6;PSMC4;MAP3K7;PSMD10;PSMB1;FCER1G
prerank,cellular response to lectin (GO:1990858),0.6231309403055545,1.9318689227148107,0.0,0.02406762804574838,0.255,32/104,13.62%,CARD11;KLRD1;CLEC10A;LYN;MUC3B;MUC3A;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;MALT1;IKBKB;PSMB7;PSME2;FBXW11;RPS6KA5;PDPK1;PAK2;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;TAB3;PSMD6;PSMC4;MAP3K7;PSMD10;PSMB1;FCER1G
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.6231224085084677,1.9305957152039268,0.0,0.023309298856290402,0.26,32/105,13.62%,CARD11;KLRD1;CLEC10A;LYN;MUC3B;MUC3A;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;MALT1;IKBKB;PSMB7;PSME2;FBXW11;RPS6KA5;PDPK1;PAK2;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;TAB3;PSMD6;PSMC4;MAP3K7;PSMD10;PSMB1;FCER1G
prerank,negative regulation of platelet activation (GO:0010544),-0.7290453183845838,-1.9134321407735988,0.0,0.24120302040367,0.451,5/16,8.47%,APOE;PRKG1;SERPINE2;CD9;PDGFA
prerank,catecholamine metabolic process (GO:0006584),-0.7517803127270313,-1.9121274923738985,0.0023584905660377358,0.1846974177216914,0.46,4/14,1.81%,PRKN;RNF180;SNCAIP;COMT
prerank,positive regulation of interleukin-2 production (GO:0032743),0.7589885960838866,1.899880641672129,0.0,0.04288179717436452,0.439,8/25,5.83%,CCR2;CARD11;PTPRC;IL1B;PLCG2;MALT1;IRF4;GLMN
prerank,inflammatory response (GO:0006954),0.5815829323125552,1.899230410582678,0.0,0.041107243494115694,0.44,48/195,10.43%,CIITA;CCR2;ITGAL;CD44;IL1B;CYBB;FPR1;GPR68;CD40;LTB4R;XCR1;ITCH;FPR3;CCR1;NFKB1;PTX3;ADGRE5;STAT3;NFAM1;FOS;PTGER2;REL;MAPKAPK2;CXCL10;PTGER4;IKBKB;OLR1;PARP4;HP;HPR;TRAF3IP2;ITGB2;HSPG2;TAC4;ADORA1;CCRL2;AFAP1L2;F11R;NOX1;RAC1;HDAC9;IL6;TACR1;NRROS;HRH1;NLRC4;PTGER3;ANXA1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.7272345605982131,1.8990445701052194,0.0,0.039100735428825674,0.44,15/33,14.95%,CARD11;TESPA1;CD226;PTPN22;CD300A;LAPTM5;RC3H1;PRNP;EZR;KCNN4;RPS3;LGALS3;PTPRJ;RAB29;RELA
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.7698685699565629,1.8946299106412001,0.0,0.041173545499751364,0.467,7/23,8.24%,CD74;DPP4;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,regulation of interleukin-8 production (GO:0032677),0.6444861899848027,1.8927087679475003,0.0,0.04058629916412114,0.483,20/69,12.55%,CD74;PTPRC;IL1B;PTPN22;BCL3;KLF4;SYK;STAT3;HSPA1A;TIRAP;ANXA4;AFAP1L2;CD2;TLR3;IL6;ANXA1;RIPK1;CACTIN;MAP2K5;TLR2
prerank,camera-type eye morphogenesis (GO:0048593),-0.8191433287195597,-1.8827562386305732,0.0,0.21839837120186847,0.586,6/10,11.91%,SKI;LRP6;NF1;KDM2B;SHROOM2;VEGFA
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6821918836152547,-1.8779252825133037,0.0053475935828877,0.194817824172195,0.617,10/17,12.06%,CACNA1D;SLC8A1;CACNB2;CACNA2D1;KCNJ2;CACNA1C;ANK2;ATP1A2;HCN2;SCN1B
prerank,central nervous system neuron differentiation (GO:0021953),-0.5784376974490579,-1.8691284514181332,0.0,0.1921431453245619,0.665,10/33,6.91%,OPHN1;LRP6;NTRK2;MAP2;CTNNB1;MDGA2;SPOCK1;GRID2;RYK;FAIM2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.8385197841241789,1.8626838698895651,0.0,0.07174178382532435,0.693,2/12,0.33%,CCR2;IL1B
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.8599722521405374,1.8611956016282478,0.0017825311942959,0.07030895293278275,0.701,2/11,2.35%,CIITA;JAK2
prerank,anterior/posterior axis specification (GO:0009948),-0.7187499009092664,-1.858875005490483,0.0024330900243309003,0.19317325812398817,0.72,3/15,5.64%,SKI;WLS;TASOR
prerank,Fc receptor signaling pathway (GO:0038093),0.590551620240644,1.8554432961773697,0.0011560693641618498,0.07438256257251781,0.731,38/110,13.62%,CARD11;GRAP2;VAV3;LYN;PLCG2;SYK;PSME3;PAK1;NFKB1;FOS;MALT1;IKBKB;PSMB7;PSME2;PPP3CA;FBXW11;MAP3K1;GRB2;PDPK1;PAK2;PSME4;RAC1;SOS1;PSMB8;PSMD9;PSMA5;PIK3CA;PSMB3;TAB3;PSMD6;PSMC4;MAP3K7;PSMD10;BTK;PSMB1;MAPK8;KIT;FCER1G
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.7969635302627082,1.8522772138019983,0.0016286644951140066,0.07570363003480855,0.753,1/17,0.01%,PLBD1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.8394853360886128,1.8482155272765581,0.0017241379310344827,0.0783383697356845,0.781,7/12,8.53%,PTPRC;LYN;PTPN22;CD300A;RC3H1;CBFB;ELF1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.8104044254105394,1.8471814245444773,0.0017301038062283738,0.07691032653737775,0.787,5/15,4.95%,KMO;TAT;KYNU;HGD;HAAO
prerank,regulation of viral entry into host cell (GO:0046596),0.7051765406642296,1.8430624125136332,0.0015037593984962407,0.08023726646302479,0.796,7/30,7.45%,CD74;CIITA;PTX3;TRIM26;TRIM62;LGALS1;TRIM25
prerank,acute inflammatory response (GO:0002526),0.7524404375132534,1.841974782914749,0.0015698587127158557,0.07853358253742349,0.801,6/23,10.29%,PLSCR1;IL6R;HP;HPR;IL6;MBL2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.5876519104917161,1.8388420753894357,0.0011574074074074073,0.07959555776562241,0.819,37/109,13.62%,CARD11;GRAP2;VAV3;LYN;PLCG2;SYK;PSME3;PAK1;NFKB1;FOS;MALT1;IKBKB;PSMB7;PSME2;PPP3CA;FBXW11;MAP3K1;GRB2;PDPK1;PAK2;PSME4;RAC1;SOS1;PSMB8;PSMD9;PSMA5;PIK3CA;PSMB3;TAB3;PSMD6;PSMC4;MAP3K7;PSMD10;BTK;PSMB1;MAPK8;FCER1G
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.8425647557669972,1.8382977600684578,0.0,0.07782999951877577,0.821,2/12,0.33%,CCR2;IL1B
prerank,regulation of cytokine production (GO:0001817),0.5846834460400478,1.836139804795589,0.0,0.07807061163600199,0.831,32/126,10.43%,CCR2;CLEC9A;FGR;FFAR4;PTPRC;FOXP1;LYN;CD47;ACE2;BCL6;NFAM1;PLD4;MAPKAPK2;NPTN;PTGER4;EIF2AK2;ATP2B1;IL33;ADRA2A;SRGN;IFIH1;MAPK14;CD276;RPS6KA5;GLMN;TRAF3;AFAP1L2;HDAC9;IL6;IRF7;IGF2BP3;ANXA1
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.7511909181778563,1.828771407171875,0.0015151515151515152,0.08516793996654763,0.868,3/22,3.25%,CCR2;LILRB1;LAPTM5
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.8352679549193699,1.8284269490095089,0.006589785831960461,0.08339427267674847,0.87,3/12,3.76%,CD74;CD44;TAF9
prerank,positive regulation of B cell proliferation (GO:0030890),0.7110915993387971,1.8250530730888264,0.0,0.08493286921929387,0.881,5/29,1.74%,CD74;VAV3;PTPRC;TNFSF13B;CD40
prerank,regulation of collagen biosynthetic process (GO:0032965),0.7627098066960194,1.8198738898858442,0.006600660066006601,0.08953533344383668,0.897,4/19,8.68%,CIITA;VIM;SCX;IL6
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.8492296196702838,1.81850109291932,0.005110732538330494,0.08921203650194202,0.906,3/11,3.76%,CD74;CD44;TAF9
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7716965086236443,1.8183922681831992,0.001557632398753894,0.0870213823968175,0.906,6/19,8.24%,CD74;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.7447194589840243,1.8181265425898845,0.004784688995215311,0.08519807724183658,0.907,9/22,17.44%,IL1B;CYRIB;MALT1;FBXO38;STX7;B2M;MAP3K7;TRAF2;HSPD1
prerank,tryptophan metabolic process (GO:0006568),0.8608864328195023,1.8175690089416445,0.003629764065335753,0.08413724515166583,0.907,5/11,10.21%,KMO;KYNU;HAAO;ATP7A;KYAT1
prerank,T cell activation involved in immune response (GO:0002286),0.8381612538194911,1.8162311355317429,0.0017699115044247787,0.08431674570350874,0.912,4/12,1.36%,CD74;ITGAL;LCP1;LILRB1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8013366033178115,1.8131074076695364,0.006568144499178982,0.08754232672681206,0.927,4/14,3.25%,CD74;PLCG2;LILRB1;LAPTM5
prerank,positive regulation of cytokine production (GO:0001819),0.5419781046925501,1.8131066286362543,0.0,0.08550645866339783,0.927,53/292,8.68%,CD74;CCR2;CLEC9A;CARD11;FGR;PTPRC;IL1B;FOXP1;RARA;CYRIB;CD226;PTPN22;PAEP;PLCG2;LILRB1;SULF2;CD40;SYK;POLR3F;NFKB1;STAT3;HSPA1A;NFAM1;DHX58;LAPTM5;SORL1;MALT1;POLR3A;PTGER4;EIF2AK2;MRE11;IL6R;LRRFIP1;IL33;ADRA2A;RAB7B;IRF4;IFIH1;MAPK14;CD276;GLMN;IL17RA;TIRAP;ADAM17;DDX41;TMED10;PLCB1;AFAP1L2;CD2;NOX1;TLR3;IL6ST;IL6
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7938169686101385,1.8094209890018897,0.0032414910858995136,0.08869400117535374,0.935,2/15,1.95%,CCR2;SYK
prerank,regulation of B cell activation (GO:0050864),0.7238920318021913,1.8079729951524801,0.004629629629629629,0.08897729156306977,0.939,10/25,11.74%,FOXJ1;LAPTM5;THEMIS2;AHR;IKZF3;SAMSN1;ZFP36L2;IL6;SLAMF8;FCGR2B
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.7743156823930458,-1.807448478739014,0.0,0.32970035236529627,0.909,3/10,4.11%,ABCA1;APOE;PRKACA
prerank,mesonephric tubule development (GO:0072164),-0.701239361723925,-1.8068492343192617,0.0024271844660194173,0.29875439841886736,0.911,6/15,9.27%,SALL1;ROBO2;NPNT;PKD2;FGFR2;SLIT2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.7572772654097416,1.8053541068389944,0.0029940119760479044,0.09061033878883532,0.945,5/20,1.07%,IL1B;HCK;LYN;PRKCE;PTPN22
prerank,response to axon injury (GO:0048678),-0.6571037767096988,-1.8032722112120974,0.0,0.2828193584440744,0.927,12/18,27.19%,RTN4RL1;TREM2;P2RY12;APOD;P2RX4;NREP;DPYSL3;MTR;TYROBP;SOD1;DHFR;MORN4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6145074349349248,-1.8025277301711047,0.005681818181818182,0.26135949658425645,0.928,7/20,7.58%,KCNMA1;SLC8A1;ATP1B3;KCNJ2;ATP6AP1;ATP1B1;ATP1A2
prerank,negative regulation of immune response (GO:0050777),0.5570669291882988,1.802027355683333,0.0,0.09350698816085995,0.954,37/154,13.31%,CCR2;FGR;HCK;LYN;CRHR2;CYSLTR2;PLCG2;CREB1;LILRB1;FYN;ITCH;SYK;RXFP2;CD300A;PTGER2;DHX58;SPI1;PTGER4;HTR4;MYH9;DPEP1;RC3H1;MAPK14;ADAM17;CYSLTR1;SAMSN1;GNB1;IL6;PRKAR2A;ADCY7;CACTIN;GLP2R;ACOD1;FCGR2B;ADCY5;LGALS3;GNG2
prerank,tryptophan catabolic process (GO:0006569),0.8391381496212269,1.7996781918191924,0.008944543828264758,0.09547488811536547,0.958,4/11,10.21%,KMO;KYNU;HAAO;KYAT1
prerank,melanocyte differentiation (GO:0030318),-0.748782070879659,-1.793329718648298,0.0024813895781637717,0.26764582597562697,0.939,4/11,3.12%,LRMDA;MITF;MEF2C;ENPP1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5710981730515586,-1.7917715211070848,0.003289473684210526,0.25272100679257653,0.941,7/29,9.00%,CACNA1D;WNK1;SLMAP;CD63;KCNN2;DPP10;SNTA1
prerank,indolalkylamine catabolic process (GO:0046218),0.857992050335188,1.789478571556354,0.007407407407407408,0.1105755081744284,0.974,4/10,10.21%,KMO;KYNU;HAAO;KYAT1
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7322739793527112,1.7882069386223656,0.004838709677419355,0.11031327697662856,0.975,9/21,8.53%,FOXP1;LYN;PTPN22;STAP1;NFAM1;PRKCH;CD300A;CBFB;ELF1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.8158307588052972,1.785232134575176,0.003389830508474576,0.11322042491785378,0.981,4/13,7.23%,CD74;CD44;PTTG1IP;DYRK1A
prerank,response to interferon-gamma (GO:0034341),0.6093535682244972,1.7851590591585327,0.0,0.11115786252534139,0.981,7/67,1.74%,CD74;CIITA;SP100;CD47;KYNU;DAPK1;CD40
prerank,positive regulation of immune response (GO:0050778),0.603244035637274,1.7824742626165215,0.00129366106080207,0.11343272379272493,0.982,15/64,13.34%,CD74;PTPRC;CD226;LILRB1;POLR3F;PLSCR1;CD177;ITGB2;IL6ST;IFI35;SLC15A4;FCGR2B;NLRP3;MYB;GBP5
prerank,regulation of macrophage cytokine production (GO:0010935),0.7934804590512298,1.7823727023466456,0.0032414910858995136,0.11144262113928947,0.982,4/13,3.25%,CD74;PLCG2;LILRB1;LAPTM5
prerank,negative regulation of viral entry into host cell (GO:0046597),0.7956655780772749,1.7790146864580598,0.00505902192242833,0.1151304190588129,0.983,3/12,2.60%,CIITA;PTX3;TRIM26
prerank,positive regulation of B cell activation (GO:0050871),0.6257782378835057,1.7788100654175667,0.0013245033112582781,0.11339418910279178,0.984,10/50,8.68%,CD74;VAV3;PTPRC;TNFSF13B;CD40;SYK;MAD2L2;TIRAP;EPHB2;IL6
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.6698588151755807,-1.7786285973136293,0.005208333333333333,0.27439795356132196,0.959,9/16,11.19%,SIRPA;TREM2;ABCD2;APPL2;APOD;NLRC3;PYCARD;CUEDC2;CHID1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7717068172606474,1.7781067634615517,0.001594896331738437,0.11269596168441989,0.988,6/17,8.24%,CD74;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,response to cytokine (GO:0034097),0.556206955649831,1.7757606403429884,0.0,0.1140108712426482,0.989,23/141,5.31%,CD74;CIITA;PID1;IL1B;IFNLR1;SP100;KYNU;FLT3;CD40;MCL1;MAPKAPK3;PLSCR1;JAK2;STAT3;REL;MAPKAPK2;TAF9;PTPN6;EIF2AK2;PTPN7;IL6R;PTPN12;STAT1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.7687149633330963,1.7691953640872984,0.003125,0.12295088875591029,0.991,9/18,15.26%,FFAR4;IL1B;PRKAG2;C2CD5;RTN2;BRAF;CLIP3;OCLN;SLC2A1
prerank,regulation of response to external stimulus (GO:0032101),0.5518149546117455,1.7650815652490353,0.0,0.12799602187966186,0.994,36/121,15.73%,CCR2;FGR;FOXP1;CYRIB;HCK;ACE2;SPAAR;PTPN22;SAMHD1;STK24;BCL6;JAK2;CD36;DHX58;AKNA;ADGRA2;BIRC3;TIRAP;CAMKMT;TRAF3;EPHB2;SPATA2;SBNO2;ANXA1;CYLD;FCGR2B;NMT2;AREL1;PDE6B;ADAMTS12;CASP12;RELA;MYD88;XIAP;LRP8;CELF1
prerank,regulation of monocyte differentiation (GO:0045655),0.780916754635537,1.7642115057285317,0.005084745762711864,0.12738136967987546,0.995,2/14,0.38%,CD74;FOXP1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.7824256982053593,1.7605093360073671,0.0016638935108153079,0.1314865016602236,0.997,5/13,10.95%,FGR;SYK;CD177;ITGB2;AP1G1
prerank,regulation of T cell mediated immunity (GO:0002709),0.834835067506832,1.7601225885064828,0.006791171477079796,0.13003086200500422,0.997,2/10,0.33%,CCR2;IL1B
prerank,protein autophosphorylation (GO:0046777),0.5406293244766086,1.7573471930602766,0.0,0.1328163848831427,0.998,54/157,16.75%,FGR;LRRK2;GRK5;STK10;MAP4K1;HCK;LYN;FLT3;SIK1;STK24;VRK1;DAPK1;SLK;LMTK2;MAPKAPK3;PIM1;PAK1;STK17B;JAK2;ERN1;MAPKAPK2;EIF2AK2;EIF2AK1;VRK2;TAOK3;STK4;PTK2B;PDPK1;MKNK2;PAK2;DYRK1A;SIK2;MINK1;PIKFYVE;OXSR1;CAMKK2;RIPK1;CAD;SMG1;CDK12;EIF2AK3;KIT;AKT1;MARK3;STK39;FGFR3;MAP3K13;AURKB;TAF1;INSR;DAPK3;MAP3K9;FES;HTATIP2
prerank,natural killer cell activation (GO:0030101),0.7069121481207401,1.7562898385839154,0.004709576138147566,0.13286921929388365,0.999,8/23,10.99%,SLAMF7;PTPRC;ELF4;RABL3;KLRK1;KAT7;CD2;PBX1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.62254014169356,1.7556308694741463,0.0013513513513513514,0.13185057938911743,0.999,9/48,8.49%,CCR2;IL1B;CYRIB;CD226;PTPN22;LILRB1;CD276;CD2;TLR3
prerank,positive regulation of macrophage migration (GO:1905523),-0.641209790306851,-1.7538668411235792,0.005305039787798408,0.34187998040607603,0.984,10/19,17.33%,CSF1R;TREM2;CMKLR1;P2RY12;CSF1;P2RX4;AKIRIN1;MDK;CX3CL1;CCL3
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.7547291915367815,-1.7513606001585469,0.0,0.3300443138917186,0.984,3/10,6.60%,LRP6;CTNNB1;RYK
prerank,RNA catabolic process (GO:0006401),0.6200601223201546,1.7483970774846698,0.0026917900403768506,0.1424107706123782,0.999,20/46,15.81%,DNA2;ZC3H12D;HSPA1A;ERN1;SND1;FEN1;XRN2;RNASEH2C;DCP2;LSM5;ZFP36L2;RNASE6;ZPR1;METTL3;RNASEH2A;RNASEH1;RNH1;PNPT1;NCBP1;SIDT2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.5861096294993261,1.747486031144342,0.0049813200498132005,0.14198379500979905,0.999,24/72,13.66%,CD74;PTPRC;TRAF1;IFNGR1;SYK;JAK2;PTPN6;IKBKB;VRK2;SUMO1;BIRC3;STAT1;HIPK1;CBFB;SPATA2;ELF1;SPPL2A;PTPN1;CYLD;RIPK1;RNF31;CLIP3;LIFR;AGPAT1
prerank,cellular response to ATP (GO:0071318),-0.6814017433640591,-1.7468321979408223,0.007075471698113208,0.32632688354846173,0.986,5/14,7.77%,RYR3;P2RY12;P2RX7;P2RX4;HSP90B1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.8046473563001226,1.7454176024797965,0.008291873963515755,0.14367356351660074,1.0,2/12,0.33%,CD44;IL1B
prerank,regulation of cellular component size (GO:0032535),0.6700505487276176,1.7430314634141177,0.0044444444444444444,0.14608226184556367,1.0,12/30,8.86%,VAV3;RAP1GAP2;RIN3;EPS8;MSN;PICALM;PTEN;MTPN;RARG;EZR;RAC1;PPP1R15A
prerank,positive regulation of neutrophil migration (GO:1902624),0.7435484311937424,1.7422524872449487,0.006359300476947536,0.14535547446789138,1.0,6/18,8.24%,CD74;CAMK1D;RIPOR2;RAC2;TIRAP;RAC1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.7483985192599297,1.742044294826804,0.004754358161648178,0.1437372230509973,1.0,3/17,4.55%,KCNE3;RNF207;SUMO1
prerank,lymphocyte proliferation (GO:0046651),0.7004348528203376,1.7414224461756214,0.007598784194528876,0.1428853633781326,1.0,5/22,2.53%,PTPRC;FLT3;CD40;MSN;ELF4
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.80777609937138,1.739583038690891,0.006589785831960461,0.14456973134248122,1.0,4/11,6.46%,PTPRC;KLRD1;LILRB1;AHR
prerank,alpha-amino acid catabolic process (GO:1901606),0.666790547970643,1.73881516540574,0.0029850746268656717,0.14403447704293057,1.0,8/29,11.97%,KMO;TAT;KYNU;HGD;HAAO;KYAT1;MTRR;ACAT1
prerank,positive regulation of cytokinesis (GO:0032467),0.6669080388010813,1.73784120624242,0.004373177842565598,0.14403674526943916,1.0,10/32,9.34%,SVIL;CDC14A;PRKCE;RACGAP1;CUL3;KIF23;CDC42;PKN2;RHOA;SPAST
prerank,regulation of leukocyte activation (GO:0002694),0.7693650516559273,1.7359539208747954,0.008319467554076539,0.14569219939682396,1.0,3/14,2.34%,CD74;LYN;PLSCR1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6906005201479729,-1.7348475937071401,0.011876484560570071,0.35101830794115246,0.99,10/14,25.67%,PRKG1;MEF2C;LRP1;AIF1;SLIT2;SERPINE1;IGFBP5;TRIB1;CORO1B;NDRG4
prerank,positive regulation of interleukin-8 production (GO:0032757),0.6210256452187259,1.7346585897744908,0.0025974025974025974,0.14629792551224674,1.0,10/49,8.68%,CD74;IL1B;SYK;STAT3;HSPA1A;TIRAP;AFAP1L2;CD2;TLR3;IL6
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.7728082294645752,1.7326245470804966,0.008183306055646482,0.14837381742190106,1.0,7/14,14.95%,CARD11;TESPA1;CD226;KCNN4;RPS3;RAB29;RELA
prerank,regulation of interleukin-2 production (GO:0032663),0.637070760073337,1.729440609482603,0.0013717421124828531,0.15246146195922428,1.0,13/43,10.43%,CCR2;CARD11;PTPRC;IL1B;PLCG2;LAPTM5;MALT1;IRF4;GLMN;PRNP;EZR;RPS3;ANXA1
prerank,response to molecule of bacterial origin (GO:0002237),0.583762364703194,1.7283590857313607,0.002484472049689441,0.15259283815557642,1.0,15/69,8.68%,IL1B;FOXP1;CYRIB;PTPN22;MAPKAPK3;JAK2;RPS6KA3;ERBIN;MAPKAPK2;SLPI;PELI1;TIRAP;ADAM17;IFNAR1;IL6
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5967232892663791,1.7278741117545353,0.0,0.1517386083855866,1.0,11/63,8.68%,CD74;VAV3;PTPRC;IL1B;TNFSF13B;CD40;CD276;TIRAP;EPHB2;IL6ST;IL6
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6769285794966181,1.7262297478754782,0.008902077151335312,0.15291798721489638,1.0,6/27,12.31%,CD74;CD44;PTTG1IP;DYRK1A;SPRED3;PSMD10
prerank,tyrosine metabolic process (GO:0006570),0.7996052975134516,1.7256370381487114,0.007207207207207207,0.1523880561672705,1.0,2/11,1.15%,TAT;HGD
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6982673718100552,1.7250446068067893,0.007518796992481203,0.1516950887764355,1.0,1/23,0.01%,PLBD1
prerank,negative regulation of viral life cycle (GO:1903901),0.7450954240465703,1.7246923952539013,0.006644518272425249,0.15076382223352955,1.0,3/15,2.60%,CIITA;PTX3;TRIM26
prerank,positive regulation of type 2 immune response (GO:0002830),0.7678672464464839,1.7245359142996877,0.008130081300813009,0.14924810096195062,1.0,4/14,8.68%,CD74;RARA;DENND1B;IL6
prerank,cation transmembrane transport (GO:0098655),-0.50508606073588,-1.7244795391962775,0.0,0.3709634984432108,0.994,14/44,13.00%,MFSD12;TRPM3;PKD2;SLC7A1;ATP1B1;SLC36A4;SFXN1;ATP1A2;SLC25A20;SLC22A5;SLC7A2;SLC7A8;SLC3A2;TRPM2
prerank,receptor signaling pathway via STAT (GO:0097696),0.6982497459356148,1.7227098155573695,0.007429420505200594,0.15079562406762806,1.0,9/25,10.46%,CCR2;STAT4;STAT5A;JAK2;STAT3;STAT5B;STAT1;IFNAR1;IL31RA
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.584232559618423,1.7223121372413535,0.0024479804161566705,0.14982763340950614,1.0,16/69,8.68%,CCR2;PTPRC;IFNGR1;PLCG2;OAS2;SYK;JAK2;STAT3;IL33;SPN;IFIH1;TIRAP;CD2;EPHB2;TLR3;IL6
prerank,positive regulation of locomotion (GO:0040017),-0.5646577151524533,-1.720225137515329,0.009287925696594427,0.36982856714840434,0.995,7/27,10.66%,CSF1R;TREM2;P2RY12;AIF1;CFAP20;PPM1F;CCDC25
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6580124249843127,1.7198428710533373,0.002886002886002886,0.1530692303442179,1.0,6/29,4.57%,KLRD1;CYRIB;CD226;STAP1;SPI1;KLRK1
prerank,apical junction assembly (GO:0043297),0.5972107598484375,1.716521316163018,0.008086253369272238,0.15708110884639975,1.0,15/53,15.83%,PECAM1;MARVELD3;FRMPD2;CLDN1;CTNNA1;AFDN;PKN2;PAK2;F11R;PDCD6IP;RHOA;CLDN14;TBCD;OCLN;APC
prerank,calcium ion import across plasma membrane (GO:0098703),-0.6754179249401343,-1.7153304562499236,0.012531328320802004,0.37022286869842397,0.997,5/14,13.56%,SLC8A1;CACNA2D1;TRPV2;TRPM2;TRPV4
prerank,ganglioside biosynthetic process (GO:0001574),0.7503643189174645,1.7144587833207479,0.0068143100511073255,0.15937344604674292,1.0,5/15,8.27%,ST3GAL1;ST8SIA4;ST8SIA6;B4GALT5;ST6GALNAC3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5798334174394858,1.7139827720871543,0.0012376237623762376,0.1587505280099239,1.0,16/68,12.55%,CD74;IL1B;PLCG2;SYK;STAT3;IL6R;IL33;RAB7B;IFIH1;IL17RA;TIRAP;TLR3;IL6;MBP;APP;TLR2
prerank,regulation of mRNA processing (GO:0050684),-0.5453484566291987,-1.7136302099316032,0.003215434083601286,0.3596264431302879,0.997,15/32,14.62%,QKI;SON;AHCYL1;CDK11B;SRSF3;SAFB2;SRPK1;KHDRBS3;TIA1;JMJD6;SRPK2;DHX9;KHDRBS2;IWS1;PTCD2
prerank,cellular response to interferon-gamma (GO:0071346),0.5672222311485784,1.7134214168062616,0.0012004801920768306,0.15815144365563868,1.0,25/88,14.94%,CIITA;CD44;SP100;HCK;CD47;IFNGR1;DAPK1;OAS2;JAK2;TRIM26;TRIM62;IRF2;STAT1;IRF4;OASL;TRIM25;ICAM1;IRF7;B2M;ACOD1;TLR2;GBP5;SYNCRIP;GBP2;GBP3
prerank,heart process (GO:0003015),0.7561190685830679,1.7128975389014356,0.014423076923076924,0.1576277840299406,1.0,4/14,7.08%,ACE;FYN;GPX1;SGCD
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6941742278979468,1.7127029154240263,0.013157894736842105,0.15633805735123488,1.0,3/24,3.76%,CD74;CD44;TAF9
prerank,cytokine-mediated signaling pathway (GO:0019221),0.5015554055881629,1.7123711439067575,0.0,0.1552287162872244,1.0,143/532,15.01%,CIITA;CCR2;GRAP2;CD44;IL1B;IFNLR1;SP100;TRAF1;HCK;STAT4;LCP1;FPR1;FLT3;SAMHD1;IL27RA;IFNGR1;IL18RAP;FYN;ITGAX;TNFSF13B;OAS2;CD40;MCL1;MAP3K8;CNN2;ANXA2;STAT5A;SYK;CCR1;BCL6;PSME3;PIM1;MSN;NFKB1;JAK2;STAT3;VIM;MAP3K14;TRIM26;FOS;CD36;CRK;IFIT2;SLA;IL10RA;CXCL10;GPR35;PTPN6;SPI1;STAT5B;NFKBIA;MMP1;CBL;IL6R;IKBKB;PSMB7;CDC42;PSME2;TRIM62;IRF2;BIRC3;F13A1;IL33;TRAF3IP2;STAT1;IL2RG;PELI1;ITGB2;IRF4;IRAK4;FBXW11;RPS6KA5;IL17RA;UBE2N;CCND1;GRB2;PTK2B;ADAM17;CSF2RB;TALDO1;OASL;PDCD4;PAK2;ARF1;TRIM25;TRAF3;PLCB1;IFNAR1;PSME4;IL6ST;IFI35;SOS1;IL6;HGF;CAPZA1;OPRM1;ICAM1;IL1R2;IRF7;PSMB8;SMAD4;PSMD9;LMNB1;PSMA5;FN1;ANXA1;IL31RA;PIK3CA;RIPK1;B2M;YWHAZ;IL17RB;PSMB3;FOXO3;TAB3;PSMD6;JAGN1;PSMC4;RPLP0;MAP3K7;PSMD10;SNRPA1;EBI3;HSPA9;LIFR;PSMB1;STAT2;KIT;AKT1;CSK;TNFRSF1B;JUNB;FCER1G;TYK2;IFIT1;PTPRJ;CANX;TGFB1;IL18;GBP2;RELA;IFITM3;MYD88
prerank,positive regulation of defense response to virus by host (GO:0002230),0.6874473099290896,1.7121140678301516,0.005943536404160475,0.15415216310293384,1.0,7/24,12.39%,PTPN22;LILRB1;DTX3L;TRAF3IP2;STAT1;PARP9;PQBP1
prerank,regulation of neuron apoptotic process (GO:0043523),-0.42495519492780365,-1.711530938743638,0.0,0.35202147103668485,0.997,33/96,14.18%,PRKN;LGMN;APOE;TREM2;MEF2C;NTRK2;GRN;CTNNB1;NF1;RASA1;PPARGC1A;ADAM8;GRID2;NRBP2;FAIM2;ATF4;EGLN3;CDK5R1;KDM2B;NAE1;EGLN2;BACE1;SNX6;CPEB4;PTPRZ1;CDK5;MSH2;SET;EPHA7;MDK;SRPK2;TGFB2;BAX
prerank,defense response to symbiont (GO:0140546),0.5566383640317176,1.7111236988479113,0.0,0.15447362737268258,1.0,31/92,15.01%,PTPRC;IFNLR1;SAMHD1;LILRB1;OAS2;CD40;PLSCR1;MAP3K14;IFIT2;EIF2AK2;IRF2;STAT1;IFIH1;FLNA;OASL;DDIT4;RNASE1;TLR3;IL6;IRF7;RNASE6;SETD2;ACOD1;PQBP1;TLR2;NT5C3A;STAT2;IFIT1;RELA;IFITM3;MYD88
prerank,immunoglobulin mediated immune response (GO:0016064),0.8281199728907769,1.7108737929035671,0.010889292196007259,0.15331675783192442,1.0,2/10,2.32%,CD74;GAPT
prerank,calcium ion import into cytosol (GO:1902656),-0.6558659573836934,-1.7098560147208073,0.017811704834605598,0.3430008154204693,0.997,5/15,13.56%,SLC8A1;CACNA2D1;TRPV2;TRPM2;TRPV4
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.7068614903205438,-1.7097230204590947,0.011848341232227487,0.3303534213285553,0.997,7/11,17.56%,P3H2;P4HA1;EGLN3;EGLN2;P4HB;OGFOD1;CRTAP
prerank,manganese ion transport (GO:0006828),-0.6703544984761043,-1.7095216910158757,0.015544041450777202,0.3185304222828886,0.997,7/14,16.15%,SLC11A1;TRPC4;SLC11A2;TRPC1;TRPC7;TRPC3;ATP2C1
prerank,myotube differentiation (GO:0014902),-0.6461550186517511,-1.70849959762768,0.008670520231213872,0.31019045770793646,0.997,9/17,16.24%,IGF1;SKI;MEF2C;PLD3;ADGRB3;SORT1;JAM2;ADAMTS5;MYEF2
prerank,regulation of interferon-gamma production (GO:0032649),0.5714241913028716,1.7083517881760302,0.003703703703703704,0.1568501952134547,1.0,13/71,8.49%,CCR2;IL1B;RARA;CYRIB;CD226;CD47;PTPN22;LILRB1;LAPTM5;CD276;PRNP;CD2;TLR3
prerank,regulation of small molecule metabolic process (GO:0062012),-0.5415637656246675,-1.7075881824055292,0.006024096385542169,0.30246056105694835,0.998,8/28,11.50%,PRKN;APOE;TTC39B;PDK1;ARV1;PANK2;DGKQ;FMO5
prerank,cellular response to chemokine (GO:1990869),0.6145316457001041,1.7032784826313527,0.002628120893561104,0.16503349226314096,1.0,11/46,13.84%,CCR2;CCR1;CXCL10;GPR35;RIPOR2;PTK2B;RHOA;OXSR1;DUSP1;STK39;LRCH1
prerank,dendritic cell migration (GO:0036336),0.7541491967274307,1.70306293779183,0.008077544426494346,0.1637595168321803,1.0,3/16,1.98%,CCR2;EPS8;CCR1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.6704693350848232,1.6993981833175604,0.008797653958944282,0.16911792831733158,1.0,9/29,10.46%,CCR2;STAT4;STAT5A;JAK2;STAT3;STAT5B;STAT1;IFNAR1;IL31RA
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.830743183104149,1.6989867321254293,0.007017543859649123,0.16835026402405817,1.0,2/10,4.55%,KCNE3;SUMO1
prerank,granulocyte differentiation (GO:0030851),0.7169922662994658,1.6964182714973581,0.012213740458015267,0.17141570419297636,1.0,4/18,6.26%,CBFA2T3;RARA;SPI1;DEK
prerank,B cell mediated immunity (GO:0019724),0.8039252993673188,1.696217244454878,0.010582010582010581,0.17016688586605444,1.0,1/10,0.02%,CD74
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.682691284462252,1.696069811013591,0.015015015015015015,0.16895040241633977,1.0,7/25,13.21%,CD226;PLCG2;LAPTM5;MALT1;B2M;MAP3K7;KIT
prerank,T cell receptor signaling pathway (GO:0050852),0.5284800647730974,1.6957826334591801,0.001122334455667789,0.1678931017021063,1.0,39/138,13.41%,CARD11;GRAP2;PTPRC;PTPN22;PLCG2;FYN;PSME3;PAK1;NFKB1;MALT1;IKBKB;PSMB7;ZAP70;PSME2;NFKBIZ;THEMIS2;BCAR1;RC3H1;FBXW11;CD276;DENND1B;UBE2N;PDPK1;PAK2;PSME4;PSMB8;PSMD9;PSMA5;PIK3CA;RNF31;NFKBID;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;ICOSLG;PSMB1;CSK
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.783856111768332,1.6946925345186863,0.006420545746388443,0.16863613760679896,1.0,10/13,14.27%,IL27RA;OAS2;JAK2;STAT3;STAT1;OASL;IL6ST;EBI3;TYK2;CANX
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.697626704099698,1.694079448412798,0.0078125,0.16827269835723344,1.0,7/18,8.68%,LYN;CAMK1D;SLC8B1;IL6R;PTK2B;ADAM17;IL6
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.7971958084612424,1.6938820195863504,0.0034071550255536627,0.1671876109966612,1.0,4/12,5.92%,CD74;FOXP1;KLF4;TIRAP
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.7070798181526692,-1.6934883514362886,0.009828009828009828,0.3354240044578589,0.999,3/11,6.60%,LRP6;CTNNB1;RYK
prerank,regulation of lamellipodium organization (GO:1902743),0.7573646413085815,1.69338535513395,0.008051529790660225,0.16663219549117025,1.0,5/14,8.24%,CD44;CDC42;CARMIL1;CAPZB;RAC1
prerank,response to peptide (GO:1901652),0.651321755916158,1.6931256766455152,0.0027359781121751026,0.1657375661929563,1.0,13/33,13.15%,STAT4;FYN;STAT5A;STAT3;CACNA1A;ERBIN;STAT5B;KAT7;STAT1;PRNP;ANXA1;GNAI1;STAT2
prerank,cellular response to purine-containing compound (GO:0071415),-0.7274673964270421,-1.6930799051677918,0.007751937984496124,0.3264320777373738,0.999,4/10,13.00%,SLC8A1;RYR3;P2RY6;TRPM2
prerank,fatty acid oxidation (GO:0019395),-0.4629450141739437,-1.69181392645462,0.0,0.3202476116181245,1.0,28/57,28.87%,ABCD2;ECHS1;PPARGC1A;PECR;ABCD4;ECHDC1;ACAD10;HADHB;ACADM;HADH;HADHA;ECI1;ECI2;ABCD3;CPT2;ACADL;ACADS;PHYH;ILVBL;ADIPOR2;PEX13;ADH5;ACAT2;ACAD11;ACOX1;CROT;SLC27A2;PPARD
prerank,acute-phase response (GO:0006953),0.7944973918199791,1.6905894173240201,0.010416666666666666,0.16919118759864224,1.0,4/12,10.29%,PLSCR1;IL6R;IL6;MBL2
prerank,regulation of defense response (GO:0031347),0.5635002876287017,1.6902734345962933,0.001221001221001221,0.1681956137793858,1.0,27/76,15.73%,CCR2;FGR;FOXP1;HCK;ACE2;PTPN22;SAMHD1;BCL6;JAK2;DHX58;AKNA;BIRC3;TIRAP;TRAF3;SPATA2;SBNO2;ANXA1;CYLD;FCGR2B;AREL1;ADAMTS12;CASP12;RELA;MYD88;XIAP;LRP8;CELF1
prerank,response to ATP (GO:0033198),-0.6155312390372408,-1.689473052568779,0.007936507936507936,0.3176887588508096,1.0,7/18,14.62%,RYR3;P2RY12;P2RX7;P2RX4;HSP90B1;DGKQ;TRPC3
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5968152084817024,-1.6873869869820517,0.023391812865497075,0.3139111953735628,1.0,10/20,20.90%,SLC8A1;CACNA1C;PRKACA;ATP2A2;ATP1B1;ANK2;ATP1A2;CALM1;GSTO1;RYR2
prerank,regulation of defense response to virus by host (GO:0050691),0.6550402304964814,1.6862625213084423,0.002898550724637681,0.17445077713600834,1.0,8/30,12.39%,IFNLR1;PTPN22;LILRB1;DTX3L;TRAF3IP2;STAT1;PARP9;PQBP1
prerank,regulation of actin filament-based process (GO:0032970),0.5657151552083339,1.6830384872078996,0.0012422360248447205,0.17945368271119017,1.0,17/70,8.98%,RND3;IQGAP2;IQGAP1;CNN2;PAK1;CELSR1;ARHGAP18;CRK;CORO1A;CCDC88A;RAC2;DLC1;F11R;RHOBTB3;EZR;RAC1;RHOA
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.7862398493737545,1.6818078990258012,0.006872852233676976,0.180302454149238,1.0,7/12,11.74%,NOTCH2;DOCK10;DOCK11;LFNG;PTK2B;IL6;FCGR2B
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.6364199560600734,-1.6790394101747623,0.012626262626262626,0.33171800800050777,1.0,5/15,12.08%,LGMN;FGF2;P2RX4;VEGFA;PRKD1
prerank,lymphocyte mediated immunity (GO:0002449),0.7765878791131327,1.6786145489868247,0.009983361064891847,0.18572849328692193,1.0,3/12,6.91%,MYO1G;KLRD1;GNL1
prerank,lipid droplet organization (GO:0034389),-0.5781265289925024,-1.67508562919868,0.002881844380403458,0.335435249353915,1.0,12/22,36.07%,PPIA;CDS1;RAB3GAP1;CDS2;AUP1;PPID;BSCL2;ZFYVE1;FITM2;FAF2;PLA2G4C;PNPLA3
prerank,membrane depolarization during action potential (GO:0086010),-0.5469752591024037,-1.6734677635690625,0.018691588785046728,0.33181256932718817,1.0,9/26,12.06%,CACNA1D;SLC8A1;SCN1A;KCNJ2;CACNA1C;SCN3A;ATP1A2;HCN2;SCN1B
prerank,negative regulation of B cell activation (GO:0050869),0.6764534630676085,1.6725925830975368,0.014084507042253521,0.1961032503051399,1.0,8/21,11.74%,LYN;FOXJ1;CD300A;LAPTM5;RC3H1;SAMSN1;ID2;FCGR2B
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.5770657981558168,-1.6724927406302321,0.008264462809917356,0.3260635162460948,1.0,7/22,15.91%,MAN1C1;MAN1A2;DERL2;UBC;TRIM13;RNF103;RNF139
prerank,regulation of interleukin-6 production (GO:0032675),0.5428370595492729,1.6721231762876587,0.0,0.19554743990022092,1.0,19/96,8.68%,CD74;IL1B;CD47;PTPN22;PLCG2;SYK;STAT3;FOXJ1;MAPKAPK2;PTPN6;IL6R;IL33;RAB7B;IFIH1;IL17RA;TIRAP;AFAP1L2;TLR3;IL6
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6115720964643189,1.6714366918792407,0.009114583333333334,0.19544537563724718,1.0,8/42,10.73%,CCR2;CCR1;CXCL10;GPR35;PTK2B;CIB1;OXSR1;RBM15
prerank,negative regulation of synaptic transmission (GO:0050805),0.6797435876319632,1.6711457703771073,0.01524390243902439,0.1944707335461414,1.0,5/23,8.43%,LRRK2;IL1B;PTEN;ARF1;SLC30A1
prerank,defense response to virus (GO:0051607),0.5376567530072415,1.6703057214063726,0.0,0.19467329686723023,1.0,32/100,15.01%,PTPRC;IFNLR1;SAMHD1;LILRB1;OAS2;CD40;PLSCR1;MAP3K14;IFIT2;CXCL10;EIF2AK2;IRF2;STAT1;IFIH1;FLNA;OASL;DDIT4;RNASE1;TLR3;IL6;IRF7;RNASE6;SETD2;ACOD1;PQBP1;TLR2;NT5C3A;STAT2;IFIT1;RELA;IFITM3;MYD88
prerank,tight junction assembly (GO:0120192),0.5866609502606324,1.6695987767059188,0.005420054200542005,0.1945332417734208,1.0,13/49,15.83%,PECAM1;MARVELD3;FRMPD2;CLDN1;CLDN12;AFDN;PAK2;F11R;PDCD6IP;CLDN14;TBCD;OCLN;APC
prerank,response to cholesterol (GO:0070723),-0.6025183492611592,-1.668122108650003,0.011527377521613832,0.33106703973211643,1.0,11/17,24.24%,TGFBR2;LRP6;TGFBR1;GRAMD1A;SMO;GPLD1;CCL3;PMVK;PTCH1;OSBPL7;MLC1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.6532201000316117,-1.6676920980407537,0.02564102564102564,0.324106016577379,1.0,7/14,14.23%,CSTF2;RTRAF;FAM98B;TSEN2;TSEN34;ZBTB8OS;RTCB
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.5617407950879593,-1.6673907457435402,0.008450704225352112,0.31716366459151524,1.0,10/23,15.05%,PREB;DERL2;LMAN1;HSP90B1;AUP1;NPLOC4;TMED9;DERL1;SEC13;HERPUD1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.6261159105499973,1.6672025578199665,0.0072254335260115606,0.19755126332729048,1.0,2/33,1.98%,CD74;CCR1
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.7193446889782127,-1.6663423862116704,0.017114914425427872,0.3130338099964113,1.0,6/10,18.64%,HK3;HK1;PFKL;PFKP;GFPT1;PFKM
prerank,mesenchymal to epithelial transition (GO:0060231),-0.726934716557204,-1.666175892380466,0.004576659038901602,0.306177598871167,1.0,2/10,1.01%,BASP1;SALL1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.7549248702027769,1.6660460210219974,0.011400651465798045,0.19859522625559425,1.0,3/13,5.55%,CD74;TAF9;IFIH1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.5130090442213519,1.6659603767953504,0.0,0.1973024335148929,1.0,44/163,13.41%,CARD11;GRAP2;VAV3;PTPRC;PTPN22;PLCG2;FYN;SYK;PSME3;PAK1;NFKB1;NFAM1;CD79B;MALT1;IKBKB;PSMB7;ZAP70;PSME2;NFKBIZ;THEMIS2;BCAR1;RC3H1;FBXW11;CD276;DENND1B;UBE2N;PDPK1;PAK2;PSME4;PSMB8;PSMD9;PSMA5;PIK3CA;RNF31;NFKBID;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;ICOSLG;BTK;PSMB1;CSK
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5971398946902772,1.665669278146362,0.006493506493506494,0.1963737903071568,1.0,19/47,18.47%,PID1;ACE2;PLCG2;SYK;CD36;CD177;ITGB2;MAPK14;GRB2;DHRS4;RIPK1;ACOD1;TGFB1;GSTP1;THBS1;RNF41;CYBA;MMP8;PRKCD
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5330096810837868,1.6630449288803948,0.001182033096926714,0.2004243834482863,1.0,25/116,12.41%,FGR;HCK;LYN;CRHR2;CYSLTR2;PLCG2;CREB1;FYN;SYK;RXFP2;PTGER2;PTGER4;HTR4;MYH9;DPEP1;MAPK14;ADAM17;CYSLTR1;GNB1;IL6;PRKAR2A;ADCY7;GLP2R;FCGR2B;ADCY5
prerank,tRNA modification (GO:0006400),-0.4415349118188858,-1.6628580713056555,0.00975609756097561,0.3083273828840938,1.0,46/62,38.19%,ALKBH8;NSUN2;TRMT1;ANKRD16;METTL6;DUS2;QTRT1;ELP5;TYW5;METTL2A;METTL2B;CDKAL1;METTL1;DTWD2;SSB;THUMPD1;OSGEP;THUMPD2;TRMT10A;WDR4;MTO1;TRMT44;TRMT6;TRMT12;TPRKB;LCMT2;NSUN6;TRMT112;GTPBP3;TRMT9B;TRMT5;BCDIN3D;DTWD1;PUS7;QTRT2;FTSJ1;ALKBH1;CTU2;AARS2;THG1L;TRMT61A;PUSL1;CTU1;MOCS3;ADAT2;WDR6
prerank,positive regulation of chemokine production (GO:0032722),0.6030236725381188,1.662669470809667,0.009320905459387484,0.19960670855747928,1.0,14/44,12.55%,CD74;IL1B;SYK;EIF2AK2;IL6R;IL33;IL17RA;TIRAP;ADAM17;TLR3;IL6;MBP;APP;TLR2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.7084271182542521,-1.662462044975609,0.00468384074941452,0.3022628059883753,1.0,3/10,2.49%,PRKG1;SERPINE2;CD9
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5591998095978602,1.6618899773258962,0.0024330900243309003,0.19988559165192943,1.0,16/73,8.68%,CCR2;PTPRC;IFNGR1;PLCG2;OAS2;SYK;JAK2;STAT3;IL33;SPN;IFIH1;TIRAP;CD2;EPHB2;TLR3;IL6
prerank,positive regulation of T cell cytokine production (GO:0002726),0.6928534030561407,1.6602557965325688,0.014218009478672985,0.2018450759628016,1.0,9/20,17.23%,IL1B;MALT1;DENND1B;IL6;B2M;NLRP3;MAP3K7;IL18;TRAF2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.8081462052334516,1.6600710758098922,0.008389261744966443,0.20073300550674988,1.0,8/11,14.27%,STAT4;IL27RA;JAK2;STAT3;STAT1;IL6ST;EBI3;CANX
prerank,response to lipid (GO:0033993),0.5284220398834809,1.6589698391682954,0.002306805074971165,0.20172141457279083,1.0,20/105,8.17%,IL1B;FOXP1;RARA;PTPN22;PPARG;MAPKAPK3;JAK2;STAT3;CD36;RPS6KA3;ERBIN;MAPKAPK2;STAT5B;SLPI;PELI1;TIRAP;TRIM16;ADAM17;RARG;IFNAR1
prerank,O-glycan processing (GO:0016266),0.5819881406948837,1.6554330424192658,0.006578947368421052,0.20780597226204778,1.0,10/54,12.72%,ST3GAL1;ST3GAL4;MUC3B;MUC3A;GXYLT1;B4GALT5;GALNT2;GALNT10;GALNT5;XXYLT1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.6048968912878337,1.6547646764934518,0.013422818791946308,0.2077991337498829,1.0,19/44,16.11%,CD44;NGF;KLF4;NGFR;GPX1;RPS6KA3;DPEP1;CAST;CARD16;HGF;CSNK2A1;RPS6KA1;MAP2K5;SH3RF1;AKT1;DHCR24;XIAP;THBS1;USP47
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.7697970411336739,1.6540563828925727,0.021052631578947368,0.20780670341896548,1.0,2/12,1.14%,IL1B;PAEP
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.6050986865028005,1.6539411185859119,0.008075370121130552,0.2065923137032038,1.0,19/46,13.63%,STAT4;LCP1;CNN2;ANXA2;MSN;JAK2;CDC42;PSME2;TALDO1;PDCD4;PAK2;ARF1;PLCB1;CAPZA1;LMNB1;RPLP0;SNRPA1;HSPA9;TYK2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.628384150158443,1.6536170452030534,0.011510791366906475,0.20571255259194995,1.0,7/31,5.83%,LYN;LILRB1;CD300A;SPN;RC3H1;LST1;GLMN
prerank,positive regulation of cell death (GO:0010942),0.5725417013659887,1.6525335735952877,0.005134788189987163,0.20650506720081804,1.0,16/59,11.74%,LRRK2;FYN;MAP3K5;FOS;CD36;PICALM;HP;HPR;ITGB2;FAF1;PRNP;DDIT4;RARG;DAXX;RIPK1;FCGR2B
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5091901261373112,1.6525196574773284,0.0010976948408342481,0.20508184008929906,1.0,60/153,16.06%,LRRK2;MAP4K1;SGK3;PRKCE;VRK1;CAMK1D;LMTK2;AKT3;MAPKAPK3;PKN1;ERN1;PRKCH;RPS6KA3;CSNK1G1;MAPKAPK2;STK38;IKBKB;VRK2;HIPK2;MAPK14;RPS6KA5;HIPK1;STK4;PDPK1;MKNK2;PKN2;PAK2;DYRK1A;MAPK12;STK38L;CSNK1G3;TNKS;LATS1;PIKFYVE;CSNK2A2;CSNK2A1;TLK2;RIPK1;DMPK;NLK;LATS2;RPS6KA1;SMG1;MORC3;MAPK8;EIF2AK3;AKT1;PDK3;MARK3;STK39;ROCK1;TLK1;RPS6KA2;MAP3K13;BRSK1;MAPK1;TBK1;TAF1;DYRK2;RPS6KB1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.6388558193396108,-1.6520517209059074,0.02127659574468085,0.32559107621957245,1.0,6/14,15.82%,CPEB2;CPEB1;CNBP;CPEB4;DHX9;CPEB3
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.6402755443174103,1.6514756255326724,0.013235294117647059,0.2057641306149511,1.0,7/27,8.98%,CCR2;CD44;CYRIB;CD47;ITGB2;IL6;RHOA
prerank,positive regulation of behavior (GO:0048520),-0.7247372398079073,-1.650497150994383,0.016241299303944315,0.3226687035336106,1.0,4/10,14.35%,MEF2C;NLGN1;CFAP20;NPAS2
prerank,bicellular tight junction assembly (GO:0070830),0.5873320786168508,1.6501334889271277,0.011095700416088766,0.2072532107889367,1.0,12/46,15.83%,PECAM1;MARVELD3;FRMPD2;CLDN1;AFDN;PAK2;F11R;PDCD6IP;CLDN14;TBCD;OCLN;APC
prerank,defense response to tumor cell (GO:0002357),0.786409043660975,1.64802912410129,0.013769363166953529,0.21058152762545723,1.0,4/10,3.78%,KLF4;DAPK1;LAPTM5;SPI1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.5262105351867479,1.6473838618794454,0.0,0.21037355767767077,1.0,23/117,11.27%,FGR;HCK;LYN;CRHR2;CYSLTR2;PLCG2;CREB1;FYN;SYK;RXFP2;PTGER2;PTGER4;HTR4;MYH9;DPEP1;MAPK14;ADAM17;CYSLTR1;GNB1;IL6;PRKAR2A;ADCY7;GLP2R
prerank,B cell activation (GO:0042113),0.5569924350934042,1.644450582983626,0.0062266500622665,0.2153090435039714,1.0,21/68,14.75%,ITGA4;PTPRC;FLT3;PLCG2;CD40;NFAM1;CD79B;RABL3;CHRNA4;MALT1;ZAP70;ADAM17;EPHB2;HDAC9;CTPS1;TPD52;SLC25A5;BTK;KIT;PTPRJ;GPS2
prerank,negative regulation of cyclase activity (GO:0031280),0.725908515179142,1.64387457168946,0.014586709886547812,0.21511218499594512,1.0,1/14,0.04%,CCR2
prerank,second-messenger-mediated signaling (GO:0019932),0.5438210811981287,1.641373629543875,0.0036188178528347406,0.21914801922758162,1.0,17/82,9.92%,CCR2;LRRK2;FPR1;PLCG2;XCR1;NDNF;CCR1;CD36;MCTP2;ACKR2;CCR9;PPP1R9B;CCRL2;PDPK1;GUCY1A1;HRH1;CAMKK2
prerank,regulation of peptide hormone secretion (GO:0090276),0.555662785654737,1.6405221071146718,0.007537688442211055,0.21956062846397792,1.0,10/67,8.68%,DPP4;ITPR1;IL1B;RAP1A;CACNA1A;SLC8B1;RFX3;ADRA2A;CLOCK;IL6
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6610359908056002,1.6385562945967171,0.016224188790560472,0.2226569656363684,1.0,4/23,9.43%,CBFA2T3;SIK1;CRY1;GIT1
prerank,rRNA methylation (GO:0031167),-0.5643230816322443,-1.6383439986202226,0.01791044776119403,0.3501238948272154,1.0,13/22,29.01%,METTL15;ZCCHC4;DIMT1;NOP2;NSUN3;EMG1;FTSJ3;NSUN5;MRM1;TRMT112;MRM3;BUD23;FDXACB1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.7284961023172031,1.636649094309326,0.021630615640599003,0.2252318132623512,1.0,9/14,18.43%,DHX58;ANKRD17;OASL;PUM2;TLR3;USP15;TLR2;PUM1;ZDHHC5
prerank,hemidesmosome assembly (GO:0031581),-0.6935221439249732,-1.6351768935353812,0.01804123711340206,0.3522727600403878,1.0,2/11,0.88%,DST;ITGA6
prerank,cardiac muscle cell contraction (GO:0086003),-0.5949114867000466,-1.633991791059287,0.032448377581120944,0.3484658349037412,1.0,10/19,22.25%,CACNA1D;CACNA2D1;SCN1A;KCNJ2;CACNA1C;SCN1B;PKP2;FGF12;SCN3B;GSN
prerank,protein hydroxylation (GO:0018126),-0.6263252806968561,-1.6329927199020224,0.021333333333333333,0.34492726455422396,1.0,9/15,23.17%,ASPH;P3H2;P3H3;EGLN3;VPS33B;OGFOD1;PLOD3;VIPAS39;PLOD1
prerank,cellular response to interleukin-6 (GO:0071354),0.6535775976477799,1.6327088542313697,0.01037037037037037,0.23314626696028984,1.0,13/26,10.03%,PID1;NFKB1;JAK2;STAT3;PTGIS;SPI1;CBL;IL6R;STAT1;IL6ST;IL6;SMAD4;SBNO2
prerank,ameboidal-type cell migration (GO:0001667),0.5747052461965497,1.6325876148527751,0.012080536912751677,0.23187950145169312,1.0,9/51,7.18%,ITGB7;ITGA4;SRGAP2;PKN1;SEMA4A;PDLIM1;GPC3;GDNF;PKN2
prerank,lymphocyte migration (GO:0072676),0.6360998518298873,1.630377472528536,0.011347517730496455,0.23536574481378061,1.0,5/32,5.36%,MYO1G;RET;MSN;ZAP70;CKLF
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.6398045680106034,1.6297568640656726,0.01171303074670571,0.2353678969489464,1.0,8/28,11.13%,ITPR1;MAP3K5;ERN1;ATP2A3;BBC3;ATP2A1;PPP1R15A;AIFM1
prerank,regulation of membrane depolarization (GO:0003254),0.6875463540876929,1.6264576242822513,0.01875,0.24156380414051828,1.0,4/18,3.91%,LRRK2;NEDD4L;GJA5;HCN4
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.7313148187350208,1.6259976886745524,0.016,0.24123922201476783,1.0,1/13,0.04%,CCR2
prerank,negative regulation of secretion (GO:0051048),0.7841087387578675,1.6244884124626082,0.012681159420289856,0.24336772749875682,1.0,1/10,0.02%,CD74
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6512721188971404,1.6239594407454407,0.020895522388059702,0.24298655531224228,1.0,6/26,8.68%,CCR2;IL1B;SULF2;NOX1;IL6ST;IL6
prerank,T cell differentiation in thymus (GO:0033077),0.7220708530248896,1.6239176900136745,0.024752475247524754,0.24158486349767636,1.0,4/14,8.65%,PTPRC;RABL3;ADAM17;ZFP36L2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.6275417090289638,1.6234240159440294,0.02359882005899705,0.24128642161364033,1.0,7/27,10.41%,PID1;IL1B;PIP4K2A;PTPRE;TNS2;PIP4K2B;PTPN1
prerank,regulation of plasminogen activation (GO:0010755),-0.649706385025538,-1.6230743584509832,0.031862745098039214,0.36931698616299424,1.0,5/12,12.08%,PLGRKT;SERPINE2;CTSZ;HPN;SERPINE1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5221858226494244,1.622284410220782,0.002296211251435132,0.24245915756024788,1.0,26/112,11.05%,CCR2;PTPRC;FOXP1;RARA;CD47;PTPN22;IFNGR1;PLCG2;LILRB1;OAS2;SYK;JAK2;STAT3;MAPKAPK2;PTPN6;IL33;SPN;IFIH1;TIRAP;CD2;EPHB2;TLR3;IL6;ARG2;RIPK1;CACTIN
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5898595976046093,1.6209807072081857,0.018691588785046728,0.24403960037972966,1.0,15/44,15.86%,IL1B;LYN;PTPN22;CD300A;RGS2;SORL1;STK38;PDCD4;PAQR3;PTPN1;DUSP1;RGS14;PTPRJ;GSTP1;IRAK3
prerank,cellular response to interleukin-12 (GO:0071349),0.5864929707811875,1.6206624595643924,0.011857707509881422,0.24319855253934683,1.0,20/48,13.63%,STAT4;CD47;LCP1;CNN2;ANXA2;MSN;JAK2;CDC42;PSME2;TALDO1;PDCD4;PAK2;ARF1;PLCB1;CAPZA1;LMNB1;RPLP0;SNRPA1;HSPA9;TYK2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6590915006686825,1.617719281134691,0.02406015037593985,0.24866825275356794,1.0,3/22,1.29%,CD44;IL1B;KLF4
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6832638187710602,1.6170827132556995,0.026234567901234566,0.24872723828467241,1.0,7/18,13.62%,PLCG2;DOCK2;SYK;DYSF;IFI35;SBNO2;FCER1G
prerank,epithelial cell migration (GO:0010631),0.6021036622701468,1.6169846219283612,0.006906077348066298,0.2474379080736423,1.0,17/37,18.30%,DPP4;PKN1;ZEB2;ADGRA2;STAT1;FAP;PKN2;PLXND1;PXN;RHOA;PIK3CA;KIT;ROCK1;STARD13;KANK1;PKN3;PTP4A3
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7192707093000666,1.6147860618358425,0.026533996683250415,0.25114809722994125,1.0,2/14,1.26%,ACE2;ACE
prerank,regulation of cell communication (GO:0010646),0.5950747511238281,1.6144352641822295,0.015214384508990318,0.25060994937202113,1.0,9/35,10.43%,GRK3;GRK5;CRK;GJA5;CDC42SE2;MTCH1;GRK6;PTPN1;ANXA1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.7561628378662796,1.6138654020757532,0.021052631578947368,0.2505753240896002,1.0,4/11,5.43%,STAP1;CD177;SPI1;ITGB2
prerank,regulation of inflammatory response (GO:0050727),0.48949629777656367,1.6106830634955054,0.0010660980810234541,0.25689344443709883,1.0,48/190,15.84%,CCR2;FFAR4;IL1B;FOXP1;HCK;CD47;ACE2;KLF4;PPARG;METRNL;BCL6;JAK2;PTGIS;AKNA;NFKBIA;PTGER4;SMPDL3B;NFKBIZ;BIRC3;IL33;IL17RA;ABCC1;PDCD4;PDE2A;SPATA2;TLR3;IFI35;IL6;SBNO2;ANXA1;CYLD;RIPK1;ACOD1;NLRP3;APP;TLR2;AREL1;ADAMTS12;TNFRSF1B;IL18;CASP12;GPS2;TNFAIP6;RELA;MYD88;XIAP;CELF1;PROC
prerank,regulation of phagocytosis (GO:0050764),0.569843987988929,1.6105406289166935,0.011826544021024968,0.25585715347199595,1.0,12/53,5.37%,FGR;PTPRC;IL1B;HCK;CD47;DOCK2;CAMK1D;SYK;PLSCR1;DYSF;SCARB1;IL2RG
prerank,regulation of B cell apoptotic process (GO:0002902),0.737035605626141,1.6094427309573172,0.026101141924959218,0.25688427932087804,1.0,3/12,1.99%,FOXP1;LYN;BCL6
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6796828042803177,1.6093329921135426,0.018633540372670808,0.25565073911667646,1.0,11/18,20.64%,CYRIB;SHTN1;RIPOR2;PTK2B;BCAS3;ARFGEF1;ROCK1;KANK1;KRIT1;KIF20B;LLGL2
prerank,T cell migration (GO:0072678),0.7368103393796335,1.609307467940752,0.02226027397260274,0.2542738104268332,1.0,5/13,6.27%,MYO1G;MSN;CXCL10;ZAP70;CXCL16
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5750206148369554,1.6086353366156696,0.01912568306010929,0.2544711949446583,1.0,17/44,17.02%,ZC3HAV1;MEX3D;BTG2;RC3H1;GIGYF2;YTHDF3;ZFP36L2;EIF4ENIF1;METTL3;TNRC6B;ROCK1;PNPT1;TNRC6A;CELF1;PUM1;PABPC1;CNOT8
prerank,regulation of interleukin-12 production (GO:0032655),0.5704067564174492,1.6086217554725377,0.015706806282722512,0.25307179229322524,1.0,11/47,8.49%,FOXP1;CD47;PLCG2;LILRB1;CD40;SYK;LAPTM5;MAPK14;TIRAP;PLCB1;TLR3
prerank,melanosome localization (GO:0032400),-0.5605387180291271,-1.6083387440168864,0.03151862464183381,0.41182416210945655,1.0,9/21,17.51%,MLPH;BBS2;SHROOM2;MREG;MYO5A;ARL6;BLOC1S5;VPS33B;RAB11A
prerank,regulation of T cell cytokine production (GO:0002724),0.7014042180150516,1.607481019277182,0.03210272873194221,0.2541576882700702,1.0,5/15,13.54%,CCR2;MALT1;B2M;MAP3K7;TNFRSF1B
prerank,cardiac muscle tissue development (GO:0048738),0.5728554290313707,1.6074781812538144,0.014588859416445624,0.25275350214703113,1.0,7/50,9.94%,NOTCH2;SIK1;GJA5;BMPR2;HCN4;SGCD;SMAD4
prerank,regulation of calcium-mediated signaling (GO:0050848),0.6541978558239753,1.6072645916387027,0.01601164483260553,0.2518456183299545,1.0,3/25,1.24%,ITPR1;LRRK2;PLCG2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.631007938095113,1.6070038586541993,0.02463768115942029,0.2510509139622785,1.0,3/28,0.77%,CCR2;CYRIB;CD47
prerank,keratan sulfate catabolic process (GO:0042340),-0.6774313966100398,-1.6068898829744434,0.01647058823529412,0.4094641483900064,1.0,3/11,3.82%,HEXB;GALNS;GNS
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5649956266023349,-1.6068592756393656,0.027472527472527472,0.40209294864801,1.0,9/21,20.90%,SLC8A1;CACNA1C;PRKACA;ANK2;ATP1A2;AKAP6;CALM1;GSTO1;RYR2
prerank,neutrophil migration (GO:1990266),0.5605710181834694,1.6052576565418604,0.012804097311139564,0.2539294748448749,1.0,10/58,9.35%,JAML;PECAM1;SYK;CD177;CXCL10;CKLF;ITGB2;IRAK4;GBF1;PIKFYVE
prerank,positive regulation of cell division (GO:0051781),0.5929607467271679,1.6045075250376915,0.01692524682651622,0.2541481312242128,1.0,10/38,9.34%,SVIL;CDC14A;PRKCE;RACGAP1;CUL3;KIF23;CDC42;PKN2;RHOA;SPAST
prerank,positive regulation of viral life cycle (GO:1903902),0.6560165826401014,1.6040821068792965,0.02021772939346812,0.2536907225314533,1.0,3/22,6.49%,CD74;TSG101;LGALS1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6916383758892389,1.6035826494220873,0.023112480739599383,0.25344030293280007,1.0,4/17,6.91%,MYO1G;BACH2;STAT3;GNL1
prerank,endothelial cell development (GO:0001885),0.6442415622076105,1.602898786847054,0.024615384615384615,0.2536527820392099,1.0,7/25,9.18%,PECAM1;RAP1A;MSN;RAPGEF2;PDE2A;EZR;ICAM1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.6284561994294144,-1.6027239049283806,0.03125,0.40946080169475163,1.0,4/15,12.08%,LGMN;FGF2;P2RX4;PRKD1
prerank,cellular response to interleukin-2 (GO:0071352),0.770536172507623,1.6019256835763667,0.02280701754385965,0.25316548457169774,1.0,5/11,6.49%,STAT5A;SYK;STAT5B;IL2RG;PTK2B
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.770536172507623,1.6019256835763667,0.02280701754385965,0.25316548457169774,1.0,5/11,6.49%,STAT5A;SYK;STAT5B;IL2RG;PTK2B
prerank,regulation of lymphocyte differentiation (GO:0045619),0.6779555454908706,1.600889042366759,0.031007751937984496,0.25430290470475214,1.0,7/18,13.30%,CCR2;IKZF3;CD2;ZFP36L2;SLAMF8;PRELID1;METTL3
prerank,regulation of establishment of cell polarity (GO:2000114),0.6875652558443598,1.6008174106736273,0.023006134969325152,0.25316488480026517,1.0,10/16,19.16%,CYRIB;SHTN1;RIPOR2;PTK2B;BCAS3;ARFGEF1;ROCK1;KANK1;KRIT1;KIF20B
prerank,regulation of cellular respiration (GO:0043457),0.7016179296173096,1.5996665489767128,0.026153846153846153,0.25447087650049083,1.0,7/17,14.26%,CBFA2T3;IFNLR1;NOA1;IFNAR1;PRELID1;PNPT1;VCP
prerank,modulation by host of viral genome replication (GO:0044827),-0.635647936307825,-1.5966772194847023,0.0199501246882793,0.4226246223532247,1.0,6/13,15.39%,PRKN;EIF2AK4;TBC1D20;IFI27;FBXL2;CCNK
prerank,ceramide biosynthetic process (GO:0046513),0.5782526725056257,1.5964182056290517,0.01742627345844504,0.26097699764696236,1.0,8/40,8.27%,CERS6;ST8SIA4;ST8SIA6;CERS1;SAMD8;SGMS1;SGMS2;ST6GALNAC3
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.7097233626749356,1.5960697902578267,0.0594059405940594,0.26061788369098166,1.0,4/15,5.39%,CD74;CD44;TAF9;PTTG1IP
prerank,heterotypic cell-cell adhesion (GO:0034113),0.6382690660857442,1.5954350604881349,0.020527859237536656,0.2608205888024031,1.0,6/25,7.79%,ITGB7;ITGA4;ITGAX;ITGAD;ITGB2;CD2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6754205545567528,1.5952957944083588,0.03286384976525822,0.2598348676189587,1.0,7/17,12.08%,PTPN22;BCL3;KLF4;ANXA4;ANXA1;CACTIN;MAP2K5
prerank,negative regulation of coagulation (GO:0050819),-0.6294276299865403,-1.595007027743984,0.019753086419753086,0.4201713574622889,1.0,5/14,12.08%,APOE;HS3ST5;SERPINE2;CD34;SERPINE1
prerank,regulation of multicellular organismal development (GO:2000026),0.6328937463986869,1.591769339515612,0.028400597907324365,0.26713178528195936,1.0,7/25,10.75%,SPAAR;OAS2;RACGAP1;NIPBL;SCX;DUSP6;TDG
prerank,organelle transport along microtubule (GO:0072384),0.6048105494140193,1.5912378948463477,0.021398002853067047,0.2672437273388324,1.0,10/31,12.10%,UXT;KIF5B;COPG2;CDC42;FBXW11;RAB6A;PAFAH1B1;PEX14;ARHGAP21;HTT
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5675919333356525,1.591191882499667,0.0196078431372549,0.26600696171059174,1.0,13/46,12.99%,ITGB7;ITGA4;ATRNL1;SRGAP2;NTNG2;LAMB1;RAC1;PXN;RHOA;FN1;MEGF9;ITGA8;USH2A
prerank,cardiac muscle cell action potential (GO:0086001),-0.5046042966529029,-1.5911686781333823,0.01730103806228374,0.4266694746607245,1.0,11/30,12.06%,CACNA1D;SLC8A1;CACNA2D1;SCN1A;KCNJ2;CACNA1C;ATP1B1;ANK2;ATP1A2;HCN2;SCN1B
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5200308273790762,1.5905796032437594,0.0048134777376654635,0.26609864649898196,1.0,16/86,8.69%,CD74;CD44;PTPRC;PECAM1;PLCG2;FYN;JAK2;PTPN6;IL6R;ITGB2;PRNP;PTK2B;SAMSN1;PAK2;IL6;HGF
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.501491292905943,1.5900909285255296,0.005681818181818182,0.2660269507806076,1.0,31/121,14.55%,CD74;CD44;PTPRC;NEDD9;LYN;FLT3;PECAM1;PLCG2;ACE;CD40;JAK2;STAT3;IL6R;PRNP;PTK2B;PAK2;PARP14;IL6ST;IL6;HGF;PARP9;PTPN1;IL31RA;UNC119;CASS4;KIT;HCLS1;PTPRJ;FGFR3;TGFB1;IL18
prerank,regulation of protein targeting to membrane (GO:0090313),0.618939565135619,1.5898216990200342,0.023633677991137372,0.26527987693302596,1.0,8/28,10.60%,TCAF2;FYN;C2CD5;MYO1C;ITGB2;PRNP;CIB1;FIS1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7702347073474753,1.5876050276548623,0.035398230088495575,0.2693811487797506,1.0,5/10,3.82%,LYN;STAT5A;JAK2;STAT3;STAT5B
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.6898912759607172,1.586615599306925,0.024311183144246355,0.2702453578489042,1.0,9/18,9.94%,JAK2;STAT3;SPI1;CBL;IL6R;STAT1;IL6ST;IL6;SMAD4
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.6280308560034221,1.586147147304721,0.029498525073746312,0.26997629542371326,1.0,8/24,10.60%,TCAF2;FYN;C2CD5;MYO1C;ITGB2;PRNP;CIB1;FIS1
prerank,B cell differentiation (GO:0030183),0.5666879852236167,1.5853918208624478,0.007926023778071334,0.2703632437055134,1.0,14/46,14.75%,ITGA4;PTPRC;FLT3;PLCG2;NFAM1;CD79B;RABL3;ADAM17;HDAC9;TPD52;SLC25A5;KIT;PTPRJ;GPS2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5681193972175815,1.5836951198011842,0.024896265560165973,0.27292200589067817,1.0,9/43,10.41%,PID1;IL1B;PIP4K2A;PTPRE;SORL1;TNS2;SIK2;PIP4K2B;PTPN1
prerank,phosphorylation (GO:0016310),0.4668924016976607,1.5834716882874678,0.0,0.2721253203076857,1.0,116/384,15.65%,GRK3;FGR;LRRK2;GRK5;RARA;STK10;MAP4K1;SGK3;RUNX3;HCK;LYN;PRKCE;LIMD1;DGKG;CERKL;SIK1;STK24;NADK;CDK13;VRK1;CREB1;DAPK1;FYN;RET;MAP3K5;LMTK2;AKT3;SYK;PIM1;PAK1;PKN1;STK17B;PRKAG2;JAK2;STAT3;ERN1;PRKCH;IP6K3;BMPR2;MAPKAPK2;BIRC6;STK38;EIF2AK2;BCR;IKBKB;ZAP70;VRK2;GMFG;TAOK3;SIK3;HIPK2;RPS6KA5;CDK14;HIPK1;MAP3K1;STK4;PTK2B;PDPK1;MKNK2;PKN2;PAK2;DYRK1A;SIK2;COQ8A;EPHB2;ACVR2A;MINK1;STK38L;LATS1;BRAF;OXSR1;CSNK2A1;TLK2;CAMKK2;PPP4R1;GRK6;PIK3CA;YWHAZ;PRKG2;DMPK;PRKAG1;NLK;LATS2;MAP4K3;PRKAA1;PIK3R4;APP;CCNT1;CDK12;MAP3K20;MORC3;BTK;MAPK8;EIF2AK3;AKT1;PDK3;LIMK2;CSK;MARK3;TYK2;HCST;STK39;ROCK1;PRKAA2;TLK1;LMTK3;HASPIN;TGFB1;MAP3K13;AURKB;BRSK1;MAPK1;TBK1;TAF1;MAML1;DYRK2
prerank,blood circulation (GO:0008015),0.5635151985803769,1.581784707687109,0.01837270341207349,0.2748218133598542,1.0,10/49,9.32%,ACE2;ACE;TBC1D8;GPX1;CXCL10;HCN4;OLR1;STAT1;SGCD;GUCY1A1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.5163480022020275,1.5809450186106053,0.0012077294685990338,0.27555082119433166,1.0,20/87,8.98%,RND3;IQGAP2;IQGAP1;NOTCH2;EPS8;PAK1;CELSR1;ARHGAP18;CRK;CORO1A;CCDC88A;RAC2;DLC1;ARHGDIB;PTK2B;F11R;RHOBTB3;EZR;RAC1;RHOA
prerank,negative regulation of signaling receptor activity (GO:2000272),0.6405652277525414,1.5791669138709454,0.019374068554396422,0.27863261495735714,1.0,7/25,8.29%,ACE2;PPARG;CBLB;CBL;TSG101;CNRIP1;EPHB2
prerank,nucleotide catabolic process (GO:0009166),0.6985805676905124,1.5791609103619437,0.0176,0.27735249554679314,1.0,6/16,14.72%,SAMHD1;GDA;GPX1;DERA;VCP;NT5C2
prerank,positive regulation of inflammatory response (GO:0050729),0.522218683250676,1.5789381936392786,0.00851581508515815,0.2766048415955237,1.0,18/86,12.55%,CCR2;IL1B;CD47;NFKBIA;PTGER4;NFKBIZ;IL33;IL17RA;ABCC1;PDCD4;PDE2A;TLR3;IL6ST;IFI35;IL6;RIPK1;APP;TLR2
prerank,B cell receptor signaling pathway (GO:0050853),0.6114231599677626,1.5785066499815879,0.02531645569620253,0.27642385484486487,1.0,7/32,5.28%,VAV3;PTPRC;PLCG2;SYK;NFAM1;CD79B;BCAR1
prerank,lymphocyte differentiation (GO:0030098),0.5348999926166172,1.578430704510473,0.008620689655172414,0.2753743300734847,1.0,20/68,14.75%,ITGA4;PTPRC;FLT3;PTPN22;PLCG2;NFAM1;CD79B;RABL3;LFNG;ZAP70;KAT7;ADAM17;HDAC9;PBX1;TPD52;SLC25A5;KIT;NFIL3;PTPRJ;GPS2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.6235295559843883,1.578402555975519,0.03863298662704309,0.2741465717356383,1.0,11/27,14.99%,MAP3K5;MAP3K8;NFKB1;CCDC88C;IKBKB;KAT7;FBXW11;MAP3K7;MAP3K20;MAPK8;MAPK1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.5996002936119564,1.5769984165578468,0.02812939521800281,0.27616001897818876,1.0,8/31,8.49%,PLCG2;CD40;SYK;LAPTM5;MAPK14;TIRAP;PLCB1;TLR3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.640518345879201,1.5764186147901937,0.045925925925925926,0.2763158791032881,1.0,7/23,9.47%,IFNGR1;PPARG;JAK2;SUMO1;STAT1;PARP14;PARP9
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.70754767939158,1.5754885942813865,0.03205128205128205,0.2772343022467339,1.0,3/13,8.69%,LRRK2;NFE2L2;HGF
prerank,regulation of vasculogenesis (GO:2001212),0.700630829784239,1.5748858111039996,0.0330188679245283,0.2774198919517315,1.0,3/14,3.13%,RIN2;RAP1A;RAPGEF2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5567426759946803,1.5737532332782833,0.021052631578947368,0.2788940108681531,1.0,20/50,16.11%,CD44;NGF;KLF4;NGFR;GPX1;RPS6KA3;DPEP1;PAK2;CARD16;HGF;CSNK2A1;RPS6KA1;MAP2K5;SH3RF1;AKT1;CAAP1;DHCR24;XIAP;THBS1;USP47
prerank,dendritic cell chemotaxis (GO:0002407),0.719507911529653,1.5730383561735048,0.026578073089700997,0.2793202409171084,1.0,2/14,1.98%,CCR2;CCR1
prerank,tRNA processing (GO:0008033),-0.4255824618481983,-1.5718442211996269,0.014285714285714285,0.4886806928066523,1.0,43/61,36.21%,NSUN2;TRMT1;ANKRD16;TRNT1;CSTF2;POP1;QTRT1;ELP5;TYW5;RTRAF;FAM98B;RPP30;TSEN2;CDKAL1;METTL1;DTWD2;TSEN34;PTCD1;SSB;ZBTB8OS;THUMPD1;RTCB;KARS1;TRMT10A;WDR4;TRMT6;LCMT2;NSUN6;ELAC2;TRMT9B;DTWD1;RPP40;QTRT2;FTSJ1;POP5;CTU2;AARS2;TSEN54;RPP21;POP7;THG1L;TRMT61A;CTU1
prerank,endocrine system development (GO:0035270),-0.5509305202917048,-1.571233543547775,0.01749271137026239,0.4832245217661785,1.0,8/21,28.59%,SALL1;TGFBR1;NF1;MDK;DKK3;HOXD3;SOX2;WNT4
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6341454870477047,1.5694638206669203,0.03328290468986384,0.2866466576685373,1.0,8/22,15.12%,IL1B;CREB1;PPARG;ZBTB20;CREBL2;AKT1;SIRT4;ANGPTL3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.7539189195063413,1.569090789449523,0.036585365853658534,0.2863185811370794,1.0,2/10,0.33%,PID1;IL1B
prerank,positive regulation of JNK cascade (GO:0046330),0.5288630073317114,1.5683638811632976,0.011166253101736972,0.28687352305681585,1.0,25/70,18.69%,IL1B;TRAF1;MAP3K5;AXIN1;TAOK3;TRAF4;HIPK2;TIRAP;PTK2B;TRAF3;PLCB1;MBIP;MINK1;RIPK1;FCGR2B;APP;SH3RF1;NCF1;DUSP22;WNT7A;RASSF2;TRAF2;MMP8;SEMA3A;FZD7
prerank,regulation of cartilage development (GO:0061035),0.6532225639214926,1.5678309588055768,0.03755868544600939,0.28695478831186183,1.0,3/18,4.20%,TRPS1;BMPR2;SCX
prerank,organophosphate catabolic process (GO:0046434),0.7412597299714101,1.567572714916595,0.03666666666666667,0.28629380512444713,1.0,1/11,0.01%,PLBD1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.6049941871153095,-1.5672889473214204,0.040100250626566414,0.4893542983542718,1.0,8/15,22.51%,RAB3GAP2;ZFAND2A;SPCS3;RAB3GAP1;SEC61G;SRPRB;RYR2;ZFAND2B
prerank,cellular response to cytokine stimulus (GO:0071345),0.46163856251162927,1.5667491625747172,0.0,0.2869762159650308,1.0,106/416,14.95%,CCR2;GRAP2;PID1;IL1B;IFNLR1;HCK;STAT4;CD47;FPR1;FLT3;IL27RA;IFNGR1;DAPK1;FYN;ITGAX;CD40;MCL1;STAT5A;SYK;CCR1;BCL6;PIM1;NFKB1;JAK2;STAT3;VIM;FOS;CD36;CRK;PTGIS;ERBIN;SLA;IL10RA;CXCL10;RIPOR2;PTPN6;STAT5B;MMP1;PTPN7;CBL;IL6R;IKBKB;F13A1;PTPN12;STAT1;IL2RG;ITGB2;RC3H1;IRF4;IRAK4;CCND1;GRB2;ZFAND6;CSF2RB;NFE2L2;CIB1;PDE2A;IFNAR1;IL6ST;ZFP36L2;SOS1;IL6;HGF;RHOA;OPRM1;ICAM1;IL1R2;OXSR1;TANK;RPS3;SBNO2;FN1;ANXA1;IL31RA;PIK3CA;RIPK1;YWHAZ;CACTIN;FOXO3;DUSP1;ACOD1;TLR2;EBI3;LIFR;ADAMTS12;MAPK8;STAT2;KIT;AKT1;GBP5;CSK;TNFRSF1B;JUNB;TYK2;HCLS1;STK39;LRCH1;IFIT1;PNPT1;SYNCRIP;PTPRJ;TGFB1;IL18;GBP2;GBP3;RELA
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6354476049354574,1.5666873982715683,0.046104928457869634,0.28584091842691284,1.0,4/20,5.23%,PRKCE;TCAF2;NEDD4L;ADRA2A
prerank,positive regulation of T cell migration (GO:2000406),0.6501271527539051,1.5666455981733702,0.0401854714064915,0.28470683965462684,1.0,8/20,13.79%,CCR2;CXCL10;SPN;ADAM17;RHOA;OXSR1;APP;STK39
prerank,potassium ion export across plasma membrane (GO:0097623),0.7224377513380107,1.5664528306828442,0.03482587064676617,0.2839854935784221,1.0,2/13,3.32%,KCNE3;KCNQ1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5917383110579841,1.5660358361616995,0.03008595988538682,0.2836374190877214,1.0,11/33,15.66%,GLI1;PLCG2;PSME3;PTPN6;FBXW7;PSME2;PTEN;ID2;EZH2;TAF1;INO80
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6241537536580575,1.5653917660964713,0.025677603423680456,0.283929838877626,1.0,5/26,4.77%,ITPR1;PTPRC;PLCG2;SLC8B1;IBTK
prerank,positive regulation of vasculogenesis (GO:2001214),0.7632111068193503,1.56488243437908,0.037606837606837605,0.28391929494165075,1.0,3/10,3.13%,RIN2;RAP1A;RAPGEF2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.606302250966689,1.563720136106471,0.028416779431664412,0.285598698682669,1.0,8/29,6.92%,LYN;NOTCH2;RASGRP4;NGF;JAK2;ERBIN;GRB2;SHOC2
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6687775959771145,-1.563581873487551,0.04285714285714286,0.49626939123080777,1.0,4/10,7.35%,PLA2G15;ENPP2;PNPLA8;PLA2G4A
prerank,negative regulation of biosynthetic process (GO:0009890),0.685067775658196,1.5632454035957513,0.037953795379537955,0.2855979874403859,1.0,2/16,3.46%,CIITA;ABCB7
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5303785224603031,1.5617460995964343,0.015950920245398775,0.28785795770322053,1.0,16/67,8.24%,NEDD9;DOCK5;NDNF;UTRN;JAK2;CD36;CRK;CDC42;CARMIL1;RSU1;PTK2B;PLEKHA2;FLNA;CIB1;S100A10;RAC1
prerank,regulation of response to biotic stimulus (GO:0002831),0.6080731272896984,1.5616312090844586,0.01862464183381089,0.28692817120897823,1.0,9/28,7.50%,FGR;FOXP1;PTPN22;SAMHD1;CD36;DHX58;BIRC3;TIRAP;TRAF3
prerank,positive regulation of T cell activation (GO:0050870),0.5363114558529123,1.5610515842758494,0.01717791411042945,0.28715813028344106,1.0,9/62,8.68%,CCR2;PTPRC;IL1B;CYRIB;CD47;ZAP70;CD276;IL6ST;IL6
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6980667065020576,1.559777689585455,0.04690117252931323,0.28895431970634544,1.0,3/14,1.95%,CCR2;PTPN22;SYK
prerank,neuron projection regeneration (GO:0031102),-0.6855842013344227,-1.5597317670151802,0.024213075060532687,0.5032213976162145,1.0,6/10,24.56%,RTN4RL1;PTN;NREP;MTR;OMG;DHFR
prerank,cellular response to mechanical stimulus (GO:0071260),0.5527089091400199,1.5593706758740735,0.02849740932642487,0.2887548236763914,1.0,12/46,10.54%,IL1B;CD40;CNN2;NFKB1;MAP3K14;PTGER4;MAP3K1;PDE2A;F11R;TLR3;PIEZO1;CASP2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5851985478654562,1.5588500545737938,0.03207810320781032,0.28876569812533126,1.0,8/36,8.29%,CCR2;JAK2;NCOA3;FBXW7;ADRA2A;ADAM17;BUD31;EPHB2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6457175007698811,-1.5578348312342716,0.035623409669211195,0.5022679872104567,1.0,4/12,7.59%,BIN1;CTNNA3;CACNA1C;JUP
prerank,regulation of lymphocyte migration (GO:2000401),0.7580920655357628,1.5571728227183326,0.03600654664484452,0.2917600736930489,1.0,4/10,5.26%,STK10;MSN;SLC8B1;SPN
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6711826061844497,1.5571676465215276,0.03398058252427184,0.2905732755558713,1.0,2/17,0.24%,CBFA2T3;PID1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6578272586255423,1.556930031526821,0.03426791277258567,0.28990956244719085,1.0,4/18,5.26%,ITGB7;ITGA4;SELL;SPN
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.726174496988305,1.5568731282487192,0.04047217537942664,0.2888365004620337,1.0,1/11,0.08%,GRK3
prerank,ganglion development (GO:0061548),-0.6585581348343439,-1.5568520359475322,0.022988505747126436,0.49829201214479724,1.0,4/11,12.04%,NRP1;NRP2;CTNNB1;TUBB3
prerank,response to organic cyclic compound (GO:0014070),0.5444650725936212,1.556507919452288,0.023622047244094488,0.28855408158354856,1.0,12/52,14.55%,LRRK2;HLCS;IL1B;KYNU;STAT3;STAT5B;TIPARP;TLR3;ANXA1;STRN3;TGFB1;IL18
prerank,phagolysosome assembly (GO:0001845),0.7092478443028033,1.5564144617313689,0.045454545454545456,0.2875869464930832,1.0,7/12,13.34%,CORO1A;RAB7B;RAB7A;RAB39A;RAB34;PIKFYVE;ARL8B
prerank,positive regulation of acute inflammatory response (GO:0002675),0.6903210940242712,1.5550975995350813,0.04723127035830619,0.28959920437593234,1.0,4/14,10.41%,IL1B;IL6ST;IL6;PTGER3
prerank,establishment of melanosome localization (GO:0032401),-0.5554297342622462,-1.554852695199746,0.046831955922865015,0.4980146278703058,1.0,8/19,17.51%,MLPH;BBS2;SHROOM2;MREG;MYO5A;ARL6;BLOC1S5;RAB11A
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.5776844182086538,1.554298336977725,0.03409090909090909,0.29030372790290854,1.0,6/34,11.22%,PTPRC;PTPN22;LAPTM5;EPHB2;IL6;GPI
prerank,negative regulation of lyase activity (GO:0051350),0.6724600496623593,1.5536024807368192,0.032679738562091505,0.29065536375332496,1.0,1/16,0.04%,CCR2
prerank,negative regulation of cellular component movement (GO:0051271),0.6796835658835818,1.5532649539412426,0.04091653027823241,0.29038706088843375,1.0,3/15,2.68%,SP100;CCDC125;CRK
prerank,phosphatidylinositol metabolic process (GO:0046488),0.4995265140552335,1.5531212246317563,0.011560693641618497,0.2896392674933535,1.0,25/109,12.06%,PLBD1;PLCG2;PIP4K2A;PIK3C2A;IP6K3;MTMR14;INPP5F;OCRL;PI4K2B;PTEN;MTMR3;INPP4A;IMPA1;PIK3R6;PLEKHA2;ARF1;PLCB1;MTMR4;SYNJ1;PITPNM1;PIKFYVE;PIP4K2B;PIK3CA;CDIPT;PIK3R4
prerank,establishment of endothelial barrier (GO:0061028),0.5946992007550438,1.5515929259583765,0.03671071953010279,0.29204473435321415,1.0,9/29,9.18%,PECAM1;RAP1A;MSN;RAPGEF2;AFDN;PDE2A;F11R;EZR;ICAM1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5873445813698319,1.5514060048628648,0.034532374100719423,0.29133904152163104,1.0,12/33,14.95%,KLF4;NGFR;PPARG;STAT3;FOS;SPI1;KLF5;NR3C1;FOXO3;TEAD1;TGFB1;RELA
prerank,phospholipid catabolic process (GO:0009395),0.6262520551456332,1.5510282116959793,0.036818851251840944,0.2911419101556227,1.0,4/24,5.58%,PLBD1;PRDX6;SMPDL3A;GPCPD1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5187711410755245,-1.551001758619417,0.036414565826330535,0.5043385491003187,1.0,7/24,6.22%,TGFBR2;NRP1;ROBO2;NRP2;ROBO1;FGFR2;ACVR1
prerank,morphogenesis of an epithelium (GO:0002009),-0.5098247283623145,-1.550890949734225,0.03303303303303303,0.49733730713576424,1.0,6/25,11.63%,LRP6;ARHGAP12;FGFR2;KDM2B;TRAF3IP1;LAMA3
prerank,endothelial cell migration (GO:0043542),0.5759975890668024,1.5508765013017058,0.02168021680216802,0.29032568932884634,1.0,9/37,10.70%,DPP4;MYH9;ADGRA2;STAT1;FAP;PLXND1;PXN;RHOA;PIK3CA
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5582027068331132,1.5498862142708525,0.023876404494382022,0.291554750033119,1.0,12/40,9.63%,XPO1;RPL5;LAPTM5;FBXW7;AXIN1;HIPK2;GLMN;PTEN;PTK2B;LATS1;CSNK2A2;CSNK2A1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.6631664670300161,1.5483993195820605,0.03560371517027864,0.29397161764143365,1.0,3/20,4.15%,GRK3;RGS2;CRY1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.5499266551125289,-1.5483392254614043,0.045454545454545456,0.49999145182538185,1.0,7/19,10.74%,CUX1;PTPRD;IL1RAPL1;FBXW8;CDKL3;CAPRIN2;SS18L1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.4696705494968827,1.5476479544437978,0.0010660980810234541,0.29468193136980325,1.0,29/198,8.70%,PLBD1;LGALS13;LRRK2;PTPRC;LIMD1;CERKL;NADK;PLCG2;DUSP16;ITPKC;PIP4K2A;PAK1;STAT3;GPD2;IP6K3;PLD4;OCRL;ITPK1;PPP3CA;PTEN;INPP4A;IMPA1;PAK2;PXYLP1;PLCB1;PLCD4;COQ8A;EPHB2;SYNJ1
prerank,protein phosphorylation (GO:0006468),0.4518371141827584,1.5474761167443136,0.0,0.29403547663423685,1.0,129/478,14.30%,GRK3;FGR;LRRK2;GRK5;RARA;STK10;MAP4K1;SGK3;RUNX3;HCK;LYN;PRKCE;FLT3;SIK1;STK24;CDK13;VRK1;CREB1;DAPK1;FYN;SLK;CAMK1D;RET;MAP3K5;LMTK2;AKT3;MAPKAPK3;SYK;PIM1;PAK1;PKN1;STK17B;PRKAG2;JAK2;ERN1;PRKCH;RPS6KA3;IP6K3;BMPR2;CSNK1G1;MAPKAPK2;BIRC6;STK38;PTPN6;EIF2AK2;EIF2AK1;ABI1;CRY1;BCR;IKBKB;ZAP70;VRK2;GMFG;TAOK3;SIK3;HIPK2;MAPK14;RPS6KA5;CDK14;HIPK1;MAP3K1;STK4;PTK2B;PDPK1;MKNK2;PKN2;PAK2;DYRK1A;MAPK12;CCNH;SIK2;COQ8A;EPHB2;ACVR2A;TLR3;MINK1;STK38L;CSNK1G3;TNKS;LATS1;USP15;BRAF;OXSR1;CSNK2A2;CSNK2A1;TLK2;CAMKK2;PPP4R1;GRK6;RIPK1;YWHAZ;PRKG2;DMPK;PRKAG1;NLK;LATS2;MAP4K3;PRKAA1;CAD;RPS6KA1;PIK3R4;MAP3K7;APP;CCNT1;SMG1;TLR2;CDK12;MAP3K20;MORC3;BTK;MAPK8;EIF2AK3;KIT;AKT1;PDK3;LIMK2;CSK;MARK3;TYK2;HCST;STK39;ROCK1;PRKAA2;TLK1;LMTK3;RPS6KA2;HASPIN;FGFR3;TGFB1
prerank,transport along microtubule (GO:0010970),0.7089701077511095,1.5473964697416602,0.032148900169204735,0.2930498229320486,1.0,9/13,17.90%,APBA1;COPG2;CDC42;ARHGAP21;APP;CLIP3;DYNC1I2;BAG3;BORCS5
prerank,B cell proliferation (GO:0042100),0.6686986448803872,1.5469248325506948,0.047775947281713346,0.2930586320690746,1.0,3/17,2.32%,PTPRC;CD40;GAPT
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.745683789984998,1.546821580088089,0.04482758620689655,0.2922079506112607,1.0,2/10,1.29%,PTPRC;KLF4
prerank,regulation of cell size (GO:0008361),0.6277421042687018,1.546738945195701,0.02607361963190184,0.2913038438961651,1.0,9/23,8.98%,VAV3;RAP1GAP2;MSN;PTEN;MTPN;RARG;EZR;RAC1;RHOA
prerank,response to retinoic acid (GO:0032526),0.5334008487933347,1.545825678015696,0.01673101673101673,0.29226147574110184,1.0,8/59,7.88%,RARA;LYN;CREB1;RET;TRIM16;SETX;PTK2B;RARG
prerank,positive regulation of defense response (GO:0031349),0.5055217264353622,1.5451239336151585,0.00718562874251497,0.29281118029939807,1.0,20/89,13.34%,CCR2;IL1B;CD47;POLR3F;PLSCR1;NFKBIA;PTGER4;NFKBIZ;IL33;IL17RA;ABCC1;PDCD4;PDE2A;TLR3;IFI35;SLC15A4;RIPK1;APP;TLR2;GBP5
prerank,regulation of mast cell degranulation (GO:0043304),0.692243702751583,1.5449285320030006,0.035897435897435895,0.2921848051331062,1.0,5/14,4.17%,FGR;LYN;SYK;CD300A;UNC13D
prerank,cellular response to interleukin-15 (GO:0071350),0.7010856382856712,1.5445437948845409,0.03764320785597381,0.2908835353893071,1.0,6/13,7.51%,STAT5A;STAT3;STAT5B;IL2RG;GRB2;PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.7010856382856712,1.5445437948845409,0.03764320785597381,0.2908835353893071,1.0,6/13,7.51%,STAT5A;STAT3;STAT5B;IL2RG;GRB2;PLCB1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5927623081019207,1.5444728068604876,0.038011695906432746,0.2899859595752772,1.0,7/28,10.41%,PID1;IL1B;PIP4K2A;PTPRE;TNS2;PIP4K2B;PTPN1
prerank,epithelial tube morphogenesis (GO:0060562),-0.48775638236939717,-1.5439268712112484,0.025396825396825397,0.5092274935834401,1.0,8/32,9.27%,CSF1R;MEF2C;CTNNB1;PKD2;RHOB;ACVR1;SCRIB;SLIT2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7491059471010284,1.543521490530947,0.028169014084507043,0.29124431014038177,1.0,3/10,1.36%,PTPRC;KLRD1;LILRB1
prerank,cellular lipid catabolic process (GO:0044242),0.6046978698093669,1.5434367303538366,0.03551136363636364,0.29038463632502987,1.0,4/27,5.83%,PLBD1;SMPDL3B;NUDT19;CEL
prerank,regulation of cell-cell adhesion (GO:0022407),0.5687188344289077,1.5429251956515777,0.026027397260273973,0.29046426472582615,1.0,10/39,14.80%,DPP4;CD47;FUT4;AFDN;MINK1;MEGF10;NF2;CITED2;TGFB1;PTPRG
prerank,leukocyte tethering or rolling (GO:0050901),0.6599909671773548,1.5429183587466246,0.04113924050632911,0.2894262714490592,1.0,4/17,5.26%,ITGB7;ITGA4;SELL;SPN
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5829661728170318,1.542654648789871,0.03840682788051209,0.2889702305191483,1.0,4/33,1.95%,DPP4;LYN;RET;SYK
prerank,lipid catabolic process (GO:0016042),0.6656312316812484,1.5426192583775837,0.043209876543209874,0.28802020541696927,1.0,3/18,5.83%,PLA1A;HSD17B14;CEL
prerank,regulation of T cell activation (GO:0050863),0.565352171756059,1.542419762821381,0.023968042609853527,0.2874940515337686,1.0,5/42,3.25%,CCR2;CYRIB;CD47;PTPN22;LAPTM5
prerank,prostanoid biosynthetic process (GO:0046457),0.6814024539035861,1.5420925124740767,0.05081967213114754,0.28717056190949775,1.0,2/15,3.17%,CD74;PTGIS
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6624550966572065,1.5413087588668786,0.02823920265780731,0.2879394646172032,1.0,5/17,11.88%,LYN;EIF2AK2;TAOK3;RNF13;KLHDC10
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5246593885336083,1.5405306457562735,0.022988505747126436,0.28871702092392554,1.0,29/67,17.85%,VAV3;CYBB;FYN;MAPKAPK3;WASF2;CRK;MAPKAPK2;ABI1;CDC42;VEGFC;BCAR1;ELMO2;MAPK14;PTK2B;PAK2;RAC1;PXN;RHOA;PGF;NCF2;PIK3CA;NCF1;ROCK1;CYFIP2;ELMO1;SHB;PIK3R2;SH2D2A;CYBA
prerank,peptidyl-serine modification (GO:0018209),0.47526390496117443,1.5403654620631437,0.0033112582781456954,0.2880166153294688,1.0,58/166,15.65%,LRRK2;MAP4K1;SGK3;PRKCE;VRK1;CAMK1D;LMTK2;AKT3;NDNF;MAPKAPK3;PKN1;PRKCH;RPS6KA3;CSNK1G1;MAPKAPK2;STK38;IKBKB;VRK2;HIPK2;MAPK14;RPS6KA5;HIPK1;STK4;PDPK1;MKNK2;PKN2;PAK2;DYRK1A;MAPK12;GALNT2;STK38L;CSNK1G3;TNKS;LATS1;CSNK2A2;CSNK2A1;TLK2;DMPK;LATS2;RPS6KA1;SMG1;MORC3;MAPK8;EIF2AK3;AKT1;PDK3;MARK3;STK39;ROCK1;TLK1;RPS6KA2;MAP3K13;BRSK1;MAPK1;TBK1;TAF1;POGLUT1;DYRK2
prerank,positive regulation of cell killing (GO:0031343),0.71454518542383,1.538756951565235,0.043548387096774194,0.29065141720537047,1.0,7/13,18.69%,SYK;NOX1;RAC1;MAPK8;DVL2;CYBA;FZD7
prerank,cardiac conduction system development (GO:0003161),0.6122720518643804,1.5384927920490985,0.03453453453453453,0.2902492431975015,1.0,6/24,17.09%,NOTCH2;GJA5;HCN4;SMAD4;MAML1;SMAD5
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.6149502877599482,1.5384156365176735,0.038461538461538464,0.28938391295427596,1.0,4/24,4.77%,ITPR1;PTPRC;PLCG2;IBTK
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.7423679808008321,1.5377601435968966,0.04406779661016949,0.2899904185516246,1.0,2/10,5.84%,DPP4;FAP
prerank,positive regulation of lipid transport (GO:0032370),-0.6279502366482169,-1.5373181997401841,0.0345679012345679,0.5263595282666801,1.0,4/12,3.76%,APOE;LRP1;SPP1;ABCB4
prerank,vitamin D metabolic process (GO:0042359),-0.626067317543845,-1.5372958775555812,0.050761421319796954,0.5192045780517969,1.0,1/13,0.16%,LGMN
prerank,negative regulation of B cell proliferation (GO:0030889),0.7111657234335126,1.5370580198108783,0.04878048780487805,0.29054091386264436,1.0,4/11,11.74%,LYN;CD300A;RC3H1;FCGR2B
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.49704213034395706,1.534379639450321,0.0047169811320754715,0.2954442607182985,1.0,31/93,18.69%,IL1B;TRAF1;MAP3K5;SPI1;EIF2AK2;AXIN1;TAOK3;TRAF4;HIPK2;TIRAP;PTK2B;TRAF3;PLCB1;MBIP;MINK1;RELL1;MAP3K4;RIPK1;FCGR2B;KLHDC10;APP;EMC10;SH3RF1;NCF1;DUSP22;WNT7A;RASSF2;TRAF2;MMP8;SEMA3A;FZD7
prerank,membrane protein proteolysis (GO:0033619),0.5804708610333134,1.5338401026915645,0.032624113475177303,0.29573552358579536,1.0,14/37,14.95%,NAPSA;NGFR;RET;NFKB1;MYH9;PARL;ADAM17;SPPL2A;ADAM19;MBTPS1;BACE2;TGFB1;ADAM9;RELA
prerank,positive regulation of T cell proliferation (GO:0042102),0.540445486626497,1.5333921530861643,0.01948051948051948,0.29575137431412457,1.0,12/55,12.77%,CCR2;PTPRC;IL1B;IL27RA;SYK;CD276;IL6ST;IL6;RPS3;ANXA1;ICOSLG;EBI3
prerank,neurotransmitter uptake (GO:0001504),-0.6269827221119368,-1.5328948906408602,0.042352941176470586,0.5294613720605376,1.0,5/12,11.86%,GLUL;SLC1A3;SNAP25;ATP1A2;SLC29A1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5923430468929625,1.5324388636812114,0.03367496339677892,0.29693875465760233,1.0,4/30,7.23%,CD74;CD44;PTTG1IP;DYRK1A
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.46560210552776443,-1.5323308147886168,0.019083969465648856,0.5248712662736533,1.0,11/39,11.91%,TGFBR2;LRP6;SALL1;NRP1;NPNT;FGF2;CTNNB1;PKD2;SEMA3E;SLIT2;VEGFA
prerank,type I interferon signaling pathway (GO:0060337),0.5578345146068424,1.5321847646633229,0.023066485753052916,0.2954194109269765,1.0,20/41,16.67%,SP100;SAMHD1;OAS2;IFIT2;IRF2;STAT1;IRF4;OASL;IFNAR1;IFI35;IRF7;PSMB8;STAT2;TYK2;IFIT1;GBP2;IFITM3;MYD88;IRF5;IFNAR2
prerank,cellular response to type I interferon (GO:0071357),0.5578345146068424,1.5321847646633229,0.023066485753052916,0.2954194109269765,1.0,20/41,16.67%,SP100;SAMHD1;OAS2;IFIT2;IRF2;STAT1;IRF4;OASL;IFNAR1;IFI35;IRF7;PSMB8;STAT2;TYK2;IFIT1;GBP2;IFITM3;MYD88;IRF5;IFNAR2
prerank,natural killer cell mediated immunity (GO:0002228),0.6781469771439923,1.5311398215687457,0.047775947281713346,0.2968655445895035,1.0,4/15,4.57%,SLAMF7;KLRD1;KIF5B;KLRK1
prerank,peptidyl-tyrosine modification (GO:0018212),0.5282172410597556,1.530155460874266,0.024296675191815855,0.2981271923340546,1.0,13/56,8.29%,FGR;HCK;LYN;FLT3;FYN;SYK;JAK2;PTPN6;ABI1;ZAP70;PTK2B;DYRK1A;EPHB2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5767770304514716,1.52958278698583,0.0364656381486676,0.29852980325382117,1.0,11/34,15.88%,PTPN22;DUSP16;PTPRO;PTPN6;PTPN12;TNS2;DUSP6;PTPN1;DUSP1;PTPRJ;DUSP22
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5156894693072824,-1.5293721185904166,0.03058103975535168,0.530016338872297,1.0,8/24,9.85%,PLA2G15;LPCAT1;PNPLA8;SLC27A1;PLA2G4A;CDS2;SERAC1;GPAM
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6961664520561065,1.5287370477821198,0.03257328990228013,0.29949372411468467,1.0,3/14,7.16%,ITGA4;CD40;PDCD4
prerank,response to prostaglandin E (GO:0034695),0.7448206069225252,1.5285950120749485,0.047957371225577264,0.298798082120245,1.0,4/10,13.31%,PTGER2;PTGER4;GNB1;GNG2
prerank,negative regulation of viral process (GO:0048525),0.531417841608615,1.5274525218757695,0.017218543046357615,0.3004674291397315,1.0,15/57,10.80%,ZC3HAV1;OAS2;PTX3;PLSCR1;TRIM26;EIF2AK2;SLPI;FAM111A;TRIM62;STAT1;IFIH1;HEXIM1;OASL;MBL2;TRIM14
prerank,calcium ion transport into cytosol (GO:0060402),-0.5363376277977119,-1.5263320837819498,0.022598870056497175,0.5344626076665973,1.0,8/21,22.32%,SLC8A1;CACNA2D1;CACNA1C;TRPM2;TRPV4;RYR2;GRIN2B;ADRA1A
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6585957074392172,-1.5251634146107025,0.05630630630630631,0.5318533087340956,1.0,4/10,12.56%,PDE3B;WNK1;SERPINE1;JAM3
prerank,camera-type eye development (GO:0043010),-0.5154182557760977,-1.525109955945418,0.02108433734939759,0.5253131479865217,1.0,11/25,24.88%,SKI;CACNA1C;NF1;RAB3GAP1;SHROOM2;VEGFA;EFEMP1;CEP290;CRYBA4;FBN2;NES
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.5584386031766226,-1.5245732198775879,0.03608247422680412,0.520682261370349,1.0,15/18,37.10%,POLD3;PCNA;LIG3;GINS1;POLA1;RFC3;LIG1;GINS3;POLE;POLE3;RFC4;MCM4;GINS4;GINS2;POLD2
prerank,receptor internalization (GO:0031623),0.542653448220006,1.5241166309914989,0.04249667994687915,0.3069595629354167,1.0,8/44,6.33%,GRK3;LILRB1;SYK;CD36;PICALM;SNX1;ITGB2;GRB2
prerank,atrial septum development (GO:0003283),0.6828065162351087,1.5231461018995827,0.065,0.30825163587026316,1.0,3/13,2.95%,NOTCH2;GJA5;BMPR2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6883848615322703,1.5225857294861367,0.05016722408026756,0.30860301345897895,1.0,4/14,9.55%,CCR2;PTK2B;ADAM17;OXSR1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.7397124617295718,1.5223368188453719,0.0427807486631016,0.3081767384647597,1.0,1/10,0.03%,DPP4
prerank,regulation of T cell chemotaxis (GO:0010819),0.7312930800565178,1.5216515919798483,0.04070796460176991,0.30879017860782093,1.0,4/11,9.55%,CCR2;CXCL10;ADAM17;OXSR1
prerank,NAD biosynthetic process (GO:0009435),0.63576310666793,1.5199563254599455,0.04242424242424243,0.31188268445120465,1.0,6/20,12.18%,KYNU;PTGIS;HAAO;NAXE;PARP9;NMNAT3
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6359711960487067,1.5198497345158168,0.06946688206785137,0.3111194618523204,1.0,10/18,18.37%,HEG1;CCDC125;CUL3;RIPOR2;DLC1;ITGA3;KCTD13;ABL2;KANK1;SCAI
prerank,response to lipopolysaccharide (GO:0032496),0.47660917684100007,1.5194257993123181,0.00904977375565611,0.31113938274554886,1.0,39/138,15.86%,IL1B;FOXP1;TNIP3;PTPN22;STAP1;LILRB1;MAPKAPK3;NFKB1;JAK2;VIM;RPS6KA3;ERBIN;MAPKAPK2;CXCL10;SLPI;SCARB1;PELI1;MAPK14;TIRAP;ADAM17;PDCD4;CARD16;IFNAR1;IL6;NFKBIB;RHOA;GIT1;SBNO2;CACTIN;ACOD1;NLRP3;MAPK8;TNFRSF1B;ADAM9;GSTP1;RELA;MYD88;SRR;IRAK3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.7306443113839693,1.5189003374656644,0.05217391304347826,0.3103639659293242,1.0,2/10,9.43%,CBFA2T3;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),0.7306443113839693,1.5189003374656644,0.05217391304347826,0.3103639659293242,1.0,2/10,9.43%,CBFA2T3;GIT1
prerank,integrin-mediated signaling pathway (GO:0007229),0.5067425388480721,1.5183978448259319,0.025830258302583026,0.31060357743024297,1.0,14/73,6.49%,ITGB7;FGR;NEDD9;HCK;CD47;SYK;CUL3;ERBIN;RCC2;MYH9;CDC42;BCAR1;ITGB2;PTK2B
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.663032487833218,1.5181135197224362,0.05930807248764415,0.31022325925359245,1.0,4/17,7.23%,CD74;CD44;PTTG1IP;DYRK1A
prerank,regulation of steroid metabolic process (GO:0019218),-0.5167397700041558,-1.5180580547204405,0.03592814371257485,0.5391927658907215,1.0,7/23,11.50%,APOE;TTC39B;STUB1;ARV1;PANK2;DGKQ;FMO5
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5532041303558541,-1.517026854726257,0.05454545454545454,0.5366900908538422,1.0,6/18,6.82%,NAPA;GRIA2;SLC17A6;GRIK4;GRID2;GRIK1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6886539664580515,1.516947797185357,0.05175292153589316,0.3119424634160679,1.0,7/14,10.41%,LYN;STAT5A;JAK2;STAT3;STAT5B;PXN;PTPN1
prerank,regulation of cytoskeleton organization (GO:0051493),0.4793433756609557,1.5146632588335127,0.009269988412514484,0.316200388310154,1.0,32/108,15.07%,RND3;IQGAP2;IQGAP1;PAK1;CELSR1;ARHGAP18;CRK;CORO1A;CCDC88A;RAC2;CLIC4;DLC1;DIAPH1;CAPN2;PAK2;PHLDB2;F11R;RHOBTB3;EZR;KATNBL1;RAC1;RHOA;CYLD;PRKAA1;ROCK1;PRKAA2;CLASP1;CAPN6;ARHGAP17;STMN3;MAPK1;RHOG
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5806612114818285,1.514262970801275,0.04456824512534819,0.31623846621360296,1.0,13/32,17.75%,KLF4;AKT3;PIK3C2A;CIB1;HDAC9;RHOA;ANXA1;MAP2K5;THBS1;STARD13;MAP3K3;JCAD;HDAC7
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4936068853590272,1.513953062673686,0.013496932515337423,0.3159238114421316,1.0,11/90,8.34%,CCR2;PLAC8;FFAR4;SYK;JAK2;CD36;UCP2;IRF4;PRKAB2;THRA;ELOVL6
prerank,regulation of stem cell proliferation (GO:0072091),0.6551684886603174,1.512834132907213,0.05546492659053834,0.31755627957903454,1.0,3/17,3.95%,PTPRC;ACE;EIF2AK2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.6554139122252354,1.512539554906969,0.04813664596273292,0.3172488420604912,1.0,3/17,3.32%,KCNE3;NEDD4L;KCNQ1
prerank,actin-myosin filament sliding (GO:0033275),0.5665273511777515,1.5124779024188522,0.026350461133069828,0.3154369716558926,1.0,4/38,3.70%,TNNC1;TPM4;VIM;MYL4
prerank,muscle filament sliding (GO:0030049),0.5665273511777515,1.5124779024188522,0.026350461133069828,0.3154369716558926,1.0,4/38,3.70%,TNNC1;TPM4;VIM;MYL4
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.7180015702366964,1.5122517450733741,0.048027444253859346,0.31497480368874614,1.0,3/10,7.88%,RARA;PPARG;RARG
prerank,superoxide anion generation (GO:0042554),0.6857409294350393,1.5122224728213771,0.05863192182410423,0.31408001334276386,1.0,5/13,17.85%,CYBB;NOX1;NCF2;NCF1;CYBA
prerank,response to fatty acid (GO:0070542),0.6516992964309757,1.5121811654507717,0.0688,0.3131969215752987,1.0,4/17,13.24%,PID1;CD36;FOXO3;PDK3
prerank,regulation of chemokine production (GO:0032642),0.5624789850463074,1.5119191718255462,0.04281767955801105,0.31282268510844674,1.0,8/36,8.68%,CD74;FOXP1;EIF2AK2;IL6R;IL33;ADAM17;TLR3;IL6
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5826863376387253,-1.5116424266414845,0.05154639175257732,0.5505013378642629,1.0,8/16,20.90%,SLC8A1;CACNA1C;PRKACA;ANK2;ATP1A2;CALM1;GSTO1;RYR2
prerank,zymogen activation (GO:0031638),-0.44291617127315686,-1.510275813066776,0.024305555555555556,0.5493693968215058,1.0,9/39,9.13%,LGMN;ASPH;VSIR;KLK3;PLAU;FURIN;MMP14;PGK1;TBC1D10A
prerank,negative regulation of cell junction assembly (GO:1901889),0.5944373465989166,1.509632880862798,0.04899135446685879,0.31716023409708144,1.0,13/25,16.89%,IL1B;ACE;RCC2;IKBKB;DLC1;PTEN;PHLDB2;BCAS3;TLR2;ROCK1;THBS1;DUSP22;ARHGAP6
prerank,SNARE complex assembly (GO:0035493),0.7311853353835187,1.5092001294134623,0.06642728904847396,0.3171940828510676,1.0,2/10,1.51%,UVRAG;STXBP6
prerank,Notch signaling involved in heart development (GO:0061314),0.7005804902927641,1.5085471896631923,0.051194539249146756,0.31779037921401715,1.0,2/11,5.11%,NOTCH2;RBPJ
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5824607167773083,1.507643399946939,0.047619047619047616,0.3189197220167129,1.0,1/29,0.01%,PLBD1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.649962990840712,1.5075379846386228,0.05317324185248713,0.3181770777441397,1.0,6/15,10.00%,IQGAP2;ACTR3;ACTR2;ARPC1B;ARPC2;ARPC4
prerank,intestinal lipid absorption (GO:0098856),0.7054892890046625,1.50721114355876,0.05342237061769616,0.3180085288489068,1.0,3/11,5.83%,LDLR;CD36;CEL
prerank,receptor metabolic process (GO:0043112),0.5318951779619349,1.507086782329539,0.021080368906455864,0.3173181940415329,1.0,10/53,6.33%,GRK3;UVRAG;LILRB1;LMTK2;SYK;CD36;PICALM;SNX1;ITGB2;GRB2
prerank,mucosal immune response (GO:0002385),0.6812284373069178,1.5060305067126543,0.049342105263157895,0.31891464415593757,1.0,1/15,0.53%,IFNLR1
prerank,epiboly involved in wound healing (GO:0090505),0.6522267920543743,1.5039229853515146,0.0438871473354232,0.32301620367259354,1.0,4/16,8.98%,CD44;LCP1;FLNA;RHOA
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.512202445670168,1.5038127647035906,0.018820577164366373,0.3222783671840803,1.0,13/67,8.29%,FGR;HCK;LYN;FLT3;FYN;SYK;JAK2;PTPN6;ABI1;ZAP70;PTK2B;DYRK1A;EPHB2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5754899653663474,1.5014363446744912,0.05150214592274678,0.32692727313210174,1.0,9/30,13.17%,PTPRC;CD300A;PTPN6;INPP5F;SAMSN1;PARP14;SH3BP5;NF2;MVP
prerank,dopamine metabolic process (GO:0042417),-0.5534750412728879,-1.501028347510804,0.0398936170212766,0.5792920652268282,1.0,3/18,1.81%,PRKN;SNCAIP;COMT
prerank,regulation of humoral immune response (GO:0002920),-0.442537000626668,-1.5004920054025412,0.018656716417910446,0.5747331751583107,1.0,11/44,13.69%,C1QB;C1QA;C1QC;C3AR1;PROS1;C4B;C5AR1;SUSD4;C5AR2;CLU;C3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.48284983902820866,1.500119748310987,0.01696969696969697,0.3289349056380384,1.0,26/87,16.33%,GPR132;KLF4;PSME3;PSMB7;PSME2;PTEN;CDKN2C;AVEN;PSME4;ZFP36L2;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;DCUN1D3;PSMC4;PSMD10;PSMB1;WEE1;APC;BRD7;RBL2;USP47;PSMD12;RB1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6067194705939911,1.4992612011564523,0.046686746987951805,0.33008069859098405,1.0,9/22,14.75%,PTPN22;CD300A;LAPTM5;PRNP;EZR;FCGR2B;LGALS3;PTPRJ;GPS2
prerank,positive regulation of sodium ion transport (GO:0010765),-0.6284773587331502,-1.4991968366403585,0.05121293800539083,0.5738619436968339,1.0,7/12,32.24%,AHCYL1;SCN1B;PKP2;SCN3B;WNK3;SCN4B;NOS1
prerank,neurotransmitter secretion (GO:0007269),-0.4440386917159712,-1.4986757094473222,0.023715415019762844,0.5696408776208479,1.0,19/44,23.44%,SYT1;PTPRN2;PCLO;NRXN2;SNAP25;GAD2;CDK5;SNPH;STX1A;LIN7A;CPLX1;RIMS1;RAB3A;NRXN1;GAD1;SYN2;SLC32A1;PDZD11;CPLX2
prerank,cellular response to fatty acid (GO:0071398),0.7067896484879708,1.4982661665745425,0.06949152542372881,0.3315698569112485,1.0,1/12,0.24%,PID1
prerank,polyol metabolic process (GO:0019751),0.5382839268536903,1.4975139581455745,0.0348993288590604,0.3321906505370903,1.0,12/46,8.70%,PLCG2;ITPKC;IP6K3;PLD4;OCRL;ITPK1;PTEN;INPP4A;IMPA1;PLCB1;PLCD4;SYNJ1
prerank,protein dephosphorylation (GO:0006470),0.47024738883637573,1.4973867199822013,0.010169491525423728,0.3314973527949221,1.0,50/135,17.99%,PTPRC;DAPP1;PTPN22;DUSP16;PTPRE;PPP2R5A;PTPRU;PTPRO;PPP1R12A;SDHAF2;PTPN6;PTPN7;PPP3CA;PTPN12;FBXW11;TNS2;PTEN;MTMR3;SSU72;PPTC7;PPP2R2A;PPP4R2;MTMR4;DUSP6;PPP1R15A;RPRD1B;PPP4R1;PTPN1;PDP2;DUSP12;DUSP1;PPP2R3A;PPP1R15B;PPP1CB;PPM1D;TIMM50;PTPRJ;PPP2R5C;PTPRG;DUSP26;ILKAP;PPP2R5E;PPM1G;DUSP22;EYA3;LHPP;MTMR2;TAB1;PTPN4;PTPRA
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7017888140758811,1.4965457039328085,0.06044905008635579,0.3314838563340225,1.0,4/11,8.70%,OCRL;PTEN;IMPA1;SYNJ1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.7017888140758811,1.4965457039328085,0.06044905008635579,0.3314838563340225,1.0,4/11,8.70%,OCRL;PTEN;IMPA1;SYNJ1
prerank,response to acidic pH (GO:0010447),-0.6053467413352112,-1.496480910413065,0.036231884057971016,0.5721099880199315,1.0,4/13,12.04%,LGMN;RAB11FIP5;IMPACT;CHP1
prerank,signal release from synapse (GO:0099643),-0.4502124014175603,-1.4960267031828816,0.016260162601626018,0.5676311080166369,1.0,19/43,23.44%,SYT1;PTPRN2;PCLO;NRXN2;SNAP25;GAD2;CDK5;SNPH;STX1A;LIN7A;CPLX1;RIMS1;RAB3A;NRXN1;GAD1;SYN2;SLC32A1;PDZD11;CPLX2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6566076236245426,1.495811727994304,0.07718120805369127,0.3323934105858014,1.0,3/15,2.62%,GLI1;PLCG2;CUL3
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4635013056216053,1.4950136592304697,0.009080590238365494,0.3334798145085749,1.0,32/122,16.24%,CIITA;NIBAN1;IL1B;DNA2;GLI1;BCL3;KLF4;RPL5;NFKB1;JAK2;VIM;KAT7;IL33;FAF1;MTPN;YTHDF3;NOX1;IL6;HGF;NMD3;TLR2;AKT1;METTL3;LARP4B;EIF3E;SLC6A9;THBS1;STN1;DYRK2;RPS4X;RPS6KB1;INSR
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.43804038869196993,-1.4949140618385237,0.025735294117647058,0.5651968969462036,1.0,11/40,8.90%,P2RY12;FLT1;NTRK2;NTRK3;GNA15;FGF2;CD86;PLCG1;HTR2B;C5AR1;P2RY6
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5975834209975618,1.493971536073111,0.06307692307692307,0.33500962099755693,1.0,5/23,6.58%,KLRD1;CD226;LILRB1;KLRK1;PIK3R6
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.3997796150972268,-1.492949259040568,0.010582010582010581,0.5665997554848813,1.0,18/69,10.78%,PRKN;LGMN;APOE;CX3CR1;MEF2C;NTRK2;GRN;RASA1;PPARGC1A;HIF1A;ADAM8;NRBP2;KDM2B;SNX6;CPEB4;PTPRZ1;MSH2;SET
prerank,presynapse organization (GO:0099172),-0.6444205860910326,-1.4927149713957597,0.056074766355140186,0.5614105040661103,1.0,5/10,16.08%,NLGN1;LRRTM3;C5AR1;NLGN2;NLGN3
prerank,negative regulation of inflammatory response (GO:0050728),0.45556377453716523,1.4926415354375293,0.0021810250817884407,0.337188814123477,1.0,34/182,12.41%,FGR;FFAR4;HCK;LYN;CRHR2;CYSLTR2;PLCG2;KLF4;CREB1;FYN;PPARG;SYK;METRNL;RXFP2;PTGER2;PTGIS;PTGER4;HTR4;MYH9;SMPDL3B;DPEP1;MAPK14;ADAM17;CYSLTR1;GNB1;IL6;GIT1;SLAMF8;PRKAR2A;ADCY7;GLP2R;ACOD1;NLRP3;ADCY5
prerank,positive regulation of biosynthetic process (GO:0009891),0.5422234548865476,1.4919569256280287,0.05191256830601093,0.337870817134005,1.0,11/40,14.30%,PLCG2;CREB1;VIM;CD36;ZBTB20;SCX;MTPN;CREBL2;AKT1;SIRT4;TGFB1
prerank,sensory perception of pain (GO:0019233),0.6147745573699638,1.4904620151366461,0.05794947994056464,0.34074658344621817,1.0,2/21,3.56%,CCR2;CHRNA4
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.7098180232055504,1.4902682372453735,0.0642361111111111,0.340240425510694,1.0,3/10,3.13%,LYN;LILRB1;RAPGEF2
prerank,carbohydrate homeostasis (GO:0033500),0.5107191904257101,1.4902153020985245,0.016795865633074936,0.33936207998863394,1.0,24/67,20.50%,NGFR;PPARG;STAT3;SLC8B1;CRY1;ADRA2A;WFS1;CRY2;CYB5R4;IL6;SELENOT;PRKAA1;BACE2;PRKAA2;TENT4B;INSR;GCK;PYGL;MBD5;BAD;RPS6;PARK7;ADIPOR1;STK11
prerank,cellular response to lipopolysaccharide (GO:0071222),0.48757343438949696,1.489961230494602,0.017921146953405017,0.3390015881313743,1.0,30/101,15.01%,IL1B;HCK;LYN;PRKCE;TNIP3;PTPN22;STAP1;LILRB1;NFKB1;VIM;CXCL10;MAPK14;PDCD4;CARD16;IL6;NFKBIB;RHOA;GIT1;SBNO2;CACTIN;ACOD1;NLRP3;MAPK8;TNFRSF1B;TGFB1;IL18;ADAM9;GSTP1;RELA;MYD88
prerank,calcium-mediated signaling (GO:0019722),0.48181662269969167,1.4899483687802046,0.02497027348394768,0.33807241987251935,1.0,22/93,13.08%,CCR2;LRRK2;PTPRC;PLCG2;XCR1;CCR1;MCTP2;ACKR2;CCR9;PPP3CA;PPP1R9B;PRNP;CCRL2;PDPK1;CAMKK2;FIS1;DMPK;PRKAA1;FKBP1B;CXCR6;BTK;EIF2AK3
prerank,regulation of programmed cell death (GO:0043067),0.4624385945028429,1.4886890995174111,0.004343105320304018,0.3399405254105254,1.0,35/161,10.73%,LRRK2;FLT3;BCL3;DAPK1;SLK;ACER3;BCL6;JAK2;CXCL10;MALT1;PTPN6;BCL2L14;BIRC3;BCAR1;STAT1;DDX42;DFFA;WFS1;LGALS1;WRN;IKZF3;RARG;TOX3;TM7SF3;PHLPP1;HIP1;PIDD1;RPS3;RTN4;NLRC4;DAXX;CASP2;APAF1;USP42;RIPK1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6288986884400386,1.4878388071237156,0.0546875,0.340918732283177,1.0,4/20,8.68%,ITGA4;CD40;PDCD4;IL6
prerank,negative regulation of DNA binding (GO:0043392),0.5776898559059879,1.4876556312224012,0.06598240469208211,0.3403534083666594,1.0,9/28,14.64%,SP100;JAK2;MAD2L2;NFKBIA;SUMO1;CPNE1;TNKS;RSF1;ILRUN
prerank,mitochondrial fusion (GO:0008053),-0.5487045406422816,-1.486809067183737,0.05412371134020619,0.5779398066628034,1.0,9/18,15.58%,AFG3L2;GDAP1;MFF;MIGA2;SPG7;USP30;BAX;STOML2;MFN1
prerank,negative regulation of peptidase activity (GO:0010466),-0.424034471703765,-1.4862901521249368,0.01845018450184502,0.573859004921821,1.0,8/47,12.47%,TIMP2;LRP1;SERPINE2;CST3;SPOCK1;TIMP3;SERPINE1;SERPINI1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4640288849863565,1.4862302322674203,0.010078387458006719,0.3428838020102917,1.0,26/138,8.59%,FGR;NEDD9;HCK;LYN;RASGRP4;NGF;FLT3;STAP1;FYN;RET;LMTK2;PTPRU;SYK;JAK2;BMPR2;SLA;ABI1;ZAP70;CLNK;BCAR1;STYK1;POLR1G;PTK2B;EPHB2;ACVR2A;IL6ST
prerank,positive regulation of lyase activity (GO:0051349),-0.5742996291471066,-1.486091320496883,0.06067961165048544,0.5686825057978836,1.0,3/14,4.20%,CACNA1D;CACNA1C;NF1
prerank,ureteric bud morphogenesis (GO:0060675),-0.5596856476990574,-1.485472966898005,0.0525,0.5651881833301367,1.0,4/16,3.43%,SALL1;NPNT;FGF2;PKD2
prerank,negative regulation of cell development (GO:0010721),0.5877130432509962,1.4843159456780555,0.05680119581464873,0.3466675581222046,1.0,8/25,11.91%,IL1B;LILRB1;SORL1;FBXW7;IL6;FBN1;B2M;REST
prerank,regulation of MAP kinase activity (GO:0043405),0.4805300426549904,1.484247548924726,0.023557126030624265,0.3458408918545764,1.0,25/92,14.84%,LRRK2;IL1B;LYN;FLT3;CD40;CD300A;RGS2;SORL1;STK38;ADRA2A;TSG101;PIK3R6;PAQR3;SNF8;DIRAS1;PTPN1;DUSP1;RGS14;CDK12;PDGFD;KIT;EZH2;PTPRJ;TGFB1;GSTP1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.44713745110513076,1.484052797999276,0.003171247357293869,0.34532356163662525,1.0,44/208,11.45%,CD74;CARD11;IL1B;TRAF1;ALPK1;TNIP3;PLCG2;CD40;SLC44A2;MAP3K14;REL;ANKRD17;MALT1;IKBKB;TRIM62;BIRC3;TRAF4;NLRX1;TRAF3IP2;STAT1;S100A4;PELI1;IRAK4;TIRAP;UBE2N;SHISA5;LGALS1;PDPK1;ZFAND6;FLNA;TRIM25;TRAF3;ZDHHC13;CARD16;RHOA;ZDHHC17;CPNE1;PIDD1;TANK;RIPK1;TRIM14;RNF31;CACTIN;TAB3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4622378978105116,1.482864128015734,0.011025358324145534,0.3473368694403005,1.0,29/142,12.54%,CCR2;FPR1;XCR1;FPR3;CCR1;CD36;CACNA1A;LPAR3;PTGER2;ACKR2;CCR9;NPTN;GPR35;SLC8B1;PTGER4;ATP2B1;CAV2;TAC4;CCRL2;CYSLTR1;TACR1;CD52;SELENOT;PTGER3;FIS1;CALB2;FKBP1B;ADCY5;CXCR6
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6491361553861233,-1.4826778772001623,0.056433408577878104,0.5698614987262159,1.0,3/10,10.15%,TGFBR2;LGALS9;NCKAP1L
prerank,filopodium assembly (GO:0046847),0.6406936934948221,1.4825778166579515,0.060653188180404355,0.34718466715612606,1.0,6/16,8.57%,SRGAP2;PPP1R9B;FGD4;EZR;FGD1;FGD3
prerank,pigment granule transport (GO:0051904),-0.5307620572749979,-1.4818457658948512,0.06266318537859007,0.5615206314997438,1.0,8/18,23.51%,MLPH;BBS2;MREG;MYO5A;ARL6;BLOC1S5;RAB11A;BLOC1S6
prerank,melanosome transport (GO:0032402),-0.5307620572749979,-1.4818457658948512,0.06266318537859007,0.5615206314997438,1.0,8/18,23.51%,MLPH;BBS2;MREG;MYO5A;ARL6;BLOC1S5;RAB11A;BLOC1S6
prerank,response to peptide hormone (GO:0043434),0.5427235430970447,1.4816480036237318,0.03800786369593709,0.34840147146495376,1.0,13/43,13.83%,STAT4;CREB1;STAT5A;STAT3;STAT5B;CRY1;STAT1;TRIM16;ANXA1;GNAI1;STAT2;AKT1;ROCK1
prerank,regulation of organelle assembly (GO:1902115),0.5000955319642143,1.481634017503281,0.02457002457002457,0.3474773045768932,1.0,21/72,11.40%,HCK;TBC1D1;SDCCAG8;TBC1D8;MSN;USP6NL;TBC1D10C;TBC1D2B;TSG101;MTMR3;ATG5;RABGAP1;IFT140;EZR;PDCD6IP;PIKFYVE;TBC1D5;CYLD;SENP6;STAM;TBC1D2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6212552391972859,-1.480600941776366,0.05238095238095238,0.5606103961314629,1.0,4/11,6.22%,TGFBR2;TGFBR1;SMAD7;ACVR1
prerank,macrophage activation (GO:0042116),0.5625129490478132,1.4795833949387482,0.04172461752433936,0.351623761618789,1.0,10/34,10.03%,FOXP1;IFNGR1;PLCG2;SYK;JAK2;DYSF;CD93;ITGB2;IFI35;SBNO2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6558532902806044,1.4784582851395578,0.05564387917329094,0.3534369188640559,1.0,6/16,13.54%,PTPN22;LST1;AHR;IKZF3;LGALS3;TNFRSF1B
prerank,T-helper cell differentiation (GO:0042093),0.6559447146764515,1.4783334203784502,0.07855973813420622,0.35281634072709384,1.0,4/14,8.68%,FOXP1;PTGER4;ATP7A;IL6
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7138075465501317,1.4773752159092335,0.0663265306122449,0.3541746552002135,1.0,3/10,10.73%,LRRK2;NFE2L2;RIPK1
prerank,receptor clustering (GO:0043113),0.5860392650251792,1.4771422746911411,0.06493506493506493,0.35376083713488854,1.0,6/27,6.81%,ITGB7;ITGA4;ITGAL;SYNJ2BP;ITGB2;FLNA
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4951059220576168,1.4767096322643873,0.028186274509803922,0.3538236177985848,1.0,23/80,13.27%,CD44;NGF;KLF4;DAPK1;NGFR;MAP3K5;SYK;GPX1;RPS6KA3;MALT1;DPEP1;CARD16;HGF;CSNK2A1;FIS1;GRAMD4;NLRP3;REST;RPS6KA1;MAP2K5;SH3RF1;AKT1;DHCR24
prerank,tRNA methylation (GO:0030488),-0.46456250067108656,-1.476500770780614,0.026845637583892617,0.5699773225055215,1.0,20/34,25.06%,ALKBH8;NSUN2;TRMT1;METTL6;DALRD3;TRMT1L;METTL2A;METTL2B;METTL1;THUMPD2;TRMT10A;MTO1;TRMT44;TRMT12;LCMT2;NSUN6;TRMT112;GTPBP3;TRMT5;BCDIN3D
prerank,cardiac atrium morphogenesis (GO:0003209),0.6322018030131538,1.476361993844295,0.0499219968798752,0.3537516631499724,1.0,3/16,8.16%,NOTCH2;BMPR2;ENG
prerank,negative regulation of hemostasis (GO:1900047),-0.6090628076606662,-1.476230709020985,0.050119331742243436,0.5654949052872192,1.0,4/12,12.08%,APOE;SERPINE2;CD34;SERPINE1
prerank,regulation of establishment of protein localization (GO:0070201),-0.5938430777548489,-1.4751402957083821,0.0391644908616188,0.5642807777359177,1.0,3/13,6.28%,CTSD;TREM2;CORO2B
prerank,nerve growth factor signaling pathway (GO:0038180),0.70775951472039,1.4742971575566097,0.07142857142857142,0.35811929267733666,1.0,3/10,3.13%,NGF;RAP1A;RAPGEF2
prerank,positive regulation of endopeptidase activity (GO:0010950),0.5848928597811122,1.4742124017966511,0.057722308892355696,0.3573945450559557,1.0,6/26,4.75%,LYN;FYN;PSME3;STAT3;PICALM;PSME2
prerank,negative regulation of hormone secretion (GO:0046888),0.7042962333034462,1.4733527094692587,0.06830122591943957,0.35851076452167235,1.0,2/10,1.66%,IL1B;RAB11FIP1
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6977137643677661,1.4731151971075387,0.07833333333333334,0.358185062370864,1.0,2/11,4.15%,SIK1;CRY1
prerank,regulation of response to interferon-gamma (GO:0060330),0.665747823895995,1.4726694545766927,0.06209150326797386,0.3582986905353887,1.0,5/14,9.47%,IFNGR1;JAK2;SUMO1;STAT1;PARP9
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.6398132932612711,-1.4725145897421454,0.053117782909930716,0.5689885276119822,1.0,2/10,1.99%,LRP6;ARHGAP12
prerank,regulation of MAPK cascade (GO:0043408),0.4536743270651892,1.4723829345120343,0.014130434782608696,0.35802554037897943,1.0,34/157,15.21%,CD74;PTPRC;IL1B;IQGAP1;LYN;FLT3;PLCG2;RET;SYK;PAK1;LAPTM5;PTPN6;VRK2;TAOK3;ADRA2A;CAV2;STK4;PAK2;PHLPP1;MINK1;IL6;ZDHHC17;FN1;YWHAZ;DUSP1;PSMD10;KIT;LBH;ROCK1;PTPRJ;FGFR3;GSTP1;MAPK1;SPRED1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.6260236417111057,1.4707762207036024,0.06003159557661927,0.36105399084874046,1.0,8/19,13.09%,KLF4;NFKB1;WFS1;MTPN;MAP2K5;APP;MAPK8;SLCO1C1
prerank,neurotrophin signaling pathway (GO:0038179),0.609178141998558,1.470566667224625,0.0684931506849315,0.36059608660304826,1.0,11/21,15.08%,NGF;RAP1A;NGFR;RAPGEF2;BCAR1;GRB2;DDIT4;SOS1;KIDINS220;ZFYVE27;FRS2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.6647020218736959,1.4695173316492236,0.06156405990016639,0.3623185933828324,1.0,8/14,14.55%,RARA;MALT1;NFKBIZ;ANXA1;NFKBID;NLRP3;MYB;IL18
prerank,negative regulation of programmed cell death (GO:0043069),0.43282443441503465,1.4692753956227285,0.0010235414534288639,0.36197492737313197,1.0,94/355,17.56%,CD74;CD44;FFAR4;GRK5;HCK;NOTCH2;CAPN13;NGF;BCL3;NGFR;MCL1;ITCH;PIM1;NFKB1;HSPA1A;RPS6KA3;LAPTM5;BIRC6;MALT1;TAF9;NAA16;NFKBIA;MRE11;CBL;SCX;IKBKB;DPEP1;GDNF;BIRC3;RAB7A;ARF4;SETX;WFS1;PTK2B;ANXA4;ZFAND6;SERPINB9;FLNA;CIB1;PAK2;TNFAIP8;AVEN;TM7SF3;IL6ST;IL6;HGF;NAA15;BRAF;ANKLE2;PIDD1;UBE2Z;ANXA1;IL31RA;CASP2;RIPK1;YWHAZ;DSTYK;PRKAA1;RPS6KA1;PSMD10;HYPK;SH3RF1;AREL1;HSPA9;MAPK8;CCND2;PRELID1;AKT1;DHCR24;API5;PRKAA2;DNAJC3;YME1L1;CITED2;HDAC3;GSTP1;RELA;MYD88;XIAP;PRDX5;THBS1;MED1;PROC;RPS6KB1;USP47;PPT1;HTATIP2;SEMA4D;PSEN1;NIBAN2;SIRT1;HSPD1;BAG3;PLAUR
prerank,response to alcohol (GO:0097305),-0.49122431683567386,-1.4691874721430418,0.045454545454545456,0.5762712193768854,1.0,9/27,22.23%,TGFBR2;TGFBR1;SDF4;SLIT2;SLIT3;CCL3;PMVK;SOD1;GRIN2B
prerank,regulation of signal transduction (GO:0009966),0.4423697909467724,1.467378477326751,0.006376195536663124,0.3658669966105057,1.0,42/190,13.71%,GRK3;LRRK2;GRK5;SP100;RASGRP4;GLI1;FYN;PLSCR1;CD36;CRK;RGS2;CD177;RSPO3;CDC42SE2;RGS3;LFNG;AXIN1;GDNF;SYNJ2BP;ZDHHC7;PRNP;CBFB;PLCB1;MTCH1;SIK2;PXN;ELF1;ZDHHC17;RGS12;GIT1;GSKIP;GRK6;PTPN1;FBXL17;APP;RGS14;SNX3;CASTOR2;LIFR;CSK;ITGA3;SREBF2
prerank,amino acid import (GO:0043090),-0.505899400598209,-1.4664959918944358,0.0546448087431694,0.5808451219924101,1.0,9/21,25.33%,SLC1A3;SLC7A1;SLC36A1;SFXN1;SLC7A8;SLC22A4;SLC25A38;SLC1A1;SFXN2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.6000516163798448,1.4662062093996342,0.0625,0.36776004228054604,1.0,10/23,20.52%,PTPRC;CBLB;CBL;TSG101;SH3BP5;MVP;DUSP22;ZFYVE28;SOCS5;SH3BP5L
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4576045695891568,1.4661913832643383,0.014623172103487065,0.3668569603473325,1.0,30/140,8.98%,ARHGAP15;VAV3;TIAM1;ARHGEF18;CYRIB;SRGAP3;SRGAP2;TIAM2;RACGAP1;ARHGAP18;RABL3;ARHGAP30;SOS2;ARHGAP26;RAC2;OCRL;BCR;CDC42;TAGAP;CD2AP;DLC1;ARAP1;FGD4;ARHGDIB;DEPDC7;FGD1;RAC1;FGD3;SOS1;RHOA
prerank,hemopoiesis (GO:0030097),0.48075361581499176,1.4653885194623217,0.03132530120481928,0.3679062033814023,1.0,17/87,9.11%,PTPRC;RUNX2;RUNX3;NOTCH2;RASGRP4;FLT3;CDK13;ETV6;TET2;PLD4;GLRX5;TIRAP;HIPK1;MKNK2;ARIH2;ZFP36L2;KAT6A
prerank,cilium-dependent cell motility (GO:0060285),0.5964050013902126,1.465274169997036,0.07198748043818466,0.36722958791581367,1.0,6/22,15.25%,DNAH2;DNAH8;RFX3;CCDC39;CFAP54;EFHC2
prerank,positive regulation of cell migration (GO:0030335),0.4377364201434406,1.46523763605382,0.0031380753138075313,0.36636066401630407,1.0,37/253,8.69%,CCR2;FGR;PTPRC;IL1B;NEDD9;DOCK5;TIAM1;PRKCE;TCAF2;PECAM1;PLCG2;ITGAX;RET;CCR1;PAK1;SEMA4A;SHTN1;STAT3;CLDN1;NIPBL;BMPR2;MYO1C;RAPGEF2;GLIPR2;LAMB1;CBLL1;PPP3CA;CARMIL1;ADRA2A;BCAR1;CXCL16;PTK2B;ADAM17;CIB1;ARHGEF39;EPHB2;HGF
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5039743227363381,1.464721217781028,0.049868766404199474,0.36668606899777323,1.0,14/55,12.97%,GPR132;PSME3;PSMB7;PSME2;AVEN;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,protein mannosylation (GO:0035268),-0.4970305174723781,-1.464666683995117,0.04788732394366197,0.5823825374929171,1.0,12/22,31.58%,LARGE1;DPY19L4;RXYLT1;POMT1;DPM2;DPY19L3;FKRP;DPM3;TMTC1;DPM1;POMT2;SDF2L1
prerank,actin filament capping (GO:0051693),0.627743085441752,1.4640628815530523,0.081377151799687,0.36655464354789025,1.0,5/18,8.84%,SVIL;EPS8;ADD3;CAPZB;CAPZA1
prerank,barbed-end actin filament capping (GO:0051016),0.627743085441752,1.4640628815530523,0.081377151799687,0.36655464354789025,1.0,5/18,8.84%,SVIL;EPS8;ADD3;CAPZB;CAPZA1
prerank,regulation of macrophage activation (GO:0043030),0.5694721419518148,1.4639762659366573,0.06268221574344024,0.36583661655765093,1.0,5/30,11.74%,CD74;IL33;IL6;IL31RA;FCGR2B
prerank,myotube cell development (GO:0014904),-0.6337781366253435,-1.4637832761491523,0.06935123042505593,0.5804935153137045,1.0,2/10,0.72%,IGF1;SKI
prerank,phospholipid metabolic process (GO:0006644),0.5010279054991849,1.463380800273753,0.03383458646616541,0.36638132216543023,1.0,4/71,2.39%,PLBD1;LGALS13;PIP4K2A;AGPAT4
prerank,positive regulation of metabolic process (GO:0009893),0.4686012894042744,1.4624512177301037,0.027251184834123223,0.3677376470230061,1.0,12/103,8.34%,CCR2;PLAC8;FFAR4;CAMK1D;SYK;JAK2;CD36;UCP2;IRF4;PRKAB2;THRA;ELOVL6
prerank,protein localization to synapse (GO:0035418),-0.5946328070613087,-1.4624377789297267,0.08478802992518704,0.5799268907223598,1.0,6/12,18.98%,NLGN1;PCLO;DLG4;NRXN2;NLGN2;NRXN1
prerank,phagosome-lysosome fusion (GO:0090385),0.6944883673310713,1.4618076206912531,0.07054673721340388,0.3684518861275706,1.0,6/10,13.34%,RAB7B;RAB7A;RAB39A;RAB34;PIKFYVE;ARL8B
prerank,cellular response to retinoic acid (GO:0071300),0.5304686913136571,1.4616282082494907,0.04891304347826087,0.36795341358568484,1.0,5/42,6.49%,LYN;CREB1;RET;SETX;PTK2B
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.5409667912341509,-1.4614806707392096,0.06406685236768803,0.5781852027555748,1.0,7/18,18.28%,NUP133;NXF1;DDX19B;DDX19A;ZC3H11A;IWS1;MCM3AP
prerank,regulation of vasoconstriction (GO:0019229),0.5808605419241397,1.4614047898812055,0.055891238670694864,0.36754055227892163,1.0,4/27,4.26%,ACE2;ACE;BMPR2;ATP2B1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4544841479771671,1.4610051283633203,0.012359550561797753,0.3676370869309706,1.0,42/149,15.01%,CARD11;IL1B;TRAF1;IL18RAP;CD40;NFKB1;STAT3;HSPA1A;CD36;PRKCH;MALT1;NFKBIA;EIF2AK2;IKBKB;TRIM62;RAB7B;RPS6KA5;TIRAP;UBE2N;CIB1;MTPN;TRIM25;CLOCK;CARD16;IL6;NFKBIB;PIDD1;RPS3;NLRC4;RIPK1;TRIM14;RNF31;TAB3;NLRP3;MAP3K7;APP;TLR2;BTK;IL18;MAP3K13;RELA;MYD88
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.6322713555988758,1.4598299987004149,0.07096774193548387,0.36955685793626236,1.0,7/17,17.92%,IL1B;PPP1R12A;IKBKB;F11R;ROCK1;PROC;VCL
prerank,neuron remodeling (GO:0016322),-0.638339072202439,-1.4589273423372062,0.06382978723404255,0.5825558963071156,1.0,6/10,15.38%,C1QA;ADGRB3;FARP2;ANKS1A;C3;CX3CL1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.5506702988920666,-1.4579499636631004,0.064343163538874,0.5806963835732344,1.0,4/16,3.43%,SALL1;NPNT;FGF2;PKD2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.44461630978747085,1.457467882998421,0.010845986984815618,0.37444807328537266,1.0,43/175,15.22%,PID1;TRAF1;TNFSF13B;CD40;PSME3;JAK2;MAP3K14;ERBIN;NFKBIA;IKBKB;PSMB7;PSME2;BIRC3;STAT1;PTK2B;ADAM17;ZFAND6;NFE2L2;CIB1;TRAF3;PSME4;ZFP36L2;TANK;PSMB8;RPS3;PSMD9;PSMA5;RIPK1;CACTIN;PSMB3;FOXO3;PSMD6;PSMC4;ACOD1;PSMD10;ADAMTS12;PSMB1;AKT1;TNFRSF1B;GBP2;GBP3;RELA;TNFRSF4
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.5921715678794334,1.457159399617343,0.06559766763848396,0.37428728459637406,1.0,8/24,10.70%,ACTR3;WASF2;RAC2;CDC42;ACTR2;RAC1;ARPC2;PIK3CA
prerank,negative regulation of macrophage activation (GO:0043031),0.6347054785542177,1.457037308836685,0.0694006309148265,0.3736126305320736,1.0,4/16,11.74%,PTPRC;LDLR;IL31RA;FCGR2B
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6249018796115655,1.4566112267341023,0.0766721044045677,0.3736407365474926,1.0,3/16,13.56%,CLDN1;CLDN12;CLDN14
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5257178636540517,1.455495130148488,0.03967168262653899,0.3754796381097991,1.0,15/45,14.30%,IQGAP1;PIK3C2A;ERBIN;CBL;BCAR1;RPS6KA5;GRB2;PTK2B;ADAM17;PDPK1;SOS1;BRAF;PIK3CA;AKT1;TGFB1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6913586159258147,1.4549291664999768,0.08617594254937164,0.3759792604694034,1.0,3/11,5.29%,SP100;MAD2L2;HIPK2
prerank,regulation of immunoglobulin production (GO:0002637),0.5814813076715437,1.4548802344288432,0.07366771159874608,0.37515939560141986,1.0,7/23,17.50%,PTPRC;EPHB2;IL6;GPI;FCGR2B;TNFRSF4;SASH3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.5744469471458346,-1.4545696260029415,0.0665024630541872,0.5885016350967864,1.0,5/14,13.59%,CSF1R;CMKLR1;CSF1;AKIRIN1;MDK
prerank,regulation of intracellular signal transduction (GO:1902531),0.4265462900842879,1.4538164036322005,0.0,0.37689252322104966,1.0,116/420,16.05%,ARHGAP15;LRRK2;VAV3;IL1B;MOB3B;TIAM1;ARHGEF18;DNA2;SRGAP3;SRGAP2;TRAF1;LYN;PTPN22;PLCG2;BCL3;RPL5;PIP4K2A;PAK1;TIAM2;RACGAP1;PRKAG2;ARHGAP18;CRK;ARHGAP30;RBBP8;SOS2;ARHGAP26;TAF13;TAF9;NFKBIA;MRE11;RAC2;OCRL;BCR;VRK2;CDC42;TAGAP;DLC1;ARAP1;TAOK3;BIRC3;TRAF4;HIPK2;RBBP4;FGD4;MAPK14;PTEN;ARHGDIB;HIPK1;STK4;PRKAB2;SGMS1;PDPK1;ZFAND6;DEPDC7;WRN;PAK2;TRAF3;PDE2A;DDIT4;EZR;PHLPP1;FGD1;RAC1;MINK1;RPF2;FGD3;SOS1;BRIP1;RHOA;KAT6A;CPNE1;SLC15A4;NEK8;CSNK2A2;CSNK2A1;PIDD1;ARHGEF6;PIP4K2B;ARHGAP21;DAXX;CYLD;PRKAR2A;PRKAG1;ING2;NET1;PRKAA1;TAF7;RPA3;GNAI1;CASTOR2;NF2;RPL11;PEX5L;PIP5K1A;AKT1;LBH;CHD4;ARHGEF3;PRKAA2;ARHGAP17;MAPKAP1;PPP2R5C;AURKB;USP7;RELA;MAPK1;RHOG;PHF20;SPRED1;XIAP;TAF1;DYRK2;RNF41;BRD7;PRR5
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6524378070903009,1.452720833061539,0.07348242811501597,0.37867835280342355,1.0,5/14,16.94%,KLF4;RHOA;MAP2K5;THBS1;STARD13
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5445268840834483,1.4521002787085822,0.052486187845303865,0.3793264807685494,1.0,8/36,10.73%,CD74;HSPA1A;LAPTM5;ADAM17;PARP14;CPNE1;PARP9;RIPK1
prerank,prostanoid metabolic process (GO:0006692),-0.5827037095410967,-1.45184832704837,0.08673469387755102,0.5932318250682176,1.0,3/13,7.00%,HPGDS;PTGS1;PLAA
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.711094262733755,1.4512519046555459,0.0776173285198556,0.38043944579323524,1.0,3/10,9.55%,CCR2;ADAM17;OXSR1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4427223761143233,1.4508737011382489,0.008403361344537815,0.38040897314160865,1.0,36/214,11.03%,CD74;CD44;FFAR4;PTPRC;IL1B;LYN;NOTCH2;PTPN22;RAP1A;SYK;CCR1;CD36;RAPGEF2;PTPN6;GLIPR2;FBXW7;SYNJ2BP;PRXL2C;LMO3;TIRAP;PTEN;PTK2B;CIB1;EZR;EPHB2;DUSP6;ZDHHC17;OPRM1;ICAM1;BRAF;SPRED3;SMAD4;FN1;PTPN1;YWHAZ;DSTYK
prerank,carboxylic acid catabolic process (GO:0046395),-0.5928639099308044,-1.450393801030442,0.07621247113163972,0.5936316342285936,1.0,5/12,2.94%,PON3;NPL;RENBP;AMDHD2;NAGK
prerank,pinocytosis (GO:0006907),0.6899918469050853,1.449354392020887,0.08181818181818182,0.3833889219051315,1.0,5/10,6.63%,DOCK2;MAPKAPK3;MAPKAPK2;CARMIL1;RAB34
prerank,inositol phosphate metabolic process (GO:0043647),0.5184547559573957,1.4489780864256312,0.05319148936170213,0.38347483004061605,1.0,12/46,8.70%,PLCG2;ITPKC;IP6K3;PLD4;OCRL;ITPK1;PTEN;INPP4A;IMPA1;PLCB1;PLCD4;SYNJ1
prerank,ventricular septum morphogenesis (GO:0060412),-0.47830512336523756,-1.4483293399885309,0.06230529595015576,0.5962476384954412,1.0,11/27,16.96%,TGFBR2;TGFBR1;ROBO2;ROBO1;SMAD7;ACVR1;SLIT2;SLIT3;SOX4;TGFB2;SOX11
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.46219049587635547,-1.4474876081148769,0.059800664451827246,0.5942565441885559,1.0,8/30,8.05%,ST6GAL1;MCFD2;MGAT5;ALG8;RPN1;TUSC3;LMAN1;OSTC
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.46550652449197905,1.4468311462432342,0.03195266272189349,0.38795604756364266,1.0,32/94,17.63%,IL1B;MAP3K8;PSME3;NFKB1;NFKBIA;IKBKB;PSMB7;PSME2;PELI1;IRAK4;FBXW11;RPS6KA5;UBE2N;PLCB1;PSME4;IL1R2;PSMB8;PSMD9;PSMA5;PSMB3;TAB3;PSMD6;PSMC4;MAP3K7;PSMD10;PSMB1;RELA;MYD88;IRAK3;PSMD12;MAP3K3;TAB1
prerank,regulation of innate immune response (GO:0045088),0.5026034113925082,1.446368849456034,0.05263157894736842,0.38821108600036364,1.0,21/57,16.67%,FGR;PTPN22;SAMHD1;POLR3F;PLSCR1;DHX58;PTPN6;BIRC3;TIRAP;IFI35;SLC15A4;PARP9;PTPN1;CACTIN;ACOD1;FCGR2B;GBP5;XIAP;LRP8;IRAK3;IFNAR2
prerank,cardiac cell development (GO:0055006),-0.6005350915195476,-1.4456934686365932,0.07272727272727272,0.5959558672428927,1.0,3/11,14.24%,SLC8A1;VEGFA;CXADR
prerank,myeloid cell differentiation (GO:0030099),0.5152175451372611,1.445396251791024,0.05059920106524634,0.38976931226082634,1.0,14/47,14.81%,LYN;RASGRP4;TET2;JAK2;SPI1;HIPK2;TIRAP;RPS14;KAT6A;SLC25A5;HSPA9;KIT;HCLS1;KMT2E
prerank,positive regulation of response to external stimulus (GO:0032103),0.45468541071609647,1.445078573725491,0.021664766248574687,0.3896041650440649,1.0,28/128,14.55%,CCR2;IL1B;CD47;POLR3F;PLSCR1;DHX58;ANKRD17;NFKBIA;PTGER4;NFKBIZ;IL33;IL17RA;ABCC1;OASL;PDCD4;PUM2;PDE2A;TLR3;IFI35;SLC15A4;USP15;RIPK1;ACOD1;APP;TLR2;GBP5;TGFB1;IL18
prerank,peptide hormone secretion (GO:0030072),0.5676677702849219,1.4440352716536224,0.08157099697885196,0.39134758826454497,1.0,4/26,10.43%,FFAR4;CYB5R4;IL6;ANXA1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.47713783487806816,1.443541711672052,0.0267639902676399,0.39177807430833056,1.0,17/85,8.29%,ARHGEF18;LYN;NOTCH2;RASGRP4;NGF;EPS8;DENND3;JAK2;RABL3;DENND1A;ERBIN;BCR;DLC1;ARHGDIB;GRB2;SHOC2;EPHB2
prerank,toxin transport (GO:1901998),0.6825238989708057,1.4433370500797682,0.1111111111111111,0.39132379567879055,1.0,3/10,14.52%,ANTXR2;RAB40B;RAB29
prerank,regulation of transmembrane transport (GO:0034762),0.5531218639977893,1.443256457518067,0.055873925501432664,0.39058210866487303,1.0,4/31,2.59%,FFAR4;ACE2;PIM1;NEDD4L
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5802010323566661,1.4426962962303937,0.07840236686390532,0.3910137103075939,1.0,11/26,18.38%,IQGAP1;STAT5B;PTPN12;PDPK1;ZFP36L2;ZPR1;MED1;DUSP22;KNSTRN;FOXC1;SYAP1
prerank,negative regulation of developmental growth (GO:0048640),-0.45880588536763667,-1.4416067719265622,0.05466237942122187,0.6059256015357369,1.0,8/30,10.80%,DIP2B;DCC;ULK2;MAP2;FGF13;CDKL3;BBS2;WWC1
prerank,extracellular transport (GO:0006858),0.651867547974223,1.441130352937697,0.09391304347826086,0.39407723081247914,1.0,4/12,9.20%,TSG101;ADCY10;CABYR;WWP2
prerank,chromatin organization (GO:0006325),0.4470134493571109,1.440813678344048,0.015625,0.39392111161125654,1.0,48/132,20.07%,JARID2;BAZ1A;PADI1;KDM6A;PAK1;BAZ2B;SPI1;INO80C;RBBP4;SMARCA5;FAM47E;SETD7;PHF19;SETDB2;EZH1;SETD5;SMARCE1;DAXX;TADA2A;SETD2;BAZ2A;ATRX;MYB;EZH2;SMARCC2;KAT2B;CHRAC1;HDAC3;RSF1;INO80;KDM4B;NPM3;HMGN1;RB1;BPTF;SUPT4H1;SIRT1;LRWD1;PADI2;SMARCD3;HCFC2;HDAC1;HP1BP3;GATAD1;EHMT1;PBRM1;SATB1;SUPV3L1
prerank,lipoprotein transport (GO:0042953),0.6876699219990917,1.440492857119321,0.08672566371681416,0.39382215780112456,1.0,6/10,13.99%,PPARG;CD36;ZDHHC17;UNC119B;UNC119;VMP1
prerank,microvillus organization (GO:0032528),0.650897061632342,1.4388859147862914,0.09046052631578948,0.3969019449630804,1.0,5/13,8.54%,FXYD5;RAP1A;RAPGEF2;EZR;MINK1
prerank,carbohydrate transport (GO:0008643),0.6753173789108033,1.438357048164246,0.0868824531516184,0.39726913739140607,1.0,2/11,2.23%,SLC23A2;SLC23A1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.48137245428895886,1.4376947863701128,0.05576679340937896,0.39806416820165147,1.0,19/65,16.29%,GPR132;PSME3;PSMB7;PSME2;NABP1;AVEN;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;PABIR1;AURKB;USP47;PSMD12
prerank,neuron development (GO:0048666),-0.3361932064024927,-1.4376089157477403,0.007874015748031496,0.6166171278929583,1.0,29/141,9.08%,OPHN1;PTPRM;ATP8A2;PPP1R9A;APOE;DTNBP1;MEF2C;CAMSAP1;WNK1;NTRK2;NLGN1;TENM4;MAP2;PLP1;ERCC6;HMGB1;TMEM108;TENM2;CNTN4;EPHA5;GPRIN3;RYK;RASGRF1;DCX;SRRM4;CDK5R1;SH3GL2;TBC1D23;GPM6A
prerank,fatty acid beta-oxidation (GO:0006635),-0.4005014371784609,-1.4373243951691528,0.01652892561983471,0.6124587939730607,1.0,26/51,28.87%,ABCD2;ECHS1;IVD;ABCD4;ECHDC1;ACAD10;HADHB;ACADM;HADH;HADHA;ECI1;ECI2;ABCD3;CPT2;ACADL;ACADS;AMACR;GCDH;ACAT2;ACAD11;ACOX1;ACOT8;CROT;DECR2;SLC27A2;PPARD
prerank,positive regulation of protein transport (GO:0051222),-0.3871914439469928,-1.4373060431616684,0.018957345971563982,0.6075288220210057,1.0,27/67,22.36%,FRMD4A;IGF1;TREM2;PPIA;CD33;IL1A;ADAM8;PLK3;CHP1;TGFB2;TENM1;MYOM1;BMP6;ATP2C1;TPR;APBB1;IER3IP1;APBB3;EXOC1;OAZ1;RIPOR1;CEP290;ANG;MYH10;RACK1;PPID;CLN3
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5297775448246844,1.436962273499625,0.052845528455284556,0.3991070191231599,1.0,7/39,9.18%,ITGA4;CD40;NDNF;PDPK1;NFE2L2;PDCD4;ICAM1
prerank,cell part morphogenesis (GO:0032990),0.6433363034452311,1.4358448301793814,0.07993197278911565,0.4010837589519326,1.0,6/13,14.12%,PID1;FIS1;PACSIN2;DNM1L;PNPT1;MYH14
prerank,actin filament organization (GO:0007015),0.4467486533073526,1.4356674310666442,0.019867549668874173,0.40056148062115243,1.0,42/151,17.11%,MYO1G;RND3;NEDD9;SVIL;LCP1;EPS8;TPM4;MAD2L2;MYO1E;MYO1C;SHROOM3;CORO1A;ABI1;RAC2;CDC42;CD2AP;CARMIL1;PPP1R9B;BCAR1;ELMO2;BIN3;MYO5B;FLNA;RHOBTB3;RAC1;RHOA;HIP1;ARPC4;CASS4;TMOD3;ARHGAP17;TRIOBP;ENAH;MYO1F;FHOD1;RHOG;ELMO1;SHROOM1;PLS1;PROX1;CGNL1;FLII
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.47460043192866014,1.4336869633825766,0.05276073619631902,0.4046927942826084,1.0,18/76,12.53%,LRRK2;CUL3;LAPTM5;MALT1;CRY1;FBXW7;AXIN1;BIRC3;PTTG1IP;DCUN1D1;WFS1;MYCBP2;FBXO4;TANK;DCUN1D3;RCHY1;PSMD10;FANCI
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.588999260571013,1.4334006732680347,0.07963246554364471,0.40447607762872645,1.0,2/20,4.15%,SIK1;CRY1
prerank,regulation of T cell differentiation (GO:0045580),0.5439871923609134,1.432891238667682,0.06963788300835655,0.4048888520544413,1.0,7/33,13.49%,CCR2;ZAP70;CBFB;CD2;PRELID1;METTL3;FANCA
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5930614112162256,-1.4325693014637035,0.07106598984771574,0.6207808347030299,1.0,5/13,11.91%,TGFBR2;NRP1;CTNNB1;SEMA3E;VEGFA
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5831852269368073,1.4322621853156408,0.07941176470588235,0.4056465421704873,1.0,4/24,3.63%,CCR2;LYN;CCR1;CXCL10
prerank,C-terminal protein amino acid modification (GO:0018410),-0.5904258935518318,-1.4321935031350232,0.1024390243902439,0.6173043118549199,1.0,8/11,19.55%,FOLH1;ATG12;GPLD1;TTL;ATG7;AGBL1;AGBL4;LCMT1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6155234214313434,1.4320723229465382,0.08128834355828221,0.40520684621677544,1.0,6/17,14.22%,PTPN22;LAPTM5;PRNP;EZR;LGALS3;PTPRJ
prerank,dephosphorylation (GO:0016311),0.44670509841293043,1.4314355343111413,0.022123893805309734,0.4059534628508719,1.0,47/147,17.99%,PTPRC;DAPP1;PTPN22;DUSP16;PTPRE;PPP2R5A;PTPRU;PTPRO;PPP1R12A;SDHAF2;PTPN6;PTPN7;PPP3CA;PTPN12;FBXW11;PTEN;MTMR3;PXYLP1;PPP2R2A;PPP4R2;MTMR4;DUSP6;PPP4R1;PTPN1;PDP2;DUSP12;DUSP1;PPP2R3A;PPP1CB;PPM1D;SGPP2;TIMM50;PTPRJ;PPP2R5C;SGPP1;PTPRG;DUSP26;DUSP28;ILKAP;PPP2R5E;PPM1G;LHPP;MTMR2;PLPPR2;TAB1;PTPN4;PTPRA
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5230346781790621,1.4311450495805604,0.06571428571428571,0.4057249348765277,1.0,4/37,1.84%,JAML;ITGAL;ALCAM;NECTIN1
prerank,regulation of protein metabolic process (GO:0051246),0.5131586236117157,1.430530738009665,0.06648575305291723,0.40640322619187147,1.0,16/44,13.05%,ACE;KLF4;LDLR;NEDD4L;SPOP;FAF1;PARL;WFS1;NEDD8;GSAP;MTPN;TRAF3;SNF8;MAP2K5;APP;MAPK8
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5605402531645137,1.4304482969995647,0.06537890044576523,0.40568426167494304,1.0,1/27,0.02%,CD74
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4726052623133065,1.4302568948442889,0.04785894206549118,0.40519511706117495,1.0,20/80,14.18%,LRRK2;CUL3;LAPTM5;MALT1;CRY1;FBXW7;AXIN1;BIRC3;PTTG1IP;DCUN1D1;UBE2N;WFS1;MYCBP2;FBXO4;DCUN1D3;RCHY1;PSMD10;FANCI;RPS2;HDAC3
prerank,regulation of wound healing (GO:0061041),0.518385211639712,1.429853485628667,0.049930651872399444,0.40528909181320916,1.0,8/42,10.43%,PRKCE;CASK;CLDN1;CRK;ADRA2A;EPHB2;ARFGEF1;ANXA1
prerank,regulation of catecholamine secretion (GO:0050433),-0.4648581226859681,-1.4295817560075932,0.06441717791411043,0.6217303029426068,1.0,20/29,36.24%,PRKN;DTNBP1;SYT1;SYT9;SYT7;KCNA2;STX1A;SYT6;SYT8;KCNB1;SYT3;SYT11;SYT12;CHGA;SYT13;DRD2;SYT10;SYT4;SYT5;SYT17
prerank,peptidyl-asparagine modification (GO:0018196),-0.45279203002083207,-1.4285014718945,0.061224489795918366,0.6211459225176433,1.0,8/31,8.05%,ST6GAL1;MCFD2;MGAT5;ALG8;RPN1;TUSC3;LMAN1;OSTC
prerank,skeletal muscle organ development (GO:0060538),-0.47603829836470346,-1.4282471462516009,0.03715170278637771,0.6172736343728668,1.0,8/26,13.14%,LARGE1;BASP1;MEF2C;CFLAR;IGSF8;FXR1;MYL6;DISP1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.6424665813275671,1.4266507043400805,0.09813874788494077,0.41259016452594627,1.0,5/13,17.02%,ZC3HAV1;RC3H1;NUDT21;PNPT1;CNOT8
prerank,regulation of sodium ion transport (GO:0002028),-0.44384608089107414,-1.4266300324434018,0.05806451612903226,0.6187961695995925,1.0,16/34,22.04%,WNK1;AHCYL1;SLMAP;P2RX7;WNK2;P2RX4;SNTA1;SCN1B;PER1;NKAIN3;PKP2;FGF12;YWHAH;SCN3B;WNK3;SPTBN4
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.6603236734503314,1.4266225323011408,0.09700176366843033,0.4117107042488035,1.0,3/11,11.01%,MALT1;NFKBIZ;NFKBID
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.566461167731229,-1.4264577954721742,0.08737864077669903,0.614705702875552,1.0,2/13,0.41%,LGMN;ASPH
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5698660565168017,-1.4258416278478547,0.09343434343434344,0.6123541197654352,1.0,10/14,37.12%,WNK1;ATP1B1;WNK2;CHP1;GLRX;WNK3;DMD;TESC;ACTN4;FXYD2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5869092165315918,-1.4254170303034455,0.09501187648456057,0.6091794655490655,1.0,9/12,32.24%,WNK1;ATP1B3;ATP1B1;WNK2;GLRX;WNK3;FXYD1;DMD;NOS1
prerank,positive regulation of MAPK cascade (GO:0043410),0.42833934898454984,1.4247683341561064,0.007291666666666667,0.4156035708793509,1.0,33/245,9.50%,CD74;LRRK2;CD44;FFAR4;PTPRC;IQGAP1;NOTCH2;FLT3;PTPN22;RAP1A;PLCG2;RET;CD40;CCR1;CD36;RAPGEF2;LAPTM5;GLIPR2;EIF2AK2;FBXW7;PRXL2C;TAOK3;ADRA2A;CAV2;TIRAP;PTK2B;PIK3R6;CIB1;IL6;OPRM1;ICAM1;DIRAS1;BRAF
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.544995582893431,1.4247613047334664,0.07194244604316546,0.4146876861943993,1.0,10/30,10.73%,TNIP3;CD40;IKBKB;BIRC3;UBE2D3;TRAF3;TLR3;TANK;IRF7;RIPK1
prerank,cellular response to interleukin-1 (GO:0071347),0.4424364342082665,1.424731690505251,0.027808676307007785,0.41382061582643775,1.0,38/143,15.01%,IL1B;CD47;CD40;MAP3K8;PSME3;NFKB1;PTGIS;NFKBIA;IKBKB;PSMB7;PSME2;PELI1;RC3H1;IRAK4;FBXW11;RPS6KA5;UBE2N;PLCB1;PSME4;IL1R2;TANK;PSMB8;PSMD9;PSMA5;CACTIN;PSMB3;TAB3;PSMD6;PSMC4;ACOD1;MAP3K7;PSMD10;ADAMTS12;PSMB1;GBP2;GBP3;RELA;MYD88
prerank,regulation of insulin secretion (GO:0050796),0.4577080516200004,1.4243701546536323,0.03909952606635071,0.4138047911375328,1.0,16/101,12.41%,DPP4;ITPR1;IL1B;RAP1A;CACNA1A;SLC8B1;RFX3;ADRA2A;CLOCK;TM7SF3;IL6;PSMD9;CACNA2D2;GLUD1;REST;ADCY5
prerank,stress-activated MAPK cascade (GO:0051403),0.487330842940732,1.4243338687942928,0.04521963824289406,0.41296582443095414,1.0,20/61,14.99%,MAP3K5;MAP3K8;NFKB1;SH2D3C;PTGER4;IKBKB;MAPK14;FBXW11;UBE2N;MINK1;ARHGEF6;MAP4K3;TAB3;MAP3K7;MAP2K3;MAP3K20;MAPK8;MAP3K13;GPS2;MAPK1
prerank,neutrophil mediated immunity (GO:0002446),0.41981759931501966,1.4241631746419736,0.0010162601626016261,0.4124480535625489,1.0,84/432,10.86%,ATP8B4;PLAC8;FGR;ITGAL;CD44;PTPRC;IQGAP2;IQGAP1;STK10;CYBB;CD47;FPR1;PECAM1;RAP1A;CDK13;ACE;LILRB3;MCEMP1;DOCK2;ITGAX;CLEC12A;CNN2;ANXA2;NFKB1;SLC44A2;PTX3;ADGRE5;HSPA1A;NFAM1;CD36;GM2A;CD300A;RAB3D;SELL;CD177;PRDX6;PTPN6;TBC1D10C;SLPI;UNC13D;PSMB7;ERP44;OLR1;CPPED1;CD93;HP;GMFG;DIAPH1;RAB7A;PRCP;ITGB2;IRAK4;MAPK14;GLIPR1;RAB6A;AP2A2;CYSTM1;ACTR2;OSTF1;ADAM17;SVIP;NBEAL2;PSAP;PTGES2;RAC1;TMEM179B;TSPAN14;IL6;DERA;RHOA;IDH1;PGM1;CPNE1;SLC15A4;FUCA1;KCMF1;PSMA5;PRG2;MAGT1;STOM;APAF1;RAB44;TMC6;B2M
prerank,cellular response to cAMP (GO:0071320),0.5495808946313132,1.4240951372767752,0.06340057636887608,0.4116800802712033,1.0,7/30,7.93%,RAP1A;RAPGEF2;KCNQ1;HCN4;AHR;PDE2A;EZR
prerank,regulation of macrophage migration (GO:1905521),-0.6295363785530876,-1.4240818698690958,0.0787037037037037,0.6095147948058585,1.0,4/10,9.24%,CX3CR1;P2RY12;CSF1;MTUS1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6570832224466402,1.4240694674435783,0.12371134020618557,0.41083816785457755,1.0,5/11,16.82%,NEDD4L;PICALM;TAX1BP3;SNX33;GOPC
prerank,ERBB signaling pathway (GO:0038127),0.4808035124180166,1.4232342302957035,0.04481434058898848,0.4120882816350428,1.0,20/64,14.99%,IQGAP1;NRG2;PIK3C2A;CUL5;ERBIN;CBL;PTPN12;BCAR1;RPS6KA5;GRB2;PTK2B;ADAM17;PDPK1;SOS1;BRAF;PIK3CA;MVP;AKT1;TGFB1;MAPK1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4704514096150087,1.4231640966948396,0.052503052503052504,0.41135700549631893,1.0,28/70,18.36%,CYBB;LNPEP;PSME3;CD36;IKBKB;PSMB7;PSME2;MFSD6;TAP1;PSME4;PSMB8;NCF2;PSMD9;PSMA5;B2M;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;NCF1;FCER1G;SNAP23;PSMD12;CYBA;PDIA3;FCGR1A;TAPBP
prerank,myeloid cell development (GO:0061515),0.6087902386113074,1.4219447907365432,0.0794912559618442,0.41360815734212386,1.0,7/18,15.77%,FOXP1;ANXA2;NRROS;APP;TLR2;KIT;MED1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.5127419081995311,-1.4218424295376317,0.07799442896935933,0.613349498695411,1.0,16/20,48.12%,ACVR1;BMPR1B;PTCH1;LMX1B;MDFI;AIDA;NBL1;GLI2;GREM1;LHX1;ACVRL1;FBXL15;SFRP1;SHH;NOG;WNT8B
prerank,purine nucleotide catabolic process (GO:0006195),0.6523769951821846,1.4211318493919347,0.09001636661211129,0.41476504774401585,1.0,2/13,2.70%,GDA;GPX1
prerank,negative regulation of phosphorylation (GO:0042326),0.47055040877504556,1.4204340847516719,0.03753026634382567,0.415626144119431,1.0,16/85,9.61%,CBFA2T3;NIBAN1;LRRK2;PID1;LYN;STAP1;IBTK;PRKRIP1;PTEN;CDKN2C;PRNP;CIB1;PAQR3;EPHB2;GIT1;ANKLE2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6403801629195643,1.4204167973940274,0.09933774834437085,0.41476048400464116,1.0,5/15,14.30%,DPP4;FAP;IL6;CLASP1;TGFB1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6491565472184828,1.420024574395899,0.0831858407079646,0.4148779089188892,1.0,2/13,2.50%,TESPA1;FOXJ1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6172330281299079,1.4197437207874848,0.11038961038961038,0.4147342454925856,1.0,4/15,5.34%,TIAM1;RSPO3;GPC3;RNF213
prerank,"wound healing, spreading of cells (GO:0044319)",0.5685062432702696,1.4194227946405693,0.07976366322008863,0.414610708640603,1.0,8/24,16.52%,CD44;LCP1;ADAM17;FLNA;RHOA;MRTFA;ITGA5;WNT7A
prerank,regulation of T cell proliferation (GO:0042129),0.4909586173398466,1.4190259579227777,0.05144291091593475,0.41472120727304174,1.0,11/61,13.54%,PTPRC;IL1B;LILRB1;SPN;CD276;GLMN;IL6ST;IL6;ANXA1;LGALS3;TNFRSF1B
prerank,microvillus assembly (GO:0030033),0.6343453629521478,1.4184215499237107,0.09446254071661238,0.4154654821475378,1.0,5/14,8.54%,FXYD5;RAP1A;RAPGEF2;EZR;MINK1
prerank,actin nucleation (GO:0045010),0.5759291957148156,1.4179382031232077,0.08265802269043761,0.4158276664492478,1.0,6/21,10.00%,IQGAP2;ACTR3;ACTR2;ARPC1B;ARPC2;ARPC4
prerank,negative regulation of catabolic process (GO:0009895),0.5121762378161994,1.4178511968708503,0.06191117092866756,0.4151787200634094,1.0,15/47,19.01%,CBFA2T3;IL1B;MAD2L2;ADRA2A;ZDHHC7;FLNA;AZIN1;GIT1;PRKAA1;SNX3;SNX12;IRAK3;SF3B3;PIN1;PRKCG
prerank,positive regulation of RNA metabolic process (GO:0051254),0.5075307759125,1.417629571487531,0.0636237897648686,0.4148926593391519,1.0,16/45,14.95%,IL1B;NFKB1;HSPA1A;ERN1;SETX;DYRK1A;RIOK1;IL6;RBM22;RIPK1;NMD3;ZPR1;HNRNPLL;PNPT1;TGFB1;RELA
prerank,cranial nerve development (GO:0021545),-0.6123100444230011,-1.4171444939142153,0.08837209302325581,0.6265056354677704,1.0,2/11,1.01%,CHD7;SALL1
prerank,receptor-mediated endocytosis (GO:0006898),0.4434095015609575,1.417072703555725,0.02106430155210643,0.4154954203493688,1.0,28/132,11.74%,GRK3;CLEC9A;HPX;LILRB1;LDLR;SYK;CD36;EPS15;SORL1;INPP5F;PICALM;HP;HPR;SCARB1;SNX1;ITGB2;CAV2;HSPG2;AP2A2;CXCL16;GRB2;PIKFYVE;SNX9;AP1G1;SCARB2;LMBRD1;AP2B1;FCGR2B
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.6163057029239434,1.4164609599195443,0.11367127496159754,0.41623645059469055,1.0,6/16,10.90%,DTX3L;MAD2L2;SMCHD1;WRAP53;PARP9;KMT5B
prerank,cellular response to sterol (GO:0036315),-0.5710352971589695,-1.4164368062191368,0.08785529715762273,0.6248830079912807,1.0,7/13,24.24%,LRP6;GRAMD1A;SMO;GPLD1;PTCH1;OSBPL7;MLC1
prerank,positive regulation of protein modification process (GO:0031401),0.4258395935102581,1.416436539050684,0.007518796992481203,0.4154026515833153,1.0,42/203,13.39%,CD74;NIBAN1;LRRK2;IL1B;LYN;FGF22;PECAM1;ACE;CD40;PPP2R5A;PAK1;FGF5;NPTN;AXIN1;DLC1;CCND3;VEGFC;UBE2N;CCND1;STK4;WDFY2;ADAM17;SVIP;CIB1;DYRK1A;ENG;RAC1;ACVR2A;HGF;RALB;PGF;ANKLE2;CAMKK2;DAXX;RIPK1;DVL3;APP;CLIP3;CCND2;ATG10;AKT1;LIMK2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.6883987844789372,1.4153368891122367,0.1206611570247934,0.4173668753479793,1.0,3/10,4.59%,RACGAP1;RCC2;CDC42
prerank,lipoprotein localization (GO:0044872),0.6556841372077611,1.415133228214586,0.09743589743589744,0.4170155827384354,1.0,7/11,17.94%,PPARG;CD36;ZDHHC17;UNC119B;UNC119;VMP1;ZDHHC3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6764504169114309,1.414884276670096,0.0903010033444816,0.41681179047155537,1.0,2/11,1.95%,LYN;SYK
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6056623050808386,1.4148236753992294,0.08647798742138364,0.4160683121810932,1.0,4/16,9.32%,FPR1;NDNF;CD36;GUCY1A1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5725476696957306,1.414464626104076,0.0865533230293663,0.41609916644893763,1.0,4/21,5.07%,NGF;NGFR;FYN;BIRC3
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.6054970005614551,-1.4143281660736218,0.07920792079207921,0.627960139516761,1.0,8/11,29.23%,TIMM9;TIMM10B;AGK;NDUFA13;TIMM13;TIMM8B;ROMO1;TIMM29
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4161109332983176,1.4142990816230316,0.005122950819672131,0.41560213750377156,1.0,70/348,14.30%,CD74;NIBAN1;LRRK2;CD44;PTPRC;IL1B;IQGAP1;LYN;FGF22;NGF;PECAM1;RAP1A;PLCG2;CD40;PAK1;SH2D3C;FGF5;PRKAG2;JAK2;BMPR2;MAD2L2;RBPMS;RAPGEF2;NPTN;MRE11;IL6R;GDF1;AXIN1;CCND3;VEGFC;TRAF4;RPS6KA5;CCND1;STK4;PRNP;WDFY2;PTK2B;ADAM17;CIB1;PAK2;BMP3;ENG;RAC1;CACUL1;ACVR2A;IL6;HGF;RALB;LATS1;CREBL2;BRAF;PGF;CAMKK2;SMAD4;DAXX;SNX9;RIPK1;PRKAG1;DVL3;APP;MAP2K3;PDGFD;CLIP3;CCND2;AKT1;LIMK2;HCLS1;HDAC3;PTPRJ;TGFB1
prerank,ether lipid metabolic process (GO:0046485),0.6271641355373999,1.4140345451708711,0.08538587848932677,0.41542822493165227,1.0,7/14,14.52%,AGPS;PAFAH1B1;FAR1;NCEH1;TMEM86B;PLA2G6;GNPAT
prerank,negative regulation of neurogenesis (GO:0050768),0.5330618139741234,1.413359416005546,0.08226950354609928,0.4163040121437358,1.0,11/34,13.28%,IL1B;NGFR;RAPGEF2;SORL1;PTEN;IL6;RHOA;RTN4;B2M;REST;LRP4
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5708020218076286,1.4130693999865003,0.09923664122137404,0.4161586066549942,1.0,4/22,6.73%,AHNAK;HPCA;GPR35;CACNB1
prerank,cellular protein modification process (GO:0006464),0.4091791852572084,1.4129334339325033,0.0,0.4156697909923096,1.0,241/982,15.86%,GRK3;FGR;LRRK2;PTPRC;HLCS;ST3GAL1;ST8SIA4;GRK5;RARA;DAPP1;STK10;ST3GAL4;MAP4K1;SGK3;RUNX3;HCK;LYN;PRKCE;ZC3HAV1;PTPN22;SIK1;STK24;CDK13;VRK1;CREB1;DAPK1;FEM1C;DUSP16;ST8SIA1;FYN;PARP8;DTL;RET;MAP3K5;LMTK2;AKT3;PTPRE;TNC;PPP2R5A;PTPRU;PTPRO;SYK;PSME3;PIM1;PAK1;PKN1;PPP1R12A;STK17B;PRKAG2;JAK2;ASB5;CUL3;ERN1;PRKCH;SDHAF2;IP6K3;CUL5;BMPR2;NOTUM;FUT4;MAPKAPK2;BIRC6;STK38;ST8SIA6;UBE2E1;PTPN6;KLHL11;LAMB1;EIF2AK2;PTPN7;B4GALT5;BCR;IKBKB;GPC3;PSMB7;FBXW7;ZAP70;VRK2;PSME2;PARP4;PPP3CA;GMFG;TAOK3;SIK3;F13A1;PTPN12;HIPK2;DCAF5;UBE2D3;FBXW11;RPS6KA5;FBXL8;CEL;CDK14;DCUN1D1;PTEN;TIPARP;SHISA5;HIPK1;ARF4;MAP3K1;STK4;MTMR3;WFS1;PTK2B;LGALS1;FBXW2;PDPK1;NEDD8;MKNK2;ATG5;ELOB;PKN2;PAK2;PARP14;DYRK1A;UBXN7;PPP2R2A;ZDHHC6;FBXO4;PPP4R2;MTMR4;COP1;PSME4;SIK2;COQ8A;SERP2;ACVR2A;MINK1;DUSP6;STK38L;IL6;CSNK1G3;COPS3;SUMF2;TNKS;LATS1;WWP2;PARP9;BRAF;OXSR1;CSNK2A1;FBN1;TLK2;PSMB8;FBXO32;CAMKK2;PPP4R1;PSMD9;GRK6;PSMA5;FN1;PTPN1;ANXA1;MBTPS1;PDP2;KLHL5;SUMF1;YWHAZ;PRKG2;DMPK;PRSS23;PTP4A2;PRKAG1;NLK;PSMB3;UBE2S;LATS2;MAP4K3;DUSP12;DUSP1;PSMD6;DCUN1D3;PPP2R3A;PSMC4;PRKAA1;PIK3R4;PIGS;APP;CCNT1;PSMD10;PPP1CB;WIPI2;CDK12;MAP3K20;B3GALT2;PPM1D;UST;MORC3;BTK;PSMB1;MAPK8;EIF2AK3;ATG10;AKT1;PDK3;FBXL12;LIMK2;CSK;MARK3;TYK2;DCAF10;FBXO30;KTN1;SLC35A1;HCST;STK39;ROCK1;SIRT4;PRKAA2;DNAJC3;TLK1;LMTK3;TIMM50;PTPRJ;HASPIN;TGFB1;PPP2R5C;TRIOBP;STT3B;MAP3K13;AURKB;PTPRG;BRSK1;MAPK1;FBXO7;DUSP26;PMM2;PTAR1;THBS1;TBK1;TAF1;SEPHS1;ILKAP;MAML1;DYRK2;PIGH;PPP2R5E;PROC;PPM1G;IRAK3
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.44301812342851116,1.4117596745126313,0.019036954087346025,0.41776297310399496,1.0,22/140,10.60%,CCR2;FPR1;XCR1;FPR3;CCR1;CD36;CACNA1A;LPAR3;PTGER2;ACKR2;CCR9;NPTN;GPR35;PTGER4;TAC4;CCRL2;CYSLTR1;TACR1;CD52;SELENOT;PTGER3;FIS1
prerank,negative regulation of immune effector process (GO:0002698),0.6334197711064568,1.411750133198823,0.12147887323943662,0.4169115792161898,1.0,6/13,12.86%,CD47;LILRB1;CD300A;RC3H1;SLAMF8;LGALS3
prerank,response to cAMP (GO:0051591),0.5265210800086146,1.4112781754700972,0.07660738714090287,0.4172240179015415,1.0,8/37,7.93%,RAP1A;RAPGEF2;KCNQ1;HCN4;STAT1;AHR;PDE2A;EZR
prerank,inositol phosphate catabolic process (GO:0071545),0.6509142759256455,1.4106113472248205,0.09948542024013722,0.4180437944734315,1.0,4/12,8.70%,OCRL;PTEN;IMPA1;SYNJ1
prerank,negative regulation of blood coagulation (GO:0030195),-0.4275417859444234,-1.410567816889901,0.07590759075907591,0.6372335922443203,1.0,7/38,14.52%,APOE;SERPINE2;PLAU;CD34;PDGFA;SERPINE1;F8
prerank,RNA transport (GO:0050658),-0.3715613562416974,-1.4104166078706244,0.023474178403755867,0.6331005917245276,1.0,25/71,19.43%,TGFBR2;SRSF5;SRSF3;DDX39B;RBFOX1;RNPS1;CKAP5;SRSF7;NUP155;NUP188;KIF5C;RTRAF;THOC5;DHX38;NXF1;FLOT1;SIDT1;ZC3H11A;SRSF2;DDX39A;TPR;ATXN2;CASC3;SRSF1;HNRNPA2B1
prerank,digestive tract morphogenesis (GO:0048546),0.6366490459106227,1.410059626368932,0.10732538330494037,0.4185114649510679,1.0,3/14,9.25%,GLI1;NIPBL;ID2
prerank,regulation of superoxide anion generation (GO:0032928),0.6432349429062426,1.409993171336538,0.1111111111111111,0.41782823868310215,1.0,6/14,18.47%,SYK;CD177;ITGB2;TGFB1;GSTP1;PRKCD
prerank,muscle cell development (GO:0055001),-0.4506095034168477,-1.4094277143199492,0.05573770491803279,0.6321278157602075,1.0,8/30,14.24%,BIN1;IGF1;SLC8A1;NEBL;ANK2;NRAP;VEGFA;CXADR
prerank,positive regulation of cell communication (GO:0010647),-0.4556165057701535,-1.4091149379745662,0.04391891891891892,0.6286925683730952,1.0,9/28,18.73%,SYT1;WLS;DLG4;ILK;CD80;CLSTN2;SOX11;RIMS1;RIMS3
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.51761181704525,-1.4086345995666147,0.09192200557103064,0.6259186307764655,1.0,6/17,13.59%,BIN1;SERPINE2;TENM4;PTN;PTPRZ1;MDK
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6170301562772653,1.408235901699131,0.09197324414715718,0.4214752744204396,1.0,4/16,4.57%,SLAMF7;CORO1A;KIF5B;KLRK1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.6056825838227224,1.4081943668535428,0.0995260663507109,0.4207354396181825,1.0,2/17,4.58%,PTPRC;KAT7
prerank,positive regulation of superoxide anion generation (GO:0032930),0.650328798721596,1.4078393485856695,0.10420168067226891,0.42084379533962385,1.0,6/13,18.47%,SYK;CD177;ITGB2;TGFB1;GSTP1;PRKCD
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.4481103681292142,-1.4074229656471193,0.05863192182410423,0.6257171297261386,1.0,10/32,6.59%,CUX1;PTPRD;RAP2A;IL1RAPL1;TNIK;HECW1;ADGRB3;FBXW8;CDKL3;CAPRIN2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6032644287577356,1.4068209357443275,0.09984152139461172,0.4226303584903156,1.0,3/17,3.32%,KCNE3;GJA5;KCNQ1
prerank,neutrophil activation involved in immune response (GO:0002283),0.41477986008600043,1.4059367682290276,0.0010152284263959391,0.42399996739245627,1.0,81/428,10.86%,ATP8B4;PLAC8;FGR;ITGAL;CD44;PTPRC;IQGAP2;IQGAP1;STK10;CYBB;CD47;FPR1;PECAM1;RAP1A;CDK13;LILRB3;MCEMP1;DOCK2;ITGAX;CLEC12A;CNN2;ANXA2;SYK;NFKB1;SLC44A2;PTX3;ADGRE5;HSPA1A;NFAM1;CD36;GM2A;CD300A;RAB3D;SELL;CD177;PRDX6;PTPN6;TBC1D10C;SLPI;UNC13D;PSMB7;ERP44;OLR1;CPPED1;CD93;HP;GMFG;DIAPH1;RAB7A;PRCP;ITGB2;MAPK14;GLIPR1;RAB6A;AP2A2;CYSTM1;ACTR2;OSTF1;SVIP;NBEAL2;PSAP;PTGES2;RAC1;TMEM179B;TSPAN14;DERA;RHOA;IDH1;PGM1;CPNE1;SLC15A4;FUCA1;KCMF1;PSMA5;PRG2;MAGT1;STOM;APAF1;RAB44;TMC6;B2M
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5665946015243462,-1.4058530810174892,0.1108433734939759,0.627022432149016,1.0,3/13,2.94%,LARGE1;RENBP;NAGK
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5401998981075085,1.4046824613713176,0.06488011283497884,0.42644392446859253,1.0,9/34,8.24%,NEDD9;DOCK5;CRK;CDC42;CARMIL1;FLNA;CIB1;S100A10;RAC1
prerank,secondary palate development (GO:0062009),-0.5554058452344987,-1.4036061909845596,0.09226932668329177,0.6307944646739084,1.0,2/14,0.65%,TGFBR2;CHD7
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6067054702660012,1.4024009417414436,0.1044776119402985,0.4315550188250338,1.0,5/16,8.98%,ST3GAL4;FUT4;ITGB2;IL6;RHOA
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.48652081968094024,1.4020041636130183,0.059045226130653265,0.4315916228563673,1.0,16/61,15.34%,LYN;NOTCH2;RASGRP4;NGF;JAK2;ERBIN;GPR35;GRB2;SHOC2;F11R;RAC1;NET1;LRRC59;ARHGEF3;LPAR6;RASGEF1A
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6127070480691204,1.4019652679414643,0.09763779527559055,0.43083568826737495,1.0,3/17,3.63%,CCR2;CCR1;CXCL10
prerank,histone H2B ubiquitination (GO:0033523),0.6712274464525627,1.4019593058188442,0.09734513274336283,0.4299718687179942,1.0,4/10,5.31%,DTX3L;UBE2E1;WAC;RNF20
prerank,protein mono-ADP-ribosylation (GO:0140289),0.678575111661945,1.4013676844720642,0.11055276381909548,0.43068387029233945,1.0,5/11,9.47%,PARP8;PARP4;TIPARP;PARP14;PARP9
prerank,Golgi organization (GO:0007030),0.44093791780391195,1.4005594813148277,0.03944315545243619,0.4319414935029057,1.0,34/112,17.62%,ATP8B4;LRRK2;VRK1;FAM174B;USP6NL;GOLPH3L;CDC42;PI4K2B;STX17;STX6;GCC2;TMED10;GBF1;STX5;BCAS3;ATL3;ARFGEF1;LMAN2L;ARHGAP21;FHDC1;YWHAZ;TRAPPC11;HTT;STX16;CLASP1;VMP1;RAB29;VCPIP1;TMED7;HACE1;TJAP1;PI4K2A;BET1;ATP8B2
prerank,regulation of cytokinesis (GO:0032465),0.461178993448885,1.4004204334555461,0.046019900497512436,0.4314917149227635,1.0,17/78,12.38%,SVIL;UVRAG;CDC14A;PRKCE;RACGAP1;CUL3;KIF20A;BIRC6;KIF23;CDC42;PKN2;RHOA;SPAST;GIT1;SETD2;PIK3R4;CSPP1
prerank,ephrin receptor signaling pathway (GO:0048013),0.46071986921918723,1.4003758307923784,0.044171779141104296,0.4307515905977886,1.0,18/82,10.00%,VAV3;TIAM1;LYN;ACTR3;FYN;PAK1;CRK;CDC42;AP2A2;ACTR2;EFNA2;RAC1;EPHB2;ARPC1B;RHOA;GIT1;ARPC2;ARPC4
prerank,positive regulation of DNA repair (GO:0045739),-0.3912383230812808,-1.3998475816029636,0.06140350877192982,0.6404622972563586,1.0,16/46,14.35%,EYA4;SPIRE1;SLF2;MGMT;ERCC6;HMGB1;SLF1;XRCC1;CEBPG;FMN2;TMEM161A;ZCWPW1;TIGAR;PCNA;DHX9;NPAS2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5356656874877681,1.399607373488277,0.0898716119828816,0.4318657024917172,1.0,10/35,13.21%,PTPRC;BCL3;JAK2;IL10RA;CRLF3;DOT1L;IL6;NLK;NF2;KIT
prerank,nucleocytoplasmic transport (GO:0006913),0.5105349551027447,1.399592267409028,0.07920792079207921,0.431042094133568,1.0,16/40,21.30%,BACH2;XPO1;RSRC1;MALT1;SNRPD2;SNRPB;NUP98;RGS14;GEMIN7;NCBP1;HTATIP2;PHAX;DDX20;NEMF;SNUPN;GEMIN8
prerank,secretory granule organization (GO:0033363),-0.6100120997505034,-1.3995062307431763,0.07459207459207459,0.6373928367350529,1.0,2/10,0.61%,ABCA1;DTNBP1
prerank,cell junction organization (GO:0034330),-0.3674122293021277,-1.3992914695920424,0.01485148514851485,0.6339408924370545,1.0,20/71,14.24%,OPHN1;APBB2;TJP1;MYO9A;C1QA;FBLIM1;PPFIA4;ILK;SEMA3E;SDK1;TJP2;CHRNA7;SMAD3;GRM5;PPFIBP1;NLGN2;PPFIBP2;AGRN;TGFB2;CXADR
prerank,T cell differentiation (GO:0030217),0.5154435833929112,1.3988852412693065,0.06500691562932227,0.43195027349577325,1.0,11/40,13.62%,PTPRC;PTPN22;RABL3;SPI1;LFNG;ZAP70;ADAM17;ZFP36L2;ANXA1;KIT;FCER1G
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.4561711900394407,-1.3982177626426215,0.0660377358490566,0.6337140414979794,1.0,7/28,11.82%,CAMSAP1;MAP2;MAP1B;CLASP2;MAP1A;MAPRE1;CAMSAP2
prerank,vasodilation (GO:0042311),-0.5657249916164494,-1.3981752031034742,0.09732360097323602,0.62969843628797,1.0,4/13,21.84%,KCNMA1;ADRB1;SOD2;SOD1
prerank,negative regulation of MAPK cascade (GO:0043409),0.4544664926142434,1.3980452717732734,0.051682692307692304,0.43324390502932475,1.0,25/87,15.86%,PTPRC;IL1B;LYN;CD300A;RGS2;SORL1;STK38;SYNJ2BP;LMO3;PTEN;EZR;PAQR3;EPHB2;DUSP6;SPRED3;SMAD4;PTPN1;DUSP1;PSMD10;RGS14;PTPRJ;GSTP1;DUSP26;SPRED1;IRAK3
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6317283519816961,1.3978788389274797,0.11627906976744186,0.43279096443663434,1.0,4/13,8.68%,PTPRC;JAK2;DOT1L;IL6
prerank,oligosaccharide metabolic process (GO:0009311),0.4980001660229229,1.3976222660285673,0.06684491978609626,0.4325849972269812,1.0,5/46,3.57%,ST8SIA4;ST3GAL4;ST8SIA1;FUT4;ST8SIA6
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4676223809341702,1.3975062864896746,0.04234122042341221,0.43202860457957426,1.0,19/76,13.15%,CBFA2T3;LRRK2;HSPA1A;LAPTM5;FBXW7;ANKIB1;SUMO1;AXIN1;ARIH1;PTEN;RNF217;HECTD1;ELOB;COP1;ARIH2;SUMO2;RCHY1;PSMD10;PABIR1
prerank,synaptic vesicle cycle (GO:0099504),-0.4424409474932804,-1.3966492837777627,0.0761904761904762,0.6309436707575906,1.0,12/30,23.44%,NLGN1;PCLO;SLC17A6;SNAP25;SYT7;CDK5;STX1A;CPLX1;RIMS1;RAB3A;SLC32A1;CPLX2
prerank,regulation of mRNA metabolic process (GO:1903311),-0.5992709019663173,-1.3965612119872044,0.0827250608272506,0.6271788989592704,1.0,9/11,24.87%,CDK11B;SAFB2;SRPK1;SRPK2;DHX9;IWS1;PTCD2;SAFB;SRPK3
prerank,regulation of cellular catabolic process (GO:0031329),0.47909585477284783,1.396285267572122,0.06765067650676507,0.4343890778933686,1.0,13/62,10.96%,ITPR1;LRRK2;DAPK1;PIP4K2A;DRAM1;DCAF12;MTMR3;PSAP;RMC1;MTMR4;DEPDC5;PIP4K2B;SCARB2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5935992127248297,-1.396234782779487,0.09382151029748284,0.6242372532986465,1.0,3/10,3.13%,PDE3B;RNF157;UBE2B
prerank,cell-matrix adhesion (GO:0007160),0.44927080315836976,1.3959210851413864,0.046948356807511735,0.4345054767946256,1.0,9/95,5.43%,ITGB7;ITGA4;ITGAL;CD44;TIAM1;RCC2;BCR;DLC1;ITGB2
prerank,positive regulation of nervous system development (GO:0051962),-0.4050883411439393,-1.395884208801872,0.0648854961832061,0.6216623954534367,1.0,16/42,20.43%,CX3CR1;PTPRD;NUMB;IL1RAPL1;NLGN1;GRID2;TGM2;IL1RAP;NLGN2;SNW1;CLSTN2;NLGN3;SOX11;TRIM32;NRXN1;DLG5
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6614671644993748,1.3958201344088301,0.11036789297658862,0.4338936637448667,1.0,4/11,6.13%,PTGIS;DLC1;FAP;DFFA
prerank,embryonic hemopoiesis (GO:0035162),-0.5848303201775185,-1.3955009218155061,0.07692307692307693,0.6189705878072866,1.0,5/12,9.78%,TGFBR2;KITLG;TAL1;ATF4;THOC5
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4695590117130363,1.3950286962973193,0.06557377049180328,0.43500706742835665,1.0,21/72,13.22%,PSME3;MAP3K14;REL;MALT1;PSMB7;PSME2;BIRC3;FBXW11;TIRAP;PSME4;TLR3;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;PSMB1;AKT1
prerank,neutrophil degranulation (GO:0043312),0.4114307505145762,1.3949727181360068,0.0010152284263959391,0.4343067939691226,1.0,80/425,10.86%,ATP8B4;PLAC8;FGR;ITGAL;CD44;PTPRC;IQGAP2;IQGAP1;STK10;CYBB;CD47;FPR1;PECAM1;RAP1A;CDK13;LILRB3;MCEMP1;DOCK2;ITGAX;CLEC12A;CNN2;ANXA2;NFKB1;SLC44A2;PTX3;ADGRE5;HSPA1A;NFAM1;CD36;GM2A;CD300A;RAB3D;SELL;CD177;PRDX6;PTPN6;TBC1D10C;SLPI;UNC13D;PSMB7;ERP44;OLR1;CPPED1;CD93;HP;GMFG;DIAPH1;RAB7A;PRCP;ITGB2;MAPK14;GLIPR1;RAB6A;AP2A2;CYSTM1;ACTR2;OSTF1;SVIP;NBEAL2;PSAP;PTGES2;RAC1;TMEM179B;TSPAN14;DERA;RHOA;IDH1;PGM1;CPNE1;SLC15A4;FUCA1;KCMF1;PSMA5;PRG2;MAGT1;STOM;APAF1;RAB44;TMC6;B2M
prerank,cellular response to alkaloid (GO:0071312),-0.5243533261120892,-1.394425384821376,0.11764705882352941,0.6188044674880061,1.0,5/17,11.69%,SLC8A1;RYR3;BLM;TGM2;CASP3
prerank,mitochondrial genome maintenance (GO:0000002),0.6400409822931294,1.3942626736160875,0.12060301507537688,0.43526681682120877,1.0,2/11,2.02%,AKT3;LONP1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6441767934535313,1.3938739487521588,0.1157167530224525,0.4353861978297446,1.0,4/12,8.68%,IL1B;STAP1;IL33;IL6
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.46734306784079926,1.3936643753544977,0.05955334987593052,0.43509331489308806,1.0,18/70,13.72%,ITGB7;ITGA4;ATRNL1;SRGAP2;NTNG2;SIPA1L3;SPI1;LAMB1;RAC1;PXN;RHOA;FN1;MEGF9;RILPL2;ITGA8;USH2A;METTL3;TBCD
prerank,intestinal absorption (GO:0050892),0.6411271262995072,1.3934413520165554,0.10891089108910891,0.4348461628683566,1.0,4/13,7.62%,CD36;KCNQ1;ADRA2A;F11R
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5655109193556805,1.3932508204230856,0.10237388724035608,0.43444518185001946,1.0,2/22,0.53%,LRRK2;SP100
prerank,regulation of protein phosphorylation (GO:0001932),0.41518179008511924,1.3931050307425878,0.009394572025052192,0.43400520438558804,1.0,54/256,13.39%,CD74;FGR;NIBAN1;LRRK2;PID1;IL1B;LYN;FGF22;PECAM1;FYN;CD40;PPP2R5A;PAK1;FGF5;CCDC88C;NPTN;CCDC88A;AXIN1;IBTK;CCND3;VEGFC;ITGB2;PTEN;CCND1;STK4;PRNP;WDFY2;ADAM17;CIB1;MOB1B;PAQR3;ENG;RAC1;EPHB2;ACVR2A;HGF;RALB;PGF;CAMKK2;FN1;DAXX;RIPK1;CACTIN;DVL3;PPP1R15B;APP;NDUFS4;CLIP3;CCND2;EIF2AK3;STAT2;AKT1;NSD1;LIMK2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.5499640856925037,-1.3927666900183178,0.08557457212713937,0.6207999131351614,1.0,9/13,40.02%,SYT1;SCAMP5;STX1A;CACNA1I;KCNB1;SYT10;SYT4;CACNA1H;HYAL3
prerank,regulation of tube diameter (GO:0035296),0.6298322179255598,1.3927167452566025,0.11954765751211632,0.4333438813796845,1.0,2/13,1.26%,ACE2;ACE
prerank,vascular process in circulatory system (GO:0003018),0.6298322179255598,1.3927167452566025,0.11954765751211632,0.4333438813796845,1.0,2/13,1.26%,ACE2;ACE
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.43705302537149016,1.3926090059847964,0.04228571428571429,0.43275690267236766,1.0,27/114,13.54%,TRAF1;TNFSF13B;CD40;PSME3;JAK2;MAP3K14;NFKBIA;IKBKB;PSMB7;PSME2;BIRC3;STAT1;PTK2B;ADAM17;TRAF3;PSME4;PSMB8;PSMD9;PSMA5;RIPK1;PSMB3;FOXO3;PSMD6;PSMC4;PSMD10;PSMB1;TNFRSF1B
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4633673623089268,1.3924679563934723,0.05693069306930693,0.43230823917394595,1.0,23/75,16.33%,IL1B;LYN;HEG1;CD300A;PKIB;RGS2;SORL1;STK38;HEXIM1;PTEN;PAQR3;LATS1;PTPN1;PRKAR2A;LATS2;DUSP1;RGS14;AKT1;PTPRJ;GSTP1;APC;IRAK3;RB1
prerank,vesicle transport along actin filament (GO:0030050),0.587883460210431,1.3918136993964298,0.11692307692307692,0.4330260490379834,1.0,4/19,6.50%,MYO1G;MYO1E;MYO1C;MYO5B
prerank,negative regulation of JUN kinase activity (GO:0043508),0.6664806894450368,1.3917980232513212,0.12295081967213115,0.4322349916152143,1.0,3/10,14.84%,PTPN22;PDCD4;GSTP1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4307921647400351,1.391522357318909,0.020902090209020903,0.4321137955802473,1.0,30/158,11.45%,CD74;CARD11;ALPK1;CD40;SLC44A2;MAP3K14;REL;ANKRD17;MALT1;IKBKB;TRIM62;BIRC3;TRAF3IP2;S100A4;PELI1;IRAK4;TIRAP;UBE2N;SHISA5;LGALS1;FLNA;TRIM25;ZDHHC13;CARD16;RHOA;ZDHHC17;RIPK1;TRIM14;RNF31;TAB3
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.5066703904388665,1.3911869298162605,0.08310626702997276,0.43212807569838163,1.0,13/43,14.95%,KLF4;NGFR;PPARG;STAT3;FOS;SPI1;KLF5;NR3C1;FOXO3;REST;TEAD1;TGFB1;RELA
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6447285476285693,1.3898537885388138,0.13410596026490065,0.43471213668335607,1.0,2/12,2.67%,PLCG2;CD36
prerank,protein ADP-ribosylation (GO:0006471),0.5470744943431618,1.3891136890642346,0.09272467902995721,0.4356515356018091,1.0,14/28,21.77%,ZC3HAV1;PARP8;PARP4;TIPARP;ARF4;PARP14;TNKS;PARP9;SIRT4;PARP12;SIRT1;PARP11;SIRT3;PARP1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.635707714598433,1.3890697383766761,0.13275862068965516,0.4349424174644021,1.0,3/11,9.95%,STK24;MAP3K5;GSKIP
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.49282831252722237,1.38903775139655,0.07397622192866579,0.43419824740020974,1.0,15/46,15.21%,PTPRC;LYN;SYNJ2BP;LMO3;PTEN;EZR;EPHB2;DUSP6;SPRED3;SMAD4;PTPN1;RGS14;GSTP1;DUSP26;SPRED1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4043401576689505,-1.388338011915125,0.04929577464788732,0.6324229180278645,1.0,14/44,14.89%,KCNMA1;WNK1;ATP1B3;KCNJ2;ATP1B1;ANK2;WNK2;KCNN2;KCNMB2;AKAP6;KCNJ6;KCNN3;KCNJ9;GABBR1
prerank,RNA modification (GO:0009451),-0.3770035932779706,-1.3877844233601293,0.030434782608695653,0.6303485610142936,1.0,36/54,36.21%,NSUN2;TRMT1;ANKRD16;JMJD6;QTRT1;ELP5;TYW5;NOP2;ADAR;NSUN3;CDKAL1;METTL1;DTWD2;SSB;THUMPD1;FTSJ3;NSUN5;WDR4;ADARB1;TRMT6;LCMT2;NSUN6;TRMT9B;NAT10;BCDIN3D;DTWD1;PUS7;QTRT2;FTSJ1;ALKBH1;CTU2;AARS2;THG1L;RBM15B;TRMT61A;CTU1
prerank,positive regulation of cell cycle process (GO:0090068),0.4546882119281843,1.387608537199608,0.045077105575326216,0.43714117806609104,1.0,18/91,12.77%,IL1B;SVIL;CDC14A;PRKCE;RACGAP1;PLSCR1;CUL3;RCC2;FEN1;KIF23;CDC42;PKN2;RHOA;SPAST;DYNC1H1;CSPP1;MAP3K20;ATRX
prerank,chromatin remodeling (GO:0006338),0.44167061393760965,1.3875502405402247,0.04946996466431095,0.436459585700199,1.0,37/100,20.17%,JARID2;BAZ1A;KDM6A;PAK1;BAZ2B;GATAD2B;INO80C;RBBP4;SMARCA5;EZH1;SMARCE1;DAXX;TADA2A;MBD2;BAZ2A;ATRX;MYB;SRCAP;CHD4;SMARCC2;KAT2B;CHRAC1;RSF1;INO80;KDM4B;NPM3;RB1;BPTF;SIRT1;SMARCD3;HCFC2;HDAC1;GATAD1;ACTB;PBRM1;SATB1;HNRNPC
prerank,photoreceptor cell development (GO:0042461),-0.5437165743773902,-1.3873186938264845,0.09798994974874371,0.627952244491656,1.0,5/14,20.31%,DCX;MYO7A;VEGFA;ARL3;CEP290
prerank,transcription by RNA polymerase III (GO:0006383),-0.44190908537819534,-1.3868727541441288,0.08231707317073171,0.6257742748783153,1.0,11/27,17.88%,IVNS1ABP;GTF3C3;CRCP;GTF3C4;ICE2;GTF3C2;POLR3H;SNAPC4;GTF3C5;SNAPC1;POLR2K
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.47722722763325526,1.3868051939944743,0.0685785536159601,0.43751254890554775,1.0,18/59,15.45%,CARD11;BCL3;MAP3K14;REL;NFKBIA;IKBKB;BIRC3;TLR3;TANK;RIPK1;RNF31;TAB3;MAP3K7;TLR2;AKT1;ROCK1;RELA;TBK1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5924966426985678,1.386691112598102,0.11146496815286625,0.43614256925256956,1.0,4/17,5.37%,STAT5A;STAT3;STAT5B;IL2RG
prerank,cellular response to interleukin-7 (GO:0098761),0.5924966426985678,1.386691112598102,0.11146496815286625,0.43614256925256956,1.0,4/17,5.37%,STAT5A;STAT3;STAT5B;IL2RG
prerank,membrane lipid biosynthetic process (GO:0046467),0.4688536163023856,1.38650408214355,0.07942708333333333,0.43584861124975866,1.0,16/58,16.34%,CERS6;ST3GAL4;ACER3;ST8SIA6;CERS1;ELOVL5;SAMD8;SGMS1;SGMS2;ELOVL6;SPTSSB;SGPP2;SGPP1;FA2H;VAPA;HACD4
prerank,macrophage migration (GO:1905517),0.6290666081148871,1.386219466181104,0.1174496644295302,0.43584629109187856,1.0,2/13,5.36%,CCR2;CKLF
prerank,neutrophil chemotaxis (GO:0030593),0.49033363746026265,1.3849158487265218,0.08192457737321196,0.43821226246299555,1.0,9/53,13.62%,JAML;SYK;CXCL10;CKLF;ITGB2;GBF1;PIKFYVE;LGALS3;FCER1G
prerank,monosaccharide transmembrane transport (GO:0015749),0.6041807307691067,1.384790350659424,0.12116316639741519,0.4377286862554458,1.0,2/16,2.23%,SLC23A2;SLC23A1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5929616947743939,1.3846772799345903,0.0989010989010989,0.4371543105100717,1.0,2/18,6.49%,CCR2;PTK2B
prerank,reverse cholesterol transport (GO:0043691),-0.5441242924804373,-1.3840234101679547,0.12408759124087591,0.6324067070314405,1.0,2/13,0.41%,ABCA1;APOE
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5471754662804635,-1.3840052812608816,0.11302211302211303,0.6285827908276,1.0,3/13,7.58%,ATP1B3;ATP1B1;ATP1A2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5453253201525593,-1.383456743887921,0.11166253101736973,0.626527211040691,1.0,5/13,6.69%,PLXNA4;NRP1;NRP2;PLXNB2;PLXNA2
prerank,regulation of monooxygenase activity (GO:0032768),0.5525817649965665,1.3834331357141174,0.12444444444444444,0.43949726319369864,1.0,3/23,4.80%,IL1B;NOSTRIN;GDNF
prerank,microtubule nucleation (GO:0007020),-0.4974192586507287,-1.3832019716921347,0.1046831955922865,0.6236623805377028,1.0,9/19,24.02%,TUBGCP5;CLASP2;GOLGA2;CCDC57;TPPP;TUBGCP6;NDEL1;TUBGCP2;TPX2
prerank,regulation of JUN kinase activity (GO:0043506),0.5279297246417661,1.3824680390355004,0.0811554332874828,0.4410270414390611,1.0,12/33,17.23%,PTPN22;MAP3K5;PAK1;TAOK3;PDCD4;MAP3K4;RPS3;DVL3;MAP3K7;GSTP1;DVL2;TRAF2
prerank,cell chemotaxis (GO:0060326),0.47377231558794347,1.3822317188012705,0.07958921694480103,0.44079783413448254,1.0,13/60,13.21%,CCR2;XCR1;CCR1;ACKR2;CCR9;BCAR1;ELMO2;CCRL2;ABCC1;HGF;CXCR6;PIP5K1A;KIT
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5800696100765863,1.3814727040993144,0.12658227848101267,0.44186365010924206,1.0,4/19,5.92%,PRKCE;TNIP3;ITGB2;TIRAP
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.45300405224493717,1.3812734118484853,0.07255139056831923,0.4415823670916968,1.0,28/95,15.01%,IL1B;CYRIB;TNIP3;STAP1;LILRB1;NFKB1;VIM;CXCL10;MAPK14;TIRAP;PDCD4;CARD16;IL6;NFKBIB;RHOA;GIT1;SBNO2;CACTIN;ACOD1;FCGR2B;NLRP3;TLR2;MAPK8;TNFRSF1B;ADAM9;GSTP1;RELA;MYD88
prerank,regulation of microglial cell activation (GO:1903978),0.6081679093879325,1.3805182062878003,0.12271973466003316,0.44261533939025965,1.0,3/15,1.77%,PTPRC;STAP1;LDLR
prerank,mitochondrion distribution (GO:0048311),0.6294059718935048,1.379576270438706,0.10619469026548672,0.44436116067511044,1.0,3/12,12.82%,LRRK2;CLUH;DNM1L
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.605991854876557,1.3789336321850598,0.11888111888111888,0.4452210092199326,1.0,6/14,20.32%,RAPGEF2;PKIB;PRKAR2A;HTT;SIRT1;PKIA
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.6417106022815097,1.3787368483191538,0.11512027491408934,0.444933816390803,1.0,5/12,19.51%,UVRAG;SETX;FYCO1;INSR;JMJD4
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6135517988035079,1.3777205556854628,0.09728867623604466,0.44675127748025706,1.0,8/15,15.08%,NGF;NGFR;BCAR1;GRB2;DDIT4;SOS1;ZFYVE27;FRS2
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5591365052376721,1.3772228448660015,0.12074303405572756,0.447295350027404,1.0,8/20,13.92%,MCUB;SLC8B1;MAIP1;PARL;LETM1;PMPCA;MICU3;YME1L1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5899432343909616,1.376220065244637,0.1035031847133758,0.4490747156576896,1.0,3/17,4.57%,KLRD1;CD226;KLRK1
prerank,regulation of stress fiber assembly (GO:0051492),0.4589007207048587,1.3760066159398028,0.07099143206854346,0.4488368518602234,1.0,18/74,8.98%,ARHGEF18;CD47;PAK1;WASF2;ARHGEF10L;PTGER4;CCDC88A;CDC42;DLC1;ARAP1;CARMIL1;PAK2;S100A10;PHLDB2;F11R;RAC1;PXN;RHOA
prerank,lipid droplet formation (GO:0140042),-0.5837077515422102,-1.3756974710428238,0.12408759124087591,0.6469805138156003,1.0,6/10,27.83%,CDS1;CDS2;AUP1;BSCL2;ZFYVE1;FITM2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5559229697361335,-1.3748323416496553,0.13076923076923078,0.646112200319369,1.0,4/13,11.27%,HEXB;ARSB;CSPG4;HEXA
prerank,mitochondrion morphogenesis (GO:0070584),0.6462459098492519,1.3745554055392302,0.10912343470483005,0.4518686245612832,1.0,5/11,14.12%,PID1;FIS1;DNM1L;PNPT1;MYH14
prerank,granulocyte chemotaxis (GO:0071621),0.4853873091807819,1.3732273092421492,0.07922077922077922,0.4545344806463005,1.0,10/55,13.62%,JAML;SYK;CXCL10;CKLF;ITGB2;GBF1;PIKFYVE;ANXA1;LGALS3;FCER1G
prerank,regulation of cell killing (GO:0031341),0.6070533411094418,1.3732038607678463,0.1168,0.4537826762930464,1.0,8/16,18.69%,NOX1;RAC1;ICAM1;CR1L;MAPK8;DVL2;CYBA;FZD7
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5773205665531632,-1.3724785612983856,0.10657596371882086,0.6506999664071735,1.0,3/11,2.61%,BIN1;CACNB2;CACNA2D1
prerank,nuclear migration (GO:0007097),0.6159404144603682,1.3723176101292052,0.11091234347048301,0.4553529594450737,1.0,4/13,11.89%,SYNE3;FBXW11;PAFAH1B1;DYNC1H1
prerank,small GTPase mediated signal transduction (GO:0007264),0.43972825414730254,1.3723135453145878,0.0568445475638051,0.4545378795005846,1.0,25/103,11.33%,GRAP2;RIN2;TIAM1;ARHGEF18;TIAM2;SHTN1;CCDC88C;ARHGAP18;RASGRP2;ARHGAP30;RAPGEF2;CCDC88A;BCR;ADRA2A;MAPK14;GRB2;SHOC2;NUCB2;RAC1;GNB1;SOS1;RALB;RASSF1;RHEB;NTN1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.495898084267955,-1.3717744994864693,0.10741687979539642,0.6492031143781652,1.0,5/18,11.36%,PRKN;SPIRE1;MFF;VPS35;RALA
prerank,response to muramyl dipeptide (GO:0032495),0.6411171006319016,1.371472050102713,0.12166666666666667,0.45585610079812827,1.0,3/12,3.19%,PTPN22;VIM;ERBIN
prerank,response to UV-A (GO:0070141),0.6263505295174036,1.3711930634332081,0.11764705882352941,0.4557929591912346,1.0,4/14,13.22%,MMP1;CERS1;CCND1;AKT1
prerank,cellular response to organic substance (GO:0071310),0.43449100568726956,1.371183768690962,0.048863636363636366,0.4550010782987476,1.0,20/116,10.24%,LRRK2;PID1;IL1B;FLT3;KLF4;STAT3;BMPR2;NCOA3;PTPN6;STAT5B;PTPN7;CERS1;PTPN12;ADRA2A;TIPARP;CIB1;ACVR2A;RHOA;NCOA2;NCOA1
prerank,cellular response to zinc ion (GO:0071294),-0.5287492379012924,-1.3707350630886188,0.10833333333333334,0.6490752442931833,1.0,13/15,42.77%,P2RX4;GLRA2;MT2A;MT3;ATP13A2;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H
prerank,negative regulation of binding (GO:0051100),0.4513900067266746,1.3707235707725067,0.07160194174757281,0.4552795047631586,1.0,22/81,15.36%,LRRK2;SP100;JAK2;IFIT2;SORL1;NFKBIA;SLPI;MITD1;SUMO1;CARD16;TMC8;PEX14;RALB;CPNE1;MAPK8;AKT1;ROCK1;IFIT1;RSF1;ILRUN;AURKB;DISC1
prerank,B cell homeostasis (GO:0001782),0.6573286235562276,1.370075674419513,0.125,0.45618384598991263,1.0,5/10,10.04%,LYN;GAPT;DOCK10;DOCK11;CAMLG
prerank,regulation of cellular component movement (GO:0051270),0.48255387713772846,1.3699533635683248,0.08485639686684072,0.45566496568339376,1.0,12/49,8.98%,SP100;LYN;PKN1;NRG2;ARHGAP18;INPP5F;ARAP1;DIAPH1;ADAM17;PKN2;MYCBP2;RHOA
prerank,regulation of microtubule nucleation (GO:0010968),0.6733112885538182,1.3693189922303644,0.12195121951219512,0.4564928480545611,1.0,4/10,9.43%,PAK1;HSPA1A;MECP2;GIT1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.45811347959417076,1.3692499678785053,0.07380073800738007,0.45587457262145237,1.0,18/75,13.83%,GRK5;RASGRP4;RGS2;RGS3;CRY1;PPP1R9B;ZDHHC7;CAMKMT;PLCB1;SYP;RGS12;GIT1;GRK6;NMT2;RGS14;PDE6B;PDE6H;ROCK1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6568536274413234,1.369170580340885,0.13157894736842105,0.4552567263032047,1.0,3/10,10.21%,KYNU;ATP7A;KYAT1
prerank,negative regulation of viral genome replication (GO:0045071),0.5037970007228713,1.3690070450400218,0.08689655172413793,0.45486461629181096,1.0,8/40,7.15%,ZC3HAV1;OAS2;PLSCR1;EIF2AK2;SLPI;FAM111A;IFIH1;OASL
prerank,positive regulation of coagulation (GO:0050820),0.6469849979440198,1.3689058482040397,0.14310051107325383,0.45349168637748116,1.0,1/10,0.58%,ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.6469849979440198,1.3689058482040397,0.14310051107325383,0.45349168637748116,1.0,1/10,0.58%,ST3GAL4
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5940085317137146,1.3687821871681398,0.1085899513776337,0.45299269510649176,1.0,3/16,4.57%,KLRD1;CD226;KLRK1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.39821283472190544,1.3687290628933233,0.007070707070707071,0.45233815071587813,1.0,99/476,15.31%,CD74;CIITA;NFE2;IL1B;RUNX2;RARA;SP100;SP3;RUNX3;GLI1;BCL3;KLF4;CREB1;RET;MAP3K5;PPARG;NFKB1;PITX3;ATF7IP;DTX3L;STAT3;EHF;NSD3;ELF4;FOS;MAD2L2;CRLF3;NAA16;MYRF;SCX;TBL1XR1;ATAD2;IKBKB;PICALM;MED30;RYBP;AXIN1;RFX3;WAC;DEAF1;HIPK2;STAT1;RNF20;MED13;IRF4;FBXW11;TRIM16;SEC14L2;AHR;TADA3;DYRK1A;PLCB1;AFAP1L2;CLOCK;CTCF;ELF1;IL6;KAT6A;NAA15;ID2;CREBL2;PARP9;ZNF496;IRF7;CAMKK2;SMAD4;PSMD9;NCOA1;IL31RA;ING2;FOXO3;MED12;DVL3;ETS2;REST;RPS6KA1;MED14;NFYA;TFAM;TEAD1;MAP2K3;MYB;AKT1;NSD1;LBH;NCF1;SMARCC2;CITED2;NFIL3;TGFB1;RSF1;KMT2E;RELA;MAZ;GPATCH3;SERTAD3;RHOG;KMT2A;CREBBP
prerank,regulation of cell junction assembly (GO:1901888),0.5405239661550905,1.368110608642109,0.11521418020679468,0.452921214024619,1.0,8/27,9.42%,PDLIM5;RAP1A;PRKCH;MYO1C;RAPGEF2;CBFB;F11R;SETD5
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4763595522189988,1.367520361922159,0.08083441981747067,0.45360151391514797,1.0,8/53,10.43%,XCR1;CCR1;LPAR3;HTR1D;HTR4;OPRM1;HRH1;ANXA1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5099477489769054,1.3672397687288638,0.1031636863823934,0.4535248441265348,1.0,9/41,13.98%,CD44;IL1B;CD47;PTPRU;AFDN;PIEZO1;ADAM19;MEGF10;CITED2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5311737425418955,1.3669391885827828,0.12148148148148148,0.4534779480744214,1.0,4/26,8.98%,ST3GAL1;ST3GAL4;B4GALT5;ACAN
prerank,negative regulation of locomotion (GO:0040013),0.6293523361058977,1.3666741700828027,0.13494809688581316,0.4533740386064797,1.0,2/12,2.68%,CCDC125;CRK
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5436271001256049,1.3664480166678217,0.11574074074074074,0.4531407692474002,1.0,7/24,7.62%,ARHGEF18;WASF2;DLC1;ARAP1;PAK2;PHLDB2;F11R
prerank,regulation of cell migration (GO:0030334),0.4007610664972076,1.366306928547439,0.003045685279187817,0.4526631305596994,1.0,59/382,9.28%,CD74;FGR;IL1B;NEDD9;TIAM1;CYRIB;SRGAP3;SRGAP2;SGK3;FGF22;TCAF2;PECAM1;STK24;ACE;NGFR;SLK;ITGAX;RET;NTNG2;PTPRU;CCR1;PAK1;SEMA4A;FGF5;STAT3;DOCK10;CLDN1;MYO1C;RCC2;SORL1;LAMB1;DPEP1;CLIC4;CBLL1;PPP3CA;DLC1;TMSB10;CARMIL1;ADRA2A;BCAR1;RNF20;AFDN;PTEN;CXCL16;PTK2B;ADAM17;FLNA;CIB1;YTHDF3;LMNA;PLXND1;ENG;ARHGEF39;RAC1;EPHB2;MINK1;HGF;RHOA;MGAT3
prerank,regulation of lysosomal lumen pH (GO:0035751),0.6450283903716045,1.3661284651916592,0.12241379310344827,0.4523629569430524,1.0,1/12,0.22%,LRRK2
prerank,toll-like receptor signaling pathway (GO:0002224),0.44965070391572665,1.365544854677751,0.07074340527577938,0.4529895264625872,1.0,23/84,12.96%,TNIP3;PLCG2;MAPKAPK3;CD36;RPS6KA3;MAPKAPK2;IKBKB;BIRC3;ITGB2;UBE2D3;IRAK4;TIRAP;MAP3K1;TRAF3;SFTPA1;SFTPA2;TLR3;RIPK1;TAB3;PIK3R4;MAP3K7;TLR2;BTK
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5609466946984841,1.365533502605735,0.12366412213740458,0.4522312084914662,1.0,6/23,8.70%,INPP5F;OCRL;PTEN;MTMR3;MTMR4;SYNJ1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.41333515424671097,-1.365484171597279,0.07796610169491526,0.6635435611723192,1.0,9/38,7.59%,CACNA1D;BIN1;CTNNA3;CACNB2;CACNA2D1;KCNJ2;CACNA1C;ANK2;JUP
prerank,adipose tissue development (GO:0060612),-0.5698538527391217,-1.3648384601868573,0.11185682326621924,0.6620275647511431,1.0,8/11,33.08%,ARID5B;NAMPT;SH3PXD2B;PGRMC2;DYRK1B;SPTLC2;LRP5;DGAT2
prerank,positive regulation of cellular respiration (GO:1901857),0.6500075738020297,1.3644395844603605,0.14814814814814814,0.454289339666318,1.0,6/11,20.01%,IFNLR1;IFNAR1;PRELID1;VCP;PINK1;PARK7
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.5026874374075311,1.3642132619459615,0.09752747252747253,0.4540877154993491,1.0,11/39,16.32%,FXYD5;KLF4;MAD2L2;AKNA;MBP;MAP2K5;NF2;AKT1;TGFB1;ASS1;MYADM
prerank,maintenance of protein location in nucleus (GO:0051457),0.5594017981403363,1.3640576994315161,0.13476263399693722,0.45368856170785765,1.0,2/20,1.25%,SP100;BCL3
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.43555970761803964,-1.3635331051681947,0.07796610169491526,0.6629743716968655,1.0,15/28,27.98%,LGMN;APOE;PTN;EIF2AK4;ZDHHC2;CHRNA7;SQSTM1;ADCY8;TYROBP;AKAP5;EPHA4;ADCY1;NSG1;CALB1;ABL1
prerank,cell junction assembly (GO:0034329),-0.327933583776612,-1.3634634355684898,0.015625,0.6593968271802284,1.0,23/100,16.08%,OPHN1;TJP1;MYO9A;ITGA6;PKP4;FLCN;NLGN1;FBLIM1;CDH11;NRXN2;ILK;RYK;SDK1;GPM6A;CDK5;NLGN2;TRPV4;TLN2;ADGRL3;SLITRK1;PKP2;KIRREL3;NLGN3
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5204111165899291,1.3628866179062846,0.12352941176470589,0.4558154848163574,1.0,4/30,3.31%,PTPRC;FLT3;ACE;PLD4
prerank,DNA double-strand break processing (GO:0000729),0.5766029822814911,1.3626147103456447,0.1289308176100629,0.4557434112381899,1.0,6/18,13.51%,DNA2;RBBP8;MRE11;UBE2N;EXD2;RNF138
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.4771096746469453,1.3618779441692677,0.08108108108108109,0.4568412194468882,1.0,17/57,14.55%,LYN;FLT3;CD40;JAK2;STAT3;INPP5F;IL6R;PARP14;IL6ST;IL6;PARP9;IL31RA;NF2;KIT;HCLS1;FGFR3;IL18
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3987500603940185,1.3618603614456795,0.0020304568527918783,0.45611254143168206,1.0,71/390,10.07%,FGR;VAV3;NEDD9;TIAM1;CYBB;HCK;LYN;RASGRP4;FGF22;NGF;FLT3;ACTR3;STAP1;NGFR;FYN;RET;LMTK2;SULF2;MAPKAPK3;SYK;PAK1;FGF5;PIK3C2A;JAK2;STAT3;WASF2;KL;CRK;ATP6V0E1;GTF2F2;RAPGEF2;SLA;MAPKAPK2;ABI1;POLR2C;CBL;ZAP70;CDC42;VEGFC;CLNK;BCAR1;ELMO2;STYK1;CAV2;MAPK14;AP2A2;POLR1G;GRB2;SETX;PTK2B;ACTR2;EFNA2;SHOC2;PAK2;GIGYF2;PLCB1;DDIT4;RAC1;PXN;EPHB2;ARPC1B;SOS1;HGF;RHOA;ATP6V1H;GIT1;TRIM71;PGF;ARPC2;ARPC4;NCF2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.42711468794124957,1.3615276016940414,0.038335158817086525,0.45621314457028084,1.0,19/151,9.50%,CD74;CD44;FFAR4;PTPRC;NOTCH2;PTPN22;RAP1A;CCR1;CD36;RAPGEF2;GLIPR2;FBXW7;PRXL2C;TIRAP;PTK2B;CIB1;OPRM1;ICAM1;BRAF
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.5096510915235689,-1.3612368244614061,0.09610389610389611,0.6633781851070126,1.0,10/15,32.20%,DERL2;HSP90B1;AUP1;NPLOC4;DERL1;HERPUD1;SEC61B;FAF2;TMEM129;SYVN1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5937367323875549,1.3611059945680177,0.13050570962479607,0.4565315932439609,1.0,4/15,5.03%,SIK1;LDLR;FBXW7;SCARB1
prerank,actin filament-based transport (GO:0099515),0.5661385704414412,1.3605851477526636,0.11801242236024845,0.4571427606567951,1.0,4/21,6.50%,MYO1G;MYO1E;MYO1C;MYO5B
prerank,renal filtration (GO:0097205),0.6683172351338835,1.3601915357017615,0.13969335604770017,0.45738270023346167,1.0,5/10,13.69%,SULF2;MYO1E;TBC1D8B;TMEM63C;ITGA3
prerank,response to tumor necrosis factor (GO:0034612),0.4448878929585014,1.3599681986825947,0.07692307692307693,0.45722468891485996,1.0,25/91,17.86%,PID1;CD40;JAK2;ERBIN;IKBKB;CXCL16;ZFAND6;NFE2L2;CIB1;ZFP36L2;TANK;RPS3;RIPK1;CACTIN;MAP4K3;ACOD1;ADAMTS12;AKT1;GBP2;ADAM9;GBP3;RELA;AFF3;SIRT1;YBX3
prerank,positive regulation of cell population proliferation (GO:0008284),0.39885634848172236,1.3587694520920222,0.003033367037411527,0.45962913435563857,1.0,71/423,15.09%,CD74;DPP4;PID1;PTPRC;IL1B;FOXP1;GRK5;RARA;TIAM1;HCK;LYN;CD47;GLI1;FGF22;FLT3;CDK13;ITGAX;ACER3;TBC1D8;PIM1;PAK1;FGF5;CUL3;PRKCH;PTPN6;LAMB1;SCX;IL6R;GDNF;VEGFC;RBPJ;ADRA2A;STAT1;PTEN;PTK2B;ADAM17;CIB1;MECP2;CNOT6;NOX1;DOT1L;CACUL1;IL6ST;IL6;ID2;PGF;CSNK2A1;RPRD1B;FN1;IL31RA;MCTS1;GLP2R;NAP1L1;SLC25A5;MEGF10;NDUFS4;PDGFD;LIFR;CCND2;AKT1;EZH2;HCLS1;GNAI2;COX17;FGFR3;TGFB1;IL18;RELA;MAZ;RHOG;RPS15A
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.6483234894928338,1.3584716026955164,0.11247803163444639,0.45961377684120136,1.0,5/10,19.43%,JARID2;ATRX;MYB;SIRT1;DNMT1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4426654530877778,1.3579580794827781,0.08010012515644556,0.4601861479037014,1.0,25/79,17.09%,CD74;AP1S3;RACGAP1;AP1S2;KIF23;RAB7A;AP2A2;MFSD6;CAPZB;ARF1;DCTN3;CAPZA1;PIKFYVE;KIF3B;AP1G1;AP2B1;FCGR2B;DYNC1H1;FCER1G;CANX;KIF5A;AP2S1;SEC24C;AP1M1;DYNC1I2
prerank,atrial septum morphogenesis (GO:0060413),0.6396911278843055,1.3573885129278733,0.13924050632911392,0.4609488151302292,1.0,2/10,2.95%,NOTCH2;BMPR2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.5561799794357696,1.3571780997726584,0.12713178294573643,0.46071939901014225,1.0,8/21,12.90%,PDZD8;MCUB;SLC8B1;MAIP1;ATP2A1;FIS1;LETM1;MICU3
prerank,covalent chromatin modification (GO:0016569),0.599953316265131,1.3566920979906707,0.1260229132569558,0.46115210563008974,1.0,7/14,20.01%,HLCS;SETD5;MBD2;AURKB;SIRT1;HDAC1;PARK7
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.37265004829569864,-1.3564784940942833,0.04741379310344827,0.6764169159045991,1.0,10/57,3.96%,DLGAP1;MEF2C;GRIA4;LRRC7;NLGN1;DLGAP4;DLG2;DLG4;GRIA2;GRIA1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.6366804802732667,1.3563820208225401,0.1362126245847176,0.46121748443759986,1.0,4/11,11.47%,RIN3;STAP1;SLAMF8;DUSP1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6423559098818903,1.3562233566336108,0.1265164644714038,0.46086756561781655,1.0,4/11,7.35%,LIMD1;STAT3;XPO5;PUM2
prerank,protein monoubiquitination (GO:0006513),0.4983850651154154,1.355847262956467,0.11748251748251748,0.4610077904856622,1.0,11/36,10.24%,DTL;DTX3L;CUL3;UBE2E1;PEX12;WAC;RNF20;UBE2D3;TRIM25;UBE2W;FANCL
prerank,negative regulation of cell motility (GO:2000146),0.4318509041556683,1.3555193080709083,0.05807200929152149,0.4610962501582395,1.0,14/108,5.94%,CD74;SRGAP3;SRGAP2;STK24;NGFR;PTPRU;CCDC125;CRK;DPEP1;CLIC4;DLC1;RNF20;AFDN;PTEN
prerank,negative regulation of blood pressure (GO:0045776),0.6246617534221754,1.355357627372391,0.13764510779436154,0.46072184381251957,1.0,2/13,5.35%,BMPR2;PRCP
prerank,regulation of lamellipodium assembly (GO:0010591),0.51875680600639,1.3553164062296086,0.09423347398030943,0.4600485060195459,1.0,9/34,10.70%,ACTR3;WASF2;RAC2;CDC42;ACTR2;CAPZB;RAC1;ARPC2;PIK3CA
prerank,cellular response to leucine starvation (GO:1990253),-0.5967758862722266,-1.3545372159423625,0.1189873417721519,0.6799712408549401,1.0,8/10,30.96%,SESN3;EIF2AK4;LARS1;IMPACT;SESN2;SESN1;RRAGD;MTOR
prerank,regulation of immune effector process (GO:0002697),-0.4037372902563798,-1.3542799153635166,0.07246376811594203,0.6771802752139243,1.0,11/41,13.69%,C1QB;C1QA;C1QC;C3AR1;PROS1;C4B;C5AR1;SUSD4;C5AR2;CLU;C3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.49277197017958885,1.3538615327759513,0.10700132100396301,0.46304760901136466,1.0,10/47,8.24%,NEDD9;DOCK5;CRK;RCC2;CDC42;CARMIL1;FLNA;CIB1;S100A10;RAC1
prerank,GPI anchor metabolic process (GO:0006505),-0.44330545699641666,-1.3535561672202703,0.08641975308641975,0.6760714201854041,1.0,19/26,39.04%,PIGN;PIGG;PGAP2;PIGP;PIGB;PIGA;DPM2;GPLD1;PIGV;DPM3;PIGU;DPM1;PIGO;PGAP3;MPPE1;PIGZ;PIGW;PIGQ;PGAP1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.4243909690941619,1.3529729504573493,0.05568181818181818,0.4645721260340852,1.0,34/132,14.73%,LRRK2;IL1B;ZC3HAV1;DAPK1;ITCH;MSN;PIK3C2A;DTX3L;PLEKHF1;LAPTM5;ZBTB20;ATF6;PRXL2C;ADRA2A;PTTG1IP;RC3H1;FAF1;SVIP;EZR;PTPN1;SNX9;TRIM14;FOXO3;PRKAA1;APP;PFKFB3;SH3BP4;ABCD1;TNFRSF1B;ROCK1;PRKAA2;PNPT1;PFKFB4;ADAM9
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.49452794152785395,-1.352583814254232,0.12128712871287128,0.6758351203166049,1.0,9/17,13.51%,BIN1;APOE;IGF1;NTRK2;RTN3;GGA3;CHRNA7;CLU;ABCA7
prerank,response to sterol (GO:0036314),-0.5684803565626377,-1.3522195837415147,0.14840182648401826,0.6733760603539246,1.0,2/11,1.23%,TGFBR2;TGFBR1
prerank,peripheral nervous system development (GO:0007422),0.5451223566305964,1.3514895050071571,0.11958146487294469,0.46756207197049887,1.0,3/23,4.80%,NGF;ADGRG6;GDNF
prerank,regulation of cell motility (GO:2000145),0.42648193614969376,1.3512869703916452,0.06050228310502283,0.46725382717950775,1.0,23/121,9.28%,CYRIB;SGK3;FGF22;SLK;PKN1;FGF5;CCDC125;NRG2;DOCK10;ARHGAP18;CRK;RCC2;INPP5F;TMSB10;DIAPH1;FLNA;PKN2;LMNA;PLXND1;RAC1;MINK1;RHOA;MGAT3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6233723379953322,1.3511631804312578,0.1510673234811166,0.46682064435080745,1.0,1/12,0.38%,FOXP1
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.32285246158855063,-1.3503184301898103,0.03759398496240601,0.6762600167461537,1.0,26/124,9.08%,OPHN1;PTPRM;CSF1R;PPP1R9A;APOE;DTNBP1;CAMSAP1;NLGN1;MAP2;PLP1;ERCC6;ODF2;HMGB1;TMEM108;PKD2;CNTN4;WDPCP;LIMA1;CEP78;GPRIN3;RYK;RASGRF1;CDK5R1;SH3GL2;TBC1D23;GPM6A
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.45439447581344244,1.3499994985770727,0.08547008547008547,0.46905402878584856,1.0,18/76,12.55%,IL1B;PTPN22;BCL3;LAPTM5;SPI1;NFKBIA;EIF2AK2;PDCD4;EZR;TLR3;IFI35;RHOA;CPNE1;RPS3;CYLD;NLRP3;APP;TLR2
prerank,peptidyl-arginine modification (GO:0018195),0.6043317475835769,1.3495131324881107,0.12207357859531773,0.46951113140024947,1.0,3/15,5.92%,PADI1;KRTCAP2;PRMT8
prerank,transferrin transport (GO:0033572),-0.42542566357179423,-1.3492074337977034,0.06810035842293907,0.6765353455242958,1.0,13/33,13.44%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6AP1;ATP6V1D;TFRC;MCOLN1;ATP6V0D1;ATP6V0A1;ARHGAP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5376359043166132,1.3485709280523497,0.13233082706766916,0.4712151904297232,1.0,8/26,18.12%,FOXP1;CRY1;CRY2;CLOCK;CNOT2;STRN3;SIRT1;HDAC1
prerank,regulation of interferon-beta production (GO:0032648),0.47784751939707454,1.3485478304279888,0.10228802153432032,0.470480982049707,1.0,13/46,12.55%,LILRB1;OAS2;POLR3F;DHX58;REL;POLR3A;IFIH1;TIRAP;TRAF3;TLR3;IRF7;CACTIN;TLR2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4838235286719549,1.3484207633907148,0.09358288770053476,0.4700233544218057,1.0,15/49,14.55%,LYN;FLT3;CD40;JAK2;STAT3;IL6R;PARP14;IL6ST;IL6;PARP9;IL31RA;KIT;HCLS1;FGFR3;IL18
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.5412431541152849,1.3482829330278496,0.10307692307692308,0.4696044718219176,1.0,9/25,13.42%,CCDC88A;CBL;ARAP1;RBPJ;AFAP1L2;HIP1;RTN4;AKT1;PDE6H
prerank,cell-cell junction maintenance (GO:0045217),-0.5670998588954848,-1.3480816482935107,0.14108910891089108,0.6769616877834441,1.0,2/11,0.35%,CSF1R;TJP1
prerank,positive regulation of secretion by cell (GO:1903532),-0.35407619684663394,-1.3480514850918632,0.04,0.6733954337465923,1.0,13/70,5.38%,FRMD4A;IGF1;DTNBP1;TREM2;CADPS;PPIA;CD33;IL1A;ATP6AP1;CLASP2;RAB9A;ADAM8;P2RX4
prerank,chondrocyte differentiation (GO:0002062),0.5043423294716838,1.3479335248289048,0.12936046511627908,0.46972221885321785,1.0,5/32,4.20%,RUNX2;RUNX3;SULF2;BMPR2;SCX
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.495474666033639,1.3477357796725347,0.11517615176151762,0.4694488753414661,1.0,4/41,4.77%,ITPR1;PTPRC;PLCG2;IBTK
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.5837280925533096,-1.3476798499461031,0.1522248243559719,0.671244119447759,1.0,4/10,11.89%,COMT;SMOX;HNMT;ALDH7A1
prerank,postsynaptic membrane organization (GO:0001941),-0.49235671210830184,-1.3471891401579432,0.1189873417721519,0.6694297088174315,1.0,8/17,18.98%,APOE;NLGN1;DLG4;NRXN2;NLGN2;NLGN3;LHFPL4;NRXN1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.5658280673430033,1.3470362150780764,0.1238244514106583,0.4704401319485133,1.0,8/19,12.95%,KLF4;TAF9;IFIH1;CBFB;ELF1;PARP9;MAP2K5;LIFR
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.5350805856680917,-1.346660196047304,0.13144329896907217,0.6678929937840352,1.0,9/14,38.41%,ENTPD1;ENTPD5;NUDT16;ENTPD7;NUDT1;ENTPD3;ENTPD6;NUDT18;ENTPD2
prerank,fat cell differentiation (GO:0045444),0.46423318856001916,1.3457822664501573,0.08472400513478819,0.4727880154296998,1.0,5/57,1.99%,PID1;FFAR4;KLF4;PPARG;METRNL
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.48294043654624097,-1.345121542518601,0.12121212121212122,0.6694622093446118,1.0,11/17,32.20%,DERL2;HSP90B1;AUP1;NPLOC4;DERL1;HERPUD1;HM13;SEC61B;FAF2;TMEM129;SYVN1
prerank,mesoderm development (GO:0007498),0.5699580752368281,1.3436596660347389,0.15275590551181104,0.477384080609957,1.0,4/18,12.96%,HCK;JAK2;IKZF3;BTK
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3950844005829219,1.3429269824820034,0.01443298969072165,0.4785277746587318,1.0,32/308,6.36%,CCR2;CLEC9A;PLAC8;FGR;FFAR4;IL1B;TIAM1;ITGAX;SYK;JAK2;NFAM1;FOXJ1;CD36;PRKCH;BMPR2;MAD2L2;SORL1;NCOA3;GLIPR2;PTGER4;EIF2AK2;UCP2;SCX;B4GALT5;GDNF;RFX3;IL33;ADRA2A;IRF4;GLMN;TRIM16;PRKAB2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.5285168614030911,1.3423352621966358,0.12305516265912306,0.4792850273575849,1.0,5/26,4.80%,IL1B;RET;MCL1;HSPA1A;GDNF
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6033436067567001,1.3419141364718656,0.15091210613598674,0.479619328420376,1.0,5/14,17.23%,MALT1;TIRAP;TLR3;MAP3K7;TRAF2
prerank,cytoplasmic translational initiation (GO:0002183),-0.49390239053830515,-1.341880123140531,0.11748633879781421,0.6770605180684041,1.0,8/17,14.89%,EIF4A1;DENR;EIF2S2;DHX29;EIF3M;EIF5;EIF4G1;EIF4H
prerank,negative regulation of protein binding (GO:0032091),0.44934443302698,1.340891077314256,0.08333333333333333,0.4815521054744651,1.0,24/71,20.01%,ITGA4;LRRK2;IFIT2;SORL1;SLPI;MITD1;ATP2A3;CARD16;TMC8;PEX14;RALB;B2M;MAPK8;AKT1;ROCK1;IFIT1;AURKB;DISC1;TFIP11;PRKCD;PIN1;ACTB;STYX;PARK7
prerank,positive regulation of type I interferon production (GO:0032481),0.4489211644848973,1.3408781839552608,0.08958837772397095,0.4808218261102398,1.0,22/73,17.44%,PTPN22;OAS2;POLR3F;NFKB1;DHX58;POLR3A;MRE11;LRRFIP1;STAT1;IFIH1;DDX41;TLR3;IRF7;SETD2;PQBP1;TLR2;RELA;MYD88;CREBBP;TBK1;IRF5;HSPD1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.616279550271694,1.3408334951994523,0.13870967741935483,0.4801686723023371,1.0,3/13,4.70%,LRRK2;CHMP4A;CHMP4B
prerank,regulation of p38MAPK cascade (GO:1900744),0.4976929114157324,1.3402687966068847,0.12944523470839261,0.480912489296092,1.0,12/35,13.52%,IL1B;PTPN22;SPI1;EZR;PHLPP1;MINK1;RELL1;MAP3K4;CYLD;DUSP1;EMC10;NCF1
prerank,cartilage development (GO:0051216),0.4724657043631538,1.3397869085892131,0.11080711354309165,0.4813462162254332,1.0,5/49,4.20%,CD44;RUNX2;RUNX3;SULF2;SCX
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.39652733992210887,1.3397518203368408,0.01020408163265306,0.4806874293297691,1.0,80/348,15.77%,CD74;PID1;IL1B;FGF22;NGF;PTPN22;IFNGR1;PLCG2;KLF4;STAP1;RPL5;LILRB1;ITGAX;ITCH;ANXA2;MSN;FGF5;ATF7IP;PLSCR1;DTX3L;STAT3;HSPA1A;CD36;RNF207;LAPTM5;INPP5F;SCX;ATF2;RBPJ;IL33;MAPK14;AFDN;UBR5;WFS1;TADA3;SERPINB9;NFE2L2;MTPN;SETDB2;PDE2A;EZR;MBIP;EPHB2;CTCF;TLR3;IL6;SNF8;ID2;OLFM1;BRAF;TBC1D5;RPS3;ADAM19;FN1;PTPN1;PRKAG1;MED26;PRKAA1;MAP2K5;APP;TLR2;RPL11;MAPK8;ZPR1;EIF2AK3;AKT1;TLE1;TNRC6B;ROCK1;CITED2;TNRC6A;TGFB1;RAB29;MAZ;MAPK1;MYD88;OCLN;CELF1;PPHLN1;MED1
prerank,regulation of JNK cascade (GO:0046328),0.4349534970399036,1.3396498815255546,0.07962529274004684,0.4802204726152426,1.0,32/101,18.87%,IL1B;TRAF1;MARVELD3;MAP3K5;ITCH;AXIN1;TAOK3;TRAF4;HIPK2;TIRAP;PTK2B;TRAF3;PLCB1;PHLPP1;MBIP;MINK1;CYLD;RIPK1;FCGR2B;APP;SH3RF1;NCF1;HDAC3;GPS2;DUSP22;WNT7A;RASSF2;TRAF2;MMP8;SEMA3A;FZD7;PINK1
prerank,cellular response to lipid (GO:0071396),0.4105594743526955,1.3393146596971643,0.03862660944206009,0.48038960321406865,1.0,39/191,15.01%,PID1;IL1B;MAP4K1;LYN;TNIP3;STAP1;CREB1;LILRB1;RET;MSN;NFKB1;VIM;NCOA3;CXCL10;MAPK14;SETX;AHR;PTK2B;PDCD4;CARD16;IL6;NFKBIB;RHOA;GIT1;SBNO2;NR3C1;CACTIN;ACOD1;NLRP3;GNAI1;ADCY5;MAPK8;NRIP1;PDK3;TNFRSF1B;ADAM9;GSTP1;RELA;MYD88
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.513666836792768,-1.3388547942760503,0.11704834605597965,0.6847276253294416,1.0,8/15,39.20%,SMOX;PAOX;DDC;ASMT;SAT2;MOXD1;SRM;AANAT
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5149698748821222,-1.3385432980032488,0.15,0.6823947601503393,1.0,9/15,34.21%,ENTPD1;ENTPD5;AK1;ENTPD7;CMPK2;AK4;ENTPD3;ENTPD6;NME2
prerank,positive regulation of gene expression (GO:0010628),0.39247681912204246,1.3382339283380458,0.004048582995951417,0.48241801628286896,1.0,98/442,16.06%,CD74;CLEC9A;FGR;NIBAN1;PID1;IL1B;FGF22;NGF;PTPN22;IFNGR1;PLCG2;BCL3;KLF4;STAP1;RPL5;LILRB1;ITGAX;MSN;FGF5;PLSCR1;STAT3;VIM;HSPA1A;NFAM1;CD36;ERN1;MYO1C;TAF1A;RNF207;PTGER4;EIF2AK2;SCX;ATF2;RBPJ;IL33;ADRA2A;MAPK14;GLMN;SMARCA5;AFDN;UBR5;POLR1G;DEK;SETX;TADA3;SERPINB9;NFE2L2;DYRK1A;PDE2A;YTHDF3;EZR;MBIP;EPHB2;CTCF;TLR3;IL6;SNF8;RBM22;ID2;OLFM1;BRAF;RPS3;ADAM19;FN1;RIPK1;PRKAG1;MED26;PRKAA1;APP;TLR2;RPL11;MAPK8;ZPR1;HNRNPLL;EIF2AK3;AKT1;METTL3;TLE1;TNRC6B;AGPAT1;ROCK1;KAT2B;CITED2;LARP4B;TNRC6A;POLR1B;TGFB1;EIF3E;TENT4B;MAZ;MAPK1;MYD88;OCLN;THBS1;CELF1;MED1;RPS4X;RPS6KB1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.5214454080816807,1.3381100797729217,0.1287988422575977,0.48198673120621394,1.0,12/27,18.90%,LIMD1;STAT3;PUM2;IL6;RIPK1;EIF4ENIF1;TNRC6B;TGFB1;PUM1;AJUBA;DDX6;MAP2K1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4354528029419575,1.338059044039145,0.09612983770287141,0.4806278402539973,1.0,24/78,17.09%,CD74;AP1S3;RACGAP1;AP1S2;KIF23;RAB7A;AP2A2;CAPZB;ARF1;DCTN3;CAPZA1;PIKFYVE;KIF3B;AP1G1;AP2B1;FCGR2B;DYNC1H1;FCER1G;CANX;KIF5A;AP2S1;SEC24C;AP1M1;DYNC1I2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4354528029419575,1.338059044039145,0.09612983770287141,0.4806278402539973,1.0,24/78,17.09%,CD74;AP1S3;RACGAP1;AP1S2;KIF23;RAB7A;AP2A2;CAPZB;ARF1;DCTN3;CAPZA1;PIKFYVE;KIF3B;AP1G1;AP2B1;FCGR2B;DYNC1H1;FCER1G;CANX;KIF5A;AP2S1;SEC24C;AP1M1;DYNC1I2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3701986073631296,-1.3378024289531223,0.06818181818181818,0.6815018778962204,1.0,21/59,19.97%,PTPRM;CD84;CADM1;ROBO2;ROBO1;CNTN4;PLXNB2;HMCN1;PTPRT;SDK1;PVR;NECTIN4;IGSF11;KIRREL3;CNTN6;PLXNB3;PALLD;NECTIN2;NEXN;CELSR2;CDH4
prerank,Golgi localization (GO:0051645),0.6278100886655213,1.3376953643357494,0.15780730897009967,0.48081692423951733,1.0,4/11,10.92%,UVRAG;CDC42;ARHGAP21;YWHAZ
prerank,membrane repolarization during action potential (GO:0086011),0.610686684969068,1.3370798648650684,0.16264090177133655,0.48162464933432164,1.0,2/13,3.32%,KCNE3;KCNQ1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.45421341118830905,-1.3364097917129176,0.12121212121212122,0.6830439681393006,1.0,7/22,11.82%,APOE;CAMSAP1;MAP2;MAP1B;MAP1A;CHRNA7;CAMSAP2
prerank,positive regulation of cell differentiation (GO:0045597),0.4030887780799667,1.3357560610136685,0.03488372093023256,0.48432678353826325,1.0,39/237,10.64%,FFAR4;IL1B;RUNX2;RIN2;TIAM1;NGF;RAP1A;CREB1;PPARG;NFKB1;CD36;PRKCH;RPS6KA3;BMPR2;RAPGEF2;CTNNA1;RIPOR2;GLIPR2;IL6R;CDC42;GDNF;BTG1;LMO3;MAPK14;WDFY2;PLCB1;MAPK12;ACVR2A;IL6ST;IL6;HGF;RHOA;CPNE1;ID2;CREBL2;OLFM1;SMAD4;NUDT21;CCDC71L
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5601377037850477,1.335377985499012,0.13302034428794993,0.484543474838233,1.0,3/20,4.30%,PID1;PPP2R5A;PICALM
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.49571253891246736,1.3341813512908063,0.13342696629213482,0.4868621642001854,1.0,6/38,3.17%,IL1B;CD47;KLF4;JAK2;CD36;PTGIS
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5419503990479984,1.33390670467405,0.1337386018237082,0.48679916708105414,1.0,3/24,4.30%,PID1;PPP2R5A;PICALM
prerank,aerobic respiration (GO:0009060),-0.4693444420148749,-1.3326783285154982,0.12702702702702703,0.6928585954575568,1.0,12/20,25.96%,UQCRC2;ME3;SDHB;OXA1L;SLC25A14;NDUFS7;MTFR1L;ATP5F1D;UQCR10;UQCRC1;NDUFS8;SURF1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.5767190989478248,1.3325310770157393,0.1362179487179487,0.48958962833898734,1.0,4/16,8.27%,ST8SIA4;ST8SIA1;ST8SIA6;ST6GALNAC3
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6387026484526129,1.332460564704626,0.1624790619765494,0.48901447025781875,1.0,1/10,0.22%,LRRK2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6228137187016071,1.3323880734410043,0.1447587354409318,0.48843491434744984,1.0,4/13,6.67%,ITGA4;AKT3;ADAM17;PDPK1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6235467227954045,1.3323579464714561,0.16576576576576577,0.48774596860126446,1.0,2/10,2.59%,PRKCE;NEDD4L
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5806576345784261,1.3312398332372568,0.1500815660685155,0.4898099214012852,1.0,7/16,18.49%,LRRK2;GBF1;PPP1R15A;TAPT1;VAPA;HSPA5;UBAC2
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.4590053246731725,-1.331231212922783,0.12857142857142856,0.6941875938870459,1.0,1/22,0.16%,LGMN
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.43235455370943804,1.3310305181950741,0.08146399055489964,0.4896120870814236,1.0,18/94,11.13%,ITPR1;STK24;MAP3K5;MCL1;CUL3;ERN1;CUL5;ATP2A3;BBC3;HIPK2;CRIP1;ATP2A1;PPP1R15A;MSH6;GSKIP;CASP2;APAF1;AIFM1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.5803227709883289,-1.3305713478664047,0.14349775784753363,0.6930474886353521,1.0,2/10,2.10%,DLGAP1;DLGAP4
prerank,regulation of phospholipase C activity (GO:1900274),-0.4931841871007259,-1.3302601748362997,0.15128205128205127,0.6906052912863121,1.0,4/15,7.17%,FLT1;NTRK3;FGF2;PLCG1
prerank,DNA replication (GO:0006260),0.4274225514811458,1.3301624900930489,0.07300115874855156,0.49108266205114537,1.0,33/105,18.20%,DNA2;BAZ1A;RBBP8;POLL;CDC45;MRE11;FEN1;FAM111A;KAT7;ORC5;MCM6;RBMS1;POLD4;WRN;ORC4;BRIP1;RECQL5;NAP1L1;RPA3;POLA2;MCM2;PCLAF;RNASEH2A;DONSON;MCMBP;ORC6;MCM9;POLG2;POLB;HUS1;POLD1;ORC2;RAD17
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6049553982981636,1.329809735356703,0.14795918367346939,0.49125488823814695,1.0,5/13,5.43%,PPARG;LDLR;SYK;CD36;ITGB2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.337893565349044,-1.3297708435467288,0.04678362573099415,0.6888436850825463,1.0,29/84,14.15%,QKI;SON;DDX5;SRSF3;SFSWAP;RBFOX1;RNPS1;RBFOX2;SRPK1;KHDRBS3;SRSF7;TIA1;TRA2A;SRRM4;JMJD6;FXR1;NOVA1;RBFOX3;RBM5;THRAP3;RBM3;FXR2;NOVA2;PTBP1;RBM25;SNW1;SRPK2;KHDRBS2;WTAP
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4417485665126044,-1.329359934373819,0.10461538461538461,0.6868871664053576,1.0,8/25,16.72%,CACNB2;CAPN3;ANK2;PLCG1;TRPC1;AKAP6;CX3CL1;CEMIP
prerank,protein catabolic process (GO:0030163),-0.3583386454678805,-1.3286762107870729,0.05327868852459016,0.6858010353220391,1.0,8/59,8.37%,PRKN;CTSD;APOE;CAPN3;LAMP2;TPP1;IDE;UCHL3
prerank,regulation of microtubule-based movement (GO:0060632),-0.5553576627684842,-1.3285610404200259,0.15763546798029557,0.6828618999922249,1.0,8/11,27.24%,MAP2;TTC21B;LAMP1;NEFH;HDAC6;IGBP1;CFAP298;HAP1
prerank,copper ion homeostasis (GO:0055070),0.5719257750861021,1.328122003767555,0.15639810426540285,0.4948622330648307,1.0,8/17,16.54%,PRNP;ARF1;ATP7A;ATOX1;APP;CUTC;XIAP;SLC31A1
prerank,regulation of cytoplasmic transport (GO:1903649),0.6315144097482057,1.3274447591780831,0.16666666666666666,0.49583750908464985,1.0,1/11,0.22%,LRRK2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.488985402063527,-1.3274041905061191,0.13043478260869565,0.6836758318176434,1.0,8/17,19.78%,NRP1;ROBO1;FGF2;SLIT2;VEGFA;GPLD1;EFNB2;PIK3R3
prerank,intracellular pH reduction (GO:0051452),-0.4239098574184099,-1.3273506248410625,0.08013937282229965,0.6805675678950446,1.0,14/33,16.13%,ATP6V1C1;ATP6V0B;SLC11A1;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;DMXL2;ATP6V0D1;ATP6V0A1;CLCN3;GPR89B;GPR89A
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.40077072305247985,1.3269003717540453,0.02854122621564482,0.4964568910928449,1.0,60/234,15.86%,CARD11;IL1B;TRAF1;PLCG2;IL18RAP;CAMK1D;PPARG;CD40;NFKB1;STAT3;HSPA1A;NFAM1;TRIM26;CD36;PRKCH;MALT1;NFKBIA;EIF2AK2;IKBKB;TRIM62;ATF2;RAB7B;HIPK2;RPS6KA5;TIRAP;PTEN;UBE2N;BUD31;CIB1;MTPN;TRIM25;CLOCK;CARD16;IL6;NFKBIB;PIDD1;RPS3;NLRC4;RIPK1;TRIM14;RNF31;TAB3;NLRP3;MAP3K7;APP;TLR2;BTK;KIT;AKT1;HCLS1;LPAR5;CRTC3;IL18;MAP3K13;RELA;MYD88;TAF1;DVL2;LRP8;IRAK3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4290746641880298,1.326788885598809,0.07441860465116279,0.49597459372225766,1.0,25/108,11.91%,NGF;DAPK1;NGFR;MAP3K5;PPARG;SYK;JAK2;LAPTM5;MALT1;ATP2A3;DLC1;BBC3;MTCH1;HIP1;PIDD1;RPS3;NLRC4;CASP2;FIS1;APAF1;RIPK1;GRAMD4;AIFM1;NLRP3;REST
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4499639420442462,1.3263005168481794,0.10090556274256145,0.4965279020517323,1.0,23/66,16.33%,KLF4;PSME3;ANKRD17;PTPN6;PSME2;CCND3;PTEN;CDKN2C;CCND1;ADAM17;PLCB1;ID2;ANXA1;DCUN1D3;CCND2;AKT1;WEE1;KMT2E;INO80;APC;BRD7;RBL2;RB1
prerank,regulation of aerobic respiration (GO:1903715),0.5964848889309204,1.3261380539293093,0.14106583072100312,0.4962020812138742,1.0,6/15,18.87%,CBFA2T3;ATP7A;ABCD1;VCP;COX7A2;PINK1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4978414255984256,1.3259124742324637,0.14102564102564102,0.4960306102694721,1.0,12/33,14.81%,GLI1;PLCG2;ANKRD17;CCND3;CCND1;ADAM17;PLCB1;ANXA1;CCND2;AKT1;EZH2;KMT2E
prerank,negative regulation of cellular protein localization (GO:1903828),0.499280500196212,1.325399461331136,0.12893982808022922,0.49659343125007577,1.0,13/34,19.02%,NEDD4L;CTNNA1;RIPOR2;SPI1;PICALM;LATS1;LATS2;TAX1BP3;ILRUN;SNX33;GOPC;LZTFL1;ANKRD13A
prerank,regulation of neuron migration (GO:2001222),0.5351292513438384,1.3253250422922596,0.14456035767511177,0.4960495054975413,1.0,5/26,3.13%,SRGAP2;NTNG2;SHTN1;NIPBL;RAPGEF2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4732801278412258,1.3251953481059282,0.11633986928104575,0.49564175152164613,1.0,9/51,8.54%,LRRK2;SRGAP2;NGF;PAK1;SHTN1;TAOK3;SNX1;ATP7A;MINK1
prerank,activation of phospholipase C activity (GO:0007202),-0.41966484829788836,-1.324594547242197,0.13069908814589665,0.6871212933692186,1.0,8/29,8.90%,P2RY12;NTRK2;GNA15;CD86;PLCG1;HTR2B;C5AR1;P2RY6
prerank,polyol biosynthetic process (GO:0046173),0.5720535196731342,1.3240983329294707,0.15673981191222572,0.49760158279689326,1.0,4/16,7.80%,ITPKC;ACER3;IP6K3;CYP27A1
prerank,purine-containing compound catabolic process (GO:0072523),0.6119408357293721,1.3234860516683806,0.13866231647634583,0.49843436854873946,1.0,2/13,2.70%,GDA;GPX1
prerank,positive regulation of TOR signaling (GO:0032008),-0.400074387128658,-1.322780478657847,0.08664259927797834,0.6900839866390505,1.0,14/40,15.24%,TREM2;RPTOR;FLCN;GAS6;FNIP1;GPR137B;KLHL22;LARS1;MIOS;NCKAP1L;LAMTOR5;SEC13;PIH1D1;RRAGC
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5361855855062877,-1.3224005432650665,0.13043478260869565,0.6847768670372266,1.0,5/12,12.80%,IGF1;SPPL3;CAMTA1;AKAP6;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5361855855062877,-1.3224005432650665,0.13043478260869565,0.6847768670372266,1.0,5/12,12.80%,IGF1;SPPL3;CAMTA1;AKAP6;PTBP1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5196184193715347,1.3222873830930935,0.12917933130699089,0.5007647048645462,1.0,3/27,2.59%,FXYD5;UTRN;NEDD4L
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4059252958296172,-1.3219692137906003,0.10033444816053512,0.6829434280189863,1.0,9/32,16.72%,CAPN3;P2RX7;P2RX4;PLCG1;TRPC1;AKAP6;TRPC3;CX3CL1;CEMIP
prerank,cardiolipin metabolic process (GO:0032048),-0.5278199320702893,-1.3216482085552184,0.14824120603015076,0.6807949226842128,1.0,6/13,13.51%,PNPLA8;SLC27A1;PLA2G4A;HADHB;TAMM41;HADHA
prerank,RNA interference (GO:0016246),-0.505558026204499,-1.32033744356174,0.1402439024390244,0.6819139459151673,1.0,6/17,18.03%,AGO3;TSN;AGO1;DHX9;TSNAX;DROSHA
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.36362235180747415,-1.3198335051839727,0.04807692307692308,0.6803013596454587,1.0,22/59,32.02%,ACACA;OSBPL1A;CH25H;ELOVL4;HOGA1;CBR4;HSD17B8;PER2;LIPH;ABCD3;MLYCD;OSBPL6;AMACR;OXSM;OSBPL7;NDUFAB1;ACOT8;OSBP;ALDH1A2;SLC27A2;OSBPL2;HSD17B10
prerank,regulation of mast cell activation (GO:0033003),0.6295945006302961,1.3196222960442818,0.15424610051993068,0.5070390796240015,1.0,3/10,2.34%,CD226;LYN;PLSCR1
prerank,regulation of apoptotic process (GO:0042981),0.3827761394640741,1.3189524897888376,0.006,0.5080503685236478,1.0,168/676,17.56%,CD74;CD44;VAV3;FFAR4;GRK5;TIAM1;ARHGEF18;HCK;NOTCH2;CAPN13;NGF;FLT3;BCL3;DAPK1;LILRB1;NGFR;SLK;MAP3K5;MCL1;ITCH;BCL6;PIM1;TIAM2;NFKB1;STK17B;JAK2;HSPA1A;RPS6KA3;IFIT2;PHLDA1;SOS2;BIRC6;CXCL10;MALT1;TAF9;PTPN6;NAA16;NFKBIA;MRE11;CBL;BCL2L14;SCX;IKBKB;DPEP1;ATF6;RYBP;GDNF;BIRC3;BCAR1;STAT1;FGD4;DDX42;FAF1;ARF4;DFFA;STK4;SETX;WFS1;PTK2B;LGALS1;ANXA4;ZFAND6;SERPINB9;FLNA;WRN;IKZF3;CIB1;PAK2;PAWR;MTCH1;TNFAIP8;SAP18;RARG;TOX3;AVEN;PHLPP1;FGD1;FGD3;IL6ST;DUSP6;SOS1;IL6;HGF;LATS1;NAA15;ING3;OLFM1;HIP1;BRAF;ANKLE2;PIDD1;ARHGEF6;RPS3;RTN4;NLRC4;UBE2Z;DAXX;ANXA1;IL31RA;CASP2;CALHM2;APAF1;USP42;RIPK1;YWHAZ;DSTYK;AIFM1;NET1;LATS2;FOXO3;DCUN1D3;PRKAA1;REST;RPS6KA1;HTT;PSMD10;HYPK;SH3RF1;MAP3K20;CLIP3;AREL1;DNM1L;NF2;HSPA9;ERCC3;MAPK8;CCND2;PRELID1;AKT1;DHCR24;API5;ARHGEF3;PRKAA2;DNAJC3;YME1L1;CITED2;RPS6KA2;HDAC3;VCP;GSTP1;RELA;MYD88;CASP6;CREBBP;XIAP;RNF122;PRDX5;THBS1;LRP8;MED1;TRIM35;APC;PROC;RPS6KB1;USP47;DAPK3;PPT1;IRF5;HTATIP2;SEMA4D;PSEN1;NIBAN2;RASSF2;TRAF2;SIRT1;HSPD1;BAG3;PLAUR
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.48974876916651094,1.3188376285593706,0.1323529411764706,0.5075982697572987,1.0,12/39,17.15%,ITPKC;PIP4K2A;TTC7A;PIK3C2A;IP6K3;PI4K2B;PIP4K2B;PIK3CA;SMG1;EFR3A;PI4K2A;PIK3R2
prerank,positive regulation of protein secretion (GO:0050714),-0.35123000997991494,-1.3182087382104426,0.05319148936170213,0.6826427962268586,1.0,24/69,21.31%,FRMD4A;IGF1;TREM2;WLS;PPIA;CD33;IL1A;ADAM8;TLR4;SOX4;NLGN2;TGFB2;MYOM1;BMP6;LRRC8A;APBB1;IER3IP1;APBB3;EXOC1;CAPN10;TCF7L2;ANG;MYH10;PPID
prerank,axonal transport (GO:0098930),-0.4125917871801019,-1.3178330614558542,0.11,0.6807959585958655,1.0,7/36,5.26%,DST;DTNBP1;TMEM108;KIF1B;KIF1A;AP3M2;HIF1A
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.4513339868881335,-1.3177479830827226,0.1323943661971831,0.6778648240547336,1.0,11/22,31.13%,GTF2H2;GTF2H1;UBC;ERCC2;GTF2H3;GTF2H5;UBA52;XPC;GTF2H4;DDB1;CHD1L
prerank,calcium ion homeostasis (GO:0055074),0.42775915355232497,1.3177049392721731,0.09219858156028368,0.5099426836609176,1.0,16/95,12.61%,CCR2;CD40;CCR1;NPTN;SLC8B1;ATP2B1;ATP2A3;STIM2;WFS1;ATP2A1;SLC30A1;DMPK;TMEM203;SLC10A7;ATP13A3;SLC24A4
prerank,myeloid leukocyte differentiation (GO:0002573),0.45316856005968853,1.3176024550091352,0.11096938775510204,0.5094413160052146,1.0,10/65,6.72%,CBFA2T3;FOXP1;RARA;PPARG;SPI1;MYH9;CDC42;MAPK14;DEK;EFNA2
prerank,positive regulation of innate immune response (GO:0045089),0.504040844395763,1.3174102276750503,0.12181303116147309,0.5091874748851333,1.0,6/30,9.23%,POLR3F;PLSCR1;SPI1;TRIM62;IFI35;SLC15A4
prerank,regulation of myeloid cell differentiation (GO:0045637),0.44984325205751563,1.3168151457332493,0.10240202275600506,0.5099140356780223,1.0,25/62,20.68%,NFE2;LYN;SPI1;H3-3A;KMT2C;PTK2B;CBFB;PURB;RBM15;LGALS3;HSPA9;TNRC6B;KAT2B;TNRC6A;KMT2E;KMT2A;CREBBP;THBS1;FES;ASH2L;HDAC1;HOXA9;WDR5;RUNX1;ZBTB16
prerank,cell cycle G1/S phase transition (GO:0044843),0.45051835327646483,1.3166844868727712,0.1116751269035533,0.5095279401260184,1.0,11/61,9.45%,GPR132;CUL3;CUL5;EIF4EBP1;CRLF3;CDKN2C;CCND1;CCNH;CACUL1;LATS1;TRIM71
prerank,positive regulation of phosphorylation (GO:0042327),0.39590542200965284,1.3164413267193564,0.03397027600849257,0.5094027624186378,1.0,52/240,14.35%,CD74;NIBAN1;LRRK2;IL1B;LYN;FGF22;FLT3;PECAM1;RET;LMTK2;CD40;PAK1;FGF5;NPTN;ZBTB20;MRE11;AXIN1;CCND3;VEGFC;PRXL2C;GLMN;CCND1;STK4;WDFY2;ADAM17;CIB1;ENG;RAC1;EPHB2;ACVR2A;HGF;RALB;PGF;CAMKK2;DAXX;RIPK1;DSTYK;PRKAA1;DVL3;APP;BTBD10;PFKFB3;CLIP3;CCND2;KIT;AKT1;LIMK2;PRKAA2;HDAC3;FGFR3;TGFB1;PFKFB4
prerank,negative regulation of T cell activation (GO:0050868),0.48967763689063426,1.3162878577355472,0.13807531380753138,0.509023026113455,1.0,6/35,5.83%,PTPN22;LILRB1;LAPTM5;RIPOR2;SPN;GLMN
prerank,C4-dicarboxylate transport (GO:0015740),0.5828311406010378,1.315782937906012,0.16323024054982818,0.5095782718855817,1.0,5/14,11.50%,LRRC8D;SLC25A13;SLC25A30;SLC25A12;SLC25A18
prerank,positive regulation of kinase activity (GO:0033674),0.4256648323021696,1.3157446957469972,0.07110091743119266,0.5089245405839946,1.0,18/107,11.10%,CD74;PTPRC;IQGAP1;FLT3;RAP1A;RET;LMTK2;PRKAG2;RAPGEF2;MRE11;TRAF4;PTK2B;EPHB2;CACUL1;DAXX;SNX9;DSTYK;PRKAG1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5613983861280125,1.3153811805901068,0.15916398713826366,0.5091698920034764,1.0,5/18,15.63%,SAMHD1;DERA;FUCA1;STT3B;BPGM
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5573329041721072,-1.3146789259065566,0.14742014742014742,0.6857325029953288,1.0,3/11,6.94%,PRKN;HIF1A;ATF4
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6415670548553283,1.3145866228149516,0.1736111111111111,0.5104193601856455,1.0,3/10,8.62%,PTPN22;TIRAP;IFI35
prerank,chromatin assembly or disassembly (GO:0006333),0.6229815739830584,1.3141030426173372,0.16555183946488294,0.510950129318335,1.0,2/11,5.32%,CHAF1A;RBBP4
prerank,superoxide metabolic process (GO:0006801),0.5105093154172683,1.314011703072657,0.1346704871060172,0.5104333844798953,1.0,7/29,13.52%,CYBB;ATP7A;NOX1;CYB5R4;NRROS;NCF2;NCF1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.44612439243146035,1.313754146518097,0.1090458488228005,0.5103728901073594,1.0,29/73,22.07%,NGF;NGFR;PPARG;JAK2;LAPTM5;ATP2A3;DLC1;BBC3;MTCH1;HIP1;PIDD1;NLRC4;CASP2;APAF1;RIPK1;AIFM1;EIF2AK3;VCP;CASP12;TRAF2;HSPD1;BAD;MUL1;XDH;ANP32B;DIABLO;BID;CASP9;SENP1
prerank,histone ubiquitination (GO:0016574),0.5382657453768246,1.313746560981477,0.1648177496038035,0.5096344186502952,1.0,6/21,7.94%,DTX3L;UBE2E1;WAC;RNF20;UBE2N;UBR2
prerank,protein O-linked mannosylation (GO:0035269),-0.4742726345535982,-1.3134269291906464,0.13089005235602094,0.6866299355215891,1.0,10/18,31.58%,LARGE1;RXYLT1;POMT1;DPM2;FKRP;DPM3;TMTC1;DPM1;POMT2;SDF2L1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.49961287913805297,1.3133489679589982,0.14825581395348839,0.5100052651592711,1.0,11/33,13.52%,CCDC88A;CBL;FBXW7;ARAP1;ADRA2A;ADAM17;AFAP1L2;HIP1;AKT1;PDE6H;NCF1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5528332086370016,1.313181706932966,0.17034700315457413,0.5096973985225167,1.0,5/17,13.22%,IL1B;SORL1;ADRA2A;PRKAA1;AKT1
prerank,myelin assembly (GO:0032288),-0.576342821270132,-1.3125911821248417,0.15035799522673032,0.6863306833222284,1.0,7/10,29.15%,TENM4;CD9;EPB41L3;TPPP;CNTNAP1;NCMAP;ABCA2
prerank,canonical glycolysis (GO:0061621),-0.44249608144846264,-1.3121215792888345,0.1130952380952381,0.6818255831246808,1.0,9/24,21.01%,HK3;HK1;PFKL;PGK1;PFKP;ENO2;PGAM1;PFKM;ENO3
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.44249608144846264,-1.3121215792888345,0.1130952380952381,0.6818255831246808,1.0,9/24,21.01%,HK3;HK1;PFKL;PGK1;PFKP;ENO2;PGAM1;PFKM;ENO3
prerank,cellular response to ketone (GO:1901655),0.493785394007613,1.3120001435756443,0.13943661971830987,0.5121961178328577,1.0,12/35,13.31%,MAP4K1;MSN;PTGER2;PTGER4;AHR;GNB1;NR3C1;ACOD1;GNAI1;ADCY5;KLF9;GNG2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3871072720144001,1.3117459095266562,0.028747433264887063,0.5121611517328194,1.0,87/336,16.42%,VAV3;FOXP1;UVRAG;LYN;SAMHD1;BCL3;DTL;MCL1;BCL6;PAK1;DTX3L;POLI;NIPBL;BTG2;RBBP8;MAPKAPK2;CHRNA4;TAF9;USP3;MRE11;FEN1;CRY1;FAM111A;SUMO1;PARP4;ATF2;TAOK3;WAC;MAPK14;UBR5;CCND1;GRB2;SETX;SETD7;CRIP1;CEP63;WRN;GNL1;MBD4;CIB1;USP45;MSH3;MAPK12;NABP1;DOT1L;PSME4;BACH1;PPP1R15A;MSH6;PIDD1;TLK2;TANK;IRF7;FANCC;RPS3;FANCL;CASP2;KMT5B;RECQL5;SUSD6;NUPR2;RAD54L;SPIDR;ERCC3;PCLAF;ERCC4;METTL3;FANCA;TNFRSF1B;SIRT4;VCP;XRCC2;BRSK1;VCPIP1;XIAP;TAF1;DYRK2;INO80;ENDOV;MCM9;APC;POLB;INIP;USP47;NSMCE4A;UBA6;HUS1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.4886203196410051,1.3114996541561486,0.1377840909090909,0.5120710362014766,1.0,16/38,18.92%,PTPRC;NEDD9;ACE;PRNP;PTPN1;UNC119;APP;SH3BP5;CASS4;MVP;LRP8;RELN;EFNA1;LILRA5;FCGR1A;NCK2
prerank,microtubule polymerization (GO:0046785),-0.42958834228193943,-1.3106963678217267,0.10397553516819572,0.683502943702634,1.0,11/28,20.55%,TUBGCP5;FGF13;CLASP2;CKAP5;GOLGA2;CCDC57;TRPV4;TPPP;TUBGCP6;NDEL1;TUBGCP2
prerank,aorta development (GO:0035904),-0.5043484119860887,-1.310516041846733,0.1590909090909091,0.6809164457114755,1.0,4/14,3.43%,LRP1;ROBO2;ROBO1;PKD2
prerank,muscle organ development (GO:0007517),-0.36515751213439757,-1.3100050661907758,0.07391304347826087,0.6796238686916014,1.0,10/54,8.52%,LARGE1;IGF1;MEF2C;SGCE;CAPN3;MRAS;MKX;FXR1;POU6F1;SPEG
prerank,nucleosome organization (GO:0034728),0.4599003970283377,1.3094499359634006,0.1196236559139785,0.5164645544396331,1.0,19/55,18.42%,NFE2;CHAF1A;H3-3A;SMARCA5;CTCF;ACTR6;SMARCE1;DAXX;ARID2;SETD2;NAP1L1;ATRX;SRCAP;SMARCC2;RSF1;INO80;BPTF;SMARCD3;BRD2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5915713251209945,1.3091929216814913,0.1602787456445993,0.5164235190417716,1.0,2/14,1.14%,IL1B;PAEP
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6294686514474426,1.309136445795721,0.17870036101083034,0.5158194703512052,1.0,2/10,5.29%,SP100;HIPK2
prerank,central nervous system development (GO:0007417),-0.2904373494963095,-1.3091318036584352,0.0,0.6796666178460108,1.0,66/250,17.03%,PRKN;ZFHX3;ATXN1;TGFBR2;CX3CR1;WWP1;CHD7;MARCKS;C1QA;ADAM23;ROBO2;PKD2;TPP1;CNTN4;PLXNB2;SMO;MTF1;NF1;APOD;NFIB;AFF2;SPOCK1;CAPG;RAB3GAP1;GRIK1;DCX;JRKL;CDK5R1;NCOA6;POU6F1;SH3GL2;TBC1D23;AATK;LOXL3;ZFHX2;PTPRZ1;CDK5;UFC1;SHROOM2;PHF8;EPHA7;DHX30;SERPINI1;MEIS3;ROGDI;EIF2B5;SOX4;UFM1;C3;SETD1A;ADGRL3;RNF103;NPAS2;TAGLN3;POU3F3;TPPP;ADGRL2;PAFAH1B2;CNTNAP2;CNTN6;ADGRG1;SCYL2;PHGDH;IER3IP1;SOX11;HAPLN2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.43358597422277423,1.308955381680709,0.11627906976744186,0.5155800076324402,1.0,25/67,18.36%,CYBB;PSME3;CD36;IKBKB;PSMB7;PSME2;TAP1;PSME4;PSMB8;NCF2;PSMD9;PSMA5;B2M;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;NCF1;SNAP23;PSMD12;CYBA;PDIA3;FCGR1A;TAPBP
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.4134421344061423,-1.3089193324385369,0.10526315789473684,0.6773205710856176,1.0,9/31,10.01%,OPHN1;PARD3B;MYO9A;RAP2A;LRRC7;DLG2;SCRIB;MTCL1;PARD3
prerank,body fluid secretion (GO:0007589),-0.5004095514402518,-1.3083281362981456,0.14814814814814814,0.6762446634114626,1.0,4/15,15.96%,ERBB4;VEGFA;SLC22A4;GPAT4
prerank,regulation of intracellular pH (GO:0051453),0.49960661784753707,1.3071340837576753,0.14266117969821673,0.5195474238567415,1.0,5/34,7.87%,LRRK2;SLC9A7;SLC4A7;SLC4A8;NOX1
prerank,DNA packaging (GO:0006323),0.5834188555957652,1.3066437853321098,0.16396103896103897,0.5201046418610685,1.0,4/16,11.13%,CHAF1A;RBBP4;KAT6A;AIFM1
prerank,response to cadmium ion (GO:0046686),0.5181017110039356,1.305663167333817,0.14739884393063585,0.5219800503885648,1.0,8/26,14.99%,FOS;SUMO1;HAAO;DAXX;MAPK8;AKT1;NCF1;MAPK1
prerank,activin receptor signaling pathway (GO:0032924),-0.49427160374394963,-1.305432218470771,0.1641025641025641,0.6833102268911412,1.0,5/15,17.12%,TGFBR1;ACVR1;ACVR2B;SMAD3;ACVR1B
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5313273817282629,1.3052124446517324,0.14618973561430793,0.5224099820927097,1.0,5/23,6.73%,FYN;DIAPH1;PRNP;PTK2B;CACNB1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6113433996738059,1.3049185869647337,0.1783876500857633,0.52239235431677,1.0,4/11,8.69%,PAK1;BCAR1;RAC1;HGF
prerank,regulation of protein secretion (GO:0050708),0.40805219099979106,1.3036923633408921,0.07954545454545454,0.5249169911309125,1.0,15/119,8.68%,DPP4;ITPR1;IL1B;RAP1A;DNAJC1;CACNA1A;SLC8B1;GOLPH3L;CD2AP;RFX3;ADRA2A;TMED10;CLOCK;EZR;IL6
prerank,cellular response to oxidative stress (GO:0034599),0.4146358074484897,1.3035783659647435,0.08089887640449438,0.5244879779915501,1.0,29/118,15.38%,LRRK2;CYBB;DAPK1;LONP1;HSPA1A;FOS;GPX1;GSR;PRDX6;VRK2;SETX;NFE2L2;PXN;MGAT3;FANCC;CAMKK2;RPS3;NCF2;FOXO3;ERMP1;PRKAA1;MAPK8;AKT1;NCF1;PRKAA2;PNPT1;GSTP1;MAPK1;PRDX5
prerank,regulation of cell-substrate adhesion (GO:0010810),0.47271319846747706,1.3027206435839636,0.13414634146341464,0.5259378018598855,1.0,9/42,8.98%,NDNF;PTPRO;JAK2;RAC2;RSU1;RAC1;MINK1;ATXN3;RHOA
prerank,response to leucine (GO:0043201),-0.5649305621813135,-1.3024374912322523,0.1976470588235294,0.6877103443562324,1.0,5/10,8.36%,RPTOR;KLHL22;SESN3;LARS1;UBR1
prerank,cellular response to leucine (GO:0071233),-0.5649305621813135,-1.3024374912322523,0.1976470588235294,0.6877103443562324,1.0,5/10,8.36%,RPTOR;KLHL22;SESN3;LARS1;UBR1
prerank,vascular transport (GO:0010232),-0.32564268539262103,-1.3022889600030285,0.05263157894736842,0.6852307198800132,1.0,17/81,12.84%,SLCO2B1;SLC24A3;LRP1;ABCC3;SLC1A3;ABCG2;SLC7A1;ATP8A1;SLC2A3;SLC27A1;ATP1A2;TFRC;SLC22A5;SLC7A2;SLC7A8;SLC29A1;SLC15A2
prerank,positive regulation of blood coagulation (GO:0030194),0.5467881909058168,1.3019546200466827,0.17061611374407584,0.5271351897419287,1.0,1/17,0.58%,ST3GAL4
prerank,presynaptic endocytosis (GO:0140238),-0.4375148886310759,-1.3018469684468823,0.13761467889908258,0.6837145066056914,1.0,7/24,16.08%,OPHN1;SYT1;NLGN1;CDK5;STX1A;NLGN2;NLGN3
prerank,regulation of protein kinase activity (GO:0045859),0.41871929278888376,1.3015961490072772,0.09278350515463918,0.5273830607874455,1.0,29/106,17.63%,FGR;PTPRC;IQGAP1;UVRAG;RAP1A;PRKAG2;RAPGEF2;TRAF4;PRKRIP1;PTK2B;PDPK1;PAK2;CACUL1;CAMKK2;GSKIP;DAXX;SNX9;DBNDD2;PRKAG1;TAF7;MAP2K3;AKT1;GSTP1;SPRED1;RELN;RB1;RASSF2;SIRT1;TAB1
prerank,prostaglandin metabolic process (GO:0006693),0.5078168914970802,1.3015250226392288,0.17780938833570412,0.5268192324191199,1.0,2/26,3.17%,CD74;PTGIS
prerank,regulation of protein kinase C signaling (GO:0090036),0.589401220001417,1.3010224930252803,0.17580645161290323,0.5273325282375506,1.0,2/14,1.74%,DGKG;CD40
prerank,dendrite self-avoidance (GO:0070593),0.5688064514717482,1.3010207885361873,0.17038216560509553,0.5265831081689794,1.0,3/16,6.72%,EMB;NPTN;IGSF9
prerank,calcium ion transmembrane transport (GO:0070588),-0.34118555080378316,-1.3008285129750705,0.055900621118012424,0.6843532260178711,1.0,27/86,16.20%,CACNA1D;SLC8A1;RYR3;SLC24A3;GAS6;CACNA2D1;TRPV2;TRPM3;PKD2;CACNA1C;ATP2A2;TRPC4;P2RX7;P2RX4;AFG3L2;TRPC1;MCOLN1;MCOLN3;ATP2B3;TRPC7;TRPM2;SPG7;TRPV4;TRPC3;STOML2;ATP2C1;MCOLN2
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4383661232102485,1.3007153096902424,0.11779448621553884,0.5266801820755078,1.0,17/66,14.30%,LRRK2;FLT3;MAP3K5;CD40;PAK1;TAOK3;ADRA2A;PIK3R6;DIRAS1;MAP3K4;RPS3;DVL3;MAP3K7;PDGFD;KIT;EZH2;TGFB1
prerank,positive regulation of protein metabolic process (GO:0051247),0.4170873260568019,1.3004984172831817,0.1053864168618267,0.5265237495340351,1.0,33/110,16.93%,IL1B;PAEP;KLF4;DTL;ITCH;ASB5;NEDD4L;SORL1;NFKBIA;GPC3;AXIN1;RAB7A;TIPARP;WFS1;MTPN;STX5;SNF8;WWP2;CSNK2A1;MAP2K5;APP;AREL1;MAPK8;AKT1;VCP;TGFB1;IL18;SLC6A9;APC;RNF41;HACE1;WNT7A;PSEN1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4189915447193875,1.300180126492241,0.11072261072261072,0.526596616337417,1.0,23/100,13.15%,CBFA2T3;LRRK2;XPO1;HSPA1A;TAF9;ANKIB1;SUMO1;RYBP;ARIH1;WAC;GLMN;RNF217;HECTD1;ELOB;COP1;ARIH2;TLK2;CAMLG;SUMO2;RCHY1;PSMD10;RPL11;PABIR1
prerank,negative regulation of nervous system development (GO:0051961),0.5577429756921511,1.2994374105886215,0.16507936507936508,0.527763964859937,1.0,6/17,12.55%,IL1B;SORL1;IL6;B2M;REST;TLR2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4885637991330469,-1.29874060072926,0.16184971098265896,0.6882614785096373,1.0,9/16,30.29%,AUTS2;ARHGAP24;RASGRF1;PIK3CG;ALS2;GABARAP;KBTBD7;CADM4;PIK3CB
prerank,cellular response to UV-A (GO:0071492),0.6179695240553655,1.2987228856430602,0.1952054794520548,0.5288927893751505,1.0,2/11,4.65%,MMP1;CERS1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.46888838534267,-1.2984565281850735,0.16620498614958448,0.6861159827839092,1.0,6/18,13.59%,TENM4;PTN;NF1;DAAM2;PTPRZ1;MDK
prerank,regulation of hippo signaling (GO:0035330),0.5478845135426587,1.2981803678154968,0.16802610114192496,0.5295331124360572,1.0,7/17,13.48%,MOB3B;LIMD1;MAPK14;NEK8;MAP2K3;NF2;MARK3
prerank,regulation of establishment of planar polarity (GO:0090175),0.42039029343216744,1.2981443707193385,0.09815950920245399,0.5288891323708305,1.0,29/88,19.89%,TIAM1;PSME3;CELSR1;PSMB7;CDC42;PSME2;AP2A2;PSME4;RAC1;RHOA;PSMB8;PSMD9;PSMA5;PSMB3;AP2B1;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;DVL2;AP2S1;PSMD12;WNT7A;VANGL1;SMURF2;FZD7;FZD3;PSMF1
prerank,glucose transmembrane transport (GO:1904659),-0.47155881269521704,-1.297622100230037,0.12885154061624648,0.6861764770119557,1.0,8/18,32.59%,SORT1;SLC2A3;SLC2A9;SLC2A5;RAB4B;SLC2A8;PPARD;SLC45A1
prerank,actin filament bundle organization (GO:0061572),0.49232407365910197,1.2966923192609607,0.155049786628734,0.5321254959499901,1.0,5/33,7.93%,NEDD9;LCP1;EPS8;PAWR;EZR
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.5115131768437434,1.2965883821262287,0.16248153618906944,0.5316701802060497,1.0,3/26,2.67%,IL1B;KLF4;CD36
prerank,regulation of protein neddylation (GO:2000434),0.6303283808452105,1.2962952797910308,0.1704745166959578,0.5317770546103324,1.0,4/10,12.95%,RPL5;DCUN1D1;DCUN1D3;RPL11
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.4288568646144456,-1.2958381551469529,0.11641791044776119,0.6895170140578304,1.0,9/25,21.01%,HK3;HK1;PFKL;PGK1;PFKP;ENO2;PGAM1;PFKM;ENO3
prerank,protein export from nucleus (GO:0006611),0.511886847809395,1.2955839674162015,0.15766423357664233,0.5328725716424831,1.0,5/27,5.80%,XPO1;DUSP16;XPO5;XPO6;XPO4
prerank,presynapse assembly (GO:0099054),-0.48097737295827425,-1.295532638581578,0.16326530612244897,0.6877734279061044,1.0,5/16,3.58%,PTPRD;IL1RAPL1;NLGN1;PCLO;LRRTM3
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4690081061403584,1.2955285705772794,0.13678618857901725,0.532275848890011,1.0,15/48,15.86%,PTPRC;SAMHD1;STAP1;PPARG;PARP14;YTHDF3;CARD16;IL6;CACTIN;OTUD4;STAT2;METTL3;GPS2;GSTP1;IRAK3
prerank,heme biosynthetic process (GO:0006783),-0.45104750372310753,-1.2952366500379586,0.14942528735632185,0.6859254301335466,1.0,13/22,32.51%,ABCG2;FLVCR1;FECH;ALAS1;CPOX;COX10;FXN;SLC25A38;PGRMC1;ABCB10;HMBS;UROD;ATP5IF1
prerank,cotranslational protein targeting to membrane (GO:0006613),0.42352450151868715,1.2940807020642584,0.11229314420803782,0.5355391286300697,1.0,43/91,24.66%,RPL5;RPS10;RPL37A;RPL6;RPS18;RPS14;TRAM1;RPL35A;RPL13;SEC63;RPS3;RPS21;SRP72;SRP19;RPLP0;RPL34;RPL19;RPL11;RPL30;RPL4;RPS2;RPL7;RPS15A;RPS4X;RPL32;RPSA;RPS13;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;RPL10A;RPS25;RPL9;RPS16;SSR2;RPL23;RPL17;RPL37;RPL36
prerank,energy reserve metabolic process (GO:0006112),0.5598793544554085,1.2938122288573863,0.17567567567567569,0.5354661251230123,1.0,3/19,9.06%,PID1;PRKAG2;UGP2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.470981716368677,1.2937796372834984,0.16049382716049382,0.5348085529587271,1.0,17/41,18.24%,NEDD9;ACE;STAP1;FYN;FBXW7;ADRA2A;PRNP;ADAM17;PTPN1;UNC119;CASS4;NCF1;LRP8;RELN;EFNA1;LILRA5;FCGR1A
prerank,intracellular sterol transport (GO:0032366),-0.5227863745017027,-1.2935591424752821,0.16030534351145037,0.6886026176435149,1.0,4/13,12.88%,ABCA1;ARV1;SERAC1;NPC1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.4244285000592948,1.2933699206132658,0.1103030303030303,0.5351390226834697,1.0,14/83,9.45%,GPR132;CUL3;CUL5;EIF4EBP1;CRLF3;CDC45;CDK14;CDKN2C;CCND1;CCNH;CACUL1;BACH1;LATS1;TRIM71
prerank,negative regulation of defense response (GO:0031348),0.4297515235525132,1.2933251666125831,0.10362047440699126,0.5345197513951816,1.0,9/77,4.33%,FFAR4;KLF4;PPARG;ITCH;METRNL;DHX58;PTGIS;PTGER4;SMPDL3B
prerank,regulation of nervous system process (GO:0031644),-0.47379586533570994,-1.2932710186008687,0.15363128491620112,0.6866653608306508,1.0,5/18,13.32%,DLGAP1;DLGAP4;TMEM108;CHRNA7;HTR2C
prerank,cellular response to chemical stress (GO:0062197),0.41577487454158135,1.2924111626034303,0.11290322580645161,0.5362356828818411,1.0,24/96,15.38%,LRRK2;CYBB;LONP1;HSPA1A;GPX1;GSR;PRDX6;LRRC8D;VRK2;SETX;NFE2L2;NOX1;MGAT3;FANCC;NCF2;PIK3CA;FOXO3;ERMP1;PRKAA1;NCF1;PRKAA2;PNPT1;GSTP1;PRDX5
prerank,positive regulation of cyclase activity (GO:0031281),-0.5007643617510555,-1.29217511984871,0.14357682619647355,0.6876627212872295,1.0,3/14,4.20%,CACNA1D;CACNA1C;NF1
prerank,cellular component maintenance (GO:0043954),0.5755814431208622,1.2918571833972157,0.16923076923076924,0.536975799767943,1.0,7/12,20.07%,FYN;CLDN1;PRNP;ITGA3;INSR;MTMR2;SUPV3L1
prerank,heart looping (GO:0001947),-0.378085527927417,-1.2916884706238148,0.11387900355871886,0.6863433827480192,1.0,4/39,3.96%,TGFBR2;MEF2C;PKD2;SMO
prerank,mRNA catabolic process (GO:0006402),0.454790565379434,1.2914909286014888,0.13692946058091288,0.5372365995347365,1.0,14/44,14.63%,ZC3H12D;HSPA1A;ERN1;RC3H1;XRN2;DCP2;LSM5;ZFP36L2;DHX34;TUT7;METTL3;RNH1;PNPT1;MRTO4
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.5582230273443214,1.2913557777051141,0.16833333333333333,0.5368575328766576,1.0,4/15,11.91%,ZFP36L2;NR3C1;ANXA1;REST
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.6167995092240622,1.2911943784603188,0.18840579710144928,0.5365414150251074,1.0,3/10,21.18%,GNB1;PDE6B;SAG
prerank,positive regulation of interleukin-4 production (GO:0032753),0.5619587085147378,1.2902814750396536,0.18670886075949367,0.5383003975373017,1.0,5/17,13.62%,RARA;SYK;IRF4;NLRP3;FCER1G
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.5148391822786929,1.2892316545807643,0.16071428571428573,0.5404537114833929,1.0,3/25,2.67%,IL1B;KLF4;CD36
prerank,prostaglandin biosynthetic process (GO:0001516),0.550485872775186,1.2892292897103323,0.196513470681458,0.5397188740166001,1.0,2/18,3.17%,CD74;PTGIS
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5447980692651136,1.2891059757800618,0.1634920634920635,0.5393184801336802,1.0,5/18,9.68%,LILRB1;LILRB3;FBXW7;TLR3;FBN1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4600876814165096,1.2888059960057527,0.14360313315926893,0.5393454134130415,1.0,8/47,7.70%,SIK1;FYN;NFKB1;RAPGEF2;PTGIS;CRY1;FBXW7;ERLIN1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5474091830027927,1.2887580804095737,0.1752411575562701,0.5387228951330099,1.0,5/17,11.83%,PTPRC;PPP1R12A;CD300A;PPP1R15A;PPP1R15B
prerank,synaptic membrane adhesion (GO:0099560),-0.5089993524097747,-1.288484805711196,0.16535433070866143,0.6944264735572326,1.0,6/14,23.96%,PTPRD;GPC6;SLITRK1;PTPRF;GPC4;SLITRK3
prerank,protein localization to Golgi apparatus (GO:0034067),0.5022081176756982,1.2881624672643508,0.1774891774891775,0.5395788914395483,1.0,8/27,13.34%,SORL1;RAB6A;GCC2;TMED10;PAQR3;GBF1;VPS13A;GBP5
prerank,extracellular structure organization (GO:0043062),0.39313879909049243,1.2878777999928037,0.06458557588805167,0.5395536587074783,1.0,28/204,10.27%,ITGB7;ITGA4;ITGAL;CD44;CD47;PECAM1;ITGAE;ITGAX;TNC;NDNF;COL5A2;MMP1;LAMB1;ITGAD;ITGB2;HSPG2;TEX14;F11R;ATP7A;ADAMTS6;TGFBI;PXDN;ACAN;ICAM1;FBN1;ADAM19;NCAN;FN1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5458880900019756,1.287862986809897,0.1781874039938556,0.5388627575656295,1.0,8/18,17.75%,AKT3;PIK3C2A;CIB1;HDAC9;ANXA1;MAP3K3;JCAD;HDAC7
prerank,long-term synaptic potentiation (GO:0060291),0.5237606438420008,1.2867664497731766,0.16869300911854104,0.5411274823396287,1.0,4/21,12.58%,CRHR2;NPTN;PTK2B;RGS14
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.47210435497142705,1.2856291105061957,0.144,0.5435255956002206,1.0,2/40,0.24%,LRRK2;PID1
prerank,negative regulation of phagocytosis (GO:0050765),0.5529758474093999,1.2853944749895665,0.1841680129240711,0.543422063007202,1.0,7/17,12.61%,CD47;PLSCR1;CD300A;DYSF;FCGR2B;TLR2;SNX3
prerank,determination of heart left/right asymmetry (GO:0061371),-0.374525507232465,-1.2852389857345659,0.1033210332103321,0.7025760361657215,1.0,4/42,3.96%,TGFBR2;MEF2C;PKD2;SMO
prerank,potassium ion homeostasis (GO:0055075),-0.42995791156718194,-1.284932214971933,0.1276595744680851,0.7007286810765856,1.0,5/23,7.58%,KCNMA1;ATP1B3;KCNJ2;ATP1B1;ATP1A2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5629914664353242,1.2844177428106538,0.17147435897435898,0.545201122089378,1.0,3/16,5.35%,ACE;BMPR2;PRCP
prerank,neuron differentiation (GO:0030182),-0.3031779397189612,-1.2841469951913136,0.038461538461538464,0.7004596599520735,1.0,32/165,15.07%,OPHN1;ATP8A2;MEF2C;LRP6;PTPRD;WNK1;TGFBR1;NTRK2;IL1RAPL1;TENM4;ERCC6;CTNNB1;TENM2;ATP2B2;SPOCK1;LDB1;EPHA5;NRBP2;RYK;CDK5R1;MYO7A;CDK5;SNPH;CASP3;VEGFA;ITM2C;SOX4;ERCC2;TGFB2;MANF;HS6ST1;TENM1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.40975413140355804,1.2833934340152813,0.10325476992143659,0.547165622994831,1.0,28/119,13.14%,PLCG2;ITPKC;PIP4K2A;TTC7A;PIK3C2A;IP6K3;MTMR14;INPP5F;OCRL;PI4K2B;PTEN;MTMR3;INPP4A;IMPA1;PIK3R6;PLEKHA2;ARF1;MTMR4;SYNJ1;PITPNM1;PIKFYVE;PIGF;PIP4K2B;PIK3CA;CDIPT;PIK3R4;SMG1;PIP5K1A
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5708977186738334,1.2828166876838278,0.18325434439178515,0.5479672101544487,1.0,1/13,0.22%,LRRK2
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5231685135861225,-1.2827626816598616,0.18159806295399517,0.7022168984263625,1.0,2/12,1.64%,BIN1;SERPINE2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.4489965764392201,-1.2827211956170663,0.16991643454038996,0.6995322878005377,1.0,4/20,6.59%,APOE;NLGN1;CAMK1;CAPRIN2
prerank,external encapsulating structure organization (GO:0045229),0.3914288530834855,1.2823559203202517,0.07327586206896551,0.5484611362809015,1.0,27/205,10.27%,ITGB7;ITGA4;ITGAL;CD44;CD47;PECAM1;ITGAE;ITGAX;TNC;NDNF;COL5A2;MMP1;LAMB1;ITGAD;ITGB2;HSPG2;F11R;ATP7A;ADAMTS6;TGFBI;PXDN;ACAN;ICAM1;FBN1;ADAM19;NCAN;FN1
prerank,alpha-amino acid metabolic process (GO:1901605),0.4585189728233616,1.2822386681856166,0.1675603217158177,0.5480317712043222,1.0,12/45,17.48%,KMO;DPEP1;SLC25A13;ATP7A;KYAT1;SLC25A12;MTRR;GLUD1;ASS1;SRR;PYCR2;DDAH1
prerank,positive regulation of protein catabolic process (GO:0045732),0.42491563814994987,1.282166000756645,0.1409313725490196,0.5475069305057004,1.0,28/84,16.01%,IL1B;DTL;ITCH;MSN;ASB5;NEDD4L;SORL1;GPC3;AXIN1;ADRA2A;RAB7A;PTTG1IP;FAF1;TIPARP;EZR;STX5;SNF8;WWP2;CSNK2A1;SNX9;AREL1;TNFRSF1B;VCP;ADAM9;SNX33;APC;RNF41;HACE1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5201699100121888,1.2820405327114832,0.17397881996974282,0.5471242398613555,1.0,7/24,14.30%,IL1B;SULF2;NOX1;IL6ST;IL6;EIF2AK3;TGFB1
prerank,synaptic vesicle recycling (GO:0036465),-0.4098806387131157,-1.2820356024469952,0.12837837837837837,0.6991981531219639,1.0,9/31,18.78%,OPHN1;SYT1;NLGN1;SYT7;CDK5;STX1A;NLGN2;NLGN3;RAB3A
prerank,mRNA polyadenylation (GO:0006378),0.5036588643613052,1.2819746910086072,0.17404129793510326,0.5458446287355031,1.0,15/26,19.48%,SSU72;FIP1L1;TUT1;SCAF8;TENT2;PAPOLG;MTPAP;APP;PNPT1;TENT4B;CPSF3;PAPOLA;PABPC1;CSTF3;WDR33
prerank,RNA polyadenylation (GO:0043631),0.5036588643613052,1.2819746910086072,0.17404129793510326,0.5458446287355031,1.0,15/26,19.48%,SSU72;FIP1L1;TUT1;SCAF8;TENT2;PAPOLG;MTPAP;APP;PNPT1;TENT4B;CPSF3;PAPOLA;PABPC1;CSTF3;WDR33
prerank,MAPK cascade (GO:0000165),0.37927234407991356,1.2813433755562125,0.042355371900826444,0.546739242888943,1.0,69/295,15.34%,LRRK2;IL1B;RASGRP4;FGF22;FLT3;FYN;RET;MAP3K5;MAP3K8;PSME3;PAK1;NFKB1;FGF5;NRG2;JAK2;KL;CUL3;RAPGEF2;MAPKAPK2;RASA3;PTGER4;PTPN7;IKBKB;PSMB7;PSME2;GDNF;TAOK3;IL2RG;FBXW11;GRB2;SETX;SHOC2;CSF2RB;MAPK12;PAQR3;PSME4;MINK1;DUSP6;ZFP36L2;SOS1;HGF;BRAF;ABHD17B;PSMB8;CAMKK2;PSMD9;PSMA5;MBP;IL31RA;PIK3CA;PRKG2;PSMB3;PSMD6;PSMC4;MAP3K7;PSMD10;PPP1CB;MAP3K20;PSMB1;MAPK8;KIT;MARK3;FGFR3;TGFB1;IL18;MAPK1;FRS2;SPRED1;RASGEF1A
prerank,regulation of dopamine secretion (GO:0014059),-0.42956623840191854,-1.2813103557002348,0.13142857142857142,0.6986966686924503,1.0,6/25,9.15%,PRKN;DTNBP1;SYT1;SYT9;SYT7;KCNA2
prerank,positive regulation of immunoglobulin production (GO:0002639),0.486656458229346,1.2808355397099855,0.14553314121037464,0.5474194877236859,1.0,6/31,11.22%,PTPRC;MAD2L2;EPHB2;IL6;KMT5B;GPI
prerank,retinoic acid metabolic process (GO:0042573),-0.49227774987443496,-1.2808321805909482,0.15223097112860892,0.6974411576796281,1.0,11/14,50.80%,BCO2;SCPEP1;ALDH1A2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1
prerank,eye photoreceptor cell development (GO:0042462),-0.4853314438711483,-1.2802174031186067,0.18848167539267016,0.6966213106763337,1.0,3/15,20.31%,MYO7A;VEGFA;CEP290
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.5603641361960243,1.2800441417293391,0.17467948717948717,0.54882084279435,1.0,3/15,2.87%,NFKB1;CD36;PRKCH
prerank,regulation of blood circulation (GO:1903522),0.4830557572518356,1.279790683505077,0.16407355021216408,0.5487731912981277,1.0,5/34,11.04%,ACE2;ACE;KCNQ1;CELF2;DMPK
prerank,defense response to Gram-positive bacterium (GO:0050830),0.47802160947811634,1.2797192139695652,0.16806722689075632,0.5482210990420512,1.0,9/40,15.01%,FGR;TIRAP;ADAM17;IL6;MBL2;RNASE6;TLR2;GBP2;MYD88
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.555404919277104,1.2796721227922618,0.20806451612903226,0.5476200895077077,1.0,4/16,9.45%,ZC3H12D;RC3H1;ZFP36L2;TRIM71
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5093138198016627,1.279615171271916,0.17507418397626112,0.5470378960987538,1.0,8/25,14.26%,LONP1;CUL3;KLHL15;ATXN3;UBE2W;FBXL17;YME1L1;VCP
prerank,V(D)J recombination (GO:0033151),-0.5518483572885922,-1.2795993256448188,0.18414322250639387,0.695787943873756,1.0,6/11,20.28%,HMGB1;DCAF1;HMGB2;LIG3;LIG1;TCF3
prerank,positive regulation of cellular metabolic process (GO:0031325),0.415218049806565,1.2791479708445377,0.13163972286374134,0.5476065152300644,1.0,26/98,17.19%,PID1;IFNLR1;ACE2;KLF4;PPARG;ANXA2;NFKBIA;INPP5F;MAPK14;GRB2;IFNAR1;TBC1D5;DHRS4;RIPK1;ACOD1;SLCO1C1;PRELID1;AKT1;AGPAT1;TGFB1;RAB29;THBS1;RNF41;INSR;WNT7A;CHCHD2
prerank,positive regulation of cell motility (GO:2000147),0.38579727072149544,1.2786082105889383,0.07340425531914893,0.5483123035786573,1.0,27/205,8.69%,FGR;IL1B;NEDD9;TIAM1;TCAF2;PECAM1;ITGAX;RET;CCR1;PAK1;SEMA4A;STAT3;CLDN1;MYO1C;LAMB1;CBLL1;PPP3CA;CARMIL1;ADRA2A;BCAR1;CXCL16;PTK2B;ADAM17;CIB1;ARHGEF39;EPHB2;HGF
prerank,cellular senescence (GO:0090398),0.5053716771694521,1.278531367100798,0.16691729323308271,0.5477842687499918,1.0,11/27,19.66%,SPI1;MAPK14;KAT6A;ID2;ECRG4;SIRT1;SMC6;PRKCD;SMC5;MAP2K1;TERF2
prerank,negative regulation of cytokine production (GO:0001818),0.39387453803367933,1.277238203957805,0.07819383259911894,0.5505362888220746,1.0,35/163,12.08%,FFAR4;PTPRC;RARA;PTPN22;BCL3;KLF4;LILRB1;ITCH;FOXJ1;DHX58;LAPTM5;NPTN;PTPN6;PTGER4;ATP2B1;NLRX1;SRGN;IFIH1;RPS6KA5;PRNP;ANXA4;PDCD4;TRIM25;EZR;RAC1;HDAC9;IL6;FN1;ANXA1;CYLD;ADCY7;CACTIN;ACOD1;FCGR2B;MAP2K5
prerank,response to interleukin-6 (GO:0070741),0.6148596994643135,1.277145350529593,0.20898100172711573,0.5500777469947037,1.0,3/10,3.17%,PID1;NFKB1;PTGIS
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.5670964829088423,-1.2764469452401537,0.17857142857142858,0.703730829800946,1.0,3/10,14.26%,CACNB2;CACNA2D1;CALM1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5424938543984875,1.2764305410852361,0.1761006289308176,0.5512087744617287,1.0,9/20,16.93%,NGFR;NFKB1;ADAM17;SPPL2A;MBTPS1;TGFB1;ADAM9;RELA;PSEN1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.45258848292205855,1.2763424753658001,0.15657894736842104,0.5507256264686703,1.0,20/48,19.49%,AKT3;CD40;STAT5A;PIK3C2A;MAPK14;ADAM17;PDPK1;CIB1;HDAC9;ANXA1;MAP2K3;AKT1;TGFB1;THBS1;MAP3K3;SIRT1;JCAD;HDAC7;TMSB4X;FGFR1
prerank,protein heterooligomerization (GO:0051291),-0.47041744322917745,-1.2760375347168,0.15760869565217392,0.7023323949438923,1.0,8/17,22.23%,PKD2;MAT2A;CPSF6;CBR4;HSD17B8;TMEM120A;FARSA;GRIN2B
prerank,receptor recycling (GO:0001881),0.6223742217227494,1.2758625919336122,0.20203735144312393,0.5512946252790155,1.0,2/10,3.49%,LMTK2;SORL1
prerank,tRNA wobble uridine modification (GO:0002098),-0.49203554409655653,-1.2758619902560635,0.18205128205128204,0.7001265556188258,1.0,10/14,38.77%,ALKBH8;TRMU;ELP1;MTO1;GTPBP3;TRMT9B;CTU2;CTU1;MOCS3;KTI12
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3935070663808411,1.275295232722497,0.09681093394077449,0.5521146850218535,1.0,36/136,17.25%,SP100;SIK1;KLF4;ITCH;PIM1;FOXJ1;MAD2L2;PTGIS;ERBIN;SPI1;NFKBIA;SUMO1;NFKBIE;PRNP;WFS1;ANXA4;FLNA;TRAF3;PEX14;WWP2;ID2;CYLD;CACTIN;ACOD1;NLRP3;MAP2K5;PSMD10;ZNF431;USP7;TNFRSF4;TAF1;BHLHE40;IRAK3;RB1;PROX1;SIRT1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5321405808926435,-1.2752297747253076,0.17824074074074073,0.6993988437566535,1.0,2/11,4.96%,CD34;LGALS9
prerank,positive regulation of DNA replication (GO:0045740),0.552373945890367,1.274796728380365,0.184640522875817,0.552658146292631,1.0,4/16,5.76%,DNA2;GLI1;KAT7;FAF1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3989868525777615,1.2747802645027893,0.10569105691056911,0.5519772484928692,1.0,40/124,19.89%,TIAM1;PSME3;CELSR1;CCDC88C;PSMB7;CDC42;PSME2;PPP3CA;AP2A2;PLCB1;PSME4;RAC1;GNB1;RHOA;PSMB8;PSMD9;PSMA5;NLK;PSMB3;AP2B1;PSMD6;PSMC4;DVL3;MAP3K7;PSMD10;PDE6B;PSMB1;GNG2;TNRC6B;TNRC6A;DVL2;AP2S1;PSMD12;WNT7A;VANGL1;SMURF2;FZD7;FZD9;FZD3;PSMF1
prerank,organelle fusion (GO:0048284),-0.44760842378856874,-1.274680289225059,0.1440677966101695,0.6984021884005697,1.0,8/22,15.58%,AFG3L2;GDAP1;MFF;MIGA2;SPG7;USP30;BAX;MFN1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5064874616680104,1.27467092486633,0.18126888217522658,0.551565342125518,1.0,8/26,12.55%,TREML4;PTPN22;TIRAP;TLR3;IFI35;SLC15A4;RTN4;TLR2
prerank,actin filament polymerization (GO:0030041),0.5014050562087264,1.2739760853695548,0.17196531791907516,0.5525994464997488,1.0,7/29,11.51%,PSTPIP1;JAK2;PSTPIP2;MSRB1;DIAPH1;RAC1;TTC17
prerank,regulation of erythrocyte differentiation (GO:0045646),0.4749407097666326,1.273926490571209,0.17236467236467237,0.5519914977428066,1.0,10/35,12.93%,LYN;STAT3;HSPA1A;SPI1;STAT5B;STAT1;MAPK14;ACVR2A;FOXO3;HSPA9
prerank,histone mRNA catabolic process (GO:0071044),0.538393019287788,1.2736626941218034,0.20100502512562815,0.5519693902855444,1.0,7/15,14.89%,DCP2;TUT1;ERI1;TENT2;MTPAP;TUT7;TENT4B
prerank,regulation of endocytic recycling (GO:2001135),0.6026718917088523,1.2734811710443226,0.19630872483221476,0.5517476564683031,1.0,3/11,4.34%,SORL1;INPP5F;EHD2
prerank,activation of GTPase activity (GO:0090630),0.41732250872980986,1.2734715351333954,0.11952662721893491,0.5510590191447041,1.0,18/89,9.65%,RAP1GAP2;TIAM1;TBC1D1;TBC1D8;TIAM2;CCDC125;SIPA1L3;FOXJ1;TBC1D9;USP6NL;TBC1D10C;TBC1D2B;BCR;TBC1D8B;RABGAP1L;RABGAP1;BCAS3;TBC1D5
prerank,positive regulation of interleukin-13 production (GO:0032736),0.609530660885148,1.2734512189797798,0.19269102990033224,0.5504032114656774,1.0,2/10,5.53%,RARA;IRF4
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5027572219383477,1.2734291296640863,0.1815519765739385,0.5497516903782442,1.0,7/26,12.20%,ALPK1;ITCH;IFIH1;UBE2N;CYLD;TAB3;MAP3K7
prerank,organonitrogen compound catabolic process (GO:1901565),-0.35115829300367246,-1.2733234609152506,0.11162790697674418,0.7001054917902458,1.0,18/57,14.75%,NPL;LTA4H;CAPN3;RENBP;AMDHD2;NAGK;PLA2G15;TPP1;ENPP2;PNPLA8;PLA2G4A;IDE;UCHL3;TRHDE;TXN2;RIDA;SGPL1;PDXDC1
prerank,positive regulation of protein acetylation (GO:1901985),-0.5296591634648941,-1.272890246042495,0.19082125603864733,0.6987595709110043,1.0,7/12,22.07%,DIP2B;CAMK1;TERF2IP;DDX3X;FAM161A;RAPGEF3;DIP2A
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.5436747306756499,-1.2728753743650532,0.18225419664268586,0.696128861780083,1.0,1/10,0.23%,DNMT3A
prerank,protein localization to lysosome (GO:0061462),0.48987366770532775,1.272794374251507,0.18992805755395684,0.5506587955608614,1.0,8/28,12.51%,LAPTM5;SORL1;RAB7A;GCC2;RTN4;SCARB2;LMBRD1;SH3BP4
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4194786841062108,1.2725336522938306,0.13059250302297462,0.5506540452382362,1.0,20/87,15.54%,CD44;FGF22;NDNF;FGF5;KL;GTF2F2;POLR2C;CBL;GRB2;SETX;SHOC2;ZFP36L2;TRIM71;DSTYK;FLRT1;FGFR3;MAPK1;FRS2;SPRED1;NCBP1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3878554773819232,1.2721198026568101,0.10307017543859649,0.5510327094897854,1.0,45/151,18.38%,CD44;RUNX2;IQGAP1;RAP1A;KLF4;NDNF;ERN1;BMPR2;RAPGEF2;MAPKAPK2;STAT5B;PTPN12;BCAR1;MAPK14;SETX;PDPK1;CIB1;PDE2A;ACVR2A;ZFP36L2;HGF;SMAD4;NR3C1;ANXA1;DSTYK;MAP2K5;MAP2K3;ADAMTS12;ZPR1;AKT1;KIDINS220;TGFB1;EHD1;RELA;STMN2;MED1;DUSP22;RPS6KB1;WNT7A;RAB35;KNSTRN;NR4A1;FOXC1;APPL1;SYAP1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.533901114844469,1.2719640925488946,0.1996904024767802,0.5507178220048133,1.0,4/18,5.28%,LYN;FPR1;FPR3;BCAR1
prerank,negative regulation of apoptotic process (GO:0043066),0.37187315614169547,1.2717288699923568,0.021233569261880688,0.5506629665869973,1.0,111/444,17.56%,CD74;CD44;FFAR4;GRK5;HCK;NOTCH2;CAPN13;NGF;BCL3;KLF4;NGFR;MCL1;ITCH;NDNF;PIM1;NFKB1;HSPA1A;GPX1;PRKCH;RPS6KA3;BIRC6;MALT1;TAF9;NAA16;NFKBIA;MRE11;CBL;SCX;IKBKB;DPEP1;GDNF;BIRC3;RNF213;ARF4;DFFA;SETX;WFS1;PTK2B;ANXA4;ZFAND6;SERPINB9;FLNA;CIB1;PAK2;TNFAIP8;TOX3;AVEN;CARD16;IL6ST;IL6;HGF;NAA15;BRAF;ANKLE2;CSNK2A2;CSNK2A1;PIDD1;UBE2Z;ANXA1;IL31RA;CASP2;PIK3CA;RIPK1;YWHAZ;DSTYK;PRKAA1;RPS6KA1;MAP2K5;PSMD10;HYPK;SH3RF1;AREL1;HSPA9;MAPK8;CCND2;PRELID1;AKT1;DHCR24;TLE1;API5;HCLS1;PRKAA2;DNAJC3;YME1L1;CITED2;HDAC3;GSTP1;UNC5B;RELA;MAZ;MAPK1;MYD88;XIAP;PRDX5;THBS1;ITGA5;MED1;PROC;RPS6KB1;USP47;RB1;PPT1;MAEA;HTATIP2;SEMA4D;PSEN1;NIBAN2;SIRT1;HSPD1;BAG3;PLAUR
prerank,mRNA destabilization (GO:0061157),0.4676419143549689,1.2716852784374184,0.16096866096866097,0.5500610046804432,1.0,12/38,15.93%,ZC3H12D;MEX3D;RC3H1;GIGYF2;YTHDF3;ZFP36L2;TRIM71;TUT7;METTL3;ROCK1;CELF1;PUM1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6001505846668248,1.2714218921485565,0.2037037037037037,0.5499853764398767,1.0,4/10,11.01%,MALT1;NFKBIZ;RC3H1;NFKBID
prerank,ventricular septum development (GO:0003281),-0.3911202393768807,-1.2712605848861067,0.13620071684587814,0.6990187911866182,1.0,12/37,14.08%,TGFBR2;SALL1;TGFBR1;ROBO2;ROBO1;SMAD7;MATR3;ACVR1;SLIT2;SLIT3;SOX4;TGFB2
prerank,cellular sodium ion homeostasis (GO:0006883),-0.47938028829623913,-1.2708902794991697,0.1595744680851064,0.6976384820724363,1.0,4/15,7.58%,SLC8A1;ATP1B3;ATP1B1;ATP1A2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5579214307381332,1.2706149319693054,0.19440124416796267,0.5514746017725134,1.0,8/15,22.06%,SAMHD1;YTHDF3;CACTIN;STAT2;METTL3;TTLL12;MUL1;PTPN2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.40939582736134883,1.2705879500756259,0.1140861466821886,0.5508432759744384,1.0,52/110,23.89%,RPL5;RPS10;RPL37A;RPL6;RPS18;HELZ2;RPS14;RPL35A;PPP2R2A;MAGOHB;RPL13;ETF1;DHX34;RPS3;RPS21;UPF2;DCP1A;RPLP0;RPL34;SMG1;RPL19;RPL11;RPL30;RPL4;RPS2;RPL7;EIF3E;RPS15A;NCBP1;RPS4X;PABPC1;SMG6;GSPT1;RPL32;RPSA;RPS13;UPF3B;RPS6;RPL18A;RPS27;RPLP2;UPF3A;RPL22;RPS7;RPS12;PPP2CA;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,protein-containing complex subunit organization (GO:0043933),0.40851475931401976,1.2704333703782686,0.11435239206534423,0.5505361537186501,1.0,24/109,16.23%,CD74;TRAF1;WIPF1;CD40;SKAP2;PICALM;CD2AP;PTK2B;ELOB;NUP98;PEX14;CAPZA1;FANCC;SNX9;TEAD1;DNM1L;FANCA;CLDN14;KMT2A;OCLN;SLC2A1;CREBBP;APC;SEH1L
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5211937034717605,1.270054988678832,0.19111111111111112,0.5501442831689136,1.0,8/21,16.57%,IL1B;MCL1;HSPA1A;GDNF;MAP2K5;AKT1;UNC5B;EYA3
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5211937034717605,1.270054988678832,0.19111111111111112,0.5501442831689136,1.0,8/21,16.57%,IL1B;MCL1;HSPA1A;GDNF;MAP2K5;AKT1;UNC5B;EYA3
prerank,Rac protein signal transduction (GO:0016601),0.538105508473984,1.269427827784166,0.20657276995305165,0.5510928717087945,1.0,7/18,16.01%,TIAM1;EPS8;RAC2;RAC1;RHOG;ELMO1;HACE1
prerank,protein O-linked glycosylation (GO:0006493),0.4084254414396672,1.269333683852422,0.12662721893491125,0.5506309684490405,1.0,8/96,4.22%,ST3GAL1;ST3GAL4;MUC3B;MUC3A;TET2;GXYLT1;ST8SIA6;B4GALT5
prerank,GTP metabolic process (GO:0046039),0.5552908610241103,1.2691888110955687,0.1890625,0.5502994675780026,1.0,1/15,0.22%,LRRK2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4709443195190059,1.2685886353646383,0.1786703601108033,0.5511923605918086,1.0,15/37,20.01%,RPL5;TAF9;RYBP;WAC;HIPK2;CSNK2A2;CSNK2A1;TLK2;CAMLG;RPL11;USP7;TAF1;EIF3H;N4BP1;PARK7
prerank,response to interleukin-1 (GO:0070555),0.42701727647231125,1.268340864424115,0.13221153846153846,0.5511390023233081,1.0,18/73,15.86%,IL1B;CD47;CD40;NFKB1;PTGIS;TAF9;RC3H1;TANK;ANXA1;CACTIN;ACOD1;APP;ADAMTS12;GBP2;GBP3;RELA;MYD88;IRAK3
prerank,positive regulation of catabolic process (GO:0009896),0.43488096529977266,1.267784941144861,0.159846547314578,0.5518985680281295,1.0,20/65,16.01%,IL1B;DTL;ITCH;ASB5;NEDD4L;SORL1;GPC3;AXIN1;RAB7A;TIPARP;STX5;SNF8;WWP2;CSNK2A1;AREL1;VCP;ANGPTL3;APC;RNF41;HACE1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4480244042092899,1.2676645097405195,0.16087516087516088,0.5515104189316175,1.0,15/55,15.93%,PID1;ACE2;RAC2;MAPK14;PARL;ARF4;GRB2;RAC1;PIKFYVE;DHRS4;RIPK1;ACOD1;PDK3;THBS1;RNF41
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.545423719081422,1.2673524542562342,0.19656786271450857,0.5516318476228843,1.0,5/18,6.67%,ITGA4;AKT3;PPARG;ADAM17;PDPK1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.36837891367464,-1.2671469074161643,0.1018867924528302,0.7071940686272765,1.0,5/43,6.22%,TGFBR2;MEF2C;PKD2;SMO;ACVR1
prerank,regulation of mRNA catabolic process (GO:0061013),0.39612039567586904,1.266932846528437,0.12080536912751678,0.5520371207411072,1.0,31/121,16.29%,ZC3HAV1;XPO1;PSME3;VIM;HSPA1A;MAPKAPK2;PSMB7;PSME2;RC3H1;PUM2;DCP2;YTHDF3;PSME4;ZFP36L2;PSMB8;PSMD9;PSMA5;IGF2BP3;DCP1A;YWHAZ;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;AKT1;PNPT1;PUM1;PABPC1;TNPO1;PSMD12
prerank,regulation of response to oxidative stress (GO:1902882),-0.5324956574269908,-1.2669142052712872,0.20657276995305165,0.7052663018971349,1.0,1/11,0.12%,PRKN
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.3608213572602113,-1.266541752129596,0.11742424242424243,0.7039085106092401,1.0,7/47,12.47%,BIN1;TIMP2;SERPINE2;SPOCK1;TIMP3;SERPINE1;SERPINI1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5060178691159811,1.2660563473011932,0.17655786350148367,0.5536255142172597,1.0,11/26,19.74%,CBLB;CBL;FBXW7;ADRA2A;TSG101;ADAM17;APP;NCF1;ZFYVE28;NCK2;SOCS5
prerank,cobalamin metabolic process (GO:0009235),0.5405612072251071,1.265889845343309,0.22705314009661837,0.5533700837073272,1.0,5/17,13.59%,MMAB;ABCC1;MTRR;LMBRD1;MMAA
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.37059856656025403,1.265753255261517,0.025278058645096056,0.5530251125109129,1.0,88/417,17.01%,CIITA;CBFA2T3;JARID2;FOXP1;RUNX2;RARA;SP3;LIMD1;BCL3;KLF4;PPARG;SCML4;BCL6;ATF7IP;NIPBL;NAB1;CIART;SPI1;CRY1;MTA3;MBD1;SUMO1;KAT7;RFX3;RBPJ;DEAF1;HEXIM1;FBXW11;MBTD1;RPS6KA5;KLF10;AHR;ARID4A;PDCD4;MECP2;SETDB2;PLCB1;THRA;CRY2;CLOCK;SAP18;GATAD2A;CTCF;PHF12;UIMC1;HDAC9;PEX14;CBFA2T2;RBAK;KAT6A;WWP2;ID2;SMARCE1;RCOR3;SMAD4;SBNO2;NR3C1;DAXX;RBM15;SPEN;DEDD2;EIF4A2;TAF7;REST;MBD2;L3MBTL2;MYB;TLE1;LBH;EZH2;SMARCC2;CITED2;HDAC3;NFIL3;TGFB1;RSF1;RELA;TNFRSF4;BHLHE40;PHC3;ZNF148;BRD7;USP47;RB1;SCMH1;PROX1;NIBAN2;FOXK1
prerank,regulation of mitochondrion organization (GO:0010821),0.44562964325899707,1.2656584655253338,0.15147453083109919,0.5525771777237771,1.0,11/47,13.71%,LRRK2;PID1;CYRIB;FBXW7;PARL;PDE2A;CSNK2A2;FIS1;DNM1L;STAT2;SREBF2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5216992272275177,1.2653488412664762,0.1903323262839879,0.5527163415286277,1.0,3/22,5.23%,IL1B;PPP2R5A;ADRA2A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5605826263907732,1.2650554850728422,0.20504731861198738,0.5527703028574958,1.0,2/15,1.69%,PRKCE;PPARG
prerank,stem cell differentiation (GO:0048863),0.4567986440961309,1.2647728161399567,0.1768033946251768,0.5528291140581439,1.0,3/39,1.26%,PTPRC;JARID2;ACE
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5855603441335577,1.26406250839556,0.21415929203539824,0.5540491004108193,1.0,2/10,2.59%,PRKCE;NEDD4L
prerank,transport across blood-brain barrier (GO:0150104),-0.3140568610259178,-1.2640108422783145,0.07865168539325842,0.7098877610796157,1.0,18/83,12.84%,SLCO2B1;SLC24A3;LRP1;ABCC3;SLC1A3;ABCG2;SLC7A1;ATP8A1;SLC2A3;FABP5;SLC27A1;ATP1A2;TFRC;SLC22A5;SLC7A2;SLC7A8;SLC29A1;SLC15A2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.5326513378780999,1.263888711426382,0.1875,0.5538177523620089,1.0,3/20,4.30%,PID1;PPP2R5A;PICALM
prerank,fatty acid biosynthetic process (GO:0006633),-0.33804210787128397,-1.263671090594758,0.09615384615384616,0.7082585193373916,1.0,20/63,26.08%,ACACA;LTA4H;HACD2;LTC4S;ELOVL7;ABHD3;ELOVL4;CBR4;HSD17B8;FADS3;LIPH;ABCD3;ACOT7;ELOVL1;MLYCD;OXSM;TECR;NDUFAB1;SCD;ACSBG1
prerank,neurogenesis (GO:0022008),-0.3750115644966465,-1.2635841900276377,0.12411347517730496,0.7059152799705942,1.0,10/43,14.08%,ERCC6;BTBD3;DAGLA;SPOCK1;RYK;METTL14;WDR62;FAT4;ROGDI;TGFB2
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5051606522763097,1.2635295224383123,0.19905956112852666,0.5541097000206728,1.0,9/24,19.97%,PRKCH;NCOA3;TRIM16;CBFB;ROCK1;SGPP1;MED1;FOXC1;RUNX1
prerank,regulation of developmental growth (GO:0048638),0.4909956345912769,1.2633759442161996,0.17018072289156627,0.5538627325272101,1.0,11/29,16.24%,SPAAR;STAT5A;NIPBL;STAT5B;PLCB1;LATS1;OLFM1;LATS2;APP;FGFR3;INSR
prerank,response to glucagon (GO:0033762),0.5259135054464182,1.2632720477013097,0.1941747572815534,0.5534367950122396,1.0,6/19,12.41%,CYSLTR2;CREB1;CRY1;PRKAR2A;ADCY7;ADCY5
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.4163491132043581,1.2630875772518126,0.14319526627218934,0.5532469428095722,1.0,42/87,24.66%,RPL5;RPS10;RPL37A;RPL6;RPS18;RPS14;RPL35A;RPL13;SEC63;RPS3;RPS21;SRP72;SRP19;RPLP0;RPL34;RPL19;RPL11;RPL30;RPL4;RPS2;RPL7;RPS15A;RPS4X;RPL32;RPSA;RPS13;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;RPL10A;SEC61A2;RPS25;RPL9;RPS16;RPL23;RPL17;RPL37;RPL36
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.36873379003276346,1.2629186006713435,0.02512562814070352,0.5530167927331354,1.0,102/509,15.50%,CD74;CARD11;FGR;FFAR4;PTPRC;IL1B;IQGAP1;ALPK1;LYN;FGF22;FLT3;PLCG2;FYN;RET;CD40;SLC44A2;FGF5;NRG2;JAK2;MAP3K14;KL;DHX58;REL;RAPGEF2;LAPTM5;ANKRD17;MALT1;PTPN6;EIF2AK2;RAC2;CBL;IKBKB;TRIM62;BBC3;BIRC3;ADRA2A;TRAF3IP2;S100A4;PELI1;CAV2;HEXIM1;IRAK4;TIRAP;UBE2N;SHISA5;GRB2;LGALS1;PDPK1;FLNA;OASL;PDCD4;PUM2;TRIM25;ZDHHC13;CARD16;ENG;RAC1;TLR3;IFI35;IL6;HGF;RHOA;ZDHHC17;CPNE1;RNF13;USP15;HIP1;RPS3;RTN4;FN1;FIS1;PIK3CA;RIPK1;TRIM14;RNF31;RHEB;TAB3;MAP3K7;APP;TLR2;PDGFD;CASS4;DNM1L;KIT;NCF1;HCLS1;HCST;ROCK1;HDAC3;PTPRJ;FGFR3;TGFB1;IL18;UNC5B;RELA;MAZ;MYD88;RHOG;FRS2;THBS1;TBK1;MIER1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.42815520005505836,1.2628560358794627,0.1460122699386503,0.5525157539241368,1.0,11/70,13.61%,PLBD1;SLC44A2;ABCA3;CEPT1;PCYT1A;CSNK2A2;CSNK2A1;SLC44A1;TMEM86B;SLC44A5;PLA2G6
prerank,regulation of TOR signaling (GO:0032006),-0.3393623424368176,-1.2626658551656766,0.07281553398058252,0.7065580504912541,1.0,21/67,18.10%,TREM2;GNA12;RPTOR;EPM2A;FLCN;GAS6;FNIP1;RFFL;LARS1;UBR1;DGKQ;MIOS;LAMTOR5;FBXO9;SEC13;TSC2;PIH1D1;RRAGC;AKT1S1;SMCR8;ITFG2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4881631309946493,1.262546827560782,0.1956521739130435,0.5525557389746728,1.0,9/29,10.73%,CD40;IKBKB;BIRC3;UBE2D3;TRAF3;TLR3;TANK;IRF7;RIPK1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5132051963284991,1.261926559225566,0.1819571865443425,0.5535433826823756,1.0,7/22,13.52%,IL1B;SPI1;MINK1;RELL1;MAP3K4;EMC10;NCF1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.44256838418666067,1.2619108986375718,0.16557161629434955,0.5529046363664862,1.0,10/51,10.44%,PPARG;BMPR2;SORL1;LEMD3;HIPK2;UBE2D3;ACVR2A;FBN1;SMAD4;LEMD2
prerank,regulation of myotube differentiation (GO:0010830),0.5024127482570699,1.2618183176465536,0.18694362017804153,0.5524590063293859,1.0,10/24,21.33%,SIK1;MAPK14;HDAC9;PIEZO1;DMPK;HDAC3;MAML1;HDAC1;ATP11A;HDAC5
prerank,endodermal cell fate commitment (GO:0001711),-0.5426708013338525,-1.2617107050138703,0.19809069212410502,0.707013088419114,1.0,5/10,31.73%,CTR9;RTF1;SOX2;LEO1;CDC73
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.46643072777479144,-1.2616610313700585,0.18205128205128204,0.7045700465760001,1.0,6/18,23.12%,DERL2;UBC;TRIM13;RNF103;RNF139;UBA52
prerank,positive regulation of programmed cell death (GO:0043068),0.3774331317647627,1.2611519739104515,0.06589958158995816,0.5534762260097209,1.0,55/272,13.05%,LRRK2;VAV3;TIAM1;ARHGEF18;NGF;DAPK1;LILRB1;NGFR;MAP3K5;SYK;BCL6;TIAM2;STK17B;IFIT2;LAPTM5;PHLDA1;SOS2;ATF6;RYBP;FGD4;FAF1;STK4;PAWR;MTCH1;TNFAIP8;SAP18;RARG;FGD1;FGD3;DUSP6;SOS1;IL6;LATS1;ING3;OLFM1;PIDD1;ARHGEF6;NLRC4;UBE2Z;CASP2;CALHM2;APAF1;RIPK1;AIFM1;NET1;LATS2;FOXO3;DCUN1D3;REST;HTT;MAP3K20;CLIP3;DNM1L;ERCC3;MAPK8
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.42012919720156433,1.2606073577268728,0.14645858343337334,0.554144324442169,1.0,20/73,14.28%,JARID2;GPX1;MYO1C;TAF1A;SPI1;H3-3A;RBBP4;GLMN;SMARCA5;POLR1G;DEK;PHF19;CGGBP1;MECP2;CTCF;TDG;PPM1D;EZH2;KAT2B;POLR1B
prerank,arachidonic acid metabolic process (GO:0019369),-0.3772420770845215,-1.2602569850534193,0.14181818181818182,0.7064266128966934,1.0,6/35,7.35%,HPGDS;PTGS1;MGLL;DAGLA;PNPLA8;PLA2G4A
prerank,Golgi inheritance (GO:0048313),0.5891753276673738,1.2599863763426775,0.19715808170515098,0.5549820391291929,1.0,5/11,15.20%,VRK1;GBF1;STX5;YWHAZ;VCPIP1
prerank,glucose homeostasis (GO:0042593),0.41952149283835877,1.2599419457727763,0.13967861557478367,0.5544053162153609,1.0,27/83,20.50%,NGFR;PPARG;STAT3;SLC8B1;CRY1;LRRC8D;ADRA2A;WFS1;CRY2;CYB5R4;IL6;SELENOT;PRKAA1;BACE2;PRKAA2;INSR;GCK;FOXK1;PIK3R2;SIRT1;PYGL;MBD5;BAD;RPS6;PARK7;ADIPOR1;STK11
prerank,negative regulation of cell communication (GO:0010648),0.5181054563119907,1.2596920637380395,0.17896389324960754,0.5543888978715226,1.0,3/21,10.41%,IL1B;OPRM1;PTPN1
prerank,iron ion transport (GO:0006826),-0.3610038410161972,-1.2593770148289407,0.1111111111111111,0.7068032767767796,1.0,16/47,13.44%,ATP6V1C1;ATP6V0B;SLC11A1;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6AP1;SLC11A2;ATP6V1D;TFRC;FTH1;MCOLN1;ATP6V0D1;ATP6V0A1;ARHGAP1
prerank,positive regulation of GTPase activity (GO:0043547),0.38537248207464975,1.2592420310398207,0.0962566844919786,0.5548880666140151,1.0,30/188,7.62%,RAP1GAP2;TIAM1;SRGAP2;TBC1D1;RAP1A;CD40;TBC1D8;TIAM2;CCDC125;SIPA1L3;DOCK10;FOXJ1;TBC1D9;RASGRP2;RAPGEF2;USP6NL;TBC1D10C;DOCK11;TBC1D2B;BCR;PICALM;ARAP1;RSU1;TBC1D8B;CAV2;AFDN;RABGAP1L;S100A10;RABGAP1;F11R
prerank,regulation of microtubule depolymerization (GO:0031114),-0.4219123411835406,-1.2591240203657315,0.15568862275449102,0.7050353552634858,1.0,8/25,13.56%,NAV3;CAMSAP1;MAP1B;FGF13;CLASP2;MAP1A;CAMSAP2;TRPV4
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5747289885253514,1.2590067430428773,0.2099644128113879,0.5548479689735829,1.0,2/13,9.97%,CYRIB;STX7
prerank,regulation of protein sumoylation (GO:0033233),-0.4646017005410007,-1.2585951701119111,0.16477272727272727,0.7042079487002801,1.0,4/17,14.58%,CAPN3;CTNNB1;SAE1;PIAS4
prerank,cellular response to peptide (GO:1901653),0.4423886379756907,1.2582645264536025,0.15645371577574968,0.5561903418727561,1.0,10/56,6.89%,ITGA4;PTPN22;NGFR;FYN;VIM;CD36;CACNA1A;PRNP;CACNB1;ABCC1
prerank,icosanoid secretion (GO:0032309),0.576757426710691,1.258213768944043,0.205,0.5556314507085268,1.0,3/12,11.60%,ACE;ANXA1;ABCC4
prerank,neutrophil activation (GO:0042119),0.5825523389397868,1.2577272753231912,0.2222222222222222,0.5561873112515312,1.0,5/12,19.45%,SYK;FCER1G;KMT2E;PRKCD;PREX1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.42967502831971754,1.257479056169669,0.1444723618090452,0.5561446150920244,1.0,16/66,15.01%,FFAR4;FOXP1;JAK2;STAT3;CD36;MALT1;TRIM16;CARD16;IL6;GIT1;NLRC4;NLRP3;APP;GBP5;GSTP1;MYD88
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4657190305247816,1.2573722920918446,0.13559322033898305,0.55572937650707,1.0,11/38,13.34%,POLR3F;PLSCR1;DHX58;ANKRD17;OASL;PUM2;IFI35;SLC15A4;USP15;ACOD1;GBP5
prerank,carboxylic acid metabolic process (GO:0019752),0.4675993073668249,1.2571250534231089,0.18061674008810572,0.555687340526255,1.0,9/33,15.26%,ST3GAL1;SLC23A2;SLC23A1;PTGIS;GLUD1;SIRT4;GNE;CSGALNACT1;SLC2A1
prerank,regulation of interleukin-10 production (GO:0032653),0.4524339094514244,1.2568483262860326,0.16910785619174434,0.555719030767671,1.0,7/44,8.68%,CD47;PLCG2;LILRB1;SYK;STAT3;IRF4;IL6
prerank,cytoplasmic translation (GO:0002181),0.4154393156569147,1.256291822130162,0.14320096269554752,0.5564582674080436,1.0,45/91,24.66%,RPL5;RPS10;RPL37A;RPL6;RPS18;RPS14;RPL35A;RPL22L1;RPL13;ETF1;RWDD1;RPS3;RPS21;EIF4A2;RPLP0;RPL34;RPL19;RPL11;RPL30;RPL4;TMA7;RPS2;RPL7;RPS15A;DRG2;RPS4X;GSPT1;RPL32;RPSA;EIF2B3;RPS13;RPS6;RPL18A;RPS27;RPL22;RPS7;RPS12;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17;RPL37;RPL36
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5411817267008452,1.2557212816598795,0.19457735247208932,0.5572667519923713,1.0,3/17,6.36%,PPARG;PRKAG2;PRKAB2
prerank,sympathetic nervous system development (GO:0048485),-0.4898701185258886,-1.2553010973788004,0.1928020565552699,0.7121806744322464,1.0,4/15,4.20%,NRP1;NRP2;CTNNB1;NF1
prerank,peptidyl-lysine acetylation (GO:0018394),0.6022325974552631,1.2551522249245142,0.2148014440433213,0.5580492298404723,1.0,4/10,17.25%,KAT7;KAT2B;CREBBP;SIRT1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.42781988737058463,-1.2549067370797253,0.1774193548387097,0.7108020144869553,1.0,4/25,10.27%,PRKN;SLC8A1;CNNM2;CNNM4
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4868920779233025,1.2539160750615195,0.17837078651685392,0.560696363238901,1.0,3/29,3.63%,CCR2;CCR1;CXCL10
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.4749499156159126,-1.2536002170663791,0.19362745098039216,0.712476614115456,1.0,9/16,20.97%,ATP5F1A;ATP5PO;ATP5MG;ATP5PD;ATP5PF;STOML2;ATP5F1D;ATP5MC3;ATP5MF
prerank,tetrapyrrole metabolic process (GO:0033013),0.5304850595961728,1.253594357024505,0.23482428115015974,0.5609053702825053,1.0,5/18,13.59%,MMAB;ABCC1;MTRR;LMBRD1;MMAA
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.43122543008031383,1.253568349122804,0.1626733921815889,0.5603026726498236,1.0,20/59,15.65%,LRRK2;LMTK2;HIPK2;HIPK1;PDPK1;DYRK1A;TNKS;OXSR1;CSNK2A2;CSNK2A1;NLK;CAD;MAPK8;AKT1;STK39;ROCK1;MAPK1;TBK1;TAF1;DYRK2
prerank,actin filament bundle assembly (GO:0051017),0.47734477336104647,1.2528620720964967,0.17613636363636365,0.561467883320438,1.0,5/33,7.93%,NEDD9;LCP1;EPS8;PAWR;EZR
prerank,regulation of viral genome replication (GO:0045069),0.43809485416677135,1.252783388326291,0.17183462532299743,0.5610082048731974,1.0,10/56,7.18%,ZC3HAV1;OAS2;PLSCR1;EIF2AK2;SLPI;FAM111A;STAU1;IFIH1;OASL;PKN2
prerank,regulation of autophagosome assembly (GO:2000785),0.4778797281357621,1.252439932953035,0.18543956043956045,0.561271947864178,1.0,8/33,10.25%,LRRK2;PIP4K2A;CHMP4A;CHMP4B;MTMR3;RALB;PIKFYVE;PIP4K2B
prerank,BMP signaling pathway (GO:0030509),0.42958237220398776,1.2518818534219223,0.14967741935483872,0.5620227835633035,1.0,10/62,9.94%,RUNX2;BMPR2;SCX;GDF1;HIVEP1;PDCD4;ENG;ACVR2A;USP15;SMAD4
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5165539753759762,1.25181048665266,0.19631901840490798,0.561521214160441,1.0,8/22,18.98%,CYRIB;TMSB10;KANK3;ARFGEF1;MYADM;KANK1;PRKCD;TMSB4X
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.603742145858765,1.2515220234903712,0.23008849557522124,0.5616323141382682,1.0,4/10,12.53%,RUNX3;IRF4;CBFB;SH3RF1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.49353885451129714,1.2512295846397437,0.18181818181818182,0.5617193844844989,1.0,13/27,19.15%,CD36;IRAK4;TIRAP;MAP3K1;TAB3;MAP3K7;TLR2;BTK;MYD88;IRAK3;HSPD1;TAB1;TLR1
prerank,epithelial cell development (GO:0002064),0.5214665505070015,1.2509414059583146,0.19448698315467075,0.5618216752966085,1.0,7/20,21.18%,SIPA1L3;SLC4A7;PDZD7;RILPL2;WNT7A;WNT5B;DACT2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.37841735324259157,1.2508987849586168,0.08779443254817987,0.5612551704599672,1.0,37/199,15.21%,FFAR4;IL1B;PAEP;IFNGR1;MARVELD3;LNPEP;RAB11FIP1;PTPRO;SDHAF2;BMPR2;MAD2L2;RGS2;NPTN;ACOT11;SPI1;PTGER4;ATP2B1;RBPJ;SRGN;RPS6KA5;PTEN;ARHGDIB;ADAM17;HDAC9;SLAMF8;SPRED3;RHEB;PGAM5;FCGR2B;SLC6A4;USF3;LRP4;TIFAB;ROCK1;TGFB1;PTPRG;SPRED1
prerank,positive regulation of neuron migration (GO:2001224),0.5880578756749162,1.2505759004258181,0.21465076660988075,0.561426440292676,1.0,3/11,3.13%,SHTN1;NIPBL;RAPGEF2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.37509825757004933,1.2505508361155093,0.06521739130434782,0.5608168154815577,1.0,60/291,15.52%,PID1;IL1B;LYN;SPAAR;TNIP3;RAP1A;STAP1;CREB1;DAPK1;LILRB1;RET;NFKB1;VIM;FOS;RAPGEF2;KCNQ1;NCOA3;CXCL10;HCN4;DPEP1;CERS1;MAPK14;TIRAP;CAPN2;SETX;AHR;PTK2B;PDCD4;PDE2A;EZR;CARD16;PXN;GNB1;IL6;NFKBIB;RHOA;GIT1;CAMKK2;RPS3;SBNO2;CACTIN;ACOD1;NLRP3;SH3BP4;TLR2;MAPK8;NRIP1;AKT1;PDK3;GNG2;NCF1;TNFRSF1B;VCP;ADAM9;GSTP1;RELA;MAPK1;MYD88;PRDX5;TAF1
prerank,regulation of type I interferon production (GO:0032479),0.411948687321464,1.2503596265793144,0.15587529976019185,0.5606976356878026,1.0,24/84,15.45%,PTPN22;ITCH;POLR3F;NFKB1;DHX58;POLR3A;MRE11;LRRFIP1;NLRX1;IFIH1;TIRAP;DDX41;TRIM25;TRAF3;IRF7;CYLD;ACOD1;PQBP1;ILRUN;RELA;GPATCH3;MYD88;CREBBP;TBK1
prerank,regulation of mRNA stability (GO:0043488),0.38688205487247374,1.2502128651743296,0.10321864594894561,0.5604017759971404,1.0,39/145,16.29%,TENT5A;XPO1;PSME3;FASTKD1;MEX3D;VIM;HSPA1A;MAPKAPK2;PSMB7;PSME2;GDNF;RC3H1;GIGYF2;PUM2;DCP2;YTHDF3;PSME4;ZFP36L2;PSMB8;PSMD9;PSMA5;IGF2BP3;DCP1A;YWHAZ;PSMB3;PSMD6;PSMC4;PSMD10;EIF4ENIF1;PSMB1;AKT1;METTL3;ROCK1;PAIP1;CELF1;PUM1;PABPC1;TNPO1;PSMD12
prerank,synaptic vesicle endocytosis (GO:0048488),-0.38454295364849544,-1.249782793822691,0.1384083044982699,0.7221885898770644,1.0,9/33,13.25%,OPHN1;SYT1;NLGN1;ITSN1;DNM1;CDK5;STX1A;DNAJC6;NLGN2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.47342429901242855,-1.2495722015552904,0.17902813299232737,0.7202920169615745,1.0,9/16,24.03%,DDX5;RBFOX2;EGLN2;PPARGC1B;ESR1;AR;NCOA4;ARID1A;SAFB
prerank,chromatin assembly (GO:0031497),0.4655237527670545,1.24919298749507,0.2011251758087201,0.5624114762172977,1.0,15/38,22.45%,CHAF1A;H3-3A;RBBP4;SMARCA5;CTCF;EZH1;DAXX;NAP1L1;ATRX;RSF1;SIRT1;BRD2;PRDM9;ANP32B;ASF1A
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5045092212545421,-1.2487423053713163,0.21962616822429906,0.7204150322248581,1.0,3/12,9.11%,ABCD2;PPARGC1A;IRS1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4795243452916346,1.2486990556756385,0.1906721536351166,0.5629840610370772,1.0,9/32,10.70%,ACTR3;WASF2;RAC2;CDC42;CARMIL1;ACTR2;RAC1;ARPC2;PIK3CA
prerank,response to hydrogen peroxide (GO:0042542),0.45251836520655253,1.2486308056481932,0.1857335127860027,0.5624961059327364,1.0,12/45,11.31%,STK24;FYN;MAP3K5;GPX1;HP;SETX;NFE2L2;IL6;RPS3;ANXA1;RIPK1;NET1
prerank,mitotic cell cycle phase transition (GO:0044772),0.37854029710515646,1.2484956801912375,0.09698275862068965,0.5621877783172481,1.0,45/203,15.09%,GPR132;EPS8;SDCCAG8;CNTRL;PPP1R12A;CUL3;CUL5;HAUS8;PHLDA1;EIF4EBP1;CRLF3;CCNJL;CHMP4B;CCND3;FBXW11;FBXL8;CDK14;CDKN2C;CCND1;CEP63;PAFAH1B1;PPP2R2A;PLCB1;HAUS1;CCNH;CACUL1;DCTN3;LATS1;SPAST;TRIM71;CEP250;FBXL17;UBE2S;LATS2;DYNC1H1;PPP1CB;CCND2;HAUS3;FBXL12;CLASP1;WEE1;USP37;BCAT1;BRSK1;ANAPC7
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5981173640362093,1.2483940502074085,0.1989795918367347,0.5618145013745156,1.0,1/10,1.26%,ACE
prerank,negative regulation of response to external stimulus (GO:0032102),0.3985200978037722,1.2482677314000574,0.13043478260869565,0.56146318920847,1.0,13/105,5.94%,FFAR4;KLF4;CASK;PPARG;ITCH;METRNL;CRK;DHX58;PTGIS;PTGER4;INPP5F;SMPDL3B;PTEN
prerank,regulation of phospholipid metabolic process (GO:1903725),0.6094404974805964,1.2481535899490304,0.21288014311270126,0.5611103635884986,1.0,4/10,8.05%,ABCA3;MTMR3;MTMR4;DNAJC19
prerank,inorganic cation transmembrane transport (GO:0098662),-0.274627881971785,-1.2480664277241502,0.02702702702702703,0.7199685757811115,1.0,57/268,16.20%,CACNA1D;SLC8A1;KCNK13;RYR3;SLC24A3;KCNQ5;SLC11A1;KCND2;GAS6;SLC1A3;KCNQ3;SCN1A;ATP6V0C;TRPV2;ATP1B3;TRPM3;PKD2;KCNJ2;CACNA1C;ATP2A2;ATP1B1;TRPC4;P2RX7;SLC11A2;P2RX4;SLC6A15;SCN3A;SLC36A1;ATP5PO;SLC9A9;SLC9A6;KCNN2;ATP1A2;HPN;TRPC1;KCNA2;MCOLN1;ATP6V0D1;KCNK6;MCOLN3;HCN1;HCN2;SLC39A7;SCN1B;SLC25A14;SLC25A27;KCNN3;TRPC7;TRPM2;TRPV4;SLC6A8;TRPC3;KCNA1;SLC39A6;CCDC51;ATP2C1;MCOLN2
prerank,N-terminal protein amino acid modification (GO:0031365),-0.4913700477053833,-1.247603624022907,0.18434343434343434,0.7190014254573124,1.0,4/14,3.64%,METAP1D;NAA50;NAA40;METAP2
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.47270555012425,-1.2474248391096316,0.1927710843373494,0.7171071439440373,1.0,7/16,18.16%,AUTS2;CTNNB1;CTR9;BCOR;SNW1;PIH1D1;BRCA1
prerank,sensory perception of taste (GO:0050909),0.6010415608683163,1.247160109291455,0.21908127208480566,0.563054785051196,1.0,1/10,2.67%,CD36
prerank,synapse assembly (GO:0007416),-0.32291012208240155,-1.2471237279713663,0.10824742268041238,0.7156047397456117,1.0,19/67,16.92%,NLGN1;FGF13;LRRTM3;PLXNB2;NRXN2;GABRG2;GRID2;RYK;SDK1;LGI2;GPM6A;CDK5;NLGN2;ADGRL3;GABRB3;SLITRK1;KIRREL3;NLGN3;GABRA2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.5502539922594888,1.2469182821949845,0.21870047543581617,0.5630195894411723,1.0,3/15,3.00%,RPL5;DTX3L;MAD2L2
prerank,sodium ion homeostasis (GO:0055078),-0.431422111686977,-1.2467053917069415,0.1531791907514451,0.7144548538432374,1.0,4/21,7.58%,SLC8A1;ATP1B3;ATP1B1;ATP1A2
prerank,regulation of cation channel activity (GO:2001257),-0.3084952723828027,-1.2466920145636018,0.07471264367816093,0.7119951920030536,1.0,14/89,5.04%,MEF2C;GRIA4;FGF14;LRRC7;CACNB2;NLGN1;SLMAP;FGF13;DLG2;DLG4;GRIA2;GRIA1;PRKACA;ANK2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.40885006511881833,1.2461151425638162,0.1276595744680851,0.5644663611566629,1.0,10/91,5.03%,FGR;LRRK2;PTPRC;HCK;SYK;RAB3D;CD177;INPP5F;PICALM;SCARB1
prerank,regulation of GTPase activity (GO:0043087),0.38043667853187807,1.2456803120193596,0.12150537634408602,0.5650013916433854,1.0,36/177,12.51%,ARHGAP15;LRRK2;VAV3;SRGAP2;RAP1A;CD40;DOCK10;CRK;RASGRP2;RAPGEF2;RCC2;USP6NL;DOCK11;OCRL;PICALM;KLRK1;ARAP1;RSU1;FGD4;CAV2;AFDN;S100A10;RABGAP1;F11R;PLXND1;FGD1;FGD3;BCAS3;ARFGEF1;SNX9;ADAP1;NET1;TBC1D2;DVL3;PLXNC1;SH3BP4
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4889052353371949,-1.2452324859868387,0.20199501246882792,0.7141400027189124,1.0,5/15,7.60%,SKI;MAGI2;SMAD7;ACVR1;ACVR2B
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.38410751893870404,1.2451121936343537,0.10491071428571429,0.5658131737432426,1.0,23/152,12.41%,GRK5;GNA14;CRHR2;FPR1;ADGRG5;ADGRG6;ADGRE5;WASF2;RXFP2;LPAR3;PTGER2;CXCL10;HTR1D;PTGER4;ADRA2A;PDE2A;PSAP;PTGER3;S1PR5;ADCY7;GLP2R;GNAI1;ADCY5
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.497420839069031,-1.2449293973249478,0.20789473684210527,0.7125987569519276,1.0,3/14,5.04%,ATP1B3;ATP1B1;ANK2
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.3984669675241211,-1.2448782005744616,0.16560509554140126,0.7103516765411407,1.0,3/31,6.15%,TGFBR2;TGFBR1;FGFR2
prerank,histone H4 deacetylation (GO:0070933),0.607439444604175,1.2447005364231691,0.2098976109215017,0.5662245500216101,1.0,7/10,26.14%,HDAC9;REST;HDAC3;HDAC1;RCOR1;SIRT2;HDAC2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3869923200072798,1.2444671277536365,0.11771300448430494,0.5661997868200974,1.0,48/148,19.03%,DNA2;RPL5;PIP4K2A;PRKAG2;RBBP8;TAF13;TAF9;MRE11;HIPK2;RBBP4;HEXIM1;MAPK14;HIPK1;PRKAB2;PDPK1;WRN;RPF2;BRIP1;KAT6A;CSNK2A2;CSNK2A1;PIP4K2B;DAXX;PRKAG1;ING2;PRKAA1;TAF7;RPA3;RPL11;AKT1;CHD4;PRKAA2;MAPKAP1;PPP2R5C;AURKB;USP7;PHF20;TAF1;DYRK2;BRD7;PRR5;HUS1;HDAC1;RAD17;PIN1;CHEK2;TTC5;EHMT1
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.4846211753439626,-1.2442914116569594,0.1925925925925926,0.7098598651873292,1.0,4/15,2.94%,LARGE1;RENBP;AMDHD2;NAGK
prerank,regulation of protein binding (GO:0043393),0.3918315826337328,1.2442453833693594,0.1351981351981352,0.5661240797988685,1.0,38/114,20.25%,LRRK2;TIAM1;DTX3L;CRK;IFIT2;RAPGEF2;SORL1;SLPI;MITD1;HIPK2;PRMT8;STK4;CARD16;TMC8;PEX14;RALB;SNAPIN;B2M;NMD3;APP;RPL11;MAPK8;AKT1;MARK3;ROCK1;IFIT1;AURKB;DISC1;TAF1;PSEN1;TFIP11;PRKCD;PIN1;STK3;ACTB;STYX;PARK7;AKTIP
prerank,clathrin coat assembly (GO:0048268),0.5453720017522689,1.2441635068598336,0.2078559738134206,0.5656664827731528,1.0,4/15,9.43%,PIK3C2A;EPS15;PICALM;HIP1
prerank,actin polymerization or depolymerization (GO:0008154),0.44570286718055974,1.243870570752045,0.1870026525198939,0.5657176228418119,1.0,7/50,5.07%,SVIL;PSTPIP1;JAK2;PSTPIP2;MSRB1;ABI1;DIAPH1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.40442513181261286,1.2436180202397153,0.1600496277915633,0.565684322752157,1.0,29/85,19.89%,TIAM1;PSME3;CELSR1;PSMB7;CDC42;PSME2;AP2A2;PSME4;RAC1;RHOA;PSMB8;PSMD9;PSMA5;PSMB3;AP2B1;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;DVL2;AP2S1;PSMD12;WNT7A;VANGL1;SMURF2;FZD7;FZD3;PSMF1
prerank,regulation of synapse assembly (GO:0051963),-0.35130794642485796,-1.243371436415597,0.1346153846153846,0.7103592731072107,1.0,21/46,23.96%,MEF2C;PTPRD;IL1RAPL1;NLGN1;ROBO2;GRID2;VPS35;GPC6;IL1RAP;SLIT1;NLGN2;CLSTN2;EIF4G1;SLITRK1;NLGN3;LHFPL4;NRXN1;DLG5;CUX2;GPC4;SLITRK3
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5094782447216023,1.2425167805925565,0.21362229102167182,0.5678720632807263,1.0,7/21,12.86%,PTPN22;FOXJ1;LAPTM5;LST1;SAMSN1;FCGR2B;LGALS3
prerank,positive regulation of protein kinase activity (GO:0045860),0.38700006249756214,1.2422579204739221,0.11576626240352811,0.5678743734489278,1.0,28/148,11.10%,PTPRC;NEDD9;IQGAP1;RAP1A;ACE;PAK1;PRKAG2;RAPGEF2;CCDC88A;IL6R;AXIN1;TAOK3;TRAF4;ADRA2A;STK4;PRNP;PTK2B;CIB1;PAK2;CACUL1;MINK1;RALB;RHOA;DAXX;PTPN1;SNX9;UNC119;PRKAG1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4029660847822476,-1.2417365297995522,0.16459627329192547,0.7135024240209834,1.0,5/26,7.88%,CACNA1D;ATP1B3;ATP1B1;ANK2;NETO1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.5342844427609995,1.2415228870724497,0.2353823088455772,0.5690381144446286,1.0,4/17,7.78%,FOXJ1;RFX3;BTG1;SULT2B1
prerank,positive regulation of interferon-beta production (GO:0032728),0.4674853247063833,1.241281548265508,0.18938307030129126,0.5689896321675869,1.0,10/33,16.59%,OAS2;POLR3F;DHX58;POLR3A;IFIH1;TLR3;IRF7;TLR2;TBK1;IRF5
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5507819447753265,1.241257435533611,0.2185430463576159,0.5683934664196802,1.0,4/15,7.78%,PRKCH;NCOA3;TRIM16;SULT2B1
prerank,regulation of cell population proliferation (GO:0042127),0.36027597361730096,1.2410401504790616,0.016080402010050253,0.5682988086860216,1.0,127/691,15.95%,DPP4;CBFA2T3;IL1B;GRK5;RARA;IFNLR1;TIAM1;SGK3;HCK;STAT4;LYN;CD47;ACE2;GLI1;FGF22;NGF;FLT3;CDK13;KLF4;ITGAX;ACER3;TBC1D8;PTPRU;STAT5A;BCL6;PAK1;FGF5;JAK2;STAT3;HSPA1A;CUL3;BTG2;BMPR2;RAPGEF2;FABP7;BIRC6;CXCL10;PTPN6;STAT5B;EIF2AK2;ABI1;CCDC88A;SCX;IL6R;GDNF;DLC1;VEGFC;BTG1;ADRA2A;PPP1R9B;STAT1;RBBP4;TNS2;KCNH1;GLMN;PTEN;CDKN2C;KLF10;PTK2B;ADAM17;CIB1;MECP2;CNOT6;SULT2B1;NOX1;RARG;LMNA;DOT1L;ENG;CTCF;CACUL1;IL6ST;IFI35;IL6;RHOA;OPRM1;ID2;TRIM71;PGF;CSNK2A1;RPRD1B;FN1;ARID2;IL31RA;MCTS1;GLP2R;S100A11;NAP1L1;REST;SLC25A5;UTP20;NUPR2;APP;SH3BP4;PDGFD;PPM1D;NF2;LIFR;CCND2;STAT2;KIT;AKT1;EZH2;JUNB;HCLS1;GNAI2;KAT2B;CD164;COX17;RPS6KA2;PTPRJ;FGFR3;TGFB1;PPP2R5C;RELA;MAZ;RHOG;RPS15A;XIAP;THBS1;CELF1;APC;CDCA7L;DUSP22;RPS4X;RNF41;BRD7
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.47471115761404714,-1.2409891362225332,0.18227848101265823,0.7135263918693049,1.0,7/16,16.46%,PIGN;PIGG;PIGP;PIGB;PIGA;DPM2;PIGV
prerank,N-glycan processing (GO:0006491),0.5248150365648502,1.2406490018719005,0.2197452229299363,0.5686741355723245,1.0,3/18,3.57%,ST8SIA4;ST8SIA1;ST8SIA6
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5347552975924861,-1.2401320268478229,0.22018348623853212,0.7139228749021327,1.0,6/10,24.87%,IVD;ACADM;ACADL;ACADS;GCDH;ACAD11
prerank,mesoderm formation (GO:0001707),0.5323092481444016,1.239648440799186,0.21798780487804878,0.5706668558829774,1.0,4/17,13.69%,BMPR2;SCX;ITGA8;ITGA3
prerank,fatty acid catabolic process (GO:0009062),-0.33938163736741345,-1.2396072863900645,0.08374384236453201,0.7130967871706722,1.0,30/67,28.87%,ABCD2;PCCA;ECHS1;PLA2G15;AIG1;PECR;ABCD4;ECHDC1;ACAD10;ABHD3;HADHB;ACADM;HADH;HADHA;ECI1;ECI2;ABCD3;CPT2;ACADL;ACADS;PHYH;ILVBL;PEX13;ACAT2;ACAD11;ACOX1;ACOT8;CROT;SLC27A2;PPARD
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4640254037724698,1.2395176539324788,0.17762237762237762,0.5703412838583195,1.0,12/34,16.25%,LYN;CD300A;SMPDL3B;RAB7B;TLR3;CACTIN;GRAMD4;ACOD1;OTUD4;GPS2;IRAK3;CD300LF
prerank,stem cell development (GO:0048864),0.5337589353001875,1.2394850365572059,0.21555915721231766,0.5697675414382778,1.0,4/16,16.64%,PTPRC;TAPT1;WNT7A;KLHL12
prerank,cAMP-mediated signaling (GO:0019933),0.49896901002636873,1.239344290973979,0.20583717357910905,0.5694711198499993,1.0,5/24,7.50%,ADGRG6;RAPGEF2;PDE7A;AHR;PDE2A
prerank,pre-replicative complex assembly (GO:0036388),0.4203602247079784,1.239197908478799,0.191025641025641,0.5691514539448839,1.0,19/64,17.58%,PSME3;PSMB7;PSME2;ORC5;MCM6;ORC4;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MCM2;ORC6;PSMD12;ORC2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.4350490067543711,1.2390878679524184,0.1702127659574468,0.5687585556328068,1.0,14/56,12.55%,ALPK1;PLCG2;MAPKAPK3;CD36;RPS6KA3;MAPKAPK2;IRAK4;TRAF3;SFTPA1;SFTPA2;TLR3;TAB3;MAP3K7;TLR2
prerank,protein complex oligomerization (GO:0051259),0.4082687079820488,1.2386577962600003,0.14925373134328357,0.5692587909355686,1.0,19/85,14.93%,CARD11;LRRC8C;CLDN1;UPB1;LRRC8D;RNF213;PRMT8;PDCD6IP;SPAST;ATL3;NLRC4;NUDT21;LETM1;DNM1L;YME1L1;PNPT1;CUTC;EHD1;ATL1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4907996479521818,1.2386332781297358,0.21091445427728614,0.5686668528572304,1.0,11/25,19.77%,PRPF6;DBR1;SRSF10;PRPF3;SRSF4;SLU7;DDX23;TXNL4A;SF3B3;SF3B1;SMNDC1
prerank,cardiocyte differentiation (GO:0035051),0.5925660999254313,1.2382042466365573,0.2522202486678508,0.5691059492063888,1.0,1/10,1.20%,SIK1
prerank,negative regulation of T cell proliferation (GO:0042130),0.48718540867757065,1.2379400183258285,0.2152080344332855,0.5691192745140905,1.0,5/28,6.35%,LILRB1;SPN;RC3H1;GLMN;PRNP
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.43002762333945044,-1.237735547773597,0.1810810810810811,0.7168270304453538,1.0,8/21,18.80%,IGF1;FGF2;FOXJ2;P2RY6;GJA1;IGFBP5;ADAMTS1;FGF9
prerank,response to thyroid hormone (GO:0097066),-0.5020343005427311,-1.2377242787768763,0.2109375,0.7144634631410232,1.0,4/13,8.15%,CTSB;LMO2;THRB;HPN
prerank,lamellipodium assembly (GO:0030032),0.4898218450741462,1.2372727599219835,0.19938650306748465,0.570276448814795,1.0,6/26,9.70%,SRGAP2;PTPRO;CCDC88A;CARMIL1;RAC1;ARHGEF6
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.5009080078105944,1.2358701728918835,0.20411392405063292,0.5732810451607071,1.0,7/22,12.97%,PSMB7;NFE2L2;PSME4;PSMB8;PSMA5;PSMB3;PSMB1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.44495523090571737,-1.2356852355602383,0.20424403183023873,0.7184847620782383,1.0,9/19,13.51%,BIN1;APOE;IGF1;NTRK2;RTN3;GGA3;CHRNA7;CLU;ABCA7
prerank,negative regulation of cell activation (GO:0050866),-0.48460459467675665,-1.2355113165416387,0.2004950495049505,0.7167332368949703,1.0,3/14,8.47%,APOE;TREM2;PDGFA
prerank,mitochondrial fission (GO:0000266),-0.46258708883545097,-1.23549142047259,0.18295739348370926,0.7144102149505358,1.0,5/16,14.27%,PRKN;GDAP1;DNM1;MFF;MTFR1L
prerank,apoptotic process (GO:0006915),0.3772221306977579,1.2353779900031103,0.0857449088960343,0.5738833690525041,1.0,52/203,15.24%,IL1B;PRKCE;NOTCH2;PAEP;DAPK1;NGFR;PLSCR1;JAK2;IFIT2;NFKBIA;BCL2L14;DLC1;BBC3;ITGB2;FAP;STK4;AHR;PTK2B;ATP2A1;PDCD4;CIB1;DDX41;PAWR;KREMEN1;CD2;DDIT4;PPP1R15A;HIP1;PIDD1;ARHGEF6;RTN4;CSRNP1;CASP2;APAF1;PIK3CA;RIPK1;DMPK;AIFM1;NLRP3;MAP3K7;APP;TLR2;MCM2;ERCC3;AKT1;DHCR24;CASP7;CYFIP2;CASP12;MYD88;ELMO1;CASP6
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5074468843418359,-1.2351203344958601,0.24281984334203655,0.7131947287645841,1.0,8/12,31.51%,MTTP;P4HB;APOC4;APOC1;DGAT1;SOAT2;ACSL3;LPCAT3
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.360150316160025,1.2351156571644335,0.033099297893681046,0.5738799415008834,1.0,105/497,17.02%,CIITA;CBFA2T3;JARID2;FOXP1;RUNX2;RARA;SP3;LIMD1;BCL3;KLF4;DAPK1;PPARG;SCML4;BCL6;ATF7IP;NIPBL;NAB1;BTG2;CIART;BMPR2;SPI1;EIF2AK2;EIF2AK1;CRY1;MTA3;MBD1;SUMO1;KAT7;RFX3;RBPJ;DEAF1;HEXIM1;FBXW11;MBTD1;RPS6KA5;KLF10;AHR;ARID4A;PDCD4;GIGYF2;MECP2;SETDB2;PLCB1;THRA;CRY2;CLOCK;SAP18;GATAD2A;CTCF;PHF12;UIMC1;HDAC9;MRPL13;PEX14;CBFA2T2;RBAK;KAT6A;WWP2;ID2;TRIM71;SMARCE1;RCOR3;SMAD4;RPS3;SBNO2;IGF2BP3;NR3C1;DAXX;RBM15;SPEN;S100A11;DEDD2;PAIP2;TAF7;REST;MBD2;EIF4ENIF1;L3MBTL2;MYB;EIF2AK3;TLE1;LBH;EZH2;SMARCC2;CITED2;SYNCRIP;HDAC3;NFIL3;TGFB1;RSF1;RELA;TNFRSF4;BHLHE40;PHC3;ZNF148;BRD7;USP47;RB1;DAPK3;SCMH1;PROX1;NIBAN2;CAPRIN1;FOXK1;CNOT8
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.42429818941456116,1.2349811932977297,0.18181818181818182,0.5735893131378776,1.0,20/60,16.62%,RUNX2;NFKB1;ATF7IP;MED30;MED13;PTEN;CCND1;CBFB;MECP2;MED6;IL6;MED26;MED12;MED14;PPM1D;TNRC6B;TNRC6A;RELA;MED1;MED7
prerank,regulation of cilium assembly (GO:1902017),0.424113628326641,1.2347306206052115,0.16581632653061223,0.5735817258472069,1.0,18/62,15.05%,TBC1D1;SDCCAG8;TBC1D8;USP6NL;TBC1D10C;CCDC88A;TBC1D2B;ATG5;RABGAP1;IFT140;TBC1D5;CYLD;TAPT1;TBC1D2;HTT;LIMK2;EVI5;DYNLT2B
prerank,amide biosynthetic process (GO:0043604),0.44478117435776143,1.234711479734074,0.18181818181818182,0.5729841802290792,1.0,11/47,15.27%,CERS6;CERS1;SAMD8;SGMS1;SGMS2;ARG2;SPTSSB;PCSK5;ASL;ASS1;FA2H
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.5633380886793569,1.2345597129506272,0.22820919175911253,0.5727236093135609,1.0,3/12,3.04%,IQGAP1;PTPRO;MYO1E
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3799573556937586,1.2344481840562933,0.1436651583710407,0.5723503818064904,1.0,29/145,13.88%,GPR132;SDCCAG8;DTL;CNTRL;PSME3;HAUS8;RCC2;PSMB7;PSME2;CCND1;CEP63;PAFAH1B1;MECP2;HAUS1;AVEN;PSME4;DCTN3;PSMB8;PSMD9;PSMA5;CEP250;PSMB3;PSMD6;PSMC4;DYNC1H1;PSMD10;PSMB1;HAUS3;CLASP1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.47068340403975373,1.234343731756551,0.2054794520547945,0.5720127138575672,1.0,11/31,18.87%,FBXW7;AXIN1;DCUN1D1;PTEN;UBE2N;UBE2S;DCUN1D3;RPS2;FZR1;PIN1;PINK1
prerank,cellular copper ion homeostasis (GO:0006878),0.5546655979917692,1.2342449411258396,0.24752475247524752,0.5716176328282186,1.0,6/14,16.54%,PRNP;ARF1;ATP7A;ATOX1;APP;SLC31A1
prerank,positive regulation of phagocytosis (GO:0050766),0.4424546923778221,1.2338638107182875,0.18473895582329317,0.5719240804787153,1.0,6/47,1.56%,PTPRC;IL1B;CD47;STAP1;DOCK2;CAMK1D
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4533665983252872,1.2334530219554103,0.20427236315086783,0.5723570865291402,1.0,8/42,8.24%,RIN2;UTRN;CD36;PTK2B;PLEKHA2;CIB1;S100A10;RAC1
prerank,positive regulation of wound healing (GO:0090303),0.45956475795540624,1.2334234967442184,0.19830028328611898,0.5717912467973233,1.0,6/36,10.43%,ST3GAL4;PRKCE;CLDN1;ADRA2A;ARFGEF1;ANXA1
prerank,striated muscle cell differentiation (GO:0051146),-0.4680974239886896,-1.2333341068693215,0.1883289124668435,0.7167178633976737,1.0,4/16,4.52%,SKI;MEF2C;PLD3;SORT1
prerank,ESCRT III complex disassembly (GO:1904903),-0.5375148090172723,-1.2330818651912907,0.21445221445221446,0.7128801074445285,1.0,5/10,20.19%,VPS4B;CHMP5;CHMP1B;CHMP7;CHMP2A
prerank,ESCRT complex disassembly (GO:1904896),-0.5375148090172723,-1.2330818651912907,0.21445221445221446,0.7128801074445285,1.0,5/10,20.19%,VPS4B;CHMP5;CHMP1B;CHMP7;CHMP2A
prerank,positive regulation of histone modification (GO:0031058),0.46482745894980415,1.233011943463573,0.20056497175141244,0.5722702070304256,1.0,7/33,11.15%,IL1B;NIPBL;RPS6KA5;UBE2N;FAM47E;TADA2A;ING2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.4965862403977376,1.2329671986584396,0.21461897356143078,0.571741328732241,1.0,6/22,17.25%,STAP1;PRKRIP1;CDKN2C;ANKLE2;ROCK1;SIRT1
prerank,regulation of axon guidance (GO:1902667),-0.5350376330204824,-1.2329522349835587,0.21445221445221446,0.710930532478555,1.0,5/10,14.41%,NRP1;ZSWIM8;VEGFA;ZSWIM6;ZSWIM5
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4347505114878063,-1.2327434224300207,0.19375,0.7092433414052951,1.0,7/22,7.19%,FLT1;NTRK3;FGF2;FGFR2;PLAA;PLCG1;GNA13
prerank,regulation of interleukin-4 production (GO:0032673),0.5207447489247236,1.2324246557011835,0.20801232665639446,0.5725104106186921,1.0,5/21,13.62%,RARA;SYK;IRF4;NLRP3;FCER1G
prerank,cellular calcium ion homeostasis (GO:0006874),0.38414126008217764,1.2322351156602613,0.13919821826280623,0.5723820327484549,1.0,25/133,12.90%,CCR2;CD40;CCR1;PDZD8;MCUB;NPTN;SLC8B1;ATP2B1;ATP2A3;MAIP1;CAV2;STIM2;WFS1;ATP2A1;SLC30A1;LETM1;DMPK;CALB2;TMEM203;FKBP1B;SLC10A7;ATP13A3;PACS2;SLC24A4;MICU3
prerank,plasma membrane tubulation (GO:0097320),0.5568272384369689,1.2311604580723587,0.2282958199356913,0.5745290534169094,1.0,6/13,15.78%,EHD2;CHMP4A;BIN3;SNX9;PACSIN2;SNX33
prerank,detection of visible light (GO:0009584),0.5332675056632434,1.2305860720203128,0.21150592216582065,0.5753234714637423,1.0,3/16,14.77%,CEP250;PDE6B;GNA11
prerank,endoplasmic reticulum organization (GO:0007029),0.4102640975098399,1.2305629454705955,0.17676143386897405,0.5747554191656677,1.0,19/72,15.98%,LRRK2;SHTN1;TMCC1;CAV2;PRNP;TRAM2;TRAM1;STX5;ATL3;RTN4;LMAN2L;SPTSSB;APP;DNM1L;EIF2AK3;UBE2J2;ATL1;VCPIP1;VAPA
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5299768694565721,1.2297678588226229,0.22712933753943218,0.5755889776043084,1.0,8/16,16.89%,RCC2;DLC1;PTEN;PHLDB2;BCAS3;THBS1;DUSP22;ARHGAP6
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5299768694565721,1.2297678588226229,0.22712933753943218,0.5755889776043084,1.0,8/16,16.89%,RCC2;DLC1;PTEN;PHLDB2;BCAS3;THBS1;DUSP22;ARHGAP6
prerank,heterochromatin assembly (GO:0031507),0.5060893343498072,1.2296249205161203,0.22023809523809523,0.5753069867392314,1.0,8/20,18.12%,H3-3A;SMCHD1;EZH1;MBD2;BAZ2A;RRP8;SIRT1;HDAC1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.37394890231666134,-1.2288081230190737,0.1717171717171717,0.7186307382968464,1.0,15/37,25.14%,GRIA4;GRIA2;DAGLA;GRIK4;GRID2;GRIK1;CDK5R1;CPEB4;GRM5;GRIA3;GRM7;GRIN2B;CLN3;HOMER3;KCNB1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.49522964863265595,1.2287605025297266,0.22427035330261136,0.5768362599280921,1.0,4/23,6.35%,RARA;LILRB1;LAPTM5;PRNP
prerank,regulation of sensory perception of pain (GO:0051930),-0.5127229389566555,-1.22872964403621,0.23940149625935161,0.7165378352846259,1.0,4/11,19.92%,MGLL;ZFHX2;CCL3;TMEM100
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5987714148287444,1.2281205719736263,0.2338568935427574,0.5779099906267741,1.0,1/10,0.33%,IL1B
prerank,regulation of primary metabolic process (GO:0080090),0.38413428826627993,1.227576197276389,0.13631156930126,0.5786890335200595,1.0,37/126,16.98%,PPARG;LDLR;PSME3;TBL1XR1;PSMB7;PSME2;HELZ2;PRKAB2;AZIN1;PSAP;PSME4;ELOVL6;NFYC;ID2;NCOA2;PSMB8;LACTB;OPA3;PSMD9;PSMA5;NCOA1;IDI1;FDPS;PSMB3;PSMD6;PSMC4;NFYA;PSMD10;PSMB1;SREBF2;HDAC3;GPS2;CREBBP;MED1;PSMD12;MVD;MVK
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.39646760750449456,-1.2269623197724324,0.1737704918032787,0.7198342472294716,1.0,6/29,7.88%,APOE;SYNGR1;DLG4;ZDHHC2;RAB3GAP1;NETO1
prerank,nervous system development (GO:0007399),-0.2649276355699324,-1.2269443577348391,0.0,0.7176049354610478,1.0,96/429,16.08%,NAV2;MERTK;OPHN1;NAV3;PRKN;RAPGEF5;ATXN1;WWP1;CHD7;MEF2C;EVL;ERBB4;MYLIP;MARCKS;TGFBR1;NELL1;ADAM23;NLGN1;ROBO2;FEZ2;ROBO1;ERCC6;FGF2;FGF13;GFRA1;CHRM3;PTN;PKD2;TPP1;RBFOX1;DLG4;CNTN4;CHRM2;SMO;MTF1;WDPCP;NF1;BTBD3;LIMK1;NRXN2;RBFOX2;DAGLA;SPOCK1;LDB1;CAPG;LSAMP;RYK;GRIK1;IGSF8;DCX;DPF2;SRRM4;SDK1;JRKL;EFNB3;SH3GL2;NAB2;GPM6A;FEZ1;RBFOX3;PTPRZ1;WDR62;CDK5;EFNA5;MOBP;RBM45;FAT4;VEGFA;DHX30;SERPINI1;ROGDI;NLGN2;SPG7;DPF3;MDK;ATXN10;ADGRL3;CYP51A1;RNF103;NPAS2;PPP2R5D;TAGLN3;NFASC;NINJ1;IRF2BPL;MTR;IGF2BP2;TENM1;SLITRK1;POU3F3;ADGRB1;CRMP1;KIRREL3;ADGRV1;CNTN6;NLGN3
prerank,regulation of adenylate cyclase activity (GO:0045761),0.5018816800044343,1.226564093530398,0.2106060606060606,0.5807012864125894,1.0,1/22,0.04%,CCR2
prerank,glycolytic process (GO:0006096),-0.39569939969315626,-1.2262264289826434,0.2018348623853211,0.7175982511178836,1.0,13/28,28.53%,HK3;HK1;PFKL;PGK1;ENO2;PGAM4;PGAM1;PFKM;ENO3;LDHA;ALDOA;PFKFB1;GAPDHS
prerank,dendritic spine morphogenesis (GO:0060997),0.5518951990732296,1.2261071218797202,0.21405228758169934,0.5812957071278859,1.0,4/15,8.29%,DOCK10;CDC42;PTEN;EPHB2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4366424481623693,1.2259587026917478,0.19920844327176782,0.5810246288584591,1.0,19/49,21.43%,NFE2;H3-3A;RAB7B;KMT2C;CBFB;CIB1;RBM15;TNRC6B;KAT2B;TNRC6A;KMT2E;KMT2A;THBS1;ASH2L;HDAC1;WDR5;RUNX1;MTURN;RBBP5
prerank,T cell mediated immunity (GO:0002456),0.5619012037095266,1.2256929772013172,0.23278688524590163,0.5810670574765084,1.0,2/13,6.91%,MYO1G;GNL1
prerank,calcium ion import (GO:0070509),-0.40141034771437367,-1.225449678143745,0.18633540372670807,0.7177430931409731,1.0,7/28,6.77%,CACNA1D;SLC8A1;CACNB2;CACNA1C;ATP2A2;TRPC4;AFG3L2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4032736177381779,1.2253938407718656,0.178743961352657,0.5812066600728958,1.0,20/85,15.98%,CBFA2T3;LRRK2;HSPA1A;FBXW7;ANKIB1;SUMO1;ARIH1;RNF217;HECTD1;ELOB;COP1;ARIH2;ATXN3;SUMO2;RCHY1;PSMD10;PABIR1;VCP;TAF1;TMTC3
prerank,tricarboxylic acid metabolic process (GO:0072350),0.5690190111187623,1.2253604660160333,0.24668874172185432,0.5806527326924746,1.0,5/12,15.02%,IDH1;GLUD1;IREB2;SIRT4;ASS1
prerank,glycoprotein biosynthetic process (GO:0009101),0.4023585505554199,1.22517368837477,0.17575757575757575,0.5804925977300287,1.0,11/79,8.30%,ST8SIA4;ST3GAL4;ST8SIA1;BMPR2;FUT4;ST8SIA6;B4GALT5;CHST12;ATP7A;XYLT1;SERP2
prerank,positive regulation of cation channel activity (GO:2001259),0.45281888341047427,1.225053366440063,0.19498607242339833,0.5801607042972305,1.0,1/40,0.04%,CCR2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5187531258250021,1.2250379157094178,0.24466338259441708,0.5795607746018344,1.0,2/17,5.11%,NOTCH2;RBPJ
prerank,cellular defense response (GO:0006968),0.4521651630519592,1.2245574122424674,0.19917582417582416,0.5801762437739971,1.0,9/40,15.76%,CD300C;LSP1;CCR9;SPN;PTK2B;NCF2;NCF1;RELA;ZNF148
prerank,brain development (GO:0007420),-0.2875738586292573,-1.2242245093360509,0.07079646017699115,0.7192845954705726,1.0,37/136,16.82%,ZFHX3;ATXN1;TGFBR2;CX3CR1;ROBO2;CTNNA2;CNTN4;PLXNB2;NF1;APOD;NFIB;AFF2;RAB3GAP1;CDK5R1;BBS2;NCOA6;POU6F1;TBC1D23;AATK;ZFHX2;UFC1;SHROOM2;PHF8;EPHA7;MEIS3;ROGDI;UFM1;SETD1A;ADGRL3;VPS51;ADGRL2;PAFAH1B2;CNTNAP2;ADGRG1;SCYL2;PHGDH;IER3IP1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.46729330425017485,1.224184609821191,0.2214484679665738,0.5805221934382729,1.0,8/32,13.86%,CREB1;PRKAG2;ZBTB20;PRKAB2;CREBL2;AKT1;SIRT4;PRKAA2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.4566978252879631,-1.2238588145822806,0.1978021978021978,0.7182702265423425,1.0,6/16,18.18%,APPL2;ERLIN2;WDTC1;APOC1;BRCA1;ACADL
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.48334916686791257,-1.2234657446965,0.21728395061728395,0.7149462478907991,1.0,3/14,4.03%,SLCO2B1;ABCG2;BLVRB
prerank,heme catabolic process (GO:0042167),-0.48334916686791257,-1.2234657446965,0.21728395061728395,0.7149462478907991,1.0,3/14,4.03%,SLCO2B1;ABCG2;BLVRB
prerank,relaxation of cardiac muscle (GO:0055119),-0.4862402429341024,-1.223438949717689,0.20506329113924052,0.7127970407773685,1.0,5/13,7.58%,SLC8A1;KCNJ2;ATP1B1;P2RX4;ATP1A2
prerank,negative regulation of axonogenesis (GO:0050771),-0.4105714917699994,-1.2233796293695265,0.20249221183800623,0.7107087056136336,1.0,8/27,8.20%,DIP2B;DCC;ULK2;MAP2;FGF13;CDKL3;ARHGDIA;EFNB3
prerank,cell differentiation in hindbrain (GO:0021533),-0.5173823771626914,-1.2231751549175063,0.23170731707317074,0.7091567424667394,1.0,3/11,6.91%,OPHN1;GRID2;FAIM2
prerank,"phototransduction, visible light (GO:0007603)",0.5364838215395652,1.222803973698155,0.21105527638190955,0.5833954688688765,1.0,4/14,21.18%,GNB1;PDE6B;GNA11;SAG
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5283339491057708,-1.222796528430488,0.2347417840375587,0.7081078672315431,1.0,5/10,22.47%,PRKN;OXA1L;HDAC6;MT3;ETFBKMT
prerank,cellular amino acid catabolic process (GO:0009063),0.3995243330262853,1.2227672853649458,0.16484848484848486,0.5828704651649046,1.0,23/87,18.41%,KMO;KYNU;HGD;HIBADH;HAAO;DLD;BCKDHA;KYAT1;BCKDHB;MTRR;GLUD1;CARNS1;ACAT1;OGDH;GCSH;HIBCH;AMT;BCAT1;SARDH;DDAH1;AUH;HMGCLL1;SHMT1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4999112882340475,1.2227422062823308,0.19969742813918306,0.5823065630869174,1.0,4/23,11.25%,SLC9A7;SLC12A7;SLC12A6;SLC12A9
prerank,miRNA metabolic process (GO:0010586),0.5118382810416195,1.2226893580211484,0.19659442724458204,0.5818044234968542,1.0,6/20,14.89%,SND1;XPO5;DGCR8;TRIM71;TUT7;TENT4B
prerank,cellular response to estrogen stimulus (GO:0071391),0.538539504087812,1.22186467534412,0.23618090452261306,0.5833021530334518,1.0,3/14,9.21%,RARA;SERPINB9;BCAS3
prerank,intracellular protein transmembrane transport (GO:0065002),0.4443166015538146,1.2216454643761663,0.20481927710843373,0.5832260959516584,1.0,11/42,11.13%,C2CD5;PEX16;PEX12;GRPEL2;RTN2;DNAJC19;TIMM21;PEX14;SEC63;TOMM40;AIFM1
prerank,necroptotic process (GO:0070266),0.5313499999089054,1.22149966436858,0.250814332247557,0.5829713391083602,1.0,7/16,15.37%,ITPK1;TLR3;CYLD;RIPK1;PGAM5;DNM1L;IPMK
prerank,cellular response to amyloid-beta (GO:1904646),0.45778576939125415,1.2213464791880493,0.23783031988873435,0.5827268206681434,1.0,11/35,12.23%,ITGA4;NGFR;FYN;CD36;CACNA1A;PRNP;CACNB1;ABCC1;ICAM1;FCGR2B;APP
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.40639270087914786,1.2213445689451596,0.17647058823529413,0.5821065222358112,1.0,16/78,13.15%,CBFA2T3;LRRK2;HSPA1A;ANKIB1;SUMO1;ARIH1;RNF217;HECTD1;NFE2L2;ELOB;COP1;ARIH2;SUMO2;RCHY1;PSMD10;PABIR1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.48516785045841376,1.220988638724121,0.2287390029325513,0.5823521388303854,1.0,8/27,15.31%,ATAT1;KAT7;KAT6A;MORF4L1;MSL3;KAT2B;PHF20;CREBBP
prerank,central nervous system neuron axonogenesis (GO:0021955),0.5658272213633524,1.220215999622957,0.2525083612040134,0.5837086960230061,1.0,4/12,8.29%,B4GALT5;PTEN;MYCBP2;EPHB2
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.45978329320821976,-1.2201780263339095,0.22167487684729065,0.7141560376007409,1.0,3/15,2.19%,TREM2;OSBPL11;OSBPL8
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4561030441935958,1.2198906141617758,0.2034139402560455,0.5838427442171505,1.0,9/35,9.21%,IQGAP2;HCK;NOTCH2;STAP1;CDC42;ARHGDIB;PTK2B;F11R;BCAS3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3857751590288034,-1.2198839625019577,0.16793893129770993,0.7129607693623166,1.0,7/35,4.20%,PTPRM;APOE;MEF2C;SPARC;FLT1;ATP5F1A;NF1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.374371303683747,-1.2197309562781202,0.17870722433460076,0.7111843160610072,1.0,13/37,12.63%,SIRPA;TREM2;ABCD2;APPL2;PLD3;APOD;HIF1A;NLRC3;PYCARD;CUEDC2;CHID1;PER1;TLR4
prerank,metanephros development (GO:0001656),-0.3915617064872293,-1.2197027670850205,0.13392857142857142,0.7090927972347661,1.0,4/26,4.20%,BASP1;ROBO2;PKD2;NF1
prerank,proteolysis (GO:0006508),0.3650739420774648,1.2195798947982168,0.11275026343519494,0.584025748587291,1.0,45/252,13.97%,DPP4;NAPSA;CAPN13;ACE;RET;LNPEP;LONP1;RSPRY1;ATG4C;TINAGL1;MALT1;MMP1;FAM111A;OLR1;PRCP;SRGN;RNPEPL1;PARL;FAP;CAPN2;FBXW2;ADAM17;NEDD8;CPQ;HGF;SPPL2A;ACAN;CPNE1;LACTB;ADAM19;MBTPS1;CASP2;SENP6;RNPEP;ERMP1;PSMD6;PSMC4;ADAMTS12;CAPN7;BACE2;ATG4D;PCSK5;CASP7;YME1L1;CAPN6
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.4535658377369921,-1.2192863111421044,0.2169576059850374,0.7083325088441336,1.0,8/17,15.81%,ATP5F1A;ATP5PO;ATP5MG;ATP5PD;ATP5PF;STOML2;ATP5F1D;ATP5MC3
prerank,negative regulation of gene expression (GO:0010629),0.3615783263280174,1.2188001956353363,0.0945945945945946,0.5853333547210771,1.0,94/302,20.01%,FFAR4;JARID2;FOXP1;ZC3H12D;NOTCH2;PTPN22;KLF4;DAPK1;PTBP3;CCR1;NFKB1;HSPA1A;ERN1;BTG2;REL;NPTN;SPI1;PTGER4;EIF2AK2;ATP2B1;PICALM;FBXW7;H3-3A;RBBP4;SRGN;RPS6KA5;TIPARP;PHF19;PARP14;GIGYF2;MECP2;SETDB2;DCP2;ENG;LSM5;HDAC9;MRPL13;ZFP36L2;CPNE1;WWP2;ID2;OLFM1;TRIM71;PARP9;RPS3;IGF2BP3;PRKAA1;PAIP2;FCGR2B;REST;APP;EIF4ENIF1;PPM1D;EIF2AK3;METTL3;EZH2;TNRC6B;RNH1;PRKAA2;KAT2B;PNPT1;CITED2;SYNCRIP;TNRC6A;TGFB1;OCLN;TAF1;CELF1;PPHLN1;ZNF148;SNX12;PTBP2;RBL2;MYADM;RB1;DAPK3;PSEN1;CAPRIN1;CNOT8;SIRT1;DDX6;MMP8;HDAC1;SHMT1;PINK1;MAP2K1;SHQ1;RPS13;DNMT1;TERF2;N4BP1;NDFIP2;RUNX1;PARK7
prerank,positive regulation of organelle assembly (GO:1902117),0.4448451006934901,1.2185994788736934,0.22777777777777777,0.5852494417118309,1.0,11/44,12.10%,LCP1;PIP4K2A;CCDC88A;CNOT6;PDCD6IP;RALB;CNOT2;PIP4K2B;TAPT1;DYNC1H1;HTT
prerank,regulation of protein export from nucleus (GO:0046825),0.486454899486258,1.2181301511326215,0.23467862481315396,0.5858721239193021,1.0,4/23,9.00%,IL1B;SP100;XPO4;RBM22
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5044241341215101,1.2179221833820695,0.23873873873873874,0.5857323839994714,1.0,8/20,19.37%,RUNX2;RBPJ;NFE2L2;SMAD4;RELA;CREB3;SMAD5;CARF
prerank,positive regulation of ossification (GO:0045778),-0.3601930435125014,-1.217838669498677,0.18382352941176472,0.7107394833741043,1.0,14/39,16.96%,SLC8A1;MEF2C;NELL1;PTN;TMEM119;P2RX7;ACVR1;ACVR2B;TGFB2;BMPR1B;PKDCC;BMP6;ADGRV1;SOX11
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.3891295017730252,-1.217711255500811,0.1794871794871795,0.7089483143590039,1.0,19/29,35.65%,BCL9;CTNNB1;TCF7L2;RUVBL1;TCF7L1;BCL9L;PYGO2;MEN1;PYGO1;MYC;KAT5;LEO1;TRRAP;AXIN2;CDC73;TLE3;LEF1;SMARCA4;TCF7
prerank,phasic smooth muscle contraction (GO:0014821),0.5910548345210115,1.2176933826032088,0.25618374558303886,0.5857047480825481,1.0,4/10,13.74%,HTR1D;GDNF;PTGER3;TIFAB
prerank,carbohydrate biosynthetic process (GO:0016051),0.49990737410596836,1.2175487405258856,0.24336973478939158,0.585417636156221,1.0,3/21,3.57%,ST3GAL4;FUT4;ST8SIA6
prerank,negative regulation of signal transduction (GO:0009968),0.36473631694208447,1.21710264449276,0.10855949895615867,0.5859503499980875,1.0,50/249,16.96%,LRRK2;PID1;PTPRC;IL1B;LYN;CD47;PIP4K2A;SULF2;PTPRE;HERC4;NOTUM;RGS2;CRY1;GPC3;SMPDL3B;FBXW7;APCDD1;PTPN12;TNS2;PTEN;DDIT4;CARD16;WWP2;CSNK2A2;CSNK2A1;PIP4K2B;PTPN1;CACTIN;NLK;NTN1;RGS14;OTUD4;ADAMTS12;AKT1;METTL3;TLE1;EZH2;TAX1BP3;CNMD;PTPRJ;VCP;GPS2;MAZ;THBS1;TSPAN15;IRAK3;RPS6KB1;RB1;MTMR2;NIBAN2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.35005061108980245,1.216611732165912,0.009,0.5865816982052288,1.0,235/1082,17.52%,CD74;CIITA;PLAC8;NFE2;PID1;IL1B;RUNX2;RARA;SP100;SP3;RUNX3;GLI1;TNIP3;HNF4G;ACTR3;BCL3;KLF4;CREB1;LILRB1;RET;IER2;MAP3K5;PPARG;CD40;PPP1R12A;NFKB1;PITX3;ATF7IP;TET2;FOSL2;PLSCR1;DTX3L;STAT3;EHF;NSD3;FOXJ1;ELF4;FOS;TCF20;RPS6KA3;BMPR2;MAD2L2;REL;AKNA;NCOA3;CXCL10;CRLF3;TAF9;SPI1;STAT5B;NAA16;NFKBIA;MYRF;SCX;TBL1XR1;ATAD2;ZEB2;IKBKB;PICALM;MED30;CAMTA2;ATF6;KAT7;RYBP;AXIN1;PPP3CA;GDNF;ATF2;PRPF6;IRF2;RFX3;RBPJ;HIVEP1;IL33;WAC;DEAF1;HIPK2;STAT1;RNF20;MED13;NUFIP1;KLF5;IRF4;FBXW11;HELZ2;RPS6KA5;RFX5;SMARCA5;ARF4;TRIM16;CDC5L;KMT2C;SEC14L2;KLF10;SETX;AHR;ACTR2;CREBRF;TADA3;NFE2L2;DYRK1A;PLCB1;AFAP1L2;THRA;CLOCK;MED6;ZBED4;RARG;TOX3;DOT1L;E2F2;ENG;GABPB1;GABPB2;CTCF;ACVR2A;TLR3;ELOF1;ELF1;IL6;HGF;SCAF8;KAT6A;TNKS;NAA15;BCAS3;ID2;CREBL2;NCOA2;E4F1;PARP9;ZNF496;IRF7;MEF2B;RPRD1B;CAMKK2;SMAD4;SBNO2;PSMD9;NCOA1;NR3C1;IL31RA;CSRNP1;RIPK1;PBX1;ING2;CCNT2;FOXO3;MED12;ZNF507;DVL3;TAF7;ETS2;NLRP3;REST;RPS6KA1;BCLAF3;ATF6B;MAP2K5;MED14;NFYA;APP;CCNT1;TFAM;TEAD1;TLR2;MAP2K3;ATRX;NFATC2IP;MYB;ZPR1;EIF2AK3;NRIP1;AKT1;NSD1;LBH;NCF1;JUNB;HCLS1;SREBF2;SMARCC2;KAT2B;CITED2;MRTFA;HDAC3;NFIL3;TGFB1;CRTC3;RSF1;IL18;FHOD1;GPS2;KMT2E;RELA;MAZ;GPATCH3;SERTAD3;RHOG;KMT2A;ASXL2;CREBBP;TBK1;DVL2;PHF5A;MAML1;INO80;MED1;ZMIZ2;BRD7;ELF2;HMGN1;PAXBP1;ELL;WNT7A;IRF5;RAI1;PROX1;BPTF;HTATIP2;PSEN1;NIBAN2;FOXK1;CREB3L4;CREB3;SMAD5;ELK4;PIK3R2;CHCHD2;SUPT4H1;SIRT1;ATF1;NR4A1;SS18;PADI2;PHF10
prerank,regulation of DNA replication (GO:0006275),0.4282237284367175,1.2165703595730164,0.20540540540540542,0.5860666123103315,1.0,7/49,5.76%,DNA2;GLI1;ANKRD17;CCDC88A;KAT7;ORC5;FAF1
prerank,carbohydrate catabolic process (GO:0016052),-0.3708295791893003,-1.2161097173522704,0.17518248175182483,0.7117252506062519,1.0,16/38,28.53%,HK3;HK1;PFKL;NEU1;PGK1;MAN2B2;ENO2;PGAM4;PGAM1;PFKM;MAN2C1;ENO3;LDHA;ALDOA;PFKFB1;GAPDHS
prerank,JNK cascade (GO:0007254),0.443084645275667,1.21592420199227,0.2105997210599721,0.5870703675048151,1.0,14/40,17.63%,MAP3K5;SH2D3C;PTGER4;UBE2N;MINK1;ARHGEF6;MAP4K3;TAB3;MAP3K7;MAPK8;MAP3K13;GPS2;MAP2K4;TAB1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5409295455168799,1.215909597501896,0.24444444444444444,0.586482854936149,1.0,6/15,16.09%,BTG2;EIF4ENIF1;TNRC6B;TNRC6A;TENT4B;PABPC1
prerank,adenine nucleotide transport (GO:0051503),0.514905068278334,1.2158660888025021,0.25588697017268447,0.5859652886805884,1.0,4/17,11.97%,LRRC8C;LRRC8D;ABCC4;SLC25A5
prerank,positive regulation of stress fiber assembly (GO:0051496),0.44216012243479125,1.2156462569751776,0.18675496688741722,0.5858331195410381,1.0,10/44,8.98%,CD47;PAK1;ARHGEF10L;CCDC88A;CDC42;CARMIL1;S100A10;RAC1;PXN;RHOA
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.37907094411593084,1.215461084346596,0.15935334872979215,0.5856738099519451,1.0,40/129,20.17%,LRRK2;PSME3;NFKB1;CSNK1G1;TBL1XR1;ZEB2;GPC3;PSMB7;ADGRA2;RNF146;AXIN1;PSME2;UBR5;PSME4;CSNK1G3;TNKS;PSMB8;GSKIP;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;VCP;TGFB1;XIAP;LYPD6;USP47;PSMD12;DAPK3;LRRK1;KANK1;SMURF2;PIN1;FZD9;PSMF1;SCEL;USP8
prerank,glycoprotein metabolic process (GO:0009100),0.4211554076713492,1.214086768539932,0.2081151832460733,0.5886743672513042,1.0,6/53,4.40%,ST8SIA4;ST3GAL4;ST8SIA1;ST8SIA6;B4GALT5;ERP44
prerank,ERAD pathway (GO:0036503),-0.31482089145260883,-1.2139597368137176,0.14893617021276595,0.716680710450635,1.0,28/83,21.90%,PRKN;ECPAS;STUB1;ERLIN2;DERL2;CCDC47;HSP90B1;AUP1;NPLOC4;RNF121;USP19;DNAJB2;SGTB;DERL1;TRIM13;ANKZF1;RNF103;HERPUD1;TMUB2;RNF139;GET4;FAM8A1;UBQLN2;DNAJB9;UBE2G2;SEC61B;BRSK2;FBXO44
prerank,negative regulation of GTPase activity (GO:0034260),0.48590738758158863,1.213959196514559,0.2276064610866373,0.5883987276329394,1.0,8/22,13.84%,LRRK2;RCC2;KLRK1;F11R;BCAS3;ARFGEF1;SH3BP4;LRCH1
prerank,negative regulation of cation channel activity (GO:2001258),0.4841888668356981,1.2137857478280287,0.21601208459214502,0.5882645450024864,1.0,5/26,14.65%,KCNE3;GPR35;EPHB2;FKBP1B;SLC6A9
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.5817215153861385,1.2137729606520962,0.26501766784452296,0.5876706624652059,1.0,5/10,18.10%,PRKCH;NCOA3;TRIM16;MED1;FOXC1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.38381408216477747,1.213653781361533,0.1528735632183908,0.587361285083937,1.0,18/118,8.68%,LRRK2;PID1;SP100;CYRIB;PDLIM5;BCL6;PAK1;NEDD4L;PDZD8;LFNG;ADGRA2;GDNF;RC3H1;CAPZB;PAK2;PHLDB2;PLXND1;IL6
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3981174256331124,1.2135327736048973,0.19781553398058252,0.587038936010006,1.0,24/72,19.49%,FGR;LYN;FLT3;JAK2;PTPN6;CBL;HGF;FN1;PIK3CA;PDGFD;KIT;NCF1;HCLS1;HCST;IL18;UNC5B;MAZ;INSR;SEMA4D;SIRT1;BECN1;HAX1;PIK3R5;FGFR1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.472555622329561,1.2133662904303748,0.23646723646723647,0.5868418435447146,1.0,13/29,22.94%,SAMHD1;PTPN6;YTHDF3;PTPN1;CACTIN;STAT2;METTL3;IFNAR2;ABCE1;TTLL12;MUL1;PTPN2;UBE2K
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.37867112410154213,1.2131296166694756,0.13109425785482123,0.5867947111078343,1.0,36/172,13.66%,DGKG;PLCG2;PIP4K2A;SLC44A2;PIK3C2A;PLSCR1;AGPAT4;MTMR14;INPP5F;OCRL;PI4K2B;PTEN;MTMR3;INPP4A;IMPA1;PIK3R6;PLEKHA2;ARF1;CEPT1;MTMR4;SYNJ1;PCYT1A;CPNE1;PITPNM1;PIKFYVE;FAR1;CSNK2A2;CSNK2A1;PIP4K2B;PIK3CA;CDIPT;SLC44A1;PIK3R4;SLC44A5;PIP5K1A;AGPAT1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.46204527766923126,-1.2123599209733187,0.21502590673575128,0.7194298210773834,1.0,3/15,1.54%,PRKN;IGF1;BCL2L1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.42534760127334115,1.2122968723844247,0.19215686274509805,0.5883011086085355,1.0,18/54,14.84%,TRAF1;SYK;HSPA1A;LAPTM5;IKBKB;BIRC3;HIPK1;ADAM17;CARD16;SPATA2;SPPL2A;CPNE1;CYLD;RIPK1;RNF31;CLIP3;GPS2;GSTP1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5493582895280114,1.2117427368677804,0.2455573505654281,0.5891312367498173,1.0,3/13,6.17%,CBLB;CBL;TSG101
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.3408006908319125,-1.2116019272029537,0.1678832116788321,0.7197706007464497,1.0,5/53,0.75%,OPHN1;PRKN;APOE;TREM2;GNA12
prerank,regulation of defense response to virus (GO:0050688),0.5425458094184747,1.2115669991693974,0.2372322899505766,0.588967179464726,1.0,3/14,7.50%,IFNLR1;ITCH;TRAF3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.4143890590178393,-1.2110968790658367,0.20771513353115728,0.7191579004098754,1.0,2/21,0.93%,PRKN;ABCD2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5678404725622693,1.2108385375150934,0.24818840579710144,0.5902176771213821,1.0,2/11,2.59%,KCNE3;NEDD4L
prerank,amino sugar metabolic process (GO:0006040),0.5803816766578728,1.2107380588860361,0.2522361359570662,0.5898468465281953,1.0,4/10,15.04%,ST3GAL1;GNE;SLC35A3;CSGALNACT1
prerank,positive regulation of histone acetylation (GO:0035066),0.489742624745272,1.2106857886958498,0.22844175491679275,0.589358320252197,1.0,5/23,10.46%,IL1B;KAT7;RPS6KA5;SMAD4;TADA2A
prerank,heart contraction (GO:0060047),0.4533146903780787,1.210538320010555,0.22343324250681199,0.5891386518200004,1.0,6/41,7.08%,ACE;TNNC1;GPX1;KCNQ1;MYL4;SGCD
prerank,cellular response to BMP stimulus (GO:0071773),0.4071521437930615,1.2100863430631188,0.18695106649937265,0.5897127840671925,1.0,13/66,15.47%,RUNX2;BMPR2;SCX;GDF1;HIVEP1;PDCD4;ENG;ACVR2A;USP15;SMAD4;ADAMTS12;TGFB1;USP9X
prerank,artery development (GO:0060840),-0.41039616882039553,-1.2099672325728552,0.20414201183431951,0.7205155399556918,1.0,8/23,7.60%,NRP1;TGFBR1;ROBO2;ROBO1;PKD2;SMAD7;NF1;ACVR2B
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.37098871585356896,1.2095514114076034,0.152317880794702,0.5904525111884634,1.0,47/152,20.17%,LRRK2;SULF2;PSME3;NFKB1;RSPO2;CSNK1G1;RSPO3;TBL1XR1;ZEB2;GPC3;PSMB7;ADGRA2;RNF146;AXIN1;PSME2;UBR5;PSME4;CSNK1G3;TNKS;CSNK2A1;PSMB8;GSKIP;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;TLR2;PSMB1;VCP;TGFB1;XIAP;DISC1;LYPD6;USP47;PSMD12;DAPK3;LRRK1;KANK1;SMURF2;WNT5B;PIN1;FZD9;PSMF1;SCEL;USP8
prerank,rRNA catabolic process (GO:0016075),-0.459840887442331,-1.2094285699238438,0.2219178082191781,0.7200759550305218,1.0,6/16,19.78%,XRN1;TRIR;EXOSC9;EXOSC5;EXOSC10;EXOSC3
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.40514944299757916,-1.2094218666720646,0.1807909604519774,0.7179512434802241,1.0,11/24,34.28%,PKD2;PRKACA;AKAP6;CALM1;GSTO1;FKBP1A;PDE4D;DMD;NOS1;JPH3;CALM2
prerank,defense response to bacterium (GO:0042742),0.3889305520382544,1.2093800642889272,0.16819221967963388,0.5902717157610251,1.0,21/105,15.01%,FGR;OAS2;SYK;ANKRD17;SLPI;IL6R;SPN;TIRAP;ADAM17;TLR3;IL6;SLAMF8;NLRC4;MBL2;RNASE6;TLR2;RPL30;PLA2G6;FCER1G;GBP2;MYD88
prerank,ureteric bud development (GO:0001657),-0.4481768287201515,-1.2089294855402535,0.21481481481481482,0.7172044607975109,1.0,6/17,9.27%,SALL1;ROBO2;NPNT;PKD2;FGFR2;SLIT2
prerank,regulation of cell development (GO:0060284),0.4532595266904007,1.208483176237691,0.21089385474860337,0.5919924820969077,1.0,8/36,13.22%,IL1B;NOTCH2;ADGRA2;CLOCK;HDAC9;SLAMF8;RHEB;AKT1
prerank,mitochondrion transport along microtubule (GO:0047497),0.5423826401483596,1.2082577444749063,0.2586490939044481,0.5919767343990193,1.0,2/13,9.34%,UXT;SPAST
prerank,neuropeptide signaling pathway (GO:0007218),0.41719973612780265,1.208095220989885,0.20584498094027953,0.5917773820749365,1.0,6/58,9.12%,CYSLTR2;LTB4R;RAPGEF2;SORL1;CYSLTR1;OPRM1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.527080044596351,-1.2078266762325296,0.2444933920704846,0.7184413846429211,1.0,4/10,15.38%,CX3CR1;CTNNB1;VEGFA;CX3CL1
prerank,regulation of B cell differentiation (GO:0045577),0.5180662807747396,1.2078190638497002,0.22635135135135134,0.5919597653321241,1.0,6/17,12.96%,SYK;IKZF3;ZFP36L2;ID2;SLAMF8;BTK
prerank,tRNA wobble base modification (GO:0002097),-0.46892114062633244,-1.2076143601750664,0.260752688172043,0.7169831715760627,1.0,10/14,38.77%,ALKBH8;MTO1;GTPBP3;TRMT9B;ALKBH1;CTU2;CTU1;MOCS3;ADAT2;KTI12
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.35557732835409656,1.2074838807558974,0.12943632567849686,0.5921726570116945,1.0,65/248,18.72%,LRRK2;LIMD1;GLI1;PTPRU;PTPRO;PSME3;NFKB1;CUL3;CCDC88C;SDHAF2;MAD2L2;NOTUM;CSNK1G1;TBL1XR1;ZEB2;GPC3;PSMB7;ADGRA2;RNF146;AXIN1;PSME2;CDK14;UBR5;STK4;TMEM131L;KREMEN1;PSME4;CSNK1G3;TNKS;LATS1;PSMB8;GSKIP;PSMD9;PSMA5;CYLD;PSMB3;LATS2;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;LRP4;TLE1;VCP;TGFB1;INVS;XIAP;DVL2;APC;LYPD6;USP47;IGFBP6;PSMD12;DAPK3;KLHL12;PSEN1;LRRK1;KANK1;HDAC1;SMURF2;UBAC2;PIN1;FZD7;STK3
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4005676340720247,-1.2072301681444584,0.19877675840978593,0.7160558546372472,1.0,16/27,36.24%,SYT1;SDF4;SYT9;SYT7;SYT6;RIMS1;RIMS3;SYT8;SYT3;SYT11;SYT12;SYT13;SYT10;SYT4;SYT5;SYT17
prerank,sterol biosynthetic process (GO:0016126),0.4645939838234547,1.2071219058752944,0.24186704384724186,0.5924283040999425,1.0,11/33,19.00%,PRKAG2;HSD17B7;ACAA2;MSMO1;IDI1;FDPS;NSDHL;DHCR24;MVD;MVK;LBR
prerank,negative regulation of protein processing (GO:0010955),0.5535150100082648,1.206849183157183,0.2590759075907591,0.5925159556324512,1.0,2/12,6.35%,LRRK2;PRNP
prerank,mismatch repair (GO:0006298),0.47353205292056394,1.2067892693561892,0.23615160349854228,0.5920522780024622,1.0,11/27,16.89%,MLH1;POLD4;MSH3;MSH6;SETD2;TDG;RPA3;RNASEH2A;MCM9;PMS1;POLD1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.4802435255372285,-1.206715044487015,0.24509803921568626,0.7157050829568301,1.0,6/14,18.75%,BFAR;TMEM33;BAX;DAB2IP;UFL1;DNAJB9
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.41259835006557716,-1.2060415337769452,0.20461095100864554,0.7156838682879626,1.0,9/22,20.90%,PKD2;ATP1B1;ANK2;P2RY6;AKAP6;CALM1;STAC2;GSTO1;RYR2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.5250135776302838,-1.206014693624455,0.2517814726840855,0.7137004772210984,1.0,3/10,1.34%,OPHN1;MYO9A;RAP2A
prerank,leukotriene metabolic process (GO:0006691),0.5109397906850919,1.2059685749720113,0.2334384858044164,0.5935345291617751,1.0,7/19,16.57%,ALOX5AP;MAPKAPK2;DPEP1;ABCC1;DPEP2;ABCC10;MGST3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.48324333200808217,-1.205658614721329,0.2400990099009901,0.7127494250719478,1.0,6/12,18.18%,PIBF1;ERLIN2;WDTC1;APOC1;BRCA1;ACADL
prerank,negative regulation of endocytosis (GO:0045806),0.47907733049585605,1.205640251643849,0.2434915773353752,0.5937518724256547,1.0,8/24,16.81%,LILRB1;CD300A;PICALM;RAC1;UNC119;LGALS3;SNX33;MTMR2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.46791449204883073,-1.2055804386710047,0.23529411764705882,0.7109234534723295,1.0,12/15,38.34%,HPN;SMARCB1;SNW1;SP1;RRP1B;CHD1;TAF11;CTDP1;LEF1;TFAP4;SMARCA4;NUCKS1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5742908776663185,1.2054619423868167,0.2559322033898305,0.5935953081099222,1.0,5/10,18.90%,LYN;RNF13;GSTP1;MAPK1;MAP2K1
prerank,DNA-dependent DNA replication (GO:0006261),0.37720002616669357,1.2049986358843077,0.17114093959731544,0.594192373599877,1.0,33/128,17.58%,DNA2;BAZ1A;PSME3;CDC45;PSMB7;PSME2;ORC5;MCM6;POLD4;WRN;ORC4;PSME4;PSMB8;PSMD9;PSMA5;RECQL5;PSMB3;PSMD6;PSMC4;RPA3;POLA2;DDX23;PSMD10;PSMB1;MCM2;MCMBP;ORC6;POLG2;POLB;PSMD12;POLD1;LRWD1;ORC2
prerank,histone monoubiquitination (GO:0010390),0.4861479788551809,1.2046831004662266,0.2298325722983257,0.594410414179916,1.0,5/24,5.31%,DTX3L;UBE2E1;RYBP;WAC;RNF20
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.43324198531904135,1.2045183769991006,0.22739361702127658,0.5942138749697178,1.0,11/45,15.01%,JAK2;STAT3;CD36;MALT1;TRIM16;IL6;NLRC4;NLRP3;APP;GBP5;MYD88
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3962853308961599,1.2041906397887665,0.19781553398058252,0.5944457125155905,1.0,18/79,17.09%,CASK;SULF2;PPARG;BMPR2;SORL1;LEMD3;HIPK2;UBE2D3;ACVR2A;SMAD4;PTPN1;LEMD2;ADAMTS12;CNMD;VWC2L;THBS1;NIBAN2;SMAD5
prerank,replication fork processing (GO:0031297),0.4439304655423358,1.2041546285890474,0.23323615160349853,0.5939461925632156,1.0,7/38,12.77%,DNA2;SAMHD1;MRE11;FAM111A;WRN;EXD2;ATRX
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.45660427676987014,1.2040562093705112,0.23959827833572453,0.5935798913745362,1.0,8/33,11.41%,STAT3;HSPA1A;STAT5B;RAB7B;STAT1;MAPK14;ACVR2A;FOXO3
prerank,hexose transmembrane transport (GO:0008645),-0.41455005901278263,-1.2038965346592931,0.1954674220963173,0.7139407190255865,1.0,8/21,32.59%,SLC2A3;SLC2A9;SLC2A5;SLC50A1;SLC2A8;SLC45A3;PPARD;SLC45A1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.46754852292039417,-1.202900693079813,0.2285012285012285,0.7148700320777447,1.0,3/15,6.15%,TGFBR2;TGFBR1;FGFR2
prerank,base-excision repair (GO:0006284),0.4260192509689341,1.2017233003157455,0.21973684210526315,0.5989173945749857,1.0,14/48,16.89%,DNA2;POLL;FEN1;APEX2;POLD4;WRN;MBD4;SMUG1;TDG;PARG;RPA3;POLB;USP47;POLD1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.33697184270614206,-1.2016103847781454,0.13618677042801555,0.7167741620695094,1.0,13/54,14.89%,CACNA1D;KCNMA1;BIN1;KCNJ2;CD63;KCNN2;DPP10;KCNMB2;AKAP6;KCNJ6;KCNN3;KCNJ9;GABBR1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5561612609656887,1.2015486910455841,0.24956672443674177,0.5988035194187074,1.0,3/11,9.94%,RGS2;LMNA;SMAD4
prerank,regulation of urine volume (GO:0035809),-0.5358478523095555,-1.2012592767991017,0.24433249370277077,0.7158539383252241,1.0,7/10,45.85%,NPR3;ADCY6;HAS2;NPR1;TFAP2B;HYAL2;ADM
prerank,regulation of cell cycle (GO:0051726),0.35796961452392534,1.2010628279294415,0.10714285714285714,0.5994258895138918,1.0,67/271,16.74%,PTPRC;GRK5;RARA;IQGAP1;RUNX3;CDC14A;NOTCH2;SIK1;LILRB1;DTL;STAT3;ERN1;ANKRD17;SND1;CRLF3;BIRC3;PPP1R9B;HIPK2;RNF20;RBBP4;FBXL8;FAP;CDKN2C;CCND1;LIN52;PDCD4;AFAP1L2;MAPK12;GBF1;PPP1R15A;ID2;E4F1;CSNK2A2;CSNK2A1;RASSF1;RPRD1B;LIN37;CYLD;FBXL17;TXLNG;DUSP1;DCUN1D3;NUPR2;LIN9;MAP3K20;NF2;PCLAF;DHCR24;METTL3;FBXL12;JUNB;KAT2B;PNPT1;CITED2;RPS6KA2;TGFB1;UHRF2;RPS15A;RRP8;XIAP;THBS1;APC;PUM1;RB1;DAPK3;MAEA;PROX1
prerank,DNA replication initiation (GO:0006270),0.4490292985751238,1.2008994363375354,0.24212034383954154,0.5992347587251785,1.0,19/37,26.18%,CDC45;ORC5;MCM6;ORC4;RPA3;POLA2;MCM2;ORC6;LRWD1;ORC2;CDC34;NOC3L;POLE2;ORC1;DBF4;PRIM1;RPA1;MCM3;MCM7
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3972432882451982,1.200763017927942,0.20219244823386115,0.5989792661217829,1.0,20/74,16.29%,LIMD1;PSME3;PSMB7;PSME2;RBPJ;NFE2L2;ELOB;PSME4;BACH1;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;CITED2;CREBBP;PSMD12
prerank,regulation of lipid metabolic process (GO:0019216),0.39285445563299926,1.2006800696502764,0.17443249701314217,0.5985656127073454,1.0,23/88,16.98%,IL1B;PPARG;PRKAG2;TBL1XR1;HELZ2;PSAP;ELOVL6;NFYC;ID2;NCOA2;LACTB;OPA3;NCOA1;IDI1;FDPS;NFYA;SREBF2;HDAC3;GPS2;CREBBP;MED1;MVD;MVK
prerank,phospholipid homeostasis (GO:0055091),-0.5149480164397958,-1.200542130629508,0.2589928057553957,0.716080747466775,1.0,1/11,0.18%,ABCA1
prerank,histone deubiquitination (GO:0016578),0.5112282486235057,1.200540406770217,0.25840978593272174,0.5983133375571413,1.0,6/18,14.89%,USP3;USP49;ATXN7;UIMC1;USP15;USP7
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.43550292131113266,-1.2004061140204125,0.22969187675070027,0.7144661940199301,1.0,6/19,6.15%,MEF2C;ERBB4;TGFBR1;VGLL4;FGF2;FGFR2
prerank,positive regulation of integrin activation (GO:0033625),-0.5017206186166978,-1.2003376985987269,0.2493573264781491,0.7126801690327325,1.0,4/11,16.81%,P2RY12;SKAP1;SRC;PLEK
prerank,macromolecule catabolic process (GO:0009057),-0.3974586806496768,-1.1998026708703113,0.20462046204620463,0.7122278922620114,1.0,6/26,8.37%,LGMN;CAPN3;SNX25;TPP1;IDE;UCHL3
prerank,connective tissue development (GO:0061448),0.44514145825776946,1.1996371190865163,0.21676300578034682,0.5998842068420845,1.0,4/35,7.66%,CD44;SULF2;SCX;ATP7A
prerank,positive regulation of glucose import (GO:0046326),-0.4187445872114413,-1.1993233983381228,0.20743034055727555,0.7117325504299401,1.0,5/21,10.64%,IGF1;OSBPL8;RHOQ;IRS1;PIK3R1
prerank,regulation of hydrolase activity (GO:0051336),0.3972272238369197,1.1987334496759046,0.2,0.6014780913687988,1.0,15/71,11.08%,ARHGAP15;VAV3;CRK;OCRL;FGD4;FBXW11;WRN;PAFAH1B1;RABGAP1;PLXND1;FGD1;FGD3;TDG;SCARB2;ADAP1
prerank,peptidyl-threonine modification (GO:0018210),0.4055331377416072,1.1983098562266248,0.2219482120838471,0.6019101419923215,1.0,21/66,15.65%,LRRK2;LMTK2;HIPK2;HIPK1;PDPK1;DYRK1A;GALNT2;TNKS;OXSR1;CSNK2A2;CSNK2A1;NLK;CAD;MAPK8;AKT1;STK39;ROCK1;MAPK1;TBK1;TAF1;DYRK2
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4488194460747727,-1.1974747019950758,0.22305764411027568,0.7152938396189531,1.0,6/17,28.38%,MAFG;KLF7;AJAP1;CD24;MAFF;CAV1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5014779928634935,1.196699725002457,0.2602965403624382,0.6054063620763254,1.0,5/18,12.66%,ZFP36L2;NR3C1;ANXA1;REST;KLF9
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5066987180115683,1.1966428792713093,0.26178861788617885,0.6049394994198575,1.0,8/18,22.74%,GDNF;ATP7A;PDP2;ABL2;POR;PARK7;SIRT3;TNF
prerank,metanephric mesenchyme development (GO:0072075),-0.5201565915914109,-1.1964732327191268,0.24944320712694878,0.7165701342595813,1.0,2/10,3.43%,BASP1;PKD2
prerank,histone mRNA metabolic process (GO:0008334),0.4606809233536887,1.1964716567824472,0.2467343976777939,0.6047485549959581,1.0,10/27,15.54%,SNRPB;DCP2;TUT1;ERI1;TENT2;MTPAP;TUT7;TENT4B;CPSF3;NCBP1
prerank,outer dynein arm assembly (GO:0036158),0.5362696609719841,1.1962397388060244,0.25538971807628524,0.6047384546285751,1.0,3/14,11.62%,DNAH8;DNAAF5;ODAD1
prerank,positive regulation of bone mineralization (GO:0030501),-0.3599445107200604,-1.196116706589222,0.2,0.7156993133762309,1.0,12/35,15.96%,SLC8A1;MEF2C;NELL1;PTN;TMEM119;P2RX7;ACVR1;ACVR2B;BMPR1B;PKDCC;BMP6;ADGRV1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3716578032218766,1.196001968534266,0.15924276169265034,0.604768436239154,1.0,40/144,19.16%,IL1B;TCAF2;FYN;C2CD5;MYO1C;SORL1;RAC2;FBXW7;BBC3;ITGB2;UBE2D3;XPO4;UBR5;PRNP;FLNA;CIB1;ARIH2;RBM22;BCAS3;CSNK2A2;FIS1;RNF31;YWHAZ;MAPK8;ZPR1;HCLS1;SREBF2;UBE2J2;HDAC3;TGFB1;RAB29;TMEM30A;PSEN1;PIK3R2;BAG3;ATG13;PRKCD;PINK1;BAD;KIF20B
prerank,vacuolar acidification (GO:0007035),-0.41772963232213167,-1.1954412729877313,0.2134502923976608,0.7157692700302718,1.0,7/21,12.44%,SLC11A1;GRN;ATP6V0D2;TCIRG1;DMXL2;ATP6V0D1;ATP6V0A1
prerank,response to chemokine (GO:1990868),0.5450316828249361,1.1954159869574776,0.261986301369863,0.6056748246815552,1.0,7/13,18.10%,RIPOR2;RHOA;OXSR1;DUSP1;STK39;LRCH1;FOXC1
prerank,protein homotetramerization (GO:0051289),-0.3423933612462416,-1.1953819886894186,0.18181818181818182,0.7139468842747931,1.0,13/49,13.12%,RYR3;ACACA;APPL2;PKD2;KCNJ2;ALDH9A1;GOLGA2;MCOLN1;HCN1;USP16;TRPM2;CBR4;AQP4
prerank,double-strand break repair via homologous recombination (GO:0000724),0.38452459803938255,1.1947988166255075,0.1824561403508772,0.60661737329112,1.0,27/95,18.72%,SAMHD1;NIPBL;RBBP8;POLL;CDC45;MRE11;FEN1;MCM6;UBE2N;WRN;NABP1;MORF4L1;RECQL5;RPA3;EXD2;RAD54L;SPIDR;MCM2;ERCC4;RNF138;XRCC2;INO80;MCM9;HUS1;SMC6;RAD21;SMC5
prerank,positive regulation of apoptotic process (GO:0043065),0.3546444043905425,1.1940677738822976,0.12332990750256938,0.6078745613982534,1.0,59/293,13.05%,VAV3;TIAM1;ARHGEF18;NGF;SIK1;DAPK1;LILRB1;NGFR;MAP3K5;BCL6;TIAM2;STK17B;IFIT2;PTGIS;PHLDA1;SOS2;ATF6;RYBP;DLC1;BTG1;FGD4;FAF1;FAP;STK4;PRNP;PAWR;MTCH1;TNFAIP8;SAP18;RARG;FGD1;FGD3;DUSP6;SOS1;IL6;LATS1;ING3;OLFM1;PIDD1;ARHGEF6;RPS3;NLRC4;UBE2Z;CASP2;CALHM2;APAF1;RIPK1;AIFM1;NET1;LATS2;FOXO3;DCUN1D3;REST;HTT;MAP3K20;CLIP3;DNM1L;ERCC3;MAPK8
prerank,intracellular protein transport (GO:0006886),0.3516599044584519,1.1934720020709757,0.1184346035015448,0.6087731119764066,1.0,61/304,14.67%,CD74;AP1S3;TBC1D1;XPO1;STX11;NGFR;RAB19;TBC1D8;SYK;STAT3;TBC1D9;C2CD5;RABL3;MYO1C;LAPTM5;SORL1;USP6NL;TBC1D10C;TBC1D2B;XPO5;XPO6;RAB7A;SNX1;MAIP1;PTTG1IP;TBC1D8B;XPO4;STX17;RAB6A;ARF4;RABGAP1L;KATNB1;RTN2;STX6;RABGAP1;ARF1;TMED10;STX5;STX12;SNF8;TBC1D5;SLU7;STX7;HIKESHI;SNX9;STAM;TBC1D2;NUP153;EIF4ENIF1;CLIP3;RPL11;AKT1;STX16;SGSM1;TLK1;EVI5;TGFB1;FAM53C;RAB29;SCFD2;EHD1
prerank,cytoplasmic microtubule organization (GO:0031122),-0.3343124936421945,-1.1930894618967964,0.1856060606060606,0.7193338202589274,1.0,19/54,15.41%,DST;CAMSAP1;NUMA1;TUBGCP5;VPS4B;CLIP1;PLK3;CLIP2;KATNAL1;FIGNL2;CEP126;FIGN;CAMSAP2;CHP1;TRPV4;HOOK1;CCDC88B;TPPP;TUBGCP6
prerank,phospholipid biosynthetic process (GO:0008654),0.4507407194096981,1.19302580048415,0.23226703755215578,0.6092582977989793,1.0,11/36,16.47%,AGPAT4;SAMD8;SGMS1;SGMS2;CPNE1;FAR1;IDI1;FDPS;PIP5K1A;GNPAT;MVD
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4573860835536964,-1.1924086930440687,0.24808184143222506,0.7194602537047814,1.0,6/15,21.29%,AAK1;SMAP1;BMP2K;SCYL2;UBQLN2;SNAP91
prerank,regulation of histone methylation (GO:0031060),0.5460139528230883,1.1923393559572595,0.24369747899159663,0.6104115054885816,1.0,2/13,5.98%,JARID2;FAM47E
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.4986327396003792,1.1922900980523363,0.2571428571428571,0.6099283938339135,1.0,8/18,15.93%,DHX58;ANKRD17;BIRC3;OASL;PUM2;USP15;GPATCH3;PUM1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4929050393225078,1.1918791768518937,0.24846625766871167,0.6103990489868163,1.0,4/22,6.87%,LYN;IFNGR1;PICALM;GSAP
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3039094843425594,-1.1917954682551382,0.1320754716981132,0.7194019831576189,1.0,15/75,10.46%,OPHN1;DCC;MEF2C;MAP2;MAP1B;CTNNA2;CNTN4;BTBD3;FGFR2;RYK;AFG3L2;MAP1A;PARD3;KLF7;CDK5
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.50779049245176,-1.191673397665318,0.25961538461538464,0.7178259718107223,1.0,2/11,2.23%,MERTK;GAS6
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.5112028331130185,-1.1915532468014831,0.2699228791773779,0.7162114600028062,1.0,3/10,12.63%,VSIR;NCKAP1L;TLR4
prerank,lipoprotein catabolic process (GO:0042159),-0.4955660274268294,-1.191385975418017,0.25526932084309134,0.7147661486895044,1.0,4/11,7.30%,CTSD;APOE;ABHD17C;ABHD10
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.47983762660753837,1.1911222117547782,0.2507204610951009,0.611750144663433,1.0,2/24,5.21%,PID1;SLC25A13
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.401438048426939,1.1908622896166239,0.21635220125786164,0.61182638062937,1.0,15/67,11.40%,TBC1D1;SDCCAG8;TBC1D8;USP6NL;TBC1D10C;TBC1D2B;CDC42;CAPZB;ATG5;RABGAP1;IFT140;RAC1;TBC1D5;CYLD;TBC1D2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.48035546956765607,-1.190360498906329,0.2591687041564792,0.7160366807987258,1.0,5/13,34.28%,SLC8A1;CALM1;CAV1;PDE4D;CALM2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.44188635797359765,1.1899852702225773,0.2532188841201717,0.6134913355033372,1.0,13/35,18.37%,HEG1;CCDC125;CUL3;RIPOR2;DLC1;EPHB2;ITGA3;MAPKAP1;STMN3;KCTD13;ABL2;KANK1;SCAI
prerank,DNA integrity checkpoint signaling (GO:0031570),0.43761326928927546,1.1896339887484098,0.22809457579972184,0.613786364052438,1.0,13/36,18.82%,DNA2;CDC45;CDC5L;CEP63;CLOCK;DOT1L;BRIP1;MAP3K20;DONSON;HUS1;RAD17;CHEK2;SETMAR
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4269089308261639,-1.1891993125816884,0.2540106951871658,0.7175340672302594,1.0,6/19,13.59%,CSF1R;CMKLR1;CSF1;AKIRIN1;JAM3;MDK
prerank,protein localization to mitochondrion (GO:0070585),0.5650094333175556,1.1891356092229497,0.25752508361204013,0.6144100093620277,1.0,2/11,5.30%,LRRK2;MAIP1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.36099657458802553,-1.1891127292745032,0.19343065693430658,0.7158528255898653,1.0,17/40,23.51%,SYT1;PCLO;STX2;SNAP25;SYT7;CDK5;SNPH;STX1A;CPLX1;RIMS1;STX1B;RIMS3;RAB3A;SNAP29;CPLX2;SYT8;BLOC1S6
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3952893264101367,1.1889889684285386,0.21625,0.614210718901059,1.0,17/76,12.31%,KLF4;ITCH;FOXJ1;PTGIS;ERBIN;SPI1;NFKBIA;FAF1;ANXA4;TRAF3;NFKBIB;CYLD;CACTIN;ACOD1;NLRP3;MAP2K5;PSMD10
prerank,tRNA 5'-leader removal (GO:0001682),-0.48209007974544293,-1.1889832464438017,0.2591743119266055,0.7143229044814263,1.0,10/13,34.64%,POP1;RPP30;RPP14;SSB;RPP40;POP4;POP5;RPP21;POP7;RPP25L
prerank,collagen fibril organization (GO:0030199),-0.30231136893469795,-1.1889762244883784,0.12941176470588237,0.7124166009235663,1.0,34/88,30.28%,DST;P3H2;ITGA6;COL27A1;TGFBR1;NF1;P4HA1;COL15A1;LOXL3;LAMA3;P4HB;COL19A1;TGFB2;COL12A1;COL4A2;CRTAP;SERPINH1;COL23A1;ADAMTS2;PLOD3;PLEC;PLOD1;COLGALT1;CD151;COL11A2;COL26A1;ITGB4;COL6A2;COL24A1;COLGALT2;COL6A3;P3H4;COL4A6;P4HA3
prerank,regulation of ossification (GO:0030278),-0.36216675358503814,-1.1889334764969388,0.19014084507042253,0.7106375295024074,1.0,9/36,8.07%,MEF2C;LRP6;ANKH;ENPP1;PTN;ACVR1;BMP2K;NBR1;S1PR1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.3065385731355827,-1.1885874921103181,0.12,0.7097579419268757,1.0,38/72,32.95%,GTF2H2;ERCC6;COPS4;POLD3;TCEA1;GTF2H1;UBC;XRCC1;POLR2A;COPS7A;ERCC2;COPS2;PCNA;LIG3;PPIE;ISY1;POLR2K;RFC3;LIG1;GTF2H3;XAB2;COPS7B;POLR2H;GTF2H5;CDK7;POLR2J;UBA52;COPS6;ERCC1;RFC2;GTF2H4;DDB1;PRPF19;MNAT1;RFC4;POLR2L;COPS8;ERCC8
prerank,negative regulation of cell migration (GO:0030336),0.36798799130711396,1.1882814624683982,0.18531073446327684,0.6154493539500998,1.0,17/137,8.24%,CD74;SRGAP3;SRGAP2;STK24;MARVELD3;NGFR;PTPRU;DPEP1;CLIC4;DLC1;RNF20;AFDN;PTEN;ARHGDIB;PHLDB2;ENG;RAC1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4970994895520494,1.1880366528387594,0.26356589147286824,0.6154830296599624,1.0,8/19,20.01%,GPX1;NOX1;PXDN;MAOB;PRDX5;CYBA;CAT;PARK7
prerank,response to amino acid starvation (GO:1990928),-0.31355662388387506,-1.1880357280510032,0.1404494382022472,0.7094919060098663,1.0,19/72,12.08%,LARP1;ATP6V1C1;RPTOR;ATP6V0B;FLCN;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;SESN3;EIF2AK4;ATF4;LARS1;IMPACT;ATP6V1D;MIOS;ATP6V0D1;LAMTOR5;PRKD1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.38310362481252236,1.187997232265761,0.2016706443914081,0.6149701394803826,1.0,20/98,13.69%,PRKCE;TCAF2;FYN;C2CD5;PRKCH;MYO1C;KIF5B;BBC3;ITGB2;PRNP;PDPK1;CIB1;EPHB2;FIS1;YWHAZ;CLIP3;LGALS3;MAPK8;AKT1;ITGA3
prerank,midbody abscission (GO:0061952),0.5083040444443516,1.1878967951350947,0.27217125382262997,0.6146402501375964,1.0,5/17,8.01%,KIF20A;MITD1;CHMP4A;CHMP4B;PDCD6IP
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.4439545416676856,-1.1871367457075226,0.23255813953488372,0.7103472805982701,1.0,6/16,13.94%,APOE;TREM2;LRP1;CLU;ABCA7;CYP51A1
prerank,exit from mitosis (GO:0010458),0.5404580369952883,1.186827247839471,0.28711256117455136,0.6167540975229125,1.0,5/12,13.88%,EPS8;CHMP4B;SPAST;UBE2S;CLASP1
prerank,kinetochore organization (GO:0051383),-0.4843741409377623,-1.1866049309580509,0.26865671641791045,0.7102022142615529,1.0,12/13,40.16%,POGZ;CENPE;CENPA;CENPF;DLGAP5;CENPT;NDC80;MIS12;CENPH;CDT1;CENPW;NUF2
prerank,positive regulation of leukocyte activation (GO:0002696),0.5064375800624863,1.1865620336234088,0.26595744680851063,0.6168285682448409,1.0,3/18,7.79%,CD226;IL33;CD2
prerank,mononuclear cell differentiation (GO:1903131),0.4705951978469567,1.1862568030874916,0.25153374233128833,0.6170039143684096,1.0,5/24,4.24%,LYN;FLT3;LILRB1;PPARG;MYH9
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3615921955050617,1.1861652405853815,0.17888888888888888,0.6166302087288387,1.0,37/161,16.64%,LIMD1;GLI1;PTPRU;PTPRO;PSME3;CUL3;CCDC88C;SDHAF2;MAD2L2;NOTUM;PSMB7;AXIN1;PSME2;STK4;TMEM131L;KREMEN1;PSME4;LATS1;PSMB8;PSMD9;PSMA5;CYLD;PSMB3;LATS2;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;LRP4;TLE1;INVS;DVL2;APC;IGFBP6;PSMD12;KLHL12
prerank,photoperiodism (GO:0009648),0.46773440747729433,1.186118634335149,0.2559880239520958,0.6161632673837203,1.0,11/28,15.63%,SIK1;CRY1;FBXL8;CRY2;CLOCK;ID2;FBXL17;PPP1CB;PDE6B;FBXL12;BHLHE40
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5333337694134854,1.1860017200540167,0.2779605263157895,0.6158341511069648,1.0,2/14,3.00%,CD226;MAD2L2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.534296200586084,1.185827857699705,0.2621359223300971,0.61564440762447,1.0,3/13,9.47%,PTGIS;NAXE;PARP9
prerank,response to amyloid-beta (GO:1904645),0.430163920987,1.1856952725136847,0.25603217158176944,0.6153535339733527,1.0,11/44,12.23%,ITGA4;NGFR;FYN;CD36;CACNA1A;PRNP;CACNB1;ABCC1;ICAM1;FCGR2B;APP
prerank,regulation of chromosome segregation (GO:0051983),0.5048033980586538,1.1856334821028562,0.2533783783783784,0.6149023507961116,1.0,8/16,18.72%,PUM2;IHO1;CSNK2A2;CSNK2A1;AURKB;PUM1;SMC6;SMC5
prerank,cellular protein-containing complex assembly (GO:0034622),0.3684709027881804,1.1854187636477787,0.17358078602620086,0.6148767479158458,1.0,38/159,18.92%,TESPA1;TIAM1;UVRAG;STXBP6;LONP1;PIK3C2A;HSPA1A;EPS15;PICALM;CHMP4A;CHMP4B;AXIN1;NUP98;PXN;HIP1;SMAD4;RTN4;SNX9;IMMP2L;DNAJB12;AIFM1;SRP19;CCDC39;NUP153;POMP;TBCD;TGFB1;CENPC;TCP1;AP2S1;COX7A2;TRAF2;HSPD1;BBS10;CYBA;NUP93;NCK2;SHQ1
prerank,RNA methylation (GO:0001510),-0.32117156522069096,-1.1853631043874404,0.14479638009049775,0.7120202562649028,1.0,30/60,26.18%,ALKBH8;NSUN2;METTL6;ZCCHC4;METTL14;DIMT1;NOP2;NSUN3;METTL2A;METTL2B;METTL1;TGS1;ZC3H13;FTSJ3;WTAP;METTL8;NSUN5;THUMPD2;TRMT10A;MTO1;TRMT44;TRMT6;TRMT12;LCMT2;NSUN6;TRMT112;GTPBP3;TRMT5;BCDIN3D;BUD23
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.46946995134872094,-1.1851149243673549,0.26344086021505375,0.710870200393154,1.0,6/13,17.65%,LGMN;EIF2AK4;ZDHHC2;CHRNA7;SQSTM1;ADCY8
prerank,positive regulation of RNA splicing (GO:0033120),0.4527205143797195,1.1850812769601256,0.24599708879184862,0.6151732983269124,1.0,10/29,15.54%,HSPA1A;ERN1;PRDX6;SETX;NUP98;DYRK1A;RBM22;ZPR1;HNRNPLL;NCBP1
prerank,nuclear transport (GO:0051169),0.5107966803287803,1.18477456717341,0.27287853577371046,0.6153428868495999,1.0,4/16,12.58%,XPO1;RSRC1;NUP98;RGS14
prerank,negative regulation of autophagy (GO:0010507),0.41118044552897737,1.1843409432936993,0.23175416133162613,0.6158054528219791,1.0,12/54,13.22%,LRRK2;PTPN22;MCL1;STAT3;EIF4G3;IL10RA;HGF;TLK2;PIK3CA;TAB3;SMG1;AKT1
prerank,microtubule-based transport (GO:0099111),0.5310167227027561,1.1839833868438452,0.27336860670194,0.6161303076979054,1.0,4/12,17.09%,ADCY10;CABYR;HTT;DYNC1I2
prerank,potassium ion transport (GO:0006813),-0.28708302393762375,-1.1833932971680252,0.11904761904761904,0.7138518144642713,1.0,21/120,10.45%,KCNMA1;KCNK13;SLC24A3;KCNQ5;KCND2;SLC1A3;KCNQ3;ATP1B3;PKD2;KCNJ2;SLC9A9;SLC9A6;KCNN2;ATP1A2;HPN;KCNMB2;KCNA2;KCNK6;KCNJ6;HCN1;HCN2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.5087007871217774,-1.1829804672602575,0.2708803611738149,0.7131557466535818,1.0,3/11,19.00%,MEF2C;TGFB2;EFNB2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4722652322375797,1.1828287701849411,0.25997045790251105,0.6185007798240283,1.0,7/25,11.41%,STAT3;HSPA1A;STAT5B;STAT1;MAPK14;ACVR2A;FOXO3
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5397204139555764,1.1824710621459094,0.27346278317152106,0.6188001047791188,1.0,1/13,0.24%,PID1
prerank,RNA destabilization (GO:0050779),0.5003003322397654,1.1823918640069009,0.2737341772151899,0.618431312605572,1.0,8/18,19.28%,MEX3D;GIGYF2;YTHDF3;METTL3;ROCK1;CELF1;PUM1;FTO
prerank,cristae formation (GO:0042407),-0.3833666898694572,-1.181945873263035,0.2309941520467836,0.7143758504965873,1.0,11/27,15.81%,ATP5F1A;ATP5PO;APOO;AFG3L2;ATP5MG;ATP5PD;CHCHD6;ATP5PF;SPG7;ATP5F1D;ATP5MC3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5445681958687031,1.1815482543922433,0.292436974789916,0.6199527477397153,1.0,6/12,16.32%,GMDS;UGP2;PARG;SLC35A3;CSGALNACT1;FUT8
prerank,negative regulation of cilium assembly (GO:1902018),-0.4820061763094623,-1.181258195401118,0.2562189054726368,0.7145192406529792,1.0,7/12,28.65%,EVI5L;ODF2L;TCHP;CDK10;CEP97;TBC1D7;CCP110
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5056544153289805,1.1801726977642957,0.27184466019417475,0.6229890939637818,1.0,4/18,10.79%,LRRK2;RAP1A;SLC4A8;SNAPIN
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5148754163443117,1.1798802131794133,0.28192371475953565,0.6231092714608933,1.0,2/16,4.20%,VIM;SCX
prerank,detection of calcium ion (GO:0005513),-0.4718771572614828,-1.1797344812071286,0.27383863080684595,0.7171430991785341,1.0,4/13,20.90%,SYT1;KCNMB2;CALM1;RYR2
prerank,regulation of filopodium assembly (GO:0051489),-0.35879976595859026,-1.1795451650752333,0.2116788321167883,0.7158289987521854,1.0,15/38,15.10%,NRP1;NLGN1;TENM2;MYO10;RHOQ;FXR1;GPM6A;PIK3R1;FXR2;RALA;DPYSL3;TRPM2;AGRN;TENM1;PALM
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.47198536216055303,1.1792250173914722,0.25948406676783003,0.6242092907612781,1.0,10/22,18.96%,CDK13;KAT7;SCAF8;CCNT2;CCNT1;CDK12;HMGN1;ELL;SUPT4H1;BRD4
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.37858034549260744,1.1789074209932018,0.22325581395348837,0.6243896709434027,1.0,17/95,12.84%,IL1B;ST3GAL1;ST3GAL4;EXT1;B4GALT5;GPC3;HSPG2;CHST12;PXYLP1;XYLT1;ACAN;NCAN;GALNT5;SDC3;SLC10A7;CHST15;UST
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3052320466737932,-1.1784337021486622,0.13612565445026178,0.717276578317695,1.0,15/75,13.56%,SLC8A1;CACNA2D1;TRPV2;ATP1B3;KCNJ2;SLC39A10;ATP1B1;SLC9A9;SLC9A6;ATP1A2;KCNJ6;HCN2;TRPM2;KCNJ9;TRPV4
prerank,actin crosslink formation (GO:0051764),0.536101743260309,1.1780574493141809,0.27545909849749584,0.6260278333767759,1.0,3/12,6.81%,LCP1;EPS8;FLNA
prerank,positive regulation of JUN kinase activity (GO:0043507),0.48164855603964435,1.1776010550610783,0.2627627627627628,0.626656769410753,1.0,9/23,17.23%,MAP3K5;PAK1;TAOK3;MAP3K4;RPS3;DVL3;MAP3K7;DVL2;TRAF2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4050366988566232,-1.1770762516154452,0.20474777448071216,0.7194586458195211,1.0,8/25,17.34%,WNK1;ATP1B3;ATP1B1;ANK2;WNK2;TCAF1;GLRX;ACTN2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.33961683199412795,1.176907929691612,0.034,0.6278614339280674,1.0,173/834,17.52%,CIITA;PLAC8;PID1;RUNX2;RARA;SP3;GLI1;TNIP3;HNF4G;ACTR3;CDK13;KLF4;CREB1;LILRB1;NGFR;IER2;PPARG;CD40;PPP1R12A;NFKB1;TET2;FOSL2;PLSCR1;STAT3;EHF;FOXJ1;ELF4;FOS;TCF20;RPS6KA3;BMPR2;REL;AKNA;NCOA3;CXCL10;CRLF3;TAF9;SPI1;STAT5B;NFKBIA;SCX;TBL1XR1;ATAD2;ZEB2;IKBKB;MED30;CAMTA2;ATF6;KAT7;PPP3CA;GDNF;ATF2;PRPF6;IRF2;RFX3;RBPJ;HIVEP1;IL33;HIPK2;STAT1;MED13;NUFIP1;KLF5;IRF4;HELZ2;RPS6KA5;RFX5;SMARCA5;ARF4;CDC5L;KMT2C;KLF10;SETX;AHR;ACTR2;CREBRF;NFE2L2;THRA;CLOCK;MED6;ZBED4;RARG;TOX3;DOT1L;PLXND1;E2F2;ENG;GABPB1;GABPB2;ACVR2A;TLR3;ELF1;IL6;HGF;KAT6A;TNKS;BCAS3;NCOA2;E4F1;IRF7;MEF2B;RPRD1B;SMAD4;SBNO2;NCOA1;NR3C1;CSRNP1;RIPK1;PBX1;CCNT2;FOXO3;MED12;ZNF507;DVL3;TAF7;NLRP3;REST;RPS6KA1;BCLAF3;ATF6B;MAP2K5;MED14;APP;CCNT1;TEAD1;TLR2;CDK12;ATRX;NFATC2IP;MYB;NRIP1;JUNB;HCLS1;SREBF2;KAT2B;CITED2;MRTFA;HDAC3;TGFB1;CRTC3;RSF1;IL18;FHOD1;GPS2;RELA;KMT2A;ASXL2;CREBBP;TBK1;DVL2;MAML1;INO80;MED1;ZMIZ2;PAXBP1;ELL;WNT7A;IRF5;PROX1;BPTF;HTATIP2;CREB3L4;CREB3;SMAD5;ELK4;PIK3R2;CHCHD2;SUPT4H1;SIRT1;ATF1;NR4A1;SS18;PHF10
prerank,vesicle transport along microtubule (GO:0047496),0.47445759100229146,1.1768372229618536,0.27629513343799056,0.6274305207568593,1.0,8/23,14.78%,KIF5B;FBXW11;PAFAH1B1;KIF3B;DYNC1H1;HTT;KIF5A;FYCO1
prerank,negative regulation of protein catabolic process (GO:0042177),-0.34348581324133365,-1.1767631250320891,0.17288135593220338,0.7184913259594246,1.0,12/40,15.42%,TIMP2;NELL1;SNRNP70;CTSA;CST3;TIMP3;FMN2;RIC1;CYP51A1;DAB2IP;PTPN3;ADGRB1
prerank,arachidonate transport (GO:1903963),0.5606989867672755,1.1766614806130404,0.298932384341637,0.6266803035661896,1.0,2/10,10.43%,ACE;ANXA1
prerank,arachidonic acid secretion (GO:0050482),0.5606989867672755,1.1766614806130404,0.298932384341637,0.6266803035661896,1.0,2/10,10.43%,ACE;ANXA1
prerank,estrogen metabolic process (GO:0008210),0.5116034280802598,1.1764406327896153,0.2707993474714519,0.6265941169720385,1.0,4/15,17.80%,HSD17B14;HSD17B7;HSD17B11;HSD17B2
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.46619433650916686,-1.1763809394863833,0.2789598108747045,0.7177350521062332,1.0,5/13,12.18%,CACNB2;CACNA1C;ANK2;KCNN2;GJA1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.43370735815564665,1.1761258481309875,0.23978201634877383,0.6268271863062473,1.0,5/39,11.09%,FFAR4;TM7SF3;SELENOT;PSMD9;GLUD1
prerank,response to purine-containing compound (GO:0014074),-0.41920664214405773,-1.1758843801231416,0.24338624338624337,0.7174015317017809,1.0,6/17,14.62%,P2RX7;P2RX4;P2RY6;DGKQ;TRPM2;TRPC3
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3985973814762931,-1.175778697558582,0.24079320113314448,0.7159045774285626,1.0,9/25,15.54%,CTNNA3;FGF13;CACNA1C;ATP2A2;ANK2;JUP;CXADR;CALM1;PKP2
prerank,neuron cell-cell adhesion (GO:0007158),-0.45784489017413493,-1.1756757572471257,0.24552429667519182,0.7143686901040284,1.0,10/14,18.98%,NLGN1;NCAM2;CNTN4;NRXN2;CDK5R1;ASTN1;ASTN2;NLGN2;NLGN3;NRXN1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.36538417116615773,-1.1756302387186945,0.1896551724137931,0.7126805712862697,1.0,19/31,36.24%,SYT1;SCAMP5;RAB3GAP1;SYT9;SYT7;STX1A;SYT6;CBARP;SYT8;CACNA1I;KCNB1;SYT3;SYT11;SYT12;SYT13;SYT10;SYT4;SYT5;SYT17
prerank,synapse organization (GO:0050808),-0.27899849692800244,-1.1753173999547095,0.125,0.7118122210202321,1.0,28/125,16.08%,APBB2;CX3CR1;C1QB;PTPRD;C1QA;CACNB2;NLGN1;C1QC;NRXN2;PPFIA4;RYK;SEMA3E;SDK1;C5AR1;GPM6A;CHRNA7;GPC6;GRM5;CDK5;PPFIBP1;NLGN2;PPFIBP2;AGRN;ADGRL3;SLITRK1;CX3CL1;KIRREL3;NLGN3
prerank,cellular metal ion homeostasis (GO:0006875),0.375144623899435,1.175215860588062,0.21575342465753425,0.6285430134261563,1.0,17/102,12.61%,CCR2;CD40;CCR1;NEDD4L;NPTN;SLC8B1;ATP2B1;ATP2A3;STIM2;ATP2A1;SLC30A1;LETM1;DMPK;TMEM203;SLC10A7;ATP13A3;SLC24A4
prerank,regulation of ion transport (GO:0043269),-0.3058781552366268,-1.1750559246963448,0.1559633027522936,0.7108095725453097,1.0,18/76,14.30%,PRKN;DTNBP1;WNK1;SYT1;KCNJ2;P2RX7;P2RX4;SYT9;ITGB3;SYT7;KCNA2;SNX6;KCNJ6;CA2;PER1;KCNJ9;SYT6;NKAIN3
prerank,dendritic cell differentiation (GO:0097028),0.47135689133714254,1.1745539831990481,0.26021180030257185,0.6295995228544062,1.0,3/22,1.36%,LYN;FLT3;LILRB1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3705271410809994,-1.1743949986719662,0.2310126582278481,0.7110264495455864,1.0,7/29,10.34%,NAPA;COPA;RAB6B;GOLGA5;VTI1B;GOSR2;COPE
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.4212462357908938,-1.1743563997636246,0.2572178477690289,0.7093766007254407,1.0,5/18,7.68%,GNA15;CHRM3;RGS10;CHRM2;CDK5R1
prerank,mitotic cytokinetic process (GO:1902410),0.48444297767214,1.1742510461354272,0.2716236722306525,0.6297642658862844,1.0,6/20,8.98%,KIF20A;MITD1;CHMP4A;CHMP4B;PDCD6IP;RHOA
prerank,pre-miRNA processing (GO:0031054),-0.462405650106147,-1.1740776384965226,0.2692307692307692,0.7084284515352547,1.0,5/14,19.06%,AGO3;AGO1;ADAR;DROSHA;LIN28B
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.47941290006329923,1.1737757351742184,0.26666666666666666,0.630375042529247,1.0,6/22,15.77%,MED30;MED13;MED12;PSMC4;MED14;MED1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.39126132347189607,1.1734224386334506,0.22896039603960397,0.6306328577146916,1.0,17/78,15.07%,PID1;PRKCE;PPP2R5A;PRKCH;KIF5B;PICALM;ZDHHC7;PDPK1;CIB1;EPHB2;STX7;CLIP3;LGALS3;AKT1;ITGA3;TGFB1;RHOG
prerank,epidermal cell differentiation (GO:0009913),0.42879407407738046,1.1733470053791393,0.2645861601085482,0.6302053129943856,1.0,12/41,20.64%,GLI1;BCR;CLIC4;ANXA1;USH2A;ERCC3;PIP5K1A;ADAM9;MED1;HDAC1;SCEL;UGCG
prerank,mRNA transport (GO:0051028),-0.2925546403864997,-1.1733226676116488,0.13496932515337423,0.7087895313633882,1.0,34/101,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;KIF5C;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;ZC3H11A;SEC13;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;NUP37;HNRNPA2B1
prerank,neuronal action potential (GO:0019228),-0.4080095071222146,-1.1730835086207112,0.2523076923076923,0.7077689764282041,1.0,5/22,15.09%,SCN1A;SCN3A;KCNMB2;KCNA2;KCNA1
prerank,inner ear morphogenesis (GO:0042472),-0.406940383232197,-1.173044706088074,0.23268698060941828,0.7061260590677649,1.0,4/22,8.15%,CHD7;MYO6;FGFR2;HPN
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3747597034724422,1.1726399587562535,0.19560185185185186,0.6314155731264305,1.0,30/100,19.49%,FGR;LYN;FLT3;PIP4K2A;JAK2;PTPN6;CBL;PTEN;HGF;PIP4K2B;FN1;PIK3CA;PDGFD;PIP5K1A;KIT;NCF1;HCLS1;HCST;PPP2R5C;IL18;UNC5B;MAZ;MAPK1;INSR;SEMA4D;SIRT1;BECN1;HAX1;PIK3R5;FGFR1
prerank,lytic vacuole organization (GO:0080171),-0.37449327082836814,-1.1725864994383157,0.21875,0.7057027560323759,1.0,9/32,7.99%,ABCA1;HPS4;GRN;ZKSCAN3;TPP1;ARSB;TPCN2;GAA;MYO7A
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4040624116714432,1.1725717924843928,0.25359477124183005,0.6310231761536524,1.0,21/59,16.62%,RUNX2;NFKB1;MED30;MED13;PTEN;CCND1;SETX;CBFB;MECP2;THRA;MED6;IL6;MED26;MED12;MED14;PPM1D;TNRC6B;TNRC6A;RELA;MED1;MED7
prerank,mRNA export from nucleus (GO:0006406),-0.2957589402566263,-1.172570520683619,0.1310344827586207,0.7040152494189031,1.0,35/102,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;DDX19A;ZC3H11A;SEC13;IWS1;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;NUP37;HNRNPA2B1
prerank,peptide catabolic process (GO:0043171),0.4809804146784844,1.1725616383315383,0.2857142857142857,0.6304496696739362,1.0,4/23,7.46%,ACE;LNPEP;DPEP1;CPQ
prerank,regulation of gene expression (GO:0010468),0.3388843287075842,1.1721661481256864,0.035,0.6308528592266794,1.0,185/903,16.33%,CD74;PID1;PTPRC;IL1B;FOXP1;MBNL1;AHNAK;SP3;RUNX3;LYN;NOTCH2;LIMD1;ACE2;FGF22;NGF;KDM6A;PTPN22;IFNGR1;PLCG2;KLF4;STAP1;RPL5;LILRB1;PTBP3;ITGAX;CCR1;BCL6;SAP30;MSN;NFKB1;PITX3;FGF5;PLSCR1;STAT3;NSD3;HSPA1A;TRIM26;CD36;GPX1;NAB1;REL;RNF207;PRX;SPI1;SCX;PICALM;FBXW7;MBNL3;KAT7;RYBP;GDNF;ATF2;NFKBIZ;IRF2;RFX3;RBPJ;RPL6;BTG1;IL33;RNF20;RC3H1;MAPK14;CD276;RPS6KA5;GLMN;AFDN;TIPARP;UBR5;AHR;PHF19;CRIP1;TADA3;SERPINB9;CGGBP1;CREM;SRSF10;NFE2L2;PARP14;MECP2;SETDB2;PUM2;TRAF3;PDE2A;CLOCK;EZR;TOB2;ENG;MBIP;EPHB2;CTCF;PHF12;NFYC;TLR3;ZBTB11;IL6;BACH1;AFF1;NKAPL;SNF8;RBAK;CPNE1;ASCC1;WWP2;ID2;CREBL2;NCOA2;OLFM1;TRIM71;PARP9;BRAF;METTL4;RPS3;SBNO2;ADAM19;IGF2BP3;FN1;BNC2;NR3C1;DAXX;YTHDC1;NUDT21;TDG;TRIM14;NFKBID;CACTIN;PRKAG1;ING2;SRRT;NLK;MED26;PRKAA1;ZNF507;REST;BAZ2A;NFYA;APP;TRIM17;PQBP1;MSL3;TLR2;ICOSLG;ATRX;RPL11;MYB;MAPK8;ZPR1;HNRNPLL;EIF2AK3;AKT1;NSD1;TLE1;EZH2;TNRC6B;HCLS1;RBM38;ROCK1;PRKAA2;CITED2;TNRC6A;NFIL3;TGFB1;ZNF431;RELA;MAZ;MAPK1;MYD88;SERTAD3;OCLN;CREBBP;MARF1;TAF1;DVL2;BHLHE40;CELF1;ZNF148;MED1;SNX12;PUM1;PTBP2;FOXN2;RBL2;AFF3;INSR;MYADM;RB1
prerank,cellular response to cadmium ion (GO:0071276),0.47435254675540295,1.1720371859822183,0.26785714285714285,0.6305859597309853,1.0,7/24,14.99%,FOS;SUMO1;DAXX;MAPK8;AKT1;NCF1;MAPK1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.4194048552967418,1.171725246186642,0.2540983606557377,0.6308210823377407,1.0,9/47,10.64%,CREB1;PPARG;METRNL;PIM1;LMO3;WDFY2;ID2;CREBL2;CCDC71L
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.43152648001284377,-1.171555237865307,0.28337874659400547,0.7052190521695614,1.0,6/18,13.09%,TREM2;CORO2B;CCT2;DKC1;CHP1;CCT8
prerank,DNA geometric change (GO:0032392),0.4703672942460833,1.1714909710547592,0.270392749244713,0.6307943879818494,1.0,6/24,11.15%,DNA2;MRE11;WRN;ASCC3;ANXA1;RECQL5
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.4387436267739939,-1.1713999822167618,0.2518891687657431,0.7039243696545602,1.0,10/16,27.13%,ACACA;CBR4;HSD17B8;MLYCD;DIP2A;GCDH;PPCS;ACSS1;SCD;FASN
prerank,histone H3 acetylation (GO:0043966),0.4261971685591447,1.171200913143086,0.25312934631432543,0.6309345990417633,1.0,11/40,13.93%,TAF9;SPI1;KAT7;TRIM16;TADA3;MBIP;KAT6A;TADA2A;JADE3;MAP3K7;KAT2B
prerank,regulation of RNA export from nucleus (GO:0046831),-0.4888193071736675,-1.1709708588753471,0.27114427860696516,0.703490692733725,1.0,6/11,16.28%,NSUN2;CPSF6;AKAP8L;DHX9;IWS1;TPR
prerank,regulation of cellular amine metabolic process (GO:0033238),0.4100216064512159,1.1704030125679326,0.22413793103448276,0.6323252414749182,1.0,13/50,12.97%,PSME3;PSMB7;PSME2;AZIN1;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,positive regulation of transmembrane transport (GO:0034764),0.5407112187461994,1.1701524229340337,0.27257799671592775,0.6323799989367842,1.0,5/13,12.73%,C2CD5;ACSL5;AZIN1;BRAF;CLIP3
prerank,positive regulation of cell aging (GO:0090343),0.5552289296612744,1.1701501725861876,0.2895622895622896,0.6317879263295729,1.0,4/11,17.25%,LMNA;ARG2;B2M;SIRT1
prerank,endomembrane system organization (GO:0010256),0.35445151595173224,1.1699956784359469,0.18907103825136612,0.6316092464063326,1.0,39/178,16.13%,ATP8B4;LRRK2;FAM174B;PLEKHF1;DYSF;USP6NL;GOLPH3L;TMCC1;LEMD3;CDC42;SRGN;CAV2;PI4K2B;STX17;TMED10;GBF1;SYP;BCAS3;ATL3;ARFGEF1;LMAN2L;ARHGAP21;LEMD2;DMPK;TRAPPC11;SPTSSB;HTT;DNM1L;EIF2AK3;SYNGR2;CLASP1;VMP1;RAB29;ATL1;TMED7;SNX33;VAPA;HACE1;TJAP1
prerank,regulation of DNA binding (GO:0051101),0.4221710274616913,1.1699621692964701,0.26768377253814146,0.6311043975117983,1.0,13/44,14.64%,SP100;NGF;BCL3;PPARG;JAK2;NFKBIA;SUMO1;DOT1L;CPNE1;MAPK8;TGFB1;RSF1;ILRUN
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.48599909125619134,-1.169260585554171,0.27525252525252525,0.7066960174261165,1.0,3/12,5.24%,CTSB;LMO2;THRB
prerank,negative regulation of histone methylation (GO:0031061),0.559243614923566,1.169196864227918,0.306368330464716,0.6323870924805184,1.0,1/10,0.35%,JARID2
prerank,positive regulation of signal transduction (GO:0009967),0.34920665822778857,1.168796487310664,0.1833508956796628,0.6328254861912963,1.0,48/238,16.52%,CD74;LRRK2;PTPRC;IL1B;CD226;GLI1;SULF2;JAK2;STAT3;ERN1;MYO1C;PTGIS;RSPO2;RSPO3;SORL1;NPTN;RBPJ;LMO3;CAV2;PTEN;TRIM16;PTK2B;RAB34;FLNA;TSPAN14;IL6ST;IL6;CSNK2A1;RPS3;DSTYK;HTT;TLR2;TUBD1;PDE6H;AGPAT1;KAT2B;CITED2;TXNDC15;GPS2;ASXL2;CREBBP;DISC1;POGLUT1;MAML1;ITGA5;TSPAN5;RELN;WNT7A
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.34283866275423996,-1.1683909221556916,0.19269102990033224,0.7075606328985898,1.0,9/35,8.48%,PLXNA4;NRP1;NRP2;PLXNB2;ARHGDIA;SEMA3D;SEMA3E;PLXNA2;SEMA6D
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.4744691112314416,1.1683288858450405,0.2753403933434191,0.6334221050450181,1.0,6/22,11.65%,LYN;PTPN22;RAB7B;TIRAP;IFI35;ACOD1
prerank,regulation of kinase activity (GO:0043549),0.37932890026307353,1.168098283211275,0.24299065420560748,0.6334492995292808,1.0,5/89,1.62%,CD74;FGR;FLT3;RET;LMTK2
prerank,protein targeting to ER (GO:0045047),0.3787626412651189,1.1677287517504469,0.22977725674091443,0.6337649967432641,1.0,42/99,23.89%,RPL5;RPS10;CHMP4A;CHMP4B;RPL37A;RPL6;RPS18;RPS14;RPL35A;RPL13;SEC63;RPS3;RPS21;SRP72;SRP19;RPLP0;RPL34;RPL19;RPL11;RPL30;RPL4;RPS2;RPL7;RPS15A;RPS4X;SPCS2;RPL32;RPSA;RPS13;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;RPS12;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,response to estradiol (GO:0032355),0.4490766050545651,1.167225091482437,0.27801418439716313,0.6345055291581108,1.0,7/31,14.30%,STAT3;NCOA3;STAT5B;ANXA1;NRIP1;STRN3;TGFB1
prerank,acylglycerol catabolic process (GO:0046464),-0.3685873375239452,-1.167193948301019,0.23104693140794225,0.7094479336556362,1.0,4/30,6.25%,ABHD12;MGLL;DAGLA;FABP5
prerank,negative regulation of macroautophagy (GO:0016242),0.459784600451286,1.1671894673499903,0.2727272727272727,0.6339994137212529,1.0,7/26,13.22%,LRRK2;CHMP4A;CHMP4B;CLEC16A;PIK3CA;SMG1;AKT1
prerank,negative regulation of histone modification (GO:0031057),0.5168030604270957,1.166482464681238,0.26788685524126454,0.6351490025831708,1.0,1/14,0.35%,JARID2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.46367622396459673,1.1663717598723575,0.2665684830633284,0.6348181354282038,1.0,7/27,14.30%,FGR;FLT3;PTK2B;PIK3R4;KIT;FGFR3;TGFB1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.46927943223266194,1.166234989259878,0.2765321375186846,0.6346105764091887,1.0,1/24,0.16%,TRPS1
prerank,regulation of presynapse assembly (GO:1905606),-0.41566064578192385,-1.1660938992927956,0.2650273224043716,0.7092183369167573,1.0,6/18,15.18%,PTPRD;IL1RAPL1;VPS35;GPC6;EIF4G1;SLITRK1
prerank,regulation of presynapse organization (GO:0099174),-0.41566064578192385,-1.1660938992927956,0.2650273224043716,0.7092183369167573,1.0,6/18,15.18%,PTPRD;IL1RAPL1;VPS35;GPC6;EIF4G1;SLITRK1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.4202825255041066,-1.1660168859065105,0.24864864864864866,0.7077242091399154,1.0,4/19,12.00%,APOE;CHRFAM7A;CHRNA7;SLC5A7
prerank,DNA metabolic process (GO:0006259),0.3461823013078899,1.1655881486821533,0.17578947368421052,0.6356133701615903,1.0,80/270,20.42%,SP100;UVRAG;DNA2;SAMHD1;LONP1;POLI;BTG2;RBBP8;POLL;CHRNA4;CDC45;USP3;MRE11;FEN1;SUMO1;PARP4;DNTT;ORC5;MCM6;UBE2N;POLD4;WRN;MBD4;USP45;ORC4;MSH3;NABP1;DOT1L;PSME4;SMUG1;BACH1;MSH6;FANCC;FANCL;TDG;KMT5B;RECQL5;PARG;DFFB;RPA3;POLA2;DDX23;EXD2;RAD54L;MCM2;ERCC3;ERCC4;FANCA;RNASEH2A;RNASEH1;VCP;XRCC2;USP7;UHRF2;ORC6;STN1;INO80;ENDOV;POLB;INIP;NSMCE4A;KPNA2;HUS1;POLD1;LRWD1;ORC2;LTO1;RAD17;RAD21;PRIMPOL;SETMAR;FANCG;DNMT1;DNASE1L1;TERF2;APEX1;PARK7;SUPV3L1;PDS5B;XPA
prerank,protein kinase A signaling (GO:0010737),0.5326278561687277,1.1648681655209279,0.28130360205831906,0.6369065290157863,1.0,2/12,7.93%,LCP1;EZR
prerank,artery morphogenesis (GO:0048844),-0.38133808644421296,-1.1645711366438898,0.23248407643312102,0.7100472252854686,1.0,6/30,4.20%,NRP1;TGFBR1;LRP1;PKD2;SMAD7;NF1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.41407650284645686,1.164371178720396,0.2519893899204244,0.6375419813578904,1.0,12/51,15.01%,JAK2;STAT3;CD36;MALT1;TRIM16;TMED10;IL6;NLRC4;NLRP3;APP;GBP5;MYD88
prerank,calcium ion transport (GO:0006816),-0.28677041178314033,-1.16434363358997,0.1417910447761194,0.709045967861048,1.0,30/113,13.56%,CACNA1D;SLC8A1;RYR3;SLC24A3;CACNB2;GAS6;CACNA2D1;TRPV2;TRPM3;PKD2;CDH23;CACNA1C;PSEN2;ATP2A2;TRPC4;P2RX7;ANK2;ATP2B2;P2RX4;TRPC1;CRACR2A;MCOLN1;CHRNA7;MCOLN3;CRACR2B;SELENOK;SLC3A2;TRPC7;TRPM2;TRPV4
prerank,regulation of protein processing (GO:0070613),0.47492761360925373,1.1641360507934373,0.28810975609756095,0.6375502705325552,1.0,3/21,10.15%,LRRK2;PRNP;NLRC4
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4570647862102915,1.1639134322523395,0.2717557251908397,0.6375761220265284,1.0,11/25,19.90%,CDK13;HEXIM1;RECQL5;NELFA;CDK12;EAF1;ELL;SUPT4H1;BRD4;RNF168;LARP7
prerank,ion homeostasis (GO:0050801),0.448352806521785,1.1635173831595476,0.2511078286558346,0.6380197020476598,1.0,5/30,7.53%,NEDD4L;SLC30A4;HCN4;SLC4A7;SLC4A8
prerank,positive regulation of transferase activity (GO:0051347),0.35997522192728926,1.1627146095792953,0.2031425364758698,0.6394809975035172,1.0,30/142,16.24%,CD74;FLT3;KLF4;RET;LMTK2;DTX3L;PKIB;SORL1;MRE11;FBXW7;AXIN1;DCUN1D1;UBE2N;EPHB2;PARM1;WRAP53;TNKS;MAP3K4;CHTF18;DSTYK;DCUN1D3;KIT;RPS2;FGFR3;TGFB1;AURKB;MAPK1;TCP1;POLG2;INSR
prerank,retrograde axonal transport (GO:0008090),-0.4502665995835644,-1.1617324449494282,0.28498727735368956,0.7151289428591266,1.0,5/16,8.32%,DST;DLG2;TMEM108;KIF1A;MAP1A
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.4743125796689169,1.161714506339808,0.28205128205128205,0.6414211631942682,1.0,4/21,6.81%,KCNE3;GJA5;KCNQ1;FLNA
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.35843731847346977,1.1614263339548743,0.20824295010845986,0.6415511719831934,1.0,63/168,21.90%,RPL5;RPS10;RPL37A;RPL6;RC3H1;RPS18;XRN2;HELZ2;PNLDC1;RPS14;RPL35A;DCP2;PPP2R2A;CNOT6;TUT1;MAGOHB;RPL13;ERI1;ETF1;TENT2;DHX34;RPS3;CNOT2;RPS21;UPF2;DCP1A;MTPAP;TUT7;RPLP0;RPL34;SMG1;RPL19;RPL11;RPL30;RPL4;RPS2;RPL7;EIF3E;MRTO4;TENT4B;RPS15A;NCBP1;RPS4X;PABPC1;SMG6;CNOT8;GSPT1;RPL32;RPSA;RPS13;UPF3B;TNKS1BP1;RPS6;RPL18A;RPS27;CNOT6L;RPLP2;UPF3A;PARN;RPL22;RPS7;CNOT3;RPS12
prerank,axon guidance (GO:0007411),-0.2564461308714799,-1.161344914056664,0.08333333333333333,0.7145616617094754,1.0,46/201,13.11%,OPHN1;PTPRM;DCC;PLXNA4;EVL;RHOH;NRP1;EPHA6;ROBO2;NRP2;FEZ2;ROBO1;CHN1;GFRA1;GAB1;CNTN4;PLXNB2;SMO;NFIB;SPTAN1;SEMA3D;EPHA5;SPTB;RYK;SEMA3E;PLXNA2;PLCG1;CDK5R1;KIF5C;EFNB3;SEMA6D;ARHGAP35;SLIT2;FEZ1;KLF7;PIK3R1;EFNA5;LAMA3;EPHA7;VEGFA;TUBB3;SCN1B;SLIT1;SLIT3;RAP1GAP;DOK1
prerank,cellular response to misfolded protein (GO:0071218),0.4708330376060904,1.1612084899025947,0.28298887122416533,0.6415068972503084,1.0,6/20,14.26%,CUL3;KLHL15;ATXN3;UBE2W;DNAJB12;VCP
prerank,histone modification (GO:0016570),0.36980531519749127,1.160766847499155,0.2361111111111111,0.6420625505142622,1.0,32/109,20.01%,HLCS;PADI1;NSD3;USP3;TBL1XR1;MTA3;RPS6KA5;PRMT8;UBE2N;ATXN7;HDAC9;KAT6A;RCOR3;MORF4L1;BAZ2A;MSL3;NSD1;EZH2;AURKB;PHF20;CREBBP;MIER1;NTMT1;EYA3;SIRT1;PADI2;HDAC1;PRKCD;EHMT1;MIDEAS;RCOR1;PARK7
prerank,peptidyl-amino acid modification (GO:0018193),-0.5073752771115105,-1.1606138879082983,0.27294117647058824,0.7150845650084705,1.0,2/10,3.64%,METAP1D;METAP2
prerank,telomere organization (GO:0032200),0.4237530273608305,1.1605223082555611,0.26812585499316005,0.6420831452887125,1.0,13/43,17.59%,SP100;DNA2;MRE11;H3-3A;POLD4;WRN;DOT1L;RPA3;ERCC4;STN1;HUS1;POLD1;LTO1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.44581582336145453,1.1602507622883345,0.27492447129909364,0.6421643105119442,1.0,12/29,21.61%,DTX3L;FBXW7;AXIN1;DCUN1D1;UBE2N;DCUN1D3;RPS2;PIN1;PINK1;PARK7;FEM1B;ARRDC4
prerank,sulfur compound catabolic process (GO:0044273),-0.3441201283634177,-1.1602283811700627,0.21830985915492956,0.7144861336696569,1.0,7/38,11.27%,HEXB;GALNS;GNS;ARSB;TXN2;CSPG4;HEXA
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4442090598532972,-1.159842405569804,0.2681704260651629,0.7137985619436797,1.0,9/15,33.35%,NLGN1;USP46;NLGN2;CNTNAP4;ADRA1A;CLN3;HAP1;DRD2;BAIAP3
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.44962783786450355,-1.159780859267829,0.2677595628415301,0.7122713075406846,1.0,7/15,14.23%,CSTF2;RTRAF;FAM98B;TSEN2;TSEN34;ZBTB8OS;RTCB
prerank,regulation of interleukin-13 production (GO:0032656),0.5300513061790524,1.1585262433336119,0.2838063439065108,0.6459023342098165,1.0,2/13,5.53%,RARA;IRF4
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5245219761627127,1.1583180578061962,0.3096774193548387,0.6457965063120579,1.0,3/13,16.91%,SORL1;GCC2;TMEM30A
prerank,regulation of microtubule polymerization (GO:0031113),-0.34745154509328036,-1.1579491679387146,0.25,0.7157609269707028,1.0,9/40,11.82%,NAV3;CAMSAP1;NUMA1;MAP2;CLIP1;CDK5R1;EML2;MAPRE1;CAMSAP2
prerank,cellular response to insulin stimulus (GO:0032869),-0.2730992979768236,-1.1577387454727526,0.1111111111111111,0.714702622755163,1.0,26/124,12.44%,PDE3B;BCAR3;ATP6V1C1;ATP6V0B;ATP6V0D2;CPEB2;ATP6V0C;TCIRG1;ENPP1;ATP6V1B2;GAB1;ATP6AP1;RAB31;CPEB1;GOT1;RHOQ;SLC27A1;ATP6V1D;PCK2;IDE;IRS1;ATP6V0D1;PIK3R1;NAMPT;MYO5A;ATP6V0A1
prerank,negative regulation of protein depolymerization (GO:1901880),-0.39598953047359114,-1.157536798284102,0.2342857142857143,0.7136445377982511,1.0,7/24,11.82%,NAV3;CAMSAP1;FGF13;CLASP2;LIMA1;PLEKHH2;CAMSAP2
prerank,negative regulation of type I interferon production (GO:0032480),0.4174565236356921,1.1563540074981298,0.2672998643147897,0.6501781637458068,1.0,13/40,15.45%,LILRB1;ITCH;DHX58;REL;NLRX1;IFIH1;TRIM25;CYLD;CACTIN;ACOD1;ILRUN;GPATCH3;TBK1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.456758903717254,1.1561889058979604,0.282798833819242,0.6499990621956424,1.0,8/26,20.01%,PLCG2;CD36;ABCB7;PIKFYVE;ABCD1;CYBA;MMP8;PARK7
prerank,regulation of Rho protein signal transduction (GO:0035023),0.3865182799167722,1.1561337966108574,0.25155666251556663,0.649563430543774,1.0,22/72,17.54%,ARHGEF18;EPS8;HEG1;CCDC125;CUL3;GPR35;RIPOR2;BCR;DLC1;ARHGDIB;F11R;RAC1;NET1;ITGA3;ARHGEF3;LPAR6;KCTD13;STARD13;ARHGEF28;GPR65;ABL2;KANK1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.41333302927680465,1.1558715405391793,0.28319783197831977,0.6496445856330129,1.0,8/43,8.69%,FFAR4;RUNX2;BMPR2;IL6R;ACVR2A;IL6ST;IL6;HGF
prerank,positive regulation of interleukin-10 production (GO:0032733),0.44557044971749526,1.1556491969680882,0.2901849217638691,0.6496024160694164,1.0,5/30,8.68%,PLCG2;SYK;STAT3;IRF4;IL6
prerank,regulation of autophagy (GO:0010506),0.35083958465136394,1.1554380397699056,0.19915254237288135,0.6495320649352485,1.0,44/216,13.86%,ITPR1;LRRK2;PTPN22;DAPK1;PIP4K2A;DRAM1;MCL1;PRKAG2;PIK3C2A;STAT3;PLEKHF1;ATP6V0E1;ERN1;EIF4G3;IL10RA;FBXW7;ATF6;DCAF12;MTMR3;PRKAB2;SVIP;PSAP;RMC1;MTMR4;HGF;ATP6V1H;CSNK2A2;DEPDC5;TLK2;EXOC7;PIP4K2B;TRIM14;PRKAG1;RHEB;FOXO3;TAB3;PRKAA1;SH3BP4;DNM1L;MAPK8;AKT1;SREBF2;ROCK1;PRKAA2
prerank,neuron projection morphogenesis (GO:0048812),0.3631662215111959,1.1548505721019489,0.22696629213483147,0.6504035497073787,1.0,18/137,9.13%,LRRK2;ALCAM;IQGAP1;SRGAP2;NGF;LMTK2;NTNG2;PAK1;SHTN1;DOCK10;CDC42;TAOK3;PTEN;ATP7A;EPHB2;MINK1;ZDHHC17;CPNE1
prerank,nucleosome assembly (GO:0006334),0.4475557032342249,1.154234696715019,0.2773722627737226,0.6514226648219786,1.0,13/31,22.45%,CHAF1A;H3-3A;RBBP4;SMARCA5;DAXX;NAP1L1;ATRX;RSF1;BRD2;HAT1;CABIN1;ANP32B;ASF1A
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.3019341117175107,-1.15422459115191,0.18316831683168316,0.7218672985878501,1.0,16/72,12.09%,NAV3;PRKN;APOE;TREM2;CAMSAP1;MAP2;FGF13;CLASP2;LIMA1;PFN1;PLEKHH2;SLIT2;EML2;MAPRE1;CAMSAP2;CLU
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.36529562920245084,-1.1541715503417016,0.22569444444444445,0.7203127684496551,1.0,10/32,20.30%,CAPN3;PKD2;PLCG1;TRPC1;P2RY6;AKAP6;CALM1;CX3CL1;CEMIP;GSTO1
prerank,regulation of embryonic development (GO:0045995),0.4348874709708225,1.1540791489423814,0.2745961820851689,0.6512281173836405,1.0,11/34,19.03%,RACGAP1;NIPBL;B4GALT5;PHLDB2;PLCB1;TDG;CLASP1;POGLUT1;INSR;NIBAN2;EHMT1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.4411616525361244,-1.1535825087548714,0.2890625,0.7204514943984529,1.0,6/15,16.43%,WHRN;SCN1A;HPN;KCNA1;ADGRV1;TMEM120A
prerank,protein localization to cell junction (GO:1902414),0.47835107948245703,1.153577361298568,0.31946508172362553,0.651907658562836,1.0,4/22,1.84%,ARHGEF18;MARVELD3;HEG1;NECTIN1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4802657658812801,-1.1535495002559155,0.2921615201900237,0.7188671994093186,1.0,5/12,23.50%,SYT1;SYT7;RIMS1;RIMS3;SYT8
prerank,positive regulation of chemotaxis (GO:0050921),-0.3365894569110726,-1.1534264719293588,0.20463320463320464,0.7175486679337413,1.0,9/43,5.38%,LGMN;TREM2;P2RY12;NRP1;NTRK3;FGF2;AIF1;PTN;P2RX4
prerank,TOR signaling (GO:0031929),0.4470339970171968,1.1531534761236706,0.2894736842105263,0.6524126428729579,1.0,13/26,21.48%,CARD11;EIF4EBP1;CCDC88A;SMG1;AKT1;MAPKAP1;PRR5;RPS6KB1;SYAP1;PINK1;RPS6;RICTOR;TIPRL
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.45122762329365435,1.1530606547179567,0.29154078549848944,0.652039126644839,1.0,7/27,7.62%,ARHGEF18;WASF2;DLC1;ARAP1;PAK2;PHLDB2;F11R
prerank,protein K48-linked ubiquitination (GO:0070936),0.3997163012258119,1.1530250431563032,0.2619974059662776,0.6515358605991275,1.0,11/54,8.29%,ITCH;DTX3L;NEDD4L;CUL3;UBE2E1;RNF146;PELI1;UBE2D3;UBR5;FBXO38;ARIH2
prerank,phagosome maturation (GO:0090382),-0.35482933225965013,-1.1529342361248716,0.23404255319148937,0.7173240050555337,1.0,13/35,12.44%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;RAB31;ATP6V1D;RAB32;MCOLN1;ATP6V0D1;MREG;ATP6V0A1
prerank,negative regulation of cholesterol transport (GO:0032375),0.5499042612366145,1.1526958534518157,0.31010452961672474,0.6517683224521726,1.0,2/10,13.71%,NFKB1;SREBF2
prerank,phagosome acidification (GO:0090383),-0.3855697107503445,-1.1526468660978666,0.24921135646687698,0.7164941087973227,1.0,9/26,12.44%,ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;ATP6V1D;ATP6V0D1;ATP6V0A1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5564105612882921,1.152224637886489,0.28471001757469244,0.6518209791650013,1.0,4/10,16.32%,KLF4;MBP;MAP2K5;MYADM
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5564105612882921,1.152224637886489,0.28471001757469244,0.6518209791650013,1.0,4/10,16.32%,KLF4;MBP;MAP2K5;MYADM
prerank,programmed necrotic cell death (GO:0097300),0.4919789567904225,1.1522054736681264,0.28731942215088285,0.6512728089879528,1.0,7/18,15.37%,ITPK1;TLR3;CYLD;RIPK1;PGAM5;DNM1L;IPMK
prerank,ATP transport (GO:0015867),0.5560995131453546,1.152123713070432,0.3188908145580589,0.6509104729067193,1.0,2/10,11.97%,CD47;SLC25A5
prerank,regulation of calcium ion transport (GO:0051924),-0.3211512063392855,-1.1517568277758035,0.204,0.7174567955222619,1.0,9/54,5.38%,CACNA1D;CD84;CACNB2;CACNA2D1;CD33;CTNNB1;PKD2;ANK2;P2RX4
prerank,cyclooxygenase pathway (GO:0019371),-0.4878116488622522,-1.151484927691427,0.30174563591022446,0.7165576504057055,1.0,2/10,0.82%,HPGDS;PTGS1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.46092484399834566,1.1511010473547842,0.29185867895545314,0.6523064322695762,1.0,8/23,15.44%,ZEB2;HIPK2;ADAM17;SMAD4;ING2;CITED2;CREBBP;THBS1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.46092484399834566,1.1511010473547842,0.29185867895545314,0.6523064322695762,1.0,8/23,15.44%,ZEB2;HIPK2;ADAM17;SMAD4;ING2;CITED2;CREBBP;THBS1
prerank,glycosphingolipid metabolic process (GO:0006687),-0.3380196382062752,-1.150817950955934,0.20463320463320464,0.7168058990970605,1.0,10/42,11.27%,HEXB;LARGE1;CERK;B3GALNT1;CTSA;GALC;NEU1;ST6GALNAC6;ST6GALNAC5;HEXA
prerank,negative regulation of cell growth (GO:0030308),-0.28112034871905345,-1.1508052479151032,0.15625,0.7151948664715613,1.0,39/121,21.83%,APBB2;DIP2B;DCC;ULK2;FLCN;VGLL4;MAP2;FGF13;ENPP1;NDRG3;IP6K2;ADAM15;CDKL3;CAPRIN2;PRDM11;SLIT2;RERG;DNAJB2;SMAD3;DCBLD2;GJA1;SLIT3;TCHP;TGFB2;APBB1;CGRRF1;ACVR1B;SPHK2;DDX3X;ING1;SESN2;HYAL1;NDUFA13;MT3;PPP2R1A;RACK1;GNG4;CCDC85B;DACT3
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.4704369057593107,1.1506000189601213,0.3071104387291982,0.6529890304950259,1.0,5/21,12.95%,RPL5;MAD2L2;PTEN;UBE2S;RPL11
prerank,lipoxygenase pathway (GO:0019372),0.5292316452313315,1.1493808641580519,0.31699346405228757,0.6555839899522814,1.0,2/14,2.70%,ALOX5AP;GPX1
prerank,protein polyubiquitination (GO:0000209),0.3380414247794528,1.1493645983921816,0.19854469854469856,0.6550353919866725,1.0,82/297,18.68%,TRAF1;DTL;LNPEP;ITCH;PSME3;DTX3L;NEDD4L;CUL3;UBE2E1;PSMB7;FBXW7;ANKIB1;RNF146;PSME2;TRIM62;ARIH1;TRAF3IP2;RNF20;RNF213;PELI1;RC3H1;UBE2D3;UBE2QL1;SPOP;FBXW11;FBXL8;UBE2N;UBR5;RNF217;FBXO38;FBXW2;HECTD1;CBFB;TRAF3;FBXO4;UBR2;PSME4;ARIH2;TNKS;WWP2;TRIM71;UBE2W;PSMB8;FBXO32;PSMD9;PSMA5;TRIM14;RNF31;HERC6;FBXL17;PSMB3;UBE2S;PSMD6;PSMC4;LONRF1;TPP2;PSMD10;UBE2G1;AREL1;PSMB1;FBXL12;FBXO30;HECTD2;UBE2J2;FBXO7;RNF166;ANAPC7;TAF1;RNF41;HACE1;FBXL16;PSMD12;TRIM36;UBE2Q2;TRAF2;RNF144A;RNF19B;SMURF2;ANAPC11;FZR1;FBXL14;ANAPC4
prerank,microtubule anchoring at centrosome (GO:0034454),0.5465465851532701,1.1493221512395893,0.3118466898954704,0.6545523516062917,1.0,2/10,7.30%,CCDC120;NIN
prerank,endothelial cell proliferation (GO:0001935),0.4896276492489149,1.1488100943715231,0.3030769230769231,0.6552707854547735,1.0,2/17,2.95%,ERN1;BMPR2
prerank,skeletal system development (GO:0001501),0.3570326352228962,1.1484970602781333,0.23008849557522124,0.6555143828654373,1.0,25/148,14.30%,TRPS1;CD44;EXT1;SULF2;ANKRD11;RPS6KA3;NOTUM;PTGER4;DEAF1;ATP7A;PAPSS1;BMP3;XYLT1;PAPSS2;RPL13;ACAN;FBN1;TLL1;NCAN;ETS2;SLC10A7;EIF2AK3;PCSK5;CNMD;FGFR3
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4804784722009971,-1.1484557717861792,0.272264631043257,0.7202814529149573,1.0,6/12,38.70%,STARD3;AKR1B1;FDX1;TSPOAP1;STAR;CACNA1H
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2895320849389464,-1.148419373962024,0.17964071856287425,0.7187303273428017,1.0,33/96,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;ZC3H11A;SEC13;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;NUP37;HNRNPA2B1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5012499074202573,-1.1482335670229171,0.29723502304147464,0.7176691254066893,1.0,3/10,8.47%,TGFBR2;FGFR2;PDGFA
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3560362569193316,1.1481241188126867,0.2157079646017699,0.6558621824569186,1.0,41/166,18.12%,RARA;NOTCH2;HNF4G;PPARG;GTF2F2;TAF1A;TAF13;GTF2E2;TAF9;POLR2C;TBL1XR1;RBPJ;SMARCA5;POLR1G;THRA;RARG;CCNH;GTF2A1;E2F2;HDAC9;NR3C1;MED26;TAF7;TFAM;TEAD1;ERCC3;KAT2B;HDAC3;POLR1B;RSF1;MAZ;CREBBP;TAF1;MAML1;MED1;TFB1M;MED7;TAF1C;NR4A1;HDAC7;HDAC1
prerank,response to muscle stretch (GO:0035994),-0.4423020847956164,-1.1480247286799004,0.2755102040816326,0.7166614137621518,1.0,2/15,3.17%,SLC8A1;CTNNB1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.39336082521259613,-1.1477666225137346,0.2680965147453083,0.7158154240060902,1.0,6/20,13.62%,CHRM3;RGS10;CHRM2;CDK5R1;CHRNA7;AGRN
prerank,sodium ion transmembrane transport (GO:0035725),-0.2865467364524031,-1.1477083610606817,0.1901840490797546,0.7143877341490477,1.0,15/84,13.78%,SLC8A1;SLC24A3;SCN1A;ATP1B3;PKD2;ATP1B1;SLC6A15;SCN3A;SLC9A9;SLC9A6;ATP1A2;HCN1;HCN2;SCN1B;SLC6A8
prerank,purine ribonucleotide transport (GO:0015868),0.49019386955393784,1.1475972558768606,0.3001579778830964,0.6566221808802708,1.0,3/16,11.60%,LRRC8C;LRRC8D;ABCC4
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.5183943460943504,1.1475548533702773,0.3058637083993661,0.6561559537445308,1.0,5/14,15.54%,ERN1;FIP1L1;TUT1;NUDT21;NCBP1
prerank,eye development (GO:0001654),0.4031906216992451,1.1473463784234672,0.2858990944372574,0.6561151335814455,1.0,9/54,10.99%,MAB21L2;SIPA1L3;NIPBL;COL5A2;ATF6;HIPK2;HIPK1;FBN1;PBX1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.3477990793836594,-1.1470515438358206,0.2421875,0.7146916030726913,1.0,12/40,15.96%,SLC8A1;MEF2C;NELL1;PTN;TMEM119;P2RX7;ACVR1;ACVR2B;BMPR1B;PKDCC;BMP6;ADGRV1
prerank,acylglycerol metabolic process (GO:0006639),-0.34673495626791967,-1.1468940841788837,0.23722627737226276,0.7135345522954294,1.0,4/37,2.13%,APOE;ABHD12;DGKZ;MGLL
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.459076064982184,-1.1466195376339874,0.29064039408866993,0.7127124516413388,1.0,6/13,16.06%,PLPP1;PGR;NR3C2;CALCOCO1;ESR1;AR
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.40602221511947223,-1.146325904116515,0.2712765957446808,0.711848372180041,1.0,4/21,4.39%,NAV3;CAMSAP1;FGF13;CLASP2
prerank,negative regulation of innate immune response (GO:0045824),0.4311613312882001,1.1461968391981412,0.2900976290097629,0.6585010043328005,1.0,10/34,13.30%,SAMHD1;DHX58;YTHDF3;USP15;SLAMF8;FAM3A;CACTIN;ACOD1;STAT2;METTL3
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.34855765775028846,1.145763137988878,0.23,0.6589710041504047,1.0,13/159,5.43%,JAML;ITGAL;ALCAM;EMB;PECAM1;NECTIN1;PCDHB11;CLDN1;SELL;CD177;NPTN;CLDN12;ITGB2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.5040510309823064,1.1452808368183727,0.3073170731707317,0.6595424627874062,1.0,5/14,15.96%,FASTKD1;FOXO3;TFAM;PNPT1;TFB1M
prerank,cellular response to drug (GO:0035690),0.4577382603789741,1.1451606916124841,0.2967189728958631,0.6592783479957641,1.0,7/25,11.91%,IL1B;KCNQ1;DPEP1;CERS1;RBM22;SLAMF8;REST
prerank,extracellular matrix assembly (GO:0085029),0.4683408982250285,1.1451311024997028,0.3086232980332829,0.6587589685302265,1.0,4/23,8.25%,NTNG2;LAMB1;ATP7A;PXDN
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.4549485178656215,-1.1447312493479929,0.2898550724637681,0.7147537055668194,1.0,2/12,0.70%,APOE;TREM2
prerank,eye morphogenesis (GO:0048592),0.47464804788705295,1.144658121061688,0.30387596899224806,0.6593148920899371,1.0,5/19,9.68%,STAT3;NIPBL;COL5A2;RARG;FBN1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.42990530584243436,-1.1445096014798493,0.28254847645429365,0.7137956783269823,1.0,10/17,44.91%,LPCAT1;PLA2G4A;SERAC1;LPGAT1;PLA2G3;CRLS1;LPCAT4;PLA2G5;PLA2G4F;PLA2G2D
prerank,fluid transport (GO:0042044),-0.4678751584521247,-1.144335193535545,0.2804878048780488,0.7126967216100074,1.0,3/12,27.15%,AQP4;SLC26A6;PDPN
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3812730035506807,1.144210162008571,0.27909887359199,0.6598450057659698,1.0,17/70,13.30%,ITCH;PSME3;EIF2AK2;PSMB7;PSME2;CBFB;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MYB;METTL3
prerank,pyroptosis (GO:0070269),-0.43414068163365244,-1.1441341090710988,0.27371273712737126,0.7116706041162661,1.0,3/15,13.86%,TREM2;CASP4;DHX9
prerank,amino acid transmembrane transport (GO:0003333),-0.3300691943634684,-1.1438338831521007,0.22262773722627738,0.7109585531478804,1.0,8/45,6.03%,SLC38A6;MFSD12;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC36A1;SFXN1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.34741579732934696,1.1433631723252835,0.23109691160809373,0.6614351255096081,1.0,49/190,17.75%,ITPR1;CYRIB;LYN;LIMD1;DGKG;TNIP3;MCL1;SPI1;CD2AP;NLRX1;STAT1;MAPK14;PTEN;CIB1;PDE2A;DDIT4;UBR2;PHLPP1;IFI35;CPNE1;DEPDC5;TANK;CYLD;RIPK1;CACTIN;DUSP1;PRKAA1;NLRP3;PSMD10;SH3BP4;MAP2K3;AKT1;TLE1;MARK3;CARD19;PRKAA2;PTPRJ;PPP2R5C;GSTP1;RELA;SPRED1;THBS1;MYADM;AJUBA;CGNL1;PIK3R2;SIRT1;PLAUR;HDAC7
prerank,positive regulation of monooxygenase activity (GO:0032770),0.44489948730787676,1.1433046785595153,0.30015082956259426,0.6610112353585529,1.0,4/26,7.66%,IL1B;GDNF;SCARB1;ATP7A
prerank,epithelial cell morphogenesis (GO:0003382),0.48443702621615287,1.142943430746525,0.302066772655008,0.6613660423227802,1.0,4/17,14.00%,SIPA1L3;CCDC88C;RILPL2;CNMD
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.37849223409640675,1.142656792456521,0.26092384519350814,0.6615161902608477,1.0,18/73,13.30%,ITCH;PSME3;SPI1;EIF2AK2;PSMB7;PSME2;CBFB;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MYB;METTL3
prerank,positive regulation of bone resorption (GO:0045780),-0.47691798940449837,-1.1421353382484507,0.3035294117647059,0.7142437407651654,1.0,4/11,5.32%,SPP1;TNFRSF11A;ATP6AP1;ADAM8
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4621657313914178,1.141793521652783,0.2916030534351145,0.663190959042039,1.0,9/24,18.87%,PSME3;GPX1;PSME2;PTK2B;LATS1;EFNA1;USP14;CTSC;PINK1
prerank,action potential (GO:0001508),0.40914872409584646,1.1412290799222218,0.3012211668928087,0.6639722660121107,1.0,4/44,3.56%,KCNE3;GNA14;KCNQ1;CHRNA4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.45570375901254034,1.1411502741860866,0.30434782608695654,0.6635885270516146,1.0,5/27,3.86%,PPARG;NFKB1;CD36;PRKCH;NFKBIA
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.38909985403651465,1.1406111843487758,0.27564102564102566,0.6644121051033475,1.0,14/61,12.97%,PSME3;PRKAG2;PSMB7;PSME2;AZIN1;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4484182646901089,-1.1403856302334079,0.2969543147208122,0.7177234826152393,1.0,8/14,26.74%,SEC23B;TBC1D20;SEC23A;SEC13;SAR1A;SEC24A;SEC24D;SEC31B
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4276525357082097,-1.1403825422769656,0.29533678756476683,0.7161410539677117,1.0,2/16,5.30%,PRKN;PDK1
prerank,regulation of glycolytic process (GO:0006110),0.3859586239305038,1.1402854780997986,0.2686002522068096,0.6646213289331313,1.0,18/68,16.93%,CBFA2T3;NUP210;PRKAG2;ZBTB20;PRXL2C;NUP98;GIT1;PRKAG1;PRKAA1;APP;PFKFB3;NUP153;PRKAA2;PFKFB4;SEH1L;INSR;GCK;PSEN1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.41898618338801547,1.1402033683822232,0.2893258426966292,0.6642503334135751,1.0,7/39,7.28%,MYO1G;MYO1E;MYO1C;KIF5B;FBXW11;MYO5B;PAFAH1B1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.464698282129228,1.1397692272861362,0.29606299212598425,0.6647410995921373,1.0,5/22,15.86%,DUSP16;DUSP6;DUSP1;PPM1D;PPM1G
prerank,regulation of cell cycle process (GO:0010564),0.36150138783825825,1.1397483991724846,0.24125874125874125,0.6641970046578036,1.0,20/104,12.06%,UVRAG;CDK13;RACGAP1;KIF20A;BIRC6;SND1;CDC42;CAV2;IHO1;E4F1;GIT1;CSNK2A2;CSNK2A1;RPRD1B;CEP250;SETD2;TXLNG;DCUN1D3;DYNC1H1;PIK3R4
prerank,negative regulation of protein phosphorylation (GO:0001933),0.35709839086032846,1.1397320002913123,0.22853957636566333,0.6636564971949434,1.0,33/150,15.21%,NIBAN1;LRRK2;PID1;PTPRC;LYN;PRKAG2;PTPN6;IBTK;PRKRIP1;PTEN;PRNP;PDPK1;SAMSN1;CIB1;PAK2;DDIT4;PAQR3;ENG;EPHB2;SPRED3;GSKIP;PMEPA1;DBNDD2;CACTIN;TAF7;PPP1R15B;MVP;AKT1;DNAJC3;TGFB1;GSTP1;OCLN;SPRED1
prerank,positive regulation of exosomal secretion (GO:1903543),0.5027489317545547,1.1394574429367768,0.317741935483871,0.6637831714303724,1.0,5/15,11.11%,RAB7A;TSG101;PDCD6IP;SNF8;STAM
prerank,positive regulation of developmental process (GO:0051094),-0.2610358031148209,-1.1393433909609785,0.12359550561797752,0.7175368173407078,1.0,36/164,16.06%,PRKN;RREB1;BASP1;APOE;NLGN1;NUMA1;SPIRE1;CAMK1;PTN;GRIP1;DLG4;CLASP2;TMEM119;ENPP2;ACVR1;ADGRL1;TFRC;MFF;RBM19;RIF1;VPS35;SHLD2;CFL1;RALA;PHLDB1;PA2G4;VEGFA;GJA1;MDK;BMPR1B;SRC;DAB2IP;HMCES;SOX5;CPEB3;AR
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3276518923047997,1.1393195609584523,0.027,0.6635553707029981,1.0,254/1646,13.75%,CD74;CIITA;CBFA2T3;BCL11A;TRPS1;NFE2;ZBTB46;IL1B;BACH2;JARID2;FOXP1;RUNX2;HIVEP2;RARA;SP100;SP3;BAZ1A;RUNX3;STAT4;LIMD1;TOX4;GLI1;HNF4G;BCL3;KLF4;UXT;CREB1;RET;MAP3K5;PPARG;MED13L;ETV6;STAT5A;SCML4;BCL6;PKN1;SAP30;POLR3F;NFKB1;PITX3;ATF7IP;FOSL2;DTX3L;STAT3;BAZ2B;EHF;NSD3;FOXJ1;ELF4;RFX7;NIPBL;FOS;KDM7A;CRK;NAB1;TCF20;RPS6KA3;CIART;MAD2L2;REL;RBBP8;ZBTB20;CRLF3;CDC45;SPI1;STAT5B;NAA16;MYRF;CRY1;SCX;TBL1XR1;ATAD2;ZEB2;IKBKB;MTA3;PICALM;MED30;MBD1;PGBD1;SUMO1;CAMTA2;ATF6;KAT7;LRRFIP1;KLF8;RYBP;AXIN1;ATF2;IRF2;RFX3;RBPJ;RPL6;ZNF319;BTG1;HIVEP1;WAC;DEAF1;HIPK2;STAT1;RNF20;MED13;KLF5;IRF4;HEXIM1;MAPK14;FBXW11;MBTD1;BBX;RPS6KA5;RFX5;CDK14;SMARCA5;KLF13;FAM47E;TSHZ1;TRIM16;CDC5L;SEC14L2;DEK;KLF10;ELOA;AHR;ANXA4;CREBRF;PHF19;TADA3;ARID4A;CBFB;CREM;SRSF10;IKZF3;NFE2L2;PDCD4;KDM3B;DYRK1A;MECP2;SETDB2;PURB;HTATSF1;PLCB1;AFAP1L2;THRA;CRY2;CLOCK;SAP18;ZFP3;MED6;GATAD2A;CCNH;TOX3;E2F2;ENG;CTCF;PHF12;UIMC1;HDAC9;NFYC;ELF1;ZBTB11;PEX14;IL6;CBFA2T2;ZNF182;BRIP1;BACH1;NFE2L1;SNF8;RBAK;KAT6A;ASCC1;WWP2;NAA15;EPC2;ID2;CREBL2;NCOA2;E4F1;SETD5;PKNOX1;PARP9;SMARCE1;ZNF496;ZFX;IRF7;MEF2B;METTL4;RCOR3;CAMKK2;SMAD4;SBNO2;PSMD9;CNOT2;NCOA1;BNC2;NR3C1;DAXX;TADA2A;IL31RA;CSRNP1;GMEB2;RBM15;SPEN;SP140;PBX1;ING2;SRRT;CCNT2;NLK;MED26;FOXO3;MED12;IKZF5;DEDD2;DVL3;TAF7;ZNF260;ETS2;REST;RPS6KA1;ZNF418;MBD2;ATF6B;BAZ2A;NUPR2;MED14;NFYA;CCNT1;LIN9;TFAM;PQBP1;MSL3;TEAD1;MAP2K3;RGS14;KLF9;ATRX;L3MBTL2;CCNL1;MYB;IFRD1;STAT2;KIT;AKT1;SRCAP;NSD1;TLE1;LBH;CHD4;EZH2;NCF1;JUNB;HCLS1;SREBF2;SMARCC2
prerank,cardiac ventricle development (GO:0003231),0.47397776104157907,1.1390608122360497,0.29264475743348983,0.6636277276385854,1.0,4/20,8.16%,GJA5;HECTD1;PDE2A;ENG
prerank,regulation of actin filament polymerization (GO:0030833),0.3866148772044472,1.1388767688602899,0.2694235588972431,0.6635104816398307,1.0,12/69,10.69%,CYRIB;HCK;PRKCE;ARHGAP18;CARMIL1;PTK2B;KANK3;MTPN;LATS1;ARFGEF1;SNX9;VASP
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4714450350628491,1.138873394326233,0.3106646058732612,0.6629354340600383,1.0,5/19,14.22%,PTPRC;PRNP;FIS1;FKBP1B;PTPRJ
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.35010211316207157,-1.1387263873025113,0.24915824915824916,0.7178205461749714,1.0,9/33,12.09%,PRKN;IGF1;FLCN;BCL2L1;SLC35F6;TFRC;MPV17L;VAT1;CLU
prerank,positive regulation of binding (GO:0051099),0.37203347715397306,1.1382289136230272,0.2788697788697789,0.6639599642805933,1.0,25/84,18.72%,LRRK2;RARA;TIAM1;NGF;PPARG;DTX3L;RAPGEF2;HIPK2;STK4;RALB;PARP9;B2M;NMD3;APP;RPL11;MARK3;TAF1;NCBP1;DPH3;PSEN1;PLAUR;MMP8;FOXC1;PIN1;STK3
prerank,amino acid transport (GO:0006865),-0.3185293244971105,-1.1379809956546154,0.24060150375939848,0.7183014207355367,1.0,10/49,12.61%,SLC38A6;SLC7A6;SLC7A1;SLC36A4;SLC7A7;SLC6A15;SLC36A1;SLC7A2;SLC7A8;SLC3A2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5192426071094114,1.1379790122315538,0.3225255972696246,0.6639925244778936,1.0,5/13,16.09%,BTG2;EIF4ENIF1;TNRC6B;TNRC6A;PABPC1
prerank,ruffle organization (GO:0031529),-0.42021223027819654,-1.13771859647632,0.2926208651399491,0.7175034533633985,1.0,3/16,4.53%,CSF1R;AIF1;LIMA1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.44910027201281155,1.1376014914924786,0.31966053748231965,0.6643652387807566,1.0,7/28,10.90%,DTX3L;MAD2L2;SMCHD1;ACTR2;WRAP53;PARP9;KMT5B
prerank,nuclear pore complex assembly (GO:0051292),0.5494410729584399,1.1373178044710408,0.34146341463414637,0.6644843222416569,1.0,4/10,18.18%,NUP98;RTN4;NUP153;NUP93
prerank,positive regulation of interferon-alpha production (GO:0032727),0.4718105807667483,1.1370219677542648,0.3159509202453988,0.6646692101737388,1.0,10/19,21.97%,STAT1;IFIH1;TLR3;IRF7;SETD2;TBK1;IRF5;HSPD1;RIPK2;TLR8
prerank,regulation of anoikis (GO:2000209),0.4738328819259843,1.1369201955877972,0.31441717791411045,0.6643582460516028,1.0,5/19,15.68%,SIK1;MCL1;PIK3CA;TLE1;ITGA5
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.44123392334866246,-1.1367754611380136,0.2918781725888325,0.7168857452408287,1.0,5/15,15.39%,DTNBP1;AP3M2;AP3B1;AP3B2;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.44123392334866246,-1.1367754611380136,0.2918781725888325,0.7168857452408287,1.0,5/15,15.39%,DTNBP1;AP3M2;AP3B1;AP3B2;BLOC1S5
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3671297797211773,1.1362663984613064,0.27548543689320387,0.6654412067543073,1.0,20/88,13.33%,PSME3;CUL5;PSMB7;FBXW7;PSME2;FBXW11;FBXL8;FBXO38;FBXO4;PSME4;PSMB8;PSMD9;PSMA5;FBXL17;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;FBXL12
prerank,bile acid metabolic process (GO:0008206),-0.36568989438297395,-1.1360741880526333,0.28173374613003094,0.7172628150699956,1.0,13/27,34.13%,OSBPL1A;CH25H;NPC1;GBA2;OSBPL6;AMACR;OSBPL7;ACOT8;OSBP;SLC27A2;OSBPL2;HSD17B10;CYP7B1
prerank,regulation of cholesterol esterification (GO:0010872),-0.49284796847824874,-1.1358981362821778,0.3194444444444444,0.7162381420903057,1.0,5/10,32.43%,APOE;APOC1;LAMTOR1;ABCA2;STARD4
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.45059934730762413,1.1354472561900923,0.3109118086696562,0.6669138553287928,1.0,2/25,3.56%,LRRK2;CHRNA4
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4036478867320333,1.1353371352924104,0.28425096030729835,0.6666181952265152,1.0,10/51,8.98%,CD47;PAK1;ARHGEF10L;CCDC88A;CDC42;CARMIL1;S100A10;RAC1;PXN;RHOA
prerank,protein tetramerization (GO:0051262),-0.3035705388349024,-1.1352147478022163,0.20179372197309417,0.7166281808485213,1.0,16/67,13.56%,RYR3;ACACA;APPL2;PKD2;KCNJ2;ALDH9A1;GOLGA2;MCOLN1;CPSF6;OXA1L;HCN1;USP16;TRPM2;CBR4;AQP4;HSD17B8
prerank,gene silencing by miRNA (GO:0035195),0.4357786208858828,1.1351466405598154,0.3174825174825175,0.6664795797029381,1.0,10/32,17.02%,LIMD1;XPO5;PUM2;CNOT6;TRIM71;TNRC6B;TNRC6A;PUM1;AJUBA;CNOT8
prerank,spinal cord development (GO:0021510),-0.46286798295488263,-1.1351241039151665,0.2711864406779661,0.7153722358309038,1.0,5/12,16.96%,PKD2;NF1;LOXL3;SOX4;SOX11
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.35696634816888834,1.13505488974136,0.24321266968325791,0.6661493842942876,1.0,33/138,18.12%,RARA;NOTCH2;HNF4G;PPARG;GTF2F2;TAF13;GTF2E2;TAF9;POLR2C;TBL1XR1;RBPJ;THRA;RARG;CCNH;GTF2A1;E2F2;HDAC9;NR3C1;MED26;TAF7;TEAD1;ERCC3;KAT2B;HDAC3;MAZ;CREBBP;TAF1;MAML1;MED1;MED7;NR4A1;HDAC7;HDAC1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.48477394962841563,1.1348418669375355,0.32591414944356123,0.6661029269572905,1.0,7/17,18.35%,HCK;STAP1;CDC42;BCAS3;HCLS1;FES;HAX1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.41236256631145085,1.134361255175265,0.29535864978902954,0.6667086445193241,1.0,4/39,2.59%,FXYD5;PRKCE;UTRN;NEDD4L
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.3804443928773542,-1.134032591707326,0.2701863354037267,0.7168533613206739,1.0,13/24,19.56%,GRN;CTNNB1;NF1;ATF4;CDK5R1;BACE1;CDK5;EPHA7;SRPK2;TGFB2;BAX;CCL3;TYROBP
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5239544449962423,1.1336040668354528,0.32669983416252074,0.6680208592774404,1.0,5/12,13.67%,SMCHD1;YTHDC1;RBM15;METTL3;CDYL
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.42078985364787574,-1.1333634702996647,0.3101449275362319,0.7171389957480531,1.0,7/17,15.54%,SLC8A1;CACNA1C;PRKACA;ATP1B1;ATP1A2;GJA1;PKP2
prerank,regulation of fibroblast proliferation (GO:0048145),0.40622717294470234,1.1332772858393523,0.2979591836734694,0.6682630811919722,1.0,2/45,2.92%,CD74;CD300A
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4394076986890327,1.1332200656524862,0.2887218045112782,0.6678536216897031,1.0,8/29,13.84%,CREB1;LDLR;ZBTB20;SCARB1;ELOVL5;CREBL2;AKT1;SIRT4
prerank,regulation of focal adhesion assembly (GO:0051893),0.3901918799101082,1.1332092200653034,0.2749360613810742,0.6673099164620516,1.0,19/54,17.99%,SLK;RCC2;DLC1;PTEN;S100A10;PHLDB2;RAC1;RHOA;BCAS3;ROCK1;CLASP1;PTPRJ;COL16A1;THBS1;DUSP22;DAPK3;ARHGAP6;VCL;PTPRA
prerank,positive regulation of response to wounding (GO:1903036),0.4586841342886034,1.1331289610524844,0.32228915662650603,0.6669603879869697,1.0,9/24,20.81%,PRKCE;CLDN1;ADRA2A;ARFGEF1;ANXA1;OCLN;KANK1;PTK2;INSL3
prerank,DNA alkylation (GO:0006305),0.477450721078597,1.1329087322068503,0.3164763458401305,0.6663651640117286,1.0,10/19,19.43%,ATF7IP;FOS;GATAD2A;MTRR;BAZ2A;ATRX;PPM1D;KMT2E;EHMT1;DNMT1
prerank,DNA methylation or demethylation (GO:0044728),0.477450721078597,1.1329087322068503,0.3164763458401305,0.6663651640117286,1.0,10/19,19.43%,ATF7IP;FOS;GATAD2A;MTRR;BAZ2A;ATRX;PPM1D;KMT2E;EHMT1;DNMT1
prerank,cognition (GO:0050890),0.41655375816417817,1.1328661524389154,0.3168724279835391,0.665900852803123,1.0,11/42,12.23%,ST3GAL4;NIPBL;CHRNA4;DGCR2;PTCHD1;RP9;MGAT3;SETD5;MAGT1;SLC1A4;APP
prerank,regulation of stem cell differentiation (GO:2000736),0.3701673341097915,1.1326967705153301,0.27106227106227104,0.6657386097633412,1.0,23/89,16.29%,ITCH;PSME3;EIF2AK2;PSMB7;PSME2;GDNF;CBFB;PSME4;ZFP36L2;PSMB8;PSMD9;PSMA5;NUDT21;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;MYB;METTL3;KMT2A;OCIAD1;PSMD12
prerank,insulin secretion (GO:0030073),-0.41175013927949766,-1.1325529350685017,0.29442970822281167,0.7178334499435675,1.0,4/19,7.40%,PTPRN2;RAB11FIP2;RAB11FIP5;SNX19
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.39356193315609017,1.1323667958500683,0.2735483870967742,0.6659409362008523,1.0,13/53,12.97%,PSME3;PSMB7;PSME2;AZIN1;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,regulation of RNA metabolic process (GO:0051252),0.387028707056669,1.131907193799268,0.2929936305732484,0.6665068925036013,1.0,17/59,16.00%,MBNL1;AHNAK;PTBP3;OAS2;PRX;MBNL3;RC3H1;OASL;METTL4;IGF2BP3;PQBP1;HNRNPLL;TNFRSF1B;RBM38;CELF1;MED1;PTBP2
prerank,amino acid import across plasma membrane (GO:0089718),-0.37376207050571747,-1.1317917006314286,0.28923076923076924,0.7184835650409163,1.0,7/24,14.55%,SLC1A3;SLC7A1;SLC36A1;SLC7A2;SLC7A8;SLC3A2;SLC22A4
prerank,ceramide metabolic process (GO:0006672),0.3996280074628268,1.1316301975701943,0.28419654714475434,0.6666467476091795,1.0,7/49,8.27%,CERS6;ACER3;CERS1;SAMD8;SGMS1;SGMS2;ST6GALNAC3
prerank,actin filament network formation (GO:0051639),0.5382345968238461,1.131212215452371,0.3333333333333333,0.6671292454109602,1.0,4/11,16.41%,LCP1;CARMIL1;FHOD1;PLS1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4076745783619943,1.1310916878679058,0.29733333333333334,0.6668447787383615,1.0,2/46,0.22%,CCR2;LRRK2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.443549489653642,1.1305056328285341,0.30858806404657935,0.6677290314230635,1.0,11/30,21.35%,HSD17B7;ACAA2;MSMO1;IDI1;FDPS;NSDHL;DHCR24;MVD;MVK;LBR;SQLE
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4737660345304318,-1.130307749429095,0.32516703786191536,0.7210051197229942,1.0,3/10,15.27%,BMPR1B;PKDCC;SOX5
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.46282734069688153,1.1300899128330735,0.3192771084337349,0.6682808284120826,1.0,9/22,16.66%,NGF;RAP1A;RAPGEF2;CIB1;AKT1;KIDINS220;EHD1;STMN2;RAB35
prerank,fibrinolysis (GO:0042730),-0.4494227402162966,-1.1300610915490772,0.28640776699029125,0.7201828593698438,1.0,3/13,21.40%,PLAU;SERPINE1;PLAT
prerank,axon extension (GO:0048675),-0.3934014855476674,-1.1300357529171694,0.31419939577039274,0.7187240188666323,1.0,14/23,20.66%,ULK2;NRP1;AUTS2;NRP2;MAP1B;SLC9A6;SLIT2;CDK5;SLIT1;SLIT3;NLGN3;HSP90AB1;SEMA5B;CYFIP1
prerank,membrane raft organization (GO:0031579),0.5100526803944959,1.1299961948160793,0.3311367380560132,0.6679417052365835,1.0,6/15,16.46%,ANXA2;S100A10;NAXE;FA2H;MYADM;PPT1
prerank,regulation of protein kinase A signaling (GO:0010738),0.47207794765307404,1.1297452757555344,0.3231240428790199,0.6680541394660707,1.0,1/20,0.22%,LRRK2
prerank,regulation of protein acetylation (GO:1901983),-0.47527547500756795,-1.129444287285724,0.3076923076923077,0.7189005906619698,1.0,6/12,27.06%,CAMK1;TERF2IP;DDX3X;FAM161A;RAPGEF3;KAT5
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.4198709511743433,-1.1291510511722183,0.29658792650918636,0.7182129466227202,1.0,5/16,22.51%,IGF1;IGFBP5;IGFBP2;IGFBP4;ZFAND2B
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.38519174486379104,1.1288228166258714,0.3122629582806574,0.6697998890063693,1.0,16/65,14.22%,EPS15;CCDC88A;CBL;CDC42;ARAP1;PTPN12;TSG101;GRB2;AFAP1L2;HIP1;EPS15L1;STAM;MVP;AKT1;PDE6H;PTPRJ
prerank,cholesterol efflux (GO:0033344),-0.3988219200752427,-1.1274741598321496,0.29461756373937675,0.7212798636330172,1.0,2/20,0.41%,ABCA1;APOE
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4468763572815156,1.1274057329095546,0.32575757575757575,0.6728246138141332,1.0,4/27,6.73%,AHNAK;HPCA;ADRA2A;CACNB1
prerank,cellular response to nutrient levels (GO:0031669),0.38786967607049616,1.1273148406593831,0.3003708281829419,0.672497176940795,1.0,12/62,13.86%,LRRK2;STK24;BMPR2;KLF10;WRN;CLEC16A;RALB;PRKAA1;NUPR2;WIPI2;SREBF2;PRKAA2
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3522879028888299,-1.1270744996066968,0.24825174825174826,0.7208581117457565,1.0,7/30,11.27%,HEXB;CHST11;ARSB;CHST9;CHPF2;CSPG4;HEXA
prerank,positive regulation of vacuole organization (GO:0044090),0.5431723541972565,1.1270350000285843,0.3378607809847199,0.6726324364929059,1.0,4/10,10.25%,PIP4K2A;ANXA2;RALB;PIP4K2B
prerank,protein-DNA complex assembly (GO:0065004),0.35595883593842575,1.1269809777897952,0.2899884925201381,0.6722067743059431,1.0,25/116,13.03%,PSME3;CHAF1A;PSMB7;PSME2;H3-3A;ORC5;MCM6;SMARCA5;ORC4;CCNH;PSME4;PSMB8;PSMD9;PSMA5;DAXX;PSMB3;PSMD6;PSMC4;NAP1L1;RPA3;PSMD10;ATRX;PSMB1;MCM2;ERCC3
prerank,regulation of T cell migration (GO:2000404),0.4779032546107921,1.1269601249775025,0.32710280373831774,0.6716897336526757,1.0,6/18,13.84%,CXCL10;RIPOR2;SPN;RHOA;APP;LRCH1
prerank,negative regulation of signaling (GO:0023057),0.44247305680826465,1.1268503262881702,0.3135215453194651,0.6713795685698101,1.0,3/25,10.41%,IL1B;OPRM1;PTPN1
prerank,glutathione metabolic process (GO:0006749),0.4180194965378569,1.126806996460245,0.31351351351351353,0.6709206235931385,1.0,6/38,6.34%,GPX1;GSR;ETHE1;DPEP1;GSTA3;GSS
prerank,neuromuscular junction development (GO:0007528),0.4500753825414137,1.126764060555952,0.32831325301204817,0.6704506569798312,1.0,2/24,6.73%,LRRK2;CACNB1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4104263643938321,1.1267498590628096,0.3125,0.6699166438946506,1.0,11/43,14.22%,EPS15;CBLB;CBL;CDC42;RAB7A;TSG101;GRB2;EPS15L1;STAM;MVP;PTPRJ
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.4458423733750444,1.1264677677692454,0.31784107946026985,0.6700861000537651,1.0,10/27,15.63%,SIK1;CRY1;FBXL8;CRY2;ID2;FBXL17;PPP1CB;PDE6B;FBXL12;BHLHE40
prerank,nucleosome disassembly (GO:0006337),0.4968682213747184,1.1263924885448175,0.3277310924369748,0.6691515919201151,1.0,4/14,13.75%,NFE2;SMARCE1;ARID2;SMARCC2
prerank,chromatin disassembly (GO:0031498),0.4968682213747184,1.1263924885448175,0.3277310924369748,0.6691515919201151,1.0,4/14,13.75%,NFE2;SMARCE1;ARID2;SMARCC2
prerank,membrane repolarization (GO:0086009),0.4972543505801848,1.1263433307712423,0.32569558101472995,0.6687094398529606,1.0,2/15,3.32%,KCNE3;KCNQ1
prerank,respiratory system development (GO:0060541),-0.3466020461346775,-1.1260243986303802,0.2686084142394822,0.7222568208565241,1.0,7/32,13.14%,BASP1;CHD7;FGF2;FGFR2;LOXL3;VEGFA;DISP1
prerank,negative regulation of immune system process (GO:0002683),0.4883570288856781,1.1257017309408603,0.33115823817292006,0.6696877125221066,1.0,1/16,0.76%,LYN
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4941595088643912,-1.1255511241530958,0.32642487046632124,0.7220931353502806,1.0,4/10,28.05%,TSN;TSNAX;DROSHA;MRPL44
prerank,cholesterol biosynthetic process (GO:0006695),0.4379185483082848,1.1248628859929524,0.31877729257641924,0.6712215083259427,1.0,11/31,21.35%,HSD17B7;ACAA2;MSMO1;IDI1;FDPS;NSDHL;DHCR24;MVD;MVK;LBR;SQLE
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.37842924314108134,-1.1241107769752947,0.27575757575757576,0.7245081794261916,1.0,10/25,21.45%,ITGA6;NRP1;KCTD20;ILK;NCKAP1L;PTGES3;SRC;AR;ANG;MIF
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5106585950024017,1.1238644470857786,0.3344768439108062,0.6731788295686854,1.0,5/13,18.18%,JAK2;RBPMS;SMAD4;TGFB1;NUP93
prerank,positive chemotaxis (GO:0050918),-0.416526746437323,-1.1237586704987863,0.29428571428571426,0.7239662520269101,1.0,9/17,21.01%,NRP1;SCRIB;SCG2;VEGFA;TSC2;CX3CL1;PLXNB3;ANGPT1;FGF10
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.39113932719112465,1.1236772065023268,0.283289817232376,0.6730869201728592,1.0,19/56,16.66%,RACGAP1;KIF20A;MITD1;KIF23;CHMP4B;BIN3;PDCD6IP;DCTN3;RHOA;SPAST;SNX9;UNC119;ROCK1;AURKB;EFHC2;SNX33;APC;TRIM36;RAB35
prerank,pyruvate metabolic process (GO:0006090),-0.3166578703060314,-1.1235421317536876,0.2441860465116279,0.7230362080156986,1.0,19/52,24.71%,HK3;HK1;ME3;PFKL;PGK1;PCK2;LDHB;ENO2;VDAC1;HOGA1;DLAT;PDHB;PGAM4;PGAM1;PFKM;ENO3;PDHA1;LDHA;ALDOA
prerank,carnitine metabolic process (GO:0009437),-0.4585372996240455,-1.1231810064656895,0.3020304568527919,0.7225800826472141,1.0,8/12,32.28%,ALDH9A1;ACADM;CPT2;ACADL;CPT1C;CROT;BBOX1;TMLHE
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.37212429178424145,-1.1229572463590236,0.29705882352941176,0.7216779439885131,1.0,4/24,9.11%,IGF1;ENPP1;PPP1R3B;IRS1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4217775553882107,-1.1228979605227918,0.3145780051150895,0.7203895069089437,1.0,6/16,9.40%,IGF1;MEF2C;ERBB4;FGF2;FGFR2;AKAP6
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5097813800176326,1.1228225352667391,0.33610648918469216,0.6735863822800103,1.0,5/12,18.68%,CUL3;ANAPC7;RB1;ANAPC11;ANAPC4
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5097813800176326,1.1228225352667391,0.33610648918469216,0.6735863822800103,1.0,5/12,18.68%,CUL3;ANAPC7;RB1;ANAPC11;ANAPC4
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5097813800176326,1.1228225352667391,0.33610648918469216,0.6735863822800103,1.0,5/12,18.68%,CUL3;ANAPC7;RB1;ANAPC11;ANAPC4
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4230527731092388,-1.1227395071542603,0.31527093596059114,0.7194052000700317,1.0,6/16,17.53%,MEF2C;SNCAIP;FLOT1;CPLX1;CAMK2A;RIMS1
prerank,regulation of myoblast fusion (GO:1901739),0.5319111262051444,1.1226981388508168,0.32538330494037476,0.6733310463865337,1.0,3/11,5.63%,RIPOR2;EHD2;MAPK14
prerank,visual system development (GO:0150063),0.4207864069426566,1.1226112640239048,0.29614325068870523,0.6729995077325963,1.0,5/37,6.10%,MAB21L2;SIPA1L3;ATF6;HIPK2;HIPK1
prerank,negative regulation of cell cycle (GO:0045786),0.3749603079421619,1.1222052996450123,0.27875,0.6734450064394782,1.0,19/73,18.50%,RUNX3;LILRB1;BTG2;BTG1;HEXIM1;PTEN;PDCD4;LATS1;LATS2;DUSP1;NUPR2;RPS6KA2;TGFB1;TRIM35;APC;RB1;NR4A1;FOXC1;HPGD
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4807180528278261,-1.1221435606563723,0.327710843373494,0.7196238887124508,1.0,7/10,39.25%,HTR2B;PLPP1;PARD3;PICK1;DGKH;DGKD;GAP43
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4664419933363062,-1.1220141222144482,0.3294930875576037,0.7185006655740892,1.0,5/11,21.69%,RASA1;NOVA1;NOVA2;IGF2BP2;PCBP4
prerank,negative regulation of anoikis (GO:2000811),0.5006932110444123,1.1219682409171787,0.33663366336633666,0.6734814706405738,1.0,6/14,21.99%,MCL1;PIK3CA;TLE1;ITGA5;PTK2;BCL2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.3913092043945865,-1.121780254034052,0.3177842565597668,0.7176936418208293,1.0,14/22,36.33%,ATF4;SMARCB1;UTP15;PHF8;PWP1;PIH1D1;DDX11;WDR43;LYAR;IPPK;WDR75;MTOR;SMARCA4;NCL
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.33823180465837177,1.1215365822874241,0.25571273122959737,0.6739183446765431,1.0,41/186,16.64%,LIMD1;GLI1;PTPRU;PTPRO;PSME3;CUL3;CCDC88C;SDHAF2;MAD2L2;NOTUM;PSMB7;APCDD1;AXIN1;PSME2;RNF213;STK4;TMEM131L;KREMEN1;PSME4;LATS1;PSMB8;PSMD9;PSMA5;CYLD;NLK;PSMB3;LATS2;PSMD6;PSMC4;DVL3;PSMD10;PSMB1;LRP4;TLE1;TAX1BP3;INVS;DVL2;APC;IGFBP6;PSMD12;KLHL12
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.40185108609991055,1.1215177233664364,0.3177441540577717,0.6734114291264489,1.0,7/45,9.94%,BMPR2;RBPMS;GDF1;BMP3;ENG;ACVR2A;SMAD4
prerank,cellular component assembly (GO:0022607),0.33516197145606147,1.1212292873683591,0.23125,0.6735481955168175,1.0,51/253,16.52%,CD74;NEDD9;TRAF1;WIPF1;LCP1;EPS8;CD40;FOXJ1;CHAF1A;SKAP2;RAC2;PICALM;ABCA3;CDC42;CD2AP;RBBP4;PTK2B;FLNA;ELOB;PAWR;YTHDF3;EZR;RAC1;PEX14;CAPZA1;RHOA;FANCC;STX7;RTN4;SNX9;VASP;YWHAZ;TEAD1;DNM1L;FANCA;CLDN14;VMP1;TGFB1;BSN;ZFYVE27;RHOG;KMT2A;OCLN;VCPIP1;SLC2A1;CREBBP;SHROOM1;APC;STAG3;PLS1;WNT7A
prerank,regulation of bone mineralization (GO:0030500),-0.3086445431050442,-1.1211647359092338,0.26382978723404255,0.7179437202804705,1.0,14/55,8.07%,SLC8A1;MEF2C;NELL1;ANKH;ENPP1;PTN;BCOR;TMEM119;P2RX7;ACVR1;BMP2K;NBR1;ACVR2B;S1PR1
prerank,macrophage activation involved in immune response (GO:0002281),0.5125764192397465,1.1205949436530058,0.3497615262321145,0.6745690369633681,1.0,5/13,10.03%,PLCG2;SYK;DYSF;IFI35;SBNO2
prerank,negative regulation of hydrolase activity (GO:0051346),0.3930096323102759,1.1205228791893709,0.29150326797385623,0.6741762934998226,1.0,11/49,14.43%,LRRK2;PTX3;RCC2;KLRK1;F11R;BCAS3;ARFGEF1;GPATCH2;SH3BP4;LRCH1;ZCCHC9
prerank,L-amino acid transport (GO:0015807),-0.3723002626189843,-1.1204030725431877,0.29393939393939394,0.7185134573870631,1.0,8/28,12.61%,SLC1A3;SLC7A1;SLC36A4;SLC36A1;SFXN1;SLC7A2;SLC7A8;SLC3A2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.47034122616767365,1.1203815188666835,0.34285714285714286,0.6739670580525909,1.0,7/19,15.19%,PRKCH;MYO1C;IKBKB;CBFB;F11R;ROCK1;OCLN
prerank,cGMP metabolic process (GO:0046068),0.5136325625504885,1.1203011163227274,0.31960461285008235,0.6736060561343202,1.0,5/12,24.95%,PDE2A;GUCY1A1;NPR2;NPPC;PDE9A
prerank,heterochromatin organization (GO:0070828),0.506592990075997,1.1198610640104896,0.3466453674121406,0.6741534516967311,1.0,6/14,18.75%,SMCHD1;SETD7;SETDB2;EZH1;SIRT1;HP1BP3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.42215973093890297,1.1197733040909632,0.3333333333333333,0.673804448974623,1.0,9/31,16.33%,KLF4;PTEN;CDKN2C;DCUN1D3;WEE1;APC;BRD7;RBL2;RB1
prerank,negative regulation of protein modification process (GO:0031400),0.3719914136502738,1.119478863730866,0.29598051157125455,0.6740002952253484,1.0,17/79,14.30%,NIBAN1;LRRK2;PID1;LYN;IBTK;PTEN;PRNP;CIB1;PAQR3;EPHB2;PPP1R15A;CACTIN;PRKAA1;PPP1R15B;CDYL;PRKAA2;TGFB1
prerank,positive regulation of synapse assembly (GO:0051965),-0.36452209717087225,-1.1194153527908868,0.27986348122866894,0.7198206626567455,1.0,13/27,23.43%,PTPRD;IL1RAPL1;NLGN1;GRID2;IL1RAP;NLGN2;AGRN;CLSTN2;NLGN3;NRXN1;DLG5;VSTM5;CUX2
prerank,cellular response to amino acid starvation (GO:0034198),-0.29320160836076803,-1.1192167443834995,0.23243243243243245,0.7189242255200905,1.0,18/71,12.08%,ATP6V1C1;RPTOR;ATP6V0B;FLCN;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;SESN3;EIF2AK4;ATF4;LARS1;IMPACT;ATP6V1D;MIOS;ATP6V0D1;LAMTOR5;PRKD1
prerank,RNA export from nucleus (GO:0006405),-0.2784842907947138,-1.119074463913113,0.2215568862275449,0.7178865818990178,1.0,34/100,19.43%,SRSF5;SRSF3;DDX39B;NUP54;RNPS1;NUP133;SRSF7;SYMPK;NUP155;ALKBH5;NUP188;UPF1;THOC5;DHX38;NXF1;DDX19B;RANBP2;ZC3H11A;SEC13;SRSF2;DDX39A;NUP85;GLE1;NUP42;SMG7;TPR;RAN;NUP35;CASC3;SRSF1;MCM3AP;FYTTD1;NUP37;HNRNPA2B1
prerank,regulation of mitochondrial fission (GO:0090140),0.447988882885349,1.1186735916443546,0.32978723404255317,0.6754540169910562,1.0,2/24,0.60%,LRRK2;CYRIB
prerank,vasculature development (GO:0001944),0.48434082893223784,1.1182670511296922,0.33226837060702874,0.6758951594047309,1.0,3/16,10.70%,BMPR2;FBXW7;PIK3CA
prerank,relaxation of muscle (GO:0090075),-0.4405528866655588,-1.1181533673425021,0.3299492385786802,0.7189185626295623,1.0,5/13,7.58%,SLC8A1;KCNJ2;ATP1B1;P2RX4;ATP1A2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.45024014767823667,1.1181209054208912,0.3195718654434251,0.6756824232642715,1.0,6/24,13.10%,FFAR4;RAPGEF2;PDE2A;PRKAR2A;GNAI1;PEX5L
prerank,positive regulation of organelle organization (GO:0010638),0.4207381124719093,1.1179470850261553,0.3265895953757225,0.6755275735520752,1.0,7/32,10.43%,UVRAG;ANXA2;C2CD5;KATNBL1;SYNJ1;ATL3;ANXA1
prerank,protein import into peroxisome matrix (GO:0016558),0.5180405932619173,1.1175403877837173,0.3397548161120841,0.6760332621449082,1.0,4/12,13.10%,PEX16;PEX12;PEX14;PEX5L
prerank,regulation of cell differentiation (GO:0045595),0.3460330098939346,1.1174331924032685,0.2785956964892412,0.6757823718721947,1.0,14/148,7.34%,TRPS1;RUNX2;TIAM1;RUNX3;NGF;SIK1;KLF4;BCL6;RPS6KA3;EIF2AK2;GDNF;CBFB;PHLDB2;PURB
prerank,bone morphogenesis (GO:0060349),-0.43168079404462056,-1.1173660915057753,0.3110539845758355,0.7196825084028208,1.0,3/14,6.15%,SKI;LRP6;FGFR2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3538899575182707,1.1172572245018677,0.2888631090487239,0.6756540593102323,1.0,16/110,13.31%,ADGRG5;ADGRG6;ADGRE5;RXFP2;LPAR3;PTGER2;RAPGEF2;CXCL10;PTGER4;ADRA2A;GNB1;PTGER3;S1PR5;ADCY7;ADCY5;GNG2
prerank,inositol phosphate biosynthetic process (GO:0032958),0.5200973113764327,1.1164554470163994,0.3395585738539898,0.6771168785845887,1.0,2/11,2.91%,ITPKC;IP6K3
prerank,regulation of protein ubiquitination (GO:0031396),0.35561594338127195,1.1164054730331001,0.2892271662763466,0.6767060999891543,1.0,27/108,15.40%,LRRK2;HSPA1A;CUL3;LAPTM5;MALT1;CRY1;FBXW7;AXIN1;BIRC3;PTTG1IP;DCUN1D1;UBE2N;WFS1;MYCBP2;FBXO4;RPS3;CAMLG;DAXX;RCHY1;PSMD10;USP4;FANCI;AKT1;HDAC3;PRMT3;XIAP;SVBP
prerank,cellular response to organonitrogen compound (GO:0071417),-0.273117598764474,-1.1163137884260106,0.19285714285714287,0.7212414620596829,1.0,24/99,10.45%,RYR3;MEF2C;P2RY12;LARP1;RPTOR;CTNNB1;PKD2;GABRG2;CPEB1;P2RX7;P2RX4;GABRB1;LARS1;IMPACT;IPO5;JUP;HSP90B1;GLRA2;P2RY6;SLIT2;AKAP6;CPEB4;HCN1;HCN2
prerank,negative regulation of bone mineralization (GO:0030502),0.5042737547218425,1.1162634736918333,0.35126050420168065,0.6765151862126725,1.0,3/13,6.49%,CCR1;SRGN;PTK2B
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.34053801803583855,1.115839912355256,0.278941565600882,0.6770584300725632,1.0,38/166,18.19%,NIBAN1;IL1B;DNA2;GLI1;BCL3;KLF4;RPL5;LDLR;VIM;CD36;ZEB2;KAT7;SCARB1;ELOVL5;FAF1;ATP7A;YTHDF3;IL6;HGF;NMD3;AKT1;METTL3;LARP4B;EIF3E;SLC6A9;ASS1;THBS1;STN1;DYRK2;RPS4X;RPS6KB1;INSR;GCK;SIRT1;DDAH1;ATAD5;MMP8;APPL1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.43856886476440293,-1.1157288666770484,0.3136729222520107,0.7214063845129592,1.0,6/15,24.35%,NEK6;TPR;CENPE;CDC16;TACC3;ANAPC1
prerank,positive regulation of viral genome replication (GO:0045070),-0.35255471031112606,-1.1156850321790595,0.2698961937716263,0.720089454271341,1.0,19/29,34.27%,LARP1;PPIA;SRPK1;ADAR;SRPK2;PPIE;VAPB;DDX3X;ADARB1;PPID;RAD23A;CNOT7;PDE12;CD28;DDB1;CCL5;PPIH;TOP2B;HACD3
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3592932191326045,1.115525054061955,0.29171528588098017,0.6772798867313519,1.0,18/107,13.14%,ITPR1;NIBAN1;MAP3K5;ERN1;ERP44;ATF6;ATP2A3;BBC3;WFS1;ATP2A1;PPP1R15A;MBTPS1;DNAJB12;AIFM1;PPP1R15B;ATF6B;EIF2AK3;ATG10
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4771985619763242,1.115435034388712,0.33534743202416917,0.6769429336353093,1.0,4/17,9.29%,RET;SYK;CIB1;PIEZO1
prerank,positive regulation of isotype switching (GO:0045830),0.49807139211246565,1.1153622287829883,0.32078559738134205,0.6765739253776362,1.0,4/15,14.30%,CD40;MAD2L2;KMT5B;TGFB1
prerank,protein deacetylation (GO:0006476),0.4059799587705763,1.1150481997833865,0.3138586956521739,0.6768253720019012,1.0,18/41,21.33%,TBL1XR1;MTA3;FLNA;HDAC9;RCOR3;MORF4L1;BAZ2A;MSL3;SIRT4;HDAC3;MIER1;SIRT1;HDAC7;HDAC1;MIDEAS;RCOR1;SIRT3;HDAC5
prerank,ketone body metabolic process (GO:1902224),-0.46817618913827974,-1.1142170902909638,0.3235294117647059,0.7228300965933045,1.0,2/10,4.05%,OXCT1;HMGCL
prerank,pulmonary valve morphogenesis (GO:0003184),0.4730192124149431,1.114113138340768,0.3226837060702875,0.6786186611932244,1.0,2/17,2.89%,NOTCH2;GJA5
prerank,hyaluronan metabolic process (GO:0030212),0.45308130249162143,1.1140427570746654,0.3439878234398782,0.6782378032839009,1.0,2/23,0.33%,CD44;IL1B
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.32024310012603485,1.1137121094526994,0.058,0.6785124625019907,1.0,290/1668,15.79%,CIITA;PLAC8;BCL11A;TRPS1;NFE2;ZBTB46;PID1;BACH2;FOXP1;RUNX2;HIVEP2;RARA;SP100;SP3;BAZ1A;RUNX3;STAT4;TOX4;GLI1;TNIP3;HNF4G;ACTR3;CDK13;KLF4;UXT;CREB1;LILRB1;IER2;PPARG;CD40;MED13L;ETV6;STAT5A;BCL6;PKN1;SAP30;PPP1R12A;NFKB1;PITX3;TET2;FOSL2;PLSCR1;STAT3;BAZ2B;EHF;FOXJ1;ELF4;RFX7;NIPBL;NEDD4L;FOS;KDM7A;CRK;TCF20;RPS6KA3;BMPR2;MAD2L2;REL;RBBP8;AKNA;NCOA3;CXCL10;ZBTB20;CRLF3;TAF9;SPI1;STAT5B;NFKBIA;CRY1;SCX;TBL1XR1;ATAD2;ZEB2;IKBKB;MTA3;GATAD2B;MED30;PGBD1;SUMO1;CAMTA2;ATF6;KAT7;LRRFIP1;KLF8;PPP3CA;GDNF;ATF2;PRPF6;IRF2;RFX3;RBPJ;ZNF319;KCNIP3;HIVEP1;IL33;DEAF1;HIPK2;STAT1;MED13;NUFIP1;KLF5;UBE2D3;IRF4;HEXIM1;MAPK14;BBX;HELZ2;RPS6KA5;RFX5;SMARCA5;KLF13;PTEN;TSHZ1;ARF4;CCND1;CDC5L;KMT2C;DEK;KLF10;SETX;WFS1;ELOA;AHR;ACTR2;ANXA4;RPS14;BUD31;CREBRF;SSU72;TADA3;CGGBP1;ARID4A;CBFB;CREM;IKZF3;NFE2L2;KDM3B;MECP2;PURB;HTATSF1;PDE2A;THRA;CRY2;CLOCK;SAP18;ZFP3;MED6;ZBED4;GATAD2A;RARG;CCNH;EZR;TOX3;DOT1L;E2F2;ENG;GABPB1;GABPB2;CTCF;PHF12;HDAC9;NFYC;ACVR2A;TLR3;ELF1;IL6;HGF;ZNF182;BRIP1;BACH1;NFE2L1;SNF8;RBAK;KAT6A;TNKS;WWP2;BCAS3;EPC2;ID2;EZH1;NCOA2;E4F1;PKNOX1;PARP9;SMARCE1;ZNF496;ZFX;IRF7;MEF2B;RCOR3;RPRD1B;SMAD4;SBNO2;CNOT2;NCOA1;NR3C1;LIN37;TADA2A;CSRNP1;GMEB2;RIPK1;SPEN;SP140;PBX1;CCNT2;MED26;FOXO3;MED12;IKZF5;ZNF507;DVL3;TAF7;ZNF260;ETS2;NLRP3;REST;RPS6KA1;ZNF418;MBD2;BCLAF3;ATF6B;MAP2K5;NUPR2;MED14;NFYA;APP;CCNT1;PSMD10;LIN9;TEAD1;TLR2;CDK12;KLF9;ATRX;PPM1D;NFATC2IP;CCNL1;MYB;IFRD1;STAT2;NRIP1;KIT;SRCAP;NSD1;CHD4;EZH2;JUNB;TNRC6B;HCLS1;SREBF2;SMARCC2;KAT2B;CITED2;TNRC6A;MRTFA;HDAC3;NFIL3;TGFB1;CRTC3;ZNF431;RSF1;IL18;SLTM;FHOD1;ZNF436;GPS2;MAFK;AURKB;SP4;RELA;MAZ;PHF20;HOMEZ;DUSP26;KMT2A;ASXL2;CREBBP;ZBTB25;TBK1;USP9X;MIER1;TAF1;DVL2;HSF5;BHLHE40;MAML1;INO80;ZNF148;MED1;ZMIZ2
prerank,monocarboxylic acid transport (GO:0015718),-0.31189744760925786,-1.1134566319169332,0.25416666666666665,0.7234499096579579,1.0,7/51,7.21%,SLCO2B1;SLC16A6;ABCC3;ABCG2;ABCB4;ATP8B1;SLC27A1
prerank,polarized epithelial cell differentiation (GO:0030859),-0.4421989000394283,-1.1134188579026205,0.3341902313624679,0.7220798005984691,1.0,3/13,1.34%,OPHN1;MYO9A;RAP2A
prerank,regulation of lipid catabolic process (GO:0050994),0.4683815639499061,1.1131453621474592,0.3435483870967742,0.6793225017505758,1.0,5/19,15.12%,IL1B;ADRA2A;PRKAA1;ABCD1;ANGPTL3
prerank,bone development (GO:0060348),0.4130229653798168,1.1130712675581818,0.3223965763195435,0.6789501136895525,1.0,4/39,3.93%,PTPRC;SULF2;NOTUM;PTGER4
prerank,regulation of biomineral tissue development (GO:0070167),-0.3700064007880431,-1.1128907485970851,0.30835734870317005,0.7221133545548712,1.0,6/26,8.07%,GAS6;ANKH;ENPP1;BMP2K;NBR1;S1PR1
prerank,regulation of angiogenesis (GO:0045765),0.3392020864345576,1.112876147589513,0.25937834941050375,0.6788676946719692,1.0,25/192,9.51%,CCR2;IL1B;SP100;KLF4;ITGAX;PPARG;CD40;PTGIS;CXCL10;ADGRA2;ATF2;SYNJ2BP;VEGFC;BTG1;HIPK2;STAT1;HSPG2;HIPK1;PIK3R6;PDPK1;MECP2;PLXND1;IL6;NAXE;PGF
prerank,regulation of cholesterol storage (GO:0010885),-0.42673076632283746,-1.1128439437637794,0.32653061224489793,0.7207940062704692,1.0,4/15,4.28%,ABCA1;TREM2;TTC39B;MSR1
prerank,cellular response to virus (GO:0098586),0.4277683309258048,1.112608130676248,0.32650273224043713,0.6789538644944662,1.0,6/30,8.68%,CXCL10;IFIH1;MAPK14;ARF1;GBF1;IL6
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5024678921096148,1.1125852746156624,0.3528428093645485,0.6784475458210113,1.0,3/13,5.11%,GLI1;PIM1;RBPJ
prerank,negative regulation of transmembrane transport (GO:0034763),0.5412851463177047,1.112212349159394,0.36212624584717606,0.6788452131164772,1.0,1/10,0.33%,IL1B
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.35638757198146265,-1.111991770086295,0.2939297124600639,0.7217691713183085,1.0,8/32,11.82%,NAV3;CAMSAP1;MAP2;FGF13;CLASP2;EML2;MAPRE1;CAMSAP2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4756204662054686,1.1116990991111926,0.36038961038961037,0.6795258087020171,1.0,7/14,20.17%,MAPKAPK2;MAPK14;TIRAP;MYD88;BOLL;YBX3;HNRNPC
prerank,DNA methylation (GO:0006306),0.45218184378365517,1.1116592679326043,0.3333333333333333,0.6790808023403747,1.0,11/23,19.43%,ATF7IP;FOS;GATAD2A;METTL4;MTRR;BAZ2A;ATRX;PPM1D;KMT2E;EHMT1;DNMT1
prerank,transepithelial transport (GO:0070633),0.484796192592058,1.1116381638287534,0.3402889245585875,0.6785889287749495,1.0,3/15,6.89%,SLC23A2;SLC23A1;ABCC1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.403879125415971,-1.1116364229513442,0.30526315789473685,0.7213425749759871,1.0,3/18,5.26%,PRKN;PPIA;HIF1A
prerank,gland development (GO:0048732),-0.3027144841014958,-1.1115761256403995,0.24242424242424243,0.7200729670049973,1.0,11/59,13.59%,SALL1;TGFBR1;PKD2;NF1;FGFR2;ARID5B;CEBPG;ARHGAP35;PHF2;PRKCSH;MDK
prerank,DNA repair (GO:0006281),0.33025920431581696,1.111206894264588,0.27007299270072993,0.6790988300167555,1.0,85/284,20.42%,UVRAG;DNA2;MLH1;DTX3L;POLI;BTG2;MAD2L2;RBBP8;POLL;CHRNA4;USP3;MRE11;FEN1;FAM111A;SUMO1;PARP4;APEX2;SMARCA5;UBE2N;POLD4;SETX;WRN;MBD4;CIB1;USP45;MSH3;NABP1;DOT1L;PSME4;SMUG1;UIMC1;ATXN3;ASCC3;BRIP1;BACH1;MSH6;ASCC1;PARP9;FANCC;FANCL;SETD2;TDG;KMT5B;RECQL5;RPA3;XRCC4;EXD2;FANCI;RAD54L;ERCC3;MAPK8;ERCC4;FANCA;RNASEH2A;VCP;XRCC2;VCPIP1;INO80;ENDOV;KDM4B;POLB;INIP;USP47;NSMCE4A;KPNA2;HUS1;MDC1;EYA3;PMS1;POLD1;SIRT1;RAD17;RAD21;CHEK2;PRIMPOL;FANCG;FTO;ALKBH2;TNKS1BP1;WDR33;RNF168;APEX1;PARK7;PDS5B;XPA
prerank,positive regulation of neurogenesis (GO:0050769),-0.2957013169094147,-1.1109403556391555,0.22748815165876776,0.7205125789988182,1.0,16/68,6.69%,CX3CR1;PLXNA4;CUX1;PTPRD;NTRK2;NUMB;IL1RAPL1;ROBO2;ROBO1;CTNNB1;PLXNB2;FBXW8;CDKL3;ARHGDIA;CAPRIN2;PLXNA2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.37049308420507004,1.1109051463331467,0.3182957393483709,0.6792406943994267,1.0,16/74,15.21%,IL1B;TIAM1;SDHAF2;MAD2L2;GLIPR2;PTEN;PHLDB2;IL6;OLFM1;SPRED3;SMAD4;USF3;EZH2;CLASP1;TGFB1;SPRED1
prerank,regulation of dendrite development (GO:0050773),-0.34081977299396765,-1.1106485003794841,0.25773195876288657,0.7199986463701359,1.0,8/37,4.13%,CSMD3;DCC;RAP2A;TNIK;HECW1;PTN;ADGRB3;MARK1
prerank,melanosome organization (GO:0032438),-0.3727970235127215,-1.1102939321689056,0.2785923753665689,0.7195669107534524,1.0,7/26,15.39%,DTNBP1;HPS4;RAB32;AP3B1;SHROOM2;LYST;BLOC1S5
prerank,negative regulation of bone remodeling (GO:0046851),-0.46478463304066847,-1.1095013969221592,0.35960591133004927,0.7203629308416094,1.0,3/11,4.87%,GPR137B;TMEM119;P2RX7
prerank,neuron projection extension (GO:1990138),-0.3483893976923072,-1.1094249740072077,0.2771929824561403,0.7191796367704445,1.0,13/32,10.46%,ULK2;NRP1;AUTS2;NRP2;MAP1B;TMEM108;CTNNB1;CDKL3;EIF2AK4;IMPACT;SLC9A6;SH3GL2;CDK5
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.33115718303000136,1.1091902836686658,0.24037460978147762,0.6829669825667566,1.0,46/259,13.29%,FXYD5;SRGAP2;CDC14A;ATAT1;ACTR3;RAP1A;PTPRO;SHTN1;FOXJ1;EXOC6;RAPGEF2;CCDC88A;OCRL;EHD2;RP2;CD2AP;RFX3;CARMIL1;PPP1R9B;FGD4;ARF4;ACTR2;FLNA;IFT140;EZR;FGD1;GBF1;RAC1;MINK1;FGD3;KIF24;ARHGEF6;EXOC7;UNC119B;CEP250;KIF3B;RILPL2;FHDC1;PTPDC1;NTN1;ABCC4;IQCB1;CFAP54;PIP5K1A;KIT;CFAP70
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5031859798751517,1.1089337475350705,0.34134615384615385,0.683046799594952,1.0,6/13,19.21%,PRPF6;SRSF10;PRPF3;USP4;AAR2;DDX20
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.47922189216917355,-1.1085548444458568,0.3347921225382932,0.7200928176312583,1.0,6/10,15.81%,ATP5F1A;ATP5PO;ATP5MG;ATP5PD;ATP5F1D;ATP5MC3
prerank,negative regulation of JNK cascade (GO:0046329),0.43438923521701195,1.108476141568839,0.3366906474820144,0.6835948326209081,1.0,9/31,14.84%,PTPN22;MARVELD3;ITCH;TAOK3;PDCD4;CYLD;HDAC3;GPS2;GSTP1
prerank,regulation of adaptive immune response (GO:0002819),0.4634562854123352,1.1082955125795984,0.3380503144654088,0.6834645125739024,1.0,8/18,17.50%,AHR;SAMSN1;IL6ST;IRF7;ADCY7;FCGR2B;SIRT1;SASH3
prerank,cortical cytoskeleton organization (GO:0030865),0.4082457896968719,1.1082034905162121,0.31713900134952766,0.683138704865177,1.0,8/41,8.98%,RND3;LCP1;RAC2;IKBKB;RHOBTB3;EZR;RAC1;RHOA
prerank,epithelial cell-cell adhesion (GO:0090136),-0.46675207748944497,-1.1081811782317672,0.3482587064676617,0.7197716575863593,1.0,2/11,7.59%,ITGB5;JUP
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.43355589386792415,-1.1080978528740009,0.37373737373737376,0.7185766394936616,1.0,5/14,7.63%,OPHN1;MYO9A;RAP2A;PATJ;SCRIB
prerank,pore complex assembly (GO:0046931),0.46667157966748735,1.1079677555372704,0.32921174652241114,0.6831612272709605,1.0,7/19,18.94%,AFDN;NUP98;TSPAN33;RTN4;NUP153;NUP93;BAD
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4976044551131172,1.1078818658037128,0.35161290322580646,0.6828129666864452,1.0,2/14,2.48%,LRRK2;HSPA1A
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5292614588487888,1.1074135739470228,0.36991150442477877,0.683438193715738,1.0,4/10,13.52%,FBXW7;ADRA2A;ADAM17;NCF1
prerank,cell-substrate junction assembly (GO:0007044),-0.33999597401358067,-1.1072110153521182,0.3006535947712418,0.7195094053690252,1.0,11/33,19.46%,DST;ITGA6;PTPRK;PEAK1;LAMA3;TESK2;SRC;WHAMM;CTTN;ACTN2;THSD1
prerank,regulation of protein localization to nucleus (GO:1900180),0.40057111669186346,1.1069826578111728,0.33423180592991913,0.6839696780248824,1.0,12/43,14.64%,NGFR;DTX3L;CTNNA1;KAT7;LATS1;PARP9;LATS2;EIF2AK3;AKT1;LIMK2;TGFB1;ILRUN
prerank,nitric oxide metabolic process (GO:0046209),0.49798165812078365,1.106240562076491,0.3583061889250814,0.6852384176187595,1.0,4/14,19.23%,CYB5B;ARG2;AKT1;CYB5R3
prerank,positive regulation of neuron death (GO:1901216),0.39179613376318984,1.1061391308355795,0.32142857142857145,0.6849223332665524,1.0,11/46,11.91%,FYN;MAP3K5;FOS;PICALM;ITGB2;PRNP;DDIT4;DAXX;FOXO3;FCGR2B;REST
prerank,lipid oxidation (GO:0034440),-0.44379149724455846,-1.1059439096251085,0.3373493975903614,0.7214387084214294,1.0,3/12,25.27%,PPARGC1A;ADIPOR2;ACOX1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4368340854544614,-1.1056762848386188,0.344559585492228,0.7206557964046935,1.0,7/14,34.91%,DAGLA;ALDH9A1;SLC5A7;CHAT;NOS1;MOXD1;ACHE
prerank,endoderm formation (GO:0001706),0.4119107926799754,1.1055400124485424,0.3414285714285714,0.6859226938286895,1.0,6/35,11.47%,ITGA4;LAMB1;ITGB2;FN1;SETD2;DUSP1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5291027352198852,1.1054584979013702,0.35241502683363146,0.685580270053169,1.0,3/10,12.44%,MMGT1;EMC9;EMC10
prerank,protein modification process (GO:0036211),0.36844262113679843,1.105287504015119,0.3189122373300371,0.6854621439568362,1.0,12/76,11.47%,ST3GAL1;ST8SIA4;STK38;PARP4;UBE2D3;FBXW2;NEDD8;PPP4R2;CSNK1G3;WWP2;UBE2S;DUSP12
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4137314439287839,1.105009333179861,0.33972602739726027,0.6855940328194927,1.0,6/33,9.18%,NDNF;CAST;WFS1;PDPK1;NFE2L2;ICAM1
prerank,P-body assembly (GO:0033962),0.5089196287933052,1.1049089242368841,0.35628227194492257,0.6853043671477537,1.0,6/12,20.43%,LIMD1;RC3H1;DYNC1H1;EIF4ENIF1;DDX6;EDC3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3539870406593892,1.104384275414205,0.2981220657276995,0.6859985733418277,1.0,21/101,14.30%,LRRK2;IL1B;FLT3;CD40;RAPGEF2;CCND3;ADRA2A;CCND1;PIK3R6;ADAM17;CIB1;RALB;RHOA;DIRAS1;PSMD10;PDGFD;CCND2;KIT;AKT1;EZH2;TGFB1
prerank,regulation of complement activation (GO:0030449),-0.3351636863710954,-1.1042598741561649,0.2572463768115942,0.7230597239737161,1.0,11/40,13.69%,C1QB;C1QA;C1QC;C3AR1;PROS1;C4B;C5AR1;SUSD4;C5AR2;CLU;C3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.41238659780071235,-1.104088438458309,0.31648936170212766,0.7221175294642271,1.0,8/17,22.22%,TREM2;PPIA;P4HB;HTRA2;MAPK7;SOD2;SOD1;BAG5
prerank,negative regulation of protein polymerization (GO:0032272),0.43196740385860916,1.1036103601832514,0.3290414878397711,0.6873695076123618,1.0,10/27,18.47%,CYRIB;DYRK1A;KANK3;ARFGEF1;CLIP3;TBCD;STMN2;MYADM;KANK1;PRKCD
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4701676818111348,1.1034721739471194,0.36900958466453676,0.6871378074497758,1.0,5/18,13.84%,FFAR4;ADRA2A;PSMD9;REST;SIRT4
prerank,regulation of RNA splicing (GO:0043484),0.3697967044492403,1.1030903732854664,0.33210332103321033,0.6875285531172179,1.0,20/69,16.00%,MBNL1;AHNAK;PTBP3;HSPA1A;ERN1;PRX;MBNL3;SETX;SRSF10;DYRK1A;RBM22;METTL4;YTHDC1;PQBP1;ZPR1;HNRNPLL;RBM38;CELF1;RBM39;PTBP2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.49081976954600165,1.102899294410491,0.37254901960784315,0.687458627231754,1.0,6/15,18.19%,STAT3;IL17RA;IL6;GBP5;MYD88;APPL1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4567992879506683,-1.102643322853233,0.3405275779376499,0.724499500073128,1.0,6/11,13.96%,IGF1;GHR;GIGYF1;IRS1;PIK3R1;TSC2
prerank,regulation of acrosome reaction (GO:0060046),0.5331278226959195,1.10253859832461,0.3644214162348877,0.687827924933154,1.0,1/10,7.51%,PLCB1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.45092304041597653,1.101918617735735,0.3496932515337423,0.6887966739372244,1.0,7/23,16.03%,JAK2;IL10RA;CRLF3;PTK2B;IL6;KIT;OCIAD1
prerank,negative regulation of neuron death (GO:1901215),-0.2782336089697869,-1.1013939085331035,0.2465753424657534,0.7265003262646645,1.0,21/93,10.78%,PRKN;LGMN;APOE;MEF2C;NTRK2;GRN;CSF1;RASA1;CD34;PPARGC1A;ADAM8;NRBP2;ATF4;KDM2B;SNX6;CPEB4;PTPRZ1;VPS35;CDK5;MSH2;SET
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.31745504871451313,1.1009811973979367,0.17717717717717718,0.6905743588973908,1.0,158/807,17.25%,CIITA;CBFA2T3;BCL11A;TRPS1;JARID2;FOXP1;RUNX2;RARA;SP100;SP3;RUNX3;LIMD1;BCL3;KLF4;UXT;CREB1;PPARG;ETV6;SCML4;BCL6;SAP30;NFKB1;ATF7IP;STAT3;FOXJ1;NIPBL;NEDD4L;NAB1;CIART;MAD2L2;SPI1;CRY1;TBL1XR1;ZEB2;MTA3;GATAD2B;MBD1;SUMO1;KAT7;LRRFIP1;KLF8;IRF2;RFX3;RBPJ;KCNIP3;HIVEP1;IL33;DEAF1;STAT1;UBE2D3;HEXIM1;FBXW11;MBTD1;RPS6KA5;CCND1;KLF10;WFS1;AHR;RPS14;FLNA;CGGBP1;ARID4A;CBFB;CREM;PDCD4;MECP2;SETDB2;PDE2A;PLCB1;THRA;CRY2;CLOCK;SAP18;GATAD2A;RARG;EZR;CTCF;PHF12;UIMC1;HDAC9;PEX14;CBFA2T2;BACH1;RBAK;KAT6A;WWP2;ID2;EZH1;E4F1;PARP9;SMARCE1;IRF7;RCOR3;SMAD4;SBNO2;CNOT2;NR3C1;DAXX;LIN37;RBM15;SPEN;FOXO3;IKZF5;DEDD2;TAF7;ETS2;REST;MBD2;MAP2K5;NUPR2;PSMD10;L3MBTL2;MYB;NRIP1;NSD1;TLE1;LBH;EZH2;SREBF2;SMARCC2;CITED2;HDAC3;NFIL3;TGFB1;ZNF431;RSF1;ZNF436;GPS2;MAFK;AURKB;RELA;MAZ;DUSP26;TNFRSF4;CREBBP;PRDX5;USP9X;MIER1;TAF1;BHLHE40;PHC3;ZNF148;MED1;DUSP22;BRD7;USP47;RB1;NCOA5;SCMH1;PROX1;BPTF;SEMA4D;PSEN1;NIBAN2;FOXK1;ELK4;SUPT4H1;SIRT1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.42562196129588387,1.1006806334968458,0.32848837209302323,0.6907556060713693,1.0,13/30,20.01%,TAF9;RYBP;WAC;SVIP;TLK2;CAMLG;RPL11;USP7;EIF3H;USP14;N4BP1;STYX;PARK7
prerank,glucan catabolic process (GO:0009251),-0.4105882361450896,-1.1006626679557854,0.33053221288515405,0.7271199435259821,1.0,7/15,22.54%,PYGB;GAA;CALM1;PHKA1;PGM2;AGL;PHKG2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4498781053180264,1.1006015051126483,0.35703703703703704,0.6904097251003699,1.0,2/21,2.48%,LRRK2;HSPA1A
prerank,regulation of endothelial cell migration (GO:0010594),-0.28251292645952714,-1.10011712369878,0.2564102564102564,0.7273374267473035,1.0,18/85,9.27%,PTPRM;ANXA3;APOE;SASH1;SPARC;NRP1;GRN;GLUL;NRP2;ETS1;FGF2;PTN;NF1;RHOB;PIK3CG;ITGB3;AAMP;SLIT2
prerank,innate immune response in mucosa (GO:0002227),-0.4756612632940409,-1.099526157674082,0.36231884057971014,0.7276455463991532,1.0,5/10,44.02%,RNASE3;CAMP;LTF;DEFA6;RPL39
prerank,regulation of catabolic process (GO:0009894),0.47123462376785286,1.099512130042811,0.3607085346215781,0.6925822398362098,1.0,5/18,8.96%,NEDD4L;ZDHHC7;FAF1;FAP;SNF8
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5137820755141239,1.099342483073313,0.37181663837011886,0.6924433430857126,1.0,6/11,22.45%,H3-3A;RBBP4;ATRX;HAT1;CABIN1;ASF1A
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.2658143965740418,-1.0986073165790249,0.2578125,0.7287955267048382,1.0,18/107,7.58%,OPHN1;DLGAP1;CX3CR1;MEF2C;DGKZ;SYT1;SNCAIP;NLGN1;DLGAP4;ABR;TMEM108;DLG4;USP46;NRG3;GRIK4;GRID2;GRIK1;ATP1A2
prerank,regulation of protein polymerization (GO:0032271),-0.3343513842184808,-1.098481286712251,0.2980769230769231,0.727779366627683,1.0,16/35,28.55%,CAMSAP1;COTL1;MAP2;RASA1;PFN1;FCHSD2;CAMSAP2;PFN2;TPPP;CTTN;GBA2;MAPRE3;ABITRAM;HSP90AA1;ABL1;DBN1
prerank,negative regulation of cell population proliferation (GO:0008285),0.321549428721282,1.0984702764941863,0.2705761316872428,0.6941135463809806,1.0,56/351,14.40%,CBFA2T3;IL1B;IFNLR1;RUNX3;LYN;NGF;MARVELD3;KLF4;PPARG;PTPRU;PAK1;JAK2;HSPA1A;BTG2;CD300A;BMPR2;RAPGEF2;FABP7;PTPN6;EIF2AK2;ABI1;DLC1;BTG1;RBBP4;TNS2;GLMN;FAP;PTEN;CDKN2C;KLF10;PTK2B;CIB1;SULT2B1;RARG;LMNA;CTCF;IFI35;IL6;OPRM1;ARID2;B2M;S100A11;REST;UTP20;NUPR2;APP;SH3BP4;PPM1D;MORC3;NF2;KAT2B;CD164;RPS6KA2;PTPRJ;TGFB1;PPP2R5C
prerank,lipid transport (GO:0006869),-0.2755177827682295,-1.0981954937401475,0.23972602739726026,0.7271560411390737,1.0,13/97,7.21%,SLCO2B1;ABCA1;APOE;ABCD2;PITPNC1;OSBPL8;ABCC3;ATP8A1;PLEKHA8;PRELID2;FABP5;ATP8B1;SLC27A1
prerank,myoblast differentiation (GO:0045445),0.49046325280598585,1.0976249032948957,0.3548895899053628,0.6956914834025508,1.0,4/14,11.91%,MBNL1;PLEKHM3;MAPK12;REST
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3504935211399444,1.0974095137313586,0.32389580973952437,0.6956596538941038,1.0,15/107,12.61%,CCR2;CD40;CCR1;NPTN;SLC8B1;ATP2B1;ATP2A3;STIM2;ATP2A1;SLC30A1;DMPK;TMEM203;SLC10A7;ATP13A3;SLC24A4
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.49372788242886445,1.0970854447748377,0.3534201954397394,0.6958468753348297,1.0,2/14,1.77%,PTPRC;LDLR
prerank,protein-DNA complex disassembly (GO:0032986),0.4723969687700868,1.0969806671077686,0.36622073578595316,0.6955702626092767,1.0,4/16,13.75%,NFE2;SMARCE1;ARID2;SMARCC2
prerank,peptidyl-proline modification (GO:0018208),-0.37245816511236696,-1.0968407151306605,0.3253012048192771,0.7293549026595307,1.0,8/25,21.31%,P3H2;FKBP5;PPIA;CWC27;OGFOD1;PPIE;FKBP7;PPID
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.4384111382037721,-1.096727948833497,0.34324324324324323,0.728245171213574,1.0,5/13,21.55%,MAP1A;ABCA7;HSP90AB1;TYROBP;TMEM35A
prerank,positive regulation of protein binding (GO:0032092),0.37678988422091814,1.0961907429265254,0.34415584415584416,0.6969837681561499,1.0,12/56,13.48%,LRRK2;TIAM1;DTX3L;RAPGEF2;HIPK2;STK4;RALB;B2M;NMD3;APP;RPL11;MARK3
prerank,respiratory electron transport chain (GO:0022904),0.48741575883131677,1.0957952123410672,0.3544520547945205,0.6974334075968003,1.0,4/14,11.50%,GPD2;SLC25A13;SLC25A12;SLC25A18
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3315304898167535,-1.0957604203324678,0.2857142857142857,0.7296197360686857,1.0,9/39,12.55%,ABCA1;TANGO2;RAB3C;PREB;SCG2;ARFGAP3;OLFM2;TANGO6;MTTP
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.4624095211883229,-1.095474038134856,0.36077481840193704,0.7289918883990104,1.0,3/11,8.47%,TGFBR2;FGFR2;PDGFA
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3257050432042521,1.0954282866063723,0.262615859938208,0.6978189587481284,1.0,57/306,14.16%,ZAR1;ST3GAL4;DNA2;EXT1;BCL3;RPL5;RBBP8;POLL;CDC45;POLR3A;RPS10;MRE11;FEN1;POLR2C;FAM111A;SCX;B4GALT5;KAT7;RPL37A;MRPL55;RPL6;ORC5;MRPL18;MCM6;RBMS1;RPS18;RPS14;WRN;RPL35A;ORC4;MRPL13;RPL13;NFKBIB;BRIP1;CREBL2;EEF1G;RPS3;IGF2BP3;RPS21;FARSB;RECQL5;NAP1L1;RPA3;RPLP0;POLA2;RPL34;BAZ2A;RPL19;RPL11;MCM2;PCLAF;RPL30;RNASEH2A;RPL4;RPS2;DONSON;RPL7
prerank,DNA replication checkpoint signaling (GO:0000076),0.4859924972597236,1.0954123071229667,0.3633276740237691,0.6973086702382181,1.0,2/16,3.74%,DNA2;CDC45
prerank,positive regulation of ATP metabolic process (GO:1903580),0.42252193720033704,1.0953169225741963,0.34411764705882353,0.6969812144751393,1.0,13/32,18.98%,PID1;ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;VCP;PFKFB4;INSR;PSEN1;PINK1;TMSB4X
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.33509536309489224,-1.0952471877309602,0.27402135231316727,0.7282494975778034,1.0,12/37,21.62%,IFT74;DYNLL2;IFT172;DYNLL1;TRAF3IP1;IFT80;IFT20;DYNC2H1;TTC21B;KIF3A;IFT27;CLUAP1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.5202105028523061,1.0949212433118922,0.3798977853492334,0.6973865092072097,1.0,5/10,18.42%,RAPGEF2;ZEB2;ATP7A;APPL1;CTNS
prerank,positive regulation of lipid catabolic process (GO:0050996),0.4606261925121554,1.094440003505075,0.3425925925925926,0.6979869541053617,1.0,1/19,0.33%,IL1B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.38281956153353397,1.0943931462687637,0.33626097867001253,0.6970082712660632,1.0,10/51,10.44%,VRK1;SUMO1;CHMP4A;CHMP4B;NUP98;PPP2R2A;LMNA;SPAST;ANKLE2;LEMD2
prerank,mitotic nuclear membrane organization (GO:0101024),0.38281956153353397,1.0943931462687637,0.33626097867001253,0.6970082712660632,1.0,10/51,10.44%,VRK1;SUMO1;CHMP4A;CHMP4B;NUP98;PPP2R2A;LMNA;SPAST;ANKLE2;LEMD2
prerank,peptide cross-linking (GO:0018149),0.4397569220859516,1.094338819248331,0.35724533715925394,0.6966076251975637,1.0,5/25,15.44%,NDNF;F13A1;FN1;ANXA1;THBS1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5169443125868651,1.0942738081080186,0.3822525597269625,0.6962114935485789,1.0,6/12,21.77%,PARP8;TIPARP;TNKS;PARP12;PARP11;PARP1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.3980149468170744,-1.0938286437407276,0.3202247191011236,0.7307890017419627,1.0,7/16,22.54%,PYGB;GAA;CALM1;PHKA1;PGM2;AGL;PHKG2
prerank,organic substance transport (GO:0071702),-0.2659119578887143,-1.0938258479417708,0.27692307692307694,0.7294139735901668,1.0,30/121,20.31%,SLCO2B1;ABCA1;LRP1B;ABCD2;MFSD12;SCAMP1;ABCG2;FLVCR1;ATP8A1;SCAMP2;PLEKHA8;SCAMP5;HSP90B1;SLC22A5;SPNS2;CHKA;TOM1;DISP1;ABCA7;SLC22A4;TXNIP;CHMP1B;VPS33B;ARRDC2;ABCD3;KIF3A;SLC50A1;ABCB9;CHMP2A;CEP290
prerank,basement membrane organization (GO:0071711),0.48407614979220737,1.0936456624365545,0.3624382207578254,0.6972021071606165,1.0,3/14,8.25%,NTNG2;LAMB1;PXDN
prerank,neuromuscular process controlling balance (GO:0050885),-0.4547067535302929,-1.0935711739696532,0.3431818181818182,0.7287569365072079,1.0,4/12,7.99%,CDH23;TPP1;PCDH15;MYO7A
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.4654429830494641,1.093405885451546,0.3588516746411483,0.6972797156622185,1.0,9/18,23.64%,MSN;EZR;SNX3;MAPK1;SNX12;MTMR2;MAP2K1;RAB21;CHMP3
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5030686866411631,1.093347995651515,0.3853989813242784,0.6968870898048253,1.0,2/12,7.30%,CCDC120;NIN
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3798584182809911,-1.0932054231413484,0.3488372093023256,0.7283763053021683,1.0,5/21,14.24%,SLC8A1;MEF2C;ACVR1;VEGFA;CXADR
prerank,nitric oxide biosynthetic process (GO:0006809),0.49799372668003783,1.0930679291429046,0.3629032258064516,0.697046214642537,1.0,4/13,19.23%,CYB5B;ARG2;AKT1;CYB5R3
prerank,maintenance of protein localization in organelle (GO:0072595),0.4528485071358175,1.0930635974505882,0.34408602150537637,0.6965103147641244,1.0,7/19,21.20%,BCL3;TAPT1;MORC3;AKT1;HSPA5;PINK1;TAF3
prerank,protein targeting to membrane (GO:0006612),0.3575320812523885,1.0928430895183987,0.3229426433915212,0.6965170163323511,1.0,17/83,13.52%,VPS37C;MYO1C;PEX16;CHMP4A;CHMP4B;PEX12;ZDHHC7;TRAM1;ZDHHC6;ZDHHC23;PEX14;SEC63;PIKFYVE;FIS1;SRP19;ABCD1;NCF1
prerank,mitochondrion localization (GO:0051646),0.4641615261636714,1.0928074953271643,0.35771065182829886,0.6960728435285556,1.0,2/19,6.98%,LRRK2;ATP2A1
prerank,ncRNA metabolic process (GO:0034660),0.4060005511569219,1.0926517743369872,0.3333333333333333,0.6959036874501817,1.0,10/37,22.66%,XPO5;DGCR8;EXD1;TRIM71;TUT7;TENT4B;DTD1;PARN;TARBP2;ZCCHC8
prerank,reticulophagy (GO:0061709),-0.4528541028194881,-1.0910026476512333,0.348780487804878,0.7330914833149154,1.0,6/12,26.40%,ULK2;UFC1;UFM1;UFL1;ATG2A;UBA5
prerank,regulation of viral release from host cell (GO:1902186),0.4394840531929314,1.090566472000631,0.3511450381679389,0.7003839133214524,1.0,4/21,7.45%,TRIM26;TRIM62;TSG101;TRIM25
prerank,positive regulation of lipid localization (GO:1905954),-0.44537104809406936,-1.0905563900574389,0.37163814180929094,0.7329240046013145,1.0,4/11,13.69%,LRP1;IKBKE;VSTM2A;C3
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4752668803016743,-1.089746020427019,0.3752808988764045,0.7324228778735009,1.0,4/10,12.11%,MYLIP;AP2A1;CLTA;AP2M1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4752668803016743,-1.089746020427019,0.3752808988764045,0.7324228778735009,1.0,4/10,12.11%,MYLIP;AP2A1;CLTA;AP2M1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.4392463636255095,1.0896988557643403,0.3533834586466165,0.7019808431439342,1.0,10/23,16.93%,NFKB1;ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;PFKFB4;INSR;PSEN1
prerank,mitochondrion disassembly (GO:0061726),-0.3330239881994108,-1.0889769760170924,0.3122923588039867,0.7332130819320094,1.0,12/34,21.84%,PRKN;ULK2;MAP1LC3B;ATG12;USP30;SQSTM1;ATG9A;FUNDC2;ATG7;ATG2A;WDR45;GABARAP
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4418314909686653,1.0886851828532047,0.36716417910447763,0.7039754220007015,1.0,9/23,20.32%,SPI1;IFI35;CPNE1;CYLD;NLRP3;RELA;HDAC7;TMSB4X;ADIPOR1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.422617257823395,1.0886759615847714,0.36363636363636365,0.7034516973069497,1.0,7/29,14.30%,FGR;FLT3;PTK2B;PIK3R4;KIT;FGFR3;TGFB1
prerank,positive regulation of T cell differentiation (GO:0045582),0.40395302555213886,1.0883821520468824,0.3300699300699301,0.7036392719300811,1.0,3/36,4.44%,TESPA1;BCL6;ZAP70
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3968873075931578,1.088358672742366,0.3333333333333333,0.7031496913918536,1.0,8/40,14.30%,IL1B;TIAM1;GLIPR2;IL6;OLFM1;SMAD4;EZH2;TGFB1
prerank,regulation of NMDA receptor activity (GO:2000310),0.41755901695176034,1.0876998886169853,0.33764367816091956,0.7042372054165768,1.0,5/32,9.12%,CCR2;DAPK1;PTK2B;EPHB2;OPRM1
prerank,protein polymerization (GO:0051258),0.3786649298056764,1.087665048307383,0.3389175257731959,0.7037832461999544,1.0,11/55,11.51%,PSTPIP1;JAK2;PSTPIP2;MSRB1;CHMP4A;CHMP4B;DIAPH1;TPPP3;RAC1;UBE2S;TTC17
prerank,negative regulation of calcium ion transport (GO:0051926),0.47182203915392557,1.0875790013823166,0.3721311475409836,0.7034596754885168,1.0,3/15,8.43%,LILRB1;ADRA2A;SLC30A1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.32822044893648283,-1.0873934531359835,0.3256578947368421,0.7362539259248178,1.0,12/35,16.50%,DDX5;RBFOX2;PLPP1;PGR;EGLN2;NR3C2;PPARGC1B;CALCOCO1;ESR1;SRC;AR;NCOA4
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4214362231172636,1.0871174626463207,0.3413940256045519,0.7040391186945201,1.0,9/31,14.21%,PEX16;PEX12;GRPEL2;DNAJC19;TIMM21;PEX14;TOMM40;AIFM1;TIMM50
prerank,selective autophagy (GO:0061912),-0.30794016797473145,-1.0868316531930229,0.28193832599118945,0.7364219839602192,1.0,15/56,17.96%,PRKN;WDFY3;ULK2;UBC;DYNLL2;NBR1;AUP1;DYNLL1;UFC1;MAP1LC3B;UFM1;USP30;SQSTM1;UFL1;HDAC6
prerank,signal transduction in response to DNA damage (GO:0042770),0.3825857312641505,1.0866257511213804,0.35958005249343833,0.7046529143639108,1.0,20/49,23.20%,BCL3;MAD2L2;MAPK14;CDC5L;GRB2;CEP63;CLOCK;DOT1L;BRIP1;MAP3K20;ATRX;DONSON;HUS1;RAD17;CHEK2;TIPRL;BID;CASP9;BATF;STK33
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5017470580494379,1.0859617182217634,0.3949152542372881,0.7057848499917123,1.0,5/12,21.95%,DIAPH1;PTK2B;FKBP1B;ANXA6;UBASH3B
prerank,smooth muscle cell differentiation (GO:0051145),-0.43698871498355185,-1.0851030853505097,0.35634743875278396,0.7397323680061364,1.0,1/12,0.72%,MEF2C
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.44473039984935026,-1.0848191543114178,0.3917995444191344,0.7391058166705243,1.0,6/11,55.53%,RTP4;PKD1L3;PKD2L1;LPO;RTP2;TAS1R3
prerank,bicarbonate transport (GO:0015701),0.4275007162281792,1.0843283972892688,0.3895522388059702,0.709295796197835,1.0,5/25,13.62%,SLC4A7;SLC4A8;CYB5R4;CYB5R1;SLC26A7
prerank,regulation of cell adhesion (GO:0030155),0.3412540215677365,1.0841924216162777,0.3217488789237668,0.7091007147086107,1.0,29/129,17.17%,CYTIP;LYN;RET;PPP1R12A;RIPOR2;RAC2;CBLL1;PPP3CA;RSU1;SPN;ARHGDIB;PTK2B;TGFBI;PLXND1;EPHB2;MINK1;ATXN3;DUSP1;PPP1CB;PLXNC1;ROCK1;CD164;PTPRJ;IL18;DUSP26;MYADM;FES;SEMA4D;ABL2
prerank,regulation of heart contraction (GO:0008016),0.35516762033454075,1.0841340325710203,0.3384253819036428,0.7087050408620482,1.0,8/90,4.82%,ITPR1;ACE2;GJA5;RNF207;KCNQ1;HCN4;ATP2B1;ATP2A3
prerank,positive regulation of hydrolase activity (GO:0051345),0.3418913825024368,1.08370559862893,0.3474860335195531,0.7092518393654548,1.0,25/137,11.72%,SRGAP2;RAP1A;CD40;DOCK10;RASGRP2;RAPGEF2;USP6NL;DOCK11;PICALM;ARAP1;RSU1;CAV2;AFDN;WRN;S100A10;PSAP;MAPK12;F11R;RHOA;BCAS3;RPS3;SNX9;NET1;TBC1D2;DVL3
prerank,double-strand break repair (GO:0006302),0.3365829252456129,1.0833508138877157,0.32450331125827814,0.7096048420802152,1.0,43/158,18.82%,DNA2;SAMHD1;DTX3L;MAD2L2;RBBP8;POLL;MRE11;FEN1;SUMO1;DNTT;SMARCA5;UBE2N;SETX;WRN;CIB1;NABP1;UIMC1;BRIP1;PARP9;MORF4L1;RECQL5;RPA3;XRCC4;EXD2;SPIDR;MAPK8;ERCC4;RNF138;VCP;XRCC2;INO80;MCM9;KDM4B;POLB;KPNA2;HUS1;MDC1;EYA3;SMC6;RAD21;SMC5;CHEK2;SETMAR
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.35149780409800324,1.0832649435411195,0.3369304556354916,0.7092607516894628,1.0,17/86,15.44%,JAK2;BMPR2;RBPMS;ZEB2;GDF1;RBPJ;HIPK2;ADAM17;BMP3;ENG;ACVR2A;SMAD4;ING2;CITED2;TGFB1;CREBBP;THBS1
prerank,cellular response to organic cyclic compound (GO:0071407),0.3380945040592171,1.0832157641019298,0.33631284916201115,0.7088379913538326,1.0,29/141,15.77%,LRRK2;IL1B;RAP1A;MSN;RAPGEF2;KCNQ1;NCOA3;CTNNA1;HCN4;GABRB2;DIAPH1;TIPARP;AHR;PDE2A;EZR;GNB1;HRH1;NR3C1;GNAI1;ADCY5;SPIDR;NRIP1;GNG2;CASP7;TGFB1;IL18;CASP6;TAF1;MED1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.34384084203403276,1.0831946282846094,0.3297997644287397,0.7083329370177869,1.0,25/101,16.52%,NIBAN1;BCL3;KLF4;RPL5;MSN;VIM;NFKBIA;PTTG1IP;FBXW11;FAF1;YTHDF3;EZR;IL6;ATG10;AKT1;METTL3;CYFIP2;LARP4B;TGFB1;EIF3E;THBS1;RPS4X;RPS6KB1;AURKAIP1;WNT7A
prerank,sphingoid biosynthetic process (GO:0046520),0.489478229777798,1.0831633684566224,0.38782608695652177,0.7073236238123476,1.0,1/11,1.60%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.489478229777798,1.0831633684566224,0.38782608695652177,0.7073236238123476,1.0,1/11,1.60%,ACER3
prerank,protein K63-linked ubiquitination (GO:0070534),0.38638387619139747,1.0831115436169707,0.3506849315068493,0.7069188167369543,1.0,11/41,12.31%,TRAF1;ITCH;TRAF3IP2;PELI1;UBE2N;HECTD1;TRAF3;ARIH2;WWP2;UBE2S;UBE2G1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.42625927423397364,1.0828814012237888,0.38145896656534956,0.7069311009129422,1.0,4/26,13.22%,ACER3;CYB5B;ARG2;AKT1
prerank,macroautophagy (GO:0016236),0.3437204269770898,1.0828769906731148,0.3242630385487528,0.7064051679179149,1.0,39/118,19.56%,UVRAG;PIP4K2A;PRKAG2;VPS37C;MTMR14;CHMP4A;CHMP4B;STX17;TSG101;MTMR3;PRKAB2;ATG5;SNF8;CSNK2A2;CSNK2A1;TBC1D5;TOMM40;PIP4K2B;PRKAG1;STAM;PRKAA1;PGAM5;PIK3R4;WIPI2;ATG10;ARL8B;PRKAA2;VCP;ILRUN;RB1CC1;FUNDC1;AMBRA1;BECN1;ATG13;STAM2;SNX14;PINK1;VPS37B;PLEKHM1
prerank,ERBB2 signaling pathway (GO:0038128),0.41563934332301783,1.0825824094637952,0.34175334323922735,0.7066412719380801,1.0,7/31,10.70%,NRG2;CUL5;ERBIN;PTPN12;GRB2;SOS1;PIK3CA
prerank,regulation of keratinocyte proliferation (GO:0010837),0.43910441836662834,1.0822221937489938,0.3660030627871363,0.7069436213459156,1.0,2/22,1.59%,NOTCH2;CASK
prerank,regulation of epithelial cell migration (GO:0010632),0.3802153100262904,1.0819331095142448,0.36375321336760924,0.7071010582480767,1.0,6/51,3.79%,DOCK5;PRKCE;PLCG2;MARVELD3;BMPR2;GLIPR2
prerank,"phagocytosis, engulfment (GO:0006911)",0.40992504711669836,1.081412726727622,0.38016528925619836,0.7078016199655692,1.0,14/36,18.24%,CD36;RAC2;MYH9;CDC42;ITGB2;XKR4;RAC1;FCGR2B;MEGF10;RHOG;ELMO1;THBS1;GULP1;FCGR1A
prerank,regulation of intracellular transport (GO:0032386),0.4041000527828489,1.0808068904529822,0.3616133518776078,0.7087571130233979,1.0,8/38,15.05%,LRRK2;LCP1;INPP5F;RINT1;PTPN1;DYNC1H1;GRIPAP1;DYNLT2B
prerank,sphingolipid biosynthetic process (GO:0030148),0.36026141202808404,1.0808034395150947,0.3443223443223443,0.7082231339167206,1.0,15/71,16.34%,CERS6;ST8SIA1;ACER3;CERS1;ELOVL5;SAMD8;SGMS1;SGMS2;ELOVL6;SPTSSB;SGPP2;SGPP1;FA2H;VAPA;HACD4
prerank,placenta development (GO:0001890),0.5020644573600391,1.0804954751230316,0.3696027633851468,0.7084598016444054,1.0,2/12,10.05%,PPARG;ADAM19
prerank,monoacylglycerol metabolic process (GO:0046462),-0.43506916579235044,-1.080334891497246,0.37158469945355194,0.7499389230852815,1.0,3/13,7.35%,ABHD12;MGLL;PLA2G4A
prerank,regulation of BMP signaling pathway (GO:0030510),0.3618917293806019,1.0796156375406285,0.3586550435865504,0.7100440004219218,1.0,14/73,15.35%,PPARG;BMPR2;SORL1;LEMD3;RBPJ;HIPK2;UBE2D3;ENG;ACVR2A;SMAD4;LEMD2;ITGA3;VWC2L;XIAP
prerank,extracellular matrix organization (GO:0030198),0.3209449799744762,1.0795261293447973,0.31191709844559584,0.709727083930133,1.0,31/276,10.27%,ITGB7;ITGA4;ITGAL;CD44;CD47;LCP1;PECAM1;ITGAE;ITGAX;TNC;NDNF;COL5A2;MMP1;LAMB1;SCX;ITGAD;ITGB2;HSPG2;CAPN2;F11R;ATP7A;ADAMTS6;TGFBI;PXDN;ACAN;ICAM1;FBN1;TLL1;ADAM19;NCAN;FN1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3121668713812757,1.0789157941865979,0.26814516129032256,0.7106669746048774,1.0,121/572,18.30%,CIITA;BCL11A;TRPS1;FOXP1;RARA;SP100;RUNX3;KLF4;UXT;PPARG;ETV6;BCL6;SAP30;NFKB1;STAT3;HSPA1A;FOXJ1;NIPBL;NEDD4L;MAD2L2;SPI1;CRY1;TBL1XR1;ZEB2;MTA3;GATAD2B;SUMO1;LRRFIP1;KLF8;IRF2;RBPJ;KCNIP3;HIVEP1;IL33;DEAF1;STAT1;UBE2D3;HEXIM1;CCND1;KLF10;WFS1;RPS14;CGGBP1;CBFB;CREM;MECP2;PDE2A;THRA;CRY2;GATAD2A;RARG;EZR;CTCF;PHF12;HDAC9;BACH1;WWP2;ID2;EZH1;E4F1;PARP9;IRF7;SMAD4;CNOT2;NR3C1;LIN37;SPEN;FOXO3;IKZF5;TAF7;ETS2;REST;MBD2;MAP2K5;NUPR2;PSMD10;ATRX;MYB;NRIP1;NSD1;EZH2;SREBF2;CITED2;HDAC3;NFIL3;ZNF431;ZNF436;GPS2;MAFK;AURKB;RELA;MAZ;DUSP26;CREBBP;USP9X;MIER1;TAF1;BHLHE40;ZNF148;MED1;DUSP22;RB1;NCOA5;PROX1;BPTF;SEMA4D;PSEN1;ELK4;SUPT4H1;SIRT1;BAG3;ORC2;MCPH1;NFATC3;EFNA1;HCFC2;FOXC1;HDAC1;CBX8;SMURF2;PRDM2
prerank,protein processing (GO:0016485),-0.27008726668014826,-1.078868768164829,0.25,0.7526358033951986,1.0,34/102,23.82%,LGMN;VSIR;MMP16;KLK3;METAP2;PSEN2;SPCS3;FURIN;LONP2;SPPL3;MMP14;AFG3L2;SEC11C;CASP4;PCSK1;BACE1;PCSK7;SPG7;STOML2;HTRA2;ZMPSTE24;HM13;PSENEN;SPRTN;AEBP1;TMEM208;ECE1;FXN;PTCH1;CLN3;EEF1AKMT4-ECE2;PCSK2;CTSH;CPE
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.3102648927054744,-1.07866458995919,0.3053435114503817,0.751819694191789,1.0,10/42,18.03%,TREM2;SLC11A1;PYCARD;OPTN;SERPINE1;TLR4;HMGB2;ADGRB1;MR1;DROSHA
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.41039740266244906,1.077862085636897,0.39092240117130306,0.7126984502845837,1.0,8/35,13.81%,ADGRG6;CD36;RAPGEF2;PDE7A;AHR;PDE2A;IRAG1;PDE7B
prerank,double-strand break repair via break-induced replication (GO:0000727),0.49583806573074785,1.0778522714152825,0.39028475711892796,0.712190204629823,1.0,3/12,13.02%,CDC45;MCM6;MCM2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.33790219610011407,-1.077849696003667,0.3412969283276451,0.7526462714250515,1.0,8/33,13.28%,WNK1;AHCYL1;CHRM3;KCNJ2;P2RX7;AKAP6;KCNJ6;KCNJ9
prerank,dendritic spine organization (GO:0097061),0.430646896209139,1.077368506109815,0.3742603550295858,0.7128326280926602,1.0,11/26,16.81%,FYN;DOCK10;CDC42;PTEN;PRNP;ARF1;EPHB2;ITGA3;INSR;WNT7A;MTMR2
prerank,mesenchymal cell differentiation (GO:0048762),-0.30861184727560403,-1.0773339063466547,0.2979591836734694,0.7526783532189311,1.0,10/51,10.00%,MEF2C;LRP6;TGFBR1;DDX5;CTNNB1;HIF1A;FGFR2;HTR2B;LOXL3;HNRNPAB
prerank,axon development (GO:0061564),-0.27730821655104043,-1.0772794275344106,0.30434782608695654,0.7514559053584561,1.0,27/78,22.04%,RTN4RL1;DCC;MAP1B;PLP1;CTNNA2;CNTN4;FGFR2;NREP;RYK;AFG3L2;CDK5R1;MAP1A;ARHGAP35;PARD3;KLF7;CDK5;CAMSAP2;MTR;SLITRK1;ADGRB1;APBB1;NEFH;RAB3A;PLPPR4;GRM7;BRSK2;SPTBN4
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.49231879973026477,1.0772487312138903,0.39322033898305087,0.7125965560458203,1.0,3/12,10.41%,ERN1;ATF6;PTPN1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.44730956670937627,-1.0762653996094746,0.38498789346246975,0.7530524261818822,1.0,3/12,0.72%,PRKG1;DOCK4;MEF2C
prerank,dopaminergic neuron differentiation (GO:0071542),0.4533470162671803,1.076098378985976,0.3834710743801653,0.7148505375671187,1.0,2/19,2.16%,CDNF;PITX3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4573963754231228,1.0759824525800417,0.38287560581583197,0.7146095570746438,1.0,4/18,7.93%,PTPRC;LAPTM5;PRNP;EZR
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.49960501793885803,1.0757043368463748,0.3829787234042553,0.7147535806637609,1.0,4/13,14.84%,JAK2;IL33;TLR2;GSTP1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.42331888369308723,-1.0756978350504398,0.3460620525059666,0.7532310669037501,1.0,3/14,9.11%,ABCD2;LONP2;IRS1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.39928707540588093,1.075336449752514,0.3756906077348066,0.7151007802948445,1.0,4/39,2.59%,FXYD5;TCAF2;UTRN;NEDD4L
prerank,positive regulation of DNA binding (GO:0043388),-0.34134781293173827,-1.0752582842310157,0.33636363636363636,0.7531036057555778,1.0,4/31,2.99%,PRKN;IGF1;SKI;HMGB1
prerank,excitatory postsynaptic potential (GO:0060079),0.4558404606177469,1.0750428309526523,0.36451612903225805,0.7152763482289929,1.0,1/19,0.22%,LRRK2
prerank,regulation of actomyosin structure organization (GO:0110020),0.48975767502924467,1.0749941177620959,0.3870967741935484,0.7148640435562366,1.0,7/13,21.36%,PTGER4;CDC42;RAC1;ROCK1;FHOD1;ALMS1;WAS
prerank,chemical synaptic transmission (GO:0007268),-0.23263980830563588,-1.074909015409616,0.1891891891891892,0.7527213011820595,1.0,60/284,16.08%,APOE;DLGAP1;LRP6;GRIA4;SYT1;PTPRN2;CACNB2;NLGN1;CAMK1;KCND2;SLC1A3;PLP1;KCNQ3;CHRM3;DLG2;NAPA;DLG4;CHRM2;GRIA2;KIF1B;GRIA1;PRKACA;GABRG3;NRXN2;GABRG2;SLC17A6;GRIK4;GRID2;SNAP25;GABRB1;GRIK1;GLRA3;HTR2B;GLRA2;FCHSD2;NOVA1;GABRA4;CHRFAM7A;CHRNA7;GAD2;RIT2;GRM5;CDK5;CAMK4;SNPH;STX1A;SLC5A7;PRKAR1A;NLGN2;SST;HTR2C;CALM1;ERC1;GABRB3;LIN7A;GIPC1;KCNA1;HTR7;CPLX1;NLGN3
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.27062031301586803,-1.0748531101402876,0.2721518987341772,0.7515080150076249,1.0,13/88,8.30%,PTPRM;APOE;SPARC;NRP1;TGFBR1;NRP2;FGF2;ATP5F1A;NF1;HIF1A;HTR2B;ITGB3;SCG2
prerank,regulation of cell death (GO:0010941),0.34706925686735035,1.0746432348150072,0.35122520420070014,0.7152215701861816,1.0,11/94,7.10%,LRRK2;SRGAP2;ACER3;HSPA1A;CD36;NOA1;CHMP4B;HP;HPR;FAF1;ATG5
prerank,regulation of lipid storage (GO:0010883),0.4446146657913409,1.0739715560174528,0.3770739064856712,0.7163322863680044,1.0,4/22,8.68%,NFKB1;NFKBIA;FBXW7;IL6
prerank,transcription by RNA polymerase II (GO:0006366),0.32039115600297596,1.073865491355966,0.3316062176165803,0.716054956168042,1.0,78/305,18.51%,RARA;NOTCH2;HNF4G;CDK13;PPARG;NFKB1;GTF2F2;TAF1A;TAF13;GTF2E2;TAF9;POLR2C;TBL1XR1;MBD1;RBPJ;DEAF1;KLF13;SNRPB;DEK;SETX;ELOA;SSU72;CBFB;ELOB;NABP1;THRA;FIP1L1;RARG;CCNH;GTF2A1;E2F2;HDAC9;ELOF1;SCAF8;RPRD2;SNAPC3;PKNOX1;RPRD1B;NR3C1;INTS2;NUDT21;GMEB2;SETD2;SRRT;CCNT2;NELFA;MED26;TAF7;INTS11;NFYA;INTS14;CCNT1;TEAD1;CDK12;ERCC3;EAF1;INTS4;KAT2B;HDAC3;MAZ;CPSF3;CREBBP;PAPOLA;TAF1;NCBP1;MAML1;MED1;ELL;MED7;INTS6;TAF1C;SUPT4H1;NR4A1;HDAC7;HDAC1;CSTF3;PHAX;POU2F2
prerank,regulation of autophagosome maturation (GO:1901096),0.4933631407217168,1.073820338215403,0.4110738255033557,0.7156306482013596,1.0,2/13,7.36%,UVRAG;CLEC16A
prerank,cilium movement (GO:0003341),0.3787455955449424,1.073110037138627,0.36436170212765956,0.7168404738783363,1.0,9/47,13.29%,DNAH9;ADCY10;DNAAF5;CABYR;CFAP61;ODAD1;CCDC39;CFAP54;CFAP70
prerank,apical protein localization (GO:0045176),0.5227807212699911,1.0723951353767847,0.4068965517241379,0.7180499777382839,1.0,6/10,19.23%,CELSR1;SHROOM3;INSC;GOPC;MAL;ACTB
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.36755230708796655,1.0719750586346515,0.37670384138785623,0.7185639550062409,1.0,22/69,18.51%,GTF2F2;TAF13;GTF2E2;TAF9;POLR2C;NABP1;GTF2A1;RPRD2;SNAPC3;RPRD1B;INTS2;SRRT;CCNT2;INTS11;INTS14;CCNT1;INTS4;NCBP1;ELL;INTS6;PHAX;POU2F2
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.43522263173023557,1.071900868066716,0.38810641627543035,0.7182140020929663,1.0,6/21,15.77%,MED30;MED13;SETX;MED12;MED14;MED1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.5211643005780646,1.071861088178144,0.4013377926421405,0.7177792832931182,1.0,2/10,3.49%,HSPA1A;SORL1
prerank,cellular respiration (GO:0045333),-0.31274476062401413,-1.0717128218258543,0.32280701754385965,0.7589792412234664,1.0,16/41,25.96%,UQCRC2;ME3;PPARGC1A;SDHB;OXA1L;SLC25A14;NDUFS7;MTFR1L;ATP5F1D;COX10;NDUFA5;UQCR10;UQCRC1;LYRM7;NDUFS8;SURF1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.4766594942428961,1.0706328572252386,0.3973727422003284,0.7202043010832375,1.0,5/14,12.31%,NFKBIA;NFKBIE;FAF1;NFKBIB;PSMD10
prerank,protein heterotetramerization (GO:0051290),-0.42811402772919716,-1.0703809954344088,0.36341463414634145,0.7613212761503958,1.0,6/13,22.23%,PKD2;CPSF6;CBR4;HSD17B8;FARSA;GRIN2B
prerank,nucleoside catabolic process (GO:0009164),0.5036907911330247,1.07020988681667,0.4121863799283154,0.7206921870146066,1.0,3/11,13.00%,UPB1;DERA;NT5C3A
prerank,UV protection (GO:0009650),0.5144233654423491,1.0700342137309815,0.37302977232924694,0.7205755250882053,1.0,2/10,4.13%,GPX1;FEN1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.39338940826205193,-1.069909483878316,0.3626062322946176,0.7611986213138356,1.0,5/16,18.19%,BCL2L1;TMEM161A;CLU;FBH1;TRIM32
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.42107745900516425,1.0698404352840718,0.3744292237442922,0.7205026628635441,1.0,10/26,14.81%,ANKRD17;CCND3;CCND1;ADAM17;PLCB1;ANXA1;MTBP;CCND2;AKT1;KMT2E
prerank,positive regulation of cell adhesion (GO:0045785),0.35857794469769577,1.0698032907863542,0.3833943833943834,0.7200516032549064,1.0,10/74,8.24%,CD47;RET;NDNF;SYK;JAK2;PPP3CA;RSU1;AFDN;CIB1;RAC1
prerank,mitotic cytokinesis (GO:0000281),0.3796625347811084,1.0697540241888954,0.3805774278215223,0.7196418215036307,1.0,16/47,17.68%,RACGAP1;KIF20A;MITD1;KIF23;CHMP4B;PDCD6IP;SPAST;SNX9;UNC119;ROCK1;EFHC2;SNX33;APC;TRIM36;RAB35;CNTROB
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.37506730983285885,-1.0696981479115513,0.3815028901734104,0.7602900739431233,1.0,8/20,18.18%,APOE;TTC39B;ARV1;DGKQ;FMO5;MBTPS2;RAN;ACADL
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.368294812848506,1.0694772699104516,0.3648989898989899,0.7197704907873166,1.0,23/63,20.87%,SP100;TRAF1;PSME3;BIRC6;BCL2L14;PAK2;TMC8;CYLD;RIPK1;DEDD2;HTT;SH3RF1;LGALS3;GSTP1;RELA;THBS1;TRAF2;DEPTOR;FGFR1;PARK7;FEM1B;ITGAV;PHIP
prerank,response to estrogen (GO:0043627),0.4070684695135999,1.0694385442052692,0.3793604651162791,0.7193202397930728,1.0,4/31,9.21%,RARA;SERPINB9;TRIM25;BCAS3
prerank,regulation of cardiac conduction (GO:1903779),0.3719041170174656,1.0691153139104843,0.3558897243107769,0.7195734570970771,1.0,6/54,6.98%,ITPR1;ACE2;GJA5;ATP2B1;ATP2A3;ATP2A1
prerank,positive regulation of growth (GO:0045927),0.36654169864427727,1.0690683131444307,0.3589420654911839,0.7191505196622132,1.0,20/64,16.24%,RPS6KA3;CDC42;H3-3A;CXCL16;WFS1;ADAM17;CIB1;MTPN;PLCB1;DDX49;CSNK2A1;RPS6KA1;PSMD10;ZPR1;PABIR1;AKT1;NCBP1;INO80;USP47;INSR
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.2850195354618439,-1.0690337875875406,0.32599118942731276,0.7607293311901464,1.0,8/65,5.48%,LDLRAD4;TGFBR2;SKI;TGFBR1;SNX25;SMAD7;STUB1;UBC
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3016399221459372,-1.0688621344230913,0.3435114503816794,0.7597722841888939,1.0,24/47,30.03%,ATP5F1A;ATP5PO;APOO;AFG3L2;TMEM11;TIMM9;ATP5MG;ATP5PD;CHCHD6;ATP5PF;SPG7;ATP5F1D;ATP5MC3;TIMM10B;AGK;NDUFA13;ATP5MF;TIMM13;SAMM50;TIMM8B;ROMO1;TIMM29;APOOL;UQCC3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3572610946593162,1.0686963549840418,0.3663003663003663,0.7195726757272869,1.0,9/75,7.31%,CCR2;KLF4;PPARG;CXCL10;ATF2;SYNJ2BP;STAT1;HSPG2;MECP2
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.48879471393881246,1.0686310755600834,0.38762214983713356,0.7192040231057344,1.0,5/13,17.51%,SPI1;FAM47E;ELOF1;ZMIZ2;PADI2
prerank,protein glycosylation (GO:0006486),0.33758211620083345,1.0685142377261487,0.36394557823129253,0.7189629857056499,1.0,14/125,10.31%,ST3GAL1;ST8SIA4;ST3GAL4;ST8SIA1;TET2;KRTCAP2;FUT4;ST8SIA6;B4GALT5;GALNT2;SERP2;GALNT10;MGAT3;MAGT1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.5240230443201275,1.068115188667401,0.40869565217391307,0.719440861241034,1.0,3/10,12.55%,JAK2;IL33;TLR2
prerank,tRNA 5'-end processing (GO:0099116),-0.41291825704297513,-1.0680377988733194,0.3767441860465116,0.7606834231597422,1.0,11/15,34.64%,POP1;RPP30;RPP14;SSB;RPP40;POP4;POP5;HSD17B10;RPP21;POP7;RPP25L
prerank,telomere maintenance (GO:0000723),0.38203573013227393,1.0678943167855317,0.37262872628726285,0.719474307239387,1.0,16/50,20.00%,SP100;DNA2;MRE11;TEP1;POLD4;WRN;RPA3;ERCC4;STN1;HUS1;POLD1;LTO1;SMC6;SMC5;TERF2;APEX1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.36345975071024916,1.06738325129223,0.3790931989924433,0.7201988180702525,1.0,22/66,20.01%,NGFR;DTX3L;KAT7;UBR5;FLNA;RBM22;PARP9;NMD3;ZPR1;EIF2AK3;AKT1;LIMK2;HCLS1;HDAC3;TGFB1;TCP1;PSEN1;PIK3R2;BAG3;PRKCD;LARP7;PARK7
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.311059828427285,-1.0662981415140393,0.31954887218045114,0.764159361199653,1.0,10/39,14.38%,MAML2;ROBO2;MAML3;ROBO1;AAK1;EPN2;BMP2K;SNW1;TGFB2;SRC
prerank,cellular response to glucose starvation (GO:0042149),0.39740742847148103,1.0661161434249238,0.37517433751743373,0.7227560640336763,1.0,14/41,17.95%,SIK1;PRKAG2;MTMR3;SIK2;PRKAG1;FOXO3;PRKAA1;PIK3R4;EIF2AK3;PRKAA2;BRSK1;RRP8;BECN1;HSPA5
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.4650889650469891,1.0658633305525371,0.3936348408710218,0.7228096828737015,1.0,2/16,2.85%,TET2;UPB1
prerank,receptor catabolic process (GO:0032801),-0.3529729161555828,-1.065819138869662,0.32515337423312884,0.7640744510668473,1.0,7/24,12.11%,LGMN;MYLIP;AP2A1;SNX25;CLTA;ZNRF3;AP2M1
prerank,erythrocyte differentiation (GO:0030218),0.3790683486139908,1.0656968676500977,0.36473755047106327,0.7226343346886244,1.0,12/44,16.61%,LYN;JAK2;HIPK2;RPS14;ID2;SLC25A5;HSPA9;KIT;HCLS1;KMT2E;MED1;ACIN1
prerank,cellular response to starvation (GO:0009267),0.3347624979688192,1.065684021494143,0.36254107338444685,0.722137720860031,1.0,39/147,17.95%,LRRK2;SIK1;STK24;MAP3K5;PRKAG2;ATP6V0E1;BMPR2;EIF2AK2;ATF2;KLF10;MTMR3;WRN;ATG5;CLEC16A;SIK2;RALB;ATP6V1H;DEPDC5;PRKAG1;RHEB;FOXO3;PRKAA1;PIK3R4;NUPR2;WIPI2;CASTOR2;MAPK8;EIF2AK3;SREBF2;PRKAA2;BRSK1;MAPK1;RRP8;SEH1L;XPR1;SIRT1;ATP6V1E1;BECN1;HSPA5
prerank,cell-cell junction organization (GO:0045216),-0.26969237357990716,-1.0654169810139267,0.33136094674556216,0.7638241709712676,1.0,18/79,14.24%,CSF1R;TJP1;CADM1;PKP4;FLCN;CADM2;CDH11;SDK1;JUP;TJP2;SMAD3;PVR;NECTIN4;NLGN2;TRPV4;TLN2;TGFB2;CXADR
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.4484996967522731,1.0650609114576033,0.3858520900321543,0.723140203184979,1.0,1/21,0.54%,PLA1A
prerank,negative regulation of response to stimulus (GO:0048585),0.36413344801112296,1.0649597134815714,0.3796178343949045,0.7228489821024716,1.0,9/60,12.08%,LYN;KLF4;CASK;AKT3;ADRA2A;WFS1;PTPN1;FCGR2B;MAP2K5
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.4600778121351552,1.0648691567273403,0.3896940418679549,0.722524648159463,1.0,6/16,14.22%,PIK3C2A;BCAR1;PTPN1;RGS14;PDGFD;PTPRJ
prerank,regulation of mitochondrial translation (GO:0070129),-0.3610790279703773,-1.0648424229268212,0.35919540229885055,0.7640115932503563,1.0,10/21,30.96%,RMND1;RCC1L;NSUN3;C1QBP;MTG1;SHMT2;FASTKD3;MPV17L2;COA3;ALKBH1
prerank,neuron projection organization (GO:0106027),-0.3950414485429564,-1.0641571371920624,0.40443213296398894,0.7646451560898342,1.0,4/15,9.42%,LGMN;ABCD2;MAP1A;CHRNA7
prerank,protein localization to membrane (GO:0072657),0.32565951946312655,1.0640062920318807,0.3793836344314559,0.7240769176124721,1.0,22/187,8.42%,ITGB7;ITGA4;ITGAL;RAP1A;SYNE3;TTC7A;PLEKHF1;C2CD5;RAB3D;RAPGEF2;IKBKB;EHD2;SYNJ2BP;KCNIP3;ITGB2;RAB34;FLNA;S100A10;F11R;EZR;ZDHHC23;TSPAN14
prerank,endocardial cushion morphogenesis (GO:0003203),-0.38724441577441093,-1.063432612079909,0.36772486772486773,0.765333795345175,1.0,3/18,14.08%,TGFBR2;ACVR1;TGFB2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.39560933820212485,-1.063169711709244,0.35714285714285715,0.7646771699310042,1.0,4/17,3.18%,IGF1;DOCK4;NRP1;AIF1
prerank,anion transmembrane transport (GO:0098656),0.3599431620930556,1.062899576607205,0.3826086956521739,0.7263069224681529,1.0,15/67,14.80%,LRRC8C;SLC23A2;SLC23A1;LRRC8D;LRRC8B;SLC25A13;SLC25A30;ABCC1;SLC25A12;SLC6A5;SLC25A18;SLC25A5;SLC35A1;SLC6A9;SLC35A3
prerank,positive regulation of protein export from nucleus (GO:0046827),0.476140968235688,1.0628086080131303,0.38870431893687707,0.7260033240731208,1.0,3/15,9.00%,IL1B;XPO4;RBM22
prerank,negative regulation of cell adhesion (GO:0007162),0.35811353703884025,1.0627258917545157,0.3828996282527881,0.7256725436997101,1.0,16/72,14.30%,PTPRC;PTPRO;RIPOR2;CBLL1;SPN;ARHGDIB;TGFBI;PLXND1;EPHB2;RHOA;DUSP1;PLXNC1;NF2;TBCD;CD164;TGFB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5104380854367915,1.0618266046832021,0.39492753623188404,0.7267626593879648,1.0,1/10,10.37%,CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5104380854367915,1.0618266046832021,0.39492753623188404,0.7267626593879648,1.0,1/10,10.37%,CEP250
prerank,regulation of exocytosis (GO:0017157),-0.3091676918658125,-1.0617593335413793,0.319672131147541,0.7672106994425625,1.0,8/46,5.23%,SYT1;IL1RAPL1;CADPS;RAB3C;STXBP5L;ATP6AP1;CLASP2;RAB9A
prerank,positive regulation of filopodium assembly (GO:0051491),-0.3595368729187523,-1.061735486613661,0.3669724770642202,0.7659169927545327,1.0,11/24,15.10%,NRP1;NLGN1;TENM2;RHOQ;GPM6A;PIK3R1;RALA;DPYSL3;AGRN;TENM1;PALM
prerank,activation of protein kinase B activity (GO:0032148),-0.34678046699473264,-1.0615811001928515,0.3509933774834437,0.7650298038154616,1.0,5/29,2.77%,IGF1;NTRK3;OSBPL8;GAS6;PPIA
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.3748067617568155,-1.0609559429450728,0.3983516483516483,0.7653530745544821,1.0,12/20,33.08%,ACACA;CBR4;HSD17B8;GCDH;DGAT1;ACSL4;SCD;ACSL3;FASN;FITM2;FAR2;DGAT2
prerank,cellular response to decreased oxygen levels (GO:0036294),-0.28612482996418726,-1.0609371396898855,0.35148514851485146,0.7640499218031539,1.0,17/65,13.14%,KCND2;CPEB2;FAM162A;STUB1;CPEB1;HIF1A;ADAM8;PGK1;EGLN3;FMN2;EGLN2;HYOU1;CPEB4;HMOX1;VEGFA;TIGAR;P4HB
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4421246489810958,1.0604229727536345,0.39457831325301207,0.7296905676692126,1.0,4/18,8.34%,ACSL5;ELOVL5;HSD17B12;ELOVL6
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.46201515329169973,-1.060315528544542,0.4036697247706422,0.7644073920400596,1.0,6/10,21.24%,CAMK1;SMARCB1;PIH1D1;SPHK2;BRCA1;RAPGEF3
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.37828466332398303,1.0603012294972396,0.4104979811574697,0.7294573722079583,1.0,8/51,9.51%,CCR2;CCR1;CXCL10;IL6R;VEGFC;ADAM17;IL6;PGF
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.35100468548482766,1.0595844837792583,0.38313253012048193,0.7306551041377305,1.0,15/80,10.70%,ACTR3;EPS8;WASF2;RIPOR2;CCDC88A;RAC2;DOCK11;CDC42;ARAP1;ACTR2;RAC1;BCAS3;ARPC2;TAPT1;PIK3CA
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.45798660773678174,1.0594411877928467,0.3961661341853035,0.7304888614801994,1.0,4/17,15.35%,CASK;ZDHHC17;ITGA3;XIAP
prerank,regulation of axonogenesis (GO:0050770),0.3700235501688478,1.059318125704162,0.3854166666666667,0.7302693368292573,1.0,12/51,13.28%,TIAM1;NGF;NGFR;PAK1;TIAM2;PTEN;PAK2;PLXND1;RHOA;RTN4;PLXNC1;LRP4
prerank,regulation of Wnt signaling pathway (GO:0030111),0.33590173214466684,1.0591530619027025,0.37803468208092483,0.7301469822950516,1.0,21/108,13.69%,LRRK2;TIAM1;SULF2;NOTUM;RSPO2;RSPO3;GPC3;APCDD1;AXIN1;CDK14;CBFB;KREMEN1;CSNK2A1;GSKIP;NLK;APP;TLR2;SNX3;TLE1;TAX1BP3;ITGA3
prerank,negative regulation of metabolic process (GO:0009892),0.37239872326270146,1.05896062888287,0.3663624511082138,0.7300905296829674,1.0,9/54,11.73%,IL1B;LNPEP;ACOT11;RBPJ;ZDHHC7;ADAM17;FIS1;RHEB;PGAM5
prerank,regulation of ruffle assembly (GO:1900027),-0.36121429120600246,-1.0586946180594214,0.3628571428571429,0.7676619718023647,1.0,6/23,5.74%,P2RY12;EVL;NLGN1;ARHGAP24;P2RX4;PFN1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3877100949864277,1.0581747577170006,0.37656903765690375,0.7314941984542201,1.0,10/38,14.08%,LRRK2;RAC2;FBXW7;UBE2D3;PARL;ARIH2;CSNK2A2;RNF31;SREBF2;UBE2J2
prerank,central nervous system neuron development (GO:0021954),0.4684194916337331,1.0579068645282408,0.391304347826087,0.7316005623890937,1.0,4/15,7.66%,RAPGEF2;B4GALT5;PTEN;ATP7A
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.389609844482813,-1.0578763966412363,0.37142857142857144,0.7686131334495301,1.0,9/18,18.98%,NLGN1;DLG4;CHRNA7;NLGN2;PRKCZ;NLGN3;RIMS1;STX1B;NRXN1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.38116359747133244,1.0578170112588379,0.39066666666666666,0.7312786918326019,1.0,9/48,8.24%,NEDD9;DOCK5;CRK;CDC42;CARMIL1;FLNA;CIB1;S100A10;RAC1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.36744303995443406,1.0574051758707022,0.3758043758043758,0.7316968836497022,1.0,15/62,16.85%,LIMD1;PPARG;NUP210;STAT3;POLR2C;H3-3A;NUP98;PUM2;TRIM71;NUP153;TNRC6A;TGFB1;PUM1;SEH1L;AJUBA
prerank,negative regulation by host of viral process (GO:0044793),-0.44871686976335146,-1.0571649248335424,0.3704600484261501,0.7692212930657581,1.0,2/10,5.09%,PRKN;EIF2AK4
prerank,retinal metabolic process (GO:0042574),-0.4329596490948981,-1.057094242456517,0.38461538461538464,0.7680914101879893,1.0,8/12,49.36%,BCO2;RDH13;DHRS13;RDH11;ABCA4;CYP1B1;ALDH1A3;ALDH8A1
prerank,nuclear membrane reassembly (GO:0031468),0.3687516461112448,1.0570534105233151,0.39015151515151514,0.7320230771278949,1.0,10/54,10.44%,VRK1;SUMO1;CHMP4A;CHMP4B;NUP98;PPP2R2A;LMNA;SPAST;ANKLE2;LEMD2
prerank,positive regulation of transport (GO:0051050),0.347192747688573,1.0570114619915454,0.36829268292682926,0.7315980473268318,1.0,10/85,5.37%,IL1B;CD47;DOCK2;CAMK1D;ANXA2;NEDD4L;C2CD5;GPC3;CBLL1;IL2RG
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.36007462869824997,-1.0565221068547774,0.3494318181818182,0.768422992720606,1.0,4/23,9.40%,IGF1;MEF2C;MMP14;AKAP6
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4925903918679535,1.0563077385329565,0.41680672268907565,0.7327020750036649,1.0,2/11,3.46%,FYN;ABCB7
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.40456606227090514,-1.056280256531232,0.37866666666666665,0.7677659003589774,1.0,5/15,17.78%,LGMN;MVB12B;PTPN18;FER;RHBDF2
prerank,cellular protein localization (GO:0034613),0.3161914667228311,1.0561733992062003,0.3498452012383901,0.7324976168976766,1.0,36/285,10.55%,CD74;LRRK2;TBC1D1;STX11;NGFR;RAB19;TBC1D8;PTPRU;CELSR1;FOXJ1;TBC1D9;NIPBL;RABL3;LAPTM5;CD177;USP6NL;TBC1D10C;TBC1D2B;SNX1;TBC1D8B;STX17;RAB6A;ARF4;RABGAP1L;FLNA;STX6;RABGAP1;ARF1;TMED10;STX5;STX12;TBC1D5;SLU7;STX7;CEP250;SNX9
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5145868576793923,1.0559318872550276,0.4192982456140351,0.7325632541942836,1.0,1/10,0.80%,PRKCE
prerank,positive regulation of axonogenesis (GO:0050772),0.37894745487456966,1.0558077499462033,0.37585733882030176,0.7323391139647584,1.0,11/43,14.87%,TIAM1;NGF;NGFR;TIAM2;SHTN1;PLXND1;RHOA;NTN1;PLXNC1;MAP3K13;ZFYVE27
prerank,sodium ion transport (GO:0006814),-0.26877663705758686,-1.0557441212770182,0.3333333333333333,0.7678784108089212,1.0,14/85,12.06%,SLC8A1;SLC24A3;FGF13;SCN1A;ATP1B3;PKD2;ATP1B1;SGK1;SLC6A15;SCN3A;ATP1A2;HCN1;HCN2;SCN1B
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4054960218958652,1.0554186820677145,0.38742690058479534,0.7327594483940632,1.0,4/30,9.31%,FOXP1;PKN1;H3-3A;NCOA2
prerank,protein secretion (GO:0009306),-0.2964325421130673,-1.0553465284062,0.32599118942731276,0.7676188700893899,1.0,11/56,12.55%,ABCA1;TANGO2;WLS;RAB3C;PREB;SNX19;SCG2;ARFGAP3;OLFM2;TANGO6;MTTP
prerank,regulation of oxidoreductase activity (GO:0051341),0.47553432848578486,1.0553452684210363,0.41706161137440756,0.7324166329249603,1.0,5/13,17.17%,HP;ATP7A;SLAMF8;SIRT4;ABL2
prerank,Rho protein signal transduction (GO:0007266),0.37031553752485424,1.05528395967837,0.3851091142490372,0.7320335278271664,1.0,13/53,15.07%,EPS8;NGFR;CELSR1;SHTN1;CDC42;ADRA2A;ARHGDIB;RHOA;NTN1;TAX1BP3;ROCK1;ARHGEF3;RHOG
prerank,regulation of cellular response to stress (GO:0080135),-0.25422009878519325,-1.055277348933391,0.2733812949640288,0.7665154040145911,1.0,35/115,19.38%,PRKN;NUAK1;RPTOR;NEK6;NUP54;ATF3;NUP133;CORO2B;BAG4;NUP155;BAG1;ATF4;NUP188;NEK4;DNAJC2;USP19;RANBP2;PTGES3;NPM1;SEC13;NPAS2;EIF4G1;NUP85;MANF;MBTPS2;HSBP1;NUP42;TPR;CAMK2A;NUP35;ADCY8;AKT1S1;HSP90AB1;CRYAB;NUP37
prerank,neural crest cell differentiation (GO:0014033),-0.3877855347689021,-1.055267053353924,0.36193029490616624,0.7652209729568092,1.0,3/18,7.34%,MEF2C;LRP6;HTR2B
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.4090216436186032,-1.0552648818606005,0.38957816377171217,0.7639240388107522,1.0,6/13,18.32%,UBA3;SAE1;NAE1;UBA7;UBA1;ATG7
prerank,skin development (GO:0043588),0.3657364619440446,1.0552404748621833,0.37831021437578816,0.7316202296427878,1.0,12/65,15.77%,CLDN1;COL5A2;BCR;CLIC4;ATP7A;ANXA1;PIP5K1A;DHCR24;ITGA3;ADAM9;FA2H;MED1
prerank,negative regulation of response to wounding (GO:1903035),0.44109070766378916,1.0550196990015432,0.386748844375963,0.7316219128128626,1.0,4/19,9.43%,CASK;CRK;INPP5F;GIT1
prerank,recombinational repair (GO:0000725),0.34959707708758614,1.0549608641408081,0.39119804400978,0.7312344917026704,1.0,19/77,16.42%,SAMHD1;RBBP8;POLL;MRE11;FEN1;UBE2N;WRN;NABP1;MORF4L1;RECQL5;RPA3;EXD2;SPIDR;ERCC4;RNF138;XRCC2;INO80;MCM9;HUS1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4523450832298257,1.054913310514121,0.40408805031446543,0.7308326442728551,1.0,7/17,16.74%,CCND3;CCND1;ADAM17;PSMD10;CCND2;AKT1;PROX1
prerank,regulation of secretion (GO:0051046),0.46989725608813426,1.05465480701912,0.40672268907563025,0.7308954870078368,1.0,2/13,3.32%,OAS2;KCNQ1
prerank,snRNA transcription (GO:0009301),0.3624121825788544,1.0546409235627985,0.39800995024875624,0.7304054063681271,1.0,22/70,18.51%,GTF2F2;TAF13;GTF2E2;TAF9;POLR2C;NABP1;GTF2A1;RPRD2;SNAPC3;RPRD1B;INTS2;SRRT;CCNT2;INTS11;INTS14;CCNT1;INTS4;NCBP1;ELL;INTS6;PHAX;POU2F2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.45979316018421995,1.0541738500839897,0.4141914191419142,0.7309511359676397,1.0,3/16,5.90%,MAD2L2;SMCHD1;KLHL15
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.47491479430750466,1.054072745741095,0.41734860883797054,0.7306616186083835,1.0,4/13,18.98%,MAD2L2;TAF1;PSEN1;TMSB4X
prerank,homeostasis of number of cells (GO:0048872),-0.4263030839576225,-1.0540565051732038,0.39949748743718594,0.7659934620614242,1.0,6/12,36.45%,CX3CR1;NAPEPLD;OCIAD2;LPCAT3;UBAP2L;CCN3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.47604105557125975,1.0539704433844985,0.3957968476357268,0.7303682498225451,1.0,6/13,19.90%,HEXIM1;RECQL5;NELFA;SUPT4H1;RNF168;LARP7
prerank,blood vessel endothelial cell migration (GO:0043534),-0.35528706351658906,-1.0539037687303183,0.34560906515580736,0.7650542881058332,1.0,8/22,19.78%,NRP1;ROBO1;FGF2;SLIT2;VEGFA;GPLD1;EFNB2;PIK3R3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.42529743238372497,-1.0532977609318837,0.37628865979381443,0.7654032311943185,1.0,11/13,44.94%,ANAPC15;TPR;LCMT1;GEN1;NDC80;CDK5RAP2;MAD2L1;XRCC3;PCID2;DYNC1LI1;CCNB1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.3396985790031058,1.0531278431876967,0.3878504672897196,0.7318839241315621,1.0,19/93,14.30%,CD44;NGF;PAK1;SH2D3C;MAD2L2;AXIN1;PTEN;STK4;DDIT4;PAQR3;IL6;LATS1;CREBL2;BRAF;APP;AKT1;NSD1;HCLS1;TGFB1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.4556148361907189,-1.0527951480364997,0.4148148148148148,0.7654130638013613,1.0,4/10,29.06%,SAE1;PIAS4;HDAC4;UBA2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.4665181317402777,1.052693850563877,0.4222972972972973,0.7323936763219849,1.0,6/15,18.74%,MRE11;ATF2;HUS1;MDC1;RAD17;CHEK2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3521670392743874,1.0522880922730244,0.39285714285714285,0.7328814203762332,1.0,15/73,14.30%,CD44;NGF;PAK1;SH2D3C;MAD2L2;AXIN1;STK4;IL6;LATS1;CREBL2;BRAF;APP;AKT1;HCLS1;TGFB1
prerank,histone acetylation (GO:0016573),0.35362408300322346,1.0522482999877254,0.3810110974106042,0.7324497870408406,1.0,17/69,15.31%,TAF9;SPI1;KAT7;ATF2;TRIM16;TADA3;MBIP;KAT6A;ING3;TADA2A;MORF4L1;JADE3;MAP3K7;MSL3;KAT2B;PHF20;CREBBP
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3654786773982995,1.0521455456189779,0.38311688311688313,0.7321625645842454,1.0,15/57,18.74%,DTL;MRE11;ATF2;TAOK3;WAC;CCND1;UIMC1;RINT1;DONSON;BRSK1;HUS1;MDC1;RAD17;FZR1;CHEK2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.42779620620243897,1.0521396625083432,0.37888198757763975,0.7316534858987314,1.0,5/21,18.18%,JAK2;RBPMS;SMAD4;TGFB1;NUP93
prerank,Rap protein signal transduction (GO:0032486),0.5016723130905826,1.0520860656875355,0.4318181818181818,0.7312561848665907,1.0,2/10,3.13%,RAP1A;RAPGEF2
prerank,positive regulation of cellular process (GO:0048522),0.30709997728717364,1.0516852320090848,0.36072144288577157,0.7317119029417803,1.0,105/565,16.28%,DPP4;IL1B;GRK5;RARA;TIAM1;HCK;LYN;CD47;GLI1;FGF22;FLT3;CDK13;DOCK2;ITGAX;CAMK1D;ACER3;TBC1D8;PAK1;FGF5;CUL3;CD36;RPS6KA3;ANKRD17;PTPN6;MYRF;SCX;IL6R;CDC42;PPP3CA;GDNF;HP;HPR;VEGFC;H3-3A;ADRA2A;IL2RG;FAF1;PTEN;CCND1;CXCL16;PTK2B;ADAM17;CIB1;MTPN;MECP2;CNOT6;NOX1;LMNA;DOT1L;RAC1;CACUL1;IL6ST;IL6;DDX49;PGF;CSNK2A1;RPRD1B;FN1;IL31RA;MCTS1;GLP2R;PRKAA1;FKBP1B;NAP1L1;FCGR2B;DYNC1H1;RPS6KA1;SLC25A5;PSMD10;CSPP1;TLR2;PDGFD;LIFR;MAPK8;CCND2;PABIR1;AKT1;EZH2;TNFRSF1B;FCER1G;HCLS1;AGPAT1;GNAI2;PRKAA2;CITED2;COX17;PTPRJ;FGFR3;TGFB1;RELA;MAZ;RHOG;RPS15A;DUSP26;THBS1;NCBP1;DVL2;INO80;CELF1;APC;CDCA7L;RPS4X;USP47;INSR;NSMCE4A
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4330075226018285,-1.0513156131263495,0.4125874125874126,0.7681061475995935,1.0,5/12,34.28%,CALM1;CAV1;PDE4D;GJD3;CALM2
prerank,import into cell (GO:0098657),0.37821765403630936,1.051221922186329,0.38544474393531,0.7322729250485964,1.0,5/41,4.55%,NEURL1B;LRRC8C;IL10RA;LRRC8D;SLC12A7
prerank,response to amino acid (GO:0043200),-0.3252074876136264,-1.0511669864546846,0.34915254237288135,0.7671628918913778,1.0,12/31,19.31%,RPTOR;CPEB1;GLRA3;LARS1;IPO5;GLRA2;CPEB4;LAMTOR5;RRAGC;CPEB3;NSMF;SESN2
prerank,anterior/posterior pattern specification (GO:0009952),-0.29598416589143267,-1.0508230840443364,0.3925619834710744,0.7667768830302261,1.0,4/53,1.75%,BASP1;SKI;TGFBR1;WLS
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.44566365167805483,-1.0502256121558782,0.38010204081632654,0.7671507828382446,1.0,9/11,36.33%,SMARCB1;PWP1;PIH1D1;DDX11;NOP53;IPPK;MTOR;SMARCA4;NCL
prerank,cellular response to exogenous dsRNA (GO:0071360),0.47472584579984806,1.0498497946169851,0.40487804878048783,0.7349760843395392,1.0,4/12,13.86%,IFIH1;RALB;PQBP1;IFIT1
prerank,substrate-dependent cell migration (GO:0006929),0.47415492960870353,1.0496686510265958,0.4099173553719008,0.7348737969536344,1.0,4/14,4.92%,PTPRC;SHTN1;CD2AP;VEGFC
prerank,bile acid and bile salt transport (GO:0015721),-0.3635808390213403,-1.0495217674948574,0.37575757575757573,0.7677490771826324,1.0,3/24,7.01%,SLCO2B1;ABCC3;ATP8B1
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.48975817055285864,1.0494788460855684,0.42657342657342656,0.7348195837140941,1.0,2/10,10.27%,LILRB1;FN1
prerank,thyroid hormone generation (GO:0006590),0.508053495247526,1.0492864257544545,0.4257246376811594,0.7347562908253894,1.0,1/10,7.46%,CPQ
prerank,microglial cell activation (GO:0001774),-0.3750233963379506,-1.0492082565512513,0.3943217665615142,0.7672582206339579,1.0,5/21,3.18%,CX3CR1;TREM2;C1QA;GRN;AIF1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.35879974015025806,-1.049142384628187,0.38006230529595014,0.7661488437457197,1.0,9/23,27.93%,COPS4;UBC;COPS7A;COPS2;COPS7B;UBA52;XPC;COPS6;DDB1
prerank,regulation of regulated secretory pathway (GO:1903305),0.3895682176744358,1.0490835381631016,0.4105409153952843,0.7347254642987983,1.0,3/34,4.17%,LRRK2;RAB3D;UNC13D
prerank,phospholipid translocation (GO:0045332),0.4040382479180279,1.0488771408912219,0.41220238095238093,0.7346602174602628,1.0,2/28,2.34%,ATP8B4;PLSCR1
prerank,protein deubiquitination (GO:0016579),0.3139791682668741,1.0488258156386938,0.396875,0.7342689413174536,1.0,71/242,18.80%,TNIP3;PSME3;NFKBIA;USP3;PSMB7;INO80C;PSME2;OTULINL;BIRC3;IL33;EIF3F;IFIH1;OTUD1;PTEN;USP49;NEDD8;TADA3;ATXN7;USP45;TRAF3;JOSD1;PSME4;SPATA2;UIMC1;USP32;ATXN3;USP31;USP48;RHOA;USP15;PSMB8;SMAD4;PSMD9;PSMA5;CYLD;USP42;RIPK1;STAM;PSMB3;PSMD6;PSMC4;NLRP3;USP40;MAP3K7;PSMD10;USP4;SNX3;OTUD4;PSMB1;KAT2B;VCP;USP37;USP7;VCPIP1;ASXL2;USP9X;INO80;APC;POLB;USP47;PSMD12;FOXK1;WDR20;TRAF2;TAB1;BECN1;USP14;USP38;SMURF2;STAM2;MBD5
prerank,protein sumoylation (GO:0016925),0.37446653493749427,1.04875347158268,0.3944020356234097,0.7339140377640492,1.0,5/49,7.22%,BCL11A;NUP210;SUMO1;IFIH1;NUP98
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.2808357373648931,-1.0485694776270496,0.3443396226415094,0.766323980066724,1.0,23/69,21.90%,ECPAS;STUB1;ERLIN2;DERL2;HSP90B1;AUP1;NPLOC4;RNF121;USP19;DNAJB2;SGTB;DERL1;TRIM13;ANKZF1;RNF103;HERPUD1;TMUB2;FAM8A1;UBQLN2;DNAJB9;UBE2G2;SEC61B;FBXO44
prerank,urogenital system development (GO:0001655),0.49572198248620536,1.0485157312286406,0.41680960548885077,0.7339281095821957,1.0,2/11,10.43%,EPHB2;ANXA1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4980402106950313,1.048458283352229,0.43478260869565216,0.7335627251807584,1.0,3/11,10.43%,LYN;RAPGEF2;ANXA1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.434857927078686,1.0481637854481627,0.417910447761194,0.7337354206550372,1.0,4/22,11.70%,LRRK2;ID2;TRIM71;NAP1L1
prerank,zinc ion homeostasis (GO:0055069),-0.34027487840057585,-1.0479250206532271,0.36807817589576547,0.766814366869838,1.0,6/28,16.42%,PRKN;SLC39A10;SLC39A7;SLC30A9;SLC39A6;MT2A
prerank,negative regulation of cell death (GO:0060548),0.3461492364580968,1.0478285305769326,0.4042806183115339,0.7340087266513051,1.0,10/88,8.02%,LRRK2;SRGAP2;FYN;HSPA1A;SORL1;CHMP4A;CHMP4B;WFS1;ATG5;TM7SF3
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.417458614798643,1.0477321206121055,0.40828402366863903,0.7337084459120159,1.0,4/26,9.68%,RARA;LILRB3;TLR3;FBN1
prerank,embryonic limb morphogenesis (GO:0030326),-0.32421772234854973,-1.047528257226002,0.3952702702702703,0.7666233314413416,1.0,6/34,4.18%,SKI;LRP6;SALL1;CTNNB1;CACNA1C;WDPCP
prerank,translational elongation (GO:0006414),-0.2675054324916641,-1.0474459581007416,0.34532374100719426,0.7655410529541755,1.0,46/101,29.83%,EEF2K;GFM2;MRPL24;MRPS9;DAP3;EEF1A1;MRPS21;MRPL1;LTN1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;GTPBP2;MRPS18B;MRPL3;MRPS22;MRPL32;MRPL47;EEF1D;RACK1;MRPL17;MRPS30;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;EEF1B2;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4356128676188209,1.0469363936040774,0.43423137876386686,0.7350675364258884,1.0,2/20,3.36%,ST3GAL4;FUT4
prerank,positive regulation of hormone secretion (GO:0046887),-0.3924988993839705,-1.046892184548199,0.3915343915343915,0.7657869955399538,1.0,9/17,39.75%,SPP1;VAMP8;SOX11;HFE;PLA2G3;C1QTNF3;GRP;TFR2;HCAR2
prerank,regulation of viral transcription (GO:0046782),0.3814178689925453,1.0468608238289863,0.3924581005586592,0.7347326877158062,1.0,13/39,19.90%,GTF2F2;POLR2C;TRIM62;HEXIM1;TRIM14;NELFA;CCNT1;RSF1;IFITM3;SUPT4H1;MDFIC;MID2;LARP7
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5073809470439923,1.046651199206423,0.41335740072202165,0.7336856266690286,1.0,2/10,6.89%,DNA2;WRN
prerank,t-circle formation (GO:0090656),0.5073809470439923,1.046651199206423,0.41335740072202165,0.7336856266690286,1.0,2/10,6.89%,DNA2;WRN
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5073809470439923,1.046651199206423,0.41335740072202165,0.7336856266690286,1.0,2/10,6.89%,DNA2;WRN
prerank,regulation of cell aging (GO:0090342),-0.451407272847169,-1.0466284549183829,0.3962703962703963,0.7652292327387061,1.0,3/11,8.02%,NUAK1;NEK6;NEK4
prerank,response to reactive oxygen species (GO:0000302),0.3691706391042153,1.0463360322609583,0.3876478318002628,0.7339088412470027,1.0,15/54,15.38%,STK24;FYN;FOS;GPX1;HP;PXN;CAMKK2;RPS3;MAPK8;AKT1;NCF1;ADAM9;GSTP1;MAPK1;PRDX5
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3944758033676134,1.0460406929331858,0.4157303370786517,0.7341150284081808,1.0,10/35,16.89%,POLL;FEN1;POLD4;MBD4;SMUG1;TDG;PARG;RPA3;POLB;POLD1
prerank,steroid catabolic process (GO:0006706),0.5026919096671486,1.04579158681198,0.41796200345423146,0.7341879982002416,1.0,2/10,12.79%,HSD17B14;HSD17B11
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3561973834119965,1.0453356360851092,0.4053030303030303,0.7347435259916613,1.0,16/72,15.54%,FGF22;FGF5;KL;GTF2F2;POLR2C;CBL;GRB2;SETX;SHOC2;TRIM71;FLRT1;FGFR3;MAPK1;FRS2;SPRED1;NCBP1
prerank,lysosome organization (GO:0007040),-0.3274572643677971,-1.0452984630837354,0.39867109634551495,0.7675360034186369,1.0,9/36,7.99%,ABCA1;HPS4;GRN;ZKSCAN3;TPP1;ARSB;TPCN2;GAA;MYO7A
prerank,lamellipodium organization (GO:0097581),0.40360711710652714,1.0450841200204262,0.40296296296296297,0.7348235994830667,1.0,7/29,13.21%,PTPRO;CCDC88A;CARMIL1;SNX1;RAC1;ARHGEF6;KIT
prerank,regulation of cell morphogenesis (GO:0022604),0.39957887419046934,1.045024560466573,0.4092219020172911,0.7344563004036458,1.0,4/30,6.61%,CD44;NTNG2;PDZD8;CAPZB
prerank,aggrephagy (GO:0035973),-0.3432343482607289,-1.0449374957252957,0.37658227848101267,0.7671553881690493,1.0,5/27,8.42%,PRKN;WDFY3;UBC;DYNLL2;DYNLL1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3748975821627478,-1.044851469507529,0.4,0.7660761664211416,1.0,10/19,24.60%,CTC1;XRN1;SRC;TEN1;TERF1;EXOSC10;HNRNPU;TINF2;PINX1;NAT10
prerank,response to light stimulus (GO:0009416),0.36459177229797646,1.0444042785656165,0.4007682458386684,0.7354345239355214,1.0,13/55,14.90%,DTL;CRY1;CRY2;CLOCK;MSH6;COPS3;GPR88;MAP4K3;ERCC3;MAPK8;PCLAF;ERCC4;BRSK1
prerank,autophagy of mitochondrion (GO:0000422),-0.31202169303314276,-1.0443886759722858,0.3645833333333333,0.7660460701798686,1.0,12/38,21.84%,PRKN;ULK2;MAP1LC3B;ATG12;USP30;SQSTM1;ATG9A;FUNDC2;ATG7;ATG2A;WDR45;GABARAP
prerank,cell projection organization (GO:0030030),-0.33466996550515526,-1.0443292524558307,0.3875,0.7649438121848854,1.0,11/30,17.39%,P2RY12;RHOH;PARVG;RHOQ;CAPG;PDGFA;NCKAP1L;PARVA;RHOU;PLEK;NEFH
prerank,thymus development (GO:0048538),-0.42493269634440967,-1.0440364787841754,0.3926829268292683,0.7644263638606403,1.0,9/13,48.98%,TGFBR1;FGF10;SOD1;EPHB3;HES1;ZBTB1;SHH;FADD;RIPK3
prerank,blood vessel diameter maintenance (GO:0097746),0.39543384353137107,1.0439483822275735,0.4070422535211268,0.7360167613689561,1.0,2/34,1.26%,ACE2;ACE
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.37095363337641235,-1.0438179405740042,0.4010840108401084,0.7637805724166828,1.0,7/20,12.08%,IGF1;NRP1;LRP1;PLAU;PDGFA;SLIT2;SERPINE1
prerank,phosphate ion homeostasis (GO:0055062),-0.43990224527004756,-1.0437719873694067,0.4160919540229885,0.7626525239911109,1.0,1/10,3.12%,ENPP1
prerank,regulation of glucose metabolic process (GO:0010906),-0.3210101805540259,-1.0433872181646056,0.3470790378006873,0.7624504832089775,1.0,4/34,9.23%,PRKN;PDK1;IRS1;DGKQ
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.49954706251015063,1.0431998996469933,0.41029900332225916,0.7372759924942432,1.0,1/11,0.26%,CD44
prerank,protein insertion into ER membrane (GO:0045048),0.38374248427958896,1.0427863432910345,0.4158415841584158,0.7376899199250916,1.0,11/37,15.98%,MMGT1;PRNP;TRAM2;TRAM1;EMC9;STX5;CAMLG;APP;EMC10;UBE2J2;VAPA
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.35087823417927316,1.042740385091817,0.40594059405940597,0.7372679213525333,1.0,27/70,22.05%,NGF;MCL1;JAK2;IL6R;HIPK1;PDPK1;CIB1;SIVA1;TLR3;DAXX;CASP2;RIPK1;DEDD2;TNFRSF1B;FGFR3;TGFB1;RNF41;TRAF2;BAG3;APPL1;BAD;ITGAV;DIABLO;BID;BCL2;GSK3B;CASP9
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.38917826850153936,1.0425766015814615,0.4067547723935389,0.7371528913645327,1.0,9/33,16.33%,KLF4;PTEN;CDKN2C;DCUN1D3;WEE1;APC;BRD7;RBL2;RB1
prerank,regulation of telomerase activity (GO:0051972),0.37380938207295433,1.0420860462970494,0.42276422764227645,0.737790657291775,1.0,13/45,16.15%,KLF4;PKIB;CERS1;PARP4;PARM1;WRAP53;TNKS;MAP3K4;ERCC4;AURKB;MAPK1;TCP1;SMG6
prerank,positive regulation of cellular protein localization (GO:1903829),0.34921571539220136,1.0420789693571093,0.3889570552147239,0.7372928062323885,1.0,17/69,15.83%,NGFR;FYN;DTX3L;CCDC88A;KAT7;PARP9;RTN4;CEP250;CENPQ;PRKAA1;EIF2AK3;AKT1;LIMK2;PRKAA2;TGFB1;SNX33;APC
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.40552914591532174,1.0420149792559068,0.4043795620437956,0.7369495533069161,1.0,5/25,9.94%,BMPR2;RBPJ;ENG;ACVR2A;SMAD4
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3467091287429928,-1.0419574322303486,0.40634005763688763,0.7651491819827658,1.0,11/25,19.36%,EVL;ARHGAP24;EVI5L;SLIT2;ODF2L;RAP1GAP;TCHP;PFN2;CDK10;PLXNB3;CEP97
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4377795531498804,1.0409407408195954,0.4263322884012539,0.7389372321855316,1.0,4/18,7.31%,DTL;RCC2;CCND1;MECP2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4125276530273923,-1.040772471001025,0.40186915887850466,0.7671483417278576,1.0,8/13,31.52%,ENTPD1;ENPP1;ENTPD5;ITPA;ENTPD7;ENPP3;ENTPD3;ENTPD6
prerank,lung epithelium development (GO:0060428),0.4999417515758044,1.040746950647333,0.4442508710801394,0.7388834728466752,1.0,1/10,2.50%,FOXJ1
prerank,sterol transport (GO:0015918),0.4470664460219861,1.0403985402355662,0.40396341463414637,0.7391782867359715,1.0,2/19,2.67%,LDLR;CD36
prerank,protein ubiquitination (GO:0016567),0.3009713668617887,1.0403701476529055,0.3854692230070636,0.7387348820242988,1.0,111/471,17.31%,DTL;LNPEP;ITCH;PSME3;DTX3L;ASB5;NEDD4L;TRIM26;CUL3;CUL5;BIRC6;UBE2E1;RNF38;TRIM7;CBL;PSMB7;FBXW7;ANKIB1;RNF146;CBLL1;PSME2;TRIM62;PEX12;ARIH1;WAC;RNF20;RNF213;PELI1;RC3H1;UBE2D3;UBE2QL1;SPOP;FBXW11;FBXL8;UBE2N;UBR5;RNF217;HLTF;FBXW2;NEDD8;CBFB;NFE2L2;ELOB;MYCBP2;TRIM25;FBXO4;UBR2;PCNP;PSME4;ARIH2;PEX14;RNF141;TNKS;WWP2;RNF13;TRIM71;UBE2W;PSMB8;FBXO32;PSMD9;PSMA5;UBE2Z;FANCL;TRIM14;RNF31;HERC6;FBXL17;PSMB3;UBE2S;PSMD6;PSMC4;LONRF1;KLHL8;TPP2;RCHY1;PSMD10;UBE2G1;TRIM17;SH3RF1;AREL1;PSMB1;FBXL12;RNF138;FBXO30;HECTD2;UBE2J2;VCP;USP7;UHRF2;FBXO7;RNF166;ANAPC7;VCPIP1;KCTD13;RNF122;USP9X;TAF1;TRIM35;RNF41;HACE1;FBXL16;PSMD12;UBA6;UBR3;TRIM36;KLHL12;MSL2;UBE2Q2;TRAF2;SIRT1;RNF144A
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3939208416788513,1.0399804960787593,0.4183535762483131,0.739144937972548,1.0,13/33,21.06%,SNRPB;SETX;SSU72;FIP1L1;SCAF8;NUDT21;MAZ;CPSF3;PAPOLA;NCBP1;CSTF3;WDR33;SLBP
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4400720417198184,1.0396814628323556,0.42694805194805197,0.7393867247759988,1.0,3/18,11.74%,ERN1;ATXN3;FCGR2B
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3371899968688348,-1.0394300286486697,0.4013377926421405,0.7695279249883933,1.0,6/27,7.35%,ABHD12;PLA2G15;GDE1;ENPP2;PNPLA8;PLA2G4A
prerank,regulation of chromosome organization (GO:0033044),-0.35672939826174543,-1.0391682887178355,0.3989501312335958,0.7689214063073434,1.0,5/22,11.49%,WAPL;YLPM1;UPF1;TERF2IP;XRCC5
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4374630872530417,1.0390098008697266,0.4253968253968254,0.7404571816336118,1.0,4/18,12.39%,RFX3;ADCY10;CABYR;CCDC39
prerank,negative regulation of lipid storage (GO:0010888),-0.3763930684255189,-1.0384214480654845,0.41228070175438597,0.769564607179494,1.0,5/19,8.25%,ABCA1;TREM2;OSBPL8;TTC39B;ITGB3
prerank,response to exogenous dsRNA (GO:0043330),0.4333715129604031,1.0383532877729584,0.42194744976816073,0.7415316518293622,1.0,6/18,15.86%,IFIH1;TLR3;RALB;PQBP1;IFIT1;IRAK3
prerank,negative regulation of chemotaxis (GO:0050922),-0.32159421582172065,-1.038083551830517,0.38461538461538464,0.7692331699655163,1.0,7/31,9.27%,ROBO2;ROBO1;AIF1;SEMA3D;SEMA3E;SEMA6D;SLIT2
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3574409889436175,-1.037982697426552,0.39420289855072466,0.7682144240569798,1.0,13/23,29.23%,TIMM9;BAX;COX18;TIMM10B;AGK;NDUFA13;TIMM13;SAMM50;TIMM8B;BMF;HSP90AA1;ROMO1;TIMM29
prerank,myeloid dendritic cell activation (GO:0001773),-0.42537585986006227,-1.0379705610265226,0.43855421686746987,0.7669955881189957,1.0,4/12,10.68%,TGFBR2;HMGB1;PYCARD;CAMK4
prerank,protein transport (GO:0015031),0.30718886114614763,1.0377734923013833,0.39121552604698673,0.7423899586755602,1.0,61/332,14.67%,CD74;NEURL1B;TBC1D1;STX11;NGFR;RAB19;LMTK2;PPARG;TBC1D8;TBC1D9;CD36;ATP6V0E1;RABL3;RAB3D;LAPTM5;IL10RA;USP6NL;TBC1D10C;GOLPH3L;TBC1D2B;MYH9;COPG2;RAB7A;SNX1;TBC1D8B;STX17;RAB6A;ARF4;RABGAP1L;RAB34;STX6;RABGAP1;ARF1;GCC2;TMED10;STX5;STX12;ZDHHC17;ATP6V1H;TBC1D5;UNC119B;SLU7;STX7;LMAN2L;HIKESHI;SNX9;KIF3B;UNC119;TBC1D2;SLC10A7;TMEM167A;STX16;SGSM1;VMP1;TLK1;EVI5;CANX;RAB29;SCFD2;EHD1;ABCG1
prerank,organic hydroxy compound transport (GO:0015850),-0.31464913622469215,-1.0375663548858718,0.39100346020761245,0.7668385902531452,1.0,3/36,7.01%,SLCO2B1;ABCC3;ATP8B1
prerank,positive regulation of receptor internalization (GO:0002092),-0.3557675755578761,-1.037535480845291,0.37900874635568516,0.7656913134936455,1.0,8/22,28.46%,MAGI2;CD63;VEGFA;SCYL2;ANGPT1;ARRB2;PICK1;EGF
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.36091919418745344,1.0374122233023169,0.40657894736842104,0.7427261707747294,1.0,18/56,18.96%,DTL;CUL3;ANKRD17;RCC2;CCND3;CCND1;ADAM17;MECP2;PLCB1;ANXA1;CCND2;AKT1;KMT2E;ANAPC7;RB1;ANAPC11;ANAPC4;BRD4
prerank,regulation of protein transport (GO:0051223),0.4109371866170748,1.0372638272106987,0.4257575757575758,0.7425502710299962,1.0,11/27,23.18%,LCP1;DNAJC1;WWP2;PTPN1;SNX3;SNX12;NDFIP2;LLGL2;HSPA8;TNF;SCFD1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4079676622144223,1.0371525641701203,0.42278860569715143,0.742293846336546,1.0,7/26,15.86%,ITCH;DHX58;CARD16;CACTIN;ACOD1;ILRUN;IRAK3
prerank,phospholipid transport (GO:0015914),0.3614859583932797,1.0371498999564852,0.40716180371352784,0.7417860638564922,1.0,18/52,19.79%,ATP8B4;LDLR;ABCA3;SCARB1;PITPNB;ABCC1;PITPNM1;ATP10B;SCARB2;PRELID1;ATP11C;ABCG1;TMEM30A;PITPNA;ATP8B2;ATP11A;ATP11B;PRELID3A
prerank,regulation of platelet activation (GO:0010543),0.4194072398175285,1.0371226440643082,0.43788819875776397,0.7413350284773949,1.0,2/21,1.95%,LYN;SYK
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.45509812349092343,1.0370950427094028,0.44551282051282054,0.740897590723548,1.0,4/16,12.88%,BCL3;INPP5F;PARP14;NF2
prerank,actin filament depolymerization (GO:0030042),-0.4371533517393149,-1.036965342543226,0.4050632911392405,0.7659515359410205,1.0,3/11,22.25%,MICAL3;CFL1;GSN
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.3176622381805541,-1.0369113114753987,0.3782051282051282,0.7648859782123557,1.0,5/34,5.63%,FLCN;TRIO;ANKRD26;ENPP1;RUNX1T1
prerank,gonad development (GO:0008406),-0.30462704748330943,-1.0357756037880992,0.37362637362637363,0.7666500759755073,1.0,17/41,33.58%,BASP1;SALL1;KITLG;MSH2;TGFB2;AR;NCOA4;NR2F2;FGF9;WNT4;INHBA;MEA1;BIK;WNT5A;MKKS;WNT2B;MAMLD1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.41415522125621035,1.0355567609471727,0.40963855421686746,0.743947410723519,1.0,9/25,20.79%,RIN3;PICALM;RAC1;UNC119;APP;MTMR2;PSEN1;ANKRD13A;ITGAV
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4799032088380085,1.0354889323439422,0.4228187919463087,0.7435995031442293,1.0,4/13,17.66%,PPARG;REST;RELA;NFATC3
prerank,regulation of water loss via skin (GO:0033561),0.463544660284661,1.0351345474423845,0.43820224719101125,0.7434378044045422,1.0,3/15,20.64%,CLDN1;FA2H;UGCG
prerank,establishment of skin barrier (GO:0061436),0.463544660284661,1.0351345474423845,0.43820224719101125,0.7434378044045422,1.0,3/15,20.64%,CLDN1;FA2H;UGCG
prerank,blood vessel morphogenesis (GO:0048514),-0.29143729564320875,-1.0349977577262497,0.36947791164658633,0.767446828221169,1.0,7/54,4.35%,TGFBR2;NRP1;TGFBR1;FLT1;SMAD7;NF1;RASA1
prerank,positive regulation of cellular component organization (GO:0051130),-0.2516304056477033,-1.0348292479488457,0.40789473684210525,0.766698637906039,1.0,27/107,16.06%,APOE;PLEKHM2;FNIP2;TREM2;TGFBR1;LRP1;CAMK1;SLF2;FNIP1;FRMPD4;ABCB4;SLF1;TAL1;LMAN1;ADGRL1;TFRC;TMED9;FLOT1;VEGFA;CLU;WARS1;TGFB2;BAX;DAB2IP;PIH1D1;TPPP;AR
prerank,response to histamine (GO:0034776),0.4957915558326458,1.0346351863314636,0.4571917808219178,0.7440657492620159,1.0,3/10,9.70%,GABRB2;DIAPH1;HRH1
prerank,Ras protein signal transduction (GO:0007265),0.32179594600678796,1.0344328218839176,0.42508324084350724,0.7440397920874315,1.0,21/137,9.80%,GRAP2;TIAM1;RAP1A;EPS8;NGFR;CELSR1;SHTN1;RASGRP2;RAPGEF2;RAC2;ADRA2A;MAPK14;ARHGDIB;GRB2;SHOC2;RAC1;GNB1;SOS1;RALB;RHOA;RASSF1
prerank,regulation of protein catabolic process (GO:0042176),0.3390155129672449,1.0344147990301478,0.42823250296559906,0.7435781261843184,1.0,31/99,19.01%,DTL;ITCH;ASB5;NEDD4L;MAD2L2;SORL1;GPC3;AXIN1;RAB7A;FAF1;TIPARP;FLNA;AZIN1;STX5;SNF8;WWP2;CSNK2A1;SNX3;AREL1;VCP;APC;SNX12;IRAK3;RNF41;HACE1;SF3B3;SMURF2;FZR1;PIN1;CHEK2;PRKCG
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.34822854818310933,-1.0341896506078618,0.37662337662337664,0.7673211207520253,1.0,9/26,18.76%,PRKN;ASAP3;LIMK1;PFN1;PFN2;CX3CL1;PLEK;RDX;SYNPO2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3434612478896052,1.0341607050883295,0.4116161616161616,0.7436972335216419,1.0,18/80,16.06%,NIBAN1;IFNGR1;BCL3;RPL5;VIM;PICALM;GSAP;YTHDF3;IL6;METTL3;PLA2G6;LARP4B;EIF3E;ABCG1;RELA;THBS1;RPS4X;RPS6KB1
prerank,negative regulation of protein metabolic process (GO:0051248),0.369454311683682,1.0340447634990377,0.42463958060288337,0.7434740327516068,1.0,8/48,7.12%,LDLR;NFKB1;PTX3;MAD2L2;EIF2AK1;PRNP;FLNA;AZIN1
prerank,embryonic organ development (GO:0048568),-0.2792115533088986,-1.034007298681177,0.3755656108597285,0.7665367213516208,1.0,12/61,14.85%,TGFBR2;SALL1;KITLG;TAL1;FGFR2;RPL10;ATF4;PDGFA;TBC1D23;GLI3;TGFB2;PKDCC
prerank,organic anion transport (GO:0015711),0.3394305645895724,1.0337741252486172,0.4217016029593095,0.7435889782187057,1.0,16/76,17.35%,LRRC8C;SLC23A1;SLC4A7;LRRC8D;SLCO1B1;SLC4A8;CYB5R4;CYB5R1;ABCC4;SLCO1C1;SLC26A7;SLC35A1;SLC35A3;SLCO4C1;SLC52A1;SLCO3A1
prerank,modulation by symbiont of host process (GO:0044003),-0.43307006513657464,-1.0336843702008571,0.42822966507177035,0.7661890168990939,1.0,3/10,7.33%,UBC;PGK1;HGS
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.4456132961301166,-1.033633714671144,0.41895261845386533,0.765102727658075,1.0,3/10,7.33%,LRP1;APOD;HGS
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.36209020275301296,1.0333809147915225,0.421259842519685,0.743920028120728,1.0,12/52,16.41%,PRKCE;PRKCH;KIF5B;PDPK1;CIB1;EPHB2;CLIP3;LGALS3;AKT1;ITGA3;RHOG;PLS1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3704900223537643,1.0325924478101354,0.4100135317997294,0.7452546417049551,1.0,12/43,18.52%,DTL;MRE11;TAOK3;NABP1;UIMC1;RINT1;PABIR1;DONSON;BRSK1;HUS1;RAD17;FZR1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.4708136258669537,1.031931937059847,0.4523809523809524,0.7462909071583486,1.0,3/13,12.51%,TAT;IDH1;OGDH
prerank,cellular response to interleukin-4 (GO:0071353),-0.4394030940436152,-1.0314845807849757,0.41854636591478694,0.7696126639507238,1.0,5/10,35.65%,STAT6;JAK3;SHPK;LEF1;TCF7
prerank,actomyosin structure organization (GO:0031032),-0.2646170518121736,-1.0314824996524792,0.41847826086956524,0.7683974822025167,1.0,5/75,3.20%,ITGB5;EPB41L2;TJP1;CAPN3;EPB41L4B
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4607034147016559,1.0312345172448982,0.4290322580645161,0.7473880054259397,1.0,5/14,11.83%,PPP3CA;PPTC7;PPP2R2A;DUSP1;PPP1R15B
prerank,triglyceride metabolic process (GO:0006641),-0.29335505992373145,-1.0308306825963194,0.3738738738738739,0.7689776725050507,1.0,13/48,25.31%,APOE;AGMO;FABP5;GPAM;GK5;GPAT4;APOC1;LIPH;LPGAT1;LMF1;PLAAT3;DGAT1;FABP4
prerank,positive regulation of endothelial cell migration (GO:0010595),0.336624197106517,1.0307995558299197,0.4265402843601896,0.747869721291564,1.0,18/84,13.22%,FOXP1;RIN2;AKT3;CD40;STAT5A;BMPR2;SCARB1;BCAR1;MAPK14;PTK2B;ADAM17;PDPK1;RAC1;BCAS3;GPI;EMC10;MAP2K3;AKT1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4535175429245474,1.0306718678137547,0.4437400950871632,0.7476562331092037,1.0,4/16,7.51%,RIPOR2;BTG1;MAPK14;PLCB1
prerank,cell differentiation in spinal cord (GO:0021515),-0.44698455097919515,-1.0306188713405942,0.41920374707259955,0.7683614344819317,1.0,6/10,38.04%,MDGA2;SOX4;SOX13;ZC4H2;SOX6;LHX1
prerank,positive regulation of cellular component movement (GO:0051272),-0.3427565321428856,-1.030537657046087,0.39622641509433965,0.7673378505992762,1.0,6/24,11.91%,CSF1R;TGFBR1;ETS1;CFAP20;CCDC25;VEGFA
prerank,insulin receptor signaling pathway (GO:0008286),-0.2735000679952586,-1.0304772883935003,0.43902439024390244,0.76629834034442,1.0,17/69,12.44%,BCAR3;ATP6V1C1;ATP6V0B;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V1B2;GAB1;ATP6AP1;RHOQ;ATP6V1D;IDE;IRS1;ATP6V0D1;PIK3R1;NAMPT;ATP6V0A1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.29134558437314123,-1.0304544276498493,0.42,0.7651601031907078,1.0,20/52,22.02%,PREB;TPP1;ATP6V0D1;HYOU1;GOSR2;ARFGAP1;SRPRB;PARP16;TATDN2;DNAJB11;GFPT1;PDIA6;CXXC1;EXTL3;VAPB;DNAJB9;FKBP14;DDX11;HDGF;PDIA5
prerank,sensory organ development (GO:0007423),0.3707448828477627,1.0303661126192452,0.41794871794871796,0.7478704194141995,1.0,6/51,6.10%,MAB21L2;SIPA1L3;ATF6;HIPK2;SMCHD1;HIPK1
prerank,negative chemotaxis (GO:0050919),-0.31675525577069685,-1.0303430899612744,0.39285714285714285,0.764240265347356,1.0,10/33,12.66%,ROBO1;SEMA3D;SEMA3E;ITGB3;PDGFA;SEMA6D;SLIT2;EPHA7;SLIT1;SLIT3
prerank,cellular response to metal ion (GO:0071248),0.3272277097646584,1.0301901720652127,0.43638392857142855,0.7477543794071547,1.0,23/123,13.86%,LRRK2;IQGAP1;PLCG2;ALOX5AP;FOS;HPCA;RASGRP2;DPEP1;CLIC4;SUMO1;KCNH1;PRNP;CPNE1;BRAF;DAXX;B2M;ADCY7;PRKAA1;CPNE2;MAPK8;AKT1;NCF1;PRKAA2
prerank,protein methylation (GO:0006479),0.3761922326677398,1.0301870745137012,0.4332874828060523,0.7472541698623671,1.0,13/40,19.03%,NSD3;PRMT8;SNRPB;RAB6A;CAMKMT;ETF1;NSD1;EZH2;PRMT3;EEF1AKMT1;NTMT1;GSPT1;EHMT1
prerank,pentose-phosphate shunt (GO:0006098),0.4987450907445723,1.0301015314637516,0.45689655172413796,0.7469722757893914,1.0,5/11,15.37%,TALDO1;RPE;DERA;RBKS;H6PD
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4122688427994529,1.0297201911370046,0.4107142857142857,0.7473748816175894,1.0,9/24,18.36%,ACE;MFSD6;TAP1;B2M;FCER1G;CANX;SEC24C;PDIA3;TAPBP
prerank,cellular macromolecule catabolic process (GO:0044265),0.3656878204040876,1.0296898254367284,0.43365253077975374,0.7469492890590251,1.0,18/49,21.21%,DENND3;SND1;XRN2;RNASEH2C;RNASE6;RIPK1;DFFB;UBE2G1;RNASEH2A;RNASEH1;PNPT1;STT3B;NCBP1;SIDT2;CHEK2;DNASE1L1;SUPV3L1;NGLY1
prerank,negative regulation of ossification (GO:0030279),0.4075892489033032,1.0295000702817005,0.4405487804878049,0.7468739377642036,1.0,4/23,6.49%,CCR1;RBPJ;SRGN;PTK2B
prerank,calcium import into the mitochondrion (GO:0036444),0.49292322496980656,1.0292578478273235,0.44703770197486536,0.7469162847581545,1.0,4/10,18.77%,MCUB;MAIP1;MICU3;MICU2
prerank,plasma membrane invagination (GO:0099024),0.40094592325466255,1.0287832636717809,0.437410071942446,0.7475206418714625,1.0,12/29,18.24%,CD36;MYH9;CDC42;ITGB2;RHOA;SNX9;FCGR2B;AURKB;ELMO1;SNX33;GULP1;FCGR1A
prerank,negative regulation of DNA metabolic process (GO:0051053),0.42166310695355924,1.028556889331736,0.4216133942161339,0.7475383367188962,1.0,9/24,19.66%,BMPR2;DFFA;MSH3;MSH6;RPS3;ERCC4;KMT2A;NIBAN2;TERF2
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.42838111149420405,1.0285413290876995,0.4296998420221169,0.7470657841749004,1.0,2/20,0.65%,IL1B;PSTPIP1
prerank,hepaticobiliary system development (GO:0061008),-0.3662540664797961,-1.0285119053091047,0.3973684210526316,0.767976795989152,1.0,6/20,13.57%,PKD2;NF1;ARID5B;CEBPG;PHF2;PRKCSH
prerank,wound healing (GO:0042060),0.35129202328849385,1.0284025276850033,0.44316730523627074,0.7468793602839371,1.0,8/62,5.35%,JAML;PAK1;CLDN1;DYSF;MYH9;PPP3CA;SCARB1;PRCP
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3369223160812645,1.0282857032506525,0.4268727705112961,0.7466315734838859,1.0,20/86,16.29%,LIMD1;PSME3;HSPA1A;PSMB7;PSME2;NFE2L2;ELOB;PSME4;BACH1;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1;CREBBP;INO80;PSMD12
prerank,regulation of osteoblast differentiation (GO:0045667),0.34001191178988094,1.028207587017341,0.435,0.7463165242579005,1.0,10/82,8.69%,FFAR4;RUNX2;LIMD1;PPARG;BMPR2;IL6R;ACVR2A;IL6ST;IL6;HGF
prerank,somite development (GO:0061053),-0.4328496588636954,-1.0281921996617551,0.43309002433090027,0.7676645546827714,1.0,5/11,27.05%,SMO;LOXL3;SOX11;PTCH1;MTHFD1
prerank,calcineurin-mediated signaling (GO:0097720),0.4959301801481731,1.028042879994866,0.4388111888111888,0.7457284665522422,1.0,5/10,24.95%,PPP3CA;NFATC3;NFAT5;NFATC2;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4959301801481731,1.028042879994866,0.4388111888111888,0.7457284665522422,1.0,5/10,24.95%,PPP3CA;NFATC3;NFAT5;NFATC2;PPP3CC
prerank,acidic amino acid transport (GO:0015800),0.43676015867541806,1.0276274707942294,0.4173354735152488,0.7462007982289484,1.0,4/17,11.50%,LRRC8D;SLC25A13;SLC25A12;SLC25A18
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.39850251242995516,1.027150735936183,0.4171686746987952,0.7467552621654725,1.0,3/26,4.22%,ST3GAL4;ST8SIA6;B4GALT5
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.40835356528977085,1.0269264329031436,0.42358078602620086,0.746778699713614,1.0,3/24,6.40%,LRRK2;HSPA1A;WFS1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.4355793611407698,-1.0267801821282327,0.4120603015075377,0.7703514016763799,1.0,1/10,0.17%,CD84
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.37026711529666295,1.0260232920484689,0.4323258869908016,0.7484258828454226,1.0,7/46,9.25%,FOXP1;PPARG;IL6R;STAT1;NOX1;IL6;ID2
prerank,positive regulation of leukocyte migration (GO:0002687),-0.34358724299730525,-1.0255961133924278,0.4409937888198758,0.7722328702651564,1.0,8/27,13.59%,AIF1;PTN;CSF1;ADAM8;NCKAP1L;VEGFA;JAM3;MDK
prerank,eosinophil migration (GO:0072677),-0.39635205007723084,-1.0252707442695828,0.4015544041450777,0.7707083608882916,1.0,6/14,31.84%,SCG2;CCL13;CX3CL1;CCL3;CCL2;CCL5
prerank,eosinophil chemotaxis (GO:0048245),-0.39635205007723084,-1.0252707442695828,0.4015544041450777,0.7707083608882916,1.0,6/14,31.84%,SCG2;CCL13;CX3CL1;CCL3;CCL2;CCL5
prerank,regulation of gluconeogenesis (GO:0006111),0.40115817404190707,1.025248478945249,0.4363103953147877,0.7497437902653956,1.0,8/27,23.36%,SIK1;CRY1;USP7;GCK;SIRT1;CLK2;PTPN2;SELENOS
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.28731872061757097,-1.0252210941325126,0.40611353711790393,0.7696403842361157,1.0,11/57,15.37%,PRKN;TREM2;SPIRE1;FAM162A;PPARGC1A;PYCARD;MFF;VPS35;RALA;BAX;HTRA2
prerank,long-term memory (GO:0007616),-0.36015490063799616,-1.0249616999125688,0.4051724137931034,0.7691430327798522,1.0,7/19,16.29%,APOE;EIF2AK4;SGK1;RASGRF1;CAMK4;CPEB3;PJA2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4492801478491173,1.0248658572439266,0.425531914893617,0.7501785694077487,1.0,6/15,15.78%,IL1B;ADRA2A;SNX9;TNFRSF1B;ADAM9;SNX33
prerank,positive regulation of immune system process (GO:0002684),-0.3897707416308199,-1.024551847172378,0.4350132625994695,0.7689971228224393,1.0,4/16,14.08%,LGALS9;NCKAP1L;VEGFA;TGFB2
prerank,regulation of neuron death (GO:1901214),0.33939244117007716,1.024136627092246,0.43028846153846156,0.7513465238845215,1.0,18/82,13.54%,LRRK2;FYN;MAP3K5;FOS;SORL1;PICALM;CHMP4A;CHMP4B;ITGB2;PRNP;DDIT4;DAXX;FCGR2B;REST;BTBD10;AKT1;DHCR24;TNFRSF1B
prerank,regulation of mononuclear cell migration (GO:0071675),0.42049140088660686,1.0240772279907424,0.44728915662650603,0.7509905413275115,1.0,3/23,2.11%,STK10;LYN;MSN
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.47586799406121477,1.0238552755578876,0.43847487001733104,0.7509957757384484,1.0,6/11,21.40%,LYN;TIRAP;ACOD1;CYBA;TLR1;TNFAIP3
prerank,regulation of macroautophagy (GO:0016241),-0.24981219715817463,-1.023589913294112,0.3885350318471338,0.7703618924342887,1.0,34/105,17.97%,LARP1;SCOC;ATP6V1C1;RPTOR;EPM2A;ATP6V0B;SNX5;ATP6V0D2;ATP6V0C;ATP6V1B2;PRKACA;SESN3;NRBP2;ATP6V1D;CDK5R1;CAPNS1;SNX6;ATP6V0D1;VPS35;CDK5;LAMTOR5;CASP3;ATP6V0A1;TRIM13;SNX32;TSC2;UCHL1;RRAGC;PAFAH1B2;GPSM1;UBQLN2;EXOC1;HDAC6;SMCR8
prerank,protein targeting to lysosome (GO:0006622),0.4212259714101871,1.0230402740552387,0.42923076923076925,0.7523885651613058,1.0,5/20,10.96%,LAPTM5;SORL1;RAB7A;GCC2;SCARB2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2903075680669871,-1.0227449075291477,0.40930232558139534,0.7714221159208314,1.0,17/52,14.15%,DDX5;RBFOX1;RNPS1;RBFOX2;KHDRBS3;SRRM4;FXR1;NOVA1;RBFOX3;RBM5;THRAP3;FXR2;NOVA2;PTBP1;RBM25;KHDRBS2;WTAP
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.44106309445181513,-1.0226649122737195,0.4138755980861244,0.7704596711959186,1.0,2/10,1.52%,DIP2B;FLCN
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3568311282198223,-1.0223912945943983,0.43478260869565216,0.7687834416348428,1.0,2/20,6.10%,HPGDS;AKR1A1
prerank,glutathione derivative metabolic process (GO:1901685),-0.3568311282198223,-1.0223912945943983,0.43478260869565216,0.7687834416348428,1.0,2/20,6.10%,HPGDS;AKR1A1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.36646173114720443,1.022150351567851,0.42570281124497994,0.7539785350021181,1.0,10/50,12.55%,IL1B;LAPTM5;EIF2AK2;PDCD4;TLR3;IFI35;RHOA;RPS3;APP;TLR2
prerank,regulation of metal ion transport (GO:0010959),-0.3793165495149379,-1.0219573549366296,0.4336734693877551,0.7688446352350892,1.0,2/16,5.04%,CACNA2D1;ANK2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.4312915306530664,1.0218123079947274,0.4342948717948718,0.7542469749709929,1.0,4/20,15.44%,SULF2;NPTN;DSTYK;THBS1
prerank,sensory perception (GO:0007600),0.367679115005585,1.0214948584984513,0.45625841184387617,0.7544746399797781,1.0,2/45,3.56%,CCR2;CHRNA4
prerank,circulatory system development (GO:0072359),-0.24606971246624332,-1.02108167798898,0.3944954128440367,0.7699642480573046,1.0,16/118,8.10%,ADAP2;TGFBR2;MEF2C;ERBB4;SALL1;TGFBR1;NTRK3;TCF25;PKD2;CACNA1C;NF1;BCOR;ACVR1;NXN;NCOA6;POU6F1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.38539982750033386,1.0209499067506433,0.4472934472934473,0.7552125096258197,1.0,5/34,3.91%,GJA5;RNF207;RGS2;KCNQ1;HCN4
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.44700100260389847,1.0205605446947748,0.4548335974643423,0.7555881110313768,1.0,4/16,13.02%,MCM6;WRN;RECQL5;MCM2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.46477367190365176,1.0204401466691715,0.4536256323777403,0.7553707269591714,1.0,3/12,14.30%,STAT3;IL6;TGFB1
prerank,cellular response to fluid shear stress (GO:0071498),0.462467517636178,1.0202609513958485,0.4422735346358792,0.755288438505165,1.0,6/12,15.02%,KLF4;NFE2L2;MAP2K5;SREBF2;HDAC3;ASS1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.34176997552055877,-1.0202298677549084,0.3805031446540881,0.7711393253800829,1.0,6/25,17.61%,MEF2C;NLGN1;CACNG2;NLGN2;NLGN3;PRRT1
prerank,negative regulation of angiogenesis (GO:0016525),0.33512459003734557,1.0202268412233795,0.4296028880866426,0.7548721077896271,1.0,11/84,9.46%,CCR2;KLF4;PPARG;CXCL10;ATF2;SYNJ2BP;STAT1;HSPG2;MECP2;E2F2;NAXE
prerank,histone lysine demethylation (GO:0070076),0.4012512970663827,1.0201319344731725,0.43805309734513276,0.754605476118904,1.0,3/25,7.20%,KDM6A;KDM7A;KDM3B
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.39746409118631604,1.0199942761678094,0.445095168374817,0.7544018508284014,1.0,6/29,13.79%,PAK1;AXIN1;CBFB;LATS1;CNOT2;STRN3
prerank,intracellular cholesterol transport (GO:0032367),-0.39287613927086595,-1.0195886865689325,0.4191780821917808,0.7716778969253822,1.0,2/15,0.76%,ABCA1;LRP6
prerank,central nervous system myelination (GO:0022010),0.4774052883290716,1.0195698461595388,0.4337979094076655,0.7549102863343724,1.0,3/11,5.94%,MYRF;B4GALT5;PTEN
prerank,homotypic cell-cell adhesion (GO:0034109),-0.30333547332723165,-1.01940409189722,0.43006993006993005,0.7709679280987027,1.0,8/39,9.02%,P2RY12;PPIA;PLPP3;ILK;MEGF11;PIK3CG;ITGB3;TJP2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3693649215255549,1.0193218364321892,0.43169398907103823,0.7549504216873422,1.0,10/43,15.44%,FOXP1;ERN1;IL6R;STAT1;NOX1;IL6;ID2;AKT1;IL18;THBS1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.497059725155929,1.018814096817934,0.44773519163763065,0.75567699953367,1.0,2/10,5.34%,TAF9;NUFIP1
prerank,homocysteine metabolic process (GO:0050667),0.4739081541922149,1.018606711781058,0.426056338028169,0.7556731626845997,1.0,2/11,10.50%,DPEP1;MTRR
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.42626306743178055,1.0183503017426876,0.4610492845786963,0.7557817331839457,1.0,4/20,9.32%,RBPJ;PDCD4;ENG;OLFM1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3841181736390206,-1.0182700181419315,0.442159383033419,0.7728581061987277,1.0,4/15,12.09%,APOE;TREM2;CHRNA7;CLU
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.2972621159588619,1.0182346307964407,0.4420289855072464,0.7555413521536438,1.0,79/341,16.39%,FEM1C;DTL;ITCH;PSME3;RNF149;DTX3L;VPS37C;NEDD4L;CUL3;BIRC6;UBE2E1;CBL;TBL1XR1;PSMB7;FBXW7;ANKIB1;RNF146;PSME2;KCTD2;ARIH1;RNF20;RNF213;PELI1;RC3H1;UBE2D3;SPOP;FBXW11;FAF1;KLHL15;RNF217;TSG101;NEDD8;NFE2L2;TRIM25;CLOCK;COP1;PCNP;PSME4;ARIH2;RNF130;ATXN3;COPS3;WWP2;RNF13;TRIM71;UBE2W;PSMB8;PSMD9;KCTD5;PSMA5;FBXL17;PSMB3;UBE2S;PSMD6;PSMC4;KLHL8;RCHY1;PSMD10;UBE2G1;AREL1;PSMB1;UBAP1;VCP;RNF150;PPP2R5C;AURKB;FBXO7;RNF166;ANAPC7;UBXN11;RMND5B;KCTD13;RNF122;USP9X;TAF1;HACE1;PSMD12;UBA6;UBR3
prerank,negative regulation of leukocyte activation (GO:0002695),-0.39444131681048356,-1.0181674913531529,0.42025316455696204,0.7719883009965455,1.0,2/15,1.60%,CD84;GRN
prerank,regulation of acute inflammatory response (GO:0002673),0.4354462479557678,1.0177786661095116,0.4613003095975232,0.7561198884682103,1.0,4/18,14.84%,IL6ST;IL6;NLRP3;GSTP1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4144530303342017,1.0173667787784646,0.45368916797488223,0.7565933539674271,1.0,10/21,22.87%,SLK;RHOA;ROCK1;CLASP1;DAPK3;VCL;PTPRA;PTK2;LIMCH1;CORO1C
prerank,regulation of neuroinflammatory response (GO:0150077),0.43143921098061494,1.0173146795080403,0.445859872611465,0.7562080278966671,1.0,5/19,14.55%,IL1B;IL33;IL6;TNFRSF1B;IL18
prerank,negative regulation of viral transcription (GO:0032897),0.4603141849534126,1.0171412418009689,0.43315508021390375,0.7560833072907965,1.0,6/13,19.90%,TRIM62;HEXIM1;TRIM14;IFITM3;MID2;LARP7
prerank,neurotransmitter transport (GO:0006836),-0.2696432366580259,-1.0171091695515722,0.4057142857142857,0.7736497031361067,1.0,27/73,24.81%,SYT1;PTPRN2;GLUL;SLC1A3;NRXN2;PPFIA4;SLC6A15;SLC17A6;SNAP25;ATP1A2;GAD2;SNPH;STX1A;SLC29A1;SLC5A7;LIN7A;CPLX1;GABRA2;RIMS1;RAB3A;NRXN1;GAD1;SYN2;SLC32A1;PDZD11;GLS;SLC1A1
prerank,entry into host (GO:0044409),0.4776277545510321,1.016851928044897,0.444633730834753,0.7562160585509127,1.0,3/13,6.33%,CBL;CBLL1;GRB2
prerank,membrane organization (GO:0061024),0.30744540280501853,1.0162720323388026,0.46129374337221635,0.757048077678034,1.0,51/227,16.46%,ACTR3;STX11;FNBP1;LDLR;PIK3C2A;EPS15;REPS1;KIF20A;DYSF;CCDC88A;OCRL;CBL;PICALM;TMCC1;MITD1;LEMD3;CHMP4A;CHMP4B;AP2A2;GRB2;ACTR2;MTCH1;PDCD6IP;SYP;SYNJ1;SPAST;HIP1;ARPC2;EPS15L1;ARPC4;LEMD2;SNX9;ATP10B;SCARB2;DMPK;STAM;AP2B1;TOR1AIP1;AGFG1;SNX3;PACSIN2;DNM1L;SYNGR2;TIMM50;SNAP23;DVL2;AP2S1;VAPA;HACE1;MYADM;PPT1
prerank,rRNA modification (GO:0000154),-0.36046710796789416,-1.0158218530002971,0.42363112391930835,0.7759418518959589,1.0,9/21,26.18%,ZCCHC4;DIMT1;NSUN3;DKC1;THUMPD1;FTSJ3;TRMT112;NAT10;BUD23
prerank,regulation of cell projection organization (GO:0031344),-0.40746285661595966,-1.0155390822255392,0.4336734693877551,0.7755558808055117,1.0,2/13,0.70%,MYO9A;TREM2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.36303177832625083,1.0147372904912508,0.45165394402035625,0.7600184520966374,1.0,14/48,19.23%,MYO1C;TAF1A;ATAD2;SMARCA5;POLR1G;DEK;ELOF1;KAT2B;POLR1B;ZMIZ2;TAF1C;PADI2;SF3B1;ACTB
prerank,negative regulation of organelle assembly (GO:1902116),0.38095024321850846,1.0144983999282056,0.4490358126721763,0.760097388149671,1.0,7/35,13.93%,LRRK2;CHMP4A;CHMP4B;SMAD4;MDM1;LIMK2;KAT2B
prerank,negative regulation of hippo signaling (GO:0035331),0.45951942589732875,1.0144549715306368,0.46755407653910147,0.7597027902674489,1.0,5/12,16.85%,LIMD1;MAPK14;MAP2K3;MARK3;AJUBA
prerank,platelet degranulation (GO:0002576),0.31808453103280726,1.0143277006445068,0.4406392694063927,0.7594822961898534,1.0,18/118,12.50%,CYRIB;PHACTR2;LYN;PECAM1;CD36;TOR4A;VEGFC;F13A1;SRGN;NHLRC2;FLNA;PSAP;HGF;FN1;CYB5R1;ABCC4;APP;TLN1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.4286040245120574,-1.01391215713325,0.45161290322580644,0.7787032678244628,1.0,6/11,17.95%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2
prerank,positive regulation of chromosome organization (GO:2001252),0.44118502236830487,1.0133803399280579,0.4366883116883117,0.7611487637664974,1.0,4/15,18.39%,MRE11;FEN1;ATRX;RAD21
prerank,Notch signaling pathway (GO:0007219),0.3526512362972116,1.0133329654797751,0.4312169312169312,0.760769894023239,1.0,8/59,8.07%,NOTCH2;ITCH;DTX3L;RBPJ;STAT1;GMDS;ADAM17;PLXND1
prerank,positive regulation of vascular permeability (GO:0043117),-0.423585474499211,-1.0127371360397208,0.4595959595959596,0.7806043774176077,1.0,6/12,18.20%,TJP1;TJP2;VEGFA;TRPV4;BMP6;ANGPT1
prerank,GPI anchor biosynthetic process (GO:0006506),-0.31926609462613276,-1.0126738814750498,0.3881578947368421,0.7795536911372482,1.0,18/30,39.04%,PIGN;PIGG;PGAP2;PIGP;PIGB;PIGA;DPM2;PIGV;DPM3;PIGU;DPM1;PIGO;PGAP3;MPPE1;PIGZ;PIGW;PIGQ;PGAP1
prerank,cell projection assembly (GO:0030031),-0.3493447443483126,-1.0119154999513087,0.4281609195402299,0.7804296564632354,1.0,11/22,22.25%,RHOH;PARVG;RHOQ;CAPG;PDGFA;NCKAP1L;PARVA;RHOU;NEFH;CYFIP1;GSN
prerank,maturation of 5.8S rRNA (GO:0000460),-0.37257228446779744,-1.0118880468416331,0.43410852713178294,0.7793215182546247,1.0,8/17,18.71%,RPF1;WDR12;C1D;LAS1L;PES1;FTSJ3;RRP15;EXOSC10
prerank,cardiac myofibril assembly (GO:0055003),-0.3827765036584536,-1.0117738991614071,0.4392764857881137,0.7784689581593709,1.0,8/15,41.41%,NEBL;NRAP;FHOD3;MEF2A;NEB;PDGFRB;OBSL1;MYL2
prerank,phospholipid dephosphorylation (GO:0046839),0.37945011585983784,1.0117713713393417,0.45518207282913165,0.7638271106816895,1.0,10/37,17.34%,INPP5F;OCRL;PTEN;MTMR3;MTMR4;SYNJ1;SGPP2;SGPP1;MTMR2;PLPPR2
prerank,cellular response to acid chemical (GO:0071229),-0.32531617109306493,-1.0114582100895797,0.4290322580645161,0.7781378718584162,1.0,12/27,19.31%,RPTOR;CPEB1;LARS1;IPO5;GLRA2;CPEB4;LAMTOR5;VEGFA;RRAGC;CPEB3;NSMF;SESN2
prerank,AMP metabolic process (GO:0046033),-0.4056856240567125,-1.011134687279165,0.45363408521303256,0.777845652606456,1.0,6/13,30.64%,ADSS2;AK3;AMPD2;NUDT2;ADSS1;AK4
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.46667411118360325,1.0108747252589996,0.4539363484087102,0.7653540344857213,1.0,1/12,1.69%,PPARG
prerank,protein localization to chromosome (GO:0034502),-0.31285969923057605,-1.0104335458571752,0.41694915254237286,0.7786283710174102,1.0,17/34,23.86%,WAPL;SLF2;TPP1;SLF1;IFFO1;TERF2IP;MSH2;XRCC5;ESR1;MRNIP;TNKS2;CHMP7;CENPA;BOD1;PARP3;TINF2;PINX1
prerank,cation transport (GO:0006812),-0.2343306469718291,-1.0093961115398622,0.4431818181818182,0.7803467786876993,1.0,26/167,13.00%,KCNMA1;SLC8A1;SLC7A6;FGF13;SCN1A;TRPM3;KCNJ2;SLC7A1;ANO10;ATP1B1;SLC36A4;SGK1;SLC11A2;SCN3A;SLC36A1;KCNN2;ATP1A2;KCNMB2;KCNA2;MCOLN1;KCNK6;KCNJ6;SLC7A8;CHP1;SLC3A2;TRPM2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.38517244159113445,1.0093527150045951,0.4408759124087591,0.7684257187171016,1.0,2/31,1.69%,LIMD1;PPARG
prerank,ganglioside metabolic process (GO:0001573),0.4188813260823592,1.0092643178533682,0.4368,0.7681457864100388,1.0,4/20,8.27%,ST8SIA4;GM2A;ST8SIA6;ST6GALNAC3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.35045413335202447,1.009239554278573,0.4426877470355731,0.7677090177764944,1.0,9/54,7.31%,AKT3;PPARG;CD40;STAT5A;PRCP;MAPK14;ADAM17;PDPK1;MECP2
prerank,regulation of mitochondrial fusion (GO:0010635),0.4689837796351866,1.0089839594151033,0.4456140350877193,0.7678044904461494,1.0,2/11,7.63%,PID1;ZDHHC6
prerank,regulation of secretion by cell (GO:1903530),-0.2821023048949925,-1.0084215167585642,0.42616033755274263,0.7816724423026701,1.0,16/54,19.09%,MEF2C;SYT1;SNCAIP;RAB3C;STXBP5L;RIC1;RALA;DISP1;SCG5;VAMP8;CPLX1;CAMK2A;RIMS1;RHBDF2;RAB3A;VAMP3
prerank,protein autoprocessing (GO:0016540),0.42587281140250444,1.0083080272988436,0.4525316455696203,0.7688320888732325,1.0,3/17,9.64%,MYRF;FAM111A;PIDD1
prerank,brain morphogenesis (GO:0048854),0.4596637163340517,1.008005926899248,0.4537671232876712,0.7690589631861787,1.0,4/12,12.09%,FBXW11;PTEN;PAFAH1B1;SLC6A4
prerank,positive regulation of cell projection organization (GO:0031346),0.3173249254908857,1.0079254176436,0.46091954022988507,0.7687367686194982,1.0,31/115,17.55%,TIAM1;LYN;NGF;RAP1A;NGFR;CAMK1D;RET;NDNF;TIAM2;RAPGEF2;NPTN;CARMIL1;SETX;PTK2B;PLXND1;CBFA2T2;RHOA;SCARB2;DVL3;PLXNC1;SNX3;KIDINS220;MAP3K13;STMN2;DVL2;RETREG3;RELN;FES;CAPRIN1;ABL2;CHODL
prerank,positive regulation of cartilage development (GO:0061036),0.4281280521590455,1.0075465398726422,0.456,0.7690857833996353,1.0,3/17,10.64%,BMPR2;SCX;TAPT1
prerank,regulation of organelle organization (GO:0033043),0.32890387222326184,1.007124320249549,0.45590062111801244,0.7695747558888055,1.0,26/80,20.62%,MSN;USP6NL;ZEB2;CLIC4;DIAPH1;PARL;CAPN2;PAK2;CLEC16A;PDE2A;F11R;EZR;STX5;FIS1;SCARB2;DNM1L;CAPN6;STMN3;MAPK1;EHD3;TBC1D25;PINK1;AKAP9;PTK2;MUL1;ARMH3
prerank,lipid homeostasis (GO:0055088),-0.27212795508035303,-1.0070526440900773,0.423728813559322,0.7841025859586038,1.0,7/57,5.97%,ABCA1;APOE;TREM2;USF2;ABCB4;PNPLA8;NR1D2
prerank,lymphocyte chemotaxis (GO:0048247),-0.3038998414346547,-1.0068967608157184,0.42700729927007297,0.7833600611967919,1.0,9/34,17.33%,GAS6;ADAM8;PIK3CG;CH25H;CCL13;GPR183;CX3CL1;CCL14;CCL3
prerank,cochlea morphogenesis (GO:0090103),0.4816452862508301,1.0068559340614893,0.4595070422535211,0.7697042081296691,1.0,2/10,13.74%,MYO3B;TIFAB
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4047463609007455,1.0059962903265176,0.44837758112094395,0.771171810403405,1.0,5/23,9.38%,ACSL5;ELOVL5;HSD17B12;ELOVL6;FAR1
prerank,metal ion export (GO:0070839),0.38839730323450117,1.0058611431111633,0.4477401129943503,0.7709933030668982,1.0,3/31,7.66%,KCNE3;KCNQ1;ATP7A
prerank,neutral amino acid transport (GO:0015804),-0.32068265304762367,-1.0053871803442482,0.44477611940298506,0.7860642816712843,1.0,6/28,12.61%,SLC38A6;SLC36A4;SLC6A15;SLC36A1;SLC7A8;SLC3A2
prerank,response to UV (GO:0009411),0.32947896683401023,1.0053860738601978,0.46878680800942285,0.7715707670111597,1.0,34/95,22.12%,BCL3;DTL;GPX1;FEN1;CCND1;WRN;MSH6;MAP3K4;MAP4K3;DCUN1D3;ERCC3;MAPK8;AKT1;PCLAF;ERCC4;METTL3;AURKB;BRSK1;RELA;CREBBP;TAF1;INO80;USP47;POLD1;PRKCD;PRIMPOL;CAT;N4BP1;RHBDD1;XPA;POLK;PARP1;CASP9;SDE2
prerank,anterograde axonal transport (GO:0008089),-0.30956374925982966,-1.0049762751328206,0.4623287671232877,0.7859747540576987,1.0,10/37,15.39%,DTNBP1;DLG2;KIF1B;KIF1A;AP3M2;KIF5C;MAP1A;AP3B1;AP3B2;BLOC1S5
prerank,maintenance of blood-brain barrier (GO:0035633),0.38271497532009824,1.004361480445896,0.45494186046511625,0.7734341794578586,1.0,10/30,19.23%,PECAM1;CLDN1;CLDN12;F11R;IL6;MBP;OCLN;TJP3;VCL;ACTB
prerank,endocytic recycling (GO:0032456),0.3534972681070512,1.0038215796142502,0.44070080862533695,0.7741762496805483,1.0,9/50,8.96%,LMTK2;EPS15;DENND1A;EHD2;RAB7A;VPS53;DENND1B;STX6;SNF8
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3709277278159149,-1.0032137764197924,0.4305177111716621,0.7894411074902994,1.0,7/18,18.19%,SKI;NF1;NLRC3;FTH1;MED25;DAB2IP;TRIM32
prerank,alanine transport (GO:0032328),-0.4326618967358837,-1.0031717253875374,0.4603960396039604,0.7883961062861027,1.0,2/10,5.83%,SLC36A4;SLC36A1
prerank,striated muscle tissue development (GO:0014706),0.38932943540873943,1.0030267464932705,0.4478442280945758,0.7755073778157955,1.0,3/29,7.08%,SVIL;BMPR2;SGCD
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3762879679876545,1.0029591786197711,0.4533715925394548,0.7751406101393791,1.0,12/34,18.81%,ERN1;MAPKAPK2;VEGFC;MAPK14;PGF;ANXA1;PIK3CA;MAP2K3;RELA;NR4A1;FOXC1;SEMA6A
prerank,hydrogen peroxide catabolic process (GO:0042744),0.4694268062777033,1.002610266968342,0.47017543859649125,0.7754066733869283,1.0,4/11,19.40%,GPX1;PXDN;PRDX5;CAT
prerank,inorganic anion transport (GO:0015698),-0.2718149949375791,-1.0025374744082505,0.47465437788018433,0.7889274780056397,1.0,19/53,29.96%,SLC11A1;TTYH3;CLCN6;ENPP1;ANO10;CLCN4;SLC26A11;SLC25A11;SLC25A14;ANO8;CLCN2;SLC26A8;SLC26A6;SLC4A10;SLC25A10;CLCN1;CLIC5;FXYD1;ENPP3
prerank,mesenchyme development (GO:0060485),-0.38668422709970374,-1.0024191916538328,0.45714285714285713,0.7880383409806596,1.0,3/15,6.15%,TGFBR1;PKD2;FGFR2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.32752105699215206,1.0021288444016625,0.460166468489893,0.7760150458837095,1.0,18/92,13.88%,FOXP1;RIN2;DOCK5;PRKCE;PLCG2;BMPR2;GLIPR2;SCARB1;BCAR1;PTK2B;RAC1;BCAS3;RTN4;GPI;EMC10;CAPN7;AKT1;CLASP1
prerank,neuron projection development (GO:0031175),0.30647800723461704,1.0021172542722472,0.4772234273318872,0.7755362303198043,1.0,22/168,8.68%,LRRK2;SRGAP2;LYN;CDNF;NGF;PAK1;SHTN1;DOCK10;BTG2;FRY;RAPGEF2;LAMB1;CDC42;GDNF;TAOK3;PPP1R9B;PTEN;FRYL;ATP7A;EPHB2;MINK1;IL6
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.33600619291278794,1.0019882977137406,0.48166259168704156,0.7753405334572054,1.0,10/76,10.41%,GNA14;FPR1;LTB4R;FPR3;GPR35;ADRA2A;TACR1;OPRM1;HRH1;PTGER3
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.41031386870161385,1.001773905395764,0.46504559270516715,0.7753433534912818,1.0,4/21,14.32%,GLI1;RAB34;TUBD1;TXNDC15
prerank,liver development (GO:0001889),-0.31589851747757064,-1.0013086364511465,0.4401294498381877,0.7898084257578338,1.0,7/32,13.57%,PKD2;NF1;PCK2;ARID5B;CEBPG;PHF2;PRKCSH
prerank,positive regulation of lymphocyte migration (GO:2000403),0.4592894556767957,1.0012156545527007,0.47126436781609193,0.7761380748885642,1.0,4/12,12.23%,CXCL10;SPN;RHOA;APP
prerank,membrane lipid metabolic process (GO:0006643),-0.3440053376872637,-1.000938826266046,0.44192634560906513,0.7895819251694841,1.0,10/22,22.27%,ST3GAL6;CERK;AGMO;ARV1;B4GALT4;SERINC1;AGK;SPHK2;ST6GALNAC4;TECR
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.4679410007913103,1.0009157961779722,0.467005076142132,0.77532579819999,1.0,4/11,11.97%,SLC25A16;PANK1;PANK4;ACAT1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.4679410007913103,1.0009157961779722,0.467005076142132,0.77532579819999,1.0,4/11,11.97%,SLC25A16;PANK1;PANK4;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.4679410007913103,1.0009157961779722,0.467005076142132,0.77532579819999,1.0,4/11,11.97%,SLC25A16;PANK1;PANK4;ACAT1
prerank,endodermal cell differentiation (GO:0035987),0.3765889628080716,1.0005383795532268,0.46262341325811,0.7757072436007105,1.0,5/31,10.71%,ITGA4;LAMB1;ITGB2;FN1;SETD2
prerank,glycogen catabolic process (GO:0005980),-0.37074173261597854,-1.0004699552284793,0.46070460704607047,0.7896647463631683,1.0,7/15,22.54%,PYGB;GAA;CALM1;PHKA1;PGM2;AGL;PHKG2
prerank,positive regulation of catalytic activity (GO:0043085),0.37336230895992434,1.0004053560984099,0.47441217150760717,0.7755033690026193,1.0,11/37,17.17%,MAPK14;WRN;CIB1;MSH3;ATP7A;MSH6;BCAS3;XRCC4;MAPK8;PSEN1;ABL2
prerank,response to nutrient levels (GO:0031667),-0.3714532039464845,-1.0002506907109394,0.4726775956284153,0.7891101691384643,1.0,4/17,14.36%,RPTOR;CD68;ATF4;EIF4G1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.42954885756488614,1.0001249256693039,0.48367029548989116,0.7756133813799312,1.0,6/18,19.25%,PTBP3;KAT2B;TGFB1;PTBP2;SHQ1;RPS13
prerank,macrophage differentiation (GO:0030225),-0.4125533925783838,-0.9997754021152561,0.46786632390745503,0.7891756827676794,1.0,2/13,3.39%,CSF1R;CSF1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.22857206753767104,-0.9997563339689395,0.5106382978723404,0.7880856536061092,1.0,48/224,16.08%,DLGAP1;LRP6;GRIA4;SYT1;CACNB2;NLGN1;CAMK1;KCND2;SLC1A3;PLP1;KCNQ3;CHRM3;DLG2;DLG4;CHRM2;GRIA2;GRIA1;PRKACA;GABRG3;NRXN2;GABRG2;GRIK4;SNAP25;GABRB1;GRIK1;GLRA3;HTR2B;GLRA2;NOVA1;GABRA4;CHRFAM7A;CHRNA7;GAD2;RIT2;GRM5;CDK5;CAMK4;PRKAR1A;NLGN2;SST;HTR2C;CALM1;GABRB3;GIPC1;KCNA1;HTR7;CPLX1;NLGN3
prerank,protein modification by small protein removal (GO:0070646),0.30021385112628063,0.999678339954877,0.5,0.7760762532642993,1.0,72/252,18.80%,TNIP3;PSME3;NFKBIA;USP3;PSMB7;INO80C;PSME2;OTULINL;BIRC3;IL33;EIF3F;IFIH1;OTUD1;PTEN;USP49;NEDD8;TADA3;ATXN7;USP45;TRAF3;JOSD1;PSME4;UIMC1;USP32;ATXN3;USP31;USP48;RHOA;COPS3;USP15;PSMB8;SMAD4;PSMD9;PSMA5;CYLD;USP42;RIPK1;SENP6;STAM;PSMB3;PSMD6;PSMC4;NLRP3;USP40;MAP3K7;PSMD10;USP4;SNX3;OTUD4;PSMB1;KAT2B;VCP;USP37;USP7;VCPIP1;ASXL2;USP9X;INO80;APC;POLB;USP47;PSMD12;FOXK1;WDR20;TRAF2;TAB1;BECN1;USP14;USP38;SMURF2;STAM2;MBD5
prerank,glycine metabolic process (GO:0006544),0.4562742634725019,0.9987779379640925,0.46938775510204084,0.7776108886690871,1.0,5/12,19.39%,DLD;GCSH;AMT;SHMT1;GLYAT
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.43631859587460253,-0.9986782959894477,0.48668280871670705,0.7897590473384346,1.0,2/10,4.11%,EPB41L4B;IQSEC1
prerank,regulation of potassium ion transport (GO:0043266),-0.32232765575270983,-0.9985014116663224,0.46779661016949153,0.7890867651283296,1.0,5/31,7.55%,CACNA1D;CD63;ANK2;KCNN2;DPP10
prerank,vesicle coating (GO:0006901),-0.278842744095843,-0.9980177051570073,0.4166666666666667,0.7868249333873443,1.0,16/61,16.02%,TGFA;NAPA;PREB;MCFD2;GRIA1;TBC1D20;GOLGA2;CTSZ;LMAN1;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,COPII vesicle coating (GO:0048208),-0.278842744095843,-0.9980177051570073,0.4166666666666667,0.7868249333873443,1.0,16/61,16.02%,TGFA;NAPA;PREB;MCFD2;GRIA1;TBC1D20;GOLGA2;CTSZ;LMAN1;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.278842744095843,-0.9980177051570073,0.4166666666666667,0.7868249333873443,1.0,16/61,16.02%,TGFA;NAPA;PREB;MCFD2;GRIA1;TBC1D20;GOLGA2;CTSZ;LMAN1;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,inhibitory synapse assembly (GO:1904862),-0.41572910311937994,-0.9976065820847827,0.45714285714285713,0.7867685992387261,1.0,5/11,16.92%,FGF13;GABRG2;LGI2;GABRB3;GABRA2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3835507067822825,-0.9973366723856419,0.4633431085043988,0.7863073191502501,1.0,7/16,18.22%,PSIP1;SFSWAP;SNRNP200;PRPF39;CWC15;SNRPC;SRSF1
prerank,neuron maturation (GO:0042551),-0.3630941941644028,-0.9972291754210764,0.4734042553191489,0.7854399253824204,1.0,7/18,15.38%,C1QA;ADGRB3;SRRM4;FARP2;ANKS1A;C3;CX3CL1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.40947633350232077,0.9969938642259221,0.4651851851851852,0.7811389919545068,1.0,6/20,15.95%,IL1B;RPS6KA5;TADA2A;PRKAA1;PRKAA2;BRD7
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.37299031725881787,0.9969866216536426,0.4642356241234222,0.7806576959330983,1.0,10/37,15.81%,SND1;XRN2;RNASEH2C;RNASE6;DFFB;RNASEH2A;RNASEH1;PNPT1;NCBP1;SIDT2
prerank,myelin maintenance (GO:0043217),0.4739264787349692,0.9968295706290532,0.4696707105719237,0.7805201990842937,1.0,4/10,13.04%,PRX;MYRF;PTEN;ABCD1
prerank,regulation of platelet aggregation (GO:0090330),0.43367399727559497,0.9967672067825669,0.48105436573311366,0.7801818087530736,1.0,3/17,7.62%,LYN;SYK;F11R
prerank,regulation of telomere capping (GO:1904353),0.3984913427343285,0.9966009201401741,0.4725609756097561,0.78005814567195,1.0,7/23,16.15%,PKIB;TNKS;MAP3K4;AURKB;USP7;MAPK1;SMG6
prerank,regulation of translation (GO:0006417),0.30716488918606083,0.9965261866455009,0.48812095032397407,0.7797198475477526,1.0,43/173,18.41%,NIBAN1;BCL3;RPL5;DAPK1;VIM;BTG2;RPS6KA3;EIF4G3;EIF2AK2;MTPN;GIGYF2;YTHDF3;MRPL13;IL6;ETF1;TRIM71;RPS3;IGF2BP3;FOXO3;EIF4A2;PAIP2;RPS6KA1;APP;EIF4ENIF1;EIF2AK3;METTL3;MTRF1;LARP4B;SYNCRIP;PAIP1;EIF3E;THBS1;NCBP1;RPS4X;RPS6KB1;DAPK3;EIF1;CAPRIN1;CNOT8;EIF3H;DDX6;GSPT1;SHMT1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.4011464045284291,0.996046355095367,0.4806201550387597,0.7802710888326211,1.0,5/24,6.71%,JARID2;SPI1;H3-3A;RBBP4;PHF19
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3307618225984551,-0.9955810873075226,0.4457831325301205,0.7886261104322931,1.0,6/27,7.59%,CTNNA3;FGF13;CACNA1C;ATP2A2;ANK2;JUP
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4703902041442102,0.9953499737341526,0.47018739352640543,0.781310958204667,1.0,5/11,19.42%,BIRC3;PELI1;RIPK1;YBX3;FZD9
prerank,positive regulation of myelination (GO:0031643),0.47464915342507363,0.9949453926352254,0.5149501661129569,0.7817323597763323,1.0,2/11,4.08%,ITGAX;MYRF
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.4866390074023863,0.9947850204827668,0.4716981132075472,0.7815928898388372,1.0,3/10,11.59%,ATF7IP;THRA;PSMC4
prerank,regulation of interleukin-1 production (GO:0032652),0.43317670032813227,0.9944069494886324,0.4608,0.7819236238902597,1.0,3/15,10.43%,FOXP1;TMED10;ANXA1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3947125859450174,0.9943299897988422,0.46439169139465875,0.7815746684134777,1.0,9/26,20.01%,LRRK2;FYN;NFE2L2;REST;AKT1;FBXO7;SIRT1;PINK1;PARK7
prerank,amino sugar biosynthetic process (GO:0046349),-0.41267076804232605,-0.9940249596345359,0.4810126582278481,0.7915599456147945,1.0,6/12,17.95%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2
prerank,cell-cell junction assembly (GO:0007043),-0.2606767175122856,-0.9940175510386482,0.475,0.7904473662259311,1.0,20/63,21.47%,TJP1;PKP4;FLCN;CD9;CTNNB1;CDH11;SMAD7;PATJ;JUP;EPB41L3;GJA1;JAM3;TRPV4;TLN2;PKP2;RHOC;ARVCF;CDH22;CLDN11;CNTNAP1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.38243196944893265,0.9938259125008797,0.4733044733044733,0.7822561155375714,1.0,7/32,14.90%,DTL;MRE11;TAOK3;UIMC1;RINT1;DONSON;BRSK1
prerank,response to iron ion (GO:0010039),-0.41566598284157585,-0.993202217395735,0.47738693467336685,0.7914898361839003,1.0,5/12,22.00%,HIF1A;SLC11A2;BMP6;FXN;HFE
prerank,mammary gland epithelium development (GO:0061180),-0.3841905115990272,-0.9930413110654064,0.4529262086513995,0.7907691223553264,1.0,2/14,0.92%,CSF1R;ERBB4
prerank,negative regulation of cellular process (GO:0048523),0.2887682031394509,0.9926671510665165,0.5191146881287726,0.7843845499466855,1.0,82/521,14.40%,CBFA2T3;IL1B;IFNLR1;SP100;SRGAP2;RUNX3;LYN;NGF;KLF4;LILRB1;CASK;PTPRU;BCL6;PLSCR1;JAK2;HSPA1A;BTG2;BMPR2;RAPGEF2;FABP7;DYSF;CRLF3;RIPOR2;PTPN6;EIF2AK2;ABI1;MYH9;CBLL1;CHMP4B;DLC1;BTG1;PPP1R9B;SPN;RBBP4;TNS2;GLMN;PTEN;ARHGDIB;CDKN2C;OSGIN2;KLF10;WFS1;PTK2B;ATG5;PDCD4;CIB1;SULT2B1;RARG;TGFBI;LMNA;UBR2;PLXND1;EPHB2;CTCF;IFI35;IL6;OPRM1;SMAD4;RTN4;ARID2;DUSP1;DCUN1D3;S100A11;FCGR2B;REST;UTP20;NUPR2;APP;PLXNC1;SH3BP4;TLR2;SNX3;PPM1D;NF2;EIF2AK3;TNFRSF1B;KAT2B;CD164;RPS6KA2;PTPRJ;TGFB1;PPP2R5C
prerank,negative regulation of TORC1 signaling (GO:1904262),0.44882633966790486,0.9923850651830011,0.4716666666666667,0.7845325929749781,1.0,3/13,12.74%,SPAAR;DEPDC5;CASTOR2
prerank,spliceosomal snRNP assembly (GO:0000387),0.37049029496707736,0.9923239135214373,0.46703296703296704,0.7841569778914385,1.0,12/38,21.30%,SNRPD2;PRPF6;SNRPB;SRSF10;COIL;PRPF3;USP4;GEMIN7;AAR2;DDX20;SNUPN;GEMIN8
prerank,multivesicular body organization (GO:0036257),0.37572463465590666,0.9921924755538988,0.4918032786885246,0.783949697980902,1.0,7/31,11.11%,VPS37C;CHMP4A;CHMP4B;TSG101;PDCD6IP;SNF8;STAM
prerank,cellular response to reactive oxygen species (GO:0034614),0.34644042276651726,0.9920874094190633,0.4718670076726343,0.7836865533793684,1.0,17/59,15.38%,MAP3K5;FOS;SETX;NFE2L2;PXN;IL6;CAMKK2;RPS3;ANXA1;RIPK1;NET1;MAPK8;AKT1;NCF1;RELA;MAPK1;PRDX5
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.30684359612724577,-0.9918119799708829,0.43795620437956206,0.7929041646627346,1.0,5/36,2.99%,PTPRM;APOE;MEF2C;FGF2;HMGB1
prerank,protein-containing complex assembly (GO:0065003),0.29502117309705905,0.9906979145864855,0.48651452282157676,0.7862762411300585,1.0,27/259,11.00%,CD74;LRRK2;TIAM1;TRAF1;WIPF1;CD40;TRAPPC5;CLDN1;CUL3;SKAP2;PICALM;AXIN1;CD2AP;AFDN;PTK2B;ELOB;TMED10;STX5;PEX14;CAPZA1;FANCC;TSPAN33;FN1;SNX9;RIPK1;DNAJB12;TRAPPC2L
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4493465000056258,0.9900258806141243,0.4793103448275862,0.7872363810316219,1.0,5/12,19.90%,HEXIM1;RECQL5;NELFA;RNF168;LARP7
prerank,regulation of vasculature development (GO:1901342),0.3885528506752594,0.989764847297584,0.47947214076246336,0.7873335893094311,1.0,4/26,8.68%,SP100;ADGRA2;PLXND1;IL6
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4208108008274112,-0.9895377363473697,0.4621212121212121,0.7977063399245474,1.0,4/11,20.94%,APOE;PORCN;ATG7;WDR45
prerank,regulation of Golgi organization (GO:1903358),0.41302853310579885,0.9891159089054221,0.46781789638932497,0.7882635385204274,1.0,7/17,20.62%,USP6NL;STX5;MAPK1;EHD3;MAP2K1;AKAP9;ARMH3
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.45751855994527807,0.9890595660850021,0.5024875621890548,0.7878765399657133,1.0,4/12,13.22%,PLCB1;SLAMF8;DUSP1;AKT1
prerank,sodium-independent organic anion transport (GO:0043252),-0.4264075666158028,-0.9890437239560272,0.47586206896551725,0.7978792736845777,1.0,1/10,0.11%,SLCO2B1
prerank,in utero embryonic development (GO:0001701),-0.327056818189252,-0.9888277572012176,0.4717607973421927,0.797319354858845,1.0,6/25,12.51%,CHD7;TGFBR1;FLCN;FGFR2;VEGFA;HINFP
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.37815982937599985,0.9888148082230838,0.47126436781609193,0.7879373490024699,1.0,7/30,17.14%,GPR35;F11R;RAC1;NET1;ARHGEF3;LPAR6;GPR65
prerank,cellular response to alcohol (GO:0097306),0.361135016409691,0.9887747557330119,0.46802721088435373,0.7875271863337503,1.0,12/42,13.31%,MAP4K1;PTGER2;CTNNA1;PTGER4;AHR;GNB1;ADCY7;GNAI1;ADCY5;KLF9;SPIDR;GNG2
prerank,bile acid biosynthetic process (GO:0006699),-0.3322667806094307,-0.9879352187730266,0.5134328358208955,0.7984583204686253,1.0,11/24,34.13%,OSBPL1A;CH25H;OSBPL6;AMACR;OSBPL7;ACOT8;OSBP;SLC27A2;OSBPL2;HSD17B10;CYP7B1
prerank,intracellular lipid transport (GO:0032365),-0.34891471547116115,-0.9879141923374245,0.4809384164222874,0.7973744612386654,1.0,6/21,8.59%,ABCD2;ACACA;PLEKHA8;ABCD4;ARV1;SLC25A20
prerank,erythrocyte development (GO:0048821),-0.42566046220898063,-0.9878650958297523,0.4818181818181818,0.7963640172002904,1.0,7/10,41.81%,ALAS1;NCKAP1L;LYAR;ABCB10;ZBTB7A;SH2B3;DMTN
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3515736413257558,0.9877795000606618,0.48326639892904955,0.7892697419712088,1.0,12/48,15.88%,SLC25A16;PANK1;ADCY10;PANK4;PAPSS1;PAPSS2;GUCY1A1;ADCY7;ACAT1;ADCY5;ADSL;GMPS
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.41606853014426437,0.9876437531748007,0.47665056360708535,0.7890680701287935,1.0,4/19,7.83%,BCL3;HIPK2;HIPK1;DDIT4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.29350096050368346,-0.987463091784302,0.44673539518900346,0.7962709992520268,1.0,5/37,5.02%,IGF1;PRKG1;MEF2C;FGF2;FOXJ2
prerank,multivesicular body assembly (GO:0036258),0.3762772570171056,0.9873971898022847,0.49519890260631,0.7891091749003668,1.0,7/30,11.11%,VPS37C;CHMP4A;CHMP4B;TSG101;PDCD6IP;SNF8;STAM
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3339373170761806,0.9873854500232108,0.4818976279650437,0.7886373059006697,1.0,16/64,17.99%,SLK;CASK;UTRN;CD36;PTK2B;PLEKHA2;CIB1;MINK1;RHOA;NF2;ROCK1;CLASP1;THBS1;DAPK3;VCL;PTPRA
prerank,base conversion or substitution editing (GO:0016553),-0.4188765009263646,-0.986917284619155,0.48743718592964824,0.7964502214147339,1.0,4/11,26.68%,ADARB2;ADAR;ADARB1;NUDT16
prerank,myoblast fusion (GO:0007520),-0.4071003345123089,-0.986725473841939,0.4864864864864865,0.7958227354303594,1.0,4/12,15.73%,CD9;ADGRB3;JAM2;ADAMTS5
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.4180211980316771,-0.9866158065869959,0.46296296296296297,0.7950043178308748,1.0,5/10,27.05%,MTHFD2L;MTHFS;DHFR;SHMT2;MTHFD1
prerank,glycerolipid catabolic process (GO:0046503),-0.3578849377797366,-0.9864712005101879,0.48214285714285715,0.7942466474168071,1.0,4/19,7.35%,ABHD12;MGLL;GDE1;PLA2G4A
prerank,regulation of axon extension (GO:0030516),-0.29972197685433866,-0.9863045640254936,0.4861111111111111,0.7935708189393792,1.0,6/37,7.74%,APOE;DIP2B;MAP2;LIMK1;CDKL3;GOLGA4
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.38831361848987683,0.986099072768425,0.46735905044510384,0.7910144300744896,1.0,10/27,18.29%,ZC3H12D;ERN1;NHP2;RNASE1;KHNYN;RNASE6;RNASEH1;CPSF3;NYNRIN;CSTF3
prerank,RNA splicing (GO:0008380),0.3215928156123063,0.9857331654288795,0.5146198830409356,0.7913031784305815,1.0,30/95,20.98%,MBNL1;RSRC1;RNPC3;SNRPD2;PRPF6;PPP1R9B;SNRPB;DBR1;SRSF10;MAGOHB;PRPF3;RP9;SRSF4;DHX8;SLU7;DDX23;SNRPA1;CDK12;SYNCRIP;NCBP1;TXNL4A;SF3B3;SF3B2;SF3B1;PDCD7;SMNDC1;HNRNPC;LUC7L3;PRPF18;NONO
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.37361043582127235,0.9853249996099185,0.4764621968616263,0.7917540891532773,1.0,10/32,16.89%,CASK;RCC2;DLC1;PTEN;PHLDB2;BCAS3;NF2;THBS1;DUSP22;ARHGAP6
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.30897404333464007,0.9850982632598883,0.5,0.7917633917973756,1.0,30/128,18.50%,RUNX2;ARHGEF18;FOS;BMPR2;CBL;SCX;GDF1;HIVEP1;PDCD4;ZFYVE9;F11R;ENG;PXN;ACVR2A;RHOA;USP15;NRROS;SMAD4;NLK;MAP3K7;TGFB1;ADAM9;USP9X;ZMIZ2;DUSP22;SMAD5;SIRT1;APPL1;SMURF2;HPGD
prerank,organelle organization (GO:0006996),0.2869969407713555,0.9847256910605328,0.5424242424242425,0.7921166790436653,1.0,65/388,13.99%,ATP8B4;LRRK2;NEDD9;LIMD1;FAM174B;CNN2;SYNE3;TSGA10IP;LONP1;SIPA1L3;PLEKHF1;PDZD8;EPS15;USP6NL;GOLPH3L;TMCC1;ABCA3;PEX16;CDC42;CHMP4A;CHMP4B;PEX12;DIAPH1;RAB7A;FGD4;CAV2;PI4K2B;STX17;HPS3;CLUH;PITPNB;CAPZB;RAB34;ATXN7;TMED10;ATP7A;YTHDF3;PDCD6IP;FGD1;GBF1;GABPB1;FGD3;PEX14;BCAS3;PIKFYVE;ATL3;ARFGEF1;STX7;LMAN2L;ARHGAP21;CFAP61;STRIP2;TTC17;TRAPPC11;SPTSSB;HTT;TFAM;PACSIN2;DNM1L;ABCD1;EIF2AK3;SIRT4;CLASP1;YME1L1;VMP1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.36061668646081035,0.9846213383845894,0.49363507779349364,0.7918518412220866,1.0,3/36,5.03%,IL1B;NOSTRIN;SCARB1
prerank,protein localization to plasma membrane (GO:0072659),0.3097980579923231,0.984596517719676,0.5294117647058824,0.7914214765498224,1.0,33/129,17.94%,RAP1A;TTC7A;PLEKHF1;C2CD5;RAB3D;RAPGEF2;CCDC88A;IKBKB;EHD2;KCNIP3;AFDN;RAB34;FLNA;S100A10;F11R;EZR;ZDHHC23;TSPAN14;TSPAN33;PACS2;PACS1;RAB40B;PIP5K1A;ROCK1;EFR3A;EHD1;ZFYVE27;TSPAN15;TSPAN5;MYADM;TSPAN17;EHD3;ZDHHC3
prerank,serine family amino acid catabolic process (GO:0009071),0.4769497928820342,0.9836147198615165,0.5043177892918825,0.7931327573035024,1.0,4/10,18.41%,DLD;GCSH;AMT;SHMT1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.32592696833983087,0.9834196503222594,0.49695493300852617,0.793086988376702,1.0,14/80,12.16%,UVRAG;RACGAP1;GOLPH3L;COPG2;KIF23;RAB6A;ARF4;PITPNB;TMED10;GBF1;RINT1;KIF3B;HTT;KDELR1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.30924700179360703,0.9832747936072228,0.5149425287356322,0.7929211613970473,1.0,26/128,14.90%,SDCCAG8;CNTRL;PPP1R12A;HAUS8;PHLDA1;FBXW11;FBXL8;CDK14;CEP63;PAFAH1B1;PPP2R2A;PLCB1;HAUS1;CCNH;DCTN3;BACH1;LATS1;CEP250;FBXL17;DYNC1H1;PPP1CB;HAUS3;FBXL12;CLASP1;WEE1;BRSK1
prerank,protein palmitoylation (GO:0018345),0.37449522840543187,0.9831618296291109,0.45718432510885343,0.7926989425576466,1.0,7/30,12.73%,HHAT;ZDHHC7;ZDHHC13;ZDHHC6;ZDHHC23;ZDHHC17;CLIP3
prerank,positive regulation of exocytosis (GO:0045921),0.371954573994366,0.9830381024804064,0.4978843441466855,0.7924707856787668,1.0,8/35,13.88%,RAB3D;UNC13D;RAB7A;TSG101;PDCD6IP;SNF8;STAM;CLASP1
prerank,protein N-linked glycosylation (GO:0006487),-0.2590268351844704,-0.9828670886047458,0.4794520547945205,0.8014878630962762,1.0,18/66,15.63%,MAN1C1;ST6GAL1;MCFD2;MGAT5;ALG8;RPN1;TUSC3;LMAN1;MPDU1;OSTC;MGAT4C;ENTPD5;ALG2;ALG9;MGAT4A;ALG10B;DPM2;GFPT1
prerank,negative regulation of interferon-beta production (GO:0032688),0.4563834135452992,0.9817733767098492,0.4974182444061962,0.7948438491482356,1.0,2/10,3.07%,LILRB1;REL
prerank,vesicle organization (GO:0016050),0.354969572228413,0.9816036159301595,0.4819277108433735,0.7947207959220541,1.0,6/46,5.51%,PLEKHF1;EPS15;CORO1A;SRGN;CAV2;PI4K2B
prerank,heart trabecula morphogenesis (GO:0061384),0.42068583365661905,0.9816000765742744,0.47709320695102686,0.7942318495933005,1.0,3/18,8.16%,ADGRG6;RBPJ;ENG
prerank,regulation of programmed necrotic cell death (GO:0062098),0.41281051964934606,0.9813194035460346,0.4677685950413223,0.7943902054907486,1.0,6/20,10.73%,BIRC3;PELI1;PDCD6IP;SPATA2;CYLD;RIPK1
prerank,pulmonary valve development (GO:0003177),0.415627966694289,0.9813120955607431,0.5023400936037441,0.793912608379768,1.0,2/18,2.95%,NOTCH2;BMPR2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4597796106401244,0.9812849266961372,0.4905008635578584,0.7934894815748749,1.0,2/11,5.03%,LDLR;SCARB1
prerank,keratinocyte differentiation (GO:0030216),0.3839207570981581,0.9812485842369822,0.4871060171919771,0.7930619303847507,1.0,8/29,20.64%,BCR;CLIC4;ANXA1;PIP5K1A;ADAM9;MED1;SCEL;UGCG
prerank,lipid translocation (GO:0034204),0.40353070527598073,0.9811414657973689,0.5015974440894568,0.7928111802993981,1.0,1/21,0.05%,ATP8B4
prerank,histone deacetylation (GO:0016575),0.3514230508254293,0.9808441145456307,0.48128342245989303,0.7929588011740276,1.0,16/43,21.33%,TBL1XR1;MTA3;HDAC9;RCOR3;MORF4L1;REST;BAZ2A;MSL3;HDAC3;MIER1;ELK4;SIRT1;HDAC1;MIDEAS;RCOR1;HDAC5
prerank,cellular iron ion homeostasis (GO:0006879),-0.27188051686952647,-0.9808296196270648,0.4915254237288136,0.8057064228787071,1.0,13/55,10.83%,FRRS1;SLC11A1;ABCG2;ATP6AP1;FLVCR1;SLC22A17;SLC11A2;TFRC;FTH1;ATP6V0D1;CAND1;FTL;HMOX1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.34259439480453374,0.9807346813781009,0.49801324503311256,0.7926892772978432,1.0,14/52,16.41%,PRKCE;PRKCH;KIF5B;PDPK1;CIB1;EPHB2;GNAI1;CLIP3;LGALS3;AKT1;ITGA3;RHOG;GPSM2;PLS1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3825414235404732,0.9805161520013324,0.4956647398843931,0.7926688748815098,1.0,11/29,23.62%,DHX37;RPS14;UTP6;RPS21;UTP20;RRP36;TBL3;NOP9;HEATR1;DCAF13;RPS16
prerank,detection of mechanical stimulus (GO:0050982),-0.3514794056195509,-0.9804836300307394,0.48661800486618007,0.8055148996903311,1.0,3/19,7.59%,CTNNB1;PKD2;JUP
prerank,positive regulation of telomere capping (GO:1904355),0.4095905785208874,0.9801190178393879,0.4901065449010654,0.7930507518820186,1.0,5/17,14.99%,PKIB;TNKS;MAP3K4;AURKB;MAPK1
prerank,mitochondrial translational termination (GO:0070126),-0.25706852421309884,-0.9794843817979215,0.49056603773584906,0.8070507508143162,1.0,52/88,37.66%,GFM2;MRPL24;MRPS9;DAP3;MRRF;MRPS21;MRPL1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS18B;MRPL3;MRPS22;MRPL32;MRPL47;MRPL17;MRPS30;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;MRPS35;MRPS28;MRPL23;MRPL9;MRPS16;MRPL54;MRPL49;MRPL42;MRPS23;MRPS2;MRPL14;MRPL36
prerank,mRNA stabilization (GO:0048255),0.3571116859902182,0.9794525062636427,0.4951590594744122,0.7940419447533298,1.0,12/40,17.86%,TENT5A;MAPKAPK2;GDNF;MAPK14;TIRAP;EIF4ENIF1;SYNCRIP;PAIP1;MYD88;PABPC1;BOLL;YBX3
prerank,nucleus organization (GO:0006997),-0.2813793998481014,-0.9791167771233479,0.4867924528301887,0.8068423369434622,1.0,9/47,6.87%,BIN1;NUMA1;IRAG2;VPS4B;NUP54;NUP133;CHMP5;SUN1;NUP155
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.3656404027718855,-0.9789891628857411,0.49872122762148335,0.8060289738271619,1.0,9/16,38.82%,RMI1;FANCM;SLX4;HFM1;CENPX;TOP2B;MUS81;MSH4;EME1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3202421986677686,0.9785690670205405,0.5129469790382244,0.7954786468721905,1.0,23/84,18.68%,PSME3;CUL3;UBE2E1;PSMB7;PSME2;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;UBE2S;PSMD6;PSMC4;PSMD10;PSMB1;AURKB;ANAPC7;PSMD12;RB1;ECRG4;ANAPC11;FZR1;ANAPC4
prerank,water-soluble vitamin metabolic process (GO:0006767),0.33252802767574235,0.978462794737685,0.5209125475285171,0.7952441140291863,1.0,16/68,19.23%,HLCS;SLC23A2;SLC23A1;MMAB;ABCC1;TPK1;MTRR;LMBRD1;ACP5;MMAA;PCCB;SLC2A1;SLC52A1;SHMT1;MTHFD1L;CYB5R3
prerank,translesion synthesis (GO:0019985),0.36124707149579705,0.9783270909209052,0.49445983379501385,0.7950437199363894,1.0,9/42,14.26%,DTL;POLI;MAD2L2;POLD4;TRIM25;RPA3;RCHY1;PCLAF;VCP
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.2982001838591596,0.9782727318606979,0.5274725274725275,0.7946738208867924,1.0,51/182,20.01%,FOXP1;NOTCH2;PTPN22;RIN3;KLF4;LDLR;CCR1;NFKB1;REL;SPI1;PICALM;FBXW7;TIPARP;PARP14;MECP2;SETDB2;ENG;CPNE1;WWP2;ID2;OLFM1;PARP9;PRKAA1;REST;APP;TNRC6B;PRKAA2;CITED2;TNRC6A;TGFB1;OCLN;TAF1;CELF1;ZNF148;SNX12;RBL2;MYADM;RB1;MTMR2;PSEN1;SIRT1;MMP8;HDAC1;PINK1;MAP2K1;ANKRD13A;DNMT1;TERF2;NDFIP2;RUNX1;PARK7
prerank,UV-damage excision repair (GO:0070914),-0.4030193023834892,-0.9782589833768988,0.5012531328320802,0.8067204325128898,1.0,6/12,27.93%,POLD3;ACTR5;POLA1;XPC;ERCC1;DDB1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.45137986983905753,0.9780978945212213,0.4933993399339934,0.7945576215856056,1.0,1/12,1.27%,VRK1
prerank,positive regulation of secretion (GO:0051047),-0.39894983574778653,-0.9776815002655654,0.4760820045558087,0.8070946728093789,1.0,7/11,53.73%,GPLD1;ACSL3;NPR1;AQP1;ABCB11;SCIN;TRH
prerank,steroid hormone biosynthetic process (GO:0120178),0.3718704012165861,0.9775168576516006,0.5028735632183908,0.7953347386164238,1.0,5/29,17.80%,HSD17B14;HSD17B7;HSD17B11;MED1;HSD17B2
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.3275998242312187,-0.9774147776320229,0.49544072948328266,0.8066680803174977,1.0,4/24,3.17%,MEF2C;CAMK1;CTNNA2;CTNNB1
prerank,anion transport (GO:0006820),0.37126802573698964,0.9773282770232353,0.4918759231905465,0.7952526536149941,1.0,4/33,5.60%,LRRC8C;LRRC8D;LRRC8B;SLCO1B1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.3950361757202911,0.9772118630140607,0.5058139534883721,0.7950277176945676,1.0,3/23,8.36%,LRRK2;KCNQ1;GNB1
prerank,sarcomere organization (GO:0045214),-0.3189166676413322,-0.9771895624521912,0.47468354430379744,0.8061696807124972,1.0,15/27,56.56%,CAPN3;ACTN2;FHOD3;CSRP2;TNNT3;MYPN;TTN;CSRP1;TNNT2;MYH6;SIX4;MYOM2;SYNPO2L;MYOZ2;TNNT1
prerank,mitochondrial translation (GO:0032543),-0.24680809892956296,-0.9771006125947677,0.5298507462686567,0.8052815822975813,1.0,50/104,31.38%,GFM2;MRPL24;MRPS9;DAP3;MRRF;LARS2;MRPS21;MRPL1;MRPS5;OXA1L;NDUFA7;MRPL45;MRPS31;MRPS17;MRPL10;GATB;MRPL43;GATC;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS18B;MRPL3;MRPS22;MRPL32;MRPL47;MRPL17;EARS2;MRPS30;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;QRSL1;MRPS18C;MTIF2;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;HARS1;MRPS35;MRPS28
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.4428407390619177,0.9759705328372011,0.5059625212947189,0.7973096183076924,1.0,3/12,17.95%,TAPT1;KDELR1;HSPA5
prerank,cellular glucan metabolic process (GO:0006073),0.46505428322487663,0.9756966113766734,0.5049833887043189,0.7974237810342562,1.0,2/11,9.06%,PRKAG2;UGP2
prerank,icosanoid metabolic process (GO:0006690),0.36249495041221486,0.9756644357818591,0.5120643431635389,0.7970044067970987,1.0,6/40,6.89%,ALOX5AP;GPX1;PTGIS;MAPKAPK2;DPEP1;ABCC1
prerank,mitotic DNA replication (GO:1902969),0.4614724393258061,0.9755838056056606,0.49547920433996384,0.7966957120452893,1.0,3/10,13.02%,CDC45;MCM6;MCM2
prerank,modification-dependent protein catabolic process (GO:0019941),0.29412755504771504,0.9754723825196592,0.5335533553355336,0.7964485612036627,1.0,53/193,19.93%,FEM1C;DTL;ITCH;LONP1;RNF149;DTX3L;NEDD4L;CUL3;BIRC6;UBE2E1;CBL;ANKIB1;RNF146;ARIH1;RNF20;RNF213;RC3H1;KLHL15;RNF217;NEDD8;TRIM25;ARIH2;RNF130;ATXN3;COPS3;RNF13;PSMD9;UBE2S;KLHL8;RCHY1;UBE2G1;AREL1;RNF150;AURKB;FBXO7;RNF166;ANAPC7;TAF1;HACE1;UBA6;UBR3;RNF144A;RNF19B;SMURF2;ANAPC11;FZR1;FBXL14;ANAPC4;PINK1;RNF168;RLIM;PSMF1;NDFIP2
prerank,motile cilium assembly (GO:0044458),0.45400285085321157,0.9753633688119198,0.49917081260364843,0.7962023254399513,1.0,2/12,12.39%,SPATA6;CCDC39
prerank,cellular response to topologically incorrect protein (GO:0035967),0.37091707740428786,0.9750346933307421,0.49791376912378305,0.7964634314708904,1.0,13/31,19.98%,HSPA1A;ERN1;TM7SF3;ATXN3;UBE2W;DAXX;PTPN1;DNAJB12;HSPA9;BAG3;HSPA5;DNAJB14;RHBDD1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.31731807467506834,-0.9744094189078577,0.5059880239520959,0.8111344795425579,1.0,4/27,3.76%,APOE;TREM2;LRP1;ABCB4
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.4076298376035309,-0.9742930776578621,0.48642533936651583,0.810327245599117,1.0,5/11,40.37%,SOX4;TGFB2;JAG1;BMP4;HEY2
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4668859049614293,0.9740225837283739,0.5148342059336823,0.7982004439059696,1.0,5/10,21.95%,RIPOR2;AKT1;LRCH1;PADI2;MIA3
prerank,adherens junction organization (GO:0034332),-0.27518479643549415,-0.9739622934178745,0.4892703862660944,0.810129462894964,1.0,10/48,12.56%,TJP1;CADM1;CTNNB1;CADM2;CDH11;SMAD7;JUP;PVR;NECTIN4;JAM3
prerank,response to organonitrogen compound (GO:0010243),0.35547090535219056,0.9739260865726003,0.5089655172413793,0.7979273504925365,1.0,8/38,16.59%,HLCS;KYNU;KAT7;IL6;DNAJB12;VCP;IRAK3;IRF5
prerank,regulation of centriole replication (GO:0046599),-0.36273573831470873,-0.9734375470366918,0.4767123287671233,0.8103852735448739,1.0,11/17,33.54%,TRIM37;NPM1;RBM14;CEP76;SPICE1;BRCA1;PLK2;CEP295NL;CDK5RAP2;STIL;PLK4
prerank,negative regulation of translation (GO:0017148),0.3213042456079019,0.9734051037923107,0.5119617224880383,0.7985393639702664,1.0,25/87,18.41%,DAPK1;MEX3D;BTG2;EIF4EBP1;EIF2AK2;GIGYF2;YTHDF3;MRPL13;TRIM71;RPS3;IGF2BP3;PAIP2;EIF4ENIF1;EIF2AK3;METTL3;ROCK1;SYNCRIP;EIF3E;CELF1;PUM1;DAPK3;CAPRIN1;CNOT8;DDX6;SHMT1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.38927176287004883,-0.9732867822070255,0.4925373134328358,0.8096687100661112,1.0,6/13,29.81%,GLUL;GOT1;MTHFS;GAD1;ACOT8;DDO
prerank,limb morphogenesis (GO:0035108),0.40541319262138564,0.9729909729225747,0.5139318885448917,0.7989513557785124,1.0,2/20,2.57%,MBNL1;NIPBL
prerank,negative regulation of defense response to virus (GO:0050687),0.4682613950297435,0.9723591807636881,0.4905982905982906,0.7998323976244556,1.0,4/10,22.58%,ITCH;ILRUN;MUL1;TARBP2
prerank,histone H2A monoubiquitination (GO:0035518),-0.3617761677349405,-0.9712622072055777,0.4846153846153846,0.8136709474604438,1.0,4/17,8.04%,BCOR;TRIM37;PCGF6;KDM2B
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2945394542876569,0.9708242904867069,0.5250544662309368,0.802667945638036,1.0,32/184,13.19%,CDC14A;SDCCAG8;CNTRL;PSME3;CUL3;HAUS8;UBE2E1;PTPN6;PSMB7;PSME2;PPP1R9B;MAD2L1BP;CEP63;PAFAH1B1;HAUS1;PSME4;DCTN3;ZFP36L2;ID2;PSMB8;PSMD9;PSMA5;CEP250;PSMB3;UBE2S;PSMD6;PSMC4;DYNC1H1;PSMD10;PSMB1;ERCC3;HAUS3
prerank,protein oxidation (GO:0018158),-0.4092618420486841,-0.9707144114947748,0.5093896713615024,0.8139527773398749,1.0,4/11,22.29%,LOXL3;TMX3;PRDX3;CHCHD4
prerank,regulation of nuclear division (GO:0051783),0.4069939010210487,0.9706865536270715,0.49686520376175547,0.80250487760741,1.0,2/20,5.46%,CDK13;CAV2
prerank,cytoskeleton organization (GO:0007010),0.3114530247429364,0.9704341456712223,0.5120551090700345,0.8025237720653763,1.0,17/114,10.01%,RND3;NEDD9;LIMD1;CNN2;SYNE3;SIPA1L3;PDZD8;RAC2;DIAPH1;FGD4;CAPZB;RHOBTB3;FGD1;RAC1;FGD3;RHOA;LRCH3
prerank,regulation of macromolecule metabolic process (GO:0060255),0.298067174205681,0.9704116078143198,0.5310421286031042,0.8020900320078299,1.0,26/170,12.37%,PTPRC;FOXP1;KDM6A;LDLR;TRIM26;GDNF;NFKBIZ;MTMR3;AHR;CRIP1;CGGBP1;ARF1;MTMR4;TOB2;CTCF;AFF1;NKAPL;IGF2BP3;TRIM14;SCARB2;NFKBID;CACTIN;ZNF507;REST;APP;TRIM17
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.24907249140276547,-0.9703636234793174,0.5093167701863354,0.8137846553990935,1.0,22/84,15.91%,BIN1;APOE;IGF1;LARP1;NTRK2;SAMD4A;RTN3;LSM14A;FXR1;GGA3;CHRNA7;PAIP2B;CNOT10;FXR2;RPL13A;CLU;RIDA;TOB1;ABCA7;IGF2BP2;CPEB3;RNF139
prerank,coenzyme A metabolic process (GO:0015936),0.4334160009351904,0.9701364330065273,0.49592169657422513,0.802195373552907,1.0,4/14,11.97%,SLC25A16;PANK1;PANK4;ACAT1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.30860886856934977,-0.9700636349031712,0.4794952681388013,0.8134037865151434,1.0,13/29,31.82%,GTF2H2;GTF2H1;UBC;ERCC2;GTF2H3;GTF2H5;CDK7;UBA52;XPC;GTF2H4;DDB1;CHD1L;MNAT1
prerank,global genome nucleotide-excision repair (GO:0070911),-0.32764438917276223,-0.9700174748399015,0.48580441640378547,0.8124100975374305,1.0,11/26,27.93%,GTF2H2;GTF2H1;UBC;ERCC2;GTF2H3;GTF2H5;UBA52;XPC;ERCC1;GTF2H4;DDB1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.377544073135172,-0.9700115474094528,0.49019607843137253,0.8113169493103611,1.0,6/13,28.65%,SYNGR1;RAB3GAP1;RAB3A;CLN3;SLC4A10;SLC8A2
prerank,ear morphogenesis (GO:0042471),-0.3375967476474092,-0.9699051492514527,0.5163934426229508,0.8104915096668118,1.0,3/20,6.15%,CHD7;MYO6;FGFR2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3361337452997644,-0.9694176171830144,0.5070821529745042,0.8106486874634844,1.0,5/21,15.38%,CX3CR1;CTNNB1;VEGFA;MDK;CX3CL1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.36658305075927444,-0.9693180140108071,0.473551637279597,0.8098030228880982,1.0,3/16,7.34%,APOE;HIF1A;HTR2B
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.39426848506479795,0.969232773379022,0.5099236641221374,0.803744748605064,1.0,4/21,7.31%,DTL;RCC2;CCND1;MECP2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.420958849159156,0.9690693309007401,0.5023400936037441,0.8036263962838535,1.0,4/16,12.39%,CDK13;RSRC1;SLU7;PQBP1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.4601186812726205,0.9687986697454529,0.5243243243243243,0.8037257606018816,1.0,2/10,3.18%,ST3GAL1;GNPDA1
prerank,skeletal system morphogenesis (GO:0048705),-0.2851946065113887,-0.9683610437905085,0.5096525096525096,0.8111855933395473,1.0,4/42,6.15%,SKI;LRP6;TGFBR1;FGFR2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3622825771526067,0.9682550235013658,0.5048275862068966,0.8044173610307741,1.0,10/36,14.84%,PTPN22;MARVELD3;ITCH;TAOK3;EZR;CYLD;DUSP1;HDAC3;GPS2;GSTP1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3685777721086594,0.9677340379597364,0.5245441795231417,0.8050542466828063,1.0,7/32,12.65%,SLC44A2;CEPT1;PCYT1A;CSNK2A2;CSNK2A1;SLC44A1;SLC44A5
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.4448973914478588,0.9675440300023428,0.504258943781942,0.8050110039551324,1.0,3/12,8.82%,CHMP4A;CHMP4B;SEC63
prerank,smoothened signaling pathway (GO:0007224),0.372893798751614,0.9674904774140923,0.5035663338088445,0.8046479922734988,1.0,4/32,8.00%,GLI1;HIPK2;HIPK1;PTCHD1
prerank,primary alcohol metabolic process (GO:0034308),-0.3272093547370157,-0.9674801297391572,0.4970588235294118,0.812307978504374,1.0,4/25,8.71%,IGF1;GDE1;PECR;DHRS3
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.395268802358416,-0.9671784381001349,0.48086124401913877,0.8119551424733159,1.0,4/12,15.59%,DPYD;DPYSL3;UMPS;CRMP1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3591330791370305,-0.9670350283602972,0.4696969696969697,0.8112203257550255,1.0,6/16,14.95%,FLCN;GPR137B;KLHL22;LARS1;LAMTOR5;PIH1D1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.42874007564439,0.9664414916209437,0.5071542130365659,0.8064593701833114,1.0,4/16,11.11%,CHMP4A;CHMP4B;SNF8;STAM
prerank,positive regulation of signaling (GO:0023056),-0.28992403951829077,-0.96544374590267,0.5144927536231884,0.8141914791619888,1.0,12/37,20.62%,SYT1;WLS;DLG4;ILK;SCRIB;CD80;CLSTN2;SOX11;RIMS1;RIMS3;VAMP3;ECE1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3972024594758528,-0.9652373482908779,0.4965034965034965,0.8136152096838856,1.0,7/11,41.48%,UQCRC2;UQCR10;UQCRC1;UQCC3;CYC1;UQCRQ;UQCR11
prerank,positive regulation of peptidase activity (GO:0010952),0.4038015910674312,0.9649967143617136,0.5264797507788161,0.8091072869708407,1.0,6/20,14.26%,PSME3;PSME2;MAPK12;TANK;PRELID1;VCP
prerank,female gonad development (GO:0008585),-0.3439912645653114,-0.9649904489305834,0.4880239520958084,0.8131739772477351,1.0,6/19,21.84%,VEGFA;EIF2B5;EIF2B4;NR2F2;ANG;SOD1
prerank,positive regulation of neuron projection development (GO:0010976),0.3140352803248981,0.9649415064711775,0.5173652694610779,0.8087273635779909,1.0,20/85,17.17%,LYN;RAP1A;CAMK1D;RET;NDNF;RAPGEF2;NPTN;SETX;PTK2B;CBFA2T2;SCARB2;SNX3;KIDINS220;STMN2;LRP8;RETREG3;RELN;FES;CAPRIN1;ABL2
prerank,Golgi ribbon formation (GO:0090161),0.4395965947406626,0.9647474237293806,0.5083892617449665,0.8086850400420489,1.0,4/13,13.77%,STX6;GCC2;FHDC1;STX16
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.36293527698773903,0.9647409497295139,0.5156695156695157,0.8082087910432018,1.0,9/34,17.15%,FGR;FLT3;PTK2B;PIK3R4;KIT;FGFR3;TGFB1;AMBRA1;PIK3R2
prerank,inner dynein arm assembly (GO:0036159),0.4647848612558825,0.9646885883093046,0.5226130653266332,0.8078294998344959,1.0,3/10,19.26%,DNAAF5;CCDC39;CFAP73
prerank,ovarian follicle development (GO:0001541),-0.3915635353692282,-0.964549459051731,0.4972972972972973,0.8131569747920725,1.0,6/13,29.36%,VEGFA;EIF2B5;EIF2B4;ANG;SOD1;INHBA
prerank,glucose import (GO:0046323),-0.3868744442597769,-0.9639004080369985,0.5314136125654451,0.8136833955081302,1.0,3/13,7.21%,SORT1;SLC2A3;SLC27A1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.3836989378977759,0.9638274900669652,0.5171898355754858,0.8092001257008969,1.0,10/26,15.86%,CD36;SMPDL3B;BIRC3;TLR3;IRF7;CACTIN;TLR2;OTUD4;GPS2;IRAK3
prerank,regulation of cellular protein localization (GO:1903827),0.3449495061572096,0.9638021574289839,0.5086551264980027,0.8087611301784527,1.0,13/45,15.20%,LCP1;GPC3;TRIM46;GBF1;RALB;PTPN1;SETD2;PRKAA1;DVL3;SPIDR;PRKAA2;VCP;VCPIP1
prerank,regulation of interferon-alpha production (GO:0032647),0.3864937438711955,0.9637364187414752,0.5117647058823529,0.808422479266092,1.0,10/23,21.97%,STAT1;IFIH1;TLR3;IRF7;SETD2;TBK1;IRF5;HSPD1;RIPK2;TLR8
prerank,peptide biosynthetic process (GO:0043043),0.30160214955726994,0.963475975702878,0.5669988925802879,0.8085096921613902,1.0,52/153,23.89%,ZAR1;RPL5;RPS10;RPL37A;MRPL55;RPL6;MRPL18;RPS18;GGTA1;RPS14;RPL35A;MRPL13;RPL13;RPS3;IGF2BP3;RPS21;FARSB;CARNS1;RPLP0;RPL34;RPL19;RPL11;RPL30;PCSK5;RPL4;RPS2;RPL7;RPS15A;MRPS6;RPS4X;MRPS33;HARS2;GSPT1;RPL32;RPSA;RPS13;MRPS15;RPS6;RPL18A;RPS27;RPLP2;RPL22;RPS7;MRPS12;RPS12;MRPS18A;RPL10A;RPS25;RPL9;RPS16;RPL23;RPL17
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.28071929876823576,-0.9628848168224572,0.5104166666666666,0.8152814935818321,1.0,15/39,27.93%,GTF2H2;POLD3;GTF2H1;UBC;ERCC2;PCNA;RFC3;GTF2H3;OGG1;GTF2H5;UBA52;ERCC1;RFC2;GTF2H4;DDB1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.4181896002374851,0.9626800902996852,0.49032258064516127,0.8097979230176061,1.0,2/16,5.03%,LDLR;SCARB1
prerank,proteasomal protein catabolic process (GO:0010498),0.2907190897428156,0.9625120951887839,0.5644104803493449,0.8096819334337066,1.0,47/201,16.68%,FEM1C;ITCH;PSME3;NEDD4L;CUL3;TBL1XR1;PSMB7;FBXW7;PSME2;KCTD2;PELI1;UBE2D3;SPOP;FBXW11;FAF1;NFE2L2;CLOCK;COP1;PCNP;PSME4;ATXN3;WWP2;TRIM71;UBE2W;PSMB8;PSMD9;KCTD5;PSMA5;DNAJB12;FBXL17;PSMB3;PSMD6;PSMC4;PSMD10;UBE2G1;AREL1;PSMB1;VCP;PPP2R5C;UBXN11;RMND5B;KCTD13;RNF122;RNF41;HACE1;PSMD12;MAEA
prerank,secondary alcohol metabolic process (GO:1902652),-0.2807933368009484,-0.962388533132146,0.5408560311284046,0.8154500562408884,1.0,5/42,10.32%,ABCA1;APOE;OSBPL1A;STARD3;CH25H
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3237992277532096,0.9623416183995923,0.5249088699878494,0.8095726819741121,1.0,20/74,17.23%,IL1B;MCL1;PSME3;HSPA1A;GPX1;BIRC6;GDNF;ICAM1;RIPK1;MAP2K5;HTT;SH3RF1;LGALS3;AKT1;GSTP1;UNC5B;RELA;THBS1;EYA3;TRAF2
prerank,signal peptide processing (GO:0006465),-0.4082995379605267,-0.9618993483388321,0.5210280373831776,0.8156073442335294,1.0,4/11,7.18%,SPCS3;FURIN;SPPL3;SEC11C
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.32277429593570045,0.9617671000476747,0.530940594059406,0.8102704564317592,1.0,7/75,6.67%,ITGA4;AKT3;STAT5A;BMPR2;VEGFC;ADAM17;PDPK1
prerank,mRNA modification (GO:0016556),0.3937090528148279,0.9615526940906122,0.5170370370370371,0.8102232899774134,1.0,10/22,21.55%,VIRMA;CBLL1;CMTR1;PUS3;METTL3;TRMT10C;PUS1;TRMT61B;PCIF1;TRUB2
prerank,ceramide catabolic process (GO:0046514),-0.3744943490345788,-0.9612175570745592,0.515970515970516,0.8163303604695495,1.0,2/14,6.05%,HEXB;NEU1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4716169120653125,0.9611719585061209,0.5027124773960217,0.8105845304168435,1.0,6/10,24.23%,HSPA1A;CITED2;BAG3;NCK1;HIF1AN;SIRT2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.4470838513049257,0.9611094492720325,0.5067567567567568,0.8102422237261847,1.0,3/12,8.29%,MYCBP2;PAFAH1B1;EPHB2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3995159588680768,0.9607866244922095,0.531055900621118,0.8104421472640106,1.0,7/20,16.74%,CCND3;CCND1;ADAM17;PSMD10;CCND2;AKT1;PROX1
prerank,regulation of fibroblast migration (GO:0010762),-0.3434865656150331,-0.960740290424544,0.5128205128205128,0.8164941516137325,1.0,4/20,3.63%,GNA12;APPL2;FGF2;RFFL
prerank,positive regulation of chromatin organization (GO:1905269),0.44333327637813164,0.9606943268771447,0.5290215588723052,0.8101481515128333,1.0,6/12,19.66%,H3-3A;UBE2N;DAXX;ATRX;MIER1;TERF2
prerank,establishment of epithelial cell polarity (GO:0090162),0.3988651488478896,0.960656479729306,0.5177419354838709,0.8097517706667383,1.0,6/19,8.98%,MSN;SIPA1L3;CDC42;EZR;CYTH3;RHOA
prerank,negative regulation of proteolysis (GO:0045861),0.36363269184953545,0.9604357195762374,0.5048543689320388,0.8097534389190783,1.0,3/34,6.35%,LRRK2;DNAJC1;PRNP
prerank,histone H3-K4 methylation (GO:0051568),0.38279063714714073,0.9600846507061722,0.5106060606060606,0.8100241711975855,1.0,9/26,21.43%,KDM6A;TET2;KMT2C;KMT2A;ASH2L;SETMAR;WDR5;PRDM9;RBBP5
prerank,metal ion transport (GO:0030001),0.3188621349835812,0.9594112165549519,0.5469678953626635,0.8110446501078599,1.0,12/86,10.56%,ITPR1;FYN;CCR1;CACNA1A;CHRNA4;ATP2A3;MMGT1;ATP2A1;KCNN4;SLC30A1;MAGT1;NIPA2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.2997075143072548,-0.9594066229585952,0.5154639175257731,0.8188352131974798,1.0,7/33,10.64%,IGF1;NYAP2;NF1;HTR2B;PIK3CG;IRS1;PIK3R1
prerank,regulation of phospholipase activity (GO:0010517),0.4535532252841837,0.9593759657331647,0.5236486486486487,0.8106397438414662,1.0,5/10,19.49%,RGS2;PDPK1;FGFR3;ANGPTL3;FGFR1
prerank,mitochondrial translational elongation (GO:0070125),-0.2497038709800073,-0.9593263940728626,0.5568862275449101,0.817953589588624,1.0,51/88,37.66%,GFM2;MRPL24;MRPS9;DAP3;MRPS21;MRPL1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS18B;MRPL3;MRPS22;MRPL32;MRPL47;MRPL17;MRPS30;MRPL50;MRPS14;MRPL51;MRPL16;MRPL11;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;MRPS35;MRPS28;MRPL23;MRPL9;MRPS16;MRPL54;MRPL49;MRPL42;MRPS23;MRPS2;MRPL14;MRPL36
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.37618373494599816,-0.9592840389137985,0.5073170731707317,0.8169802268058824,1.0,7/14,23.86%,TPP1;NABP2;TERF2IP;XRCC5;TNKS2;TINF2;PINX1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.4333603399388281,0.9589898504830747,0.5177664974619289,0.8110226091824307,1.0,4/13,9.19%,NFKBIA;NFKBIE;FLNA;LATS1
prerank,regulation of histone acetylation (GO:0035065),0.367543324434848,0.9588853149802339,0.5234042553191489,0.8107634223619287,1.0,8/33,15.95%,IL1B;SPI1;RPS6KA5;SETD5;TADA2A;TAF7;KMT2A;BRD7
prerank,stress fiber assembly (GO:0043149),0.4196325466092605,0.9588035253386322,0.5024469820554649,0.8099689603177741,1.0,7/15,17.49%,PDLIM1;CUL3;RHOA;FHDC1;KCTD13;PHACTR1;FAM171A1
prerank,contractile actin filament bundle assembly (GO:0030038),0.4196325466092605,0.9588035253386322,0.5024469820554649,0.8099689603177741,1.0,7/15,17.49%,PDLIM1;CUL3;RHOA;FHDC1;KCTD13;PHACTR1;FAM171A1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.340294267546419,-0.9583073801439232,0.49221183800623053,0.8183556621307184,1.0,6/20,18.03%,AGO3;TSN;AGO1;ZC3H7B;TSNAX;DROSHA
prerank,mRNA methylation (GO:0080009),0.4162912997631673,0.9582067891311004,0.5238095238095238,0.8107576786455855,1.0,5/15,14.39%,VIRMA;CBLL1;CMTR1;METTL3;TRMT10C
prerank,diterpenoid metabolic process (GO:0016101),-0.268957265233569,-0.9581989572631026,0.568,0.8175398375835388,1.0,8/55,16.07%,APOE;LRP1;BCO2;PECR;DHRS3;GPC6;AGRN;AKR1B1
prerank,establishment of protein localization to membrane (GO:0090150),0.3198057004771084,0.9581344925626957,0.5336721728081322,0.8104250502831443,1.0,10/66,9.50%,SYNE3;VPS37C;MYO1C;ZDHHC7;AFDN;ZDHHC6;ZDHHC23;SEC63;PIKFYVE;BRAF
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.22114985435027357,-0.9581310970244655,0.5959595959595959,0.8166284478009169,1.0,40/173,16.82%,TGFA;GAS6;NAPA;COPA;PREB;MCFD2;GRIA1;PROS1;GOLT1A;ANK2;SPTAN1;TBC1D20;CAPZA2;ERGIC3;GOLGA2;NRBP2;SPTB;DYNLL2;CTSZ;LMAN1;SEC23A;VTI1B;DYNLL1;HYOU1;GOSR2;DCTN5;ARFGAP1;ARFGAP3;COPE;ZW10;TMED9;TEX261;SEC13;BCAP31;CNIH1;F8;TMED4;TRAPPC4;WHAMM;IER3IP1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3050033516667448,-0.9576775504869468,0.540453074433657,0.8166606503481243,1.0,10/30,19.91%,BCL2L1;CFLAR;RFFL;FAIM2;HMOX1;SERPINE1;TRADD;BRCA1;DDX3X;TNFSF10
prerank,positive regulation of telomerase activity (GO:0051973),0.3625173628368502,0.9575223191678582,0.514978601997147,0.8112588401025861,1.0,9/33,15.57%,KLF4;PKIB;PARM1;WRAP53;TNKS;MAP3K4;AURKB;MAPK1;TCP1
prerank,sphingolipid metabolic process (GO:0006665),0.30405737195965526,0.9574498652466693,0.5622817229336438,0.8109322400025857,1.0,25/108,16.46%,CERS6;CERKL;ACER3;GM2A;ESYT3;CERS1;ELOVL5;ESYT1;SAMD8;SGMS1;SGMS2;PSAP;ST6GALNAC3;ELOVL6;SUMF2;SUMF1;SPTSSB;ESYT2;SGPP2;TEX2;SGPP1;FA2H;VAPA;HACD4;PPT1
prerank,genitalia development (GO:0048806),-0.39032421673680695,-0.9574190482872709,0.5232273838630807,0.8162094450871488,1.0,1/12,0.65%,CHD7
prerank,amyloid-beta metabolic process (GO:0050435),0.4146670833243409,0.9570205495864872,0.5157232704402516,0.8113700037161522,1.0,5/16,16.93%,ACE;DYRK1A;MGAT3;BACE2;PSEN1
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.3503927378976948,-0.9569468368413369,0.48753462603878117,0.8162901167527237,1.0,7/18,13.54%,FLCN;APOD;SUFU;OTUD7B;MFHAS1;CHP1;UFM1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.38244218054444606,0.9568144577061176,0.5176991150442478,0.81132093912309,1.0,4/24,9.18%,NDNF;PDPK1;NFE2L2;ICAM1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.3177575685993159,-0.9565769787992132,0.5232198142414861,0.8161601782008658,1.0,6/26,13.56%,NAV3;NUMA1;CLIP1;CDK5R1;MAPRE1;TRPV4
prerank,negative regulation of biomineral tissue development (GO:0070168),0.3861797839260369,0.9565736473774724,0.5156739811912225,0.8113731618952903,1.0,5/21,14.30%,CCR1;SRGN;PTK2B;ROCK1;TGFB1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.41549609751883265,-0.9565223269129108,0.5120772946859904,0.8151980746467768,1.0,5/10,18.53%,GABRG3;GABRG2;GABRA4;GABRA2;GABRA5
prerank,T cell proliferation (GO:0042098),0.4359248731648791,0.9562612565857981,0.5271186440677966,0.8115702718924558,1.0,3/13,9.30%,LILRB1;MSN;CTPS1
prerank,positive regulation of cellular senescence (GO:2000774),0.4671872921633543,0.955845751787421,0.5356521739130434,0.811982372811605,1.0,3/10,17.25%,ARG2;B2M;SIRT1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.45363913426171365,0.9555720304252211,0.5129533678756477,0.8120825654976063,1.0,4/11,17.65%,TPK1;NT5C3A;DCK;ERH
prerank,regulation of ATP biosynthetic process (GO:2001169),0.42602114809246616,0.9551095145985113,0.5406301824212272,0.8125913178232312,1.0,1/16,0.24%,PID1
prerank,cellular response to ionizing radiation (GO:0071479),0.34131581121048643,0.9549944278560653,0.5295698924731183,0.8123327632738042,1.0,15/47,20.19%,NIPBL;MAPK14;GRB2;WRN;CLOCK;TLK2;TANK;NET1;MAP3K20;SPIDR;INO80;HUS1;SIRT1;TNKS1BP1;TSPYL5
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3189431036040895,0.9548479528966393,0.5483091787439613,0.8121570980013247,1.0,18/78,16.74%,CCNJL;CCND3;HEXIM1;PTEN;CDKN2C;CCND1;ADAM17;CCNH;LATS1;CCNT2;LATS2;CCNT1;PSMD10;CCND2;AKT1;CDK5R2;APC;PROX1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.2696304713101535,-0.954219091799223,0.5805084745762712,0.8200769879991834,1.0,16/49,19.55%,LDLRAD4;TREM2;HMGB1;NLRC3;IMPACT;PYDC1;TRAF3IP1;RPL13A;CLU;JAM3;SRC;PRKCZ;HDAC6;DDX3X;CRYAB;LCMT1
prerank,regulation of membrane repolarization (GO:0060306),0.4364347205305248,0.95413441794826,0.5259515570934256,0.8132650387303735,1.0,2/13,3.32%,NEDD4L;KCNQ1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.36389915278123497,0.9540712461466058,0.5328467153284672,0.8129334866763606,1.0,8/30,14.08%,RAC2;FBXW7;UBE2D3;ARIH2;CSNK2A2;RNF31;SREBF2;UBE2J2
prerank,organophosphate biosynthetic process (GO:0090407),0.35293324412519367,0.9540061775316344,0.513550135501355,0.8126052713627449,1.0,9/37,18.18%,ITPKC;AGPAT4;IP6K3;TPK1;PIP5K1A;GNPAT;IPMK;GK;MOCS1
prerank,keratan sulfate metabolic process (GO:0042339),0.3614106462060749,0.9539963258695467,0.5100864553314121,0.8121462135768068,1.0,3/31,4.22%,ST3GAL1;ST3GAL4;B4GALT5
prerank,acylglycerol biosynthetic process (GO:0046463),-0.32400796418066036,-0.9538385393615189,0.5160256410256411,0.8199439236086022,1.0,9/23,26.73%,PLA2G15;AGMO;PLA2G4A;GPAM;GPAT4;LPGAT1;ANG;DGAT1;AWAT2
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.23772755821853295,-0.9536322468324689,0.5802469135802469,0.8193634722949245,1.0,29/88,21.85%,FNIP2;SLF2;VPS4B;FNIP1;SLF1;LIMK1;TAL1;PFN1;HGS;TFRC;SMAD3;FLOT1;VEGFA;CLU;WARS1;PFN2;BAX;DAB2IP;PIH1D1;TPPP;CX3CL1;TPR;PLEK;SYNPO2;RHOC;HYAL1;CHMP2A;RACK1;SLX4
prerank,response to glucocorticoid (GO:0051384),0.3738202574466671,0.9536256260971179,0.5235204855842185,0.8124699134064831,1.0,6/26,14.73%,ZFP36L2;IL6;NR3C1;ANXA1;REST;ADAM9
prerank,COPII-coated vesicle budding (GO:0090114),-0.25919820122625054,-0.9534665298929894,0.5327102803738317,0.8186866417588854,1.0,17/68,16.02%,TGFA;NAPA;PREB;MCFD2;GRIA1;SEC23B;TBC1D20;GOLGA2;CTSZ;LMAN1;SEC23A;GOSR2;SEC13;CNIH1;SEC23IP;F8;TRAPPC4
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3275175559497362,0.9534071215716713,0.5350993377483444,0.8124646595027584,1.0,12/57,15.10%,HTR1D;HTR4;ADRA2A;FLNA;PDE2A;PSAP;OPRM1;ADCY7;GNAI1;ADCY5;GNAI2;GRM8
prerank,negative regulation of reproductive process (GO:2000242),0.4047713256009835,0.9532439501989819,0.5040783034257749,0.8123430993681238,1.0,3/17,11.47%,PAEP;ARHGDIB;DUSP1
prerank,ion transport (GO:0006811),-0.23155944935604955,-0.9530800969492763,0.5316455696202531,0.8186100828589817,1.0,19/111,12.84%,SLC8A1;SLC24A3;WNK1;SLC1A3;TRPM3;ANO10;SLC25A26;SLC36A1;SLC17A6;SLC9A9;GABRB1;SLC9A6;KCNN2;MCOLN1;CHRNA7;VDAC1;SLC26A11;KCNN3;SLC15A2
prerank,lipid phosphorylation (GO:0046834),0.45072569298260584,0.9530756997829782,0.5195246179966044,0.8122375341759637,1.0,1/10,1.05%,DGKG
prerank,antibacterial humoral response (GO:0019731),0.420628817916589,0.9522559001354757,0.5444264943457189,0.8134452253021363,1.0,3/16,13.61%,SLPI;RNASE6;PLA2G6
prerank,"transcription, DNA-templated (GO:0006351)",0.28721829930557974,0.9519458002796196,0.5978494623655914,0.8136282287043899,1.0,38/207,13.32%,BCL3;NFKB1;GTF2F2;TAF1A;TAF13;GTF2E2;TAF9;POLR3A;POLR2C;SCX;MBD1;DEAF1;SMARCA5;KLF13;DEK;SETX;ELOA;CBFB;ELOB;THRA;CCNH;GTF2A1;NFKBIB;CREBL2;SNAPC3;PKNOX1;GMEB2;CCNT2;NELFA;FOXO3;TAF7;GTF3C6;BAZ2A;NFYA;CCNT1;TFAM;ERCC3;EAF1
prerank,ribosomal large subunit assembly (GO:0000027),0.381566284016391,0.9518166828440647,0.5189504373177842,0.8134230500661213,1.0,5/24,12.95%,RPL5;RPL6;RPF2;RPLP0;RPL11
prerank,protein K48-linked deubiquitination (GO:0071108),-0.33208484175904956,-0.9505654568105706,0.49221183800623053,0.823863100599441,1.0,8/23,16.01%,MINDY2;OTUD5;USP20;OTUD7A;MINDY1;OTUD7B;OTUB1;OTUD3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.38095415791094717,-0.9504183239235849,0.5224274406332454,0.8231606531003001,1.0,6/13,17.95%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2
prerank,cellular response to glucose stimulus (GO:0071333),-0.3028391875376588,-0.9499754491246983,0.5296052631578947,0.8232246561990428,1.0,6/30,7.37%,PTPRN2;RAB11FIP2;GAS6;RAB11FIP5;PRKACA;PCK2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4097689042755768,0.9497114820694371,0.5208333333333334,0.8174164591800457,1.0,6/18,17.74%,IFNGR1;PICALM;GSAP;ABCG1;RELA;EFNA1
prerank,female gamete generation (GO:0007292),0.37175247046466964,0.9496388082884117,0.5416666666666666,0.8170705615875488,1.0,9/29,20.93%,DIAPH2;IHO1;TOB2;METTL3;MARF1;USP9X;MCM9;PRDM9;PARN
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.33544386094393097,-0.9494197895419526,0.5163043478260869,0.8236249637119872,1.0,6/21,13.59%,CSF1R;CMKLR1;CSF1;MTUS1;AKIRIN1;MDK
prerank,L-glutamate transmembrane transport (GO:0015813),0.44683833529245,0.9489581666768304,0.526595744680851,0.8180612513528535,1.0,3/10,11.50%,SLC25A13;SLC25A12;SLC25A18
prerank,positive regulation of histone methylation (GO:0031062),0.3719443239741978,0.9484970969277775,0.5142857142857142,0.8185619890133952,1.0,9/24,19.68%,JARID2;FAM47E;PHF19;SMAD4;MYB;KMT2A;SIRT1;DNMT1;WDR5
prerank,negative regulation of neuron projection development (GO:0010977),0.3308356250443983,0.9484041647958282,0.5344603381014305,0.8183136112135311,1.0,9/56,10.12%,BCL11A;NGFR;PTPRO;PTEN;CIB1;PAQR3;CBFA2T2;RHOA;RTN4
prerank,regulation of integrin activation (GO:0033623),-0.35932140969351833,-0.9483317760819459,0.5171428571428571,0.8253355539608326,1.0,6/15,16.81%,FBLIM1;FARP2;JAM3;SKAP1;SRC;PLEK
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3909561614210051,0.9476642054760415,0.5408320493066255,0.8194209592397423,1.0,3/20,7.70%,SIK1;FBXW7;ERLIN1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.284188384766552,-0.9475605883760236,0.5424354243542435,0.826181740267125,1.0,8/40,14.18%,PRKN;IGF1;BCL2L1;FAM162A;PYCARD;MFF;CLU;BAX
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.4017912174364426,0.946809815651295,0.5300146412884333,0.8208217479916796,1.0,4/19,4.89%,FOXJ1;ERBIN;CLIC4;SYNJ2BP
prerank,cellular protein metabolic process (GO:0044267),0.27733410723825347,0.9466944244555585,0.6226034308779012,0.8206033968597931,1.0,66/396,14.16%,NAPSA;ST3GAL1;ST8SIA4;ZAR1;RPL5;DENND3;TNC;MSRB1;NOTUM;STK38;RPS10;MMP1;LAMB1;GPC3;ABCA3;PARP4;RPL37A;MRPL55;RPL6;MRPL18;UBE2D3;RPS18;PARL;SHISA5;WFS1;LGALS1;RPS14;FBXW2;ADAM17;NEDD8;CSF2RB;RPL35A;SFTPA1;SFTPA2;PPP4R2;MRPL13;RPL13;IL6;CSNK1G3;WWP2;FBN1;RPS3;IGF2BP3;RPS21;FN1;FARSB;MBTPS1;RIPK1;PRSS23;UBE2S;DUSP12;RPLP0;RPL34;APP;UBE2G1;RPL19;RPL11;RPL30;PCSK5;KTN1;SLC35A1;RPL4;DNAJC3;YME1L1;RPS2;RPL7
prerank,protein acylation (GO:0043543),0.35410377525199244,0.9466467466153666,0.5424460431654676,0.820243059421715,1.0,12/38,18.43%,HHAT;ZDHHC7;ZDHHC13;ZDHHC6;CLOCK;ZDHHC23;ZDHHC17;KAT6A;KAT2B;CREBBP;ZDHHC3;ZDHHC5
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.37439975566862227,-0.9465783476397917,0.5298329355608592,0.8275978740369031,1.0,3/14,3.44%,AUTS2;CTNNB1;CTR9
prerank,positive regulation of protein deacetylation (GO:0090312),0.42668218006442243,0.946491496137639,0.5287162162162162,0.8201010435574462,1.0,3/14,11.15%,NIPBL;DYRK1A;ING2
prerank,negative regulation of catalytic activity (GO:0043086),0.3833640351811674,0.946402570554755,0.5422222222222223,0.8198101309309338,1.0,6/24,17.25%,PPP1R12A;APBA3;HP;PARP9;IFIT1;SIRT1
prerank,cytosolic transport (GO:0016482),0.2975317538263446,0.9458386061165921,0.5614849187935035,0.8205303830686637,1.0,23/108,14.52%,LMTK2;EPS15;LAPTM5;TBC1D10C;RAB7A;SNX1;VPS53;RAB6A;TMEM87A;STX6;GCC2;RHOBTB3;GBF1;STX5;SNF8;PIKFYVE;TBC1D5;VPS13A;AP1G1;ANKFY1;STX16;EVI5;RAB29
prerank,xenobiotic transport (GO:0042908),-0.3591881481470298,-0.9451500299699601,0.525065963060686,0.8301269928755873,1.0,6/17,17.41%,ABCC3;ABCG2;GJA1;SLC15A2;SLC22A4;ABCC5
prerank,peptide metabolic process (GO:0006518),0.3166267617045832,0.9438036392252274,0.5602923264311814,0.8242531573422202,1.0,18/75,18.42%,ACE;LNPEP;GPX1;GSR;ETHE1;DPEP1;PARL;GSTA3;CPQ;MGAT3;BACE2;PCSK5;GSTP1;MIPEP;PSEN1;ANPEP;SPCS2;CTNS
prerank,mitochondrion organization (GO:0007005),0.2879103081023016,0.9437419377248019,0.6088840736728061,0.823896389844168,1.0,51/165,22.02%,LRRK2;PID1;AKT3;LONP1;IFIT2;CAV2;CLUH;ATP2A1;ATP7A;DNAJC19;GABPB1;TOMM40;FIS1;IMMP2L;AIFM1;TFAM;DNM1L;SIRT4;YME1L1;PNPT1;MYH14;TIMM50;RAB29;FBXO7;POLG2;TFB1M;AIP;COX7A2;CHCHD2;HSPD1;VPS13D;AIFM2;HAX1;PINK1;FANCG;NRF1;NIPSNAP2;MTFR1;PARK7;SUPV3L1;HIGD2A;MUL1;TRAK1;SIRT3;DNAJA3;BNIP3L;TRAK2;TOMM22;PARP1;BID;RHOT1
prerank,regulation of chemotaxis (GO:0050920),-0.29878860894779485,-0.9434015640796295,0.536741214057508,0.833634202564195,1.0,9/30,14.41%,TREM2;P2RY12;AIF1;P2RX4;ZSWIM8;PPM1F;ZSWIM6;GPR183;ZSWIM5
prerank,protein modification by small protein conjugation (GO:0032446),0.27654324732008445,0.9430961177790035,0.6371049949031601,0.824795981912565,1.0,75/361,17.31%,BCL11A;NUP210;ITCH;DTX3L;ASB5;NEDD4L;TRIM26;CUL3;CUL5;BIRC6;UBE2E1;RNF38;TRIM7;CBL;FBXW7;SUMO1;CBLL1;TRIM62;PEX12;ARIH1;WAC;RNF20;RNF213;UBE2D3;IFIH1;FBXW11;DCUN1D1;UBE2N;HLTF;NEDD8;NFE2L2;ELOB;NUP98;MYCBP2;FBXO4;UBR2;PCNP;ARIH2;PEX14;WWP2;UBE2W;FBXO32;UBE2Z;SUMO2;TRIM14;FBXL17;UBE2S;DCUN1D3;KLHL8;RCHY1;UBE2G1;TRIM17;NUP153;AREL1;ATG10;RNF138;UBE2J2;VCP;USP7;UHRF2;FBXO7;ANAPC7;VCPIP1;KCTD13;USP9X;TRIM35;RNF41;HACE1;SEH1L;UBA6;UBR3;MSL2;UBE2Q2;SIRT1;RNF144A
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4492614908611293,0.942819757292569,0.5375,0.8249031958785931,1.0,2/10,2.92%,STAP1;CD300A
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3747860990983172,0.9427020741919682,0.5570776255707762,0.8246638819050648,1.0,5/24,16.96%,IL1B;PTPN1;CNMD;ITGA5;NIBAN2
prerank,regulation of double-strand break repair (GO:2000779),-0.28571375235089097,-0.9425175288369794,0.5220588235294118,0.8347366015771137,1.0,9/39,10.66%,SPIRE1;SLF2;MGMT;SLF1;RNF169;FMN2;ZCWPW1;TERF2IP;SHLD2
prerank,regulation of neuron projection development (GO:0010975),0.2881154682237034,0.9423768955845865,0.5870755750273823,0.8248591928069089,1.0,20/163,8.74%,LRRK2;LYN;PDLIM5;RAP1A;CAMK1D;RET;NTNG2;NDNF;PTPRO;PAK1;RAPGEF2;NPTN;CCDC88A;PTEN;SETX;PTK2B;CIB1;PAK2;PAQR3;CBFA2T2
prerank,regulation of osteoclast differentiation (GO:0045670),0.35589656456478475,0.9419788410569004,0.526241134751773,0.8252623391857603,1.0,4/33,9.68%,LILRB3;CCR1;TLR3;FBN1
prerank,positive regulation of lipid storage (GO:0010884),-0.3279495261902672,-0.9416291445457082,0.5498575498575499,0.8358973803999313,1.0,6/21,13.69%,OSBPL11;MSR1;IKBKE;VSTM2A;APOC4;C3
prerank,axonemal dynein complex assembly (GO:0070286),0.36746031619817515,0.94121159001202,0.5464949928469242,0.8264110583404553,1.0,4/27,12.39%,DNAH8;DNAAF5;ODAD1;CCDC39
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3987607620870845,-0.9409412924021976,0.5299334811529933,0.8364854145438574,1.0,6/11,23.64%,SMARCAL1;BLM;LIG3;FBH1;FBXO5;TIMELESS
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3708683903046192,-0.9409151193986193,0.5182481751824818,0.8354648859840412,1.0,2/13,3.12%,TPST2;ENPP1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3929984046780489,-0.9406069475047509,0.5539906103286385,0.8351800548877804,1.0,6/12,41.41%,PKD2;ABCC9;ABCC8;PKD2L1;CACNA1H;P2RX3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.42590648465604286,0.9405821926637239,0.5327731092436975,0.8272331050004951,1.0,2/13,2.03%,METRNL;PIM1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3432987557042266,-0.9405343132922145,0.5398936170212766,0.8342908021282083,1.0,8/18,31.92%,KIF1B;FCHSD2;SLC5A7;ERC1;DTNA;TSPOAP1;STAC3;CHAT
prerank,long-chain fatty acid import into cell (GO:0044539),0.4611672422684998,0.9404323122218929,0.548951048951049,0.8270585080486643,1.0,5/10,22.21%,CD36;SLC2A1;RPS6KB1;ACSL1;SLC27A4
prerank,angiogenesis involved in wound healing (GO:0060055),0.4478213964970347,0.9403639976358267,0.5380530973451327,0.8267152752882403,1.0,2/11,5.35%,NDNF;PRCP
prerank,nucleotide-excision repair (GO:0006289),-0.22944845693719726,-0.940127287360281,0.6167664670658682,0.8342113855170127,1.0,36/101,24.68%,GTF2H2;ERCC6;COPS4;MMS19;POLD3;TCEA1;GTF2H1;UBC;XRCC1;POLR2A;COPS7A;ERCC2;COPS2;PCNA;SLC30A9;LIG3;PPIE;POLA1;ISY1;POLR2K;RFC3;LIG1;GTF2H3;OGG1;XAB2;COPS7B;POLR2H;GTF2H5;CDK7;SLX4;POLR2J;RAD23A;UBA52;XPC;COPS6;ERCC1
prerank,positive regulation of glycolytic process (GO:0045821),0.39204447276238663,0.9400838082973463,0.521875,0.8263326385483788,1.0,9/20,16.93%,ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;PFKFB4;INSR;PSEN1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.39204447276238663,0.9400838082973463,0.521875,0.8263326385483788,1.0,9/20,16.93%,ZBTB20;PRXL2C;PRKAA1;APP;PFKFB3;PRKAA2;PFKFB4;INSR;PSEN1
prerank,cellular response to hormone stimulus (GO:0032870),0.31628586989020535,0.939884034897763,0.5866336633663366,0.826244396388638,1.0,10/69,10.32%,RARA;STAT3;NCOA3;STAT5B;ADRA2A;SERPINB9;BCAS3;NCOA2;NCOA1;NR3C1
prerank,telomere maintenance via recombination (GO:0000722),0.43959446848903494,0.9398684136531349,0.5645438898450946,0.8257939799778711,1.0,4/11,18.72%,TEP1;ERCC4;SMC6;SMC5
prerank,positive regulation of embryonic development (GO:0040019),0.38973403558417696,0.9397514773417291,0.5475409836065573,0.8255637472163968,1.0,3/19,7.51%,SCX;B4GALT5;PLCB1
prerank,negative regulation of axon extension (GO:0030517),-0.29771703489312495,-0.9396859722108264,0.5686274509803921,0.8342575458863951,1.0,6/30,8.48%,DIP2B;MAP2;CDKL3;SEMA3D;SEMA3E;SEMA6D
prerank,positive regulation of collagen metabolic process (GO:0010714),0.40468004772248056,0.9392842666064453,0.5444078947368421,0.8260292608497988,1.0,2/17,4.20%,VIM;SCX
prerank,regulation of mitotic cell cycle (GO:0007346),0.28563312811511826,0.9391450146250433,0.5947712418300654,0.8258446523276584,1.0,42/171,18.68%,IQGAP1;SIK1;CDK13;PSME3;BTG2;EIF4EBP1;UBE2E1;PSMB7;PSME2;BTG1;RNF20;CAV2;PKN2;AFAP1L2;GBF1;PSME4;PSMB8;PSMD9;PSMA5;CYLD;PSMB3;UBE2S;PSMD6;PSMC4;APP;PSMD10;PSMB1;ERCC3;TGFB1;ANAPC7;TRIM35;RPS6KB1;PSMD12;RB1;DAPK3;MAEA;SIRT1;FOXC1;ANAPC11;FZR1;PIN1;ANAPC4
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3461763370680661,0.9391413104443987,0.5317348377997179,0.825372488351106,1.0,10/39,14.22%,EPS15;CBL;CDC42;PTPN12;TSG101;GRB2;EPS15L1;STAM;MVP;PTPRJ
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4294897284393,0.9385630452314282,0.5335570469798657,0.8261237571609473,1.0,6/13,27.82%,SORL1;TMEM30A;CD81;EDEM2;SAR1B;SEC16A
prerank,ncRNA 3'-end processing (GO:0043628),-0.36804317831788985,-0.9381958024491495,0.5416666666666666,0.8369356686977658,1.0,5/14,12.32%,INTS6L;TRNT1;INTS8;PTCD1;SSB
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.42156087164057,0.9377559650083603,0.543046357615894,0.8273467029603079,1.0,2/15,5.14%,PPARG;ELOVL5
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3438948361149274,0.9374565710232501,0.5502063273727648,0.8274938445137532,1.0,11/42,18.79%,DTL;POLI;POLD4;WRN;TRIM25;RPA3;PCLAF;VCP;POLD1;SIRT1;PRIMPOL
prerank,sulfur compound biosynthetic process (GO:0044272),0.29932065399543356,0.9373715991258738,0.5872093023255814,0.8271940815124207,1.0,25/104,20.02%,ST3GAL1;ST3GAL4;B4GALT5;GSTA3;GSS;GGTA1;CHST12;TPK1;PAPSS1;PAPSS2;ACAN;NCAN;SLC10A7;CHST15;UST;GSTP1;CSGALNACT1;GLCE;CHSY3;MGST3;GGCT;DSEL;VCAN;B4GALT3;ESD
prerank,nucleic acid-templated transcription (GO:0097659),0.340448654933637,0.9373054197347515,0.5535211267605634,0.8268424415857045,1.0,7/42,12.15%,BCL3;POLR3A;POLR2C;SCX;NFKBIB;CREBL2;BAZ2A
prerank,protein localization to condensed chromosome (GO:1903083),-0.3816719290425395,-0.9371651826521064,0.5191387559808612,0.8383628673459563,1.0,7/12,34.37%,IK;BUB3;ZW10;KNL1;SPDL1;MIS12;CDK1
prerank,negative regulation of insulin secretion (GO:0046676),-0.3461876329158423,-0.9371475955782271,0.5368421052631579,0.837338738177942,1.0,3/17,10.19%,PRKN;IRS1;KLF7
prerank,osteoclast differentiation (GO:0030316),0.38808280437441245,0.9366854682413045,0.5345622119815668,0.8276641103687505,1.0,5/22,10.03%,FOXP1;ANXA2;MAPK14;EFNA2;SBNO2
prerank,regulation of postsynapse organization (GO:0099175),0.36656213700711615,0.9365536387812629,0.5430183356840621,0.8274668000349662,1.0,2/28,1.09%,LRRK2;PDLIM5
prerank,purine nucleotide metabolic process (GO:0006163),0.3753293597783611,0.9364259503813643,0.5481481481481482,0.827281747623096,1.0,2/24,2.70%,GDA;GPX1
prerank,chloride transport (GO:0006821),-0.23984055345114197,-0.9355044821291322,0.6538461538461539,0.8403010768329291,1.0,17/74,18.53%,SLC1A3;TTYH3;CLCN6;GABRG3;ANO10;GABRG2;CLCN4;GABRB1;GLRA3;GLRA2;GABRA4;CLCN3;GABRB3;LRRC8A;GABRA2;ANO8;GABRA5
prerank,regulation of actin nucleation (GO:0051125),0.43241509111058296,0.9351551958538354,0.5493934142114385,0.8295136679179883,1.0,2/12,7.40%,CORO1A;ARF1
prerank,sterol metabolic process (GO:0016125),-0.25141778599935594,-0.9351494745576441,0.6146788990825688,0.8401029022126513,1.0,6/60,7.46%,ABCA1;APOE;OSBPL1A;ARV1;LIPA;STARD3
prerank,membrane assembly (GO:0071709),0.35304927620383425,0.9349622097294288,0.5460893854748603,0.8294466739034276,1.0,7/34,9.34%,ANXA2;PICALM;CHMP4B;CEL;PTEN;S100A10;SPAST
prerank,focal adhesion assembly (GO:0048041),0.38736132192788636,0.9349239276783804,0.5386996904024768,0.8290400497093473,1.0,3/21,4.86%,RCC2;BCR;DLC1
prerank,translational termination (GO:0006415),-0.23914606534103247,-0.9348077872970268,0.5987654320987654,0.839832116733657,1.0,52/95,35.79%,GFM2;MRPL24;MRPS9;DAP3;MRRF;MRPS21;MRPL1;MRPS5;OXA1L;MRPL45;MRPS31;MRPS17;MRPL10;MRPL43;CHCHD1;MRPS7;MRPL4;MRPL2;MRPL37;MRPS24;MRPS26;MRPS18B;MRPL3;MRPS22;MRPL32;MRPL47;MRPL17;N6AMT1;MRPS30;MRPL50;MRPS14;TRMT112;MRPL51;MRPL16;MRPL11;GSPT2;MRPS18C;MRPL44;MRPL35;MRPS11;MRPL28;MRPL46;MRPL52;MRPS35;MRPS28;MRPL23;MRPL9;MRPS16;MRPL54;MRPL49;MRPL42;MRPS23
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.3647818417307323,0.9347037539325005,0.5518796992481203,0.8290294186571557,1.0,10/25,17.24%,KAT7;HTATSF1;SCAF8;SETD5;CCNT2;CCNT1;EAF1;HMGN1;ELL;SUPT4H1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.4079125921192507,0.9342561918593807,0.5346534653465347,0.8294769348708468,1.0,2/17,5.23%,RAPGEF2;ADRA2A
prerank,embryonic appendage morphogenesis (GO:0035113),0.4309156296425559,0.9341729394691088,0.5673400673400674,0.8291743287921026,1.0,1/12,0.59%,MBNL1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3942707058441492,0.9341207186573137,0.5580286168521462,0.8288104467311599,1.0,4/19,10.05%,PTPRU;MAD2L2;AFDN;ADAM19
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2970757493757025,0.9340922758019005,0.6069767441860465,0.828389956158559,1.0,8/113,4.92%,JAML;NOTCH2;AKT3;STAT5A;CLDN1;BMPR2;LAMB1;VEGFC
prerank,cellular component disassembly (GO:0022411),0.3237353326910962,0.9340820883954916,0.5688073394495413,0.8279408810282699,1.0,4/53,6.11%,CD44;LCP1;MMP1;CAPN2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.36018342665820646,0.933887405694134,0.548936170212766,0.8279064230352762,1.0,3/31,5.94%,LRRK2;PDLIM5;PTEN
prerank,positive regulation of cell growth (GO:0030307),0.30297924335851895,0.933878893995534,0.5859649122807018,0.8274513074484156,1.0,24/96,16.80%,NGF;SHTN1;NEDD4L;RPS6KA3;CDC42;H3-3A;CXCL16;ADAM17;CIB1;MTPN;DDX49;CSNK2A1;NTN1;RPS6KA1;PSMD10;PABIR1;AKT1;ITSN2;MAP3K13;ZFYVE27;NCBP1;INO80;USP47;SEMA4D
prerank,positive regulation of histone deacetylation (GO:0031065),-0.38035941707160226,-0.933849650728941,0.5162037037037037,0.8411774386272786,1.0,5/12,12.08%,CTBP1;AKAP8;AKAP8L;VEGFA;PRKD1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.36927905046881987,0.933821611848427,0.5463768115942029,0.8271116411225673,1.0,3/27,3.77%,PTPN22;FOXJ1;PTPN6
prerank,import into nucleus (GO:0051170),0.3106779043350961,0.9337851921260243,0.5646766169154229,0.8267109514025063,1.0,17/73,18.19%,BACH2;SYK;STAT3;SNRPD2;PTTG1IP;SNRPB;HIKESHI;NUP153;EIF4ENIF1;AKT1;FAM53C;GEMIN7;KPNB1;TNPO1;HTATIP2;NUP93;APPL1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3137797893986546,0.9335297005124413,0.5739348370927319,0.8267551324856148,1.0,13/72,13.30%,DNA2;MRE11;FEN1;XRN2;POLD4;IHO1;RNASE1;RNASE6;DCP1A;RPA3;EXD2;ERCC3;ERCC4
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2903796032200356,0.9335269512172766,0.5927152317880795,0.826292058441564,1.0,28/150,15.44%,FGF22;FLT3;FYN;RET;FGF5;NRG2;KL;RAC2;GRB2;PDPK1;ENG;RAC1;HGF;CPNE1;HIP1;RTN4;PIK3CA;CASS4;KIT;HCLS1;PTPRJ;FGFR3;TGFB1;IL18;MAZ;RHOG;FRS2;THBS1
prerank,snRNA 3'-end processing (GO:0034472),-0.3335838353906702,-0.932460064366952,0.547486033519553,0.8435403557054296,1.0,7/19,20.70%,INTS6L;INTS8;EXOSC9;EXOSC5;INTS1;EXOSC3;INTS7
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3482054899012815,0.9324379211428377,0.5512820512820513,0.8280342817699003,1.0,12/32,18.60%,PPP2R5A;CD300A;DLC1;PPP1R15A;ANKLE2;PPP1R15B;TGFB1;DUSP26;PPP1R7;PTPA;PRKCD;PIN1
prerank,protein localization to vacuole (GO:0072665),0.424429209936768,0.9324375050422963,0.5453047775947282,0.8275624964009981,1.0,3/13,12.51%,RTN4;LMBRD1;SH3BP4
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3595637752534077,0.9318977997024307,0.5426470588235294,0.8282110875929253,1.0,7/29,17.23%,RET;PAK2;CYLD;RIPK1;DEDD2;THBS1;TRAF2
prerank,cellular response to hydroxyurea (GO:0072711),-0.3963249996107334,-0.9318689192744951,0.5216346153846154,0.8439205042077611,1.0,5/10,23.64%,BLM;RTF2;NSMCE3;DDX11;TIMELESS
prerank,response to insulin (GO:0032868),-0.23899686917427476,-0.9313151296202838,0.625,0.8443009701673945,1.0,13/80,12.13%,PDE3B;CPEB2;ENPP1;SORT1;RAB31;CPEB1;GOT1;RHOQ;SLC27A1;PCK2;IRS1;PIK3R1;MYO5A
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3970268261904888,0.9312893379355107,0.5418641390205371,0.8289847434551562,1.0,3/17,7.53%,RAB3D;UNC13D;SLC4A8
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.43490823949359375,0.9300613129466961,0.562390158172232,0.8310867676526259,1.0,2/11,6.98%,RUNX3;CBFB
prerank,sphingolipid catabolic process (GO:0030149),0.4111490987731135,0.9295555940440413,0.5566502463054187,0.8316728114890017,1.0,2/15,4.70%,ACER3;SMPDL3A
prerank,protein import into nucleus (GO:0006606),-0.24632978195195068,-0.9295229412777415,0.6086956521739131,0.8477306204238619,1.0,21/66,17.91%,E2F3;APPL2;KPNA6;NUP54;NUP133;NUP155;IPO5;NUP188;TNPO2;PPP1R10;IPO13;RANBP2;NUTF2;SEC13;TSC2;NUP85;TPR;FAM53A;RAN;NUP35;IPO7
prerank,cellular response to interferon-beta (GO:0035458),0.41102388172464355,0.9293142791648218,0.5537190082644629,0.8317100090571256,1.0,7/14,24.62%,STAT1;ACOD1;PNPT1;AIM2;CDC34;UBE2K;IRF1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4057968153294841,0.929234377772684,0.5443037974683544,0.8313954885424084,1.0,3/17,7.40%,WASF2;GMFG;ARF1
prerank,synaptic vesicle transport (GO:0048489),0.42646039725641166,0.9291348216230999,0.5230263157894737,0.831137832828534,1.0,4/11,14.68%,KIF5B;SYNJ1;SNAPIN;KIF5A
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.34919504902024046,0.9290716698516317,0.5569800569800569,0.8308042280800289,1.0,2/34,3.56%,LRRK2;CHRNA4
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.36289539569405677,0.9290513173812998,0.5446293494704992,0.8303795639307305,1.0,10/27,16.93%,NTNG2;CCDC88A;PTEN;FCGR2B;AKT1;BRSK1;FBXO7;EFHC2;DISC1;PSEN1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.44222438756986815,0.9288643275852395,0.5748299319727891,0.8302893360482181,1.0,2/11,8.29%,ETV6;ARIH2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.38389251727947565,0.9285778076544214,0.555379746835443,0.8304027395808316,1.0,5/20,15.83%,HEXIM1;PTEN;LATS1;LATS2;APC
prerank,cell cycle G2/M phase transition (GO:0044839),0.2919350702486022,0.9282744254362997,0.6117511520737328,0.830542497848237,1.0,25/129,14.90%,SDCCAG8;CNTRL;PPP1R12A;HAUS8;PHLDA1;FBXW11;FBXL8;CDK14;CEP63;PAFAH1B1;PPP2R2A;PLCB1;HAUS1;CCNH;DCTN3;LATS1;CEP250;FBXL17;DYNC1H1;PPP1CB;HAUS3;FBXL12;CLASP1;WEE1;BRSK1
prerank,visual perception (GO:0007601),0.30450389540404593,0.9281855920811487,0.5922330097087378,0.8302524112849318,1.0,11/84,11.39%,CRYBG3;RP2;ATF6;WFS1;ATXN7;DNAJC19;OPA3;CEP250;KIFC3;UNC119;IMPG2
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2624787701688355,-0.9279630556056437,0.5862068965517241,0.8504400316600829,1.0,9/46,11.72%,PLD1;DGKZ;LPCAT1;SLC27A1;PLA2G4A;DGKQ;GPAM;DDHD2;ABHD4
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3192446983219974,0.9278995246696979,0.5829081632653061,0.83038815659318,1.0,17/62,17.24%,CDK13;GTF2F2;POLR2C;ELOA;ELOB;CCNH;ELOF1;SETD2;CCNT2;NELFA;CCNT1;CDK12;ERCC3;EAF1;NCBP1;ELL;SUPT4H1
prerank,positive regulation of phospholipid transport (GO:2001140),-0.4118661545056104,-0.9278566789137981,0.5571428571428572,0.8496106643354714,1.0,2/10,3.76%,APOE;ABCB4
prerank,regulation of proteolysis (GO:0030162),0.33024400882455474,0.927744661695109,0.5793010752688172,0.8302402397672529,1.0,8/48,7.50%,ITCH;DNAJC1;SPOP;FBXW11;PARL;NEDD8;GSAP;TRAF3
prerank,skeletal muscle contraction (GO:0003009),0.39543745380153983,0.9272147216671558,0.545727136431784,0.8308419014808041,1.0,1/19,1.88%,TNNC1
prerank,regulation of protein modification process (GO:0031399),0.3278257710563522,0.9270713207149814,0.5876840696117804,0.8306736677089568,1.0,17/50,20.87%,LYN;CCDC88C;RABL3;CCDC88A;SPRED3;FN1;PARG;NDUFS4;ATG10;STAT2;KAT2B;SPRED1;PPIB;PIN1;PUM3;PTK2;PHIP
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3991029114525016,0.9269682960269122,0.5812101910828026,0.8304387977922667,1.0,7/20,17.02%,LIMD1;CNOT6;TNRC6B;TNRC6A;CELF1;AJUBA;CNOT8
prerank,protein localization to organelle (GO:0033365),0.2909434673420986,0.9263120274237137,0.6204545454545455,0.8313384736095941,1.0,26/133,14.70%,LRRK2;SORL1;RAB6A;PRNP;TRAM2;TRAM1;GCC2;IFT140;LMNA;PAQR3;GBF1;STX5;PPP1R15A;PIKFYVE;LAMP5;CEP250;DCP1A;LMBRD1;TOR1AIP1;APP;PACSIN2;RPL11;GBP5;UBE2J2;EHD1;GBP2
prerank,positive regulation of developmental growth (GO:0048639),0.32901537182315843,0.9260006865415449,0.5883134130146083,0.8315303619152752,1.0,11/49,16.80%,NGF;SHTN1;NEDD4L;PLCB1;NTN1;ITSN2;MAP3K13;ZFYVE27;INSR;PPIB;SEMA4D
prerank,regulation of cellular component biogenesis (GO:0044087),0.34697704687159603,0.925896662123455,0.5659574468085107,0.8312847545938152,1.0,6/39,9.19%,RAP1A;MSN;CD36;RAPGEF2;EZR;LATS1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4462917857606892,0.9257373599014249,0.5684575389948007,0.831139157170772,1.0,3/10,12.88%,INPP5F;PARP14;NF2
prerank,positive regulation of angiogenesis (GO:0045766),0.2948831622075056,0.9256533464418757,0.6011627906976744,0.8308582077851099,1.0,11/108,6.67%,IL1B;KLF4;ITGAX;CD40;PTGIS;VEGFC;BTG1;HIPK2;HIPK1;PIK3R6;PDPK1
prerank,organophosphate ester transport (GO:0015748),0.3697785270469398,0.9255663359460804,0.5593984962406015,0.8305535088806724,1.0,5/24,9.14%,LDLR;ABCA3;SCARB1;PITPNB;PITPNM1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3595161120480191,0.9255486289346035,0.5681492109038737,0.8301249762974058,1.0,11/28,18.47%,UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.3392435783991702,0.9253480321221256,0.5704514363885089,0.8300519151412594,1.0,9/42,12.80%,MAD2L2;SMCHD1;KLHL15;ACTR2;PPP4R2;WRAP53;ARID2;SETD2;SPIDR
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3924803808758604,0.9249252092722575,0.5684039087947883,0.8304622329994023,1.0,4/18,7.93%,MSN;PTTG1IP;FAF1;EZR
prerank,acylglycerol homeostasis (GO:0055090),-0.3212352711684793,-0.9248573990501653,0.5779036827195467,0.8561076573311859,1.0,2/20,5.79%,APOE;PNPLA8
prerank,regulation of pH (GO:0006885),0.43354042076223154,0.9247202751179157,0.5627009646302251,0.8304069336783569,1.0,1/11,2.07%,SLC9A7
prerank,muscle contraction (GO:0006936),0.2963836223861166,0.9245087488045509,0.6088939566704675,0.8303807175015528,1.0,8/126,3.91%,LTB4R;TNNC1;UTRN;TPM4;VIM;DYSF;MYL4;HCN4
prerank,translation (GO:0006412),0.28003542734637693,0.924420663561198,0.6268498942917548,0.8300923719319401,1.0,59/208,21.90%,ZAR1;RPL5;NOA1;MRPL57;RPS10;FARS2;RPL37A;MRPL55;VARS1;RPL6;MRPL18;RPS18;DARS2;RPS14;RPL35A;RPL22L1;MRPL13;RPL13;ETF1;RWDD1;EEF1G;RPS3;IGF2BP3;RPS21;FARSB;RPLP0;RPL34;PTCD3;RPL19;RPL11;RPL30;RPL4;TMA7;RPS2;RPL7;RPS15A;DRG2;MRPS6;RPS4X;MRPS33;HARS2;GSPT1;TUFM;RPL32;RPSA;ABCE1;RPS13;MRPS15;RPS6;RPL18A;RPS27;RPLP2;EEFSEC;RPL22;TARS1;AARS1;RPS7;MRPS12;RPS12
prerank,polyamine metabolic process (GO:0006595),-0.3666171964282616,-0.9238777883514508,0.548051948051948,0.8575192863616652,1.0,6/13,31.98%,SMOX;HDAC6;PAOX;ODC1;SAT2;DHPS
prerank,protein localization to microtubule organizing center (GO:1905508),-0.34473481196542016,-0.9235994612346391,0.5203045685279187,0.8571110286048313,1.0,8/15,38.35%,PIBF1;CEP83;CCDC14;NEDD1;CEP192;STIL;CEP131;SPAG5
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.38442621391834253,-0.9234379015643256,0.56,0.8564216851625819,1.0,9/12,40.16%,RMDN1;MAD1L1;CENPE;BOD1;NDC80;MIS12;CDT1;KIF2C;NUF2
prerank,cellular response to calcium ion (GO:0071277),0.3153148320491491,0.923387031204033,0.5940224159402242,0.8317906224286603,1.0,12/67,12.48%,IQGAP1;PLCG2;ALOX5AP;HPCA;RASGRP2;DPEP1;CLIC4;KCNH1;CPNE1;BRAF;PRKAA1;CPNE2
prerank,supramolecular fiber organization (GO:0097435),0.273462951013053,0.9232597989874382,0.6848049281314168,0.8316126848551455,1.0,61/333,15.53%,MYO1G;RND3;SLK;TPM4;VIM;CCDC88C;CD36;MAD2L2;MYO1E;MYO1C;COL5A2;SORL1;SHROOM3;CORO1A;CCDC88A;RAC2;SCX;CDC42;CD2AP;H3-3A;CARMIL1;PPP1R9B;BCAR1;ELMO2;HSPG2;BIN3;KATNA1;MYO5B;KATNB1;TPPP3;CIB1;ATP7A;TGFBI;RHOBTB3;RAC1;PXDN;TSPAN14;KIF24;RHOA;SPAST;HIP1;TLL1;TSPAN33;RIPK1;B2M;DYNC1H1;APP;CLIP3;TMOD3;TCHH;ARHGAP17;TRIOBP;MYO1F;STMN3;RHOG;ELMO1;STMN2;COL16A1;TSPAN15;USP9X;SHROOM1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.4216372857333892,0.923098559978602,0.5510887772194305,0.8314900744672498,1.0,2/13,6.98%,RUNX3;CBFB
prerank,regulation of glucose import (GO:0046324),0.3561979159383384,0.9228041468886178,0.5722070844686649,0.8316375213327258,1.0,7/30,16.24%,PID1;PRKAG2;RTN2;CREBL2;AKT1;OCLN;INSR
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.4163698241728947,0.9225580598422894,0.539708265802269,0.8316613213455747,1.0,2/12,4.15%,CBLB;CBL
prerank,regulation of myoblast differentiation (GO:0045661),0.35234047931017437,0.922468394946879,0.5510204081632653,0.8313943517473349,1.0,4/32,7.51%,RIPOR2;BTG1;MAPK14;PLCB1
prerank,transition metal ion transport (GO:0000041),-0.28423810956361045,-0.9224494214339941,0.5538461538461539,0.8577202400735205,1.0,12/35,18.25%,SLC11A1;TRPC4;SLC11A2;TFRC;FTH1;TRPC1;TRPC7;SLC30A9;TRPC3;ATP2C1;SLC31A2;CP
prerank,DNA catabolic process (GO:0006308),0.4327799140942905,0.922395727985849,0.5742049469964664,0.8310704532890333,1.0,4/11,19.63%,XRN2;DFFB;SETMAR;DNASE1L1
prerank,negative regulation of ion transport (GO:0043271),0.367466202629351,0.9222880701666621,0.5742424242424242,0.8308207705192631,1.0,3/24,6.49%,LILRB1;ADRA2A;PTK2B
prerank,positive regulation of actin filament polymerization (GO:0030838),0.33178131237412606,0.9219877107236188,0.5644504748982361,0.8309520849612843,1.0,7/44,10.69%,HCK;PRKCE;CARMIL1;PTK2B;ARPC4;SNX9;VASP
prerank,positive regulation of telomere maintenance (GO:0032206),0.3512707000845225,0.9219611852995463,0.5710144927536231,0.8305507661015558,1.0,7/31,14.99%,PKIB;MRE11;TNKS;MAP3K4;ATRX;AURKB;MAPK1
prerank,monocyte chemotaxis (GO:0002548),0.35580020824046876,0.9216780991694609,0.5694444444444444,0.8306588013417842,1.0,5/32,12.86%,PTPRO;IL6R;IL6;ANXA1;LGALS3
prerank,defense response to protozoan (GO:0042832),0.4270362560267281,0.9216641591564065,0.5731292517006803,0.8302215253432029,1.0,4/12,15.01%,CD40;IRF4;GBP2;MYD88
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.3837490715954933,-0.9215141424849064,0.5661252900232019,0.8589865330833892,1.0,3/11,14.82%,TREM2;AKAP6;ALG10B
prerank,positive regulation of autophagy (GO:0010508),0.3032976587161108,0.9208034335547398,0.5987654320987654,0.8314941540901434,1.0,18/81,15.45%,LRRK2;DAPK1;PIK3C2A;PLEKHF1;ATF6;WAC;SVIP;CAMKK2;TRIM14;FOXO3;PRKAA1;HTT;MAP3K7;SH3BP4;ROCK1;PRKAA2;FBXO7;TBK1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2992968093107536,-0.9206055835530256,0.5424242424242425,0.8601362429748591,1.0,8/28,15.91%,PRKN;TREM2;CLU;PSMC2;ECSCR;CCDC22;DAB2IP;RNF139
prerank,nitrogen compound transport (GO:0071705),-0.21899337379925052,-0.9205861673994513,0.7377049180327869,0.8590978907026594,1.0,28/141,16.74%,LRP1B;SEC14L1;SLC11A1;SCAMP1;SLC7A6;ABCG2;SLC7A1;FLVCR1;SCAMP2;SCAMP5;SLC7A7;SLC6A15;SLC36A1;HSP90B1;SLC22A5;SLC7A2;SLC7A8;SLC5A7;TOM1;SLC3A2;SLC15A2;SLC6A8;SLC22A4;SLC25A47;TXNIP;CHMP1B;VPS33B;ARRDC2
prerank,actin cytoskeleton reorganization (GO:0031532),0.31650437032299417,0.9205572185941479,0.5946969696969697,0.8315406056892988,1.0,14/63,13.21%,NEDD9;PAK1;MYH9;BCAR1;GRB2;FLNA;EZR;MINK1;RHOA;PTPN1;ANXA1;CASS4;PIP5K1A;KIT
prerank,limb development (GO:0060173),-0.29332922919311755,-0.9204046467219685,0.5738255033557047,0.8584845351525481,1.0,6/28,14.20%,CHD7;SALL1;IQCE;ZNRF3;GLI3;BMPR1B
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3146185772067531,0.9203718042226161,0.5909090909090909,0.8314183005704442,1.0,17/64,17.24%,CDK13;GTF2F2;POLR2C;ELOA;ELOB;CCNH;ELOF1;SETD2;CCNT2;NELFA;CCNT1;CDK12;ERCC3;EAF1;NCBP1;ELL;SUPT4H1
prerank,maturation of SSU-rRNA (GO:0030490),0.34779387557990277,0.9202579484102292,0.5861070911722142,0.8311966231308681,1.0,16/34,27.42%,DHX37;RPS14;UTP6;RIOK1;NOL11;RRP36;TSR3;DDX52;HEATR1;DCAF13;RPS16;WDR46;NOB1;RIOK2;WDR3;TSR1
prerank,extracellular matrix disassembly (GO:0022617),0.3176058073020567,0.9196379700913095,0.5924479166666666,0.8319940328194928,1.0,4/53,6.11%,CD44;LCP1;MMP1;CAPN2
prerank,neuron migration (GO:0001764),0.3284074454312131,0.9195658461337899,0.568241469816273,0.8316784061896106,1.0,9/48,8.24%,SDCCAG8;NDNF;CELSR1;NAV1;RAPGEF2;CEP85L;PAFAH1B1;DDIT4;RAC1
prerank,positive regulation of heart contraction (GO:0045823),0.3886274257302851,0.9195562506313801,0.5783521809369951,0.8312295692227709,1.0,2/19,3.32%,RGS2;KCNQ1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.29076757593352426,0.919253879964662,0.6216530849825378,0.831399570802075,1.0,15/104,10.44%,PPARG;HSPA1A;BMPR2;SORL1;LEMD3;HIPK2;UBE2D3;ADAM17;PDPK1;MTMR4;ACVR2A;SPRED3;SMAD4;PMEPA1;LEMD2
prerank,regulation of endocytosis (GO:0030100),0.314479099149548,0.9187210261201998,0.5854922279792746,0.8320153788310634,1.0,18/61,17.17%,LILRB1;NEDD4L;CD177;PICALM;GPC3;CBLL1;HIP1;PTPN1;PACSIN2;CLIP3;LGALS3;ROCK1;STON1;AP2S1;SNX33;SNX12;MTMR2;ABL2
prerank,protein alkylation (GO:0008213),0.3767425605420144,0.9186449719654509,0.5921450151057401,0.8317092556038741,1.0,7/22,18.23%,PRMT8;SNRPB;CAMKMT;ETF1;PRMT3;EEF1AKMT1;GSPT1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.31109127566817657,0.9182888569550686,0.5944233206590621,0.8319695715645897,1.0,12/63,13.83%,PTPN22;MCL1;STAT3;EIF4G3;IL10RA;SORL1;HP;HGF;TLK2;TAB3;AKT1;ROCK1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.35941530939468813,-0.9179780702522919,0.6045340050377834,0.8633234068372557,1.0,3/14,7.23%,GAS6;RFFL;PYDC1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2718209885633158,-0.9178908814062157,0.6086956521739131,0.8624479953045984,1.0,14/37,27.93%,GTF2H2;POLD3;GTF2H1;UBC;ERCC2;PCNA;RFC3;GTF2H3;GTF2H5;UBA52;ERCC1;RFC2;GTF2H4;DDB1
prerank,positive regulation of vasculature development (GO:1904018),0.2976014091846363,0.9178280825219303,0.6058479532163743,0.8324569048429542,1.0,10/94,6.67%,IL1B;ITGAX;CD40;PTGIS;VEGFC;BTG1;HIPK2;HIPK1;PIK3R6;PDPK1
prerank,protein kinase B signaling (GO:0043491),0.3677810313025898,0.9171453263073466,0.5701219512195121,0.8334041092574909,1.0,3/23,6.37%,IL1B;PTEN;SETX
prerank,protein destabilization (GO:0031648),-0.28800853066205884,-0.9169194039068621,0.6214285714285714,0.8637416198350629,1.0,6/32,8.08%,PRKN;CAPN3;SENP2;FBXL3;BTRC;GGA3
prerank,regulation of phosphorylation (GO:0042325),0.28937552321450366,0.9167443567103194,0.6210045662100456,0.8337856548518802,1.0,30/120,18.69%,LYN;STAP1;NUP210;PRKAG2;CCDC88C;CCDC88A;IKBKB;PRKRIP1;GLMN;CDKN2C;NUP98;ANKLE2;SLAMF8;FN1;PRKAG1;APP;NDUFS4;BTBD10;NUP153;STAT2;ROCK1;THBS1;SEH1L;GCK;PSEN1;SIRT1;NUP93;RAD17;PIN1;FZD7
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3534890062874632,-0.91629551266941,0.5646766169154229,0.8641726248695935,1.0,6/15,24.86%,ACACA;PMVK;MLYCD;DIP2A;PPCS;ACSS1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3998843327163736,-0.9160960194407214,0.5798525798525799,0.8635742824214754,1.0,6/10,28.21%,GALNT3;GALNT13;GALNT16;POGLUT2;MGAT5B;POGLUT3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.32934222072704106,0.9159905449296342,0.5970350404312669,0.8348536090178054,1.0,13/46,18.47%,IL1B;XPO4;UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD
prerank,plasma membrane repair (GO:0001778),0.4208820021208354,0.9159772277384883,0.559931506849315,0.8344118392463757,1.0,5/13,19.95%,DYSF;MYH9;ARL8B;MYOF;ANXA6
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.4124557833394455,0.9159546788201484,0.5621970920840065,0.8339903159554019,1.0,1/14,1.98%,CCR1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.3711767753248395,0.91568634852277,0.593245227606461,0.8340689912047446,1.0,7/26,16.81%,LRRK2;PTEN;PTK2B;APP;RELN;WNT7A;MTMR2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.37608514462011206,0.9152145388504326,0.5796661608497724,0.8345456110466305,1.0,6/19,24.95%,PPP3CA;HRH1;NFATC3;NFAT5;NFATC2;PPP3CC
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.2894934763921398,-0.915104960925917,0.5787781350482315,0.8648729639249327,1.0,11/32,16.78%,FHIT;CDIP1;DDX5;USP28;PYCARD;MSH2;MYBBP1A;SNW1;PPP1R13B;JMY;AEN
prerank,protein localization to cell periphery (GO:1990778),0.2861476521540163,0.9149532518405422,0.6308724832214765,0.8346030715363024,1.0,32/133,17.94%,RAP1A;TTC7A;PLEKHF1;C2CD5;RAB3D;RAPGEF2;IKBKB;EHD2;KCNIP3;RAB34;FLNA;S100A10;F11R;EZR;ZDHHC23;TSPAN14;TSPAN33;PACS2;PACS1;RAB40B;PIP5K1A;ROCK1;RAB29;EFR3A;EHD1;ZFYVE27;TSPAN15;TSPAN5;MYADM;TSPAN17;EHD3;ZDHHC3
prerank,B cell activation involved in immune response (GO:0002312),0.42251221679359274,0.91487681691368,0.5728476821192053,0.8343154500467692,1.0,3/13,11.74%,GAPT;MSH6;FCGR2B
prerank,early endosome to late endosome transport (GO:0045022),0.37987377154465407,0.9145486761459849,0.567398119122257,0.8345519565340543,1.0,3/20,8.96%,LMTK2;RAB7A;SNF8
prerank,negative regulation of kinase activity (GO:0033673),0.31483887793556703,0.9136781970866494,0.6221374045801527,0.8358478314266036,1.0,13/62,16.33%,PTPRC;PPP2R5A;PRKAG2;PRKRIP1;PDPK1;PAK2;GSKIP;DBNDD2;TAF7;AKT1;GSTP1;SPRED1;RB1
prerank,development of primary male sexual characteristics (GO:0046546),-0.28174272514547716,-0.9135026460717776,0.6033898305084746,0.8676727977628345,1.0,14/34,33.58%,LHFPL2;KITLG;MSH2;TGFB2;AR;NCOA4;FGF9;WNT4;INHBA;MEA1;BIK;WNT5A;WNT2B;MAMLD1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.36489168527481886,-0.9134687314967701,0.5639810426540285,0.8667076249893182,1.0,8/13,31.64%,ALG8;MPDU1;ALG2;ALG9;ALG1;ALG6;ALG3;ALG11
prerank,engulfment of apoptotic cell (GO:0043652),0.4075439275117198,0.9130078116179032,0.5665584415584416,0.8367294886371247,1.0,6/15,15.44%,RAC2;XKR4;RAC1;MEGF10;RHOG;THBS1
prerank,negative regulation of protein transport (GO:0051224),-0.30472914500608056,-0.912525518977193,0.5827814569536424,0.8679218299983943,1.0,6/25,17.78%,APOE;ERP29;PPM1F;CYP51A1;PKDCC;RHBDF2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.3401689669095417,0.9121672918237821,0.5650969529085873,0.8379451478407222,1.0,2/34,2.62%,IL1B;CUL3
prerank,pseudouridine synthesis (GO:0001522),0.413353216563449,0.9119508247047997,0.572139303482587,0.8379093459339912,1.0,5/13,21.55%,NHP2;PUS3;PUS1;PUS7L;TRUB2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3176890986999791,0.9113497140250798,0.6084656084656085,0.8386617838987654,1.0,10/57,11.91%,DAPK1;FYN;MAP3K5;SYK;MALT1;NLRC4;FIS1;GRAMD4;NLRP3;REST
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.35538291135431005,-0.911306892671147,0.5471204188481675,0.8697142026293914,1.0,9/14,43.97%,TGFBR1;EFEMP1;CHADL;GREM1;PTHLH;RFLNB;RFLNA;WNT9A;SNAI2
prerank,hippo signaling (GO:0035329),-0.2940950110708633,-0.9109084300932464,0.6114649681528662,0.8695165485226584,1.0,7/26,11.69%,TJP1;AMOTL1;TJP2;SAV1;WWC1;FAT4;CASP3
prerank,positive regulation of translational initiation (GO:0045948),-0.3265544029016606,-0.910537111874979,0.5666666666666667,0.8693416753704228,1.0,10/18,33.20%,LARP1;CDC123;EIF2B5;DDX3X;UHMK1;HABP4;YTHDF2;MTOR;CCL5;RPS6KB2
prerank,glutamate metabolic process (GO:0006536),-0.33177699869743177,-0.9104854527556255,0.5744125326370757,0.8683828364203173,1.0,12/19,25.84%,GLUL;GOT1;GCLC;MTHFS;ALDH18A1;GCLM;GAD1;ALDH5A1;OAT;GLS;PRODH;FPGS
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.39076716570920733,0.9104516200023461,0.5816164817749604,0.8400211344462288,1.0,4/17,11.69%,PPARG;PTEN;PDCD4;TAFA5
prerank,regulation of cellular biosynthetic process (GO:0031326),0.35989068521900713,0.9104197124777718,0.5782608695652174,0.8396287523881807,1.0,10/28,18.42%,CD47;PRKAG2;JAK2;PRKAB2;RAC1;TNFRSF1B;PRKAA2;MED1;SIRT1;CTNS
prerank,regulation of cell growth (GO:0001558),0.2771683040905603,0.9103493211694755,0.672650475184794,0.839314727900656,1.0,44/204,17.61%,SGK3;ITCH;BCL6;HSPA1A;RASGRP2;RPS6KA3;BMPR2;MAD2L2;CRLF3;CDC42;H3-3A;BTG1;PPP1R9B;BCAR1;CDKN2C;OSGIN2;CXCL16;ADAM17;CIB1;MTPN;TMC8;DDX49;CSNK2A1;SMAD4;RTN4;IL17RB;NET1;DCUN1D3;RPS6KA1;PSMD10;SH3BP4;PABIR1;AKT1;PTPRJ;TGFB1;SERTAD3;NCBP1;INO80;USP47;RB1;PPT1;ST7L;SIRT1;NUBP1
prerank,protein homotrimerization (GO:0070207),0.40964286557367996,0.910120724813444,0.5702479338842975,0.8388542817459638,1.0,3/14,13.94%,ALOX5AP;SLC1A5;PNPT1
prerank,protein trimerization (GO:0070206),0.40964286557367996,0.910120724813444,0.5702479338842975,0.8388542817459638,1.0,3/14,13.94%,ALOX5AP;SLC1A5;PNPT1
prerank,aortic valve morphogenesis (GO:0003180),-0.2928641610563652,-0.9099219270993836,0.5979381443298969,0.8686694560377589,1.0,4/30,12.66%,ROBO2;ROBO1;SLIT2;SLIT3
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3472641706533538,0.9099107005144653,0.59375,0.8388192077055407,1.0,4/32,10.79%,LRRK2;MCTP2;SLC30A1;SNAPIN
prerank,nuclear membrane disassembly (GO:0051081),0.4073276437158703,0.9096810602374557,0.5795454545454546,0.8388380038818756,1.0,1/14,1.27%,VRK1
prerank,protein import (GO:0017038),-0.23058085745853163,-0.9094269578306665,0.6699507389162561,0.8687838233516676,1.0,23/84,17.91%,APOE;ABCD2;E2F3;APPL2;LAMP2;NUP133;NUP155;IPO5;NUP188;GDAP1;TNPO2;PPP1R10;IPO13;NUTF2;CLU;SEC13;TSC2;NUP85;TPR;FAM53A;RAN;ABCD3;IPO7
prerank,cellular response to oxygen levels (GO:0071453),-0.38500469762445366,-0.909334251411867,0.5896805896805897,0.8679832541329876,1.0,3/10,9.75%,ATP6AP1;ATP6V0D1;CPEB4
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.42058378019249665,0.9092162807525174,0.5809199318568995,0.8393285019822669,1.0,2/12,9.84%,KAT7;METTL4
prerank,cellular glucose homeostasis (GO:0001678),0.33167854720941686,0.9082515047650944,0.5814917127071824,0.840808105936193,1.0,11/41,17.25%,NGFR;ERN1;ZBTB20;LRRC8D;PRKAA1;PDK3;PRKAA2;GCK;FOXK1;PIK3R2;SIRT1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.27964309309528257,0.9080346956168072,0.6592674805771365,0.8407839850255907,1.0,30/151,16.57%,CERS6;ST3GAL4;ACER3;SLC44A2;B4GALT5;CERS1;ELOVL5;GSTA3;SAMD8;SGMS1;SGMS2;CEPT1;ELOVL6;PCYT1A;CSNK2A2;CSNK2A1;ARG2;SLC44A1;SPTSSB;SLC44A5;SGPP2;PCSK5;ASL;SGPP1;GSTP1;ASS1;FA2H;VAPA;HACD4;MGST3
prerank,regulation of striated muscle contraction (GO:0006942),0.3649994552278002,0.9079327828466729,0.5879629629629629,0.8405265855036796,1.0,3/27,3.91%,GJA5;RNF207;HCN4
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3658140787346613,-0.9078876755578894,0.5714285714285714,0.8703968153052735,1.0,4/13,14.82%,IGF1;GOLGA2;CHP1;ALG10B
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3967398661029605,-0.9073724304162288,0.5899772209567198,0.8705849080855053,1.0,5/10,29.20%,CTBP1;SET;BRCA1;THAP7;KLF15
prerank,regulation of exosomal secretion (GO:1903541),-0.32541519438959693,-0.9068089384716904,0.5772357723577236,0.8708634314751706,1.0,3/19,7.33%,PRKN;VPS4B;HGS
prerank,regulation of cellular component organization (GO:0051128),0.28390310514409645,0.9062907919397863,0.6423766816143498,0.8433094534043134,1.0,34/135,18.87%,SGK3;RAP1A;ITCH;CD36;RASGRP2;MAD2L2;RAPGEF2;CD177;PICALM;BCAR1;TMC8;STK38L;LATS1;SETD5;HIP1;METTL4;PTPN1;IL17RB;NET1;PACSIN2;SLITRK4;ROCK1;STON1;AP2S1;SNX12;IRAK3;SEMA4D;ABL2;TRAF2;BBS10;NUBP1;NCLN;ARHGEF11;PINK1
prerank,spliceosomal complex assembly (GO:0000245),0.3300655594709863,0.9054642174451784,0.5924932975871313,0.8445229710705561,1.0,16/46,20.39%,CRNKL1;SNRPD2;PRPF6;SETX;SRSF10;CELF2;YTHDC1;DDX23;SF3A1;NCBP1;TXNL4A;CELF1;SF3B1;LUC7L3;SF3A2;LUC7L
prerank,protein deneddylation (GO:0000338),-0.39937850666419406,-0.9053896141931053,0.6073170731707317,0.8731248793209173,1.0,5/10,23.97%,COPS4;COPS7A;COPS2;COPS7B;COPS6
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.3776914551590831,-0.9049930452631872,0.60431654676259,0.8730014532824276,1.0,2/12,3.39%,CSF1R;CSF1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3286831625105765,0.9048113132146716,0.5967302452316077,0.8453364880954315,1.0,5/40,6.89%,SLC23A2;SLC23A1;SLC38A10;SLC25A30;ABCC1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.39492612175534536,-0.9046886282201034,0.5789473684210527,0.8726666171115113,1.0,3/10,7.88%,SYNGR1;DLG4;NETO1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3713930120607329,0.9045405634564884,0.5948795180722891,0.8454122901071867,1.0,10/22,22.74%,IKBKB;CRY2;PPP1R15A;FKBP1B;LGALS3;ROCK1;PTPA;TIPRL;GSK3B;TNF
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.41098615388270254,0.9042809273788036,0.6,0.8455074890063302,1.0,3/13,10.75%,MBD4;SMUG1;TDG
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.28176203634118435,-0.9042364272542806,0.6245954692556634,0.8726821593184043,1.0,4/33,4.22%,PRKG1;MEF2C;AIF1;APOD
prerank,cellular response to hypoxia (GO:0071456),0.2839753935975926,0.9040823069583069,0.6449771689497716,0.8454349365601752,1.0,21/126,12.97%,LIMD1;NDNF;PSME3;PTGIS;PSMB7;PSME2;HIPK2;ELOB;LMNA;CARD16;PSME4;BACH1;ACAA2;PSMB8;PSMD9;PSMA5;PSMB3;PSMD6;PSMC4;PSMD10;PSMB1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3851628692311244,0.903814286110824,0.5812883435582822,0.8454959678291137,1.0,6/17,15.54%,VIRMA;RNF20;ZC3H3;NUDT21;CCNT1;NCBP1
prerank,proteoglycan biosynthetic process (GO:0030166),0.3424934200047601,0.903442243675695,0.5948275862068966,0.8457508688632943,1.0,5/31,8.21%,EXT1;BMPR2;CHST12;PXYLP1;XYLT1
prerank,post-translational protein modification (GO:0043687),0.26595090399245447,0.9031556879934207,0.7327852004110997,0.8458629546182209,1.0,55/332,13.89%,FEM1C;DTL;TNC;PSME3;ASB5;CUL3;CUL5;NOTUM;KLHL11;LAMB1;GPC3;PSMB7;FBXW7;PSME2;DCAF5;FBXW11;FBXL8;DCUN1D1;SHISA5;WFS1;LGALS1;FBXW2;NEDD8;ATG5;ELOB;UBXN7;FBXO4;COP1;PSME4;IL6;COPS3;SUMF2;FBN1;PSMB8;FBXO32;PSMD9;PSMA5;FN1;MBTPS1;KLHL5;SUMF1;PRSS23;PTP4A2;PSMB3;PSMD6;DCUN1D3;PSMC4;APP;PSMD10;PSMB1;FBXL12;DCAF10;FBXO30;KTN1;DNAJC3
prerank,cellular response to increased oxygen levels (GO:0036295),-0.3707978202425307,-0.9031118034962016,0.5939849624060151,0.8742346473488255,1.0,5/11,28.38%,ATP6AP1;ATP6V0D1;ATG7;FAS;CAV1
prerank,negative regulation of RNA splicing (GO:0033119),0.3891219309007799,0.9030670463572843,0.5981308411214953,0.8455842297639704,1.0,4/19,9.17%,PTBP3;SRSF10;SAP18;SRSF4
prerank,glial cell differentiation (GO:0010001),0.35093052950900205,0.9028519550186314,0.5988857938718662,0.8455355630798503,1.0,3/28,4.08%,ADGRG6;STAT3;MYRF
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.31151771272148115,0.902658487051149,0.6065789473684211,0.845469160807968,1.0,8/56,10.08%,BMPR2;RBPMS;GDF1;BMP3;ENG;ACVR2A;SMAD4;PMEPA1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.38384307589638583,0.9021087327727607,0.5661538461538461,0.8460751888448851,1.0,7/18,22.03%,HSPA1A;ACAA2;SLC25A5;FZD9;MUL1;BID;GSK3B
prerank,fatty acid transport (GO:0015908),0.3880387710836598,0.9015358733253518,0.5889967637540453,0.8467667137726802,1.0,2/17,2.67%,PPARG;CD36
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.306759936962081,-0.9015055397128555,0.5955056179775281,0.8769222450014347,1.0,12/24,24.60%,CTC1;XRN1;SRC;TEN1;TERF1;TNKS2;EXOSC10;SLX4;HNRNPU;TINF2;PINX1;NAT10
prerank,regulation of necroptotic process (GO:0060544),0.3707092304642836,0.901460530459776,0.6025236593059937,0.8464516587341052,1.0,6/23,10.73%,BIRC3;PELI1;PDCD6IP;SPATA2;CYLD;RIPK1
prerank,muscle cell differentiation (GO:0042692),-0.28905295087050786,-0.9014290073838513,0.6241610738255033,0.8760350480868926,1.0,4/32,9.35%,MEF2C;NEBL;SPEG;NRAP
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.331470012226081,0.9005474985602497,0.6149732620320856,0.847754333319259,1.0,4/41,3.77%,RARA;PTPN22;LILRB1;PTPN6
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3838312997315137,0.900535068961292,0.5818476499189628,0.8473213541736664,1.0,5/19,14.84%,FFAR4;CARD16;GIT1;NLRP3;GSTP1
prerank,nuclear export (GO:0051168),-0.24047890595608779,-0.9004346908241938,0.7253886010362695,0.8773285473131129,1.0,23/80,18.22%,ATXN1;SRSF5;SRSF3;DDX39B;STRADA;RNPS1;SRSF7;NUP155;NUP188;THOC5;DHX38;NXF1;NUTF2;CHP1;ZC3H11A;SRSF2;DDX39A;NUP42;TPR;RAN;RANBP3L;CASC3;SRSF1
prerank,negative regulation of protein secretion (GO:0050709),0.331800904949707,0.900377913811767,0.6132596685082873,0.847179518590486,1.0,7/38,13.84%,IL1B;RAB11FIP1;ADRA2A;OPRM1;PSMD9;REST;SIRT4
prerank,positive regulation of endocytosis (GO:0045807),0.31841301145891393,0.9003310779140238,0.6048387096774194,0.8467999437220557,1.0,10/45,13.64%,STAP1;NEDD4L;CBL;GPC3;CDC42;CBLL1;HIP1;B2M;CLIP3;ANKFY1
prerank,regulation of feeding behavior (GO:0060259),0.430777203869914,0.9002817543693097,0.5856905158069884,0.8464390267989094,1.0,1/11,2.38%,STAT3
prerank,positive regulation of calcium ion transport (GO:0051928),-0.275585152046886,-0.9002108549085691,0.5967741935483871,0.8767710251472876,1.0,10/36,17.93%,CACNA1D;CACNB2;P2RX7;ANK2;P2RX4;CRACR2A;TRPC3;CAMK2A;CCL3;SPHK2
prerank,diacylglycerol metabolic process (GO:0046339),-0.3102440151569715,-0.9000922170878335,0.6091549295774648,0.8759782117566981,1.0,5/23,9.85%,DGKZ;PLA2G15;DAGLA;DGKQ;GPAM
prerank,cell junction maintenance (GO:0034331),0.40662515610760847,0.900044226241825,0.6282894736842105,0.8464856450257134,1.0,2/14,3.33%,CLDN1;CD177
prerank,protein targeting (GO:0006605),0.2813210856934293,0.8998165548924063,0.6293706293706294,0.8464812801827147,1.0,16/118,10.60%,AP1S3;VPS37C;MYO1C;SORL1;PEX16;PEX12;ZDHHC7;KATNB1;ZFAND6;ZDHHC6;DNAJC19;ZDHHC23;SEC63;PIKFYVE;TOMM40;FIS1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.4059042906230216,0.8996417092682841,0.5800653594771242,0.8463477811690873,1.0,4/14,10.70%,MYO1C;VEGFC;PGF;PIK3CA
prerank,response to interferon-beta (GO:0035456),0.36901838575248785,0.8995036193878578,0.6021840873634945,0.8461672968838326,1.0,10/22,22.94%,PLSCR1;STAT1;ACOD1;PNPT1;IFITM3;IFNAR2;AIM2;CDC34;BST2;UBE2K
prerank,phosphatidylserine metabolic process (GO:0006658),0.3395512440863535,0.8990856029855933,0.5963431786216596,0.8465576037927032,1.0,2/32,2.34%,PLA1A;PLSCR1
prerank,DNA damage checkpoint signaling (GO:0000077),0.34394958256076985,0.898859373162203,0.6037463976945245,0.8465532096331927,1.0,10/28,18.74%,CDC5L;CEP63;CLOCK;DOT1L;BRIP1;MAP3K20;DONSON;HUS1;RAD17;CHEK2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3833958339503173,0.8984854872971547,0.5787781350482315,0.8468263261737862,1.0,6/18,16.30%,CAMK1D;RPS6KA5;LPAR5;CRTC3;LRP8;RELN
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.32848138163056967,0.8981816575075839,0.6141522029372497,0.8469863894736926,1.0,4/43,3.77%,RARA;PTPN22;LILRB1;PTPN6
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.42949316875029986,0.8979177825979414,0.6,0.8470431958278875,1.0,2/10,13.00%,UPB1;NT5C3A
prerank,protein neddylation (GO:0045116),0.39857302020486696,0.897779236097005,0.5849673202614379,0.8468709270242865,1.0,3/13,11.55%,DCUN1D1;NEDD8;DCUN1D3
prerank,positive regulation of microtubule polymerization (GO:0031116),0.347094446463908,0.8970006917927534,0.5936599423631124,0.8479473411259532,1.0,9/28,16.69%,PAK1;HSPA1A;MECP2;RAC1;GIT1;RPS3;CLASP1;OCLN;FES
prerank,cellular amide metabolic process (GO:0043603),-0.22031376088504115,-0.896930262085157,0.7142857142857143,0.8823952083576005,1.0,43/102,29.15%,CERK;PCCA;MCCC1;PLA2G15;ST6GAL1;PLPP3;MTHFD2L;ATF4;PANK2;PLPP1;ACSF2;MTHFS;AASDHPPT;ABHD4;ACOT9;SGPL1;GPAT4;NLN;ACOT7;AEBP1;ORMDL3;MLYCD;NAPEPLD;ABCB9;PPP2R1A;OXSM;ACOT6;PLAAT3;PDZD11;CPE;DHFR;ACOT8;ORMDL1;SHMT2;FPGS;SMPD3;MTHFD1;ALDH1L1;SLC46A1;SMPD1;SMPD2;ACSL6;ABCA2
prerank,protein localization to cell-cell junction (GO:0150105),0.40399854080225545,0.8967235031133195,0.6045380875202593,0.8480430020943791,1.0,3/15,7.62%,ARHGEF18;PAK2;F11R
prerank,androgen metabolic process (GO:0008209),0.37585196218402217,0.8962195382309669,0.5987261146496815,0.8485302966588373,1.0,4/18,15.77%,HSD17B7;DHRS9;HSD17B11;MED1
prerank,embryonic digit morphogenesis (GO:0042733),-0.3211463040871519,-0.8959038966520341,0.6038251366120219,0.8837075962683193,1.0,3/18,11.75%,SALL1;WDPCP;GLI3
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.24812751870888672,-0.895638278085953,0.6621004566210046,0.8822204670793746,1.0,33/56,33.62%,NDUFAF6;NDUFAF2;OXA1L;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;FOXRED1;NDUFA5;NDUFB5;NDUFB9;NDUFB7;NDUFAF7;ACAD9;NDUFA13;TIMMDC1;NDUFAF1;BCS1L;NDUFB8;NDUFAB1;NDUFB6;NDUFS8;NDUFB10;TMEM126A;NDUFAF4;NDUFS3;NDUFS6;NDUFA11;NDUFAF8;NDUFB11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.24812751870888672,-0.895638278085953,0.6621004566210046,0.8822204670793746,1.0,33/56,33.62%,NDUFAF6;NDUFAF2;OXA1L;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;FOXRED1;NDUFA5;NDUFB5;NDUFB9;NDUFB7;NDUFAF7;ACAD9;NDUFA13;TIMMDC1;NDUFAF1;BCS1L;NDUFB8;NDUFAB1;NDUFB6;NDUFS8;NDUFB10;TMEM126A;NDUFAF4;NDUFS3;NDUFS6;NDUFA11;NDUFAF8;NDUFB11
prerank,glycolipid metabolic process (GO:0006664),0.31974732157689223,0.8948582412704763,0.6210106382978723,0.8507941192216244,1.0,11/47,12.63%,ST3GAL4;GM2A;ST8SIA6;ESYT3;ESYT1;PSAP;ST6GALNAC3;SUMF2;FUCA1;SUMF1;ESYT2
prerank,regulation of fat cell differentiation (GO:0045598),0.30042575542154626,0.8945552365377297,0.6254681647940075,0.8509163199831334,1.0,13/74,15.30%,CREB1;PPARG;LMO3;WDFY2;ZFP36L2;IL6;ID2;CREBL2;CCDC71L;AKT1;TGFB1;GPS2;ASXL2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.248078268672147,-0.8943995541456755,0.6504424778761062,0.8840603251951151,1.0,22/56,28.38%,PTPRD;NRP1;IL1RAPL1;NLGN1;GRID2;PPM1F;IL1RAP;FLOT1;VEGFA;NLGN2;CLSTN2;CNTNAP2;NLGN3;NRXN1;DLG5;CUX2;KDR;TSC1;NPHP1;NPHP4;ABL1;CAV1
prerank,protein autoubiquitination (GO:0051865),0.308195166167575,0.8939680328762053,0.6327827191867853,0.8516168031418423,1.0,17/61,17.77%,ITCH;DTX3L;CUL3;RNF146;RNF213;UBE2D3;RNF141;WWP2;RNF13;TRIM71;TRIM17;SH3RF1;UHRF2;RNF122;RNF41;TRAF2;RNF19B
prerank,generation of neurons (GO:0048699),0.27127112777990836,0.8936446057241227,0.6803551609322974,0.8517682159885338,1.0,15/190,8.24%,IL1B;RUNX2;RUNX3;SDCCAG8;IER2;NDNF;CELSR1;RACGAP1;NAV1;RAPGEF2;CEP85L;MTPN;PAFAH1B1;DDIT4;RAC1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.35930164634783607,-0.8931078786253261,0.6111111111111112,0.8860114644843002,1.0,8/13,54.08%,ADRA1B;ADRA1A;CAV1;SMTNL2;AVPR2;TBXA2R;OXTR;AVPR1A
prerank,cortical actin cytoskeleton organization (GO:0030866),0.3741362489664871,0.8928893675447566,0.5985185185185186,0.8527811095628242,1.0,6/20,20.64%,LCP1;IKBKB;ROCK1;FHOD1;FMNL1;LLGL2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.3111015520125693,-0.8928602791358049,0.6253443526170799,0.8855259373974745,1.0,9/19,24.51%,RENBP;AMDHD2;NAGK;UAP1L1;GFPT1;GNPDA2;NANS;GNPNAT1;MPI
prerank,positive regulation of nuclear division (GO:0051785),0.35292351338748246,0.8927035271485685,0.6090775988286969,0.8526910751550234,1.0,1/25,0.33%,IL1B
prerank,histone methylation (GO:0016571),0.3473409362272092,0.8926916442428835,0.6036036036036037,0.8522522814323675,1.0,7/26,19.03%,NSD3;PRMT8;NSD1;EZH2;CREBBP;NTMT1;EHMT1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2617265144037452,0.892549022391094,0.7203742203742204,0.8520697529648831,1.0,77/314,18.68%,FEM1C;ITCH;PSME3;NEDD4L;CUL3;CUL5;UBE2E1;TBL1XR1;PSMB7;FBXW7;PSME2;KCTD2;PELI1;UBE2D3;SPOP;DCAF12;FBXW11;FAF1;FBXL8;KLHL15;FBXO38;WFS1;NFE2L2;TRIM25;FBXO4;CLOCK;ERLIN1;UBR2;COP1;PCNP;PSME4;ATXN3;WWP2;TRIM71;UBE2W;PSMB8;PSMD9;KCTD5;PSMA5;DNAJB12;FBXL17;PSMB3;UBE2S;PSMD6;PSMC4;FOXRED2;PSMD10;UBE2G1;AREL1;PSMB1;FBXL12;UBE2J2;VCP;PPP2R5C;STT3B;AURKB;ANAPC7;UBXN11;RMND5B;KCTD13;RNF122;TAF1;HACE1;FBXL16;PSMD12;RB1;MAN1B1;UBR3;MAEA;ECRG4;SIRT1;HSPA5;SMURF2;ANAPC11;FZR1;FBXL14;ANAPC4
prerank,cellular response to dsRNA (GO:0071359),0.3841339115438467,0.8924467942305254,0.5940438871473355,0.8518057351234875,1.0,4/15,13.86%,IFIH1;RALB;PQBP1;IFIT1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3691828182589119,0.8917607069389203,0.5990783410138248,0.8526510376299224,1.0,3/21,8.21%,EXT1;SULF2;XYLT1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.28793115324866386,0.891529879451853,0.6487148102815178,0.8526503273021292,1.0,11/88,10.95%,AP1S3;STXBP6;EXOC6;EPS15;SORL1;AP1S2;RP2;ARF1;GBF1;VPS13A;AP1G1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.2965683105923543,-0.8913352256985477,0.6496815286624203,0.888041627061503,1.0,7/23,16.96%,BCL9;SMAD7;NREP;SMAD3;TRIM33;DKK3;SOX11
prerank,modulation by host of symbiont process (GO:0051851),-0.2838302558590419,-0.8913332608771803,0.632258064516129,0.8869941995124682,1.0,10/31,20.82%,CX3CR1;TARDBP;HPN;SMARCB1;SNW1;CCL3;SP1;HMGA2;NAPEPLD;RRP1B
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4081642077767955,0.8912384950639957,0.5979899497487438,0.8527380557095718,1.0,2/12,6.13%,WAC;CCND1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.24995380776020765,-0.8911850755082081,0.6808510638297872,0.8862850021005333,1.0,22/54,26.07%,CNOT4;CRADD;PLK3;CNOT10;SOX4;PCNA;BAX;TFDP2;TFDP1;CNOT11;ARID3A;PCBP4;CNOT7;GADD45A;MDM4;CARM1;E2F1;CDKN1A;MDM2;PLK2;RGCC;RPL26
prerank,glycolipid biosynthetic process (GO:0009247),0.32892588558613545,0.89104452721967,0.6049382716049383,0.8526780196942363,1.0,3/38,3.57%,ST3GAL4;ST8SIA1;ST8SIA6
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3129889570521307,-0.8909291691329634,0.6368563685636857,0.8857954612474421,1.0,1/20,0.42%,IGF1
prerank,cellular response to glucagon stimulus (GO:0071377),0.38056116730305845,0.8908053872655071,0.6102819237147595,0.8526757091316907,1.0,4/17,12.41%,CYSLTR2;PRKAR2A;ADCY7;ADCY5
prerank,embryonic digestive tract development (GO:0048566),-0.32062618269434595,-0.8900824667985286,0.6010230179028133,0.8867485776744832,1.0,6/18,16.96%,SALL1;FGFR2;GLI3;TGFB2;PKDCC;SOX11
prerank,signal transduction by p53 class mediator (GO:0072331),-0.27909178284311587,-0.8897197835903874,0.6197604790419161,0.8865153440282079,1.0,11/30,24.19%,FHIT;DDX5;MYO6;PYCARD;MYBBP1A;PPP1R13B;JMY;SESN2;ACER2;MDM4;HINT1
prerank,protein prenylation (GO:0018342),-0.38307083798179814,-0.8896664492200567,0.6048034934497817,0.8855964300710701,1.0,5/10,30.35%,PGGT1B;FNTB;CHML;RCE1;FNTA
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3136556565147936,-0.8891870552776725,0.6256983240223464,0.8856786090332096,1.0,7/21,18.44%,MEF2C;MAGI2;MTMR9;CALM1;GPLD1;PLEK;HSP90AB1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.37632726993985016,0.889169630760689,0.6110210696920584,0.8554090196635147,1.0,4/17,12.44%,MMGT1;EMC9;CAMLG;EMC10
prerank,transition metal ion homeostasis (GO:0055076),0.3472144532732506,0.888931770552946,0.5811836115326252,0.8554374954752051,1.0,9/28,15.35%,ABCB7;PICALM;HEPH;TMC8;B2M;HMOX2;IREB2;CUTC;XIAP
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.31387976646118876,0.8888611840076239,0.6318607764390897,0.8551094313194583,1.0,11/52,14.08%,RAC2;FBXW7;BBC3;UBE2D3;ARIH2;CSNK2A2;RNF31;YWHAZ;MAPK8;SREBF2;UBE2J2
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3754853487109744,-0.8884217733820434,0.5912408759124088,0.8864344946390835,1.0,6/11,24.37%,TRIM37;CENATAC;NPM1;RBM14;BRCA1;CCNF
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3518672226629813,0.8884062073845665,0.6054913294797688,0.8554795757093946,1.0,4/26,7.70%,PRKAG2;ELOVL5;PRKAB2;ERLIN1
prerank,response to zinc ion (GO:0010043),0.35868867485324074,0.8882145481602371,0.5959885386819485,0.8553961171118529,1.0,3/25,6.74%,SLC30A4;HAAO;CRIP1
prerank,nucleic acid metabolic process (GO:0090304),0.2994500971083531,0.8877463016386933,0.6292559899117276,0.8558579984001038,1.0,7/69,6.89%,DNA2;GTF2F2;FEN1;POLR2C;DNTT;XRN2;WRN
prerank,regulation of hormone secretion (GO:0046883),-0.34879614970092704,-0.8877112990269393,0.6318537859007833,0.8870137859487951,1.0,4/15,19.09%,SNX6;SCG5;SOX11;VAMP3
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.32377972432348656,-0.8875207623949017,0.6317280453257791,0.8864228817451864,1.0,8/18,22.36%,ZDHHC2;MMP14;VTI1B;CDK5;VAMP8;AR;STX8;CLN3
prerank,positive regulation of viral transcription (GO:0050434),0.35422591145897275,0.8872106638229293,0.6144578313253012,0.856460637664019,1.0,7/25,18.81%,GTF2F2;POLR2C;NELFA;CCNT1;RSF1;SUPT4H1;MDFIC
prerank,regulation of interleukin-17 production (GO:0032660),-0.2766865329668764,-0.8868598077869718,0.6360544217687075,0.8869379466493725,1.0,5/31,12.63%,VSIR;LY9;SLAMF6;NCKAP1L;TLR4
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.298094750592176,-0.8868077771786895,0.641566265060241,0.8860226237927401,1.0,10/26,23.29%,EPHA5;KLF7;EFNA5;C2CD2L;GPLD1;ADCY8;STXBP4;PIM3;BRSK2;CDK16
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.41255977244424813,0.8866528232944533,0.6009852216748769,0.8570684329408591,1.0,4/13,15.54%,FIP1L1;TUT1;NUDT21;NCBP1
prerank,pancreas development (GO:0031016),0.4048433498652414,0.8864097363129483,0.5759599332220368,0.8570890804650653,1.0,3/12,16.74%,SELENOT;CCDC39;PROX1
prerank,organelle fission (GO:0048285),-0.2990852671008497,-0.8859904274242792,0.6575757575757576,0.8867796050248553,1.0,4/24,9.37%,PRKN;GDAP1;DNM1;MFF
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.27677849923405495,-0.8859682275995575,0.6518771331058021,0.8858086735183751,1.0,7/33,11.91%,TJP1;GLUL;FGF2;EPN1;EPN2;JAK1;VEGFA
prerank,cellular response to nitrogen compound (GO:1901699),-0.3151570388501146,-0.8859092272200043,0.627906976744186,0.8849155861942708,1.0,7/20,24.61%,EPG5;BLM;RTF2;NSMCE3;DDX11;TIMELESS;PDE12
prerank,iron ion homeostasis (GO:0055072),-0.24441855044997035,-0.885876106173521,0.7280701754385965,0.8839479109129635,1.0,13/58,10.83%,FRRS1;SLC11A1;ABCG2;ATP6AP1;FLVCR1;SLC22A17;SLC11A2;TFRC;FTH1;ATP6V0D1;CAND1;FTL;HMOX1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.38102465843863054,-0.8858662321817888,0.6178660049627791,0.8829412530099868,1.0,1/11,0.12%,PRKN
prerank,regulation of lymphocyte activation (GO:0051249),-0.3671342472044369,-0.8858110839843532,0.6053921568627451,0.882028725904824,1.0,1/12,0.27%,PAG1
prerank,Golgi to endosome transport (GO:0006895),-0.33595104812747284,-0.8856048533473255,0.6457831325301204,0.8814827001401674,1.0,5/16,11.24%,AP2A1;SORT1;DOP1B;MON2;AP1AR
prerank,leukotriene biosynthetic process (GO:0019370),0.3901501089308325,0.8855154598371519,0.6112852664576802,0.8583647083895717,1.0,2/14,6.39%,ALOX5AP;GGTA1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.3302932100115483,-0.8851624588472756,0.6302083333333334,0.8814756612281354,1.0,9/17,30.39%,ALG8;MPDU1;ALG2;ALG9;ALG1;ALG6;ALG3;DOLPP1;DOLK
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3686823532869051,0.8849630409861687,0.6092814371257484,0.8589174137694819,1.0,8/21,16.87%,TALDO1;RPE;DERA;GPI;RBKS;PGM2L1;H6PD;GCK
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.37384807367538325,0.8848502246821727,0.6049766718506998,0.8586652901641394,1.0,2/18,3.25%,PTPN22;LAPTM5
prerank,positive regulation of macroautophagy (GO:0016239),0.31207026691963297,0.8840748619985696,0.6455525606469003,0.8596895626615685,1.0,15/48,18.87%,UVRAG;PIP4K2A;WAC;RALB;PIP4K2B;SLC25A5;HTT;MAP3K7;PRKAA2;FYCO1;TBK1;SIRT1;BAG3;VPS13D;PINK1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.35265747829837096,0.8840000138865636,0.6167192429022083,0.8593847881005054,1.0,8/23,22.94%,PRKAG2;AXIN1;APP;TGFB1;MAPK1;TNKS1BP1;RIPK2;UBE2K
prerank,positive regulation of ion transport (GO:0043270),0.31829903522550107,0.8837375869782024,0.625,0.8594156938946611,1.0,7/48,6.40%,CCR1;KIF5B;ATP2B1;GDNF;ADRA2A;STIM2;WFS1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3221411689144479,-0.8835116390816941,0.6187845303867403,0.8841224601580188,1.0,8/18,27.22%,APOE;PSEN2;BACE1;PSENEN;TMCC2;CLN3;APH1A;NSG1
prerank,regulation of cellular localization (GO:0060341),0.31544322725555973,0.8834687538714882,0.6263440860215054,0.8594628278644669,1.0,7/46,12.41%,LRRK2;LYN;UNC13D;TRIM46;DVL3;DYNC1H1;ADCY5
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.3859029872078601,0.8834311648509563,0.6370967741935484,0.8590810636386538,1.0,6/15,18.71%,CHST12;NCAN;UST;CSGALNACT1;DSEL;VCAN
prerank,regulation of neuroblast proliferation (GO:1902692),0.4008744081170133,0.8832391187254696,0.613013698630137,0.8589952311810857,1.0,1/15,0.22%,LRRK2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3366884395931648,0.883055266751949,0.6262482168330956,0.8588864457699609,1.0,4/33,5.94%,SP100;MARVELD3;SYNJ2BP;PTEN
prerank,Golgi to lysosome transport (GO:0090160),0.4218244074851738,0.8829045590345694,0.6048109965635738,0.8587060640163312,1.0,4/11,17.89%,LAPTM5;AP1G1;ANKFY1;EHD3
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3823114226661295,-0.882821664595396,0.6166281755196305,0.8847109387082864,1.0,7/10,28.13%,ABCD2;NR1H2;LPGAT1;MID1IP1;MLXIPL;SLC45A3;NR1H3
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.33012192924558875,0.8827658879765187,0.6229281767955801,0.8585290110075804,1.0,8/36,15.64%,UXT;RBBP8;RYBP;RBBP4;APAF1;L3MBTL2;EZH2;PHC3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3207829843872994,0.8825465257559663,0.6563342318059299,0.8585262653722088,1.0,7/40,12.27%,MCL1;ARMT1;CRY1;UBE2N;ING2;PARG;SMG1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.33533360148692454,0.8822609426516937,0.6174033149171271,0.8586170701185519,1.0,8/33,11.31%,MAP3K5;SETX;NFE2L2;IL6;RPS3;ANXA1;RIPK1;NET1
prerank,carbohydrate derivative transport (GO:1901264),0.3663237313285096,0.881944459807747,0.6021671826625387,0.858759490867456,1.0,4/18,14.67%,SCARB1;SLC15A4;SLC10A7;ABCG1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.37441832034780265,-0.881897190838473,0.6086956521739131,0.8847572514056692,1.0,5/11,34.28%,PKD2;CALM1;GSTO1;FKBP1A;CALM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.37441832034780265,-0.881897190838473,0.6086956521739131,0.8847572514056692,1.0,5/11,34.28%,PKD2;CALM1;GSTO1;FKBP1A;CALM2
prerank,atrioventricular valve development (GO:0003171),0.386528443939864,0.881772831050025,0.5941080196399345,0.8586229804317722,1.0,2/14,2.95%,GJA5;BMPR2
prerank,peptidyl-methionine modification (GO:0018206),-0.37154190610397186,-0.8814464955929183,0.6122448979591837,0.8847499780821375,1.0,2/12,3.64%,METAP1D;METAP2
prerank,response to hexose (GO:0009746),-0.2915765546143754,-0.8811457099700378,0.6357388316151202,0.8843789465390107,1.0,6/25,18.07%,PFKL;EIF2B5;EIF2B4;SLC2A5;GPLD1;TCF7L2
prerank,protein localization to phagophore assembly site (GO:0034497),0.4174259747868897,0.8808844160858597,0.6192109777015438,0.8598844863220805,1.0,5/11,21.60%,STX17;PACS2;WIPI2;ATG13;TRAPPC8
prerank,regulation of neuron projection arborization (GO:0150011),-0.3376505690272402,-0.8805718845330676,0.6190476190476191,0.8845968938092746,1.0,3/15,3.71%,MYO9A;GRIP1;DLG4
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.31908889723433204,0.8799091298703892,0.6525885558583107,0.8612849568589329,1.0,10/45,12.23%,MEX3D;RC3H1;MTPN;PUM2;TRIM71;PARP9;YTHDC1;NUDT21;FOXO3;APP
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4069612279056178,0.8796203165511545,0.6303236797274276,0.861369907854807,1.0,1/12,2.38%,STAT3
prerank,positive regulation of ruffle assembly (GO:1900029),-0.34851482308099835,-0.8791765002091273,0.6626794258373205,0.8868139927741376,1.0,3/13,5.74%,P2RY12;NLGN1;PFN1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3369792139471428,0.8791115392488924,0.6420612813370473,0.8618699822531863,1.0,3/30,3.32%,KCNE3;NEDD4L;KCNQ1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.37593699316479395,0.8790039921361316,0.610062893081761,0.8616264992801373,1.0,7/17,15.64%,RBPJ;STAT1;PLXND1;PBX1;KAT2B;CREBBP;MAML1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3527896975435972,0.8780083355672472,0.6188340807174888,0.8630350966075907,1.0,5/24,12.20%,ITCH;UBE2N;CYLD;TAB3;MAP3K7
prerank,positive regulation of protein polymerization (GO:0032273),0.2986425959433305,0.8779293576926411,0.6675159235668789,0.8627257198379623,1.0,10/65,10.69%,HCK;PRKCE;PAK1;CARMIL1;PTK2B;TPPP3;RAC1;RPS3;SNX9;VASP
prerank,regulation of axon regeneration (GO:0048679),0.40727781669234553,0.87761724786908,0.6242038216560509,0.8628424480828522,1.0,2/12,4.10%,STK24;INPP5F
prerank,response to laminar fluid shear stress (GO:0034616),0.41685790031859604,0.8775086219065317,0.5939716312056738,0.8625880541036837,1.0,5/10,15.02%,KLF4;NFE2L2;MAP2K5;SREBF2;ASS1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3130767522103752,0.877419942763159,0.6472868217054264,0.8623100363146298,1.0,8/48,10.54%,BCL3;MCL1;HIPK2;HIPK1;CRIP1;DDIT4;MSH6;CASP2
prerank,RNA processing (GO:0006396),0.2701098372487291,0.8771680750398626,0.7184466019417476,0.862333885965395,1.0,49/176,20.27%,MBNL1;RSRC1;RBPMS;RNPC3;SNRPD2;PRPF6;PPP1R9B;NUFIP1;RBMS1;XRN2;SNRPB;SETX;RBMS2;TUT1;LSM5;MAGOHB;PRPF3;RP9;TENT2;SRSF4;DHX8;SLU7;CELF2;NUDT21;MTPAP;TUT7;DEDD2;DDX23;SNRPA1;CDK12;SF3A1;METTL3;SYNCRIP;TENT4B;NCBP1;CELF1;RBM39;AURKAIP1;TFIP11;SUPT4H1;SF3B3;CSTF3;SF3B2;SF3B1;DDX20;PDCD7;HNRNPC;LUC7L3;SF3A2
prerank,sphingosine metabolic process (GO:0006670),0.37347858204129897,0.8771333869667078,0.6115702479338843,0.8619473438602034,1.0,4/17,14.73%,ACER3;NAAA;SGPP2;SGPP1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3001692896593649,0.8771311488616742,0.6623876765083441,0.8615026115488899,1.0,13/60,15.94%,KLF4;PKIB;FBXO4;HGF;PARM1;WRAP53;TNKS;MAP3K4;CHTF18;AURKB;MAPK1;TCP1;POLG2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3666822586434186,0.87698612813497,0.6198083067092651,0.8613086595895582,1.0,7/21,16.93%,MYH9;ADAM17;SPPL2A;ADAM19;BACE2;ADAM9;PSEN1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.42174652475569296,0.8769799975810451,0.6078767123287672,0.8608709390021548,1.0,1/11,1.24%,PLCG2
prerank,mitotic spindle assembly (GO:0090307),0.3140016885155045,0.8769473311677312,0.6352112676056338,0.860488034187813,1.0,10/42,15.76%,RACGAP1;KIF23;FLNA;RHOA;STAG1;KIF3B;STAG2;CLASP1;AURKB;KPNB1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3714852824686936,0.8767971280066368,0.6222910216718266,0.8603207851095769,1.0,2/20,2.48%,LONP1;HSPA1A
prerank,ncRNA catabolic process (GO:0034661),-0.2821010658722338,-0.8764348270684788,0.6379821958456974,0.8920412080145184,1.0,9/28,19.78%,XRN1;POP1;TRIR;EXOSC9;EXOSC5;DIS3L2;EXOSC10;LIN28B;EXOSC3
prerank,glucose metabolic process (GO:0006006),-0.23962694664459058,-0.8764073393123217,0.7105263157894737,0.8910774154283752,1.0,15/58,18.29%,APOD;GOT1;PPARGC1A;AKR1A1;PGK1;ATF4;GAA;PCK2;CRTC2;ENO2;SLC25A11;BRAT1;PER2;PGAM1;G6PC3
prerank,digestive tract development (GO:0048565),0.3302472868829591,0.8762954789788858,0.6477272727272727,0.8608182815626897,1.0,5/32,13.38%,GLI1;NIPBL;CCDC39;KIT;PCSK5
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3608802815929023,0.8759691291505893,0.6170542635658914,0.8605376920444051,1.0,8/20,17.95%,HIBADH;DLD;BCKDHA;BCKDHB;ACAT1;HIBCH;BCAT1;AUH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3608802815929023,0.8759691291505893,0.6170542635658914,0.8605376920444051,1.0,8/20,17.95%,HIBADH;DLD;BCKDHA;BCKDHB;ACAT1;HIBCH;BCAT1;AUH
prerank,negative regulation of DNA recombination (GO:0045910),0.317729607213023,0.875851896073946,0.6373477672530447,0.8603186110865835,1.0,8/43,12.77%,MAD2L2;POLR2C;SMCHD1;KLHL15;MSH3;MSH6;DAXX;ATRX
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.3761958645206821,-0.8757476202525288,0.6183574879227053,0.8914814481171934,1.0,4/11,19.78%,DKC1;EXOSC5;EXOSC10;EXOSC3
prerank,chemical homeostasis (GO:0048878),0.3035896433548177,0.8755894143087254,0.6631853785900783,0.8603583250090254,1.0,7/61,7.53%,PPARG;NEDD4L;ZBTB20;SLC4A7;FBXW7;ACOX3;SLC4A8
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.33702835208213755,-0.8755097023446399,0.6522911051212938,0.8910068367850442,1.0,3/15,7.28%,KCNJ2;ATP1B1;KCNN2
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.4092793914352963,0.875394560393381,0.6160558464223386,0.8602695547930367,1.0,3/11,7.93%,MSN;SORL1;EZR
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3158229775848382,0.8751139906766188,0.643908969210174,0.8603680276880475,1.0,11/45,19.43%,BCL6;BTG2;BTG1;NABP1;ZFP36L2;TGFB1;WEE1;TRIM35;AURKAIP1;FOXC1;FZD3
prerank,autophagy of peroxisome (GO:0030242),-0.35884283612848306,-0.8738195869047825,0.6374133949191686,0.8938042256435996,1.0,4/12,14.63%,NBR1;MAP1LC3B;USP30;SQSTM1
prerank,negative regulation of cartilage development (GO:0061037),-0.3452735911743645,-0.8737613149046849,0.6314432989690721,0.892930623972684,1.0,1/13,1.23%,TGFBR1
prerank,copper ion transport (GO:0006825),0.41543790122188884,0.873718393782668,0.6225749559082893,0.8625193559773576,1.0,5/11,16.54%,ATP7A;ATOX1;COX17;CUTC;SLC31A1
prerank,regulation of blood coagulation (GO:0030193),0.34046550774516565,0.8736944571494323,0.6447368421052632,0.8621133738544685,1.0,3/27,8.29%,ST3GAL4;FAP;EPHB2
prerank,organic cation transport (GO:0015695),-0.3065848616632497,-0.8733249861529528,0.6582633053221288,0.8928552608974656,1.0,5/20,14.55%,SEC14L1;SLC25A26;SLC22A5;SLC5A7;SLC22A4
prerank,phosphatidic acid metabolic process (GO:0046473),-0.24631927386382516,-0.8729709590127733,0.7510917030567685,0.8926405969203102,1.0,9/48,11.72%,PLD1;DGKZ;LPCAT1;SLC27A1;PLA2G4A;DGKQ;GPAM;DDHD2;ABHD4
prerank,axonal fasciculation (GO:0007413),-0.34591812457065896,-0.872859214276076,0.624113475177305,0.8918680144165393,1.0,3/12,9.16%,CNTN4;CDK5R1;ARHGAP35
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.3947542183071639,0.8726847268376802,0.6313213703099511,0.8636139946649536,1.0,5/13,12.06%,WFS1;PPP1R15A;PTPN1;PPP1R15B;ATF6B
prerank,regulation of neurogenesis (GO:0050767),0.30437735557854745,0.8724349872671296,0.6564495530012772,0.8636410759961444,1.0,9/55,12.58%,IL1B;SORL1;IL6;OPRM1;SPEN;B2M;NAP1L1;REST;RGS14
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.2950621572759731,-0.8723730713973601,0.6342182890855457,0.8919390215913869,1.0,13/24,32.51%,ABCG2;FLVCR1;FECH;ALAS1;CPOX;COX10;FXN;SLC25A38;PGRMC1;ABCB10;HMBS;UROD;ATP5IF1
prerank,positive regulation of protein maturation (GO:1903319),-0.36462094761775093,-0.8722718833847093,0.6314553990610329,0.8911506094508573,1.0,3/11,14.65%,ADAM8;SOX4;CCBE1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4121782040154101,0.8720869852798545,0.6384892086330936,0.8638208570545557,1.0,1/10,3.69%,GPR35
prerank,protein deacylation (GO:0035601),0.3565560908780591,0.8714148964459568,0.6163141993957704,0.8646285224546646,1.0,13/23,25.44%,NOTUM;ABHD17B;HDAC3;PPT1;SIRT1;ABHD17A;HDAC7;HDAC1;SIRT3;HDAC5;SIRT2;LYPLA1;SIN3A
prerank,establishment of vesicle localization (GO:0051650),0.3632277866152511,0.8710338702778607,0.6226114649681529,0.8648933962380461,1.0,5/18,14.68%,KIF5B;SYNJ1;SNAPIN;LIMK2;KIF5A
prerank,regulation of smooth muscle contraction (GO:0006940),-0.3148843208996565,-0.8710023579742362,0.6183844011142061,0.8928860546369736,1.0,3/20,6.19%,CHRM3;CHRM2;SETD3
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3347365002597809,0.8703196094800998,0.6212765957446809,0.8657659075395084,1.0,4/32,13.29%,CXCL10;FAM3A;RNASE6;RPL30
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.2616108245036941,-0.8703152531232153,0.6831683168316832,0.8933636930778383,1.0,2/36,0.83%,OPHN1;FHIT
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.2959111374616023,0.8699744854181967,0.6704260651629073,0.8659401157411327,1.0,7/66,5.46%,RUNX3;MARVELD3;CASK;FBXW7;SYNJ2BP;STAT1;CAV2
prerank,positive regulation of DNA recombination (GO:0045911),-0.28564264036578507,-0.86982993812926,0.6487341772151899,0.8933880381570779,1.0,10/27,17.31%,ERCC6;MMS19;TFRC;FUS;ZCWPW1;RIF1;SHLD2;ERCC2;HMCES;MRNIP
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.28492613302245123,-0.869576386137948,0.6586206896551724,0.8929457603285895,1.0,6/27,12.19%,PLA2G15;PNPLA8;SLC27A1;ABHD4;CHKA;PCYT2
prerank,gene expression (GO:0010467),0.25788234095004814,0.8694736190568375,0.7926455566905005,0.8663890633491044,1.0,84/348,19.68%,ZAR1;BCL3;RPL5;NUP210;RBPMS;SORL1;POLR3A;RPS10;POLR2C;SCX;RPL37A;MRPL55;RPL6;MRPL18;NUFIP1;RBMS1;RPS18;XRN2;SETX;RPS14;RPL35A;NUP98;THOC3;RBMS2;FIP1L1;GALNT2;MAGOHB;TSPAN14;MRPL13;RPL13;NFKBIB;SRSF4;CREBL2;DHX8;SLU7;RPS3;TSPAN33;IGF2BP3;RPS21;CELF2;FARSB;UPF2;YTHDC1;DEDD2;RPLP0;RPL34;BAZ2A;SMG1;AGFG1;NUP153;RPL19;RPL11;RPL30;RPL4;RPS2;SYNCRIP;RPL7;RPS15A;CPSF3;TSPAN15;NCBP1;MRPS6;RBM39;RPS4X;MRPS33;SMG6;TSPAN5;SEH1L;TFIP11;HARS2;HSPD1;TSPAN17;NUP93;GSPT1;RPL32;RPSA;ANGPT2;DDX20;RPS13;MRPS15;UPF3B;WDR33;CDC40;RPS6
prerank,cellular response to unfolded protein (GO:0034620),0.3416928560149888,0.8693477788894265,0.6277695716395865,0.8661757242383387,1.0,10/26,19.98%,HSPA1A;ERN1;TM7SF3;DAXX;PTPN1;HSPA9;HSPD1;BAG3;HSPA5;RHBDD1
prerank,positive regulation of protein processing (GO:0010954),-0.31039675803127437,-0.8690199152692692,0.6355685131195336,0.8931509989343627,1.0,3/19,8.15%,PLGRKT;ADAM8;HPN
prerank,icosanoid biosynthetic process (GO:0046456),-0.3755985994011969,-0.8688573480406501,0.6228287841191067,0.8925137386976795,1.0,3/10,7.35%,LTA4H;LTC4S;PLA2G4A
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3960330122922278,0.8688008422844188,0.6384083044982699,0.866728101059833,1.0,4/14,17.65%,UPB1;CAD;NT5C3A;ERH
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.32355346568391474,0.868737423062038,0.6557142857142857,0.866403165698852,1.0,9/35,13.22%,PPP1R12A;CD300A;CRY2;PPP1R15A;PPP1R2;FKBP1B;PPP1R15B;HTT;PPP6R2
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3226686717234946,0.8686976164602237,0.65625,0.8660227728450803,1.0,7/36,10.49%,TRAF1;BCL2L14;SGMS1;CSNK2A2;CSNK2A1;RPS3;CYLD
prerank,protein import into mitochondrial matrix (GO:0030150),0.37621556961996516,0.8686223977103095,0.6342592592592593,0.8657261604385755,1.0,5/18,14.21%,GRPEL2;DNAJC19;TIMM21;TOMM40;TIMM50
prerank,regulation of protein-containing complex assembly (GO:0043254),0.27875269928370955,0.8683630805272313,0.7103128621089224,0.865763749250587,1.0,27/110,18.05%,HCK;SYK;ATF7IP;CD36;SORL1;MMP1;EIF2AK2;SUMO1;CDC42;FAF1;TIRAP;SVIP;TMC8;RALB;LATS1;RPS3;SPIDR;LGALS3;VCP;TGFB1;RB1;AJUBA;TFIP11;TRAF2;BBS10;HSPA5;NCLN
prerank,regulation of DNA recombination (GO:0000018),0.33277360448990956,0.8680041313273211,0.6484149855907781,0.865987837704547,1.0,7/32,16.35%,MRE11;MSH3;PPP4R2;MSH6;SETD2;SPIDR;KPNA2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.27855596757481155,-0.8676215420767791,0.6726726726726727,0.8942359228473502,1.0,8/28,19.24%,COTL1;RASA1;PFN1;FCHSD2;ARHGAP35;PFN2;CTTN;GBA2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.3878657327064585,0.8674985402343552,0.6218905472636815,0.8664696506144812,1.0,1/13,0.53%,SP100
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3420174062247216,0.8674706714620012,0.6567375886524822,0.8660748838268374,1.0,7/28,16.96%,LFNG;FBXW7;WWP2;AKT1;METTL3;TSPAN15;NIBAN2
prerank,negative regulation of leukocyte migration (GO:0002686),0.41284925601869976,0.8668034501621311,0.6322463768115942,0.8668939611000451,1.0,2/10,9.80%,CD300A;SLAMF8
prerank,spindle assembly (GO:0051225),-0.23391705621862957,-0.8662505201593967,0.7511961722488039,0.8961830516554642,1.0,20/67,20.55%,STARD9;NUMA1;TUBGCP5;NEK6;PIBF1;GOLGA8B;CLASP2;NEK7;GOLGA2;LSM14A;MAPRE1;BCCIP;TUBGCP6;HAUS4;SMC1A;RAB11A;SPICE1;HAUS5;MAP9;TUBGCP2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2826843401426067,0.8662138006944199,0.7006211180124223,0.8675265526782185,1.0,22/80,16.83%,TBC1D10C;RAB7B;RAB7A;SNX1;VPS53;RAB6A;TMEM87A;STX6;GCC2;RHOBTB3;GBF1;STX5;PIKFYVE;TBC1D5;SNX3;ANKFY1;STX16;EVI5;RAB29;SNX12;DENND5A;RAB9B
prerank,regulation of isotype switching (GO:0045191),0.3935601224319866,0.8661872548287723,0.6305732484076433,0.8671231853712832,1.0,3/14,10.90%,MAD2L2;SLC15A4;KMT5B
prerank,regulation of translational initiation (GO:0006446),-0.23099717109845025,-0.8661555284371915,0.7666666666666667,0.895413763389352,1.0,19/63,19.21%,LARP1;ATF3;EIF2AK4;CDC123;KLHL25;ATF4;IMPACT;EIF5;PAIP2B;EIF2B5;NPM1;EIF4G1;EIF4H;GLE1;TPR;DDX3X;EIF3B;UHMK1;HABP4
prerank,regulation of histone modification (GO:0031056),-0.34817632873885906,-0.8659450193998491,0.6555269922879178,0.8948813224745951,1.0,4/13,11.57%,FLCN;HPF1;AKAP8;AKAP8L
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3167276034403862,0.8658268027589453,0.6530054644808743,0.8673112430810869,1.0,14/42,20.17%,GATAD2B;RBBP4;SMARCA5;ACTR6;SMARCE1;MBD2;SRCAP;CHD4;SMARCC2;INO80;HDAC1;ACTB;PBRM1;HNRNPC
prerank,monocarboxylic acid metabolic process (GO:0032787),0.27355774441982295,0.865769314025811,0.7017341040462428,0.866983256197417,1.0,10/117,9.89%,HLCS;KYNU;PPARG;ME2;CD36;ACOT11;ACOT2;NAAA;MSMO1;DLD
prerank,sulfate transport (GO:0008272),0.39342664026375473,0.865688996105917,0.6464,0.8666830894766604,1.0,2/14,5.61%,RACGAP1;SLC25A30
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3840560061884703,0.8651831769678657,0.6199677938808373,0.8671427354155723,1.0,1/16,1.40%,NGFR
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.23758892517740388,-0.864763117596548,0.6905829596412556,0.8964626534913553,1.0,19/53,26.63%,EYA4;DDX5;ERCC6;FXR1;CEBPG;TMEM161A;FXR2;TIGAR;PCNA;DHX9;NPAS2;FBH1;BRCA1;HMGA2;FGF10;RNF8;CCAR2;MYC;BABAM2
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.2581155540145056,-0.8647239260637015,0.6859205776173285,0.8955449070585809,1.0,8/41,16.96%,TGFBR2;MEF2C;SMAD7;FGFR2;SOX4;TGFB2;PKP2;SOX11
prerank,negative regulation of protein kinase activity (GO:0006469),0.2845843334840938,0.8644598185872298,0.6841477949940405,0.8680071467867425,1.0,17/88,15.21%,PTPRC;PTPRO;PRKAG2;SORL1;PRKRIP1;PDPK1;PAK2;GSKIP;PTPN1;DBNDD2;TAF7;SH3BP5;MVP;AKT1;GSTP1;DUSP26;SPRED1
prerank,inositol lipid-mediated signaling (GO:0048017),0.3057083595571802,0.8643896137860491,0.6753246753246753,0.8676901467071627,1.0,9/50,10.70%,NGF;PIK3C2A;INPP5F;KCNH1;PLCB1;PLCD4;EZR;RHOA;PIK3CA
prerank,error-free translesion synthesis (GO:0070987),-0.2951129540882673,-0.8642823824240774,0.6815642458100558,0.8954884294652459,1.0,11/22,32.71%,UBC;NPLOC4;POLH;PCNA;RFC3;SPRTN;UBA52;RFC2;POLDIP2;RFC4;REV1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3540332837045579,-0.8642666512251306,0.6379310344827587,0.8945240684274541,1.0,4/12,15.26%,SNX5;IRS1;PRKCZ;GKAP1
prerank,ncRNA export from nucleus (GO:0097064),-0.258955148291394,-0.8642557972976606,0.7043189368770764,0.893551694394428,1.0,14/36,19.38%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;NPM1;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.40209046158307993,0.8641992969434166,0.6144578313253012,0.8675984841289152,1.0,3/11,7.62%,RAPGEF2;AFDN;F11R
prerank,neuron fate commitment (GO:0048663),-0.3389253672945836,-0.8641583514335789,0.6388206388206388,0.8927665214916745,1.0,1/14,1.23%,TGFBR1
prerank,cilium organization (GO:0044782),0.2606994553445,0.8641023962865704,0.7558386411889597,0.8673302451625807,1.0,34/209,15.36%,CDC14A;ATAT1;ACTR3;TSGA10IP;FOXJ1;EXOC6;OCRL;EHD2;RP2;RFX3;ARF4;ACTR2;FLNA;IFT140;GBF1;KIF24;EXOC7;UNC119B;CEP250;KIF3B;RILPL2;FHDC1;CFAP61;PTPDC1;TTC17;ABCC4;IQCB1;CFAP54;CFAP70;TXNDC15;NUDCD3;EHD1;DYNLT2B;DISC1
prerank,glycerophospholipid metabolic process (GO:0006650),0.28892142685435873,0.8639548748287285,0.6929611650485437,0.8671830442768853,1.0,11/75,9.52%,PLA1A;IP6K3;PRDX6;ABCA3;GPCPD1;PAFAH1B1;PLCB1;SYNJ1;CPNE1;FAR1;PIGF
prerank,regulation of smoothened signaling pathway (GO:0008589),0.30397251876540055,0.8634856839227729,0.6702412868632708,0.8676090781679853,1.0,9/50,15.31%,GLI1;HERC4;GPC3;RAB34;FBXL17;TUBD1;VCP;TXNDC15;CREBBP
prerank,regulation of nervous system development (GO:0051960),-0.26352294166692025,-0.8631702231511171,0.6732283464566929,0.893920400052893,1.0,10/37,16.88%,CX3CR1;TENM4;CTNNB1;PTN;PTPRZ1;HMGB2;BHLHE41;CX3CL1;PER2;NSUN5
prerank,regulation of Notch signaling pathway (GO:0008593),0.2853247371634378,0.863110783111659,0.6979542719614922,0.8678298917624827,1.0,18/76,16.96%,STAT3;LFNG;FBXW7;SYNJ2BP;RBPJ;TSPAN14;IL6ST;WWP2;AKT1;METTL3;SREBF2;KAT2B;CREBBP;TSPAN15;POGLUT1;MAML1;TSPAN5;NIBAN2
prerank,clathrin-dependent endocytosis (GO:0072583),0.34118125085771484,0.8618718404952029,0.6244541484716157,0.8696707082011748,1.0,9/26,17.91%,INPP5F;PICALM;AP2A2;LMBRD1;AP2B1;ITSN2;CANX;AP2S1;GPR107
prerank,regulation of muscle cell differentiation (GO:0051147),0.32805290187041863,0.8615671084527721,0.6322489391796322,0.8697687160535588,1.0,7/31,12.05%,CTNNA1;CDC42;MAPK14;MAPK12;HDAC9;ID2;MEGF10
prerank,protein homooligomerization (GO:0051260),0.2730859611350401,0.861300965039072,0.7325443786982249,0.869809938468196,1.0,13/114,10.87%,CARD11;SAMHD1;ALOX5AP;UPB1;RNF213;PRMT8;PDCD6IP;SPAST;SLC1A5;ATL3;NLRC4;B2M;LETM1
prerank,mitochondrial protein processing (GO:0034982),0.39581334838912796,0.8610460559876495,0.6142131979695431,0.8698425192468888,1.0,5/11,19.73%,IMMP2L;PMPCA;YME1L1;MIPEP;IMMP1L
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.32027207383968503,0.8609295936381792,0.6547788873038516,0.8696035556346551,1.0,6/35,10.86%,CBL;PICALM;ARF1;RAC1;HIP1;B2M
prerank,positive regulation of protein import (GO:1904591),0.3332482514026196,0.8605381640118407,0.6502890173410405,0.8698595731606247,1.0,11/30,18.47%,UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD
prerank,histone H3-K9 demethylation (GO:0033169),0.40466601697636134,0.860361481033054,0.6472602739726028,0.8697259031648936,1.0,2/11,7.20%,KDM7A;KDM3B
prerank,regulation of osteoblast proliferation (GO:0033688),-0.31342882459816335,-0.8602230891758196,0.6581632653061225,0.8993123757807215,1.0,3/17,6.15%,NELL1;TMEM119;FGFR2
prerank,positive regulation of dendrite development (GO:1900006),-0.3667104422772971,-0.8600781812969152,0.6515513126491647,0.8986291213868087,1.0,2/10,14.54%,PTN;DAB2IP
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.4164676127135747,0.8593421453299617,0.6220735785953178,0.8711366671126065,1.0,2/10,6.35%,RC3H1;PRNP
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.30408504619389387,-0.8590013574857872,0.6497326203208557,0.8999377676941358,1.0,5/19,14.08%,TGFBR2;ACVR1;SLIT3;SOX4;TGFB2
prerank,primary miRNA processing (GO:0031053),0.4171213333569086,0.8589165731299246,0.6490299823633157,0.8714798188855258,1.0,3/10,13.30%,DGCR8;SRRT;METTL3
prerank,cardiac muscle cell development (GO:0055013),0.35659967164250905,0.8587067341717937,0.661144578313253,0.871434796247414,1.0,1/20,1.09%,PDLIM5
prerank,heart morphogenesis (GO:0003007),-0.24289385371543226,-0.8586410147522924,0.7423076923076923,0.8997310613605065,1.0,5/50,7.34%,CHD7;TGFBR1;FLRT2;ACVR1;HTR2B
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3642247655374957,-0.8585616569780723,0.6462264150943396,0.8988848624513993,1.0,1/11,0.72%,MEF2C
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.31578011951894647,0.8585580619292124,0.6589041095890411,0.8712547284915226,1.0,8/38,17.23%,SP100;GPX1;TMC8;ICAM1;RIPK1;LGALS3;THBS1;TRAF2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.35274391811359085,0.8585108712335918,0.6220839813374806,0.8709025385707887,1.0,7/22,15.78%,IL1B;ADRA2A;SNX9;TNFRSF1B;ROCK1;ADAM9;SNX33
prerank,tRNA export from nucleus (GO:0006409),-0.2669940082655015,-0.8579532515472826,0.7096774193548387,0.8981206532802801,1.0,13/32,19.38%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2669940082655015,-0.8579532515472826,0.7096774193548387,0.8981206532802801,1.0,13/32,19.38%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.39630366547189155,0.8576861141340707,0.6325503355704698,0.871988871334244,1.0,2/12,5.52%,CELSR1;ZDHHC7
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.3454183677575286,0.8569998036436376,0.6546546546546547,0.872810876213216,1.0,2/23,4.80%,ITGAX;GDNF
prerank,defense response to fungus (GO:0050832),0.3665835316164136,0.8569340330110855,0.6574074074074074,0.8724820769530859,1.0,2/17,9.88%,PLCG2;FAM3A
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.2971929901327357,-0.8568442990572219,0.6789772727272727,0.8994472136392196,1.0,10/21,28.46%,IGF1;LGALS9;HTR2B;KARS1;MT3;FGF10;CTSH;KDR;MYC;EGF
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.31626110868593793,0.8559354463333199,0.6821378340365682,0.8738691494052679,1.0,6/36,10.82%,GOLPH3L;RAB7A;AFDN;RAB34;GCC2;RILPL2
prerank,regulation of viral life cycle (GO:1903900),-0.30236918524509226,-0.8558708932471654,0.6771428571428572,0.9004796221469178,1.0,4/21,4.42%,HS3ST5;PPIA;KPNA6;TRIM5
prerank,RNA metabolic process (GO:0016070),0.2686591826297749,0.855519007242941,0.7281879194630873,0.8741954620984282,1.0,27/127,15.83%,FASTKD1;RBPMS;GTF2F2;SND1;POLR2C;NUFIP1;RBMS1;XRN2;RNASEH2C;SETX;RBMS2;RNASE1;TENT2;DHX8;CELF2;PAPOLG;RNASE6;DEDD2;METTL3;RNASEH2A;RNASEH1;PNPT1;SYNCRIP;PAPOLA;NCBP1;SIDT2;RBM39
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.35206684097934093,0.8555032165224558,0.6553323029366306,0.8737780590590137,1.0,5/22,13.83%,RGS2;MTPN;IL6ST;SMAD4;ROCK1
prerank,negative regulation of cell projection organization (GO:0031345),0.302977649883008,0.8554822212201759,0.6786666666666666,0.8733701140446374,1.0,8/48,8.74%,FYN;PTPRO;RAPGEF2;PTEN;PRNP;CIB1;PAQR3;CBFA2T2
prerank,myofibril assembly (GO:0030239),-0.24792998415034428,-0.8553634423693363,0.714828897338403,0.9006047158740031,1.0,6/42,21.79%,CAPN3;CFLAR;TMOD1;ACTN2;TMOD2;FHOD3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.25786727163475465,0.8550942188639615,0.7855648535564853,0.8736199138843324,1.0,67/241,20.27%,RSRC1;GTF2F2;CRNKL1;RNPC3;POLR2C;SNRPD2;PRPF6;DDX42;SNRPB;DBR1;CDC5L;USP49;BUD31;SRSF10;BUD13;DNAJC8;DDX41;FIP1L1;RBM10;LSM5;MAGOHB;DDX46;PRPF3;SF3B6;RBM22;SRSF4;DHX8;SLU7;YTHDC1;NUDT21;RBM15;SPEN;CACTIN;SRRT;FRG1;DDX23;PQBP1;SNRPA1;SF3A1;METTL3;SYNCRIP;AQR;U2SURP;CPSF3;GEMIN7;WBP11;PAPOLA;NCBP1;PHF5A;TXNL4A;PABPC1;PPWD1;SYF2;TFIP11;SF3B3;CWF19L1;CSTF3;RBM41;SF3B2;SF3B1;UPF3B;PDCD7;WDR33;CDC40;SMNDC1;HNRNPC;SF3A2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.3492213182211277,-0.8548149637745686,0.653012048192771,0.9007562549124496,1.0,2/12,9.11%,IGF1;IRS1
prerank,tRNA aminoacylation (GO:0043039),-0.2656318856155213,-0.854720469913485,0.7030716723549488,0.8999632603402093,1.0,15/37,24.45%,YARS1;LARS1;NARS1;WARS2;LARS2;WARS1;GATB;GATC;IARS1;DARS1;KARS1;PPA2;FARSA;RARS1;CARS1
prerank,rRNA transcription (GO:0009303),-0.31751210583958833,-0.8546478042825364,0.6937669376693767,0.8991431229934062,1.0,6/17,20.77%,GTF3C3;GTF3C4;GTF3C2;GTF3C5;TCOF1;ANG
prerank,sodium ion import across plasma membrane (GO:0098719),0.3695545489002018,0.8545845296330492,0.6651305683563749,0.874111699821431,1.0,2/17,3.91%,SLC9A7;HCN4
prerank,negative regulation of interleukin-1 production (GO:0032692),0.34368372332682945,0.8541777461216341,0.6423135464231354,0.8744145105147496,1.0,5/23,14.84%,FFAR4;CARD16;GIT1;NLRP3;GSTP1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2867662050370088,0.8531182817331724,0.6850490196078431,0.8758668632345776,1.0,11/76,11.89%,HCK;PRKCE;STAP1;CDC42;CARMIL1;PTK2B;KATNBL1;BCAS3;SNX9;VASP;DYNC1H1
prerank,neural crest cell migration (GO:0001755),-0.2625028052342872,-0.8530837916576385,0.7290969899665551,0.9013864290834316,1.0,6/36,8.48%,ERBB4;NRP1;SEMA3D;SEMA3E;HTR2B;SEMA6D
prerank,positive regulation of macrophage activation (GO:0043032),0.37026625972614907,0.852861175476856,0.6599063962558502,0.8758820445255024,1.0,5/17,18.03%,STAP1;IL33;THBS1;HSPD1;MMP8
prerank,response to X-ray (GO:0010165),0.3872311088614107,0.8522178057332656,0.6621160409556314,0.8765919300915924,1.0,3/14,12.04%,NIPBL;ANXA1;XRCC4
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.40650805963787834,0.8519696003413643,0.6747826086956522,0.8766177372539562,1.0,1/11,1.25%,BCL3
prerank,regulation of vacuole organization (GO:0044088),0.3526258196948102,0.8518590513081236,0.6319758672699849,0.8763660100718047,1.0,4/20,10.96%,ANXA2;MTMR3;PIKFYVE;SCARB2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.39125229771958303,0.8515244429307799,0.631578947368421,0.8764923573611468,1.0,1/13,1.10%,XPO1
prerank,diol biosynthetic process (GO:0034312),0.36407144162180494,0.8514637201120493,0.6452702702702703,0.8761600249356816,1.0,1/15,1.60%,ACER3
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2947741628983996,0.8513136477134692,0.6995073891625616,0.8759957782397616,1.0,5/62,7.08%,LRRK2;MCL1;HSPA1A;PTTG1IP;NFE2L2
prerank,positive regulation of nervous system process (GO:0031646),0.37138227748226627,0.850829675781221,0.6769706336939721,0.876443484567942,1.0,2/18,4.08%,ITGAX;MYRF
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3861811684322826,0.8507165761286298,0.6521739130434783,0.8762009549284352,1.0,4/13,14.95%,ITGB2;IL6;RHOA;RELA
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.35460131590963984,0.8504977894625878,0.65,0.8761834970319883,1.0,3/21,8.29%,CYRIB;CD2AP;EPHB2
prerank,regulation of G0 to G1 transition (GO:0070316),0.31611809986056555,0.850420955487423,0.6694444444444444,0.8758870301518002,1.0,8/38,15.64%,UXT;RBBP8;RYBP;RBBP4;APAF1;L3MBTL2;EZH2;PHC3
prerank,amyloid fibril formation (GO:1990000),0.3030275769024024,0.8501306693456535,0.7012987012987013,0.8759822976633025,1.0,13/51,16.17%,CD36;SORL1;H3-3A;HSPG2;TGFBI;TSPAN14;TSPAN33;RIPK1;B2M;APP;TSPAN15;USP9X;TSPAN5
prerank,folic acid metabolic process (GO:0046655),-0.3114223107091712,-0.8500829863839178,0.7010869565217391,0.9065744816622838,1.0,8/18,27.82%,MTHFD2L;MTHFS;DHFR;SHMT2;FPGS;MTHFD1;ALDH1L1;SLC46A1
prerank,regulation of intracellular protein transport (GO:0033157),0.33032135286307135,0.849709094238447,0.6755162241887905,0.8763044496510433,1.0,6/32,14.52%,LCP1;GCC2;BCAS3;PTPN1;TGFB1;RAB29
prerank,negative regulation of receptor internalization (GO:0002091),0.3900274902974361,0.8493416178294769,0.6440677966101694,0.8765123486656307,1.0,1/12,1.22%,RIN3
prerank,regulation of neutrophil migration (GO:1902622),0.41069033395938814,0.8489738678941501,0.6521008403361345,0.8767110890104425,1.0,4/10,15.07%,RAC2;RAC1;SLAMF8;RHOG
prerank,regulation of actin filament-based movement (GO:1903115),-0.36656325970098463,-0.8487570991168286,0.6674364896073903,0.9082876554196097,1.0,6/10,45.31%,ANK2;PDPN;PDE4D;MYBPC3;PLN;STC1
prerank,apoptotic cell clearance (GO:0043277),0.3325942003041773,0.8486659956208361,0.6507246376811594,0.8768405454160041,1.0,9/30,15.44%,RARA;RAC2;SCARB1;XKR4;RAC1;ANXA1;MEGF10;RHOG;THBS1
prerank,regulation of protein localization to membrane (GO:1905475),-0.2732241722362619,-0.8485172419016344,0.7040498442367601,0.9077827617245798,1.0,12/28,23.77%,PRKN;ZDHHC2;MMP14;VTI1B;GPC6;CDK5;VAMP8;AR;STX8;GSN;CLN3;GPC4
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3164933200465708,-0.8478465675794479,0.671957671957672,0.9081937844503923,1.0,3/16,15.27%,PTN;TGFB2;SOX5
prerank,negative regulation of T cell differentiation (GO:0045581),0.3992677643218534,0.8476556475535575,0.6655172413793103,0.878198380436073,1.0,1/10,2.50%,FOXJ1
prerank,regulation of protein kinase B signaling (GO:0051896),0.25859825827429417,0.8474183797727407,0.7818181818181819,0.8781993593399061,1.0,48/193,20.86%,FGF22;FLT3;FYN;RET;FGF5;NRG2;KL;RAC2;PTEN;GRB2;PDPK1;CIB1;PHLPP1;ENG;RAC1;HGF;CPNE1;HIP1;RTN4;PIK3CA;CASS4;KIT;AKT1;HCLS1;PTPRJ;FGFR3;TGFB1;PPP2R5C;IL18;MAZ;RHOG;FRS2;THBS1;RNF41;INSR;PIK3R2;SIRT1;HAX1;PINK1;PIK3R5;FGFR1;PARK7;TSPYL5;PTK2;MUL1;STRN;XDH;RICTOR
prerank,positive regulation of cell development (GO:0010720),-0.27074693117431897,-0.8471397039394821,0.7084745762711865,0.9085785269359783,1.0,8/31,19.56%,CX3CR1;NUMB;ATP6AP1;TGM2;SNW1;SOX11;TRIM32;TYROBP
prerank,protein localization to cilium (GO:0061512),-0.26457363823206026,-0.8468049631136388,0.7071651090342679,0.908285532557695,1.0,12/32,27.41%,ATP6V1D;ZNF423;IFT20;ARL6;TTC21B;RABEP1;ARL3;TULP2;TCTN2;TULP3;TUB;NPHP4
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.32828697046001437,0.8467890600442024,0.6734992679355783,0.8788648461406376,1.0,10/29,18.47%,CYRIB;CORO1A;KANK3;ARFGEF1;SMAD4;PIK3CA;CLASP1;MYADM;KANK1;PRKCD
prerank,cilium assembly (GO:0060271),0.2501292971181551,0.8456138397325177,0.8138572905894519,0.8805098144742569,1.0,53/296,17.93%,CDC14A;ATAT1;ACTR3;SDCCAG8;CNTRL;FOXJ1;EXOC6;HAUS8;TBC1D32;OCRL;EHD2;RP2;SPATA6;RFX3;ARF4;ACTR2;FLNA;CEP63;PAFAH1B1;HAUS1;IFT140;GBF1;DCTN3;KIF24;EXOC7;UNC119B;CEP250;KIF3B;RILPL2;FHDC1;PTPDC1;ABCC4;DYNC1H1;IQCB1;CCDC39;CFAP54;HAUS3;CFAP70;CLASP1;TXNDC15;NUDCD3;EHD1;DYNLT2B;DISC1;EXOC2;TNPO1;DYNC1I2;CEP135;BBS10;ASAP1;EHD3;CC2D2A;LZTFL1
prerank,endocardial cushion development (GO:0003197),0.34791637187823676,0.8455210773509062,0.6823161189358372,0.8802443985794977,1.0,2/21,8.16%,BMPR2;ENG
prerank,renal water homeostasis (GO:0003091),-0.291564971249759,-0.8453278676728814,0.6704545454545454,0.9104335262731962,1.0,8/23,17.65%,RAB11FIP2;ADCY9;PRKACA;PRKAR1A;ADCY3;AQP4;RAB11A;ADCY8
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.3068743677977297,-0.8452724025325081,0.6875,0.9095506288996056,1.0,8/19,27.82%,MTHFD2L;MTHFS;DHFR;SHMT2;FPGS;MTHFD1;ALDH1L1;SLC46A1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.2510027658522029,-0.8452147684936188,0.7315175097276264,0.9086729453334879,1.0,5/41,7.35%,PTGS1;MGLL;DAGLA;PNPLA8;PLA2G4A
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.32650239816416016,-0.8450709632441118,0.6666666666666666,0.9079815721746375,1.0,5/15,18.16%,STOX2;RAI2;USP22;TGFB2;BRCA1
prerank,cardiac muscle contraction (GO:0060048),0.3258104608342747,0.8450405691480386,0.680731364275668,0.8806501957222322,1.0,3/34,3.70%,TNNC1;KCNQ1;MYL4
prerank,negative regulation of nuclear division (GO:0051784),-0.35195003690775745,-0.8449800051275739,0.6633663366336634,0.9071656032109519,1.0,6/11,42.68%,TOM1L1;FBXO5;TOM1L2;BMP4;CHEK1;BMP7
prerank,neuron projection fasciculation (GO:0106030),-0.3561748976176667,-0.8447371029397464,0.6767441860465117,0.9066339831913681,1.0,3/10,9.16%,CNTN4;CDK5R1;ARHGAP35
prerank,histone lysine methylation (GO:0034968),0.3147694283555546,0.8446073069779803,0.6804407713498623,0.8809882300732427,1.0,10/33,21.43%,KDM6A;SETDB2;DOT1L;EZH2;KMT2A;ASH2L;SETMAR;WDR5;PRDM9;RBBP5
prerank,maturation of LSU-rRNA (GO:0000470),-0.27519951893584627,-0.8444930456158933,0.7025316455696202,0.9061472765402616,1.0,9/26,17.36%,MRPL1;RPF1;NOP2;WDR12;LAS1L;PES1;FTSJ3;SNU13;RRP15
prerank,negative regulation of wound healing (GO:0061045),0.3269000005125316,0.8444449794233746,0.6867469879518072,0.8808303954927837,1.0,4/28,7.33%,CASK;CRK;PTEN;PHLDB2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3059137788567933,-0.843898744845564,0.7142857142857143,0.9063763884584477,1.0,13/20,42.61%,FKBP5;PPIA;CWC27;PPIE;PPID;FKBP1A;PPIF;PPIH;PPIL6;NKTR;PPIG;PPIL3;PPIC
prerank,regulation of cell cycle phase transition (GO:1901987),0.27358757607189155,0.8438869727113563,0.725609756097561,0.8814069879345193,1.0,22/91,18.68%,PSME3;UBE2E1;PSMB7;FBXW7;PSME2;PSME4;PSMB8;PSMD9;PSMA5;PSMB3;UBE2S;PSMD6;PSMC4;PSMD10;PSMB1;ERCC3;ANAPC7;TAF1;PSMD12;ANAPC11;FZR1;ANAPC4
prerank,regulation of DNA repair (GO:0006282),0.2987240254647742,0.8436602131253017,0.6883116883116883,0.8813796619834074,1.0,9/44,11.64%,KAT7;SMCHD1;UBE2N;UBR5;DEK;UIMC1;WRAP53;RPS3;PARG
prerank,positive regulation of synaptic transmission (GO:0050806),0.2863735173096792,0.8433327246982562,0.7285012285012284,0.8815115275527342,1.0,5/72,8.29%,CCR2;CRHR2;NPTN;PTK2B;EPHB2
prerank,regulation of chromatin organization (GO:1902275),0.375664927158589,0.8429729503559591,0.6892561983471074,0.8817035366586605,1.0,5/14,14.01%,SETD5;TLK2;METTL4;PARG;TLK1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.33785706736585397,-0.8429347143682768,0.6824644549763034,0.9073866901048103,1.0,4/13,19.56%,GAS6;LAMP1;TICAM1;TYROBP
prerank,response to ketone (GO:1901654),-0.2749829100943053,-0.8425736098284241,0.6990291262135923,0.9071526653524609,1.0,5/24,14.08%,ABCB4;SLIT2;SLIT3;CATSPER2;TGFB2
prerank,regulation of neuron differentiation (GO:0045664),0.2816030183034653,0.8425139071982308,0.7095959595959596,0.8820820146591957,1.0,3/76,1.02%,LRRK2;TIAM1;NGF
prerank,cellular response to heat (GO:0034605),0.3119311557927767,0.842450590757289,0.6629213483146067,0.8817587635251772,1.0,10/35,18.70%,HSPA1A;SUMO1;ATXN3;SLU7;HIKESHI;DAXX;VCP;THBS1;BAG3;CLPB
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3245837402806568,-0.8423062826539566,0.660574412532637,0.9066696747678056,1.0,6/14,30.72%,RMND1;RCC1L;C1QBP;FASTKD3;MPV17L2;COA3
prerank,proteoglycan metabolic process (GO:0006029),0.32993143459901464,0.8419487984939991,0.6738505747126436,0.8822468486814583,1.0,7/26,15.04%,SULF2;BMPR2;CHST12;XYLT1;ADAMTS12;CNMD;CSGALNACT1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.3543872406896029,0.8415866547509002,0.6598425196850394,0.8824519185136188,1.0,4/18,7.93%,MSN;PTTG1IP;FAF1;EZR
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3243699349043061,0.8414559944817278,0.6755994358251057,0.8822467508978123,1.0,9/33,16.84%,NGF;CACNA1A;BCR;CEL;SLC4A8;GRID1;LRP8;RELN;LRRC4
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.32259653364144764,0.841307434430204,0.6749271137026239,0.8820472049591537,1.0,7/29,17.74%,SDHAF2;MAD2L2;PTEN;SPRED3;USF3;SPRED1;EFNA1
prerank,oligodendrocyte differentiation (GO:0048709),-0.3013022128849991,-0.8403533190243831,0.7099697885196374,0.9096841600688668,1.0,7/19,21.76%,PTPRZ1;CDK5;EIF2B5;EIF2B4;TPPP;NSUN5;SOX13
prerank,protein stabilization (GO:0050821),0.26076101105841804,0.8403226831889417,0.7912568306010929,0.883288940530055,1.0,42/168,18.87%,CREB1;RPL5;ATF7IP;HSPA1A;RABL3;TAF9;NAA16;FBXW7;SUMO1;PTEN;STK4;WFS1;FLNA;CCNH;STX12;NAA15;CREBL2;HIP1;CAMLG;RTN4;NLK;TSPAN1;DVL3;HYPK;MORC3;RPL11;USP7;USP9X;TAF1;TCP1;PPIB;RASSF2;HSPD1;BAG3;EFNA1;NCLN;ATP1B2;PRKCD;PIN1;STK3;CHEK2;PINK1
prerank,regulation of tissue remodeling (GO:0034103),-0.2998251987765296,-0.8401420491550677,0.7076023391812866,0.9091538319754692,1.0,4/18,19.23%,CST3;SYT7;MDK;LEPR
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.3260761479853795,-0.8400625088295236,0.7128205128205128,0.9083586011976826,1.0,8/14,37.65%,PPARGC1A;IRS1;GPLD1;SLC45A3;DDB1;IRS2;ARPP19;PMAIP1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.32132243087116874,0.839738260831938,0.6725403817914831,0.8838665912444446,1.0,6/33,9.31%,PKN1;AXIN1;H3-3A;CBFB;LATS1;NCOA2
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.2739280764360209,-0.8395167866488918,0.724025974025974,0.9084653899235909,1.0,6/26,13.69%,IGF1;OSBPL8;RHOQ;IRS1;PIK3R1;C3
prerank,cellular response to inorganic substance (GO:0071241),0.35277830287782186,0.8391173230418026,0.6661631419939577,0.8844933479119049,1.0,4/21,12.80%,DPEP1;ADCY10;ATRX;SPIDR
prerank,myelination in peripheral nervous system (GO:0022011),0.3843314532427541,0.8388552966121999,0.6587436332767402,0.8845148027912718,1.0,2/13,3.42%,ADGRG6;PRX
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.3918973927570554,0.8385786340542875,0.6752577319587629,0.8845976575475203,1.0,5/12,18.71%,CHST12;NCAN;UST;DSEL;VCAN
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2772176339552947,0.8385738049722076,0.7233782129742962,0.8841706417174675,1.0,19/86,16.93%,HCK;PRKCE;PAK1;GPX1;CARMIL1;PTK2B;KATNB1;RAC1;RPS3;SNX9;VASP;APP;CLASP1;OCLN;STMN2;RB1;FES;PROX1;PSEN1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.2823678481393927,0.8385069708486224,0.7187112763320942,0.8838549871069433,1.0,10/69,10.70%,NGF;PIK3C2A;INPP5F;KCNH1;PTEN;PLCB1;PLCD4;EZR;RHOA;PIK3CA
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.25199735931537154,0.8383417751103917,0.8302083333333333,0.8836907614925998,1.0,71/264,20.47%,CDK13;RSRC1;GTF2F2;CRNKL1;RNPC3;POLR2C;SNRPD2;PRPF6;DDX42;SNRPB;DBR1;CDC5L;USP49;BUD31;SRSF10;BUD13;DNAJC8;DDX41;FIP1L1;RBM10;LSM5;MAGOHB;DDX46;COIL;PRPF3;SF3B6;RBM22;SRSF4;DHX8;SLU7;YTHDC1;NUDT21;RBM15;SPEN;CACTIN;SRRT;FRG1;DDX23;PQBP1;SNRPA1;SF3A1;METTL3;SYNCRIP;AQR;U2SURP;CPSF3;GEMIN7;WBP11;PAPOLA;NCBP1;PHF5A;TXNL4A;PABPC1;PPWD1;SYF2;TFIP11;SF3B3;CWF19L1;CSTF3;RBM41;SF3B2;SF3B1;DDX20;UPF3B;PDCD7;WDR33;CDC40;SMNDC1;HNRNPC;SF3A2;SNUPN
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3340521538605003,0.8380063303427026,0.6787878787878788,0.8838582078646341,1.0,9/25,23.69%,EXT1;B3GALT2;CSGALNACT1;HS2ST1;NDST2;EXT2;B3GALT5;B3GNT2;NDST4
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3139124682280109,0.83785418484392,0.6680972818311874,0.8836760067043778,1.0,9/36,14.14%,PPP3CA;PLCB1;GNB1;NLK;MAP3K7;PDE6B;GNG2;TNRC6B;TNRC6A
prerank,response to growth factor (GO:0070848),0.30154861249153536,0.837013087745647,0.6900420757363254,0.8847305337883022,1.0,7/41,13.22%,KLF4;BMPR2;STAT5B;CIB1;ACVR2A;MAP2K5;AKT1
prerank,sister chromatid segregation (GO:0000819),-0.2604997075562802,-0.836908865217773,0.7475728155339806,0.9127306352000896,1.0,20/31,41.78%,KLHL22;ZW10;SMC1A;RAN;KIF18A;CENPK;NCAPG2;NDC80;NSL1;CDCA8;DSN1;KIFC1;MIS12;TOP2B;SPAG5;SGO1;TUBG1;KIF18B;ZWINT;PLK1
prerank,regulation of receptor recycling (GO:0001919),0.3701031210505749,0.8367915983813152,0.6784565916398714,0.8846533626844575,1.0,2/16,4.10%,ANXA2;INPP5F
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3152187614903111,0.8367744018418437,0.6779184247538678,0.8842591142417492,1.0,8/33,16.94%,KLF4;PPARG;MECP2;RHOA;MAP2K5;TGFB1;THBS1;STARD13
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.26779105534512143,-0.8354666866178564,0.7572254335260116,0.914549200237865,1.0,6/26,13.47%,LGMN;TAL1;USP2;CCDC57;PPP1R10;USP22
prerank,regulation of receptor internalization (GO:0002090),-0.25053918451065166,-0.8349075438219501,0.7312925170068028,0.9146220018042176,1.0,10/35,18.20%,MAGI2;DLG4;CD63;FLOT1;VEGFA;ANKRD13D;SCYL2;ATXN2;ANKRD13B;ANGPT1
prerank,protein import into peroxisome membrane (GO:0045046),0.3363204642825406,0.8347260029066598,0.6724409448818898,0.887428048830302,1.0,5/22,13.04%,PEX16;PEX12;PEX14;FIS1;ABCD1
prerank,renal system development (GO:0072001),0.294979192207641,0.8341841248714933,0.7116883116883117,0.8879285855034282,1.0,7/52,13.38%,ACE;SULF2;STAT1;WFS1;ITGA8;LRP4;PCSK5
prerank,regulation of centrosome duplication (GO:0010824),-0.26388156633790655,-0.833701553740919,0.755700325732899,0.9160199135822501,1.0,18/29,37.35%,VPS4B;CHMP5;CENATAC;NPM1;CHMP1B;CEP76;SPICE1;CHMP2A;CCNF;NAT10;GEN1;PLK2;CEP295NL;STIL;CEP131;CHMP1A;FBXW5;CHMP4C
prerank,positive regulation of cholesterol efflux (GO:0010875),0.34425630282092845,0.8334726417202284,0.6754658385093167,0.8886944898879259,1.0,3/21,4.49%,PPARG;NFKBIA;ABCA3
prerank,autophagosome assembly (GO:0000045),0.2937283503413671,0.8334577841144849,0.7200520833333334,0.8882829115698628,1.0,17/52,21.93%,RAB19;RAB7A;STX17;ATG5;STX12;PACS2;WIPI2;VMP1;RB1CC1;AMBRA1;BECN1;ATG13;RAB43;ULK1;TRAPPC8;GABARAPL1;SMURF1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.24377169159339837,0.8331687865972613,0.8674089068825911,0.8883604583235992,1.0,68/366,16.43%,SP3;RUNX3;LIMD1;SAP30;PITX3;STAT3;NSD3;RABL3;NAB1;ANKRD17;SPI1;CCDC88A;KAT7;RYBP;ATF2;IRF2;RFX3;RPL6;BTG1;ORC5;RNF20;RPS6KA5;AHR;PHF19;CREM;SRSF10;MTPN;CLOCK;ENG;PHF12;NFYC;ZBTB11;BACH1;RBAK;ASCC1;CREBL2;NCOA2;SBNO2;BNC2;NR3C1;DAXX;ING2;SRRT;NLK;FOXO3;REST;BAZ2A;NFYA;APP;PQBP1;MSL3;ATRX;MYB;NSD1;EZH2;HCLS1;NFIL3;USP37;ZNF431;RELA;SERTAD3;CREBBP;DVL2;BHLHE40;FOXN2;INSR;RB1;DAPK3
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.28197217446680634,-0.8331320659600899,0.7470238095238095,0.9161773067638767,1.0,10/24,29.70%,CFAP20;TTLL11;TTLL5;GGCX;AGBL4;CEP41;TTLL1;NAA10;TTLL3;NAA80
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3122717384804834,0.8326184409642307,0.6979591836734694,0.8888619950429653,1.0,3/37,2.17%,RIN3;NFKB1;PTX3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3247305558811745,0.8324776870230126,0.7023977433004231,0.8886738436392875,1.0,11/28,24.18%,ITCH;UBE2N;CYLD;TAB3;MAP3K7;RELA;TAB1;TNFAIP3;RIPK2;TAB2;LACC1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.3560729782767721,-0.8319439762410475,0.6937354988399071,0.9175242399729499,1.0,3/10,12.04%,ENPP1;IMPACT;CHP1
prerank,dermatan sulfate metabolic process (GO:0030205),0.38127841608102886,0.8318598644954465,0.6797274275979557,0.8892897885161025,1.0,5/13,18.71%,CHST12;NCAN;UST;DSEL;VCAN
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3364128120404657,-0.8311030747582796,0.6744186046511628,0.9181760284999108,1.0,4/13,15.26%,SNX5;IRS1;PRKCZ;GKAP1
prerank,tRNA transport (GO:0051031),-0.2526439626210937,-0.8308270818549459,0.7337883959044369,0.9177487858861761,1.0,13/35,19.38%,NUP54;NUP133;NUP155;NUP188;RANBP2;SSB;SEC13;NUP85;NUP42;TPR;RAN;NUP35;NUP37
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.38733518215660406,0.830271739096028,0.6919275123558485,0.8915998753548283,1.0,1/12,1.35%,STX11
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.2925559242912528,-0.830024045343196,0.7122507122507122,0.9182990373611658,1.0,2/21,3.17%,LRP6;CTNNB1
prerank,positive regulation of cell cycle (GO:0045787),0.28532011553447534,0.8299558395840384,0.7242268041237113,0.8917023949083176,1.0,15/62,16.74%,RARA;ANKRD17;EIF4EBP1;CCND3;CCND1;ADAM17;PKN2;APP;PSMD10;CCND2;AKT1;CITED2;RPS15A;RPS6KB1;PROX1
prerank,triglyceride biosynthetic process (GO:0019432),-0.30443350866037033,-0.8299249895769301,0.7142857142857143,0.9175259223699285,1.0,5/18,18.23%,AGMO;PCK2;GPAM;GPAT4;LPGAT1
prerank,regulation of macrophage differentiation (GO:0045649),-0.3189777681773732,-0.8291291946292049,0.6925,0.9181159830663993,1.0,2/15,3.39%,C1QC;CSF1
prerank,regulated exocytosis (GO:0045055),0.2520208041895595,0.8290330405904925,0.8067685589519651,0.8928996247510937,1.0,26/173,14.62%,CYRIB;PHACTR2;LYN;PECAM1;RAB11FIP1;CD36;TOR4A;MYH9;VEGFC;F13A1;SRGN;NHLRC2;FLNA;TMED10;PSAP;HGF;FN1;SNAPIN;CYB5R1;ABCC4;APP;TLN1;SYNGR2;ARHGAP17;TGFB1;TAGLN2
prerank,negative regulation of transport (GO:0051051),0.2911571236348362,0.8286813719946818,0.7030223390275953,0.8930666072413858,1.0,13/51,16.81%,LILRB1;PLSCR1;DYSF;RAB7A;PTEN;WWP2;FCGR2B;TLR2;SNX3;LGALS3;SNX33;SNX12;MTMR2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.39319561486102345,0.8286624019177817,0.6958762886597938,0.8926615108346636,1.0,5/11,19.55%,SYNJ2BP;E2F2;THBS1;SEMA6A;KLF2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3812865187930671,0.8283044710862513,0.6851211072664359,0.8928396264338903,1.0,5/12,15.76%,SEC14L2;MBTPS1;SREBF2;H6PD;KPNB1
prerank,phosphate ion transport (GO:0006817),-0.31247281979841157,-0.828032982079372,0.6975,0.9193077355742675,1.0,4/16,12.20%,SLC37A2;SLC25A3;SLC25A11;SLC25A14
prerank,ncRNA transcription (GO:0098781),0.38070883273567324,0.8280144559802541,0.6859504132231405,0.8929218560253729,1.0,2/13,9.38%,POLR1G;SNAPC3
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.3214919272085729,-0.8279786550880016,0.7219387755102041,0.9184429325393105,1.0,6/15,35.03%,DAGLA;GRM5;GRM7;HOMER3;HOMER2;GRM4
prerank,protein maturation (GO:0051604),-0.20846923322397204,-0.8276154683860234,0.864516129032258,0.9181837605186339,1.0,30/95,24.96%,NAA50;MMP16;NAA40;MMS19;METAP2;PSEN2;STUB1;FURIN;LONP2;MMP14;AFG3L2;PCSK1;BACE1;PCSK7;DNAJB11;CIAO1;PSENEN;LMF2;AEBP1;LMF1;ECE1;PTCH1;CLN3;EEF1AKMT4-ECE2;PCSK2;NAA10;CPE;APH1A;BOLA2;NDUFAB1
prerank,proton transmembrane transport (GO:1902600),-0.25377994214146965,-0.8274244334371461,0.7900355871886121,0.9176240852090723,1.0,7/36,12.45%,ATP6V0C;SLC36A1;ATP5PO;ATP1A2;ATP6V0D1;SLC25A14;SLC25A27
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.3138229720235547,-0.827134488025847,0.7086614173228346,0.9171828965397368,1.0,1/15,0.41%,APOE
prerank,nucleotide metabolic process (GO:0009117),-0.284765792919139,-0.8269917646499045,0.7107692307692308,0.916434763271369,1.0,9/23,30.64%,FHIT;DCTD;AK1;NMNAT2;CMPK2;RNASEH2B;GUK1;ENPP3;AK4
prerank,organelle assembly (GO:0070925),0.24373532283144198,0.8268165015685501,0.8789101917255298,0.8945050270387866,1.0,63/384,15.05%,CDC14A;LIMD1;ATAT1;ACTR3;RAB19;VPS37C;FOXJ1;EXOC6;HAUS8;CORO1A;OCRL;EHD2;ABCA3;RP2;CHMP4A;CHMP4B;RFX3;RAB7A;RC3H1;ARF4;TSG101;DHX37;ACTR2;FLNA;CEP63;ATG5;HAUS1;IFT140;YTHDF3;PDCD6IP;GBF1;STX12;KIF24;SNF8;TNKS;EXOC7;UNC119B;STX7;RPS3;CEP250;KIF3B;RILPL2;FHDC1;STAM;PTPDC1;ABCC4;DYNC1H1;IQCB1;PACS2;WIPI2;EIF4ENIF1;CFAP54;HAUS3;CFAP70;TMOD3;VMP1;HDAC3;TXNDC15;NUDCD3;EHD1;RB1CC1;CENPC;DYNLT2B
prerank,response to ionizing radiation (GO:0010212),0.2770069630805499,0.8266578007801185,0.748451053283767,0.8943504721105661,1.0,23/70,21.14%,MAPK14;GRB2;NABP1;CLOCK;COP1;UIMC1;TANK;ANXA1;NET1;DCUN1D3;PRKAA1;XRCC4;SPIDR;BRSK1;INO80;INIP;HUS1;EYA3;SIRT1;TNKS1BP1;RNF168;STK11;CLK2
prerank,cholesterol homeostasis (GO:0042632),-0.22213175563823134,-0.8264047312794398,0.8063063063063063,0.9166289435642644,1.0,8/64,13.42%,ABCA1;APOE;TTC39B;LIMA1;CNBP;MTTP;NPC1;NR1H2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.30481530042433286,0.8259192625628657,0.6984352773826458,0.8951343222034904,1.0,9/38,14.84%,TNIP3;NLRX1;STAT1;TANK;RIPK1;CACTIN;TLE1;CARD19;GSTP1
prerank,DNA conformation change (GO:0071103),-0.3070697569780519,-0.8258755558435662,0.727027027027027,0.9166983369705456,1.0,9/17,33.89%,HMGB1;TOP1;HMGB2;TOP1MT;NAA10;ABL1;HHEX;TOP2B;HMGB3
prerank,cellular response to hexose stimulus (GO:0071331),0.3329642175398321,0.8245972473020104,0.696923076923077,0.8969400622272287,1.0,5/23,13.86%,ERN1;ZBTB20;PRKAA1;PDK3;PRKAA2
prerank,postreplication repair (GO:0006301),0.2992425225856385,0.8243205547597944,0.7325268817204301,0.8969629028646537,1.0,11/45,19.48%,DTL;POLI;UBE2N;POLD4;TRIM25;RPA3;PCLAF;VCP;POLD1;PRIMPOL;WDR33
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.3630113590938898,0.8241700824761451,0.6846275752773375,0.8967866214631025,1.0,1/15,1.36%,LILRB1
prerank,negative regulation of cellular component organization (GO:0051129),0.278271575228481,0.8240913489620652,0.7560386473429952,0.8964851060162291,1.0,8/74,8.08%,LILRB1;HSPA1A;SORL1;CDC42;CARMIL1;FAP;SVIP;TMC8
prerank,regulation of cellular response to heat (GO:1900034),-0.21443744712026677,-0.8240139680190938,0.8888888888888888,0.919245119713752,1.0,22/77,19.38%,RPTOR;NUP54;CD34;NUP133;BAG4;NUP155;BAG1;NUP188;DNAJC2;RANBP2;PTGES3;SEC13;NUP85;HSBP1;NUP42;TPR;CAMK2A;NUP35;AKT1S1;HSP90AB1;CRYAB;NUP37
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.39051904305893004,0.8228797971899968,0.6944444444444444,0.8977046477834943,1.0,2/10,15.83%,CDC42;APC
prerank,regulation of pseudopodium assembly (GO:0031272),0.39051904305893004,0.8228797971899968,0.6944444444444444,0.8977046477834943,1.0,2/10,15.83%,CDC42;APC
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3307622032488733,-0.8227014265787909,0.6987951807228916,0.9207808876802352,1.0,1/13,0.40%,TGFBR2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3149059257476684,0.8221141781844071,0.7136690647482015,0.8985736446626684,1.0,6/31,16.74%,TNNC1;RBPJ;ENG;SMAD4;TGFB1;PROX1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.36113082441126565,0.8219784974510137,0.7236421725239617,0.898383961100246,1.0,5/15,14.73%,RIPOR2;EHD2;MAPK14;EHD1;ADAM9
prerank,apoptotic nuclear changes (GO:0030262),0.32894741017708945,0.8212174579497555,0.7126600284495022,0.8992266671239219,1.0,6/24,16.61%,DFFA;DEDD2;DFFB;EXOG;KPNB1;ACIN1
prerank,aminoglycan biosynthetic process (GO:0006023),0.2943292873423293,0.8210892587335178,0.7236842105263158,0.899020918926487,1.0,8/49,12.71%,EXT1;GPC3;HSPG2;PXYLP1;XYLT1;GALNT5;SDC3;B3GALT2
prerank,aminoglycan catabolic process (GO:0006026),0.3168134536101148,0.8209535052916374,0.724679029957204,0.8988148878403135,1.0,9/28,22.79%,GPC3;HSPG2;FUCA1;SDC3;CTBS;GPC1;NAGLU;IDS;HPSE
prerank,positive regulation of DNA metabolic process (GO:0051054),0.28082621650315837,0.8201582643875467,0.7597977243994943,0.8997154833671838,1.0,15/61,17.25%,MRE11;SMCHD1;UBE2N;WRN;MECP2;UIMC1;HGF;WRAP53;RPS3;ATRX;OTUD4;USP7;USP9X;EYA3;SIRT1
prerank,histone H2A ubiquitination (GO:0033522),0.3604323899019286,0.8201209562606538,0.7065573770491803,0.8993367308692158,1.0,3/17,7.94%,DTX3L;RYBP;UBR2
prerank,error-prone translesion synthesis (GO:0042276),0.3401975213710765,0.8200786583881692,0.7006172839506173,0.898967018606964,1.0,2/21,3.00%,POLI;MAD2L2
prerank,cGMP biosynthetic process (GO:0006182),0.3905236858307248,0.8198019248318786,0.6884422110552764,0.8990099248323086,1.0,3/10,23.43%,GUCY1A1;NPR2;NPPC
prerank,T cell homeostasis (GO:0043029),-0.35054027741129967,-0.8195743292502459,0.6882494004796164,0.9256833757674798,1.0,5/10,27.12%,NCKAP1L;JAK3;PPP2R3C;ZC3H8;FAS
prerank,rRNA processing (GO:0006364),0.2501118194691264,0.8195117076716731,0.7901639344262295,0.8990494198654738,1.0,36/172,15.96%,RPL5;NOL6;RPL37A;RPL6;XRN2;DHX37;RPS14;RPL35A;NHP2;UTP6;RIOK1;RPL13;ERI1;DDX49;NSA2;NOC4L;MPHOSPH6;NOL11;MAK16;RPLP0;UTP20;RPL34;RPL19;RPL11;RPL30;RRP36;NOP58;RPL4;UTP18;RPS2;RPL7;MRTO4;DDX10;TBL3;TSR3;TFB1M
prerank,mitochondrial gene expression (GO:0140053),-0.24042840037503768,-0.8193348035581663,0.8181818181818182,0.925184056342783,1.0,22/42,31.38%,GFM2;LARS2;MRPS21;NDUFA7;MRPS17;GATB;GATC;POLRMT;MRPS7;MRPL2;MRPS24;MRPS18B;SLC25A33;MRPL47;MRPS14;MRPL51;MRPL16;TEFM;QRSL1;MRPS11;HARS1;MRPS28
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3417497929985934,-0.8193058245045931,0.6899038461538461,0.9242765226121457,1.0,9/12,43.41%,IFI27;TPR;UHMK1;PTPN14;NEDD4;RBM4;BMP4;AAAS;SIRT7
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3348068630368228,0.819274457913505,0.6949685534591195,0.8990282522084029,1.0,7/22,17.88%,ABCB7;GLRX5;LYRM4;HSPA9;NUBP2;NUBP1;NFU1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3904960075914698,0.8192587490492106,0.7075306479859895,0.8986242975049221,1.0,4/11,18.90%,IL6;RIPK1;TGFB1;MAP2K1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.28356574347008573,0.8190519758822967,0.73875,0.8985158717435928,1.0,7/58,8.40%,UVRAG;POLL;MRE11;SUMO1;DNTT;UBE2N;UIMC1
prerank,Golgi to plasma membrane transport (GO:0006893),0.29310268359026215,0.8186460394825036,0.7393617021276596,0.8987726922217658,1.0,5/47,7.44%,STXBP6;EXOC6;GOLPH3L;RAB34;GCC2
prerank,mRNA splice site selection (GO:0006376),-0.25865040026156766,-0.8186338727012795,0.7549668874172185,0.9245540625661821,1.0,4/30,3.32%,SRSF5;LUC7L2;PSIP1;SFSWAP
prerank,cellular response to radiation (GO:0071478),0.29778095148543604,0.8182156778701556,0.7252124645892352,0.8990835292419938,1.0,10/40,17.25%,MAPK14;GRB2;CLOCK;TANK;GPR88;NET1;SPIDR;INO80;HUS1;SIRT1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.30083383952968107,0.8176785660132331,0.7223719676549866,0.8995572613175796,1.0,10/39,20.08%,CASK;PTPRO;RCC2;RHOA;NF2;TBCD;THBS1;KANK1;FZD7;NEXMIF
prerank,response to calcium ion (GO:0051592),0.2643274085936693,0.8174737751726302,0.7868080094228505,0.8994567505348657,1.0,10/102,5.71%,IQGAP1;PLCG2;ALOX5AP;HPCA;RASGRP2;DPEP1;CLIC4;PPP3CA;SLC25A13;KCNH1
prerank,regulation of activated T cell proliferation (GO:0046006),0.31889929369225023,0.8170785493719902,0.7052785923753666,0.899703031590476,1.0,6/30,14.55%,IL27RA;RC3H1;PRNP;RPS3;ICOSLG;IL18
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.33480946927874017,0.8169764897223912,0.6986089644513137,0.8989914813420216,1.0,7/22,22.95%,ZDHHC7;ZDHHC6;ZDHHC23;CLIP3;ZDHHC3;ZDHHC12;ZDHHC24
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.33480946927874017,0.8169764897223912,0.6986089644513137,0.8989914813420216,1.0,7/22,22.95%,ZDHHC7;ZDHHC6;ZDHHC23;CLIP3;ZDHHC3;ZDHHC12;ZDHHC24
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.31927168205493917,0.8169711199259604,0.6889226100151745,0.8985653532437267,1.0,9/25,19.89%,RPL5;HIPK2;CSNK2A2;CSNK2A1;RPL11;TAF1;EFNA1;PRKCG;PSMF1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.27804680277698596,0.8169588403451868,0.7475369458128078,0.8981549504673286,1.0,23/77,16.33%,MCL1;PSME3;HSPA1A;GPX1;BIRC6;HGF;ACAA2;CSNK2A2;CSNK2A1;RIPK1;SLC25A5;HTT;PSMD10;SH3RF1;LGALS3;PRELID1;AKT1;CAAP1;GSTP1;RELA;MAZ;THBS1;RB1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.32203396297739934,-0.816587717785308,0.7077294685990339,0.9273521552012587,1.0,2/13,9.11%,IGF1;IRS1
prerank,retina homeostasis (GO:0001895),-0.27235090801488215,-0.8158482063552875,0.736231884057971,0.9278030202759946,1.0,2/23,5.36%,WHRN;CCDC66
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3001048922650424,0.8156065717583918,0.7217514124293786,0.8999282206641728,1.0,8/37,15.21%,PRKAG2;AXIN1;DDIT4;SPRED3;APP;TGFB1;MAPK1;SPRED1
prerank,endochondral bone morphogenesis (GO:0060350),-0.34445021111936236,-0.8153718406251522,0.7103448275862069,0.9277453470353675,1.0,5/11,14.20%,MEF2C;INPPL1;TMEM119;TRPV4;BMPR1B
prerank,cellular response to estradiol stimulus (GO:0071392),0.3475098697667643,0.8153428724099602,0.6953846153846154,0.8999627051218299,1.0,5/18,22.93%,NCOA3;NRIP1;LCOR;CCDC62;FAM210B
prerank,regulation of cholesterol transport (GO:0032374),-0.294932058026426,-0.8153054478229504,0.7246376811594203,0.9269050928244326,1.0,7/20,19.71%,LRP1;ABCB4;TTC39B;ARV1;NR1H2;APOC1;OSBPL6
prerank,positive regulation of proteolysis (GO:0045862),0.2876743065073464,0.815302583398529,0.7393617021276596,0.899591889012163,1.0,17/55,20.69%,IL1B;ADRA2A;FBXW11;MAPK12;TANK;NLRC4;SNX9;TNFRSF1B;CYFIP2;ADAM9;SNX33;AURKAIP1;CTSC;PINK1;BAD;RHBDD1;SH3D19
prerank,mitotic sister chromatid cohesion (GO:0007064),0.35118110390037316,0.8152746550140343,0.7023026315789473,0.8992042326283252,1.0,6/16,20.36%,NIPBL;MAU2;HASPIN;RB1;RAD21;PDS5B
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.2527770073124404,-0.8152338312070113,0.7960526315789473,0.9260613290654153,1.0,8/30,16.96%,BCL9;SMAD7;NREP;SMAD3;TRIM33;FSTL1;DKK3;SOX11
prerank,peptidyl-lysine modification (GO:0018205),0.26374418231821206,0.8150280619620974,0.7876004592422503,0.8991802885378617,1.0,14/99,14.70%,BCL11A;NUP210;SUMO1;IFIH1;NUP98;ATP7A;HDAC9;SUMO2;SENP6;NUP153;SIRT4;KAT2B;GCSH;EEF1AKMT1
prerank,histone H4 acetylation (GO:0043967),0.2877836119474252,0.8148892546108404,0.7398160315374507,0.8989702509518188,1.0,16/47,20.70%,KAT7;ATF2;TRIM16;TADA3;KANSL1;ING3;MORF4L1;JADE3;MSL3;PHF20;KMT2A;MSL2;HAT1;EP400;WDR5;KANSL3
prerank,gliogenesis (GO:0042063),-0.31349929406002774,-0.8148055673895389,0.7131782945736435,0.9259206054292316,1.0,4/15,14.08%,CD9;NFIB;METTL14;TGFB2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2773825471949837,-0.8135740066600327,0.7441176470588236,0.9272389802226203,1.0,2/20,1.54%,DCC;BCL2L1
prerank,sensory perception of chemical stimulus (GO:0007606),0.35352168748795537,0.8134956353495116,0.6949152542372882,0.9008973427921015,1.0,3/15,16.39%,CD36;SLC24A4;UBR3
prerank,gastrulation (GO:0007369),0.36756793132522303,0.8133626467388818,0.692063492063492,0.9006819158101201,1.0,2/15,11.12%,GPC3;LMBRD1
prerank,regulation of inclusion body assembly (GO:0090083),-0.3401220593274913,-0.8132834907896365,0.6801007556675063,0.9267903641300343,1.0,3/11,9.82%,SNCAIP;SACS;DNAJB2
prerank,negative regulation of double-strand break repair (GO:2000780),0.31516231999008776,0.8131206263269893,0.7149059334298119,0.9006587391769799,1.0,4/30,6.00%,MAD2L2;SMCHD1;KLHL15;UBR5
prerank,negative regulation of mRNA processing (GO:0050686),-0.31351974886520806,-0.8128897752297165,0.7214854111405835,0.9265174543662059,1.0,8/15,26.20%,SFSWAP;RNPS1;SRSF7;PTBP1;PCBP4;C1QBP;SRSF12;BARD1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2885007141498492,-0.8124759545838997,0.7345844504021448,0.9263078382575746,1.0,10/21,24.90%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;FBXO5;BUB1B;BUB1;CENPF
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.37725799047664244,0.8124009327968725,0.6898954703832753,0.9014386392084912,1.0,4/12,13.83%,PICALM;PRNP;TMED10;ROCK1
prerank,cellular protein catabolic process (GO:0044257),0.2820388191918171,0.8123123642560078,0.7636122177954847,0.901157087431287,1.0,13/59,13.92%,DENND3;LONP1;RSPRY1;MALT1;RAB7A;FAP;AP2A2;CAPN2;RIPK1;AP2B1;UBE2G1;ADAMTS12;YME1L1
prerank,triglyceride catabolic process (GO:0019433),0.35109575764844914,0.8122263904594501,0.7012195121951219,0.9008857979676373,1.0,1/19,3.29%,FABP7
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.28758975500689826,-0.8121444191736475,0.75,0.9259252814731319,1.0,7/20,15.05%,ATP2A2;CCDC47;TGM2;SELENOK;BCAP31;BAX;HERPUD1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.3104580257136631,-0.812097543140599,0.7287671232876712,0.9250489698926223,1.0,5/17,20.22%,SORT1;FURIN;NR1H2;APOC1;LMF1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.3269172161892656,0.8117803239452227,0.698170731707317,0.9011893219525988,1.0,10/19,20.01%,FBXW7;CSNK2A2;CAMKK2;HTT;DNM1L;SREBF2;FBXO7;HAX1;PINK1;PARK7
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.31922601045012095,0.8116477274018613,0.7075757575757575,0.9009629637376836,1.0,7/25,20.01%,MAD2L2;DOT1L;NSD1;TGFB1;RB1;NIBAN2;PARK7
prerank,autophagy of nucleus (GO:0044804),-0.3080865736831591,-0.8115282716193296,0.7333333333333333,0.9250812350210259,1.0,6/16,20.94%,ULK2;ATG12;ATG9A;ATG7;ATG2A;WDR45
prerank,cellular zinc ion homeostasis (GO:0006882),-0.2699900154664512,-0.8103678052534534,0.7458745874587459,0.9262295938132539,1.0,17/26,43.19%,SLC39A10;SLC39A7;SLC30A9;SLC39A6;MT2A;MT3;LCK;ATP13A2;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;SLC39A14
prerank,cholesterol metabolic process (GO:0008203),0.2768227435413159,0.809415676268937,0.7530712530712531,0.9041846528279841,1.0,17/68,17.29%,CEL;HSD17B7;SULT2B1;CYP27A1;ACAA2;MSMO1;IDI1;FDPS;NSDHL;ABCA5;DHCR24;SOAT1;ABCG1;ANGPTL3;MVD;MVK;SCAP
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.34571491157838524,0.8093972198536963,0.7026143790849673,0.9037837262772042,1.0,8/17,17.29%,SEC14L2;ERLIN1;MBTPS1;PRKAA1;SREBF2;ABCG1;KPNB1;SCAP
prerank,regulation of oxidative phosphorylation (GO:0002082),0.3554701286065968,0.8092857584062522,0.7339593114241002,0.9035346168863613,1.0,6/16,22.85%,ATP7A;ABCD1;VCP;COX7A2;PINK1;COX7A2L
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.28179648820804637,-0.8092219564050236,0.7664835164835165,0.9264068362599882,1.0,9/21,31.13%,GTF2H2;GTF2H1;ERCC2;GTF2H3;GTF2H5;ERCC1;GTF2H4;DDB1;CHD1L
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.28179648820804637,-0.8092219564050236,0.7664835164835165,0.9264068362599882,1.0,9/21,31.13%,GTF2H2;GTF2H1;ERCC2;GTF2H3;GTF2H5;ERCC1;GTF2H4;DDB1;CHD1L
prerank,fatty acid metabolic process (GO:0006631),0.26025950579848633,0.8092070048703877,0.8002296211251435,0.9032297554291093,1.0,9/115,5.83%,PPARG;ALOX5AP;CD36;GPX1;ACOT11;ACSL5;NUDT19;ACOT2;CEL
prerank,substantia nigra development (GO:0021762),-0.2521313285094973,-0.8090634492590045,0.7796052631578947,0.9257338188404688,1.0,11/37,19.33%,BASP1;PLP1;DYNLL1;CKB;ATP5PF;CALM1;CCDC14;INA;NDRG2;FGF9;YWHAH
prerank,positive regulation of rRNA processing (GO:2000234),-0.35174735732847345,-0.808944878470618,0.725,0.9249823371844431,1.0,6/10,29.09%,DIMT1;UTP15;WDR43;TRMT112;BUD23;WDR75
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.36321131972325776,0.808289329902227,0.7277397260273972,0.904315724649383,1.0,2/14,6.81%,CD177;FLNA
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.33403912259009416,-0.808161096441656,0.7212713936430318,0.9254547152259319,1.0,4/12,42.35%,TLR4;TLR9;INAVA;NOD2
prerank,protein insertion into membrane (GO:0051205),0.308979606371762,0.8081589235712031,0.6963276836158192,0.9041032187601177,1.0,8/32,15.98%,MAIP1;PRNP;TRAM2;TRAM1;STX5;APP;UBE2J2;VAPA
prerank,determination of left/right symmetry (GO:0007368),0.3007909508488025,0.8080326379325498,0.7146814404432132,0.9038615390483357,1.0,5/36,13.98%,FOXJ1;RFX3;KIF3B;CCDC39;CITED2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3030702641474448,0.8078148092712105,0.7246575342465753,0.9037820558357604,1.0,9/35,18.83%,ALOX5AP;GGTA1;FAR1;BDH1;ACAT1;PPT1;HMGCLL1;HPGD;SLC25A1
prerank,protein depolymerization (GO:0051261),-0.2608160367960226,-0.8076845716445357,0.7414330218068536,0.925358018553499,1.0,8/27,23.28%,MICAL3;VPS4B;CKAP5;CFL1;KIF18A;GSN;NCKAP5L;NCKAP5
prerank,early endosome to Golgi transport (GO:0034498),0.37474969300676375,0.8075023645711185,0.7003424657534246,0.9038441830285642,1.0,3/11,8.41%,SNX1;RAB6A;STX5
prerank,mRNA processing (GO:0006397),0.24076987469948197,0.8074099258409246,0.8708677685950413,0.9035703251526689,1.0,75/287,19.77%,RSRC1;ERN1;GTF2F2;CRNKL1;RNPC3;POLR2C;SNRPD2;PRPF6;DDX42;SNRPB;DBR1;CDC5L;USP49;CMTR1;BUD31;SRSF10;BUD13;DNAJC8;THOC3;DDX41;FIP1L1;CCNH;RBM10;LSM5;MAGOHB;DDX46;PRPF3;SF3B6;RBM22;RPRD2;SRSF4;DHX8;RPRD1B;SLU7;YTHDC1;NUDT21;RBM15;SPEN;CACTIN;SRRT;FRG1;DDX23;PQBP1;SNRPA1;SF3A1;ERCC3;METTL3;SYNCRIP;AQR;U2SURP;CPSF3;GEMIN7;WBP11;PAPOLA;NCBP1;PHF5A;TXNL4A;CELF1;PABPC1;PPWD1;AURKAIP1;SYF2;TFIP11;SUPT4H1;SF3B3;CWF19L1;CSTF3;RBM41;SF3B2;SF3B1;UPF3B;PDCD7;WDR33;CDC40;SMNDC1
prerank,positive regulation of reproductive process (GO:2000243),-0.25590735646689045,-0.8071131962196926,0.7866666666666666,0.9254031430881309,1.0,1/31,0.19%,LHFPL2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.29681410237057027,-0.8067125193133478,0.7305699481865285,0.9251734787853622,1.0,7/18,23.72%,ATF4;UTP15;PHF8;MAF1;POLR2K;WDR43;LYAR
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.31607960150695263,0.8067073973393964,0.7318116975748931,0.9042926765367749,1.0,7/29,15.93%,DGCR8;PUM2;TRIM71;SRRT;TUT7;METTL3;PUM1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.23882470431623726,-0.8060368927370828,0.803030303030303,0.9254435973580368,1.0,17/42,24.45%,YARS1;LARS1;NARS1;WARS2;LARS2;WARS1;NARS2;TARS3;IARS1;DARS1;TARS2;KARS1;PPA2;FARSA;EARS2;RARS1;CARS1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.3499500576958494,0.8055650264103043,0.71334431630972,0.9057195878939597,1.0,2/16,2.03%,METRNL;PIM1
prerank,snRNA metabolic process (GO:0016073),0.34482393850213966,0.8049799474922393,0.7021276595744681,0.9062125058024098,1.0,5/17,16.72%,TUT1;INTS2;INTS11;INTS4;INTS6
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2721058513274965,0.8049298154342771,0.7904411764705882,0.9058624856735249,1.0,8/72,10.54%,SP100;BCL3;BTG2;HIPK2;CNOT6;PIDD1;CNOT2;CASP2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.37673280047821617,0.8048923258719025,0.6701940035273368,0.9054896691830433,1.0,4/10,18.67%,PXYLP1;XYLT1;CSGALNACT1;DSEL
prerank,activation of protein kinase activity (GO:0032147),0.2568013910807945,0.8048608456566362,0.7790834312573442,0.9051120167352804,1.0,21/106,14.55%,PAK1;JAK2;MALT1;CCDC88A;AXIN1;TAOK3;ADRA2A;TIRAP;STK4;PTK2B;PDPK1;PAK2;TLR3;MINK1;PRKAR2A;ADCY7;MAP3K7;ADCY5;AKT1;MAPKAP1;IL18
prerank,potassium ion transmembrane transport (GO:0071805),0.25364633970951844,0.8047584229022289,0.8312710911136107,0.9048417676227878,1.0,9/135,5.71%,KCNE3;KCNG4;KCNA6;SLC9A7;KCNK7;KCNQ1;HCN4;SLC12A7;KCNH1
prerank,protein polyglutamylation (GO:0018095),-0.3401832115501012,-0.8047344800513099,0.7394366197183099,0.9267757054092264,1.0,5/11,22.14%,CFAP20;TTLL11;TTLL5;CEP41;TTLL1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.33382106027930286,0.8046345931881203,0.7099236641221374,0.9045967557580229,1.0,2/20,5.23%,RAPGEF2;ADRA2A
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.30268545884263265,-0.8044167160671091,0.7265415549597856,0.9264042983416718,1.0,5/17,14.36%,SMAD7;DGKQ;PARD3;CALM1;EIF4G1
prerank,negative regulation of developmental process (GO:0051093),0.2710364707134462,0.8037209161852865,0.800251256281407,0.9056513194483867,1.0,4/69,5.44%,BCL11A;FOXJ1;SPI1;RC3H1
prerank,Wnt signaling pathway (GO:0016055),0.2625309514060997,0.8032728892594568,0.7964071856287425,0.9059151937073369,1.0,8/92,8.94%,LRRK2;PLCG2;CCDC88C;CSNK1G1;AXIN1;PTEN;RARG;CSNK1G3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.32877272651408257,0.803070261098983,0.7175572519083969,0.9058027512194525,1.0,9/21,21.89%,PNLDC1;CNOT6;CNOT2;TUT7;CNOT8;TNKS1BP1;CNOT6L;PARN;CNOT3
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3356685973451677,0.8030402726100061,0.7413793103448276,0.9054189657922109,1.0,4/21,15.28%,NUDT19;CEL;LDHD;FAAH
prerank,platelet aggregation (GO:0070527),-0.2493096433493192,-0.802719445745369,0.7973421926910299,0.9284536986439734,1.0,11/33,24.60%,P2RY12;PPIA;ILK;PIK3CG;ITGB3;GNAS;PLEK;RAP2B;FIBP;TYRO3;ACTG1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3069886992909129,-0.8022651187399495,0.7576530612244898,0.9283238209298524,1.0,1/15,0.42%,IGF1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3417520068882297,-0.8015656001331751,0.727069351230425,0.928672513901352,1.0,3/10,10.63%,BIN1;ATP1A2;VDAC1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.3780149663347831,0.8014081104534883,0.7212317666126418,0.9075851140241673,1.0,4/12,14.67%,PPARG;NFKBIA;ABCA5;ABCG1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.35142083554231635,0.8010610127771914,0.7175324675324676,0.9077145642256812,1.0,7/16,18.74%,CLEC16A;ETF1;MTRF1;IRAK3;INSR;GSPT1;TBC1D25
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.350601410543701,0.8009048473091379,0.7147286821705426,0.9075357146464402,1.0,2/15,7.23%,PTK2B;DYRK1A
prerank,catecholamine biosynthetic process (GO:0042423),-0.3388597452494436,-0.8007033764114655,0.7395348837209302,0.9291578999432605,1.0,3/11,32.79%,TGFB2;DDC;MOXD1
prerank,regulation of dendrite extension (GO:1903859),-0.29419811376775074,-0.800669252837138,0.7471590909090909,0.9282809653481691,1.0,3/18,7.00%,SYT1;RNF157;PLAA
prerank,triglyceride homeostasis (GO:0070328),-0.2545056163246632,-0.8005809585844101,0.7544378698224852,0.9275071105236038,1.0,2/26,5.79%,APOE;PNPLA8
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.312973254470723,0.8005312434530002,0.7207602339181286,0.9077092046623646,1.0,6/29,16.09%,TENT5A;GDNF;DHX34;EIF4ENIF1;PAIP1;PABPC1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2748694739291183,-0.7999940313422033,0.808955223880597,0.9275863643525498,1.0,10/24,27.61%,POLD3;UBC;XRCC1;PCNA;LIG3;RFC3;LIG1;UBA52;RFC2;POLE
prerank,response to interleukin-4 (GO:0070670),-0.339703185657305,-0.7998722406985178,0.7019230769230769,0.9268505153132736,1.0,4/10,35.65%,JAK3;SHPK;LEF1;TCF7
prerank,zinc ion transmembrane transport (GO:0071577),0.33302868053346385,0.7998674960150131,0.7003058103975535,0.9083537476395164,1.0,5/22,17.46%,SLC30A4;SLC30A1;SLC39A11;SLC39A13;SLC39A12
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.3172378099245595,-0.7994451491305344,0.7321428571428571,0.9266507358265024,1.0,6/13,32.24%,GLUL;GAD1;GLS;PRODH;GLS2;NOS1
prerank,regulation of chromatin binding (GO:0035561),0.3831972687668626,0.7993321848397708,0.715008431703204,0.9087668765187694,1.0,2/10,9.47%,DTX3L;PARP9
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.36694744450457495,0.7993179341647073,0.6954225352112676,0.9083623287383793,1.0,4/12,14.38%,UCK2;CAD;UCK1;DCK
prerank,androgen receptor signaling pathway (GO:0030521),-0.3363598748871979,-0.7986042223486031,0.7298578199052133,0.9271821070965033,1.0,4/11,22.71%,DDX5;PLPP1;AR;ARID1A
prerank,zinc ion transport (GO:0006829),0.3371401851110801,0.7981083618387416,0.7149460708782742,0.9098600487141645,1.0,3/21,8.74%,SLC30A4;SLC30A1;SLC39A11
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2633405637247277,0.7979772957127774,0.8031784841075794,0.9096530551584748,1.0,22/87,18.50%,ARHGEF18;FOS;CBL;ZFYVE9;F11R;ENG;PXN;RHOA;USP15;NRROS;SMAD4;NLK;MAP3K7;TGFB1;ADAM9;USP9X;ZMIZ2;DUSP22;SMAD5;SIRT1;APPL1;HPGD
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.28197890446886714,-0.7978447350730759,0.7556818181818182,0.9276055035070774,1.0,7/20,38.08%,STARD3;AKR1B1;FDX1;TSPOAP1;HSD17B10;STAR;CYP46A1
prerank,apoptotic mitochondrial changes (GO:0008637),0.3011956614666041,0.7959713713364758,0.7467438494934877,0.9124162679649873,1.0,13/32,21.99%,IFIT2;BBC3;ATP2A1;FIS1;DNM1L;TIMM50;HSPD1;AIFM2;GGCT;BAD;FZD9;BID;BCL2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.3330443504968901,0.795873634710782,0.7214611872146118,0.9121432123321731,1.0,7/18,20.57%,SETD7;ASH1L;SETD2;KMT2A;SETMAR;EHMT1;PRDM9
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2988473709374865,-0.7957297345383681,0.7419354838709677,0.9301192604939351,1.0,9/16,43.19%,PRMT5;C3;CHGA;ACP3;GRP;PDE6G;NECAB2;GSK3A;SLC39A14
prerank,negative regulation of translational initiation (GO:0045947),0.36211428887209746,0.795670301839092,0.7338983050847457,0.9120383516248591,1.0,4/13,14.41%,EIF4EBP1;EIF2AK1;PAIP2;EIF3E
prerank,glycosaminoglycan metabolic process (GO:0030203),0.2812386019616035,0.7956606931734055,0.7943078913324709,0.9116226527488565,1.0,8/54,11.59%,EXT1;GPC3;HSPG2;PXYLP1;XYLT1;FUCA1;GALNT5;SDC3
prerank,regulation of amyloid-beta formation (GO:1902003),0.2999739141494252,0.7952032559972736,0.7443181818181818,0.911937819436707,1.0,12/34,15.82%,IFNGR1;SORL1;PICALM;PRNP;RTN2;GSAP;TMED10;RTN4;ROCK1;ABCG1;RELA;RTN1
prerank,carnitine shuttle (GO:0006853),0.37753444927140994,0.7947743097406912,0.7137989778534923,0.9121919625245742,1.0,3/11,13.86%,PRKAG2;PRKAB2;PRKAA2
prerank,positive regulation of potassium ion transport (GO:0043268),0.29521676280645914,0.7941027811899343,0.7424023154848046,0.9128702931996088,1.0,6/38,8.36%,KCNQ1;KIF5B;ADRA2A;FLNA;KCNN4;GNB1
prerank,RNA 3'-end processing (GO:0031123),0.2664673645132881,0.7939419459009274,0.8005082592121983,0.9127121339437412,1.0,22/69,20.07%,THOC3;FIP1L1;TUT1;MAGOHB;TENT2;RPRD2;SRSF4;RPRD1B;SLU7;NUDT21;MTPAP;TUT7;PNPT1;TENT4B;CPSF3;PAPOLA;NCBP1;CSTF3;UPF3B;WDR33;CDC40;SUPV3L1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3314684692909483,0.7929766621125331,0.7142857142857143,0.9138271402222113,1.0,5/20,11.55%,ITCH;HSPA1A;DCUN1D1;DAXX;DCUN1D3
prerank,protein targeting to peroxisome (GO:0006625),0.3056789116214884,0.7928431999154169,0.7297709923664122,0.9136178584592057,1.0,6/29,13.04%,PEX16;PEX12;ZFAND6;PEX14;FIS1;ABCD1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.339422491481574,-0.7927846319492751,0.7333333333333333,0.9340779517041997,1.0,3/10,21.84%,WHRN;ADGRV1;SOD1
prerank,sensory perception of light stimulus (GO:0050953),0.25928707824333785,0.7926442286959988,0.8073170731707318,0.913500116743105,1.0,15/87,17.40%,CRYBG3;RP2;ATF6;WFS1;ATXN7;DNAJC19;OPA3;KIFC3;UNC119;IMPG2;USH2A;GRM8;EYA3;PRPH2;PITPNA
prerank,regulation of coagulation (GO:0050818),-0.3430305285217869,-0.7926296207685023,0.7186046511627907,0.9334202117099016,1.0,1/11,1.64%,HS3ST5
prerank,regulation of transforming growth factor beta production (GO:0071634),0.3374981372950979,0.7925769418997535,0.7199367088607594,0.9131658780687483,1.0,3/18,10.27%,LILRB1;SMAD4;FN1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.31396930246475846,-0.7923098956620596,0.7571801566579635,0.9330538135036525,1.0,7/14,24.27%,SFSWAP;RNPS1;SRSF7;PTBP1;PCBP4;C1QBP;SRSF12
prerank,glycogen biosynthetic process (GO:0005978),0.3633517546203153,0.7922507189662816,0.7417677642980935,0.9128296940528543,1.0,3/12,12.83%,UGP2;PGM1;PGM2L1
prerank,glucan biosynthetic process (GO:0009250),0.3633517546203153,0.7922507189662816,0.7417677642980935,0.9128296940528543,1.0,3/12,12.83%,UGP2;PGM1;PGM2L1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.23336342989887587,0.7920219848645741,0.9101123595505618,0.9127618491189013,1.0,60/327,16.43%,SP3;RUNX3;LIMD1;SAP30;PITX3;STAT3;NSD3;NAB1;SPI1;KAT7;RYBP;ATF2;IRF2;RFX3;RPL6;BTG1;RNF20;RPS6KA5;AHR;PHF19;CREM;SRSF10;CLOCK;ENG;PHF12;NFYC;ZBTB11;BACH1;RBAK;ASCC1;CREBL2;NCOA2;SBNO2;BNC2;NR3C1;DAXX;ING2;SRRT;NLK;REST;BAZ2A;NFYA;PQBP1;MSL3;ATRX;MYB;NSD1;EZH2;HCLS1;NFIL3;ZNF431;RELA;SERTAD3;CREBBP;DVL2;BHLHE40;FOXN2;INSR;RB1;DAPK3
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.32046329578357097,0.7915240640504837,0.7233704292527822,0.9131227523980426,1.0,3/23,3.99%,CCDC88C;KIF5B;CCDC88A
prerank,sterol homeostasis (GO:0055092),-0.2132598075464819,-0.7914064041027293,0.8807339449541285,0.9335928057803287,1.0,8/65,13.42%,ABCA1;APOE;TTC39B;LIMA1;CNBP;MTTP;NPC1;NR1H2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.3393498239718846,0.7913651988249871,0.7361563517915309,0.9129521277831738,1.0,9/17,21.99%,BBC3;FIS1;DNM1L;TIMM50;GGCT;BAD;FZD9;BID;BCL2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.2867268731024584,0.7912679395872629,0.757703081232493,0.9126924753649417,1.0,5/41,8.36%,ACE2;KCNQ1;FLNA;KCNN4;GNB1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.26779501494284486,-0.7912062252871404,0.7561728395061729,0.9330245596474115,1.0,5/24,11.91%,NRP1;IQSEC1;PPM1F;PIK3R1;VEGFA
prerank,mRNA metabolic process (GO:0016071),0.2594220071768067,0.7910506007358262,0.8067632850241546,0.912611356493534,1.0,25/90,21.06%,ZC3H12D;HSPA1A;ERN1;SNRPB;DCP2;LSM5;PRPF3;ZFP36L2;SRSF4;NUDT21;SF3A1;METTL3;RNH1;PNPT1;CPSF3;NCBP1;CELF1;AURKAIP1;SUPT4H1;CSTF3;SF3B2;SF3A2;PRPF18;NONO;SLBP
prerank,negative regulation of heart contraction (GO:0045822),-0.33244169172335314,-0.7909275773709066,0.7248803827751196,0.9325545077144851,1.0,2/11,7.79%,ATP1A2;PIK3CG
prerank,sprouting angiogenesis (GO:0002040),0.27936818917773176,0.7907492443274076,0.7753246753246753,0.9126653615102934,1.0,8/51,9.51%,RSPO3;ADGRA2;VEGFC;RNF213;PTK2B;ENG;NAXE;PGF
prerank,positive regulation of tissue remodeling (GO:0034105),0.38339669499869744,0.7906561404479638,0.7282051282051282,0.9123811573658311,1.0,2/10,14.55%,ROCK1;IL18
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.35696079753435916,0.7905244905062514,0.7081339712918661,0.9121663021215483,1.0,1/14,1.64%,SULF2
prerank,vasoconstriction (GO:0042310),-0.3328665529731255,-0.7900491458302916,0.7468354430379747,0.9331065248394547,1.0,2/11,7.34%,SLC8A1;HTR2B
prerank,modulation by symbiont of entry into host (GO:0052372),0.3434138216977229,0.7898994697685672,0.739424703891709,0.9127149234661367,1.0,5/16,15.99%,TRIM62;TRIM25;EXOC7;TRIM14;EXOC2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.28228270926822163,0.7894450419116753,0.758043758043758,0.9130193808297494,1.0,9/50,14.79%,CCNJL;CCND3;CDKN2C;CCND1;CCNH;CCNT2;CCNT1;CCND2;CDK5R2
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.24974787845352264,0.7891478000910337,0.8290697674418605,0.9130661251385536,1.0,26/112,18.50%,ARHGEF18;FOS;CBL;ZFYVE9;PDE2A;F11R;ENG;PXN;ZFP36L2;RHOA;USP15;NRROS;SMAD4;NR3C1;NLK;MAP3K7;TGFB1;ADAM9;USP9X;ZMIZ2;DUSP22;WNT7A;SMAD5;SIRT1;APPL1;HPGD
prerank,kidney development (GO:0001822),0.2700610790022842,0.7887012290000294,0.8059125964010283,0.9133557893197465,1.0,5/65,6.40%,ACE;SULF2;NIPBL;GDNF;WFS1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.26827166302184186,0.7881115117192714,0.8245192307692307,0.9138477906398528,1.0,19/68,19.48%,TAF1A;SNRPB;POLR1G;SETX;SSU72;FIP1L1;CCNH;SCAF8;NUDT21;ERCC3;POLR1B;MAZ;CPSF3;PAPOLA;NCBP1;TAF1C;CSTF3;POLR3K;WDR33
prerank,regulation of calcium ion import (GO:0090279),0.3196967052716478,0.7877398593221494,0.7400318979266348,0.9140480495350884,1.0,4/21,12.86%,FYN;PRNP;SLC30A1;LGALS3
prerank,positive regulation of heart rate (GO:0010460),-0.29552690115548574,-0.7876897037636895,0.7704918032786885,0.9360629296648728,1.0,6/17,22.32%,ATP2A2;ADRA1B;ADRB1;SCN3B;RYR2;ADRA1A
prerank,fatty acid transmembrane transport (GO:1902001),0.3375499745956002,0.7874244970708478,0.7527386541471048,0.9141145632108902,1.0,6/19,15.26%,PRKAG2;CD36;PRKAB2;ABCD1;PRKAA2;SLC2A1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.30806989606404395,0.7873970152936788,0.7668621700879765,0.9137352549828706,1.0,4/27,9.18%,BMPR2;PARP4;HGF;TNKS
prerank,carboxylic acid transport (GO:0046942),0.2791573671385371,0.7870879608621829,0.774365821094793,0.9137893858615128,1.0,14/55,18.99%,SLC23A2;SLC23A1;PSAP;SLC15A4;SLC1A5;SLC1A4;SLC38A1;SLC66A1;SLC6A9;SLC16A3;SLC16A4;SLC16A7;SLC6A11;SLC38A2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3020027624532617,0.7867083954720698,0.7593659942363112,0.9139399197684198,1.0,11/32,21.71%,PICALM;SAMD8;MTPN;TMED10;FOXO3;APP;ROCK1;PRKCD;PUM3;PCIF1;EIF4E
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.32406699676583595,0.7864658125908689,0.7271293375394322,0.913860132905384,1.0,2/20,6.34%,PLSCR1;GSS
prerank,purine-containing compound salvage (GO:0043101),-0.31721662495695746,-0.7862822245348214,0.7388235294117647,0.9373582950990326,1.0,4/12,27.57%,GMPR;AMPD2;HPRT1;ADK
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2799782207045274,0.7862365979728813,0.7811671087533156,0.9137960964348378,1.0,7/52,12.51%,TAT;ME2;HAAO;IDH1;MDH2;MTRR;OGDH
prerank,activation of protein kinase A activity (GO:0034199),-0.29285229853004147,-0.786166077642661,0.7785888077858881,0.9366239803845808,1.0,5/16,17.65%,ADCY9;PRKACA;PRKAR1A;ADCY3;ADCY8
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2765208926698433,0.7854593150266483,0.794973544973545,0.9145648884794428,1.0,10/57,14.63%,XPO1;RPL5;DHX37;RPL35A;RIOK1;RPF2;RPL11;RRP36;RPL7;MRTO4
prerank,ceramide transport (GO:0035627),-0.31403188298242013,-0.7848470705151626,0.7785888077858881,0.9377753721886262,1.0,2/12,5.05%,ABCB4;PLEKHA8
prerank,positive regulation of viral process (GO:0048524),-0.21657236450402745,-0.7848035842457688,0.8516746411483254,0.9369104459824541,1.0,26/60,27.93%,LARP1;PPIA;KPNA6;SRPK1;TBC1D20;POLR2A;ADAR;SRPK2;DHX9;PPIE;POLR2K;VAPB;DDX3X;CDK9;ADARB1;POLR2H;NELFCD;PPID;POLR2J;RAD23A;CNOT7;TYRO3;PDE12;CD28;NELFE;DDB1
prerank,protein localization to nucleus (GO:0034504),0.25186748260166497,0.7846983884437468,0.8331374853113983,0.9152993413483829,1.0,19/102,16.19%,BCL3;SYK;STAT3;PTTG1IP;WRN;LMNA;RPF2;PIKFYVE;HIKESHI;TOR1AIP1;NUP153;EIF4ENIF1;MORC3;RPL11;AKT1;FAM53C;GBP2;KPNB1;TNPO1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.2585122386049151,-0.7845868210984488,0.8012422360248447,0.9363424144211799,1.0,7/24,19.54%,NRP1;SEMA3D;SEMA3E;SEMA6D;VEGFA;SEMA7A;SEMA5B
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3229425453603659,0.7841634253890427,0.7357594936708861,0.915723704808737,1.0,4/19,11.45%,PAPSS1;SULT2B1;PAPSS2;TPST1
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.24773802488506147,-0.7835559230792805,0.81,0.9370523450048728,1.0,16/30,32.20%,GTF2H2;TTF1;GTF2H1;TAF1D;ERCC2;POLR2K;GTF2H3;POLR2H;GTF2H5;CDK7;TBP;GTF2H4;POLR1F;CAVIN1;MNAT1;POLR2L
prerank,regulation of protein localization (GO:0032880),0.27213833506443835,0.7831669127781876,0.8025641025641026,0.9168136102891754,1.0,13/58,13.05%,PICALM;FBXW7;SUMO1;ZDHHC7;AFDN;RABGAP1L;STX6;TRIM25;TRIM46;TRIM14;DVL3;TRIM17;MAPK8
prerank,histone H3 deacetylation (GO:0070932),0.3439349204485378,0.7831392393681306,0.7474747474747475,0.9164245125445571,1.0,5/15,18.12%,HDAC9;HDAC3;ELK4;SIRT1;HDAC1
prerank,RNA biosynthetic process (GO:0032774),0.29524069854710344,0.7830515873699678,0.7665706051873199,0.9161373886067681,1.0,6/31,14.55%,TAF13;SMARCA5;SETX;TAF7;POLA2;RSF1
prerank,response to metal ion (GO:0010038),0.2699152833525733,0.7828431268663373,0.8148148148148148,0.916043553432094,1.0,7/67,6.74%,PLSCR1;NEDD4L;SLC30A4;PPP3CA;HAAO;SLC25A13;CRIP1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.32205052709770204,0.7826036940193145,0.7293934681181959,0.9159837981172834,1.0,5/22,16.03%,IL10RA;CRLF3;IL6;KIT;OCIAD1
prerank,iron-sulfur cluster assembly (GO:0016226),0.31457322467930915,0.7823823661858506,0.7395993836671803,0.9159172106507468,1.0,7/24,17.88%,ABCB7;GLRX5;LYRM4;HSPA9;NUBP2;NUBP1;NFU1
prerank,regulation of keratinocyte migration (GO:0051547),-0.32177856546271555,-0.7823772808053838,0.7558441558441559,0.9379853223641338,1.0,2/12,4.11%,EPB41L4B;IQSEC1
prerank,histone H3-K36 demethylation (GO:0070544),-0.33620918498370156,-0.7823561512850886,0.7405660377358491,0.937086572469319,1.0,4/10,11.54%,KDM2A;KDM2B;KDM4A;PHF8
prerank,negative regulation of phosphatase activity (GO:0010923),0.3124435882436704,0.7822581760529865,0.7619760479041916,0.9156808756270599,1.0,9/25,22.03%,CRY2;PPP1R15A;GPATCH2;FKBP1B;ZCCHC9;SEMA4D;PTPA;TIPRL;GSK3B
prerank,regulation of cholesterol efflux (GO:0010874),0.30016641044576836,0.7817742139596908,0.7488921713441654,0.916023677889688,1.0,7/30,14.75%,PPARG;NFKBIA;ABCA3;NAXE;ABCA5;SREBF2;GPS2
prerank,negative regulation of chemokine production (GO:0032682),0.34682435465484,0.7808723949763555,0.7463651050080775,0.9169682009436801,1.0,4/14,14.84%,KLF4;IL6;MAP2K5;GSTP1
prerank,microtubule anchoring (GO:0034453),0.3627752228327906,0.7807898036791014,0.7293497363796133,0.9166753363413668,1.0,3/12,13.88%,GCC2;PEX14;CLASP1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.25965750567634266,-0.780696427014383,0.8036253776435045,0.938889707200419,1.0,2/27,3.13%,PRKN;UBE2B
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.3189919988358645,0.7806076925606601,0.7597503900156006,0.9165339137736462,1.0,2/22,4.01%,ACE;MRE11
prerank,aminoglycan metabolic process (GO:0006022),-0.33487312266124236,-0.7802683953893969,0.7398568019093079,0.9386262375865129,1.0,3/10,13.71%,CHST9;B3GAT1;B3GAT2
prerank,positive regulation of dendrite extension (GO:1903861),-0.2942024988038937,-0.7798195626212111,0.782967032967033,0.9384201774952848,1.0,3/17,7.00%,SYT1;RNF157;PLAA
prerank,heart development (GO:0007507),0.2395642072534504,0.7797980163553879,0.8718510405257394,0.9173592204202851,1.0,15/150,10.27%,KDM6A;PDLIM5;HEG1;PDLIM1;NIPBL;BMPR2;GPC3;DLC1;PTEN;CRIP1;SGCD;HDAC9;ID2;FBN1;FN1
prerank,regulation of rRNA processing (GO:2000232),-0.29229705026362995,-0.7796490980843641,0.7702020202020202,0.9377787975600129,1.0,9/16,29.09%,DIMT1;UTP15;WDR43;TRMT112;YTHDF2;BUD23;NUDT16;USP36;WDR75
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2516087734454636,-0.7794820829746604,0.7955271565495208,0.9371237386387123,1.0,3/27,6.47%,GNA15;C3AR1;GPR157
prerank,positive regulation of double-strand break repair (GO:2000781),0.2935414272249994,0.7790032914516182,0.7967479674796748,0.9181494417610643,1.0,9/39,12.80%,DTX3L;MAD2L2;SMCHD1;ACTR2;WRAP53;PARP9;ARID2;KMT5B;SPIDR
prerank,amyloid precursor protein catabolic process (GO:0042987),0.34836947037083044,0.7787530335824039,0.7258883248730964,0.9181145832237321,1.0,5/14,16.93%,ADAM17;DYRK1A;ADAM19;ABCG1;PSEN1
prerank,positive regulation of axon extension (GO:0045773),-0.2663670746916619,-0.7784997477606843,0.7749287749287749,0.9377686041614955,1.0,6/22,18.08%,NRP1;LIMK1;GOLGA4;VEGFA;MACF1;SEMA7A
prerank,cGMP-mediated signaling (GO:0019934),0.3592122730022588,0.7781855581124607,0.7275747508305648,0.918564447264185,1.0,3/13,11.52%,CD36;PDE2A;IRAG1
prerank,response to ethanol (GO:0045471),-0.3039113688473991,-0.7779734537062053,0.7679012345679013,0.9376596342232288,1.0,4/14,22.23%,SDF4;GLRA2;SOD1;GRIN2B
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.25643145114969246,-0.7778902432568214,0.7716049382716049,0.936869563261775,1.0,2/26,2.16%,ANAPC15;NEK6
prerank,negative regulation of interleukin-10 production (GO:0032693),0.33734573396927886,0.7778603523479454,0.7280265339966833,0.9186528322169246,1.0,1/16,1.36%,LILRB1
prerank,smooth muscle tissue development (GO:0048745),-0.3439846089123333,-0.7776700100927315,0.7345971563981043,0.9362755120143923,1.0,2/10,4.20%,SMO;NF1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.27769376157200476,-0.7774424382283865,0.7698412698412699,0.9357530014019688,1.0,3/20,5.86%,MAFB;CTR9;LDB1
prerank,glycerolipid metabolic process (GO:0046486),0.3689089200309787,0.7774042475179896,0.740924092409241,0.9189407729239298,1.0,1/11,1.05%,DGKG
prerank,negative regulation of cellular senescence (GO:2000773),0.3496033204174846,0.7773968341157863,0.7704347826086957,0.9185348352655436,1.0,1/13,1.64%,AKT3
prerank,DNA biosynthetic process (GO:0071897),0.33966912898982143,0.7773043153574424,0.7290322580645161,0.9182579794608314,1.0,3/16,6.89%,POLL;POLD4;WRN
prerank,regulation of multicellular organism growth (GO:0040014),0.3422939799584325,0.7771396706711727,0.7479541734860884,0.9180671444669,1.0,2/15,3.82%,STAT5A;STAT5B
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.38341991626479566,0.7770199803952821,0.7127468581687613,0.9178089968720866,1.0,1/10,5.05%,CARMIL1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3311664566156492,0.7769757820771375,0.7674050632911392,0.9174480777356072,1.0,3/19,8.01%,HSPA1A;CHMP4B;PDCD6IP
prerank,vasculogenesis (GO:0001570),-0.2411602412622487,-0.7766599683447917,0.8371335504885994,0.9360811521346316,1.0,4/32,11.91%,TGFBR2;RASA1;ITGB8;VEGFA
prerank,regulation of cellular senescence (GO:2000772),-0.24965762423680332,-0.7766557215084344,0.8580645161290322,0.93517205251756,1.0,4/28,8.02%,NUAK1;NEK6;ZKSCAN3;NEK4
prerank,negative regulation of DNA replication (GO:0008156),-0.30960864953241396,-0.7765651882914527,0.7749419953596288,0.9344030934176183,1.0,1/13,1.56%,WAPL
prerank,retinoid metabolic process (GO:0001523),-0.2088418854156038,-0.7762018827303296,0.949238578680203,0.9340414383404236,1.0,20/71,33.73%,APOE;LRP1;BCO2;DHRS3;GPC6;AGRN;AKR1B1;RDH13;NAPEPLD;GPC4;SCPEP1;AWAT2;SDC2;GPC2;ALDH1A2;DHRS13;RDH11;RETSAT;CYP26B1;RBP1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3342002991206813,-0.7760538140934891,0.7840909090909091,0.9324510883433162,1.0,3/11,13.09%,CCT2;DKC1;CCT8
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3342002991206813,-0.7760538140934891,0.7840909090909091,0.9324510883433162,1.0,3/11,13.09%,CCT2;DKC1;CCT8
prerank,axoneme assembly (GO:0035082),-0.24613491116433206,-0.7759955080866199,0.8047945205479452,0.9316247617329572,1.0,23/30,47.66%,CFAP74;DCX;DNAI4;LRGUK;SPAG16;SPEF1;TTLL3;CFAP46;CCDC40;RSPH9;JHY;DNAJB13;CFAP206;DRC1;SPAG17;GAS8;TTC12;DNAAF2;RSPH1;RP1;DNAAF1;CCDC65;RSPH4A
prerank,membrane lipid catabolic process (GO:0046466),0.36873612641725634,0.7757688953746972,0.737649063032368,0.9188829281371149,1.0,3/10,16.46%,SMPDL3B;FUCA1;PPT1
prerank,oxoacid metabolic process (GO:0043436),-0.24776962577719827,-0.7757258986277832,0.8146964856230032,0.931142305674297,1.0,2/27,3.12%,TPST2;ENPP1
prerank,mRNA 3'-end processing (GO:0031124),0.2560952037235441,0.7754903284051438,0.8182926829268292,0.9188588222650879,1.0,24/78,19.62%,SSU72;THOC3;FIP1L1;TUT1;MAGOHB;SCAF8;TENT2;RPRD2;SRSF4;RPRD1B;SLU7;PAPOLG;NUDT21;MTPAP;APP;TENT4B;CPSF3;PAPOLA;NCBP1;PABPC1;CSTF3;UPF3B;WDR33;CDC40
prerank,ncRNA processing (GO:0034470),0.2350910827005161,0.7746716663454027,0.8709677419354839,0.919677244264099,1.0,37/200,14.63%,RPL5;NOL6;FARS2;RPL37A;DGCR8;RPL6;XRN2;DHX37;RPS14;RPL35A;TUT1;UTP6;RPL13;DDX49;NOC4L;MPHOSPH6;INTS2;SRRT;TUT7;NOL11;INTS11;RPLP0;UTP20;RPL34;RPL19;RPL11;RPL30;METTL3;RRP36;NOP58;RPL4;INTS4;UTP18;RPS2;RPL7;MRTO4;DDX10
prerank,regulation of lipid kinase activity (GO:0043550),0.36082367389650505,0.7738931514077274,0.7327731092436974,0.9204489670945208,1.0,4/11,17.15%,PPP2R5A;RBL2;RB1;PIK3R2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.28687214601867184,0.773824582457761,0.7727910238429172,0.9201331406118656,1.0,8/38,14.86%,H3-3A;RBBP4;SMARCA5;CENPL;CENPQ;ATRX;RSF1;CENPC
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.31603006632710484,0.772746767419132,0.7625,0.9213621244035319,1.0,5/22,15.83%,HEXIM1;PTEN;LATS1;LATS2;APC
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.2999954040908141,0.7727119450270353,0.7746686303387335,0.9209875606503201,1.0,11/28,23.64%,NGF;SPI1;DAXX;DEDD2;BAG3;ZDHHC3;DIABLO;BID;BCL2;TNF;CASP8AP2
prerank,regulation of cell division (GO:0051302),0.256753854612422,0.77250062831743,0.8225214198286414,0.9209112438664969,1.0,12/72,15.13%,UVRAG;KIF20A;BIRC6;NCOA3;CIB1;GIT1;SETD2;INSC;PIK3R4;CSPP1;AURKB;ORC6
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.30952126304052063,0.7722025310927098,0.78419452887538,0.9209439366006362,1.0,8/25,22.72%,HSPA1A;DNAJB12;HSPA9;HSPA5;DNAJB14;DNAJB4;SDF2;HSPA8
prerank,mitochondrial transport (GO:0006839),-0.21543142744533933,-0.7715063561106583,0.900398406374502,0.9366563903226414,1.0,25/53,28.53%,BCL2L1;FLVCR1;TIMM44;STARD3;TIMM17A;TIMM9;GDAP1;MFF;OXA1L;SPG7;BCAP31;TMEM14C;COX18;TIMM10B;TOMM34;TIMM13;BCS1L;TOMM7;MFN2;TIMM8B;TMEM14A;HSP90AA1;ABCB10;SLC25A4;TIMM17B
prerank,oligodendrocyte development (GO:0014003),0.3486191619137864,0.7714629819472865,0.7601246105919003,0.9216072549880766,1.0,2/15,4.22%,MYRF;B4GALT5
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.19072986938293496,-0.7710791942852542,0.9565217391304348,0.936379072906972,1.0,61/125,35.48%,NEK6;CLIP1;RMDN1;CENPO;CLASP2;PPP1CC;CKAP5;NUP133;BUB3;DYNLL2;DYNLL1;WDR62;ZW10;CEP126;RANBP2;MAPRE1;MAD1L1;BCCIP;SEC13;NUP85;RAN;CENPE;KNL1;CENPA;NUP37;DCTN6;KIF18A;NDEL1;SUN2;CENPP;TACC3;PMF1;BUB1B;CENPK;CENPU;BUB1;CENPF;PLK2;DLGAP5;CENPT;SPDL1;EFHC1;NDC80;NSL1;CDCA8;B9D2;RCC1;KIF4A;DSN1;RANGAP1;MIS12;CENPN;CENPH;STIL;BIRC5;SKA2;KIF2A;MAD2L1;CENPI;TBCE;INCENP
prerank,meiosis I (GO:0007127),-0.2681711694243421,-0.7705127822156602,0.7987987987987988,0.9363435351749398,1.0,13/23,51.64%,FOXJ2;ZCWPW1;ZSCAN21;DDX4;SYCP3;SGO1;HSF2BP;FOXJ3;SLC25A31;TDRD9;MEIOB;BCL2L11;MOV10L1
prerank,embryonic skeletal system development (GO:0048706),0.2939436088282063,0.7704155491969288,0.7934472934472935,0.9227456921269543,1.0,3/35,8.21%,SULF2;DEAF1;XYLT1
prerank,regulation of cellular pH (GO:0030641),0.299015352591503,0.7704130657695997,0.7755960729312763,0.9223296481929153,1.0,3/29,7.53%,SLC9A7;SLC4A7;SLC4A8
prerank,negative regulation of secretion by cell (GO:1903531),0.28393946092985783,0.7700523542556155,0.7782485875706214,0.9224644863274768,1.0,5/38,13.54%,LILRB1;STXBP6;SLC30A1;ANXA1;TNFRSF1B
prerank,positive regulation of actin nucleation (GO:0051127),0.36030155457867863,0.7698389060179321,0.7389830508474576,0.9223659671442765,1.0,1/11,2.43%,WASF2
prerank,regulation of exit from mitosis (GO:0007096),0.28802019628345,0.7697813320295247,0.7768479776847977,0.922021281676315,1.0,4/38,6.85%,CDC14A;UBE2E1;PPP1R9B;MAD2L1BP
prerank,regulation of cellular metabolic process (GO:0031323),0.28160004613453554,0.7694924720728535,0.7906666666666666,0.9220130954002305,1.0,8/45,15.93%,PID1;PARL;ARF4;ARF1;PDK3;AGPAT1;ABCG1;RNF41
prerank,autophagosome maturation (GO:0097352),0.29026448348633305,0.7691209546627986,0.7621776504297995,0.9221315506867753,1.0,6/32,14.26%,UVRAG;STX17;TSG101;WIPI2;VMP1;VCP
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.33719276632012596,-0.7690996110407174,0.7719714964370546,0.9375934460409425,1.0,6/10,24.21%,NELL1;FURIN;RIC1;DAB2IP;RGP1;EPHA4
prerank,PERK-mediated unfolded protein response (GO:0036499),0.3657379930376691,0.7682769773590097,0.7272727272727273,0.9229365761041544,1.0,5/10,24.72%,NFE2L2;EIF2AK3;HSPA5;QRICH1;EIF2S1
prerank,L-serine metabolic process (GO:0006563),-0.3404274643798258,-0.7678347344298977,0.7630331753554502,0.938674549623202,1.0,4/10,25.78%,PSAT1;SERINC3;PHGDH;SHMT2
prerank,hyaluronan catabolic process (GO:0030214),0.3275314122168754,0.7675363744004045,0.7586206896551724,0.9236134472577109,1.0,1/18,0.26%,CD44
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3103378999889864,0.7668601889139555,0.7714723926380368,0.9242151816236854,1.0,4/23,16.74%,TNNC1;ID2;TGFB1;PROX1
prerank,water transport (GO:0006833),-0.311303079970932,-0.7665779246259584,0.7760814249363868,0.9396244922660305,1.0,5/12,52.71%,AQP4;PDPN;AQP11;AQP1;SLC5A1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.3548246130874057,0.7663567271279834,0.7353951890034365,0.9245333146134753,1.0,2/11,10.73%,TLR3;RIPK1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.27308015782686096,0.7658047085296728,0.8217562254259502,0.9249206496754241,1.0,10/48,18.18%,NUP210;PRKAG2;NOA1;NUP98;PRKAG1;NUP153;PNPT1;SEH1L;GCK;NUP93
prerank,cytosolic calcium ion transport (GO:0060401),0.29712917732344174,0.765781766180221,0.7557251908396947,0.9245381693204383,1.0,4/28,5.30%,MCUB;ATP2B1;ATP2A3;MAIP1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3385346964835311,0.7656524602327599,0.7687188019966722,0.924319236042203,1.0,3/15,13.69%,ZC3H12D;KHNYN;RNASEH1
prerank,macrophage chemotaxis (GO:0048246),0.3648200430260592,0.7656505491622526,0.75,0.9239035778974588,1.0,2/10,12.86%,CKLF;LGALS3
prerank,regulation of gastrulation (GO:0010470),0.33863942720562656,0.7655602445944396,0.7689594356261023,0.9236247738885406,1.0,4/14,15.56%,SCX;PHLDB2;CLASP1;POGLUT1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.3125034069639895,-0.7652392972384715,0.755656108597285,0.9407171782777602,1.0,4/12,12.20%,SLC37A2;SLC25A3;SLC25A11;SLC25A14
prerank,negative regulation of histone acetylation (GO:0035067),0.35520238503081203,0.7648734087437694,0.7602131438721137,0.9241912802357518,1.0,3/11,17.25%,SPI1;TAF7;SIRT1
prerank,iron ion transmembrane transport (GO:0034755),0.36479618067122566,0.7644686064214526,0.7346221441124781,0.92435766181927,1.0,1/10,3.46%,ABCB7
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.27692030687912994,-0.7644451603153865,0.8324468085106383,0.9410123729705513,1.0,6/19,16.06%,RPTOR;ICE2;NAB2;TENM1;MAF1;AR
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3219350944851823,-0.7640893589539599,0.7843137254901961,0.9396967848496558,1.0,2/11,4.89%,AGO3;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3219350944851823,-0.7640893589539599,0.7843137254901961,0.9396967848496558,1.0,2/11,4.89%,AGO3;AGO1
prerank,magnesium ion transport (GO:0015693),0.3515620351582328,0.7637664761832481,0.75,0.9249134284276821,1.0,3/12,10.56%,MMGT1;MAGT1;NIPA2
prerank,histone H4-K16 acetylation (GO:0043984),0.3200115821784892,0.7637216891017414,0.7681159420289855,0.9245573396949688,1.0,9/19,20.70%,KAT7;KANSL1;JADE3;MSL3;PHF20;KMT2A;MSL2;WDR5;KANSL3
prerank,negative regulation of potassium ion transport (GO:0043267),0.3484368984097016,0.762884911442767,0.7714285714285715,0.925374516076626,1.0,3/13,13.79%,NEDD4L;PTK2B;STK39
prerank,embryonic heart tube development (GO:0035050),-0.29906756589193617,-0.7625261012825728,0.7801047120418848,0.9411131388044157,1.0,3/14,25.67%,ACVR1;RYR2;NDRG4
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.35370374850046293,0.7618346601125401,0.7706576728499157,0.9264586778140282,1.0,2/12,7.32%,ATF7IP;SETDB2
prerank,DNA strand elongation (GO:0022616),-0.28108525157435976,-0.7616920376341824,0.807799442896936,0.9413970970459595,1.0,12/18,38.82%,POLD3;GINS1;POLA1;RFC3;GINS3;RFC4;MCM4;GINS4;GINS2;DCLRE1B;POLD2;NBN
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.25033179078813633,0.7615871041427041,0.831764705882353,0.9263749153919806,1.0,20/88,18.41%,DAPK1;NFKB1;DNAJC1;BTG2;EIF2AK2;GIGYF2;MRPL13;TRIM71;RPS3;IGF2BP3;PAIP2;EIF4ENIF1;EIF2AK3;AKT1;SYNCRIP;DAPK3;CAPRIN1;CNOT8;DDX6;SHMT1
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3350584505767785,-0.7610451243479995,0.7719298245614035,0.9414464394411117,1.0,3/10,14.66%,RIF1;TERF2IP;DCLRE1A
prerank,regulation of epithelial cell proliferation (GO:0050678),0.24795947278513067,0.7609960970847337,0.8424242424242424,0.926808689392457,1.0,5/85,5.24%,RUNX3;MARVELD3;GPX1;LAMB1;DEAF1
prerank,protein localization to chromatin (GO:0071168),0.3236825358069482,0.7609767867910339,0.7908082408874801,0.9264206987863547,1.0,7/18,18.39%,NIPBL;FAM47E;LEMD2;PPHLN1;MCM9;LRWD1;RAD21
prerank,steroid metabolic process (GO:0008202),0.2547972799911298,0.7601526676754768,0.8443337484433375,0.927199321674882,1.0,9/72,13.27%,HSD17B14;HSD17B7;SULT2B1;CYP27A1;MSMO1;DHRS4;DHRS9;RDH5;DHCR24
prerank,regulation of mitotic nuclear division (GO:0007088),0.2670271586525722,0.7598173814606827,0.8012658227848102,0.9272587967620181,1.0,3/55,5.46%,IL1B;CDK13;CAV2
prerank,positive regulation of translation (GO:0045727),0.2448930663238824,0.7593101834030306,0.8714285714285714,0.9275731226004722,1.0,4/94,2.40%,NIBAN1;BCL3;RPL5;VIM
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.27132317106147896,-0.7592141267634693,0.8113207547169812,0.9412355698347875,1.0,9/20,24.90%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;BUB1B;BUB1;CENPF
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.27132317106147896,-0.7592141267634693,0.8113207547169812,0.9412355698347875,1.0,9/20,24.90%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;BUB1B;BUB1;CENPF
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.27132317106147896,-0.7592141267634693,0.8113207547169812,0.9412355698347875,1.0,9/20,24.90%,IK;KLHL22;BUB3;ZW10;MAD1L1;TPR;BUB1B;BUB1;CENPF
prerank,gluconeogenesis (GO:0006094),0.2771210758265218,0.7587224341587256,0.809052333804809,0.9280156796332464,1.0,7/39,11.22%,CRY1;SLC25A13;SLC37A4;PGM1;MDH2;SLC25A12;GPI
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.35696849097804206,0.7582164366036656,0.75177304964539,0.928326248835724,1.0,1/11,3.37%,RSPO3
prerank,histone H2A acetylation (GO:0043968),-0.2835564044258444,-0.7582039064654182,0.8163841807909604,0.9417338137757655,1.0,8/16,28.75%,NAA40;MEAF6;SPHK2;RUVBL1;MORF4L2;DMAP1;RUVBL2;TRRAP
prerank,cellular response to amino acid stimulus (GO:0071230),0.2905601320422568,0.7579281481566187,0.8089080459770115,0.9283157657624406,1.0,6/33,12.74%,SPAAR;FYN;CAPN2;UBR2;SH3BP4;CASTOR2
prerank,regulation of protein dephosphorylation (GO:0035304),0.27873729442356154,0.7579007063449269,0.7880512091038406,0.9279341320578545,1.0,12/37,18.60%,PPP2R5A;DLC1;PPP1R15A;PPP1R2;ANKLE2;HTT;PPP6R2;TGFB1;PPP1R7;PTPA;PRKCD;PIN1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2915166582072356,-0.7575581543104968,0.81,0.941746834363303,1.0,8/14,34.21%,ENPP1;AK3;ITPA;AK1;CMPK2;ENPP3;AK4;NME2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.33072588043264595,0.7571089768970689,0.7631578947368421,0.9286613513317205,1.0,1/15,1.72%,ANKRD11
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3581461238127278,0.7569692815237195,0.7427597955706985,0.9284501280692042,1.0,3/11,15.20%,RTN4;ATL1;VCPIP1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2578925875855869,0.7569327026224582,0.8167281672816729,0.9280890441592347,1.0,16/71,15.93%,LONP1;RSPRY1;MALT1;CHMP4B;FAP;CAPN2;NEDD8;PDCD6IP;ATXN3;UBE2W;FBXL17;ADAMTS12;YME1L1;VCP;USP9X;RNF41
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2683401786538144,0.7562953952409281,0.8247422680412371,0.9286085417100025,1.0,13/54,17.59%,RPL5;RPL6;RPL35A;NHP2;RPF2;NSA2;MAK16;RPLP0;RPL11;RPL7;MRTO4;MRPL20;LTO1
prerank,response to hydroxyurea (GO:0072710),0.36045898426622086,0.7561097543142458,0.7608318890814558,0.9284484906812441,1.0,3/11,12.80%,KAT7;ATRX;SPIDR
prerank,mitotic recombination (GO:0006312),0.3317122092119197,0.755826202365656,0.7476038338658147,0.9284326339661012,1.0,4/15,18.72%,TEP1;MSH3;SMC6;SMC5
prerank,embryonic eye morphogenesis (GO:0048048),-0.3171121589754007,-0.7554793515543021,0.7961165048543689,0.9437288671971025,1.0,3/11,16.22%,LRP6;KDM2B;EFEMP1
prerank,mitochondrial transcription (GO:0006390),0.35875253119075035,0.7553894390648147,0.7538726333907056,0.9286334394358593,1.0,3/10,15.96%,FOXO3;TFAM;TFB1M
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2990388784749537,-0.7550035340011385,0.7544757033248082,0.9434842978270283,1.0,6/13,20.38%,KPNA6;NUP54;IPO5;RANBP2;NUP35;RGPD1
prerank,response to nitric oxide (GO:0071731),0.34920514283421494,0.7544531055853791,0.7519500780031201,0.9295278299104033,1.0,1/13,4.38%,DPEP1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.24212295980336723,0.7540648824455972,0.8820697954271961,0.929671402004604,1.0,20/95,15.44%,HSPA1A;ZEB2;LEMD3;HIPK2;ADAM17;PDPK1;MTMR4;ENG;LATS1;SPRED3;SMAD4;PMEPA1;ING2;LATS2;ITGA3;CITED2;TGFB1;SPRED1;CREBBP;THBS1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.2742239398778359,-0.753966404335289,0.8120300751879699,0.9440324775512126,1.0,2/18,7.58%,BIN1;ATP1A2
prerank,chromosome organization (GO:0051276),0.2440524750082025,0.7531604628543928,0.896797153024911,0.9305378164054726,1.0,28/99,22.51%,PADI1;H3-3A;SETD7;PHF19;MSH3;DOT1L;MSH6;COPS3;LATS1;EZH1;EZH2;HDAC3;HMGN1;SUPT4H1;SIRT1;LRWD1;PADI2;HDAC1;GATAD1;EHMT1;SATB1;XPA;BRWD1;HDAC5;PARP1;CUL4A;GPS1;HMG20A
prerank,skeletal muscle tissue development (GO:0007519),0.2884100075899028,0.752905233872289,0.7884892086330936,0.9304979213876253,1.0,4/32,14.12%,SVIL;CAV2;LEMD2;MYH14
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.24061051405486328,0.7524852219891924,0.8744075829383886,0.9306599925810546,1.0,19/102,18.47%,CYSLTR2;PPARG;NFKB1;C2CD5;PDPK1;HDAC9;PRKAR2A;ADCY7;ADCY5;AKT1;KAT2B;RELA;RPS6KB1;INSR;GCK;PIK3R2;NR4A1;SYAP1;PRKCD
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.29239927143671596,-0.7520791599121843,0.8141809290953546,0.9457062435696506,1.0,5/13,15.56%,USP19;CLU;NR1H2;MANF;MBTPS2
prerank,histone exchange (GO:0043486),0.2825047192819774,0.752018602677222,0.7846153846153846,0.9308917182585631,1.0,8/37,14.86%,RBBP4;SMARCA5;CENPL;ACTR6;CENPQ;SRCAP;RSF1;CENPC
prerank,regulation of transport (GO:0051049),0.2811853840532429,0.7518967511465378,0.8013698630136986,0.930641525230535,1.0,1/36,0.22%,LRRK2
prerank,linoleic acid metabolic process (GO:0043651),0.3219232853322543,0.7517891984567897,0.7590551181102362,0.9303906673190263,1.0,4/17,20.23%,ELOVL5;ABCD1;GSTP1;ACSL1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.31718864578479794,0.7514884341468979,0.7671451355661882,0.9304144171343325,1.0,4/18,14.55%,IL27RA;RPS3;ICOSLG;IL18
prerank,peroxisome organization (GO:0007031),0.29643875943458997,0.7512197937635873,0.8160741885625966,0.9303653644358084,1.0,6/25,13.04%,PEX16;PEX12;PEX14;FIS1;DNM1L;ABCD1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.27966844293118764,-0.7509531653128265,0.7978142076502732,0.9463590147834307,1.0,3/16,5.60%,APPL2;PPARGC1A;LONP2
prerank,negative regulation of cell aging (GO:0090344),0.3204080304560845,0.7508829508840457,0.7934426229508197,0.9304352377712058,1.0,1/16,1.64%,AKT3
prerank,establishment of protein localization to organelle (GO:0072594),0.2515739976210263,0.7508233074957681,0.8626237623762376,0.9301051084838117,1.0,17/72,18.87%,NEURL1B;SYK;STAT3;IL10RA;PTTG1IP;LAMP5;HIKESHI;NUP153;EIF4ENIF1;AKT1;FAM53C;KPNB1;TNPO1;TSPAN17;NUP93;APPL1;PINK1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.2445344534291808,0.750546989849156,0.8633686690223793,0.9300921580150526,1.0,7/85,8.67%,CDC14A;NIPBL;KCNQ1;RIPOR2;MYO3B;WFS1;PDZD7
prerank,autonomic nervous system development (GO:0048483),-0.27994663807161513,-0.7504469445594311,0.8100558659217877,0.9461734261261125,1.0,4/17,16.96%,NRP1;NF1;SOX4;SOX11
prerank,protein localization to cell surface (GO:0034394),0.3025453661204643,0.7503519618363123,0.8011363636363636,0.9299560656921453,1.0,7/26,18.27%,PTPRU;CD177;FLNA;USP4;PIGK;VCL;UNC50
prerank,chromosome condensation (GO:0030261),0.2798001044841324,0.7503098175004798,0.8203342618384402,0.9295991370702456,1.0,9/36,17.73%,SMC4;CSNK2A2;CSNK2A1;AIFM1;DFFB;RB1;ACIN1;MCPH1;PHF13
prerank,regulation of synapse organization (GO:0050807),0.3000239895212446,0.7501801048928384,0.7818991097922848,0.9293429971383471,1.0,8/26,17.60%,PDLIM5;SETD5;ABHD17B;YWHAZ;SLITRK4;GRIPAP1;MDGA1;ABHD17A
prerank,plasma membrane organization (GO:0007009),0.2575229485612741,0.7499792437352647,0.8520859671302149,0.9291968019310164,1.0,12/61,15.78%,PLSCR1;DYSF;MYH9;EHD2;CHMP4A;BIN3;SNX9;PACSIN2;ABCD1;ARL8B;FA2H;SNX33
prerank,potassium ion import across plasma membrane (GO:1990573),-0.2164062975065218,-0.7496716196728364,0.8825503355704698,0.9463213756862014,1.0,7/41,13.28%,ATP1B3;KCNJ2;ATP1B1;ATP1A2;KCNJ6;HCN2;KCNJ9
prerank,long-chain fatty acid transport (GO:0015909),0.2925167213590252,0.7483359454416627,0.801178203240059,0.9310026512695072,1.0,4/30,6.36%,PPARG;PRKAG2;CD36;PRKAB2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24103115278260612,0.7480747744519174,0.8835063437139562,0.9309588375048345,1.0,18/104,13.49%,UVRAG;CCNJL;CCND3;CDKN2C;CCND1;TSG101;CIB1;CCNH;RALB;SNF8;RHOA;CCNT2;HTT;CCNT1;CDK12;CCND2;AKT1;EZH2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2484628101592493,0.7477292757108073,0.8562421185372006,0.9309914970107767,1.0,13/68,20.72%,LRRK2;ACOT11;ACOT2;SULT2B1;TPST1;ACAT1;NT5C2;EFL1;BAD;GLYAT;ABHD14B;GMPR2;ACOT1
prerank,aortic valve development (GO:0003176),-0.23099143738546454,-0.747692723659652,0.8637992831541219,0.9480652870796966,1.0,5/34,12.66%,ROBO2;ROBO1;TNFRSF1A;SLIT2;SLIT3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.25927920452454767,0.746770072557542,0.8435897435897436,0.9319029529417687,1.0,11/54,15.40%,RPL5;HSPA1A;CRY1;RPS3;CAMLG;DCUN1D3;USP4;RPL11;AKT1;PRMT3;SVBP
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.29672743880513736,0.7467674454155012,0.8011363636363636,0.9314946224526754,1.0,3/26,7.17%,PLCG2;PRNP;CIB1
prerank,RNA stabilization (GO:0043489),0.28447019302958676,0.746653116236546,0.7866473149492017,0.9312393195013935,1.0,7/33,16.09%,TENT5A;GDNF;TRDMT1;TENT2;EIF4ENIF1;PAIP1;PABPC1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.2788272465449566,-0.746615250128888,0.8137755102040817,0.9485830131646016,1.0,5/17,15.44%,SASH1;TRIM5;NFKBIL1;CX3CL1;BMP6
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.3092285992858276,-0.7465992214290432,0.7952941176470588,0.9477066478675595,1.0,5/12,27.22%,PRPSAP1;AMPD2;HPRT1;MTHFD1;PRPSAP2
prerank,alcohol catabolic process (GO:0046164),-0.32448587841778864,-0.7464180281096733,0.792147806004619,0.9470222946867358,1.0,1/10,0.41%,APOE
prerank,myelination (GO:0042552),0.2646931267575267,0.7463067962630107,0.844207723035952,0.9313141358889742,1.0,4/46,4.22%,ACER3;ADGRG6;MYRF;B4GALT5
prerank,renal absorption (GO:0070293),0.3595156370332883,0.74629217263803,0.7658450704225352,0.930920716202729,1.0,1/10,3.32%,KCNQ1
prerank,ribosome assembly (GO:0042255),0.2711256665215873,0.7460706663041954,0.8373015873015873,0.9307995215503918,1.0,7/47,12.95%,RPL5;RPL6;DHX37;RPS14;RPF2;RPLP0;RPL11
prerank,positive regulation of ERAD pathway (GO:1904294),0.33693226377835417,0.7460606981719748,0.7664359861591695,0.9303991906339755,1.0,2/13,8.59%,NFE2L2;ATXN3
prerank,endosome organization (GO:0007032),0.2752783499448576,0.7459572541875293,0.8377622377622378,0.9301343716245026,1.0,13/41,23.39%,PLEKHF1;TMCC1;PI4K2B;SNX3;SNX33;PI4K2A;SNX10;HOOK3;USP8;AKTIP;CHMP2B;CORO1C;USP50
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3241025852678364,0.7451994760107445,0.8010033444816054,0.9307903873826695,1.0,2/15,6.67%,KLF4;PDPK1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.25390545225073274,-0.745141148944908,0.8652694610778443,0.9478749745776379,1.0,6/23,17.68%,HMGB1;REXO4;CECR2;CASP3;HMGB2;FBH1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.28103428825779847,0.7446747481972751,0.8233576642335766,0.9310811764837841,1.0,9/30,20.17%,BMPR2;CERS1;DCP2;ERCC4;TENT4B;STN1;NIBAN2;TERF2;HNRNPC
prerank,rRNA metabolic process (GO:0016072),0.22801365397420828,0.7445189240922258,0.9065934065934066,0.9308603740435561,1.0,29/160,14.63%,RPL5;NOL6;RPL37A;RPL6;XRN2;DHX37;RPS14;RPL35A;UTP6;RPL13;DDX49;NOC4L;MPHOSPH6;NOL11;DEDD2;RPLP0;UTP20;RPL34;RPL19;RPL11;RPL30;RRP36;NOP58;RPL4;UTP18;RPS2;RPL7;MRTO4;DDX10
prerank,striated muscle cell development (GO:0055002),-0.2897112434125747,-0.7442351171271411,0.8015873015873016,0.9481999754541961,1.0,3/14,18.69%,CAPN3;TMOD1;TMOD2
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.26269845169432704,-0.7441098208338719,0.872093023255814,0.9474722611250582,1.0,5/21,11.23%,ENSA;PPP1R8;PPP1R11;PPP4R4;MFHAS1
prerank,mitotic spindle organization (GO:0007052),-0.17504791932660907,-0.7441033986225543,0.9903846153846154,0.9465867733881375,1.0,62/153,30.44%,NEK6;CLIP1;RMDN1;PIBF1;CENPO;CLASP2;PPP1CC;CKAP5;NUP133;BUB3;GOLGA2;DYNLL2;LSM14A;DYNLL1;WDR62;ZW10;CEP126;RANBP2;MAPRE1;MAD1L1;BCCIP;SEC13;NUP85;SMC1A;RAN;CENPE;RAB11A;SPICE1;KNL1;CENPA;NUP37;DCTN6;KIF18A;MAP9;NDEL1;SUN2;CENPP;PMF1;BUB1B;CENPK;CENPU;TPX2;BUB1;PRC1;CENPF;PLK2;DLGAP5;CENPT;CCDC61;KIFC2;SPDL1;EFHC1;NDC80;NSL1;CDCA8;B9D2;RCC1;KIF4A;DSN1;CEP192;KIFC1;RANGAP1
prerank,regulation of gene silencing by RNA (GO:0060966),0.26497622660956244,0.7427464112565466,0.8342105263157895,0.9324540996252062,1.0,10/50,16.23%,NUP210;POLR2C;H3-3A;NUP98;PUM2;TRIM71;NUP153;TNRC6A;PUM1;SEH1L
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.26497622660956244,0.7427464112565466,0.8342105263157895,0.9324540996252062,1.0,10/50,16.23%,NUP210;POLR2C;H3-3A;NUP98;PUM2;TRIM71;NUP153;TNRC6A;PUM1;SEH1L
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3110309507129596,-0.741445737051773,0.7808857808857809,0.949177021577146,1.0,5/11,27.12%,LGALS9;PIH1D1;HTRA2;GSN;FAS
prerank,hexose biosynthetic process (GO:0019319),0.26814394741955994,0.7412842641710471,0.8393351800554016,0.934019185868452,1.0,8/42,12.56%,CRY1;SLC25A13;SLC37A4;PGM1;MDH2;SLC25A12;GPI;CHST15
prerank,negative regulation of dephosphorylation (GO:0035305),-0.26853539702887363,-0.7412650343965546,0.8501362397820164,0.9485265340792752,1.0,4/18,12.04%,ENSA;PPP1R8;MFHAS1;CHP1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.29995158303804914,-0.7410179918738292,0.8312020460358056,0.9479770468093164,1.0,5/12,35.85%,PPP1R3B;KHK;PPP1R3D;PPP1R3C;PPP1R3E
prerank,regulation of protein localization to centrosome (GO:1904779),0.355447744076128,0.7407946059613393,0.7820069204152249,0.9342548024699107,1.0,4/10,22.03%,CEP250;APC;MARK4;GSK3B
prerank,axonogenesis (GO:0007409),0.2202732449615451,0.7406673518426597,0.9446185997910136,0.9340216809313224,1.0,22/237,9.01%,NOTCH2;EMB;FYN;RET;LMTK2;NTNG2;PTPRO;SEMA4A;SHTN1;NPTN;KIF5B;B4GALT5;GDNF;RPS6KA5;PTEN;GRB2;EFNA2;IGSF9;EZR;EPHB2;SOS1;ZDHHC17
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.3596888866216283,0.7406599661836047,0.773851590106007,0.9336151168572849,1.0,1/10,3.00%,MAD2L2
prerank,embryonic organ morphogenesis (GO:0048562),0.2713934097457266,0.7406484539937493,0.8314606741573034,0.9332181157007986,1.0,4/42,9.68%,NIPBL;RARG;ID2;FBN1
prerank,ethanol metabolic process (GO:0006067),-0.29658280689132904,-0.7403572595210689,0.8105515587529976,0.9479554971871463,1.0,3/12,25.54%,ADH5;ACSS1;SULT1A1
prerank,regulation of endopeptidase activity (GO:0052548),0.2544731507467472,0.7402333545602134,0.8569587628865979,0.93338444721433,1.0,8/59,13.22%,PSME3;PICALM;PSME2;BIRC3;SERPINB9;PSMB8;PRELID1;AKT1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.23656219498459993,0.7398561655748723,0.9125,0.9334739951841271,1.0,20/113,15.01%,LCP1;SYK;CD36;MMP1;SUMO1;FAF1;TIRAP;TPPP3;PIEZO1;RPS3;PSMC4;RPA3;SPIDR;LGALS3;ERCC3;ERCC4;GBP5;VCP;TGFB1;MYD88
prerank,regulation of hemopoiesis (GO:1903706),0.3579836289886043,0.7385258377330003,0.7888307155322862,0.9348232607980054,1.0,5/10,19.97%,CBFB;PURB;LGALS3;CREBBP;RUNX1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3471728018973318,0.7384216372015249,0.789198606271777,0.9345401873505661,1.0,2/12,11.91%,ZFP36L2;REST
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.27007175902866193,0.7381231346350573,0.8406827880512091,0.934528518828064,1.0,10/40,18.82%,FAM111A;WRN;MSH3;EXD2;ATRX;DONSON;MCM9;POLD1;PRIMPOL;SETMAR
prerank,neuromuscular process (GO:0050905),0.3225390689885146,0.7378904658854931,0.8009868421052632,0.9344123802602172,1.0,3/16,13.74%,MYCBP2;PAFAH1B1;TIFAB
prerank,epithelium development (GO:0060429),0.23496011969317274,0.7378888571659838,0.8988372093023256,0.9340044517893239,1.0,13/107,15.24%,PPARG;JAK2;EHF;FOXJ1;STAT1;ANXA4;TRIM71;PPP2R3A;DHRS9;LGALS3;TGFB1;TAGLN2;CASP6
prerank,sulfur compound transport (GO:0072348),0.2920114325080047,0.7375893988674399,0.8214804063860668,0.9340035164522225,1.0,3/27,5.61%,RACGAP1;LRRC8D;SLC25A30
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.1975216941187054,-0.737355624585346,0.9453551912568307,0.9509018184905685,1.0,33/69,32.07%,UQCRC2;COX7C;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;COX10;NDUFA5;UQCR10;UQCRC1;COX5B;NDUFB5;NDUFB9;NDUFB7;NDUFA13;NDUFAF1;NDUFB8;NDUFAB1;COX6A1;NDUFB6;NDUFS8;NDUFB10;SDHA;COX6C;UQCC3;NDUFS3;CYC1;COA6;NDUFS6;NDUFA11
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2632367167437721,0.7372913774512222,0.8639896373056994,0.9340287767585566,1.0,15/49,22.46%,MCL1;BBC3;SGMS1;CYLD;FIS1;DNM1L;EIF2AK3;PLAUR;BECN1;PINK1;BAD;BCLAF1;BID;BCL2;SIAH1
prerank,negative regulation of cell division (GO:0051782),-0.3097087636745751,-0.7371483236633928,0.8215962441314554,0.9502625759366807,1.0,7/11,39.14%,ZFYVE19;BLM;TXNIP;MYC;E2F8;CHMP4C;E2F7
prerank,odontogenesis (GO:0042476),0.2714156098474149,0.7371020441141877,0.8373071528751753,0.9338707315992842,1.0,2/35,3.90%,ANKRD11;LAMB1
prerank,protein K63-linked deubiquitination (GO:0070536),0.2824843134770338,0.7362681243160986,0.8126760563380282,0.9345668995960812,1.0,7/31,14.89%,OTUD1;SPATA2;UIMC1;ATXN3;CYLD;OTUD4;USP7
prerank,positive regulation of macrophage differentiation (GO:0045651),0.3376333231868289,0.7361480714445964,0.772887323943662,0.934317195800127,1.0,3/11,14.30%,ID2;RIPK1;TGFB1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.29165610945444453,0.7358249694676263,0.8236196319018405,0.9343440176313361,1.0,7/27,14.65%,SLC25A13;SLC25A12;SLC1A4;SLC6A5;SLC25A18;SLC38A1;SLC6A9
prerank,histone H3-K4 trimethylation (GO:0080182),0.3462233561708815,0.7353884182356992,0.7892918825561313,0.9345019388544781,1.0,1/11,2.29%,TET2
prerank,regulation of protein autophosphorylation (GO:0031952),0.2733861566158139,0.7349802608675502,0.8328729281767956,0.9346100823753071,1.0,9/36,17.19%,PPP2R5A;MRE11;MOB1B;ENG;PDGFD;MVP;PPP2R5C;PPP2R5E;RASSF2
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.2665811390030508,-0.7346671399308478,0.8370165745856354,0.9524608939606027,1.0,3/18,4.98%,FOLH1;GOT1;NAALAD2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.31706974987656567,-0.7345207361740519,0.8004587155963303,0.9508712453528424,1.0,3/10,10.85%,MGMT;ALKBH5;ASCC2
prerank,DNA dealkylation (GO:0035510),-0.31706974987656567,-0.7345207361740519,0.8004587155963303,0.9508712453528424,1.0,3/10,10.85%,MGMT;ALKBH5;ASCC2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.35283385295611275,0.7344358385270162,0.809931506849315,0.9349148610432555,1.0,2/11,7.32%,ATF7IP;SETDB2
prerank,regulation of lipase activity (GO:0060191),0.3418749798818328,0.734125922540266,0.7887563884156729,0.9349352837608377,1.0,3/13,15.12%,RHOA;PCSK5;ANGPTL3
prerank,regulation of ATP metabolic process (GO:1903578),0.26005624172618447,0.7340594254103532,0.8496732026143791,0.9346095382262445,1.0,13/54,18.87%,NUP210;PRKAG2;NUP98;ATP7A;FIS1;PRKAG1;NUP153;ABCD1;SEH1L;COX7A2;GCK;NUP93;PINK1
prerank,cellular response to osmotic stress (GO:0071470),-0.2670271609466912,-0.7339894004983664,0.8461538461538461,0.9506734080632286,1.0,6/21,21.55%,CAPN3;PKD2;RCSD1;TRPV4;DDX3X;WNK3
prerank,monocyte differentiation (GO:0030224),0.35304140803215556,0.733675909500481,0.8036036036036036,0.934684410567056,1.0,3/10,10.46%,PPARG;MYH9;IL31RA
prerank,synaptic vesicle localization (GO:0097479),0.3282836904814729,0.7334317763074507,0.765089722675367,0.9345628314692955,1.0,4/13,14.68%,KIF5B;SYNJ1;SNAPIN;KIF5A
prerank,histone H4-K8 acetylation (GO:0043982),-0.27949123638800605,-0.7326045979053167,0.8341584158415841,0.9505718970448466,1.0,4/15,10.35%,JADE2;HCFC1;MEAF6;ING4
prerank,histone H4-K5 acetylation (GO:0043981),-0.27949123638800605,-0.7326045979053167,0.8341584158415841,0.9505718970448466,1.0,4/15,10.35%,JADE2;HCFC1;MEAF6;ING4
prerank,piRNA metabolic process (GO:0034587),0.3105137847003878,0.7321617083238109,0.7987897125567323,0.9358306606242088,1.0,1/19,5.47%,EXD1
prerank,diol metabolic process (GO:0034311),0.31024492086837957,0.7318303434366716,0.8154859967051071,0.9358671349480954,1.0,5/19,14.73%,NAAA;PRKG2;SGPP2;AKT1;SGPP1
prerank,7-methylguanosine RNA capping (GO:0009452),0.27915473684363357,0.7317947052678092,0.8240997229916898,0.9350916231984443,1.0,4/31,7.90%,GTF2F2;POLR2C;CMTR1;CCNH
prerank,7-methylguanosine mRNA capping (GO:0006370),0.27915473684363357,0.7317947052678092,0.8240997229916898,0.9350916231984443,1.0,4/31,7.90%,GTF2F2;POLR2C;CMTR1;CCNH
prerank,negative regulation of TOR signaling (GO:0032007),0.2703818497617561,0.731674309266621,0.8230337078651685,0.9348348685542508,1.0,8/36,13.86%,SPAAR;DDIT4;UBR2;DEPDC5;PRKAA1;SH3BP4;CASTOR2;PRKAA2
prerank,microtubule bundle formation (GO:0001578),0.2661499129969638,0.7315075063971248,0.8633193863319386,0.9346546066351841,1.0,7/42,13.97%,FOXJ1;NAV1;KIF20A;TPPP3;SPAST;CLASP1;CAPN6
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.27254381291579277,-0.7305043918173081,0.7974025974025974,0.9522558737728956,1.0,3/16,14.62%,IGF1;AKAP6;TRPC3
prerank,cholesterol transport (GO:0030301),0.26399577380214867,0.7304093634018636,0.8380566801619433,0.9356487922696944,1.0,9/45,15.22%,LDLR;CD36;SCARB1;CEL;STX12;ABCA5;SOAT1;ABCG1;RELCH
prerank,transcription by RNA polymerase I (GO:0006360),-0.2283610575961941,-0.7302827630035702,0.9217081850533808,0.951643639491568,1.0,12/34,22.85%,GTF2H2;TTF1;GTF2H1;TAF1D;ERCC2;POLR2K;GTF2H3;TCOF1;POLR2H;GTF2H5;CDK7;TBP
prerank,canonical Wnt signaling pathway (GO:0060070),0.24607579172996916,0.7298849638089487,0.8612862547288777,0.9359251153916844,1.0,12/68,19.43%,LRRK2;AXIN1;PTEN;RARG;DVL3;DVL2;APC;WNT7A;WNT5B;FZD7;FZD9;FZD3
prerank,sensory perception of sound (GO:0007605),0.23753052766110444,0.7293427822149575,0.8926886792452831,0.93621677812934,1.0,7/88,8.67%,CDC14A;NIPBL;KCNQ1;RIPOR2;MYO3B;WFS1;PDZD7
prerank,positive regulation of response to stimulus (GO:0048584),0.27136571342752,0.7290922043586566,0.8169582772543742,0.9361322642819863,1.0,9/40,20.56%,TAF9;IFIH1;ARG2;B2M;FCGR2B;NSMCE4A;SIRT1;PRKCD;BCLAF1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.28023416189152656,-0.7285485206620335,0.8101604278074866,0.9528170037743199,1.0,6/15,26.46%,RTN3;TMEM33;REEP1;TMEM170A;ARL6IP1;REEP4
prerank,mammary gland development (GO:0030879),-0.2521048041977386,-0.7285272361120307,0.8505434782608695,0.9519519052670163,1.0,14/21,44.36%,ERBB4;ARHGAP35;VEGFA;GPAT4;CAV1;WNT4;NOTCH4;GLI2;WNT7B;ZBTB7B;PRLR;WNT3;TGFB3;APLN
prerank,autophagosome organization (GO:1905037),0.2603839486234305,0.728418165982031,0.8611111111111112,0.9365693036127386,1.0,14/50,21.65%,RAB19;RAB7A;ATG5;STX12;PACS2;WIPI2;VMP1;RB1CC1;AMBRA1;BECN1;ATG13;RAB43;ULK1;GABARAPL1
prerank,establishment of spindle localization (GO:0051293),0.31876340173642537,0.7281350127499301,0.7713310580204779,0.9365478136222096,1.0,4/14,20.64%,DYNC1H1;CLASP1;KPNB1;LLGL2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3058966646895763,-0.7280425529917581,0.8449074074074074,0.9516539899904632,1.0,5/11,24.92%,CCT2;DKC1;CCT8;TERF1;CCT3
prerank,proteasome assembly (GO:0043248),0.33844741220178376,0.7278657874385859,0.7996742671009772,0.9364840034890638,1.0,3/11,13.01%,PSMD9;PSMD10;POMP
prerank,ribonucleoprotein complex assembly (GO:0022618),0.23068471942890512,0.7274170560506374,0.9161147902869757,0.936655602177602,1.0,33/132,20.71%,RPL5;CRNKL1;SNRPD2;PRPF6;RPL6;SNRPB;SETX;RPS14;SRSF10;RPF2;COIL;CELF2;YTHDC1;NUDT21;MCTS1;RPLP0;DDX23;RPL11;GEMIN7;NCBP1;TXNL4A;CELF1;MRPL20;RPSA;SHQ1;SF3B1;DDX20;RPS27;LUC7L3;SF3A2;LUC7L;SNUPN;PRPF18
prerank,sulfur amino acid metabolic process (GO:0000096),0.28617266293269833,0.7263802602794441,0.8107302533532041,0.9375858990828223,1.0,3/24,10.50%,DPEP1;ADO;MTRR
prerank,organic acid transport (GO:0015849),0.23758353155462475,0.7263339260422729,0.9091981132075472,0.9372356594047273,1.0,14/94,13.62%,SLC23A2;SLC23A1;LRRC8D;SLCO1B1;SLC25A30;NCOA2;SLC1A5;SLC43A2;NCOA1;SLC1A4;ABCC4;SLC38A1;SLCO1C1;SLC26A7
prerank,determination of bilateral symmetry (GO:0009855),0.28894243544333975,0.7258034196658494,0.823076923076923,0.9375102159286113,1.0,3/24,13.98%,FOXJ1;KIF3B;CITED2
prerank,establishment of mitotic spindle localization (GO:0040001),0.2814650927111455,0.7255276823616463,0.827893175074184,0.9374469891108224,1.0,7/28,16.33%,FBXW11;PAFAH1B1;INSC;HTT;CLASP1;KPNB1;GPSM2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.27770024716168706,0.7254903661084324,0.8282387190684134,0.9370877849470891,1.0,7/32,15.57%,PKIB;FBXO4;TNKS;MAP3K4;AURKB;MAPK1;TCP1
prerank,response to gamma radiation (GO:0010332),0.28679364718028894,0.7249991554217096,0.8180428134556575,0.9373396514062221,1.0,5/24,12.67%,WRN;TLK2;DCUN1D3;PRKAA1;MAP3K20
prerank,nuclear pore organization (GO:0006999),0.3278979779009349,0.7249136920412562,0.8198347107438017,0.9370415097913855,1.0,5/14,18.18%,NUP98;RTN4;NUP153;SEH1L;NUP93
prerank,regulation of fibrinolysis (GO:0051917),0.32669850450330595,0.7231618931660811,0.817717206132879,0.9388475888024778,1.0,2/13,15.44%,FAP;THBS1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.2938898018237017,0.7225154229169364,0.8217054263565892,0.9392519344298399,1.0,5/22,13.95%,VPS37C;TSG101;SNF8;STAM;UBAP1
prerank,epithelial cell differentiation (GO:0030855),0.23397069969059214,0.7222900956527945,0.9054054054054054,0.9391335119015755,1.0,16/88,19.34%,GLI1;PPARG;EHF;ZDHHC7;ANXA4;LATS1;ANXA1;DHRS9;LGALS3;AKT1;TAGLN2;CASP6;PROX1;HDAC1;FZD7;RAB10
prerank,fatty acid elongation (GO:0030497),0.3300460399828401,0.7220798469701399,0.7820945945945946,0.9390061661724818,1.0,4/13,16.34%,ELOVL5;ELOVL6;ABCD1;HACD4
prerank,regulation of phosphatase activity (GO:0010921),0.28707099463877317,0.7220241162126939,0.8320839580209896,0.9386727211997083,1.0,8/24,22.63%,PPP1R2;GPATCH2;HTT;PPP6R2;ZCCHC9;PTPA;TIPRL;PPP6R1
prerank,negative regulation of growth (GO:0045926),0.229038966232543,0.7215383272308966,0.9047085201793722,0.9388960887828515,1.0,22/121,17.25%,NOTCH2;BCL6;HSPA1A;BMPR2;CRLF3;BTG1;PPP1R9B;CDKN2C;OSGIN2;SMAD4;RTN4;DCUN1D3;SH3BP4;PNPT1;PTPRJ;FGFR3;TGFB1;SERTAD3;RB1;PPT1;ST7L;SIRT1
prerank,response to organophosphorus (GO:0046683),0.3109398934409254,0.720809208729829,0.7984375,0.9393853872754662,1.0,3/16,12.28%,STAT1;TRIM16;NDUFS4
prerank,negative regulation of interleukin-12 production (GO:0032695),0.32372473742694885,0.7207946547696569,0.8208955223880597,0.9389990084732419,1.0,4/14,17.79%,LILRB1;THBS1;IRAK3;LILRA5
prerank,ether lipid biosynthetic process (GO:0008611),0.343897332338389,0.720575618126429,0.7996794871794872,0.9388561274353712,1.0,4/10,19.36%,AGPS;FAR1;GNPAT;PEDS1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.29133293600079,0.7201121651543784,0.8172205438066465,0.9390263036060289,1.0,4/21,12.41%,ADCY10;GUCY1A1;ADCY7;ADCY5
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.31711585823472754,0.7196652918136344,0.8167202572347267,0.9391813359139982,1.0,4/15,15.01%,CD36;EIF2AK2;GBP5;MYD88
prerank,regulation of myelination (GO:0031641),0.2922894226821331,0.7192113171989943,0.8372093023255814,0.9393456574542,1.0,5/25,13.54%,ITGAX;MYRF;ZPR1;EIF2AK3;TNFRSF1B
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.28304788164775063,0.718997195881771,0.8401162790697675,0.9392157169146962,1.0,4/29,16.74%,TNNC1;ENG;TGFB1;PROX1
prerank,snRNA processing (GO:0016180),0.3118161917917495,0.7185487322294349,0.8016666666666666,0.9393773146147137,1.0,6/16,16.72%,TUT1;INTS2;INTS11;INTS14;INTS4;INTS6
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.28638605378507215,-0.7175205512207183,0.8475,0.9631665784918019,1.0,3/13,10.29%,IRAK2;EPG5;IRAK1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.28113694373520953,0.7173745212943047,0.8325859491778774,0.9404096822315972,1.0,9/26,23.11%,TET2;SETD5;SETD2;KMT5B;KMT2A;PRDM9;SMYD5;ATPSCKMT;ANTKMT
prerank,response to steroid hormone (GO:0048545),-0.22571605947575119,-0.7171040274162617,0.9212328767123288,0.9627633468521899,1.0,14/31,33.34%,PAQR8;ATP1A2;CATSPER2;TGFB2;AR;PAQR7;TFPI;NR1H3;CAV1;ATP1A1;ATP1A3;ABCA2;WBP2;CATSPERD
prerank,establishment of spindle orientation (GO:0051294),0.2765904026699373,0.7170423581754944,0.8325925925925926,0.940431239532528,1.0,6/28,16.33%,FBXW11;PAFAH1B1;INSC;HTT;CLASP1;GPSM2
prerank,aerobic electron transport chain (GO:0019646),-0.19260032458164036,-0.716870677152302,0.9558011049723757,0.9621391843719146,1.0,32/68,32.07%,UQCRC2;COX7C;NDUFA7;NDUFB4;NDUFB2;NDUFV1;NDUFV3;NDUFS7;NDUFB3;COX10;NDUFA5;UQCR10;UQCRC1;COX5B;NDUFB5;NDUFB9;NDUFB7;NDUFA13;NDUFAF1;NDUFB8;NDUFAB1;COX6A1;NDUFB6;NDUFS8;NDUFB10;SDHA;COX6C;UQCC3;NDUFS3;CYC1;NDUFS6;NDUFA11
prerank,regulation of cellular protein metabolic process (GO:0032268),0.254521534509251,0.7165013070795458,0.8664021164021164,0.9406822852480674,1.0,8/47,14.30%,KLF4;NFKB1;NFKBIA;MTPN;FOXO3;APP;AKT1;TGFB1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.2793374776289036,-0.7160360400696295,0.8213333333333334,0.9622039510141855,1.0,3/14,12.19%,SLC27A1;CHKA;PCYT2
prerank,protein-containing complex disassembly (GO:0032984),0.2488989968824542,0.7159189103792156,0.8778220451527224,0.9409920693915425,1.0,9/54,15.83%,UVRAG;AXIN1;STX17;TSG101;DVL3;WIPI2;VCP;DVL2;APC
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.30157737267291024,-0.7158636624053758,0.829736211031175,0.9614992978918754,1.0,2/11,12.87%,AUP1;DERL1
prerank,mitotic sister chromatid segregation (GO:0000070),0.2282824906989632,0.7156976978662488,0.9137115839243499,0.9408468109809958,1.0,21/98,18.39%,NIPBL;CUL3;KIF23;CHMP4A;CHMP4B;TEX14;PDCD6IP;SMC4;CSNK2A2;CSNK2A1;EML4;HASPIN;INO80;KPNB1;SEH1L;RB1;KNSTRN;MCPH1;PHF13;BECN1;RAD21
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3031898100237017,-0.7151761240146746,0.8275862068965517,0.9613574629949705,1.0,5/12,28.55%,PSAT1;SERINC3;PHGDH;MTHFD1;SEPHS2
prerank,regulation of stem cell population maintenance (GO:2000036),0.3080195703732487,0.7151533282477035,0.8086124401913876,0.9411088797024092,1.0,3/18,11.91%,NCOA3;CNOT2;REST
prerank,glial cell development (GO:0021782),-0.23535389745335727,-0.7150729890459278,0.8885350318471338,0.9605943136961738,1.0,8/25,16.96%,NF1;EIF2B5;SOX4;MDK;EIF2B4;TPPP;NSUN5;SOX11
prerank,positive regulation of intracellular transport (GO:0032388),0.2686048486310838,0.7150490881052136,0.8472418670438473,0.940825033316331,1.0,7/38,14.67%,SORL1;EHD2;ATP2A1;BCAS3;DYNC1H1;RAB29;EHD1
prerank,regulation of DNA metabolic process (GO:0051052),-0.21106025026449313,-0.7145554648389929,0.9310344827586207,0.9603101921338151,1.0,8/44,11.49%,MPHOSPH8;PDGFA;YLPM1;UPF1;POLH;TERF2IP;TOM1L1;XRCC5
prerank,regulation of TORC1 signaling (GO:1903432),0.2711948328012997,0.7143640479679066,0.8524355300859598,0.9412903132258001,1.0,6/33,12.74%,SPAAR;SIK3;CLEC16A;DEPDC5;GPR137C;CASTOR2
prerank,motor neuron axon guidance (GO:0008045),0.31339999825462433,0.713884849222892,0.8180379746835443,0.9414695812550902,1.0,6/15,18.58%,RAC2;RAC1;NTN1;RHOG;TMEFF1;SEMA3A
prerank,integrated stress response signaling (GO:0140467),0.3222049360345617,0.7132135395355795,0.8336134453781513,0.9419069155633731,1.0,4/14,17.95%,EIF2AK1;NFE2L2;EIF2AK3;HSPA5
prerank,response to interferon-alpha (GO:0035455),0.30690018137741887,0.713069735294576,0.8174342105263158,0.9416790095587757,1.0,7/16,24.80%,EIF2AK2;IFNAR1;IFITM3;IFNAR2;AXL;BST2;GATA3
prerank,negative regulation of transposition (GO:0010529),0.3108014656824182,0.7130381241635316,0.8104906937394247,0.9413120814969721,1.0,2/16,11.52%,UBR2;TUT7
prerank,regulation of trophoblast cell migration (GO:1901163),0.32602683290758405,0.7128358526879878,0.8157894736842105,0.9411573955567869,1.0,2/14,7.77%,ARHGDIB;YTHDF3
prerank,stress granule assembly (GO:0034063),-0.25907836615402113,-0.7125338363942111,0.8647887323943662,0.9615651178784768,1.0,6/20,18.27%,LSM14A;ATXN2L;RPS23;OGFOD1;ATXN2;DDX3X
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2858676424763846,0.7120215282908214,0.8328220858895705,0.9417493775679443,1.0,7/24,19.96%,ATF6;RBPJ;NFE2L2;ATF6B;HSPA5;KLF2;GCN1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2518917309429281,0.7116292415754872,0.8836898395721925,0.9418174388873168,1.0,16/52,22.67%,RC3H1;PNLDC1;DCP2;CNOT6;LSM5;CNOT2;DCP1A;TUT7;CNOT8;DDX6;TNKS1BP1;CNOT6L;EDC3;PARN;CNOT3;LSM7
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.2900596844353648,-0.7115448925899174,0.8481675392670157,0.9617350691484158,1.0,1/13,1.59%,DDX5
prerank,membrane fusion (GO:0061025),0.2680958413356453,0.7115139952406596,0.8523206751054853,0.9415666823921423,1.0,7/33,17.41%,STX11;DYSF;DNM1L;SNAP23;VAPA;HACE1;MYOF
prerank,epithelial structure maintenance (GO:0010669),-0.3089590851146547,-0.7112994563663388,0.8557213930348259,0.9611340721266743,1.0,6/11,57.36%,CXADR;TLR9;NOD2;PIWIL4;MUC6;STRAP
prerank,cellular response to copper ion (GO:0071280),0.3154547142220196,0.7105633990711474,0.8145800316957211,0.9423357352587256,1.0,2/16,10.40%,PRNP;DAXX
prerank,striated muscle contraction (GO:0006941),0.25303810586992037,0.7100422312050032,0.8854568854568855,0.9425525111459985,1.0,3/53,3.70%,TNNC1;KCNQ1;MYL4
prerank,regulation of spindle assembly (GO:0090169),0.2861526866228895,0.7097686182790064,0.8487518355359766,0.9424953197023711,1.0,5/25,11.89%,HSPA1A;CHMP4B;PDCD6IP;SENP6;DYNC1H1
prerank,muscle tissue development (GO:0060537),-0.28654530097145847,-0.7090537541777484,0.8709677419354839,0.9627243032965072,1.0,2/13,4.20%,SMO;NF1
prerank,ribosome biogenesis (GO:0042254),0.21527271183083047,0.7089562517851656,0.940854326396495,0.9430504240330062,1.0,31/187,14.63%,XPO1;RPL5;NOL6;RPL37A;RPL6;XRN2;DHX37;RPS14;RPL35A;UTP6;RIOK1;RPL13;RPF2;DDX49;NOC4L;MPHOSPH6;NOL11;RPLP0;UTP20;RPL34;RPL19;RPL11;RPL30;RRP36;NOP58;RPL4;UTP18;RPS2;RPL7;MRTO4;DDX10
prerank,neuron apoptotic process (GO:0051402),0.3001207501981022,0.7084546121327984,0.8473520249221184,0.943266193717072,1.0,7/19,22.46%,NGFR;APP;TRPC5;DIABLO;BID;BCL2;SIAH1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.31069452479256876,-0.7076718059641368,0.8151658767772512,0.9633487004988059,1.0,2/10,4.27%,TREM2;CD68
prerank,protein acetylation (GO:0006473),0.27155121660695525,0.7075859726604206,0.8571428571428571,0.943907401024968,1.0,8/30,19.19%,NAA16;CLOCK;KAT6A;NAA15;KAT2B;CREBBP;SIRT1;HAT1
prerank,sulfation (GO:0051923),-0.2928752119293215,-0.7071319873335496,0.8321513002364066,0.9630497296527291,1.0,1/11,1.64%,HS3ST5
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.3296344185358252,0.707112230091987,0.8038528896672504,0.9440607548979124,1.0,3/12,20.23%,ELOVL5;ABCD1;ACSL1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2861385561864119,0.7068207737219192,0.8445440956651719,0.9440136320086204,1.0,2/22,6.98%,BCL6;CBFB
prerank,epithelial to mesenchymal transition (GO:0001837),0.252744052420137,0.7067156095805617,0.8691588785046729,0.9437319942529794,1.0,8/47,14.30%,AKNA;RBPJ;S100A4;ENG;HGF;OLFM1;ROCK1;TGFB1
prerank,nucleoside salvage (GO:0043174),0.3325565978494851,0.7064358895886247,0.8242990654205608,0.9436732016462647,1.0,3/10,14.38%,UCK2;UCK1;DCK
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.31500809186148815,0.7062249934031899,0.8338926174496645,0.9431181224354486,1.0,3/15,16.09%,ZFP36L2;TNRC6B;PABPC1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.31500809186148815,0.7062249934031899,0.8338926174496645,0.9431181224354486,1.0,3/15,16.09%,ZFP36L2;TNRC6B;PABPC1
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.2627869222669412,0.7059988503758813,0.8778735632183908,0.9429802047092035,1.0,2/35,3.22%,PCDHB11;SELL
prerank,positive regulation of neuron differentiation (GO:0045666),-0.21381698200848928,-0.704724473895208,0.9438202247191011,0.9647763117442273,1.0,15/40,26.92%,MEF2C;BEND6;IMPACT;GPRC5B;ZEB1;SOX11;TCF4;TRIM32;TCF3;MMD;HOXD3;ZC4H2;ECT2;BRINP2;NBL1
prerank,mitotic nuclear division (GO:0140014),0.23577924305300477,0.7034080508692607,0.9138576779026217,0.9455450417774458,1.0,13/71,15.76%,EPS8;CHMP4B;FLNA;RHOA;SMC4;SPAST;STAG1;KIF3B;STAG2;UBE2S;CLASP1;INO80;KPNB1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.2560545720358198,-0.7032915359605684,0.8945868945868946,0.9653555335775016,1.0,8/18,37.65%,BCL2L1;SPG7;CAMK2A;SLC25A4;PPIF;NAIF1;ALKBH7;PMAIP1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.24864337432317804,0.7028153031204037,0.8918558077436582,0.945846675556203,1.0,4/48,6.67%,CXCL10;DIAPH1;PTK2B;PDPK1
prerank,microtubule depolymerization (GO:0007019),0.30196455974855624,0.7026102360294033,0.8306709265175719,0.9456727388159689,1.0,4/17,15.29%,KATNB1;KIF24;STMN3;STMN2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.27759684735116014,0.7016687916861648,0.8534743202416919,0.9463394689411884,1.0,3/26,11.63%,GPR35;ADRA2A;FKBP1B
prerank,centromere complex assembly (GO:0034508),-0.211351929128225,-0.7001409554838486,0.9397163120567376,0.9678054195931213,1.0,19/36,31.92%,CENPO;NPM1;POGZ;CENPE;KNL1;CENPA;RUVBL1;CENPP;MIS18BP1;CENPK;CENPU;CENPF;DLGAP5;CENPT;CENPX;RBBP7;MIS12;CENPN;CENPH
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2575924684992117,0.6991820858256159,0.8902606310013718,0.9487677822864828,1.0,9/41,18.18%,NUP210;PRKAG2;NUP98;SCARB2;PRKAG1;NUP153;SEH1L;GCK;NUP93
prerank,negative regulation of receptor binding (GO:1900121),0.3364152139306238,0.6988609349120655,0.8242530755711776,0.9487319530627332,1.0,2/10,10.86%,ATP2A3;B2M
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.2504986959945943,0.6981713636140474,0.8753351206434317,0.9491407428634038,1.0,6/46,11.73%,LNPEP;ACOT11;RBPJ;ADAM17;RHEB;PGAM5
prerank,rRNA 3'-end processing (GO:0031125),0.33248442552286334,0.6977295880287645,0.8115183246073299,0.949238316746248,1.0,2/10,10.20%,ERI1;RPS21
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.2803853380591582,-0.6976985529498391,0.8767772511848341,0.9694675915889789,1.0,4/13,21.40%,DERL2;BCAP31;UBE2G2;BRSK2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.2696219327858154,0.6976521613569373,0.866571018651363,0.9489248590836765,1.0,4/29,8.34%,ACSL5;ELOVL5;HSD17B12;ELOVL6
prerank,regulation of microtubule-based process (GO:0032886),0.2603316518100327,0.6975169383710118,0.869309838472834,0.9486848991570485,1.0,9/36,16.50%,DIAPH1;PHLDB2;CYLD;PRKAA1;ROCK1;PRKAA2;CLASP1;APC;TRIM36
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.2736179193670739,-0.6973066528747532,0.8609625668449198,0.9689690063042767,1.0,7/14,27.07%,ERCC6;MMS19;FUS;MRNIP;TIMELESS;WDR48;RAD51AP1
prerank,CENP-A containing chromatin organization (GO:0061641),0.27241125646605757,0.696955813601838,0.8548387096774194,0.9485256038931753,1.0,6/29,14.86%,RBBP4;SMARCA5;CENPL;CENPQ;RSF1;CENPC
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.27241125646605757,0.696955813601838,0.8548387096774194,0.9485256038931753,1.0,6/29,14.86%,RBBP4;SMARCA5;CENPL;CENPQ;RSF1;CENPC
prerank,DNA modification (GO:0006304),-0.24401739863686042,-0.6968471652063664,0.9154518950437318,0.968533947802498,1.0,10/22,25.94%,TERF2IP;EXOSC5;NEIL2;TERF1;OGG1;EXOSC3;PARP3;TINF2;NEIL3;PARP2
prerank,negative regulation of microtubule polymerization (GO:0031115),0.32255895314447275,0.6960113095243579,0.830220713073005,0.9491637918750339,1.0,4/12,15.29%,DYRK1A;CLIP3;TBCD;STMN2
prerank,endoderm development (GO:0007492),0.31627848578065143,0.695101524738282,0.8204697986577181,0.9497632056221412,1.0,13/13,68.40%,DUSP1;TBX20;GATA4;APELA;SOX17;EOMES;DUSP4;DUSP2;SOX7;DUSP5;KIF16B;LHX1;LAMC1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.25220146337157323,0.6934952997044143,0.872,0.951144129584582,1.0,5/40,10.86%,ANXA2;CBL;HIP1;TBC1D5;B2M
prerank,positive regulation of dephosphorylation (GO:0035306),0.2703657753708424,0.6930858516457137,0.8524096385542169,0.9511859529867284,1.0,8/27,18.60%,PPP2R5A;DLC1;ANKLE2;TGFB1;PPP1R7;PTPA;PRKCD;PIN1
prerank,chloride transmembrane transport (GO:1902476),0.24764445114040173,0.6928150495868752,0.8921052631578947,0.951088003323493,1.0,6/48,11.25%,GABRB2;SLC12A7;GABRR2;SLC4A8;SLC12A6;SLC12A9
prerank,negative regulation of protein ubiquitination (GO:0031397),0.24313294530744628,0.6908168447506444,0.9067357512953368,0.9528416148970623,1.0,10/50,15.52%,DTX3L;HSPA1A;CRY1;RPS3;CAMLG;USP4;AKT1;PRMT3;SVBP;TAF1
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.22160693492667602,-0.6905914560631313,0.9310344827586207,0.9738885528058652,1.0,12/30,28.93%,ABCD2;ABCD4;HACD2;ELOVL7;ELOVL4;ABCD3;ELOVL1;TECR;ACOX1;ACSBG1;SLC27A2;ACSL6
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.22645692971462295,0.6905588722915055,0.9499389499389499,0.952709926768708,1.0,11/82,13.88%,SDCCAG8;CNTRL;HAUS8;CEP63;PAFAH1B1;HAUS1;DCTN3;CEP250;DYNC1H1;HAUS3;CLASP1
prerank,replicative senescence (GO:0090399),-0.27933780445496315,-0.6902250089798693,0.8891566265060241,0.9733441081972027,1.0,9/12,50.61%,SERPINE1;ROMO1;CDKN2A;CHEK1;ATM;MME;TERT;PLA2R1;ATR
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.2989109447469487,0.6898056091094471,0.8615635179153095,0.9531479098418454,1.0,4/16,15.31%,NAA16;NAA15;KAT2B;CREBBP
prerank,endothelial tube morphogenesis (GO:0061154),0.33069904112823956,0.6896294015576253,0.8407871198568873,0.9529374455658159,1.0,4/10,20.44%,RBPJ;RHOA;STARD13;CCM2
prerank,response to copper ion (GO:0046688),-0.2419314358685024,-0.6892406968679732,0.9002932551319648,0.9734242230143176,1.0,14/20,42.77%,IL1A;ATP5F1D;MT2A;MT3;ATP7B;HSF1;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H
prerank,chromatin remodeling at centromere (GO:0031055),0.26591413131407204,0.6891047444504859,0.8654124457308249,0.9530985893375906,1.0,6/31,14.86%,RBBP4;SMARCA5;CENPL;CENPQ;RSF1;CENPC
prerank,synaptonemal complex assembly (GO:0007130),0.29365228856658504,0.6886073701213609,0.8267716535433071,0.9528485211856454,1.0,15/15,70.66%,STAG3;RAD21;SYCE1;SYCE3;SYCE2;SYCP2;BAG6;SYCP1;RAD21L1;TEX12;HORMAD1;REC8;TEX11;TRIP13;P3H4
prerank,synaptonemal complex organization (GO:0070193),0.29365228856658504,0.6886073701213609,0.8267716535433071,0.9528485211856454,1.0,15/15,70.66%,STAG3;RAD21;SYCE1;SYCE3;SYCE2;SYCP2;BAG6;SYCP1;RAD21L1;TEX12;HORMAD1;REC8;TEX11;TRIP13;P3H4
prerank,negative regulation of viral release from host cell (GO:1902187),0.31411148106122916,0.68826881952148,0.8245614035087719,0.9528100075321643,1.0,1/13,2.60%,TRIM26
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.2935937735858025,-0.6875606015173954,0.8482758620689655,0.9740895796282665,1.0,5/11,30.07%,QDPR;CALM1;DHFR;HSP90AA1;SPR
prerank,apoptotic DNA fragmentation (GO:0006309),0.3035258936888407,0.6873201729920131,0.8575899843505478,0.9534299478132984,1.0,4/16,15.76%,DFFA;DFFB;EXOG;KPNB1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.23333995146740685,-0.6872589370218462,0.9054441260744985,0.9734978471145461,1.0,7/21,22.75%,CHST11;CHST9;CHPF2;CSPG4;CHST3;BGN;CHSY1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.3185759380885913,0.6870074803391008,0.8291873963515755,0.9533862077899284,1.0,2/11,10.43%,RC3H1;ANXA1
prerank,peroxisomal membrane transport (GO:0015919),0.26684605727143895,0.6868025996366367,0.8660578386605784,0.9532096777258886,1.0,5/27,13.04%,PEX16;PEX12;PEX14;FIS1;ABCD1
prerank,DNA duplex unwinding (GO:0032508),0.24312078347199226,0.6865329541985334,0.9026666666666666,0.9531155471105394,1.0,8/50,13.03%,MRE11;MCM6;WRN;ASCC3;ANXA1;RECQL5;MCM2;ERCC3
prerank,cellular response to UV (GO:0034644),0.23025906705614108,0.6864960721938544,0.9240196078431373,0.9527514741101866,1.0,22/76,22.12%,MMP1;CERS1;CRIP1;CARD16;ERCC4;METTL3;AURKB;CREBBP;TAF1;INO80;USP47;POLD1;SIRT1;PRKCD;N4BP1;RHBDD1;XPA;STK11;POLK;PARP1;CASP9;SDE2
prerank,negative regulation of complement activation (GO:0045916),-0.2967213122700741,-0.6860334682454502,0.8355855855855856,0.9738358817312408,1.0,7/10,42.45%,SUSD4;CD46;A2M;SERPING1;VSIG4;CR2;CD55
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.28249201884370806,0.6856478641962385,0.8712121212121212,0.9532679324120026,1.0,2/19,4.44%,SYK;ZAP70
prerank,negative regulation of establishment of protein localization (GO:1904950),0.32427480937595343,0.685454579722809,0.8389261744966443,0.9530746512629178,1.0,4/10,19.93%,WWP2;SNX3;SNX12;NDFIP2
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.27784788531487425,-0.6851751393314313,0.8640552995391705,0.9737523840098191,1.0,3/12,13.09%,CCT2;DKC1;CCT8
prerank,organelle disassembly (GO:1903008),0.26364809554061286,0.6848446096459219,0.8960674157303371,0.9533087715802816,1.0,7/33,14.75%,VRK1;KIF5B;GBF1;STX5;MCTS1;VCP;RB1CC1
prerank,positive regulation of calcium ion import (GO:0090280),0.31858698857788154,0.6846989419652038,0.8167539267015707,0.95305438854628,1.0,2/12,12.86%,ATP2A1;LGALS3
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.24480391840163737,-0.684658001366731,0.8994708994708994,0.9733838007546911,1.0,3/19,11.89%,GOT1;PHYKPL;ALDH7A1
prerank,serine family amino acid metabolic process (GO:0009069),0.30397295815854053,0.6845236213181858,0.8352180936995154,0.9528497784796683,1.0,4/16,19.39%,SEPSECS;SRR;SHMT1;GLYAT
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.28482982175190275,0.6845033100836718,0.8660578386605784,0.9524771563017053,1.0,3/21,7.97%,PTEN;DDIT4;PAQR3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.2367870477793566,-0.6839890741691326,0.9307228915662651,0.9731254901023757,1.0,2/23,5.80%,LTA4H;LTC4S
prerank,glutamine family amino acid metabolic process (GO:0009064),0.2544657877345074,0.6835493617081672,0.8864942528735632,0.9531131080313506,1.0,7/33,17.48%,TAT;KYAT1;GLUD1;CAD;SIRT4;PYCR2;DDAH1
prerank,dendrite morphogenesis (GO:0048813),0.25618922333033833,0.6834428435182972,0.884016973125884,0.9528305320320005,1.0,8/35,16.52%,DOCK10;CDC42;PTEN;EPHB2;MINK1;LRP4;PHACTR1;WNT7A
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.22675518731982924,0.6833979487862635,0.9297619047619048,0.952482500095628,1.0,18/87,16.23%,SDHAF2;NDUFA2;NDUFS5;TIMM21;NDUFA3;NDUFA10;IMMP2L;AIFM1;NDUFS2;NDUFS4;UQCC1;COA5;NDUFA12;NDUFA9;COX17;NDUFAF5;COX16;NDUFC2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.2602885810060446,-0.6833617120085768,0.875,0.9728128910664728,1.0,3/15,11.91%,NTRK3;SCG2;VEGFA
prerank,protein targeting to mitochondrion (GO:0006626),0.24179045238339328,0.6832529938102037,0.924066924066924,0.9522303469654884,1.0,13/52,17.44%,GRPEL2;DNAJC19;TIMM21;TOMM40;FIS1;IMMP2L;AIFM1;PMPCA;TIMM50;FBXO7;MIPEP;AIP;HSPD1
prerank,synaptic vesicle membrane organization (GO:0048499),0.2943267074892574,0.6826830539911825,0.8722044728434505,0.9523996465554737,1.0,4/17,15.39%,STX11;SYP;SYNGR2;SNAP23
prerank,response to unfolded protein (GO:0006986),0.24530169563421425,0.6820803118305798,0.9072305593451568,0.9526306774120209,1.0,11/48,17.95%,HSPA1A;ERN1;ERP44;TM7SF3;DAXX;PTPN1;HSPA9;STT3B;HSPD1;BAG3;HSPA5
prerank,negative regulation by host of viral transcription (GO:0043922),-0.28273979086897644,-0.6816939226724472,0.8574938574938575,0.9733551634562313,1.0,3/12,19.41%,TARDBP;CCL3;HMGA2
prerank,peptidyl-lysine methylation (GO:0018022),-0.22184293017590287,-0.6816575639483458,0.9219219219219219,0.9725109386669608,1.0,10/26,26.95%,SETD3;SETD4;KMT5A;EHMT2;SUV39H1;N6AMT1;ETFBKMT;TRMT112;METTL21A;SMYD1
prerank,acyl-CoA metabolic process (GO:0006637),-0.21366116401673613,-0.681435604773158,0.9612676056338029,0.9718238608200305,1.0,9/35,21.89%,ACACA;SUCLG2;ACSF2;ACOT9;GPAT4;ACOT7;MLYCD;OXSM;ACOT6
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2560738150645795,0.6811975734267549,0.8906474820143885,0.9531595423833357,1.0,7/35,15.57%,PKIB;FBXO4;TNKS;MAP3K4;AURKB;MAPK1;TCP1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.3088568459273791,0.6811577859101049,0.8314424635332253,0.9527984072582025,1.0,3/13,11.91%,NFKB1;ERLIN1;REST
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.255596315999144,-0.6810492916369576,0.8690807799442897,0.9712798669769831,1.0,1/15,0.58%,ABHD12
prerank,regulation of response to stress (GO:0080134),-0.2951803947475091,-0.6807684365126582,0.8536585365853658,0.9706750735143869,1.0,7/10,39.52%,CORO2B;EIF4G1;ADCY8;MLC1;STOX1;DYRK3;CRHBP
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.25070174781468363,0.6806183349692448,0.8998628257887518,0.9529136869818168,1.0,9/37,16.50%,PHLDB2;CYLD;PRKAA1;ROCK1;PRKAA2;CLASP1;STMN3;STMN2;TRIM36
prerank,cellular response to pH (GO:0071467),0.29714616189968346,0.6796965769461489,0.8653846153846154,0.9534882033766349,1.0,1/17,1.71%,GPR68
prerank,regulation of telomere maintenance (GO:0032204),0.26890641402490295,0.6792921650915853,0.86875,0.953518564561578,1.0,6/26,16.15%,MRE11;SMG1;ATRX;ERCC4;USP7;SMG6
prerank,inorganic anion transmembrane transport (GO:0098661),0.23290445268396226,0.6790851754416255,0.933588761174968,0.9533351655441097,1.0,8/63,11.25%,GABRB2;SLC12A7;GABRR2;SLC25A30;SLC37A4;SLC4A8;SLC12A6;SLC12A9
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3196500141196636,0.6788769026331407,0.8557046979865772,0.9527602348547822,1.0,1/12,3.40%,RCC2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3196500141196636,0.6788769026331407,0.8557046979865772,0.9527602348547822,1.0,1/12,3.40%,RCC2
prerank,regulation of protein import into nucleus (GO:0042306),0.2506985650303826,0.6787370624727608,0.8787878787878788,0.9524996049183733,1.0,12/36,18.81%,UBR5;FLNA;RBM22;ZPR1;HCLS1;HDAC3;TGFB1;PSEN1;PIK3R2;BAG3;PRKCD;MDFIC
prerank,glycosaminoglycan catabolic process (GO:0006027),0.23539571573184476,0.678528756871475,0.9167750325097529,0.952311972302027,1.0,7/55,11.59%,CD44;GPC3;HSPG2;ACAN;FUCA1;NCAN;SDC3
prerank,dicarboxylic acid transport (GO:0006835),-0.22269053768506072,-0.6784989424274476,0.91875,0.9718912227246617,1.0,12/28,31.09%,SLC1A3;GJA1;GIPC1;SLC13A3;SLC1A1;SLC26A8;SLC26A6;PDPN;SLC25A10;SLC46A1;PRAF2;SLC1A6
prerank,cAMP biosynthetic process (GO:0006171),0.3300226641671592,0.6783923907579231,0.8579234972677595,0.9520666260752891,1.0,3/10,12.41%,ADCY10;ADCY7;ADCY5
prerank,"base-excision repair, AP site formation (GO:0006285)",0.2930107170886625,0.677622589967823,0.8573770491803279,0.9524404309740548,1.0,3/17,10.75%,MBD4;SMUG1;TDG
prerank,chordate embryonic development (GO:0043009),0.23929664760002484,0.676543465830455,0.9050632911392406,0.9530993158888572,1.0,9/55,16.74%,MBNL1;SULF2;DEAF1;XYLT1;TRIM71;PCSK5;TGFB1;FUT8;PROX1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.27152725043112513,0.6761262738854054,0.887905604719764,0.9531144500184643,1.0,2/23,4.32%,HERC4;GPC3
prerank,regulation of dephosphorylation (GO:0035303),0.29624294547836916,0.6750175566874396,0.8383333333333334,0.9538682474605438,1.0,4/15,16.81%,MTMR3;MTMR4;SMG6;MTMR2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.3163370911158662,0.6749209340097116,0.8571428571428571,0.9535695524470246,1.0,1/12,4.80%,GDNF
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2555571203932811,-0.6746646356839344,0.8925831202046036,0.9743675227230096,1.0,2/15,4.45%,CPEB2;ATF3
prerank,regulation of leukocyte migration (GO:0002685),0.2968873431767356,0.6746214888800384,0.8583196046128501,0.9534496422248115,1.0,4/16,15.07%,RAC2;RAC1;ANXA1;RHOG
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.28263345668831996,0.6745090519237591,0.882262996941896,0.9531699152382576,1.0,8/19,23.69%,EXT1;XYLT1;CSGALNACT1;GLCE;HS2ST1;NDST2;EXT2;NDST4
prerank,respiratory chain complex IV assembly (GO:0008535),-0.24231601455150426,-0.6743029216439217,0.9006024096385542,0.973805079014759,1.0,10/21,31.63%,OXA1L;COX10;SMIM20;COX18;BCS1L;SCO1;SURF1;FASTKD3;COA3;COA6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.28828479708501614,-0.6742150878372851,0.859122401847575,0.972139653827547,1.0,5/10,28.74%,TNFRSF1A;SPHK2;RACK1;SMPD3;SMPD2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.28828479708501614,-0.6742150878372851,0.859122401847575,0.972139653827547,1.0,5/10,28.74%,TNFRSF1A;SPHK2;RACK1;SMPD3;SMPD2
prerank,negative regulation of ATPase activity (GO:0032780),-0.25036111802581695,-0.673948654159366,0.9026315789473685,0.9715183569010034,1.0,11/16,44.65%,OXA1L;PAM16;TSC1;PXK;ATP5IF1;PPIF;TLR9;PLN;LTF;VCPKMT;THADA
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.25755335872732094,0.6734978882442979,0.8879432624113475,0.9537836019539592,1.0,3/30,7.44%,GOLPH3L;RAB34;GCC2
prerank,regulation of histone deacetylation (GO:0031063),0.3049771431317886,0.6732692572138145,0.8600682593856656,0.9536279242633425,1.0,2/13,11.15%,NIPBL;ING2
prerank,positive regulation of cilium assembly (GO:0045724),0.2867774563115459,0.6729365070247878,0.863275039745628,0.9535711698242447,1.0,5/18,20.77%,CCDC88A;TAPT1;HTT;CEP135;MARK4
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.25556716124023626,0.6729054168094655,0.8928046989720999,0.9532033888088002,1.0,7/32,18.96%,CDC45;CDK14;BACH1;ID2;ZPR1;RB1;BRD4
prerank,cellular transition metal ion homeostasis (GO:0046916),0.2224080521925515,0.6727662159070534,0.9396449704142011,0.9529498428617789,1.0,18/91,17.61%,CYB561A3;ABCB7;HEPH;PRNP;NEDD8;ARF1;ATP7A;SLC30A1;SMAD4;ATOX1;APP;HMOX2;IREB2;CCDC115;SLC31A1;SLC39A13;SLC39A12;NUBP1
prerank,negative regulation of cell differentiation (GO:0045596),0.20696879029797247,0.6727011388546562,0.9669239250275634,0.9526167467930106,1.0,30/181,17.75%,LIMD1;PPARG;SDHAF2;MAD2L2;COL5A2;NFKBIA;PTEN;PTK2B;PDCD4;ZFP36L2;IL6;ID2;SPRED3;ABCA5;REST;USF3;IQCB1;ADAMTS12;USH2A;MYB;TGFB1;ABCG1;GPS2;SPRED1;MED1;RB1;SEMA4D;SIRT1;EFNA1;HDAC7
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.23488066600240415,-0.6703476691847061,0.9258160237388724,0.9736462966536626,1.0,9/22,27.90%,WDR12;PES1;EXOSC9;FTSJ3;EXOSC10;EXOSC3;RPP40;ERI2;RRS1
prerank,muscle cell migration (GO:0014812),-0.28953759403846124,-0.6686908856583057,0.8613861386138614,0.9741549666426941,1.0,2/10,8.44%,ITGB3;AAMP
prerank,tRNA metabolic process (GO:0006399),0.2869351756956843,0.668400673888607,0.8513071895424836,0.956386157127534,1.0,2/17,6.02%,FARS2;DARS2
prerank,regulation of protein localization to cell surface (GO:2000008),0.25387726456594395,0.6680871594508397,0.9015691868758916,0.9562651184696478,1.0,10/33,23.13%,NEDD4L;PICALM;GBF1;TAX1BP3;SNX33;GOPC;KCNAB2;TNF;RAB11B;COMMD1
prerank,muscle tissue morphogenesis (GO:0060415),0.28933818912470183,0.6680808642662824,0.8731707317073171,0.9558776851183068,1.0,16/16,71.10%,PROX1;TGFBR3;ANKRD1;TBX20;MYLK2;ACTC1;TCAP;NOTCH1;TBX1;TTN;MYLK;HEY2;BMP4;BMP2;EFEMP2;ZFPM1
prerank,transcription preinitiation complex assembly (GO:0070897),-0.2746274690061241,-0.6669681445607759,0.8558139534883721,0.9747195059288404,1.0,1/12,2.06%,BDP1
prerank,nuclear envelope organization (GO:0006998),0.2782092928012868,0.6666004357334497,0.8713826366559485,0.9568701075163776,1.0,4/20,12.11%,LEMD3;LEMD2;DMPK;TOR1AIP1
prerank,electron transport chain (GO:0022900),-0.25584316592800754,-0.6665070869320997,0.8905109489051095,0.9742349843703151,1.0,4/15,22.02%,PPARGC1A;SDHB;NDUFA5;PDIA5
prerank,protein localization to centrosome (GO:0071539),-0.24495098501921078,-0.6658494573053867,0.9336870026525199,0.9738880621194917,1.0,7/17,34.24%,PIBF1;CEP83;CCDC14;NEDD1;CEP192;STIL;CEP131
prerank,endothelial cell differentiation (GO:0045446),0.30825198101091056,0.6653326762864029,0.8559322033898306,0.9576770829743343,1.0,1/12,2.95%,BMPR2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.290133728447739,-0.6649203092394146,0.8947368421052632,0.9737296037579376,1.0,3/10,13.09%,CCT2;DKC1;CCT8
prerank,telomere capping (GO:0016233),-0.2503397457575091,-0.6644100542011478,0.9047619047619048,0.9732705981919746,1.0,5/16,17.68%,CTC1;TERF2IP;DCLRE1A;TEN1;TERF1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.3145498855125606,0.6642661225003227,0.8548672566371681,0.9583062229900495,1.0,3/11,17.95%,ATF6;ATF6B;HSPA5
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.2964703085042583,0.6635438222465012,0.8583473861720068,0.9585876196992387,1.0,1/15,4.80%,GDNF
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.22147015308981904,-0.6634399081666855,0.9426751592356688,0.9732008936990958,1.0,7/25,20.19%,VPS4B;SORT1;CHMP5;LYST;CHMP1B;CHMP7;CHMP2A
prerank,glycerol metabolic process (GO:0006071),-0.2896889100177426,-0.6631455361497375,0.8665105386416861,0.9725791275336169,1.0,3/10,10.53%,GOT1;COQ3;GK5
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.24696160840211623,-0.6629840836739506,0.9285714285714286,0.9718330762725841,1.0,6/17,22.49%,IK;BUB3;ZW10;KNL1;CENPA;BOD1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.273656650666518,-0.6628711924854789,0.8758949880668258,0.9710623945286295,1.0,6/11,34.32%,ITM2C;NECAB1;ABCA7;ABCA2;ITM2A;NECAB3
prerank,cell proliferation in forebrain (GO:0021846),0.31444444354992135,0.6628295898414313,0.8543859649122807,0.9588503445307095,1.0,3/10,19.33%,AKNA;WNT7A;HOOK3
prerank,regulation of muscle contraction (GO:0006937),0.2616849080672174,0.6626495051376958,0.9015918958031838,0.9586196839950291,1.0,1/26,1.88%,TNNC1
prerank,mitochondrial membrane organization (GO:0007006),-0.2092261281822454,-0.6625435003606103,0.9530685920577617,0.9704656219790059,1.0,7/32,15.58%,BCL2L1;APOO;TMEM11;RCC1L;CHCHD6;SPG7;MFN1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.30146621151701447,0.6603374062931203,0.8833034111310593,0.9603696753078325,1.0,4/12,18.39%,FEN1;CTCF;RB1;RAD21
prerank,neural tube closure (GO:0001843),0.2509169838535433,0.6601869363059311,0.9195561719833565,0.9601082932758715,1.0,7/34,15.54%,CELSR1;DLC1;DEAF1;VASP;DVL3;TGFB1;DVL2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.2557610598157128,0.658696921999325,0.8955223880597015,0.9610069340961199,1.0,8/27,18.71%,CHST12;PXYLP1;XYLT1;NCAN;CHST15;CSGALNACT1;CHSY3;VCAN
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.31944373788411895,0.6586842813634206,0.855098389982111,0.9606232334005078,1.0,2/10,11.52%,NEDD8;TUT7
prerank,cellular response to gamma radiation (GO:0071480),0.28025089841617334,0.6575086342651754,0.9009287925696594,0.9612666707952132,1.0,3/17,12.67%,WRN;TLK2;MAP3K20
prerank,I-kappaB phosphorylation (GO:0007252),0.31169630307652263,0.6567715829164655,0.8652482269503546,0.9615389801449464,1.0,3/10,12.55%,TLR3;MAP3K7;TLR2
prerank,pharyngeal system development (GO:0060037),0.2880356942014815,0.6552659026669021,0.8933764135702746,0.9624796677820243,1.0,1/15,2.95%,BMPR2
prerank,cellular response to light stimulus (GO:0071482),0.22365058601462345,0.6549601891092991,0.9416243654822335,0.9623625886850564,1.0,19/66,22.12%,GNB1;GPR88;PDE6B;ERCC4;METTL3;AURKB;CREBBP;TAF1;INO80;USP47;POLD1;PRKCD;N4BP1;RHBDD1;POLK;SAG;PARP1;CASP9;SDE2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.27981328531094457,-0.6546660917204747,0.9046511627906977,0.9755705589985002,1.0,5/10,35.01%,DAB2IP;CADM4;PIK3CB;SPRY2;DCN
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.22675373724504203,-0.6540767391184286,0.9411764705882353,0.9751377520408111,1.0,4/19,14.65%,ROBO1;CD63;DAB2IP;CCBE1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3004066019446838,0.6539576203424848,0.8821603927986906,0.9624868799943217,1.0,3/12,22.03%,PRNP;DYRK2;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3004066019446838,0.6539576203424848,0.8821603927986906,0.9624868799943217,1.0,3/12,22.03%,PRNP;DYRK2;GSK3B
prerank,protein lipidation (GO:0006497),0.2240583663638594,0.6537556269188598,0.9335038363171355,0.9622643317432676,1.0,10/59,13.14%,HHAT;ZDHHC7;ATG5;ZDHHC13;ZDHHC6;ZDHHC23;ZDHHC17;PIGF;WIPI2;ATG10
prerank,oogenesis (GO:0048477),-0.24642947928782297,-0.6534143454590006,0.9168831168831169,0.9747547493557153,1.0,3/15,13.59%,PTN;FMN2;MDK
prerank,lysosome localization (GO:0032418),0.241839248814075,0.6532824634584147,0.9315642458100558,0.9622787781953355,1.0,10/37,19.87%,KIF5B;MYH9;RAB34;SNAPIN;KIT;ARL8B;MILR1;BORCS5;PLEKHM1;DEF8
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.25948483200023054,-0.6528161044705162,0.8952618453865336,0.9743198590009997,1.0,1/13,2.75%,B3GALNT1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.25209395280411784,-0.6517407135196991,0.9197080291970803,0.9742916179997164,1.0,7/15,28.49%,CCT2;DKC1;CCT8;RUVBL1;CCT3;NAF1;RUVBL2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.211052516994767,0.6511877923258358,0.9614457831325302,0.9637387649370494,1.0,13/94,13.88%,SDCCAG8;CNTRL;HAUS8;CEP63;PAFAH1B1;HAUS1;DCTN3;KIF24;CEP250;DYNC1H1;IQCB1;HAUS3;CLASP1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.2590980391989938,-0.651022947098919,0.9243498817966903,0.9739850709879778,1.0,3/13,14.54%,EPN2;HGS;DAB2IP
prerank,sulfur amino acid catabolic process (GO:0000098),0.3051172478374776,0.6492945705467168,0.8801431127012522,0.9649694900813748,1.0,2/10,10.50%,ADO;MTRR
prerank,metal ion homeostasis (GO:0055065),0.2404043200166892,0.6487822578714024,0.9422818791946309,0.9650092725783874,1.0,5/40,11.25%,SLC12A7;WFS1;SLC12A6;LETM1;SLC12A9
prerank,aorta morphogenesis (GO:0035909),0.2719577642170894,0.6483806728851593,0.9006309148264984,0.9649371175392949,1.0,2/17,8.16%,RBPJ;ENG
prerank,mitotic metaphase plate congression (GO:0007080),-0.1839560184471828,-0.647599855226237,0.961864406779661,0.9756800416467194,1.0,24/51,32.32%,VPS4B;RMDN1;PIBF1;CHMP5;ZW10;MAD1L1;EML3;CHMP1B;CENPE;RAB11A;CHMP7;KIF18A;CHMP2A;BOD1;PINX1;SPDL1;NDC80;RRS1;CDCA8;CEP55;KIFC1;CHMP6;MIS12;KIF22
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.24193597409265716,0.6474096233888338,0.9306122448979591,0.9653685913569438,1.0,9/38,16.23%,NDUFA2;NDUFS5;NDUFA3;NDUFA10;NDUFS2;NDUFS4;NDUFA12;NDUFA9;NDUFC2
prerank,regulation of extracellular matrix organization (GO:1903053),-0.2441862091970654,-0.6473476750127134,0.9141274238227147,0.9749990696865685,1.0,3/15,18.49%,LRP1;RIC1;AEBP1
prerank,positive regulation of ATPase activity (GO:0032781),0.23547656249738597,0.6470926484772805,0.913769123783032,0.9652520296179679,1.0,7/41,13.99%,PLSCR1;MYL4;ATP2A1;MSH3;MSH6;TOR1AIP1;VMP1
prerank,negative regulation of cell cycle process (GO:0010948),0.22159058483861935,0.6468624123260589,0.9392764857881137,0.9650498067738188,1.0,13/61,20.09%,UXT;RBBP8;RYBP;RBBP4;APAF1;L3MBTL2;EZH2;AURKB;PHC3;AURKAIP1;EHMT1;TERF2;RING1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.271416441780119,0.6466382640294644,0.8904109589041096,0.9648461240952539,1.0,5/19,15.33%,S100A10;RAC1;ROCK1;PTPRJ;COL16A1
prerank,regulation of actin filament depolymerization (GO:0030834),0.2991592089548053,0.6459578662952904,0.8820598006644518,0.9650129676733051,1.0,2/12,10.70%,MTPN;PIK3CA
prerank,DNA recombination (GO:0006310),-0.19664545786401838,-0.6457815444723524,0.9694915254237289,0.9752781133979513,1.0,14/37,28.40%,RAD51B;HMGB1;TSN;BLM;MSH2;RHNO1;IGHMBP2;FBH1;RAD51C;DMC1;ERCC1;GEN1;RAD51D;RAD54B
prerank,establishment of mitotic spindle orientation (GO:0000132),0.2615209860967428,0.6454225461754335,0.916030534351145,0.9650867169344116,1.0,5/23,16.33%,FBXW11;PAFAH1B1;INSC;HTT;GPSM2
prerank,regulation of epidermal cell differentiation (GO:0045604),0.26260677072688116,0.643443008774747,0.9103139013452914,0.9663066922217483,1.0,4/21,14.73%,CBFB;SULT2B1;ROCK1;SGPP1
prerank,sphingoid metabolic process (GO:0046519),-0.2662920021149145,-0.6402195191285771,0.9243498817966903,0.9781381696413911,1.0,4/12,18.01%,PLPP3;PLPP1;SPHK2;KDSR
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2531133247484944,0.6400771941336582,0.9152798789712556,0.968632959181273,1.0,7/29,20.43%,DCP2;CNOT6;LSM5;DCP1A;CNOT8;DDX6;EDC3
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.2594865541747087,-0.6394628636119285,0.9132530120481928,0.9777640768515976,1.0,1/12,2.75%,B3GALNT1
prerank,hexose metabolic process (GO:0019318),-0.18853896010381135,-0.6392778027816782,0.9820143884892086,0.9770358930538621,1.0,6/39,13.53%,HK1;APOD;AKR1A1;GAA;CHST1;BRAT1
prerank,embryonic axis specification (GO:0000578),-0.2437707688098658,-0.6382950688057256,0.9067357512953368,0.9768605212474863,1.0,6/15,41.95%,TASOR;PTCH1;STIL;FZD5;RIPPLY2;HOXD8
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.3058663334788765,0.6380665748870706,0.8837606837606837,0.969844007165644,1.0,1/11,3.32%,KCNQ1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.2614921417736833,-0.638019602907443,0.8963855421686747,0.9761988635320268,1.0,3/12,17.65%,C2CD2L;GPLD1;ADCY8
prerank,response to glucose (GO:0009749),0.23188416212147633,0.6375994752655546,0.9373368146214099,0.9698301558218713,1.0,8/46,16.87%,ERN1;ZBTB20;SELENOT;PRKAA1;PDK3;PRKAA2;THBS1;GCK
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.27283547487672233,0.6371706987393077,0.8961661341853036,0.969770133917223,1.0,2/16,7.22%,PRDX6;NUP98
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2324952046162507,0.6341587256158899,0.9362279511533242,0.971685858073754,1.0,8/41,18.18%,NUP210;PRKAG2;NUP98;PRKAG1;NUP153;SEH1L;GCK;NUP93
prerank,intermediate filament organization (GO:0045109),0.2796638570329148,0.6339851174053026,0.8829953198127926,0.971419909261779,1.0,1/17,2.40%,VIM
prerank,regulation of phosphate metabolic process (GO:0019220),0.2794264887999289,0.6335931583282453,0.9028662420382165,0.9713180436808295,1.0,4/16,18.20%,IKBKB;SMG6;PSEN1;RAD17
prerank,cell cycle checkpoint signaling (GO:0000075),-0.2594147192006008,-0.6335323131165264,0.9158163265306123,0.9782250759818762,1.0,5/12,25.20%,NABP2;ZW10;BUB1B;BUB1;PLK2
prerank,regulation of centrosome cycle (GO:0046605),-0.21736012623968107,-0.6333626751761979,0.9461756373937678,0.9774884490206565,1.0,8/21,25.08%,VPS4B;CHMP5;NPM1;CHMP1B;ATF5;CHMP2A;NAT10;GEN1
prerank,primary neural tube formation (GO:0014020),0.24681070251348342,0.6331790095095089,0.9222065063649222,0.9712316298584706,1.0,6/30,15.54%,CELSR1;DLC1;DEAF1;VASP;TGFB1;DVL2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.2404962402534488,0.6330040369716998,0.920114122681883,0.9705789227917725,1.0,3/29,11.97%,ACOT11;ACOT2;ACAT1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.2404962402534488,0.6330040369716998,0.920114122681883,0.9705789227917725,1.0,3/29,11.97%,ACOT11;ACOT2;ACAT1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.21105663986502837,-0.6328937773567925,0.9546827794561934,0.9769204565037204,1.0,8/25,27.57%,PRPSAP1;GMPR;AMPD2;HPRT1;SHMT2;MTHFD1;PRPSAP2;ADK
prerank,amide transport (GO:0042886),0.24902179381727962,0.6315373908613461,0.9148311306901615,0.9712745618028544,1.0,2/26,6.24%,SLC14A1;TAP1
prerank,smooth muscle contraction (GO:0006939),0.2832595496004119,0.6301848126014091,0.912828947368421,0.9718824177135378,1.0,3/14,14.68%,PIK3C2A;ROCK1;EDNRA
prerank,regulation of peptidase activity (GO:0052547),0.26866761662460265,0.6297254700229462,0.906396255850234,0.9718165350313535,1.0,6/19,19.50%,MAPK12;PSMB8;SVBP;HDAC1;PINK1;ECM1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.25702892207186645,0.6290066627562437,0.9161392405063291,0.971958487951157,1.0,4/22,15.01%,IL6;TGFB1;IL18;MYD88
prerank,stabilization of membrane potential (GO:0030322),0.279474901137479,0.6289648070732138,0.8858954041204438,0.9715953980600613,1.0,2/16,8.10%,KCNK7;KCNN4
prerank,regulation of synapse maturation (GO:0090128),-0.2630431348069675,-0.628455372199386,0.923963133640553,0.9788474719633988,1.0,3/10,18.98%,ADGRL1;DAB2IP;NRXN1
prerank,regulation of receptor binding (GO:1900120),0.308040609387987,0.6277035006188176,0.8773234200743495,0.9721533591997158,1.0,2/10,10.86%,ATP2A3;B2M
prerank,tube closure (GO:0060606),0.2437510901883918,0.6269403437420932,0.9358059914407989,0.9723179723836565,1.0,6/31,15.54%,CELSR1;DLC1;DEAF1;VASP;TGFB1;DVL2
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.2965287803653255,0.6259676679764349,0.8951747088186356,0.9726290739128395,1.0,11/11,70.37%,ABCG1;MPO;APOB;PLA2G7;AGT;AGTR1;APOA2;PLA2G10;PLA2G5;LIPC;PLA2G3
prerank,glycine transport (GO:0015816),-0.26935960125762765,-0.625241978061453,0.9148418491484185,0.9799463830303955,1.0,2/10,11.80%,SLC36A1;SLC7A8
prerank,rRNA pseudouridine synthesis (GO:0031118),0.29929755554620896,0.6251100320231506,0.893048128342246,0.9728473154733984,1.0,2/10,15.80%,NHP2;TSR3
prerank,telomere maintenance via telomerase (GO:0007004),0.2441448028864851,0.6246521485571079,0.9243085880640466,0.9727768016500103,1.0,10/28,25.32%,MRE11;NHP2;WRAP53;SHQ1;TNKS1BP1;TERF2;TELO2;RFC1;ANKRD28;RPA1
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.2544156718861977,-0.624390343941522,0.9175,0.9795991199284715,1.0,7/11,46.00%,DGKQ;WNT4;BMP5;STAR;BMP2;NR1H4;FGFR4
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.23244628418682997,0.6240944595983622,0.9487870619946092,0.9727835899317507,1.0,12/37,22.46%,BBC3;RPS3;FIS1;DNM1L;BECN1;BAD;BCLAF1;NCK1;RPS7;BID;BCL2;SIAH1
prerank,epidermis development (GO:0008544),0.2155888300397777,0.6229391325187427,0.961340206185567,0.9732299284786886,1.0,1/56,0.98%,GLI1
prerank,membrane depolarization (GO:0051899),0.2331332037548344,0.6225110037802011,0.9298737727910238,0.9731432657972099,1.0,2/32,3.56%,CACNA1A;CHRNA4
prerank,positive regulation of protein depolymerization (GO:1901881),0.2989795168269771,0.6220783431028025,0.9006968641114983,0.9730594859585412,1.0,2/11,15.29%,KATNB1;STMN2
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.24522761082756672,-0.6218474330990683,0.9419889502762431,0.9802267567764258,1.0,6/14,34.21%,AK3;AK1;NMNAT2;CMPK2;AK4;NME2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.20324628947938073,-0.6217616824615275,0.9576547231270358,0.9794238203790352,1.0,12/27,34.21%,AK2;AK6;RRM1;DTYMK;GLRX;DCTD;AK1;DUT;GUK1;AK4;RRM2B;NME2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.25258501939613465,0.6208318069195361,0.9104704097116844,0.9731033213169313,1.0,9/23,24.95%,BBC3;YWHAZ;MAPK8;BAD;BID;BCL2;YWHAQ;TP53;PPP3CC
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.25258501939613465,0.6208318069195361,0.9104704097116844,0.9731033213169313,1.0,9/23,24.95%,BBC3;YWHAZ;MAPK8;BAD;BID;BCL2;YWHAQ;TP53;PPP3CC
prerank,regulation of tau-protein kinase activity (GO:1902947),0.30020981917298023,0.6208041311931817,0.8982758620689655,0.9727222632261865,1.0,1/10,3.49%,SORL1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.28709478632721996,0.6199422045716898,0.9246935201401051,0.9729260346833841,1.0,3/12,19.55%,TRIM16;EZH2;KLF2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2473439944985756,0.6192886502659416,0.9275808936825886,0.9729989092250687,1.0,6/24,18.60%,KATNB1;TPPP3;KIF24;STMN3;STMN2;PIN1
prerank,negative regulation of transferase activity (GO:0051348),0.24286825882457186,0.6192590577934906,0.9425981873111783,0.9726275737374309,1.0,4/28,13.30%,DTX3L;CERS1;EIF4A2;ERCC4
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.2147378479456908,-0.6180468358518517,0.96,0.9807085676601378,1.0,4/23,10.78%,PLK3;ZFYVE19;NABP2;ZW10
prerank,nuclear body organization (GO:0030575),0.29078063850416963,0.6173071712637465,0.91,0.9736100921162455,1.0,3/12,13.07%,HIPK2;WRAP53;ZPR1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.2916860950101227,0.6172445757026946,0.8981324278438031,0.9732640433315516,1.0,3/12,15.02%,FUT4;AKT1;ASS1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2382161956715878,0.616564054347943,0.942008486562942,0.9733530798002292,1.0,7/32,17.11%,TAF1A;POLR1G;CCNH;ERCC3;POLR1B;TAF1;TAF1C
prerank,negative regulation of neuron differentiation (GO:0045665),-0.21305519666079958,-0.6155929117786942,0.9663608562691132,0.9811795336501298,1.0,2/22,5.09%,CNTN4;EIF2AK4
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.21459419190485543,0.614554935878366,0.9735799207397622,0.9742808917152842,1.0,15/51,21.50%,PKIB;DCP2;FBXO4;TNKS;MAP3K4;AURKB;TENT4B;MAPK1;STN1;TCP1;SMG6;TERF2;HNRNPC;PARN;CCT7
prerank,ubiquinone biosynthetic process (GO:0006744),0.2725821027257954,0.6138456963710641,0.8992,0.9743498449597208,1.0,5/15,20.88%,COQ2;COQ8A;NDUFA9;PDSS1;COQ10A
prerank,negative regulation of vascular permeability (GO:0043116),-0.2502004047561365,-0.6135427972634362,0.9502617801047121,0.9814240100822973,1.0,4/12,18.20%,SH3GL2;SLIT2;VEGFA;ANGPT1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.2925749312930535,0.6125480496692969,0.9114139693356048,0.9747938409515656,1.0,1/10,2.99%,DHX58
prerank,male meiosis I (GO:0007141),-0.23157725086771147,-0.6121462534481658,0.9476584022038568,0.9813062466354361,1.0,9/16,51.64%,FOXJ2;ZSCAN21;DDX4;SYCP3;HSF2BP;FOXJ3;SLC25A31;TDRD9;MOV10L1
prerank,glycogen metabolic process (GO:0005977),0.23776044101374996,0.6116590051855464,0.937950937950938,0.9750060359341947,1.0,8/27,22.03%,PRKAG2;UGP2;PGM1;PGM2L1;PHKA2;PYGL;PHKG1;GSK3B
prerank,methylguanosine-cap decapping (GO:0110156),0.2967242812110429,0.61137318107465,0.9142367066895368,0.9748077018743236,1.0,2/10,10.91%,DCP2;DCP1A
prerank,cAMP metabolic process (GO:0046058),0.27784941768603755,0.6108701670138852,0.9147826086956522,0.9747489210946222,1.0,3/13,12.41%,ADCY10;ADCY7;ADCY5
prerank,peptidyl-lysine monomethylation (GO:0018026),0.28717068199657975,0.610195523928846,0.9049295774647887,0.9747800186090113,1.0,2/10,10.71%,SETD7;SETD2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.27768285798594783,0.6092724508262242,0.9081632653061225,0.9749711259022408,1.0,2/13,8.34%,ELOVL5;ELOVL6
prerank,regulation of spindle organization (GO:0090224),-0.2223388646736929,-0.6090557032938179,0.9411764705882353,0.9820330723435856,1.0,10/18,38.72%,NUMA1;MAP9;TACC3;PARP3;TPX2;RNF4;FSD1;RAE1;BORA;NUP62
prerank,regulation of transferase activity (GO:0051338),0.2602814226206578,0.6080755106293727,0.931637519872814,0.9753455872365049,1.0,4/17,16.15%,PARP4;SLAMF8;SPTSSB;SMG6
prerank,vitamin transport (GO:0051180),0.23282796557390534,0.6054894389656302,0.9446022727272727,0.9765184827474552,1.0,1/29,2.23%,SLC23A1
prerank,nuclear membrane organization (GO:0071763),0.2489062503662121,0.6054313010253748,0.9251908396946565,0.9761625687974657,1.0,3/19,12.11%,CHMP4B;SPAST;TOR1AIP1
prerank,response to progesterone (GO:0032570),0.25819619372924985,0.6053320143552434,0.9244992295839753,0.9758328392558875,1.0,5/18,20.10%,CATSPER3;ACOD1;TGFB1;THBS1;ABHD2
prerank,neural tube development (GO:0021915),-0.23578713947713495,-0.6048004276814654,0.9564102564102565,0.9832873488961181,1.0,7/15,33.25%,PKD2;SOX4;SOX11;PTCH1;ALDH1A2;DACT1;STIL
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.23109172525598398,-0.6042223106115615,0.9532019704433498,0.9827298210281257,1.0,7/16,24.93%,TERF1;TNKS2;HNRNPA2B1;SLX4;TINF2;PINX1;NAF1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.25189043363575964,-0.6023452737249579,0.9441747572815534,0.982800334743758,1.0,2/12,14.09%,TMEM119;BHLHE41
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.2521697783526519,0.5995026763319786,0.9292452830188679,0.9789211001486219,1.0,6/18,24.87%,IL6;RIPK1;TGFB1;MAP2K1;TNF;TP53
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.24052739963197245,-0.5981883735856708,0.9484777517564403,0.9839480327166054,1.0,5/13,30.07%,QDPR;CALM1;FPGS;HSP90AA1;SPR
prerank,mesenchyme morphogenesis (GO:0072132),-0.22064115616735436,-0.5961575676591478,0.9463806970509383,0.9840599817866087,1.0,10/17,48.00%,ACVR1;TGFB2;MDM4;BMP2;ACVRL1;HEY1;TBX2;HEYL;NOG;ISL1
prerank,regulation of mitotic spindle organization (GO:0060236),0.22582994468047218,0.5957898580558671,0.9758522727272727,0.9806432913610849,1.0,5/35,12.26%,HSPA1A;CHMP4B;PDCD6IP;DYNC1H1;GNAI1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.27467011488827786,0.5953884250255608,0.9224555735056543,0.9804769247330957,1.0,2/13,9.68%,NRROS;FBN1
prerank,secretion (GO:0046903),-0.23009322714894956,-0.5951379383341272,0.95,0.9836896077182918,1.0,9/14,50.07%,SLC22A4;RIMS1;GUCA1B;PRKCI;NPR1;FBLN5;DRD3;VIP;ABCB11
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.22057923376575422,-0.5949169182072405,0.9621621621621622,0.982940570687925,1.0,5/17,29.99%,COX7C;COX10;COX5B;COX6A1;COX6C
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2749747462021187,0.5939235190229342,0.9109947643979057,0.9809185479860766,1.0,6/12,23.83%,HUS1;RAD17;CHEK2;SETMAR;STK33;ORC1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.20846540680908937,-0.5933561256529535,0.9757412398921833,0.9827461009288545,1.0,7/20,30.64%,ADSS2;AK3;AMPD2;ATIC;HPRT1;ADSS1;AK4
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.2785431370806279,0.5917839650772361,0.9354304635761589,0.9816735662771192,1.0,4/13,19.94%,RPS21;UTP20;TBL3;NOP9
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.22918845609169586,0.5917132423703975,0.9462989840348331,0.981314600234283,1.0,7/31,20.43%,DCP2;CNOT6;LSM5;DCP1A;CNOT8;DDX6;EDC3
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.20200483137122116,-0.5907349004305599,0.9637462235649547,0.9830675156931771,1.0,2/22,6.09%,DDX5;RPS20
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.2672823521376378,0.5902814222675115,0.9254237288135593,0.9816985405678279,1.0,1/12,6.34%,GSS
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.2458645013743267,0.5897559606642633,0.941358024691358,0.9815825261381889,1.0,6/20,19.82%,SEMA4A;SEMA4D;SEMA3A;SEMA3C;SEMA6A;SEMA4F
prerank,regulation of biosynthetic process (GO:0009889),0.28026901172290736,0.5894891358018267,0.9101899827288429,0.9813252659276177,1.0,2/11,14.84%,PIKFYVE;GSTP1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.17895234263119544,-0.5891358068116597,0.9929328621908127,0.9829304083610408,1.0,15/35,35.07%,ADCY9;ADORA3;ADCY3;ADRB1;LGR4;ADCY8;ADCY1;GIPR;RXFP1;RAF1;ADCY6;TMIGD3;CRHR1;ADCY2;TSHR
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.21353355075314012,0.5885294097198397,0.9721485411140584,0.981469832918152,1.0,12/46,18.87%,GRPEL2;DNAJC19;TIMM21;TOMM40;FIS1;AIFM1;AKT1;TIMM50;FBXO7;AIP;HSPD1;PINK1
prerank,intraciliary retrograde transport (GO:0035721),0.27592290298495037,0.5866989362161443,0.9304347826086956,0.9820280440028982,1.0,2/12,15.05%,IFT140;DYNLT2B
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2202820346970639,-0.5864226382795014,0.9558441558441558,0.9832113265384973,1.0,5/16,29.41%,ADSS2;AMPD2;ATIC;NUDT2;ADSS1
prerank,ubiquinone metabolic process (GO:0006743),0.2579637027958821,0.5857072710769411,0.9240710823909531,0.9821698362356323,1.0,5/15,20.88%,COQ2;COQ8A;AIFM2;PDSS1;COQ10A
prerank,lung development (GO:0030324),0.22245100254369501,0.5839461796261552,0.9667149059334298,0.9826567668179734,1.0,5/33,16.74%,FOXJ1;ABCA3;CCDC39;ITGA3;PROX1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.1942748175008077,-0.5836036881680716,0.9824046920821115,0.983535841843659,1.0,6/25,19.91%,FAM162A;PYCARD;MFF;BAX;PDCD5;TNFSF10
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.1894505930131299,-0.5833695203185558,0.9863013698630136,0.9827821355143215,1.0,19/31,55.26%,NFS1;CYP51A1;LSS;DHRS11;PYCR3;NOXRED1;STAR;HSD17B1;MOCS3;GPHN;PRLR;SRD5A1;SRD5A2;PYCR1;HSD3B2;ALOX5;HDC;HSD17B3;CYP19A1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.201154965336744,0.5831818317503592,0.9873417721518988,0.9826294028262881,1.0,5/64,8.34%,GPX1;ACSL5;ELOVL5;ACOT2;ELOVL6
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2322573504969808,0.5809610347884524,0.9537037037037037,0.9833486513146233,1.0,3/23,12.90%,CAMKMT;NMT2;PDE6B
prerank,mitotic chromosome condensation (GO:0007076),0.2263298394078361,0.5791089485392305,0.9503012048192772,0.9838681835889866,1.0,6/26,17.73%,SMC4;CSNK2A2;CSNK2A1;RB1;MCPH1;PHF13
prerank,glutathione biosynthetic process (GO:0006750),0.26728633194966694,0.5772783637545542,0.9327586206896552,0.9843675146819829,1.0,1/11,6.34%,GSS
prerank,male gonad development (GO:0008584),0.21642571845570135,0.5761128329184947,0.9746121297602257,0.9845266309759331,1.0,3/34,13.21%,ADAM21;ING2;KIT
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2771742154582276,0.5761059521152084,0.9401408450704225,0.9841383326100087,1.0,3/11,15.54%,ZC3H3;PAPOLA;NCBP1
prerank,sensory perception of smell (GO:0007608),0.2643227238395281,0.572167586128227,0.934931506849315,0.9855694317185527,1.0,2/11,16.39%,SLC24A4;UBR3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.19752544472010491,0.5711560239314547,0.9924717691342535,0.9856583388107562,1.0,7/63,10.54%,BTG2;WAC;CCND1;CNOT6;PIDD1;CNOT2;CASP2
prerank,megakaryocyte differentiation (GO:0030219),-0.23559324882956778,-0.5664867567898446,0.9498806682577565,0.9881977266991558,1.0,1/11,4.95%,TAL1
prerank,nucleotide biosynthetic process (GO:0009165),-0.20760436293333298,-0.5658179171073601,0.9685714285714285,0.9875904671836145,1.0,6/18,27.22%,PRPSAP1;RRM1;HPRT1;NMNAT2;MTHFD1;PRPSAP2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.23781813306830124,0.5655825195736138,0.9467275494672754,0.987263184679578,1.0,3/19,12.77%,POLR2C;DAXX;ATRX
prerank,regulation of DNA recombination at telomere (GO:0072695),0.23781813306830124,0.5655825195736138,0.9467275494672754,0.987263184679578,1.0,3/19,12.77%,POLR2C;DAXX;ATRX
prerank,ribosomal small subunit assembly (GO:0000028),-0.21430627637810185,-0.5640862770055735,0.9659090909090909,0.9873322110209511,1.0,7/16,32.60%,XRCC5;RRP7A;MRPS7;MRPS11;RPS28;RPS27L;PRKDC
prerank,quinone biosynthetic process (GO:1901663),0.25183320964004496,0.5626369856276874,0.9433656957928802,0.9881445699446694,1.0,2/14,8.27%,COQ2;COQ8A
prerank,ribosomal small subunit biogenesis (GO:0042274),0.2070771652677358,0.5616430439207286,0.9888734353268428,0.9881467083756514,1.0,12/39,23.62%,RPS14;RIOK1;NOL11;RRP36;TSR3;RPSA;RPS6;DDX52;RPS27;RPS7;RPS25;RPS16
prerank,positive regulation of mRNA processing (GO:0050685),0.22870456058145056,0.5604714707507549,0.9613601236476044,0.9882328399196962,1.0,2/21,7.22%,PRDX6;NUP98
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.24093431255633596,0.5601675192609401,0.9716535433070866,0.9879625594702778,1.0,4/18,16.22%,TIMM21;COA5;COX17;COX16
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.21492130782391217,-0.558059848642447,0.9720812182741116,0.9884702528502919,1.0,7/15,28.74%,TNFRSF1A;SPHK2;ORMDL3;RACK1;ORMDL1;SMPD3;SMPD2
prerank,spermatid development (GO:0007286),-0.1744242943949777,-0.5578304975500862,0.989247311827957,0.9877060976454611,1.0,10/32,33.72%,CEP57;JAM2;NECTIN2;RNF8;IQCG;TDRD5;ZMYND15;NME5;MKKS;SYCP3
prerank,lipid modification (GO:0030258),0.20598072552911773,0.5575822263052426,0.9852348993288591,0.9886086114326829,1.0,1/37,1.05%,DGKG
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.2638234780319787,0.5555536339265971,0.9512605042016806,0.9890552456538543,1.0,3/11,17.51%,ELOF1;ZMIZ2;PADI2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.2413101323597291,0.5552839410344236,0.9425837320574163,0.9887719679529807,1.0,7/18,23.07%,DCP2;NHP2;TCP1;SHQ1;PARN;CCT7;CCT4
prerank,protein localization to kinetochore (GO:0034501),0.2437120608000893,0.5548101295534695,0.9488448844884488,0.9885609362200025,1.0,3/14,14.78%,RCC2;MTBP;AURKB
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.26565911202969256,0.5540729397041612,0.9471766848816029,0.9884531437851313,1.0,1/10,6.86%,SVIP
prerank,response to UV-B (GO:0010224),0.2563631810160707,0.5535294304831969,0.9599332220367279,0.9882821232922366,1.0,3/12,20.50%,CRIP1;RELA;STK11
prerank,modified amino acid transport (GO:0072337),-0.21387596278205415,-0.5534359584575538,0.9673024523160763,0.9882078610653534,1.0,6/15,33.90%,SLC6A8;MGST1;PDPN;SLC46A1;SLC5A6;SLC16A12
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.19016175915392908,0.550952954979395,0.9896907216494846,0.9888655870970532,1.0,16/55,22.74%,BBC3;PAK2;RPS3;CYLD;FIS1;RIPK1;DEDD2;DNM1L;TRAF2;BECN1;BAD;BCLAF1;BID;BCL2;SIAH1;TNF
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.2195330414737124,-0.5493812594717716,0.9708222811671088,0.9885482545722141,1.0,3/14,14.05%,WDR12;PES1;FTSJ3
prerank,regulation of DNA damage checkpoint (GO:2000001),0.260344421268086,0.5493548229600836,0.956140350877193,0.9890485773524164,1.0,1/10,4.15%,CRY1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.24782407177344234,0.5486564481357993,0.9574829931972789,0.9889120893537362,1.0,3/12,14.84%,TAF7;TGFB1;GSTP1
prerank,cellular response to superoxide (GO:0071451),0.2632639153499709,0.5462840493195004,0.9614035087719298,0.9893619047076845,1.0,1/10,7.66%,ATP7A
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.22922743707293597,0.5449201457267422,0.9672897196261683,0.989432234784455,1.0,5/19,23.22%,POLL;DCK;POLD1;GMPR2;TYMS
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.20054965298415436,0.5439248858823202,0.9862637362637363,0.9894052141231118,1.0,10/38,22.21%,PTEN;CIB1;PHLPP1;AKT1;PTPRJ;PPP2R5C;SIRT1;MUL1;XDH;PPP2R5B
prerank,lipid biosynthetic process (GO:0008610),0.18187849425727956,0.5414013901880468,0.998780487804878,0.9898829309460427,1.0,12/77,20.75%,AGPAT4;AGPS;ACSL5;PRKAA1;PIP5K1A;PRKAA2;GNPAT;MVD;MVK;ACSS2;ACSL1;PDSS1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.24066241049905032,0.5403455707213186,0.9624796084828712,0.9898632021320656,1.0,1/13,3.64%,GLRX5
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.25121108606291,0.5393608660621206,0.9478260869565217,0.9897956824541461,1.0,2/12,11.35%,PTEN;UBE2S
prerank,positive regulation of transporter activity (GO:0032411),-0.21028466080184,-0.5383249623787046,0.9641025641025641,0.9906599999313294,1.0,7/13,42.32%,SGK1;WNK3;NR1H3;KCTD7;SGK2;TRPC6;PDZK1
prerank,interstrand cross-link repair (GO:0036297),0.1892846453698899,0.5377025367602224,0.9974059662775616,0.989928767125434,1.0,12/53,20.42%,MSH6;FANCC;FANCL;RPA3;FANCI;ERCC4;FANCA;VCP;MCM9;FANCG;RNF168;XPA
prerank,isotype switching (GO:0045190),0.2629001050735743,0.5349922246684181,0.9493006993006993,0.9904200127644411,1.0,4/10,23.08%,MSH6;HSPD1;RNF168;BATF
prerank,homologous chromosome segregation (GO:0045143),-0.18936426627608746,-0.5337138868734284,0.9815789473684211,0.9909754603453441,1.0,5/20,26.52%,FMN2;ZCWPW1;FANCD2;MEI4;TERB1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.20827792279078738,-0.530841267528945,0.9796437659033079,0.9907972098182617,1.0,5/14,29.41%,ADSS2;ATIC;RFK;ADK;ADSS1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.22631113165270003,-0.5298167917547679,0.9655172413793104,0.9901957947787146,1.0,7/10,42.04%,CPEB1;CPEB3;LEO1;CDC73;NCBP2;HSF1;PAF1
prerank,neural crest cell development (GO:0014032),0.19015616708084224,0.5259499541591811,0.989041095890411,0.9926584423216582,1.0,10/44,19.95%,SEMA4A;GDNF;TAPT1;KLHL12;SEMA4D;SEMA3A;SEMA3C;SEMA6A;SEMA4F;ANXA6
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.20404600581385268,0.5256697672888806,0.9840348330914369,0.9923407098879061,1.0,3/29,9.15%,MRE11;NHP2;WRAP53
prerank,regulation of transposition (GO:0010528),0.23836756990139246,0.5253511052933452,0.9579124579124579,0.9920416083542091,1.0,1/13,7.94%,UBR2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.20204899679118604,0.525246660480519,0.9770773638968482,0.9916813656962179,1.0,11/31,25.98%,BBC3;YWHAZ;MAPK8;BAD;BID;BCL2;GSK3B;YWHAQ;TP53;PPP3CC;BAK1
prerank,lysine metabolic process (GO:0006553),0.2360720692839709,0.5188857193440173,0.9633507853403142,0.9926066492890829,1.0,2/12,12.51%,DLD;OGDH
prerank,lysine catabolic process (GO:0006554),0.2360720692839709,0.5188857193440173,0.9633507853403142,0.9926066492890829,1.0,2/12,12.51%,DLD;OGDH
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.231739846800531,0.5163795459564176,0.975609756097561,0.9928674582688811,1.0,3/14,19.40%,ACOX3;ABCD1;CRAT
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.1938683725219173,0.5117905133966253,0.9871060171919771,0.9936339145687728,1.0,8/33,21.13%,MRE11;NHP2;WRAP53;STN1;SHQ1;TNKS1BP1;TERF2;TELO2
prerank,respiratory tube development (GO:0030323),0.20038932757498995,0.5117208699508864,0.982274741506647,0.9932581472751183,1.0,5/28,16.74%,ABCA3;CCDC39;PCSK5;ITGA3;PROX1
prerank,glycoprotein catabolic process (GO:0006516),0.21908948194662464,0.5111333326281484,0.9741935483870968,0.9930035783582453,1.0,17/17,78.11%,ADAMTS12;STT3B;NGLY1;EDEM2;MANBA;NEU2;EDEM1;OGA;FBXO27;MMP12;NEU4;CTSL;ADAMTS9;FBXO2;FBXO6;FBXO17;FBXO44
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.20825537058777985,-0.5073883852470363,0.979539641943734,0.9938487015971484,1.0,4/12,23.26%,HNMT;ODC1;DDC;MAOA
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.184888422377275,0.5064506928662381,0.9931972789115646,0.9937355520723828,1.0,3/44,9.59%,PRKAG2;CYP27A1;MSMO1
prerank,negative regulation of telomere maintenance (GO:0032205),0.22195148809095763,0.5044383734927691,0.9720767888307156,0.9938110766957284,1.0,5/15,21.77%,TNKS;ERCC4;SMG6;TERF2;PARP1
prerank,non-motile cilium assembly (GO:1905515),0.18995348389751288,0.49960543869264246,0.9900142653352354,0.994449836514135,1.0,4/30,17.47%,TBC1D32;CEP250;DISC1;BBS10
prerank,'de novo' posttranslational protein folding (GO:0051084),0.19217318727544028,0.49877589500656544,0.9941262848751835,0.9942236259694623,1.0,8/30,22.72%,HSPA1A;DNAJB12;HSPA9;HSPA5;DNAJB14;DNAJB4;SDF2;HSPA8
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.20944349938213386,0.49433551189353786,0.9857142857142858,0.9947239303206143,1.0,5/18,19.97%,IL6;CLASP1;TGFB1;RB1;RUNX1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.20686124584071147,0.49232554471917434,0.9810725552050473,0.9947573167609447,1.0,5/18,21.33%,HDAC3;FRS2;HDAC1;FZD7;HDAC5
prerank,gas transport (GO:0015669),-0.2124920395180915,-0.49071301456015337,0.9840182648401826,0.9956583972416245,1.0,2/10,26.33%,CA2;MYC
prerank,steroid biosynthetic process (GO:0006694),0.1735343846657849,0.4901952377379133,0.9986945169712794,0.9947537273972424,1.0,3/56,9.59%,PRKAG2;CYP27A1;MSMO1
prerank,regulation of ERAD pathway (GO:1904292),-0.20733785040201708,-0.482602318318471,0.9798206278026906,0.9959051673460995,1.0,2/11,15.05%,USP19;HERPUD1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.1731435366483641,0.4805579055483747,0.9972936400541272,0.9960829200149763,1.0,6/47,14.99%,EIF2AK2;TAOK3;PHLPP1;KLHDC10;GSTP1;MAPK1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.1962020682551076,0.4768185764479367,0.9823434991974318,0.9962952879910784,1.0,3/21,14.72%,PDE2A;ACAT1;NT5C2
prerank,positive regulation of insulin secretion (GO:0032024),0.17833038823779823,0.4743150724186401,0.9972222222222222,0.9962930445052213,1.0,11/36,25.13%,TM7SF3;PSMD9;GLUD1;PLA2G6;GCK;BAD;CFTR;TRPM4;MCU;RBP4;NNAT
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2116750777347559,0.47290128175957535,0.991304347826087,0.9961191579852398,1.0,4/13,22.02%,VDAC2;BAD;BNIP3L;RHOT1
prerank,regulation of cilium movement (GO:0003352),0.22426562892292257,0.4720826611689434,0.9753954305799648,0.9958448672814743,1.0,10/10,77.59%,CCDC39;CFAP43;CCDC65;DNAAF1;DRC1;CFAP206;CCDC40;ODAD2;CFAP298;DNAH11
prerank,negative regulation of myoblast differentiation (GO:0045662),0.20647874945068742,0.46366774276528355,0.9901800327332242,0.9966138248994557,1.0,13/13,79.37%,TGFB1;TBX3;MSTN;SOSTDC1;SOX9;NOTCH1;ANKRD2;DLL1;SOX8;PRICKLE1;BMP4;EID2B;SRA1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.21689718040561357,0.46296669865933787,0.9863481228668942,0.9963197732285223,1.0,3/12,16.71%,ADSL;GMPS;LHPP
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.19411105643392065,-0.4492387427082726,0.995085995085995,0.9984271210575084,1.0,1/10,9.23%,DGKQ
prerank,retinol metabolic process (GO:0042572),-0.17557385664278985,-0.4428600441418063,0.9951690821256038,0.9980731211309649,1.0,6/14,46.00%,DHRS3;RDH11;RETSAT;CYP1A1;CYP1B1;RDH12
prerank,mesonephros development (GO:0001823),0.21015629903960825,0.4421243665473383,0.9800664451827242,0.998225936685462,1.0,11/11,79.00%,ZBTB16;FGF1;GATA3;PAX8;OSR2;FGF8;PAX2;BMP7;BMP4;OSR1;FGF10
prerank,axonal transport of mitochondrion (GO:0019896),0.20841570145889401,0.4408004388454822,0.9913941480206541,0.9979624923404519,1.0,3/11,21.54%,SPAST;TRAK1;TRAK2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.1944923188565595,0.42838404228454857,0.9948542024013722,0.9986283078440606,1.0,3/14,20.84%,SPRED3;SPRED1;XDH
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.18018208924301765,0.41641123534708047,0.9935379644588045,0.9990720817435568,1.0,4/17,20.10%,NR3C1;ACOD1;MED1;ABHD2
prerank,heterocycle biosynthetic process (GO:0018130),-0.1627950778503265,-0.4160250152203059,1.0,0.998696859354439,1.0,14/14,83.74%,NFS1;PYCR3;NOXRED1;MOCS3;GPHN;PYCR1;ALOX5;HDC;MOCOS;LIAS;GCH1;MOCS2;MOCS1;PYCR2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.1904282694891124,0.4142380819238233,0.9948717948717949,0.9988113255645913,1.0,3/12,20.84%,ADAMTS12;SEMA6A;XDH
prerank,mesenchymal cell development (GO:0014031),0.1696809846772167,0.40592162236700563,0.9984,0.9989141434174298,1.0,18/18,83.05%,TAPT1;KLHL12;FOXC1;TBX20;NOTCH1;NRG1;PEF1;SNAI2;HEYL;CYP26C1;SOX8;PDCD6;HEY2;NOLC1;CDH2;KBTBD8;TCOF1;SOX11
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.19198277137954617,0.3944092645282453,0.9982847341337907,0.9990540165998715,1.0,2/10,15.66%,ATRX;INO80
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.14282540300537822,0.3731866646149208,1.0,0.9993264108058865,1.0,4/29,20.57%,IHO1;STAG3;RAD21;PRDM9
